PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Macilwain, C				Macilwain, C			Stanford accelerator takes lead in race to quantify CP violation	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					586	587		10.1038/35001220	http://dx.doi.org/10.1038/35001220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688170	Bronze			2022-12-28	WOS:000085288200012
J	Gottlieb, S				Gottlieb, S			Cannabinoids might reduce spasticity in multiple sclerosis	BRITISH MEDICAL JOURNAL			English	News Item																		Baker D, 2000, NATURE, V404, P84, DOI 10.1038/35003583	1	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					666	666		10.1136/bmj.320.7236.666	http://dx.doi.org/10.1136/bmj.320.7236.666			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710561	Green Published			2022-12-28	WOS:000085895300007
J	Macilwain, C				Macilwain, C			Charm, not tact, aided pioneer in fight for physics	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					586	587		10.1038/35001220	http://dx.doi.org/10.1038/35001220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688170	Bronze			2022-12-28	WOS:000085288200013
J	Gottlieb, S				Gottlieb, S			Doctors fail to follow advice in giving tPA	BRITISH MEDICAL JOURNAL			English	News Item																		Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151	2	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					666	666		10.1136/bmj.320.7236.666	http://dx.doi.org/10.1136/bmj.320.7236.666			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710561	Green Published			2022-12-28	WOS:000085895300006
J	Montgomery, AA; Fahey, T; Peters, TJ; MacIntosh, C; Sharp, DJ				Montgomery, AA; Fahey, T; Peters, TJ; MacIntosh, C; Sharp, DJ			Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							GUIDELINES	Objectives To investigate the effect of a computer based clinical decision support system and a risk chart on absolute cardiovascular risk, blood pressure, and prescribing of cardiovascular drugs in hypertensive patients. Design Cluster randomised controlled trial. Setting 27 general practices in Avon. Participants 614 patients aged between 60 and 79 years with high blood pressure. Interventions patients were randomised to computer based clinical decision support system plus cardiovascular risk chart; cardiovascular risk chart alone; or usual care. Main outcome measures Percentage of patients in each group wit a five year cardiovascular risk greater than or equal to 10%, systolic blood pressure, diastolic blood pressure, prescribing of cardiovascular drugs. Results Patients in the computer based clinical decision support system and chart only groups were no more likely to have cardiovascular risk reduced to below 10% than patients receiving usual care. Patients in the computer based clinical decision support group were more likely to have a cardiovascular risk greater than or equal to 10% than chart only patients, odds ratio 2.3 (95% confidence interval 1.1 to 4.8). The chart only group, had significantly lower systolic blood pressure compared with the usual care group (difference in means - 4.6 mm Hg (95% confidence interval - 8.4 to - 0.8)). Reduction of diastolic blood pressure did not differ between the three groups. The chart only group were twice as likely to be prescribed two classes of cardiovascular drugs and over three times as likely to be prescribed three or more classes of drugs compared with the other groups. Conclusions The computer based clinical decision support system did not confer any benefit in absolute risk reduction or blood pressure control and requires further development and evaluation before use in clinical care can be recommended. Use of chart guidelines are associated with potentially important reduction in systolic blood pressure.	Univ Bristol, Div Primary Hlth Care, Bristol BS8 2PR, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol; University of Bristol	Fahey, T (corresponding author), Univ Bristol, Div Primary Hlth Care, Bristol BS8 2PR, Avon, England.		Fahey, Tom/C-9367-2012	Fahey, Tom/0000-0002-5896-5783; Montgomery, Alan/0000-0003-0450-1606; Peters, Tim/0000-0003-2881-4180				Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Chatellier G, 1995, Medinfo, V8 Pt 2, P876; COLLINS R, 1994, TXB HYPERTENSION, P1156; *COR SERV COMM, 1994, GUID MAN MILDL RAIS; DONNER A, 1981, AM J EPIDEMIOL, V114, P906, DOI 10.1093/oxfordjournals.aje.a113261; Ebrahim S, 1998, HEALTH TECHNOL ASSES, V2, pi; Fahey TP, 1996, BMJ-BRIT MED J, V313, P93, DOI 10.1136/bmj.313.7049.93; Fahey TP, 1996, BRIT J GEN PRACT, V46, P655; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; GROVER SA, 1995, BRIT MED J, V310, P975, DOI 10.1136/bmj.310.6985.975; Haynes B, 1998, BMJ-BRIT MED J, V317, P273, DOI 10.1136/bmj.317.7153.273; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Jackson RT, 1996, BRIT MED J, V313, P64, DOI 10.1136/bmj.313.7049.64; MENARD J, 1995, J HYPERTENS, V13, P1071, DOI 10.1097/00004872-199510000-00001; Montgomery AA, 1998, J EPIDEMIOL COMMUN H, V52, P520, DOI 10.1136/jech.52.8.520; PURVES IN, 1996, PRODIGY INTERIM REPO; Randolph AG, 1999, JAMA-J AM MED ASSOC, V282, P67, DOI 10.1001/jama.282.1.67; *STAT, 1999, STAT STAT SOFTW REL	19	185	188	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					686	690		10.1136/bmj.320.7236.686	http://dx.doi.org/10.1136/bmj.320.7236.686			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710578	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000085895300022
J	Savill, J				Savill, J			More in expectation than in hope: a new attitude to training in clinical academic medicine	BRITISH MEDICAL JOURNAL			English	Article									Royal Infirm, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh	Savill, J (corresponding author), Royal Infirm, Edinburgh EH3 9YW, Midlothian, Scotland.							ARTHUR MJP, 1999, J R COLL PHYSICIANS, V33, P1; Goldacre M, 1999, MED EDUC, V33, P318, DOI 10.1046/j.1365-2923.1999.00404.x; Savill J, 1999, J ROY SOC MED, V92, P387, DOI 10.1177/014107689909200801	3	31	30	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					630	633		10.1136/bmj.320.7235.630	http://dx.doi.org/10.1136/bmj.320.7235.630			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698887	Green Submitted, Green Published			2022-12-28	WOS:000085742600031
J	Chen, FL; Hersh, BM; Conradt, B; Zhou, Z; Riemer, D; Gruenbaum, Y; Horvitz, HR				Chen, FL; Hersh, BM; Conradt, B; Zhou, Z; Riemer, D; Gruenbaum, Y; Horvitz, HR			Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; BCL-X-L; SUBCELLULAR-LOCALIZATION; MITOCHONDRIAL-MEMBRANES; ENDOPLASMIC-RETICULUM; REGULATORS CED-9; OUTER-MEMBRANE; PROTEIN; APOPTOSIS; ENCODES	The Caenorhabditis elegans Bcl-2-like protein CED-9 prevents programmed cell death by antagonizing the Apaf-1-like cell-death activator CED-4. Endogenous CED-9 and CED-4 proteins localized to mitochondria in wild-type embryos, in which most cells survive. By contrast, in embryos in which cells had been induced to die, CED-4 assumed a perinuclear localization. CED-4 translocation induced by the cell-death activator EGL-1 was blocked by a gain-of-function mutation in ced-9 but was not dependent on ced-3 function, suggesting that CED-4 translocation precedes caspase activation and the execution phase of programmed cell death. Thus, a change in the subcellular Localization of CED-4 may drive programmed cell death.	MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; Max Planck Inst Biophys Chem, Dept Biochem, D-37016 Gottingen, Germany; Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Max Planck Society; Hebrew University of Jerusalem	Chen, FL (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, WI-525, Cambridge, MA 02139 USA.		Conradt, Barbara/K-2665-2014	Conradt, Barbara/0000-0002-3731-4308; Hersh, Bradley/0000-0003-2098-4417				AKAO Y, 1994, CANCER RES, V54, P2468; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; del Peso L, 1998, J BIOL CHEM, V273, P33495, DOI 10.1074/jbc.273.50.33495; ELLEDGE SJ, 1992, P NATL ACAD SCI USA, V89, P2907, DOI 10.1073/pnas.89.7.2907; Guenther C, 1996, DEVELOPMENT, V122, P3509; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Irmler M, 1997, FEBS LETT, V406, P189, DOI 10.1016/S0014-5793(97)00271-8; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; Mello C, 1995, METHOD CELL BIOL, V48, P451; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Moriishi K, 1999, P NATL ACAD SCI USA, V96, P9683, DOI 10.1073/pnas.96.17.9683; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Ottilie S, 1997, CELL DEATH DIFFER, V4, P526, DOI 10.1038/sj.cdd.4400288; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; RIEMER D, 1993, EUR J CELL BIOL, V62, P214; Seshagiri S, 1997, CURR BIOL, V7, P455, DOI 10.1016/S0960-9822(06)00216-8; Spector MS, 1997, NATURE, V385, P653, DOI 10.1038/385653a0; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wu DY, 1997, SCIENCE, V275, P1126, DOI 10.1126/science.275.5303.1126; Xue D, 1997, NATURE, V390, P305, DOI 10.1038/36889; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	35	188	200	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1485	1489		10.1126/science.287.5457.1485	http://dx.doi.org/10.1126/science.287.5457.1485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688797	Green Submitted			2022-12-28	WOS:000085531600051
J	Priola, SA; Raines, A; Caughey, WS				Priola, SA; Raines, A; Caughey, WS			Porphyrin and phthalocyanine antiscrapie compounds	SCIENCE			English	Article							RESISTANT PRION PROTEIN; HAMSTER SCRAPIE; AMPHOTERICIN-B; VARIANT CJD; CONGO RED; PRP; INHIBITION; AGENT; PATHOGENESIS; EXPRESSION	The transmissible spongiform encephalopathies (TSEs) are fatal, neurodegenerative diseases for which no effective treatments are available. The Likelihood that a bovine form of TSE has crossed species barriers and infected humans underscores the urgent need to identify anti-TSE drugs. Certain cyclic tetrapyrroles (porphyrins and phthalocyanines) have recently been shown to inhibit the in vitro formation of PrP-res, a protease-resistant protein critical for TSE pathogenesis. We now report that treatment of TSE-infected animals with three such compounds increased survival time from 50 to 300%. The significant inhibition of TSE disease by structurally dissimilar tetrapyrroles identifies these compounds as anti-TSE drugs.	NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Priola, SA (corresponding author), NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA.				NIA NIH HHS [AG04342] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000752, ZIAAI000752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004342] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BONNETT R, 1995, CHEM SOC REV, V24, P19, DOI 10.1039/cs9952400019; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; CAUGHEY B, 1993, J VIROL, V67, P6270, DOI 10.1128/JVI.67.10.6270-6272.1993; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DEMAIMAY R, 1994, J GEN VIROL, V75, P2499, DOI 10.1099/0022-1317-75-9-2499; Dolphin D., 1978, PORPHYRINS; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; FRASER H, 1978, J COMP PATHOL, V88, P563, DOI 10.1016/0021-9975(78)90010-5; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paquette, 1992, PHOTODYNAMIC THERAPY, P145; POCCHIARI M, 1987, J GEN VIROL, V68, P219, DOI 10.1099/0022-1317-68-1-219; PRIOLA SA, UNPUB; RACE RE, 1995, NEURON, V15, P1183, DOI 10.1016/0896-6273(95)90105-1; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Sassa S, 1996, CURR MED CHEM, V3, P273; Tagliavini F, 1997, SCIENCE, V276, P1119, DOI 10.1126/science.276.5315.1119; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Will RG, 1999, LANCET, V353, P979, DOI 10.1016/S0140-6736(99)01160-5	26	264	281	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1503	1506		10.1126/science.287.5457.1503	http://dx.doi.org/10.1126/science.287.5457.1503			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688802				2022-12-28	WOS:000085531600056
J	Heine, V				Heine, V			Crystal structure - As weird as they come	NATURE			English	Editorial Material									Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge	Heine, V (corresponding author), Univ Cambridge, Cavendish Lab, Madingley Rd, Cambridge CB3 0HE, England.							HAFNER J, 1983, J PHYS F MET PHYS, V13, P2479, DOI 10.1088/0305-4608/13/12/008; Heine V., 1970, Solid state physics: advances in research and applications, P249, DOI 10.1016/S0081-1947(08)60071-5; Nelmes RJ, 1999, PHYS REV LETT, V83, P4081, DOI 10.1103/PhysRevLett.83.4081; PEYRARD M, 1983, J PHYS C SOLID STATE, V16, P1593, DOI 10.1088/0022-3719/16/9/005; SODERLIND P, 1995, NATURE, V374, P524, DOI 10.1038/374524a0	5	24	24	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					836	837		10.1038/35002691	http://dx.doi.org/10.1038/35002691			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706262				2022-12-28	WOS:000085559200030
J	Demiroglu, H; Ozcebe, OI; Barista, I; Dundar, S; Eldem, B				Demiroglu, H; Ozcebe, OI; Barista, I; Dundar, S; Eldem, B			Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behcet's disease: a randomised trial	LANCET			English	Article							ALPHA; SYMPTOMS; AZATHIOPRINE; PROGNOSIS; CELLS	Background Sight-threatening eye involvement is a serious complication of Behcet's disease. Extraocular complications such as arthritis, vascular occlusive disorders, mucocutaneous lesions, and central-nervous-system disease may lead to morbidity and even death. We designed a prospective study in newly diagnosed patients without previous eye disease to assess whether prevention of eye involvement and extraocular manifestations, and preservation of visual acuity are possible with combination treatments with and without interferon alfa-2b. Methods Patients were randomly assigned 3 million units interferon alfa-2b subcutaneously every other day for the first 6 months plus 1.5 mg colchicine orally daily and 1.2 million units benzathine penicillin intramuscularly every 3 weeks (n=67), or colchicine and benzathine penicillin alone (n=68). The primary endpoint was visual-acuity loss. Analysis was by intention to treat. Findings Significantly fewer patients who were treated with interferon had eye involvement than did patients who did not receive interferon (eight vs 27, relative risk 0.21 [95% CI 0.09-0.50], p<0.001). Ocular attack rate was 0.2 (SD 0.62) per year with interferon therapy and 1.02 (1.13) without interferon therapy (p=0.0001). Visual-acuity loss was significantly lower among patients treated with interferon than in those without interferon (two vs 13, relative risk 0.13 [95% CI 0.03-0.60], p=0.003). Arthritis episodes, vascular events, and mucocutaneous lesions were also less frequent in patients treated with interferon than in those not receiving interferon. No serious side-effects were reported. Interpretation Therapy with interferon alfa-2b, colchicine, and benzathine penicillin seems to be an effective regimen in Behcet's disease for the prevention of recurrent eye attacks and extraocular complications, and for the protection of vision.	Hacettepe Univ, Sch Med, Dept Internal Med, Ankara, Turkey; Hacettepe Univ, Sch Med, Dept Ophthalmol, Ankara, Turkey	Hacettepe University; Hacettepe University	Demiroglu, H (corresponding author), Hosdere Cad 80-19, TR-06550 Ankara, Turkey.		BARISTA, IBRAHIM/I-9027-2013					ALPSOY E, 1994, J AM ACAD DERMATOL, V31, P617, DOI 10.1016/S0190-9622(94)70226-8; ANTONELLI G, 1991, J INFECT DIS, V163, P882, DOI 10.1093/infdis/163.4.882; Azizlerli G, 1996, DERMATOLOGY, V192, P239, DOI 10.1159/000246374; AZIZLERLI G, 1997, BEHCETS DIS, P453; Calguneri M, 1996, DERMATOLOGY, V192, P125, DOI 10.1159/000246336; Calguneri M, 1996, ARTHRITIS RHEUM-US, V39, P2062, DOI 10.1002/art.1780391216; Demiroglu H, 1997, OPHTHALMOLOGY, V104, P701, DOI 10.1016/S0161-6420(97)30249-8; DINNING WJ, 1986, RECENT ADV BEHCETS D, P227; EDWARDS BS, 1985, J CLIN INVEST, V75, P1908, DOI 10.1172/JCI111905; EGLIN RP, 1982, LANCET, V2, P1356; FERON EJ, 1994, LANCET, V343, P1428, DOI 10.1016/S0140-6736(94)92549-6; Georgiou S, 1998, J INTERN MED, V243, P367; GUYER DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P350, DOI 10.1001/archopht.1993.01090030068041; HAMURYUDAN V, 1994, J RHEUMATOL, V21, P1098; Hamuryudan V, 1997, ARTHRITIS RHEUM, V40, P769, DOI 10.1002/art.1780400425; HAZNEDAROGLU IC, 1994, P 7 MED C RHEUM ATH, P185; HIJIKATA K, 1978, JPN J OPHTHALMOL, V22, P506; Kaklamani VG, 1998, SEMIN ARTHRITIS RHEU, V27, P197, DOI 10.1016/S0049-0172(98)80001-2; KANEKO F, 1985, BRIT J DERMATOL, V113, P303, DOI 10.1111/j.1365-2133.1985.tb02082.x; KANEKO F, 1985, BRIT J DERMATOL, V113, P313, DOI 10.1111/j.1365-2133.1985.tb02083.x; Kaneko Fumio, 1997, Yonsei Medical Journal, V38, P444; Kotter I, 1998, BRIT J OPHTHALMOL, V82, P488, DOI 10.1136/bjo.82.5.488; LEHNER T, 1997, BEHCETS DIS, P7; MASUDA K, 1989, LANCET, V1, P1093; MATSUMURA N, 1975, LANCET, V2, P813; MIZUSHIMA Y, 1989, J RHEUMATOL, V16, P506; O'Duffy JD, 1998, J RHEUMATOL, V25, P1938; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; SILMAN AJ, 1990, LANCET, V335, P1078; TSAMBAOS D, 1986, ARCH DERMATOL RES, V278, P335, DOI 10.1007/BF00407749; Yamashita N, 1997, Int Rev Immunol, V14, P11, DOI 10.3109/08830189709116841; YAZICI H, 1990, NEW ENGL J MED, V322, P281, DOI 10.1056/NEJM199002013220501	32	61	62	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					605	609		10.1016/S0140-6736(99)05131-4	http://dx.doi.org/10.1016/S0140-6736(99)05131-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696980				2022-12-28	WOS:000085615400011
J	Bachiller, D; Klingensmith, J; Kemp, C; Belo, JA; Anderson, RM; May, SR; McMahon, JA; McMahon, AP; Harland, RM; Rossant, J; De Robertis, EM				Bachiller, D; Klingensmith, J; Kemp, C; Belo, JA; Anderson, RM; May, SR; McMahon, JA; McMahon, AP; Harland, RM; Rossant, J; De Robertis, EM			The organizer factors Chordin and Noggin are required for mouse forebrain development	NATURE			English	Article							ANTERIOR PRIMITIVE ENDODERM; SPEMANN ORGANIZER; VISCERAL ENDODERM; SECRETED FACTOR; SONIC HEDGEHOG; NEURAL PLATE; GENE; ZEBRAFISH; CERBERUS; SUGGESTS	In mice, there is evidence suggesting that the development of head and trunk structures is organized by distinctly separated cell populations(1,2). The head organizer is located in the anterior visceral endoderm (AVE) and the trunk organizer in the node and anterior primitive streak. In amphibians, Spemann's organizer, which is homologous to the node, partially overlaps with anterior endoderm cells expressing homologues of the AVE markers cerberus, Hex and Hesx1 (refs 3-6). For mice, this raises the question of whether the AVE and node are independent of each other, as suggested by their anatomical separation, or functionally interdependent as is the case in amphibians(3-5). Chordin and Noggin are secreted bone morphogenetic protein (BMP) antagonists(7,8) expressed in the mouse node, but not in the AVE. Here we show that mice double-homozygous mutants that are for chordin and noggin display severe defects in the development of the prosencephalon, The results show that BMP antagonists in the node and its derivatives are required for head development.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Duke University; Harvard University; University of California System; University of California Berkeley; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.		McMahon, Andrew P/ABE-7520-2020; Belo, José A. A/F-4444-2012	Belo, José A. A/0000-0001-7384-0949; Bachiller, Daniel/0000-0002-5016-317X				ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Arkell R, 1997, DEVELOPMENT, V124, P1; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Dufort D, 1998, DEVELOPMENT, V125, P3015; Furuta Y, 1997, DEVELOPMENT, V124, P2203; GOLDEN JA, 1999, P NATL ACAD SCI USA, V54, P623; Hammerschmidt M, 1996, GENE DEV, V10, P2452, DOI 10.1101/gad.10.19.2452; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Oliver G, 1995, DEVELOPMENT, V121, P4045; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Rhinn M, 1998, DEVELOPMENT, V125, P845; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; ZARAISKY AG, 1995, DEVELOPMENT, V121, P3839; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zorn AM, 1999, DEV BIOL, V209, P282, DOI 10.1006/dbio.1999.9257	30	397	423	0	25	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					658	661		10.1038/35001072	http://dx.doi.org/10.1038/35001072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688202				2022-12-28	WOS:000085288200054
J	Zuber, MT; Solomon, SC; Phillips, RJ; Smith, DE; Tyler, GL; Aharonson, O; Balmino, G; Banerdt, WB; Head, JW; Johnson, CL; Lemoine, FG; McGovern, PJ; Neumann, GA; Rowlands, DD; Zhong, SJ				Zuber, MT; Solomon, SC; Phillips, RJ; Smith, DE; Tyler, GL; Aharonson, O; Balmino, G; Banerdt, WB; Head, JW; Johnson, CL; Lemoine, FG; McGovern, PJ; Neumann, GA; Rowlands, DD; Zhong, SJ			Internal structure and early thermal evolution of Mars from Mars Global Surveyor topography and gravity	SCIENCE			English	Article							HEMISPHERIC DICHOTOMY; GIANT IMPACT; FLOW; CONSTRAINTS; THICKNESS; DYNAMICS; MISSION; CHANNEL; BASINS; MANTLE	Topography and gravity measured by the Mars Global Surveyor have enabled determination of the global crust and upper mantle structure of Mars. The planet displays two distinct crustal zones that do not correlate globally with the geologic dichotomy: a region of crust that thins progressively from south to north and encompasses much of the southern highlands and Tharsis province and a region of approximately uniform crustal thickness that includes the northern lowlands and Arabia Terra. The strength of the lithosphere beneath the ancient southern highlands suggests that the northern hemisphere was a locus of high heat flow early in martian history. The thickness of the elastic lithosphere increases with time of loading in the northern plains and Tharsis. The northern lowlands contain structures interpreted as large buried channels that are consistent with northward transport of water and sediment to the lowlands before the end of northern hemisphere resurfacing.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; NASA, Goddard Space Flight Ctr, Earth Sci Directorate, Greenbelt, MD 20771 USA; Stanford Univ, Ctr Radio Astron, Moffett Field, CA 94035 USA; Grp Rech Geodesie Spatiale, Toulouse, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Massachusetts Institute of Technology (MIT); Carnegie Institution for Science; Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Stanford University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Brown University	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.		Lemoine, Frank/D-1215-2013; Banerdt, William/Q-7324-2019; Rowlands, David/D-2751-2012; Zhong, Shijie/A-5290-2010; Neumann, Gregory A/I-5591-2013	Banerdt, William/0000-0003-3125-1542; Neumann, Gregory A/0000-0003-0644-9944; Aharonson, Oded/0000-0001-9930-2495				Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Albee AL, 1998, SCIENCE, V279, P1671, DOI 10.1126/science.279.5357.1671; BANERDT WB, 1992, MARS, P249; BILLS BG, 1978, J GEOPHYS RES, V83, P3497, DOI 10.1029/JB083iB07p03497; BRACE WF, 1980, J GEOPHYS RES, V85, P6248, DOI 10.1029/JB085iB11p06248; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P3049, DOI 10.1029/JB090iB04p03049; CARISTAN Y, 1982, J GEOPHYS RES, V87, P6781, DOI 10.1029/JB087iB08p06781; Carr M., 1981, SURFACE MARS; CHOBLET G, 1998, LUNAR PLANET SCI, V30, P1556; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Dunlop D, 1997, ROCK MAGNETISM; FORSYTH DW, 1985, J GEOPHYS RES-SOLID, V90, P2623, DOI 10.1029/JB090iB14p12623; FORSYTH DW, 1993, J GEOPHYS RES-SOL EA, V98, P16073, DOI 10.1029/93JB01722; FREY H, 1988, GEOPHYS RES LETT, V15, P229, DOI 10.1029/GL015i003p00229; Frey H, 1998, GEOPHYS RES LETT, V25, P4409, DOI 10.1029/1998GL900095; Frey HV, 1996, GEOPHYS RES LETT, V23, P721, DOI 10.1029/96GL00744; GOETZE C, 1978, PHILOS T R SOC A, V288, P99, DOI 10.1098/rsta.1978.0008; Grasset O, 1998, J GEOPHYS RES-SOL EA, V103, P18171, DOI 10.1029/98JB01492; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; Kaula W.M., 1966, THEORY SATELLITE GEO; Kiefer WS, 1996, J GEOPHYS RES-PLANET, V101, P9239, DOI 10.1029/95JE03699; Klaucke I, 1997, SEDIMENTOLOGY, V44, P1093, DOI 10.1111/j.1365-3091.1997.tb02180.x; Klaucke I, 1998, GEOL SOC AM BULL, V110, P22, DOI 10.1130/0016-7606(1998)110<0022:MASOAD>2.3.CO;2; LEMOINE FG, 1999, EOS S, V80, pF618; LEMOINE FG, UNPUB; MCGILL GE, 1989, J GEOPHYS RES-SOLID, V94, P2753, DOI 10.1029/JB094iB03p02753; MCNUTT MK, 1984, J GEOPHYS RES, V89, P1180, DOI 10.1029/JB089iB13p11180; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; Morgan J, 1999, GEOLOGY, V27, P407, DOI 10.1130/0091-7613(1999)027<0407:CTTDOA>2.3.CO;2; NIMMO F, IN PRESS J GEOPHYS R; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; PHILLIPS RJ, 1973, J GEOPHYS RES, V78, P4815, DOI 10.1029/JB078i023p04815; PHILLIPS RJ, 2000, LUNEAR PLANET SCI, V31; SCHUBERT G, 1990, J GEOPHYS RES-SOLID, V95, P14095, DOI 10.1029/JB095iB09p14095; SIMONS FJ, IN PRESS J GEOPHYS R; Simons M, 1997, GEOPHYS J INT, V131, P24, DOI 10.1111/j.1365-246X.1997.tb00593.x; SJOGREN WL, 1999, EOS S, V80, pF618; SLEEP NH, 1994, J GEOPHYS RES-PLANET, V99, P5639, DOI 10.1029/94JE00216; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 1998, SCIENCE, V279, P1686, DOI 10.1126/science.279.5357.1686; Smith DE, 1996, SCIENCE, V271, P184, DOI 10.1126/science.271.5246.184; Smith DE, 1999, SCIENCE, V286, P94, DOI 10.1126/science.286.5437.94; Sohl F, 1997, J GEOPHYS RES-PLANET, V102, P1613, DOI 10.1029/96JE03419; SOLOMON SC, 1990, J GEOPHYS RES-SOLID, V95, P11073, DOI 10.1029/JB095iB07p11073; SOLOMON SC, 1982, J GEOPHYS RES, V87, P9755, DOI 10.1029/JB087iB12p09755; SPOHN T, 1999, EOS S, V80, pF619; Tanaka K. L., 1992, MARS, P345; TURCOTTE DL, 1981, J GEOPHYS RES, V86, P3951, DOI 10.1029/JB086iB05p03951; TYLER GL, 1992, J GEOPHYS RES-PLANET, V97, P7759, DOI 10.1029/92JE00513; WATTS AB, 1980, J GEOPHYS RES, V85, P5369; Wieczorek MA, 1998, J GEOPHYS RES-PLANET, V103, P1715, DOI 10.1029/97JE03136; WILHELMS DE, 1984, NATURE, V309, P138, DOI 10.1038/309138a0; ZHONG S, IN PRESS J GEOPHYS R; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839; ZUBER MT, 1992, J GEOPHYS RES-PLANET, V97, P7781, DOI 10.1029/92JE00341	55	436	444	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1788	1793		10.1126/science.287.5459.1788	http://dx.doi.org/10.1126/science.287.5459.1788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710301				2022-12-28	WOS:000085775300033
J	Voss, LD; Mulligan, J				Voss, LD; Mulligan, J			Bullying in school: are short pupils at risk? Questionnaire study in a cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Southampton Gen Hosp, Univ Child Hlth, Southampton SO21 16YD, Hants, England		Voss, LD (corresponding author), Southampton Gen Hosp, Univ Child Hlth, Southampton SO21 16YD, Hants, England.	linda.voss@phnt.swest.nhs.uk						Leff S, 1999, BRIT MED J, V318, P1076, DOI 10.1136/bmj.318.7190.1076; Olweus D., 1993, AGGRESSIVE BEHAV CUR; Salmon G, 1998, BRIT MED J, V317, P924; VOSS L, 1989, ACTA PAEDIATR SCAND, P65; WHITNEY I, 1993, EDUC RES, V35, P3, DOI 10.1080/0013188930350101	5	82	82	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2000	320	7235					612	613		10.1136/bmj.320.7235.612	http://dx.doi.org/10.1136/bmj.320.7235.612			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	291NH	10698879	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000085742600025
J	Rotmensch, S; Cole, LA				Rotmensch, S; Cole, LA			False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations	LANCET			English	Article							HETEROPHILIC ANTIBODIES; TROPHOBLASTIC DISEASE; FREE SUBUNITS; CHORIOCARCINOMA; METABOLITES; PREGNANCY; RISK; HCG	Background 12 women were diagnosed of having postgestational choriocarcinoma on the basis of persistently positive human chorionic gonadotropin (hCG) test results in the absence of pregnancy. Most of the women had extirpative surgery or chemotherapy, or bath, without significant diminution in hCG titre. Our aim was to assess whether the hCG concentrations were false-positive test results. Methods Samples were tested for hCG, hCG free beta subunit, and hCG beta-core fragment. Assay kinetics were also assessed, and samples were tested independently by competitive RIA. False-positive hCG concentrations were identified by two criteria: detection of hCG in serum and lack of detection of hCG and its degradation products in urine; and wide variations in results for different hCG assays. We corroborated false-positive hCG values by the lack of parallel changes in hCG results when serum was diluted, by false detection of other antigens, and by failure to detect hCG with in-house assays. Findings All 12 women met both criteria for false-positive hCG, and all had corroborating findings. In all 12 cases, a false diagnosis had been made, and most of the women had been subjected to needless surgery or chemotherapy. Assay kinetics indicated that heterophilic antibodies were responsible for the false-positive results. As a result of our findings all further therapy was stopped. Interpretation Current protocols for the diagnosis and treatment of choriocarcinoma should be modified to include a compulsory test for hCG in urine.	Univ New Mexico, Dept Obstet & Gynecol, Div Womens Hlth Res, HCG Reference Serv, Albuquerque, NM 87131 USA; Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA; Edith Wolfson Med Ctr, Dept Obstet & Gynecol, Holon, Israel	University of New Mexico; Yale University	Cole, LA (corresponding author), Univ New Mexico, Dept Obstet & Gynecol, Div Womens Hlth Res, HCG Reference Serv, 2211 Lomas Blvd NE, Albuquerque, NM 87131 USA.				NICHD NIH HHS [HD-35654] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD035654, R01HD035654] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAGSHAWE KD, 1976, CANCER, V38, P1373, DOI 10.1002/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO;2-E; BARTLETT WA, 1986, CLIN CHEM, V32, P2214; BERGLUND L, 1989, ACTA OBSTET GYN SCAN, V68, P377, DOI 10.3109/00016348909028676; BERKOWITZ RS, 1995, CANCER, V76, P2079, DOI 10.1002/1097-0142(19951115)76:10+<2079::AID-CNCR2820761329>3.0.CO;2-O; BOSCATO LM, 1988, CLIN CHEM, V34, P27; CHECK JH, 1995, GYNECOL OBSTET INVES, V40, P139, DOI 10.1159/000292323; CLARK PM, 1985, CLIN CHEM, V31, P1762; Cole LA, 1998, J REPROD MED, V43, P3; Cole LA, 1998, GYNECOL ONCOL, V71, P325, DOI 10.1006/gyno.1998.5181; Cole LA, 1997, CLIN CHEM, V43, P2233; Lurain JR, 1998, J REPROD MED, V43, P44; Rodabaugh KJ, 1998, J REPROD MED, V43, P75; TJANDRA JJ, 1990, IMMUNOL CELL BIOL, V68, P367, DOI 10.1038/icb.1990.50; VLADUTIU AO, 1982, JAMA-J AM MED ASSOC, V248, P2489, DOI 10.1001/jama.248.19.2489; Ward G, 1997, AM J CLIN PATHOL, V108, P417; WEBER TH, 1990, SCAND J CLIN LAB INV, V50, P77, DOI 10.3109/00365519009085803	16	174	181	1	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					712	715		10.1016/S0140-6736(00)01324-6	http://dx.doi.org/10.1016/S0140-6736(00)01324-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703803				2022-12-28	WOS:000085615600013
J	da Silveira, R; Chaieb, S; Mahadevan, L				da Silveira, R; Chaieb, S; Mahadevan, L			Rippling instability of a collapsing bubble	SCIENCE			English	Article								When a bubble of air rises to the top of a highly viscous Liquid, it forms a dome-shaped protuberance on the free surface. Unlike a soap bubble, it bursts so slowly as to collapse under its own weight simultaneously, and folds into a wavy structure. This rippling effect occurs for both elastic and viscous sheets, and a theory for its onset is formulated. The growth of the corrugation is governed by the competition between gravitational and bending (shearing) forces and is exhibited for a range of densities, stiffnesses (viscosities), and sizes-a result that arises Less from dynamics than from geometry, suggesting a wide validity. A quantitative expression for the number of ripples is presented, together with experimental results that support the theoretical predictions.	MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	da Silveira, R (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.		c, sahraoui/H-1272-2015					[Anonymous], 1986, THEORY ELASTICITY; [Anonymous], 1975, BUCKLING BARS PLATES; BUCKMASTER JD, 1975, J FLUID MECH, V69, P1, DOI 10.1017/S0022112075001279; Cerda E, 1999, NATURE, V401, P46, DOI 10.1038/43395; DASILVEIRA R, UNPUB; Debregeas G, 1998, SCIENCE, V279, P1704, DOI 10.1126/science.279.5357.1704; DEBREGEAS G, 1995, PHYS REV LETT, V75, P3886, DOI 10.1103/PhysRevLett.75.3886; Howell P. D., 1996, EUR J APPL MATH, V7, P321, DOI DOI 10.1017/S0956792500002400; JELLETT JH, 1855, DUBLIN R IRISH ACAD, V22; KANTOR Y, 1986, PHYS REV LETT, V57, P791, DOI 10.1103/PhysRevLett.57.791; LOBKOVSKY A, 1995, SCIENCE, V270, P1482, DOI 10.1126/science.270.5241.1482; Love A.E.H., 1906, TREATISE MATH THEORY; Mahadevan L, 2000, NATURE, V403, P502; Mahadevan L, 1998, NATURE, V392, P140, DOI 10.1038/32321; SPIVAK M., 1979, COMPREHENSIVE INTRO, VI; Taylor, 1969, P 12 INT C APPL MECH, P382	16	50	50	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1468	1471						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688791	Green Submitted			2022-12-28	WOS:000085531600045
J	Lu, L; Sui, ML; Lu, K				Lu, L; Sui, ML; Lu, K			Superplastic extensibility of nanocrystalline copper at room temperature	SCIENCE			English	Article							BEHAVIOR; CREEP	A bulk nanocrystalline (nc) pure copper with high purity and high density was synthesized by electrodeposition, An extreme extensibility (elongation exceeds 5000%) without a strain hardening effect was observed when the ne copper specimen was rolled at room temperature. Microstructure analysis suggests that the superplastic extensibility of the ne copper originates from a deformation mechanism dominated by grain boundary activities rather than Lattice dislocation, which is also supported by tensile creep studies at room temperature. This behavior demonstrates new possibilities for scientific and technological advancements with ne materials.	Chinese Acad Sci, State Key Lab Rapidly Solidified Nonequilibrium A, Inst Met Res, Shenyang 110015, Peoples R China; Chinese Acad Sci, Atom Imaging Solids Lab, Inst Met Res, Shenyang 110015, Peoples R China	Chinese Academy of Sciences; Institute of Metal Research, CAS; Chinese Academy of Sciences; Institute of Metal Research, CAS	Lu, K (corresponding author), Chinese Acad Sci, State Key Lab Rapidly Solidified Nonequilibrium A, Inst Met Res, Shenyang 110015, Peoples R China.	kelu@imr.ac.cn	Lu, Lei/E-3864-2012; Sui, Manling/B-6069-2013	Sui, Manling/0000-0002-0415-5881				Cai B, 1999, SCRIPTA MATER, V41, P755, DOI 10.1016/S1359-6462(99)00213-4; CHOKSHI AH, 1989, SCRIPTA METALL MATER, V23, P1679, DOI 10.1016/0036-9748(89)90342-6; COBLE RL, 1963, J APPL PHYS, V34, P1679, DOI 10.1063/1.1702656; Hahn H, 1997, NANOSTRUCT MATER, V9, P603, DOI 10.1016/S0965-9773(97)00135-9; HORVATH J, 1987, SOLID STATE COMMUN, V62, P319, DOI 10.1016/0038-1098(87)90989-6; KARCH J, 1987, NATURE, V330, P556, DOI 10.1038/330556a0; KLUG HP, 1974, XRAY DIFFRACTION PRO, P618; Koch CC, 1999, MRS BULL, V24, P54, DOI 10.1557/S0883769400051551; McFadden SX, 1999, NATURE, V398, P684, DOI 10.1038/19486; Mishra RS, 1999, MATER SCI FORUM, V304-3, P31, DOI 10.4028/www.scientific.net/MSF.304-306.31; MUKHERJEE AK, 1993, MAT SCI TECHNOLOGY, V6, pCH9; Erb U., 1993, Nanostructured Materials, V2, P383, DOI [10.1016/0965-9773(93)90044-C, 10.1016/0965-9773(93)90180-J]; Sanders PG, 1997, NANOSTRUCT MATER, V9, P433, DOI 10.1016/S0965-9773(97)00096-2; Sanders PG, 1996, PROCESSING AND PROPERTIES OF NANOCRYSTALLINE MATERIALS, P379; Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328; VanSwygenhoven H, 1997, APPL PHYS LETT, V71, P1652, DOI 10.1063/1.119785; Wang N, 1997, MAT SCI ENG A-STRUCT, V237, P150, DOI 10.1016/S0921-5093(97)00124-X	17	691	760	28	691	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1463	1466		10.1126/science.287.5457.1463	http://dx.doi.org/10.1126/science.287.5457.1463			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688789				2022-12-28	WOS:000085531600043
J	Distel, DL; Baco, AR; Chuang, E; Morrill, W; Cavanaugh, C; Smith, CR				Distel, DL; Baco, AR; Chuang, E; Morrill, W; Cavanaugh, C; Smith, CR			Marine ecology - Do mussels take wooden steps to deep-sea vents?	NATURE			English	Article							WHALE FALL; ENVIRONMENTS; BIVALVIA; COMMUNITY; MYTILIDAE; OCEAN		Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME 04469 USA; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Harvard Univ, Biol Labs, Cambridge, MA 02138 USA	University of Maine System; University of Maine Orono; University of Hawaii System; Harvard University	Distel, DL (corresponding author), Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME 04469 USA.		Distel, Daniel/A-8047-2017	Distel, Daniel/0000-0002-3860-194X				BENNETT BA, 1994, MAR ECOL PROG SER, V108, P205, DOI 10.3354/meps108205; CAMPBELL KA, 1995, GEOLOGY, V23, P321, DOI 10.1130/0091-7613(1995)023<0321:BACBIP>2.3.CO;2; DANDO PR, 1992, NATURE, V356, P667, DOI 10.1038/356667a0; DEAN HK, 1993, MALACOLOGIA, V35, P21; DELL R K, 1987, National Museum of New Zealand Records, V3, P17; Deming JW, 1997, MICROSC RES TECHNIQ, V37, P162, DOI 10.1002/(SICI)1097-0029(19970415)37:2<162::AID-JEMT4>3.0.CO;2-Q; DISTEL DL, IN PRESS MOL PHYLOGE; Feldman RA, 1998, BIOL BULL, V194, P116, DOI 10.2307/1543041; GRASSLE JF, 1987, DEEP-SEA RES, V34, P1911, DOI 10.1016/0198-0149(87)90091-4; Gustafson RG, 1998, MALACOLOGIA, V40, P63; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; KENK VC, 1985, MALACOLOGIA, V26, P253; LESCHINE SB, 1995, ANNU REV MICROBIOL, V49, P399, DOI 10.1146/annurev.mi.49.100195.002151; REID RGB, 1980, CAN J ZOOL, V58, P386, DOI 10.1139/z80-050; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; SWOFFORD DL, 1997, PAUP 4 0; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373	17	231	244	0	67	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					725	726		10.1038/35001667	http://dx.doi.org/10.1038/35001667			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693793				2022-12-28	WOS:000085423100040
J	Imai, S; Armstrong, CM; Kaeberlein, M; Guarente, L				Imai, S; Armstrong, CM; Kaeberlein, M; Guarente, L			Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ADP-RIBOSYLATION; RIBOSOMAL DNA; YEAST; INVIVO; HETEROCHROMATIN; RECOMBINATION; ACETYLATION; RESTRICTION; REPRESSION	Yeast Sir2 is a heterochromatin component that silences transcription at silent mating loci(1), telomeres(2) and the ribosomal DNA(3,4), and that also suppresses recombination in the rDNA(5) and extends replicative life span(6). Mutational studies indicate that lysine 16 in the amino-terminal tail of histone H4 and lysines 9, 14 and 18 in H3 are critically important in silencing, whereas lysines 5, 8 and 12 of H4 have more redundant functions(7-9). Lysines 9 and 14 of histone H3 and lysines 5, 8 and 16 of H4 are acetylated in active chromatin and hypoacetylated in silenced chromatin, and overexpression of Sir2 promotes global deacetylation of histones(9,10), indicating that Sir2. may be a histone deacetylase. Deacetylation of lysine 16 of H4 is necessary for binding the silencing protein, Sir3 (ref. 8). Here we show that yeast and mouse Sir2 proteins are nicotinamide adenine dinucleotide (NAD)dependent histone deacetylases, which deacetylate lysines 9 and 14 of H3 and specifically lysine 16 of H4. Our analysis of two SIR2 mutations supports the idea that this deacetylase activity accounts for silencing, recombination suppression and extension of life span in vivo. These findings provide a molecular framework of NAD-dependent histone deacetylation that connects metabolism, genomic silencing and ageing in yeast and, perhaps, in higher eukaryotes.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							ADAMIETZ P, 1984, J BIOL CHEM, V259, P6841; BANASIK M, 1994, MOL CELL BIOCHEM, V138, P185, DOI 10.1007/BF00928461; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KREIMEYER A, 1984, J BIOL CHEM, V259, P890; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; MEYER T, 1986, EUR J BIOCHEM, V155, P157, DOI 10.1111/j.1432-1033.1986.tb09471.x; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; PERO RW, 1985, MUTAT RES, V142, P69, DOI 10.1016/S0165-7992(85)80016-6; RINE J, 1987, GENETICS, V116, P9; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; SINCLAIR DA, 1997, CELL, V91, P1; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; THOMPSON JS, 1994, NATURE, V369, P245, DOI 10.1038/369245a0; Tsang AW, 1998, J BIOL CHEM, V273, P31788, DOI 10.1074/jbc.273.48.31788; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	30	2641	2776	13	252	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					795	800		10.1038/35001622	http://dx.doi.org/10.1038/35001622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693811				2022-12-28	WOS:000085423100058
J	Mesecar, AD; Koshland, DE				Mesecar, AD; Koshland, DE			Structural biology - A new model for protein stereospecificity	NATURE			English	Article									Univ Illinois, Dept Med Chem & Pharmacognosy, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Ctr Adv Mat, Berkeley, CA 94720 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mesecar, AD (corresponding author), Univ Illinois, Dept Med Chem & Pharmacognosy, Ctr Pharmaceut Biotechnol, 900 S Ashland Ave MC 870, Chicago, IL 60607 USA.			Mesecar, Andrew/0000-0002-1241-2577				Dixon M., 1979, ENZYMES, Vthird; Easson LH, 1933, BIOCHEM J, V27, P1257, DOI 10.1042/bj0271257; Lehninger A L, 1982, PRINCIPLES BIOCH; Lewis DL, 1999, NATURE, V401, P898, DOI 10.1038/44801; Mesecar AD, 1997, SCIENCE, V277, P202, DOI 10.1126/science.277.5323.202; OGSTON AG, 1948, NATURE, V162, P963, DOI 10.1038/162963b0; SEGEL IH, 1972, ENZYME KINETICS; Stryer L., 1988, BIOCHEMISTRY-US; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409	9	106	107	0	17	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					614	615		10.1038/35001144	http://dx.doi.org/10.1038/35001144			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688187				2022-12-28	WOS:000085288200039
J	Cates, W; Dallabetta, G				Cates, W; Dallabetta, G			The staying power of sexually transmitted diseases	LANCET			English	Article									Family Hlth Int, HIV AIDS Prevent & Care Dept, Tech Support, Res Triangle Pk, NC 27709 USA		Cates, W (corresponding author), Family Hlth Int, HIV AIDS Prevent & Care Dept, Tech Support, POB 13950, Res Triangle Pk, NC 27709 USA.								0	9	10	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	DEC	1999	354			S			62	62						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267DT	10691477				2022-12-28	WOS:000084342100063
J	Wallis, EJ; Ramsay, LE; Haq, IU; Ghahramani, P; Jackson, PR; Rowland-Yeo, K; Yeo, WW				Wallis, EJ; Ramsay, LE; Haq, IU; Ghahramani, P; Jackson, PR; Rowland-Yeo, K; Yeo, WW			Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE; THERAPY; EVENTS	Objective To examine the accuracy of a new version of the Sheffield table designed to aid decisions on lipids screening and detect thresholds for risk of coronary heart disease needed to implement current guidelines for primary prevention of cardiovascular disease. Design Comparison of decisions made on the basis of the table with absolute risk of coronary heart disease or cardiovascular disease calculated by the Framingham risk function. The decisions related to statin treatment when corollary risk is greater than or equal to 30% over 10 years; aspirin treatment when the risk is greater than or equal to 15% over 10 years; and die treatment of mild hypertension when the cardiovascular risk is greater than or equal to 20% over 10 years. Setting The table is designed for use in general practice Subjects Random sample of 1000 people aged 35-64 years from the 1995 Scottish health survey Main outcome measures Sensitivity, specificity, and positive and negative predictive values of the table. Results 13% of people had a coronary risk of greater than or equal to 15%, and 2.2% a risk of greater than or equal to 30%, over 10 years. 22% had mild hypertension (systolic blood pressure 140-159 mm Hg). The table indicated lipids screening for everyone with a coronary risk of greater than or equal to 15% over 10 years, for 95% of people with a ratio of total cholesterol to high density lipoprotein cholesterol of greater than or equal to 8.0, but for < 50% with a coronary risk of < 5% over 10 years. Sensitivity and specificity were 97% and 95% respectively for a coronary risk of greater than or equal to 15% over 10 years; 82% and 99% for a coronary risk of greater than or equal to 30% over 10 years; and 88% and 90% for a cardiovascular risk of greater than or equal to 20% over 10 years in mild hypertension. Conclusion The table identifies all high risk people for lipids screening, reduces screening of low risk people by more than half, and ensures that treatments are prescribed appropriately to those at high risk, while avoiding inappropriate treatment of people at low risk	Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Ramsay, LE (corresponding author), Royal Hallamshire Hosp, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	d.colley@sheffield.ac.uk		Yeo, Wilfred/0000-0001-9554-5203				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Boissel JP, 1998, JAMA-J AM MED ASSOC, V280, P1949, DOI 10.1001/jama.280.22.1949; Chalmers J, 1999, J HYPERTENS, V17, P151; COLLINS R, 1992, TXB HYPERTENSION, P1156; *COR SERV COMM, 1995, MIN HLTH GUID MAN MI; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; GROVER SA, 1995, JAMA-J AM MED ASSOC, V274, P801, DOI 10.1001/jama.274.10.801; HAQ IU, 1995, LANCET, V346, P1467, DOI 10.1016/S0140-6736(95)92477-9; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; Haq IU, 1996, CLIN SCI, V91, P773; Haq IU, 1999, QJM-INT J MED, V92, P379, DOI 10.1093/qjmed/92.7.379; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; *JOINT HLTH SURV U, 1995, SCOTT HLTH SURV; *JOINT NAT COMM PR, 1998, ARCH INTERN MED, V157, P2413; *NAT CHOL ED PROGR, 1994, CIRCULATION, V89, P1333; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Ramsay LE, 1996, LANCET, V348, P387, DOI 10.1016/S0140-6736(96)05516-X; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Ramsay LE, 1998, AM J HYPERTENS, V11, p79S, DOI 10.1016/S0895-7061(98)00063-6; *STANDM ED ADV COM, 1997, US STAT; SYTKOWSKI PA, 1997, CIRCULATION S1, V96, P437; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, HEART, V80, pS1; Wood D, 1998, EUR HEART J, V19, P1434	24	128	134	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					671	676		10.1136/bmj.320.7236.671	http://dx.doi.org/10.1136/bmj.320.7236.671			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710573	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000085895300017
J	Adhiyaman, V; Vaishnavi, A; Froese, S				Adhiyaman, V; Vaishnavi, A; Froese, S			Hypersensitivity reaction to balsalazide	BRITISH MEDICAL JOURNAL			English	Article							LUPUS-LIKE SYNDROME; ULCERATIVE-COLITIS; PATIENT											DEBOEVER G, 1989, AM J GASTROENTEROL, V84, P85; DENT MT, 1992, BRIT MED J, V305, P159, DOI 10.1136/bmj.305.6846.159-b; GRIFFITHS ID, 1977, BMJ-BRIT MED J, V2, P1188, DOI 10.1136/bmj.2.6096.1188; HABAL FM, 1988, AM J GASTROENTEROL, V83, P15; JENSS H, 1990, AM J GASTROENTEROL, V85, P332	5	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					613	613		10.1136/bmj.320.7235.613	http://dx.doi.org/10.1136/bmj.320.7235.613			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698880	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000085742600026
J	Williams, JG; Cheung, WY; Russell, IT; Cohen, DR; Longo, M; Lervy, B				Williams, JG; Cheung, WY; Russell, IT; Cohen, DR; Longo, M; Lervy, B			Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study	BRITISH MEDICAL JOURNAL			English	Article							HEALTH SURVEY QUESTIONNAIRE; GENERAL-PRACTITIONERS; CARE; CANCER	Objective To evaluate whether follow up of patients with inflammatory bowel disease is better through open access than by routine booked appointments. Design Pragmatic randomised controlled trial. Setting Two district general hospitals in Swansea and Neath, Wales. Participants 180 adults (78 with Crohn's disease, 77 ulcerative or indeterminate colitis, 25 ulcerative or idiopathic proctitis) recruited from outpatient clinics during October 1995 to November 1996. Intervention Open access follow up according to patient need. Main outcome measures Generic (SF-36) and disease specific (UK inflammatory bowel disease questionnaire UKIBDQ) quality of Life, number of primary and secondary care contacts, total resource use, and views of patients and general practitioners. Results There were no differences in generic or disease specific quality of life, Open access patients had fewer day visits (0.27 v 0.42, P < 0.05) and fewer outpatient visits (4.12 v 4.64, P < 0.01), but some patients had difficulty obtaining an urgent appointment There were no significant differences in specific investigations undertaken, inpatient days, general practitioner surgery or home visits, drugs prescribed, or total patient borne costs, Mean total cost in secondary care was lower for open access patients (P < 0.05), but when primary care and patient bome costs were added there were no significant differences in total costs to the NHS or to society, General practitioners and patients preferred open access. Conclusions Open access follow up delivers the same quality of care as routine outpatient care and is preferred by patients and general practitioners. It uses fewer resources in secondary care but total resource use is similar. Better methods of ensuring urgent access to outpatient clinics are needed.	Morriston Hosp, Sch Postgrad Studies Med & Hlth Care, Swansea SA6 6NL, W Glam, Wales; Univ York, Dept Hlth Sci & Clin Evaluat, York YO10 5DD, N Yorkshire, England; Univ Glamorgan, Sch Business, Pontypridd CF37 1DL, M Glam, Wales	Morriston Hospital; Swansea University; University of York - UK; University of South Wales	Williams, JG (corresponding author), Morriston Hosp, Sch Postgrad Studies Med & Hlth Care, Swansea SA6 6NL, W Glam, Wales.		Russell, Ian T/H-1181-2012	Cheung, Wai-Yee/0000-0002-0915-9312				ALTMAN DG, 1979, BRIT MED J, V282, P1336; *AUT ASS, 1998, MOT COSTS; Bernstein D, 1996, AM J GASTROENTEROL, V91, P434; *BRIT MED ASS, 1998, 35 BMA RPS; CHEUNG WY, IN PRESS J CLIN EPID; Drummond M., 1994, EC ANAL ALONGSIDE CO; DRUMMOND N, 1994, BRIT MED J, V308, P559, DOI 10.1136/bmj.308.6928.559; GARRATT AM, 1993, BMJ-BRIT MED J, V306, P1440, DOI 10.1136/bmj.306.6890.1440; Graham B, 1997, BRIT J GEN PRACT, V47, P170; Grunfeld E, 1996, BMJ-BRIT MED J, V313, P665; Hickman H, 1994, HLTH B, V52, P118; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Lyons RA, 1999, J PUBLIC HEALTH MED, V21, P41, DOI 10.1093/pubmed/21.1.41; MOODY GA, 1993, J ROY SOC MED, V86, P26; NAJI S, 1994, BRIT MED J, V308, P1208; Netten A, 1998, UNIT COSTS HLTH SOCI; *OFF NAT STAT, 1998, NEW EARN SURV; PETRIE JC, 1985, BRIT MED J, V290, P1960, DOI 10.1136/bmj.290.6486.1960; PROBERT CSJ, 1993, J ROY SOC MED, V86, P271; Sellu D, 1998, BRIT MED J, V316, P635, DOI 10.1136/bmj.316.7131.635a; STEWENIUS J, 1995, INT J COLORECTAL DIS, V10, P117, DOI 10.1007/BF00341210; VANDAMME R, 1994, BRIT J GEN PRACT, V44, P9; WILLIAMS J, 1993, BRIT J HEALTHC COMP, V10, P30; Williams JG, 1999, INT J MED INFORM, V56, P151, DOI 10.1016/S1386-5056(99)00048-9	24	58	58	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					544	548		10.1136/bmj.320.7234.544	http://dx.doi.org/10.1136/bmj.320.7234.544			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688560	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000085624000022
J	Hood, CJ; Lynn, TW; Doherty, AC; Parkins, AS; Kimble, HJ				Hood, CJ; Lynn, TW; Doherty, AC; Parkins, AS; Kimble, HJ			The atom-cavity microscope: Single atoms bound in orbit by single photons	SCIENCE			English	Article							OPTICAL CAVITY; SATURATED-ABSORPTION; QUANTIZED MOTION; STANDING-WAVE; SPECTROSCOPY; MOLECULES; FIELD; MICROMASER; BISTABILITY; STATISTICS	The motion of individual cesium atoms trapped inside an optical resonator is revealed with the atom-cavity microscope (ACM), A single atom moving within the resonator generates Large variations in the transmission of a weak probe Laser, which are recorded in real time. An inversion algorithm then allows individual atom trajectories to be reconstructed from the record of cavity transmission and reveals single atoms bound in orbit by the mechanical forces associated with single photons. In these initial experiments, the ACM yields 2-micrometer spatial resolution in a 10-microsecond time interval. Over the duration of the observation, the sensitivity is near the standard quantum limit for sensing the motion of a cesium atom.	CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA; Univ Auckland, Dept Phys, Auckland, New Zealand	California Institute of Technology; University of Auckland	Kimble, HJ (corresponding author), CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA.	hjkimble@cco.caltech.edu	Doherty, Andrew/D-1816-2010	Doherty, Andrew/0000-0002-8069-7754; Parkins, Andrew/0000-0002-5922-4506				AMBROSE WP, 1991, NATURE, V349, P225, DOI 10.1038/349225a0; BERMAN P, 1994, CAVITY QANTUM ELECTR; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Braginsky V. B., 1992, QUANTUM MEASUREMENT; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; CEREZ P, 1980, IEEE T INSTRUM MEAS, V29, P352, DOI 10.1109/TIM.1980.4314952; Chu S, 1998, REV MOD PHYS, V70, P685, DOI 10.1103/RevModPhys.70.685; Cohen-Tannoudji CN, 1998, REV MOD PHYS, V70, P707, DOI 10.1103/RevModPhys.70.707; COHENTANNOUDJI C, 1992, QUANTUM OPT, P21; COOK RJ, 1990, PROG OPTICS, V28, P361, DOI 10.1016/S0079-6638(08)70292-0; DALIBARD J, 1985, J PHYS B-AT MOL OPT, V18, P1661, DOI 10.1088/0022-3700/18/8/019; DELABACHELERIE M, 1994, OPT LETT, V19, P840, DOI 10.1364/OL.19.000840; Doherty AC, 1997, PHYS REV A, V56, P833, DOI 10.1103/PhysRevA.56.833; DRITZ M, 1990, PHYS REV LETT, V65, P2716; Dunningham JA, 1997, PHYS REV A, V55, P1398, DOI 10.1103/PhysRevA.55.1398; ENGLERT BG, 1991, EUROPHYS LETT, V14, P25, DOI 10.1209/0295-5075/14/1/005; GIBBS HM, 1995, OPTICAL BISTABILITY; GORDON JP, 1980, PHYS REV A, V21, P1606, DOI 10.1103/PhysRevA.21.1606; HAROCHE S, 1991, EUROPHYS LETT, V14, P19, DOI 10.1209/0295-5075/14/1/004; Hood CJ, 1998, PHYS REV LETT, V80, P4157, DOI 10.1103/PhysRevLett.80.4157; Horak P, 1997, PHYS REV LETT, V79, P4974, DOI 10.1103/PhysRevLett.79.4974; JESSEN PS, 1992, PHYS REV LETT, V69, P49, DOI 10.1103/PhysRevLett.69.49; Mabuchi H, 1999, APPL PHYS B-LASERS O, V68, P1095, DOI 10.1007/s003400050751; Mabuchi H, 1998, PHYS REV A, V58, P123, DOI 10.1103/PhysRevA.58.123; Mabuchi H, 1996, OPT LETT, V21, P1393, DOI 10.1364/OL.21.001393; MABUCHI H, UNPUB; MARTE P, 1993, PHYS REV LETT, V71, P1335, DOI 10.1103/PhysRevLett.71.1335; MOERNER WE, 1989, PHYS REV LETT, V62, P2535, DOI 10.1103/PhysRevLett.62.2535; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Munstermann P, 1999, PHYS REV LETT, V82, P3791, DOI 10.1103/PhysRevLett.82.3791; OROZCO LA, 1989, PHYS REV A, V39, P1235, DOI 10.1103/PhysRevA.39.1235; Phillips WD, 1998, REV MOD PHYS, V70, P721, DOI 10.1103/RevModPhys.70.721; REMPE G, 1990, PHYS REV LETT, V64, P2783, DOI 10.1103/PhysRevLett.64.2783; REMPE G, 1995, APPL PHYS B-LASERS O, V60, P233, DOI 10.1007/BF01135867; REMPE G, 1992, OPT LETT, V17, P363, DOI 10.1364/OL.17.000363; REN W, 1995, PHYS REV A, V51, P752, DOI 10.1103/PhysRevA.51.752; Scully MO, 1996, PHYS REV LETT, V76, P4144, DOI 10.1103/PhysRevLett.76.4144; TAN S, QUANTUM OPTICS TOOLB; VERKERK P, 1992, PHYS REV LETT, V68, P3861, DOI 10.1103/PhysRevLett.68.3861; Vernooy DW, 1997, PHYS REV A, V56, P4287, DOI 10.1103/PhysRevA.56.4287; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; WINELAND DJ, 1987, OPT LETT, V12, P389, DOI 10.1364/OL.12.000389; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; Ye J, 1999, PHYS REV LETT, V83, P4987, DOI 10.1103/PhysRevLett.83.4987; Ye J, 1999, IEEE T INSTRUM MEAS, V48, P608, DOI 10.1109/19.769669; Ye J, 1996, OPT LETT, V21, P1000, DOI 10.1364/OL.21.001000; 1998, PHYSICA SCRIPTA T, V76	48	487	500	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1447	1453		10.1126/science.287.5457.1447	http://dx.doi.org/10.1126/science.287.5457.1447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688786				2022-12-28	WOS:000085531600040
J	Goold, SD; Williams, B; Arnold, RM				Goold, SD; Williams, B; Arnold, RM			Conflicts regarding decisions to limit treatment - A differential diagnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL INTENSIVE-CARE; ADVANCE DIRECTIVES; PATIENT; RESUSCITATION; FAMILY; PREFERENCES; PHYSICIANS; FUTILITY; CONSENT	Conflicts between physicians and families about end-of-life decisions create challenging and emotionally difficult situations. In this article, we propose a "differential diagnosis" of such conflicts, distinguishing and describing the characteristics of families, physicians, and organizations and society that contribute to the "etiology" of the situation, as well as strategies for "diagnosing" the dominant factors. As a medical model, the differential diagnosis can be a useful tool to help physicians understand and manage conflicts about end-of-life care.	Univ Michigan, Med Ctr, Sch Med, Div Gen Med,Taubman Ctr 3116, Ann Arbor, MI 48109 USA; Vet Affairs Med Ctr, Ann Arbor, MI USA; Univ Pittsburgh, Ctr Bioeth & Hlth Law, Div Gen Internal Med, Pittsburgh, PA USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Goold, SD (corresponding author), Univ Michigan, Med Ctr, Sch Med, Div Gen Med,Taubman Ctr 3116, Ann Arbor, MI 48109 USA.		Goold, Susan Dorr/N-6930-2014	Goold, Susan Dorr/0000-0002-0258-9774				ARTISS KL, 1973, NEW ENGL J MED, V288, P1210, DOI 10.1056/NEJM197306072882305; Blank L L, 1998, Hosp J, V13, P145; BROCK DW, 1990, NEW ENGL J MED, V322, P1595, DOI 10.1056/NEJM199005313222209; BRODY BA, 1995, J MED PHILOS, V20, P123, DOI 10.1093/jmp/20.2.123; Buchanan AE, 1990, DECIDING OTHERS ETHI; Buckman R., 1992, BREAK BAD NEWS GUIDE; Chambliss D.F, 1996, CARING HOSP NURSES S; CHRISTAKIS NA, 1995, PROGNOSTICATION DEAT; Covinsky KE, 1996, ARCH INTERN MED, V156, P1737, DOI 10.1001/archinte.156.15.1737; DANIS M, 1988, CRIT CARE MED, V16, P594, DOI 10.1097/00003246-198806000-00006; DANIS M, 1988, JAMA-J AM MED ASSOC, V260, P797, DOI 10.1001/jama.260.6.797; Diem SJ, 1996, NEW ENGL J MED, V334, P1578, DOI 10.1056/NEJM199606133342406; EMANUEL EJ, 1993, AM J MED, V95, P619, DOI 10.1016/0002-9343(93)90358-V; EMANUEL LL, 1989, JAMA-J AM MED ASSOC, V261, P3288, DOI 10.1001/jama.261.22.3288; EMANUEL LL, 1995, J AM COLL CARDIOL, V25, P35, DOI 10.1016/0735-1097(94)00339-R; Field MJ, 1998, HEALTH SERV RES, V33, P1; Finucane TE, 1996, LANCET, V348, P1421, DOI 10.1016/S0140-6736(96)03369-7; Goold S.D., 2000, ETHICS PRIMARY CARE, P93; GREEN MJ, 1995, ANN INTERN MED, V123, P512, DOI 10.7326/0003-4819-123-7-199510010-00007; Griffith CH, 1998, ACAD MED, V73, P427, DOI 10.1097/00001888-199804000-00017; Johnson D, 1998, CRIT CARE MED, V26, P266, DOI 10.1097/00003246-199802000-00023; KAHNEMAN D, 1982, JUDGEMENT UNDERCERTA; Kinsella G, 1998, J PALLIATIVE CARE, V14, P37, DOI 10.1177/082585979801400206; Kleinman A., 1980, PATIENTS HEALERS CON; Meisel A, 1996, ARCH INTERN MED, V156, P2521, DOI 10.1001/archinte.156.22.2521; NESS DE, 1994, JAMA-J AM MED ASSOC, V272, P177; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; RANDO TA, 1985, GRIEF DYING DEATH; Rosenczweig C, 1998, CAN MED ASSOC J, V158, P617; SHELP EE, 1985, ARCH INTERN MED, V145, P697, DOI 10.1001/archinte.145.4.697; SHELP EE, 1984, J MED PHILOS, V9, P253, DOI 10.1093/jmp/9.3.253; Solomon M Z, 1993, J Law Med Ethics, V21, P231, DOI 10.1111/j.1748-720X.1993.tb01245.x; SPIKES J, 1975, PSYCHOL CARE MED ILL, P138; Stoutenbeek C P, 1997, Semin Respir Infect, V12, P294; TOMLINSON T, 1990, GERONTOLOGIST, V30, P54, DOI 10.1093/geront/30.1.54; TULSKY JA, 1995, J GEN INTERN MED, V10, P436, DOI 10.1007/BF02599915; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; YOUNGNER SJ, 1994, J AM GERIATR SOC, V42, P887, DOI 10.1111/j.1532-5415.1994.tb06565.x	39	96	101	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2000	283	7					909	914		10.1001/jama.283.7.909	http://dx.doi.org/10.1001/jama.283.7.909			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	281WT	10685716				2022-12-28	WOS:000085185000030
J	Collett, T				Collett, T			Behavior - Measuring beelines to food	SCIENCE			English	Editorial Material									Univ Sussex, Sch Biol Sci, Sussex Ctr Neurosci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Collett, T (corresponding author), Univ Sussex, Sch Biol Sci, Sussex Ctr Neurosci, Biol Bldg, Brighton BN1 9QG, E Sussex, England.							BRANINGER HD, 1957, Z VERGL PHYSIOL, V40, P264; Esch HE, 1996, J EXP BIOL, V199, P155; RONACHER B, IN PRESS J EXP BIOL; Srinivasan MV, 1996, J EXP BIOL, V199, P237; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; von Frisch K., 1967, DANCE LANGUAGE ORIEN	6	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					817	818		10.1126/science.287.5454.817	http://dx.doi.org/10.1126/science.287.5454.817			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10691558				2022-12-28	WOS:000085136400034
J	Levi-Montalcini, R				Levi-Montalcini, R			From Turin to Stockholm via St. Louis and Rio de Janeiro	SCIENCE			English	Editorial Material									CNR, Inst Neurobiol, I-00137 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR)	Levi-Montalcini, R (corresponding author), CNR, Inst Neurobiol, Viale Marx 15, I-00137 Rome, Italy.								0	8	8	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					809	809		10.1126/science.287.5454.809	http://dx.doi.org/10.1126/science.287.5454.809			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10691554				2022-12-28	WOS:000085136400027
J	Wood, D				Wood, D		British Cardiac Soc; British Hyperlipidaemia Assoc; British Hypertension Soc; British Diabetic Assoc	Joint British recommendations on prevention of coronary heart disease in clinical practice: summary	BRITISH MEDICAL JOURNAL			English	Article									British Cardiac Soc, London W1P 5AH, England; British Diabet Assoc, Birmingham, W Midlands, England		Wood, D (corresponding author), British Cardiac Soc, London W1P 5AH, England.							Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Wood D, 1998, HEART, V80, pS1	2	150	156	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					705	708						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710586	Green Published			2022-12-28	WOS:000085895300028
J	Nuorti, JP; Butler, JC; Farley, MM; Harrison, LH; McGeer, A; Kolczak, MS; Breiman, RF				Nuorti, JP; Butler, JC; Farley, MM; Harrison, LH; McGeer, A; Kolczak, MS; Breiman, RF		Active Bacterial Core Surveillance	Cigarette smoking and invasive pneumococcal disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIBIOTIC-RESISTANT PNEUMOCOCCI; LOS-ANGELES-COUNTY; RISK-FACTORS; STREPTOCOCCUS-PNEUMONIAE; MENINGOCOCCAL DISEASE; NASOPHARYNGEAL COLONIZATION; POLYSACCHARIDE VACCINE; RESPIRATORY-TRACT; EPITHELIAL-CELLS	Background: Approximately half of otherwise healthy adults with invasive pneumococcal disease are cigarette smokers. We conducted a population-based case-control study to assess the importance of cigarette smoking and other factors as risk factors for pneumococcal infections. Methods: We identified immunocompetent patients who were 18 to 64 years old and who had invasive pneumococcal disease (as defined by the isolation of Streptococcus pneumoniae from a normally sterile site) by active surveillance of laboratories in metropolitan Atlanta, Baltimore, and Toronto. Telephone interviews were conducted with 228 patients and 301 control subjects who were reached by random-digit dialing. Results: Fifty-eight percent of the patients and 24 percent of the control subjects were current smokers. Invasive pneumococcal disease was associated with cigarette smoking (odds ratio, 4.1; 95 percent confidence interval, 2.4 to 7.3) and with passive smoking among nonsmokers (odds ratio, 2.5; 95 percent confidence interval, 1.2 to 5.1) after adjustment by logistic-regression analysis for age, study site, and independent risk factors such as male sex, black race, chronic illness, low level of education, and living with young children who were in day care. There were dose-response relations for the current number of cigarettes smoked per day, pack-years of smoking, and time since quitting. The adjusted population attributable risk was 51 percent for cigarette smoking, 17 percent for passive smoking, and 14 percent for chronic illness. Conclusions: Cigarette smoking is the strongest independent risk factor for invasive pneumococcal disease among immunocompetent, nonelderly adults. Because of the high prevalence of smoking and the large population attributable risk, programs to reduce both smoking and exposure to environmental tobacco smoke have the potential to reduce the incidence of pneumococcal disease. (N Engl J Med 2000;342:681-9.) (C)2000, Massachusetts Medical Society.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Emory Univ, Sch Med, Atlanta, GA USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Butler, JC (corresponding author), Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Infect Dis, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.	jcb3@cdc.gov	McGeer, Allison/AAB-6885-2020; mcgeer, allison/H-7747-2014	McGeer, Allison/0000-0001-5647-6137; mcgeer, allison/0000-0001-5647-6137				*ACP TASK FORC AD, 1994, INF DIS SOC AM GUID, P107; [Anonymous], 1997, MMWR MORB MORT WKLY, V46, P1; *BEH RISK FACT SUR, 1997, MMWR SURVEILL SUMM, V46, P1; BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; BURMAN LA, 1985, REV INFECT DIS, V7, P133; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; Chen FM, 1998, AM J EPIDEMIOL, V148, P1212, DOI 10.1093/oxfordjournals.aje.a009611; Dagan R, 1996, J INFECT DIS, V174, P1352, DOI 10.1093/infdis/174.6.1352; DYE JA, 1994, THORAX, V49, P825, DOI 10.1136/thx.49.8.825; ESCOBEDO LG, 1995, J NATL CANCER I, V87, P1552, DOI 10.1093/jnci/87.20.1552; FAINSTEIN V, 1979, INFECT IMMUN, V26, P178, DOI 10.1128/IAI.26.1.178-182.1979; FINKLEA JF, 1969, AM J EPIDEMIOL, V90, P390, DOI 10.1093/oxfordjournals.aje.a121084; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; GREEN GM, 1967, NEW ENGL J MED, V276, P421, DOI 10.1056/NEJM196702232760801; GWINN ML, 1990, J CLIN EPIDEMIOL, V43, P559, DOI 10.1016/0895-4356(90)90160-Q; HARTGE P, 1984, AM J EPIDEMIOL, V120, P825, DOI 10.1093/oxfordjournals.aje.a113955; HENDERSON FW, 1988, J INFECT DIS, V157, P256, DOI 10.1093/infdis/157.2.256; HENDLEY JO, 1975, J INFECT DIS, V132, P55, DOI 10.1093/infdis/132.1.55; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; HOLT PG, 1987, THORAX, V42, P241, DOI 10.1136/thx.42.4.241; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; JANOFF EN, 1993, J INFECT DIS, V167, P49, DOI 10.1093/infdis/167.1.49; KARK JD, 1982, NEW ENGL J MED, V307, P1042, DOI 10.1056/NEJM198210213071702; Kim PE, 1996, CLIN INFECT DIS, V22, P100, DOI 10.1093/clinids/22.1.100; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P320; Levine OS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e28; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; LIPSKY BA, 1986, ARCH INTERN MED, V146, P2179, DOI 10.1001/archinte.146.11.2179; Margolis PA, 1997, PEDIATR PULM, V23, P417, DOI 10.1002/(SICI)1099-0496(199706)23:6<417::AID-PPUL4>3.0.CO;2-F; MILI F, 1991, CLIN IMMUNOL IMMUNOP, V59, P187, DOI 10.1016/0090-1229(91)90017-5; Musher DM, 1997, CLIN INFECT DIS, V24, P441, DOI 10.1093/clinids/24.3.441; Nafstad P, 1996, EUR RESPIR J, V9, P2623, DOI 10.1183/09031936.96.09122623; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; ODempsey TJD, 1996, INT J EPIDEMIOL, V25, P885, DOI 10.1093/ije/25.4.885; OLSON SH, 1992, AM J EPIDEMIOL, V135, P210, DOI 10.1093/oxfordjournals.aje.a116273; Pastor P, 1998, CLIN INFECT DIS, V26, P590, DOI 10.1086/514589; *PHS, 1991, DHHS PUBL; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Plouffe JF, 1996, JAMA-J AM MED ASSOC, V275, P194, DOI 10.1001/jama.275.3.194; RAMAN AS, 1983, CHEST, V83, P23, DOI 10.1378/chest.83.1.23; RodriguezBarradas MC, 1997, J INFECT DIS, V175, P590, DOI 10.1093/infdis/175.3.590; Sankilampi U, 1997, INT J EPIDEMIOL, V26, P420, DOI 10.1093/ije/26.2.420; SCHLESSELMAN JJ, 1982, CASE CONTROL STUDIES, P181; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; STANWELLSMITH RE, 1994, EPIDEMIOL INFECT, V112, P315, DOI 10.1017/S0950268800057733; Straus WL, 1996, ARCH INTERN MED, V156, P1685, DOI 10.1001/archinte.156.15.1685; STUART JM, 1988, COMMUNITY MED, V10, P139; STUART JM, 1989, LANCET, V2, P723, DOI 10.1016/S0140-6736(89)90781-2; TAKALA AK, 1995, JAMA-J AM MED ASSOC, V273, P859, DOI 10.1001/jama.273.11.859; Tappero JW, 1996, NEW ENGL J MED, V335, P833, DOI 10.1056/NEJM199609193351201; THOMAS JC, 1991, AM J EPIDEMIOL, V133, P286, DOI 10.1093/oxfordjournals.aje.a115873; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Zhu BP, 1997, AM J PUBLIC HEALTH, V87, P168; Zhu BP, 1996, AM J PUBLIC HEALTH, V86, P1582, DOI 10.2105/AJPH.86.11.1582; 1993, MMWR MORB MORTAL WKL, V42, P645; 1997, MMWR MORB MORTAL WKL, V46, P1217	58	558	578	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2000	342	10					681	689		10.1056/NEJM200003093421002	http://dx.doi.org/10.1056/NEJM200003093421002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ZW	10706897				2022-12-28	WOS:000085708800002
J	Tinetti, ME; Williams, CS; Gill, TM				Tinetti, ME; Williams, CS; Gill, TM			Dizziness among older adults: A possible geriatric syndrome	ANNALS OF INTERNAL MEDICINE			English	Article						dizziness; geriatrics; anxiety; depression; hearing disorders	POSTURAL HYPOTENSION; PERSISTENT DIZZINESS; ELDERLY PATIENTS; RISK-FACTORS; COMMUNITY; FALLS; REGRESSION; POPULATION; PREVALENCE; PEOPLE	Background: In previous studies of dizziness, the prevalence of specific causes has varied widely and either no or multiple causes have been identified. Dizziness might be better considered a geriatric syndrome that results from impairment or disease in multiple systems. Objective: To determine the predisposing characteristics and situational factors associated with dizziness. Design: Population-based, cross-sectional study. Setting: Community Participants: Probability sample of 1087 community-living persons in New Haven, Connecticut, who were at least 72 years of age. Measurements: Episodes of dizziness that occurred for at least 1 month; manifestations of dizziness; and predisposing demographic, medical, neurologic, sensory, and psychological characteristics. Results: 261 participants (24%) reported dizziness; 56% of dizzy persons described several sensations and 74% reported several triggering activities. The adjusted relative risks for characteristics associated with dizziness were 1.69 (95% CI, 1.24 to 2.30) for anxiety, 1.36 (CI, 1.02 to 1.80) for depressive symptoms, 1.27 (CI, 0.99 to 1.63) for impaired hearing, 1.30 (CI, 1.01 to 1.68) for five or more medications, 1.31 (CI, 0.92 to 1.87) for postural hypotension, 1.34 (CI, 0.95 to 1.90) for impaired balance, and 1.31 (CI, 1.00 to 1.71) for past myocardial infarction. The adjusted relative risk for dizziness was 1.38 (CI, 1.27 to 1.49) for each additional characteristic. Conclusions: The association among characteristics in multiple domains (cardiovascular, neurologic, sensory, psychological, and medication-related) and dizziness, coupled with the multiplicity of sensations and triggering activities, suggests that dizziness may be a geriatric syndrome, similar to delirium and falling. If so, an impairment reduction strategy, proven effective for other geriatric syndromes, may be effective in reducing the symptoms and disabilities associated with dizziness.	Yale Univ, Sch Med, Dept Internal Med, Program Geriatr, New Haven, CT 06504 USA	Yale University	Tinetti, ME (corresponding author), 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	tinetti@ynhh.com	Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368	NATIONAL INSTITUTE ON AGING [P60AG010469] Funding Source: NIH RePORTER; NIA NIH HHS [P60AG10469, R01AG07447] Funding Source: Medline; PHS HHS [K2300759] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1955, ARCH OPHTHALMOL-CHIC, V54, P462; BOULT C, 1991, J AM GERIATR SOC, V39, P858, DOI 10.1111/j.1532-5415.1991.tb04451.x; Cahalan D., 1969, AM DRINKING PRACTICE; COLLEDGE NR, 1994, AGE AGEING, V23, P117, DOI 10.1093/ageing/23.2.117; Colledge NR, 1996, BMJ-BRIT MED J, V313, P788; CORNONIHUNTLEY J, 1986, DHHS PUBLICATION NIH; DAVIS LE, 1994, J AM GERIATR SOC, V42, P1184, DOI 10.1111/j.1532-5415.1994.tb06986.x; DRACHMAN D, 1994, CURRENT DIAGNOSIS NE, P264; Drachman DA, 1998, JAMA-J AM MED ASSOC, V280, P2111, DOI 10.1001/jama.280.24.2111; DRACHMAN DA, 1972, NEUROLOGY, V22, P323, DOI 10.1212/WNL.22.4.323; ENSRUD KE, 1992, ARCH INTERN MED, V152, P1058, DOI 10.1001/archinte.152.5.1058; ENSRUD KE, 1994, J AM GERIATR SOC, V42, P481, DOI 10.1111/j.1532-5415.1994.tb04968.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; GRIMBY A, 1995, GERONTOLOGY, V41, P286; GRIMLEY EJ, 1990, AGE AGEING, V19, P43; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; KATSARKAS A, 1994, OTOLARYNG HEAD NECK, V110, P296, DOI 10.1016/S0194-5998(94)70772-3; KROENKE K, 1992, ANN INTERN MED, V117, P898, DOI 10.7326/0003-4819-117-11-898; Lawson J, 1999, J AM GERIATR SOC, V47, P12, DOI 10.1111/j.1532-5415.1999.tb01895.x; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; MACPHEE GJA, 1988, AGE AGEING, V17, P347, DOI 10.1093/ageing/17.5.347; MCINTOSH S, 1993, AGE AGEING, V22, P53, DOI 10.1093/ageing/22.1.53; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reuben D. B., 1991, GERIATRICS REV SYLLA, P117; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; RUBIN DB, 1987, J AM STAT ASSOC, V82, P543, DOI 10.2307/2289460; SAS Institute, 1996, SAS STAT SOFTW CHANG; Shah BV, 1996, SUDAAN USERS MANUAL; SIXT E, 1987, AGE AGEING, V16, P393, DOI 10.1093/ageing/16.6.393; SLOANE P, 1989, J AM GERIATR SOC, V37, P101, DOI 10.1111/j.1532-5415.1989.tb05867.x; SLOANE PD, 1994, J AM GERIATR SOC, V42, P847, DOI 10.1111/j.1532-5415.1994.tb06556.x; SLOANE PD, 1989, J AM GERIATR SOC, V37, P1031, DOI 10.1111/j.1532-5415.1989.tb06916.x; Sloane PD, 1999, J AM GERIATR SOC, V47, P113, DOI 10.1111/j.1532-5415.1999.tb01912.x; Spielberger C., 1983, STAI MANUAL; Tilvis RS, 1996, J AM GERIATR SOC, V44, P809, DOI 10.1111/j.1532-5415.1996.tb03738.x; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212	42	213	228	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2000	132	5					337	+		10.7326/0003-4819-132-5-200003070-00002	http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	288KY	10691583				2022-12-28	WOS:000085563000001
J	Fradin, C; Braslau, A; Luzet, D; Smilgies, D; Alba, M; Boudet, N; Mecke, K; Daillant, J				Fradin, C; Braslau, A; Luzet, D; Smilgies, D; Alba, M; Boudet, N; Mecke, K; Daillant, J			Reduction in the surface energy of liquid interfaces at short length scales	NATURE			English	Article							X-RAY; CAPILLARY WAVES; SCATTERING; FLUCTUATIONS; REFLECTIVITY; TENSION; WATER; FILMS	Liquid-vapour interfaces, particularly those involving water, are common in both natural and artificial environments. They were first described as regions of continuous variation of density(1), caused by density fluctuations within the bulk phases(2-4). In contrast, the more recent capillary-wave model(5,6) assumes a step-like local density profile across the liquid-vapour interface, whose width is the result of the propagation of thermally excited capillary waves. The model has been validated for length scales of tenths of micrometres and larger(7,8), but the structure of liquid surfaces on submicrometre length scales-where the capillary theory is expected to break down-remains poorly understood. Here we report grazing-incidence X-ray scattering experiments that allow for a complete determination of the free surface structure and surface energy for water and a range of organic liquids. We observe a large decrease of up to 75% in the surface energy of submicrometre waves that cannot be explained by capillary theory, but is in accord with the effects arising from the non-locality of attractive intermolecule interactions as predicted by a recent density functional theory(9), Our data, and the results of comparable measurements on liquid solutions, metallic alloys, surfactants, lipids and wetting films should thus provide a stringent test for any new theories that attempt to describe the structure of liquid interfaces with nanometre-scale resolution.	CEA Saclay, Serv Phys Etat Condense, F-91191 Gif Sur Yvette, France; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Berg Univ Gesamthsch Wuppertal, D-42097 Wuppertal, Germany; Ctr Univ Paris Sud, LURE, F-91898 Orsay, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; European Synchrotron Radiation Facility (ESRF); University of Wuppertal	Daillant, J (corresponding author), CEA Saclay, Serv Phys Etat Condense, F-91191 Gif Sur Yvette, France.		Mecke, Klaus R/C-5562-2013; Fradin, Cécile/D-9302-2011	Fradin, Cécile/0000-0001-8329-4953				BRASLAU A, 1985, PHYS REV LETT, V54, P114, DOI 10.1103/PhysRevLett.54.114; BUFF FP, 1965, PHYS REV LETT, V15, P621, DOI 10.1103/PhysRevLett.15.621; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; DAILLANT J, 1991, J PHYS II, V1, P149, DOI 10.1051/jp2:1991102; DAILLANT J, 1992, J CHEM PHYS, V97, P5824, DOI 10.1063/1.463741; DIETRICH S, 1995, PHYS REP, V260, P1, DOI 10.1016/0370-1573(95)00006-3; FISK S, 1969, J CHEM PHYS, V50, P3219, DOI 10.1063/1.1671544; Fukuto M, 1998, PHYS REV LETT, V81, P3455, DOI 10.1103/PhysRevLett.81.3455; GELFAND MP, 1990, PHYSICA A, V166, P1, DOI 10.1016/0378-4371(90)90099-E; Gourier C, 1997, PHYS REV LETT, V78, P3157, DOI 10.1103/PhysRevLett.78.3157; KAYSER RF, 1986, PHYS REV A, V33, P1948, DOI 10.1103/PhysRevA.33.1948; LOUDON R, 1984, MODERN PROBLEMS COND, V9, P589; Magli R, 1996, PHYS REV LETT, V77, P846, DOI 10.1103/PhysRevLett.77.846; Mecke KR, 1999, PHYS REV E, V59, P6766, DOI 10.1103/PhysRevE.59.6766; MEUNIER J, 1987, J PHYS-PARIS, V48, P1819, DOI 10.1051/jphys:0198700480100181900; NAPIORKOWSKI M, 1993, PHYS REV E, V47, P1836, DOI 10.1103/PhysRevE.47.1836; RICE SA, 1985, NATURE, V316, P108, DOI 10.1038/316108a0; Rowlinson J. S., 1982, Molecular theory of capillarity; ROWLINSON JS, 1979, J STAT PHYS, V20, P197, DOI 10.1007/BF01011513; SANYAL MK, 1991, PHYS REV LETT, V66, P628, DOI 10.1103/PhysRevLett.66.628; SENGERS JV, 1989, PHYS REV A, V39, P6346, DOI 10.1103/PhysRevA.39.6346; SINHA SK, 1988, PHYS REV B, V38, P2297, DOI 10.1103/PhysRevB.38.2297; Stecki J, 1998, J CHEM PHYS, V109, P5002, DOI 10.1063/1.477113; TOLMAN RC, 1949, J CHEM PHYS, V17, P333, DOI 10.1063/1.1747247; Tostmann H, 1999, PHYS REV B, V59, P783, DOI 10.1103/PhysRevB.59.783; van Giessen AE, 1998, J CHEM PHYS, V108, P1148, DOI 10.1063/1.475477; VANDERWAALS JD, 1993, VERH KONINK AKAD WET, V1; WEEKS JD, 1977, J CHEM PHYS, V67, P3106, DOI 10.1063/1.435276	28	215	218	3	71	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					871	874		10.1038/35002533	http://dx.doi.org/10.1038/35002533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706279				2022-12-28	WOS:000085559200050
J	Coulehan, J				Coulehan, J			Attention must be paid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					976	976		10.1001/jama.283.8.976	http://dx.doi.org/10.1001/jama.283.8.976			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284AM	10697044				2022-12-28	WOS:000085308600001
J	Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH				Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH			Using the Framingham model to predict heart disease in the United Kingdom: retrospective study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-DISEASE		N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England; N Staffordshire Hosp, Dept Epidemiol, Stoke On Trent ST4 7PA, Staffs, England; Univ Newcastle Upon Tyne, Dept Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Royal Free Hosp, Dept Endocrinol, London NW3 2QG, England	Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust; Newcastle University - UK; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Neary, RH (corresponding author), N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England.							ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; CHAMBLESS LE, 1990, STAT MED, V9, P385, DOI 10.1002/sim.4780090410; KANNEL WB, 1993, CARDIOLOGY, V82, P137, DOI 10.1159/000175864; Ramsay LE, 1996, LANCET, V348, P387, DOI 10.1016/S0140-6736(96)05516-X; Vanderpump MPJ, 1996, THYROID, V6, P155	5	73	78	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					676	677		10.1136/bmj.320.7236.676	http://dx.doi.org/10.1136/bmj.320.7236.676			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710574	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000085895300018
J	Cheng, T; Rodrigues, N; Shen, HM; Yang, YG; Dombkowski, D; Sykes, M; Scadden, DT				Cheng, T; Rodrigues, N; Shen, HM; Yang, YG; Dombkowski, D; Sykes, M; Scadden, DT			Hematopoietic stem cell quiescence maintained by p21(cip1/waf1)	SCIENCE			English	Article							IN-VITRO; CDK INHIBITORS; MICE; TRANSPLANTATION; CYCLE; MOUSE; DIFFERENTIATION; CAPACITY; 5-FLUOROURACIL; CHEMOTHERAPY	Relative quiescence is a defining characteristic of hematopoietic stem cells, while their progeny have dramatic proliferative ability and inexorably move toward terminal differentiation. The quiescence of stem cells has been conjectured to be of critical biologic importance in protecting the stem cell compartment, which we directly assessed using mice engineered to be deficient in the G(1) checkpoint regulator, cyclin-dependent kinase inhibitor, p21(cip1/waf1) (p21). In the absence of p21, hematopoietic stem cell proliferation and absolute number were increased under normal homeostatic conditions. Exposing the animals to cell cycle-specific myelotoxic injury resulted in premature death due to hematopoietic cell depletion. Further, self-renewal of primitive cells was impaired in serially transplanted bone marrow from p21(-/-) mice, leading to hematopoietic failure. Therefore, p21 is the molecular switch governing the entry of stem cells into the cell cycle, and in its absence, increased cell cycling leads to stem cell exhaustion. Under conditions of stress, restricted cell cycling is crucial to prevent premature stem cell depletion and hematopoietic death.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplantat Biol Res Ctr, Boston, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc, AIDS Res Ctr, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplantat Biol Res Ctr, 149 13th St,Room 5212, Boston, MA 02129 USA.	scadden.david@mgh.harvard.edu		Yang, Yong-Guang/0000-0003-4985-1247; Rodrigues, Neil/0000-0002-1925-7733; Cheng, Tao/0000-0002-5925-2769	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL44851] Funding Source: Medline; NIAID NIH HHS [AI07387] Funding Source: Medline; NIDDK NIH HHS [DK50234] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERARDI AC, 1995, SCIENCE, V267, P104, DOI 10.1126/science.7528940; Braun SE, 1998, BLOOD CELL MOL DIS, V24, P138, DOI 10.1006/bcmd.1998.0181; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Dao MA, 1998, EXP HEMATOL, V26, P687; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Drize NJ, 1996, BLOOD, V88, P2927, DOI 10.1182/blood.V88.8.2927.bloodjournal8882927; Gardner RV, 1997, EXP HEMATOL, V25, P495; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; Gothot A, 1998, EXP HEMATOL, V26, P562; GRZEGORZEWSKI K, 1994, J EXP MED, V180, P1047, DOI 10.1084/jem.180.3.1047; HARRISON DE, 1980, BLOOD, V55, P77; HARRISON DE, 1990, J EXP MED, V172, P431, DOI 10.1084/jem.172.2.431; HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LERNER C, 1990, EXP HEMATOL, V18, P114; Mantel C, 1996, BLOOD, V88, P3710, DOI 10.1182/blood.V88.10.3710.bloodjournal88103710; MAUCH P, 1989, BONE MARROW TRANSPL, V4, P601; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; MULLER AM, 1993, DEVELOPMENT, V118, P1343; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352; OGAWA M, 1993, BLOOD, V81, P2844; PLOEMACHER RE, 1989, BLOOD, V74, P2755; PLOEMACHER RE, 1991, BLOOD, V78, P2527; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Taniguchi T, 1999, BLOOD, V93, P4167, DOI 10.1182/blood.V93.12.4167.412k05_4167_4178; UCHIDA N, 1994, BLOOD, V83, P3758; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; WOLF NS, 1993, EXP HEMATOL, V21, P614; Yaroslavskiy B, 1999, BLOOD, V93, P2907; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	35	981	1041	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2000	287	5459					1804	1808		10.1126/science.287.5459.1804	http://dx.doi.org/10.1126/science.287.5459.1804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710306				2022-12-28	WOS:000085775300038
J	Hobbs, FDR; Davis, RC; Lip, GYH				Hobbs, FDR; Davis, RC; Lip, GYH			ABC of heart failure - Heart failure in general practice	BRITISH MEDICAL JOURNAL			English	Review							MANAGEMENT; CARE		Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Hobbs, FDR (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.			hobbs, richard/0000-0001-7976-7172				Eccles M, 1998, BMJ-BRIT MED J, V316, P1369, DOI 10.1136/bmj.316.7141.1369; FRANCIS CM, 1995, BRIT MED J, V310, P634, DOI 10.1136/bmj.310.6980.634; LIP G, 1997, EUR J GEN PRACT, V3, P85; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Stewart S, 1999, ARCH INTERN MED, V159, P257, DOI 10.1001/archinte.159.3.257	6	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					626	629		10.1136/bmj.320.7235.626	http://dx.doi.org/10.1136/bmj.320.7235.626			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698886	Green Published			2022-12-28	WOS:000085742600030
J	Tomlinson, S				Tomlinson, S			The research assessment exercise and medical research	BRITISH MEDICAL JOURNAL			English	Article									Manchester Royal Infirm, Clin Res Div 2, Manchester M13 9WL, Lancs, England; Univ Manchester, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Tomlinson, S (corresponding author), Manchester Royal Infirm, Clin Res Div 2, Oxford Rd, Manchester M13 9WL, Lancs, England.							Committee of Vice Chancellors and Principals, 1997, CLIN AC CAR REP IND; ROBERTS C, 1999, RES FORTNIGHT, V6, P1; Williams G, 1998, BRIT MED J, V316, P1079	3	34	34	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					636	639		10.1136/bmj.320.7235.636	http://dx.doi.org/10.1136/bmj.320.7235.636			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698889	Green Published			2022-12-28	WOS:000085742600033
J	Gillet, P; Chen, M; Dubrovinsky, L; El Goresy, A				Gillet, P; Chen, M; Dubrovinsky, L; El Goresy, A			Natural NaAlSi3O8-hollandite in the shocked Sixiangkou meteorite	SCIENCE			English	Article							CRYSTAL-CHEMISTRY; PRESSURE; PHASE; HOLLANDITE; MANTLE	The hollandite high-pressure polymorph of plagioclase has been identified in shock-induced melt veins of the Sixiangkou 16 chondrite. It is intimately intergrown with feldspathic glass within grains previously thought to be "maskelynite." The crystallographic nature of the mineral was established by Laser micro-Raman spectroscopy and x-ray diffraction. The mineral is tetragonal with the unit cell parameters a = 9.263 +/- 0.003 angstroms and c = 2.706 +/- 0.003 angstroms. its occurrence with the Liquidus pair majorite-pyrope solid solution plus magnesio-wustite sets constraints on the peak pressures that prevailed in the shock-induced melt veins. The absence of a calcium ferrite-structured phase sets an upper bound for the crystallization of the hollandite polymorph near 23 gigapascals.	Ecole Normale Super Lyon, Lab Sci Terre, F-69364 Lyon, France; Univ Lyon 1, CNRS, UMR 5570, F-69364 Lyon, France; Max Planck Inst Chem, D-55128 Mainz, Germany; AC, Guangzhou Inst Geochem, Guangzhou, Peoples R China; Uppsala Univ, Inst Earth Sci, S-75236 Uppsala, Sweden	Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Max Planck Society; Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS; Uppsala University	Gillet, P (corresponding author), Ecole Normale Super Lyon, Lab Sci Terre, 46 Allee Italie, F-69364 Lyon, France.			Dubrovinsky, Leonid/0000-0002-3717-7585				AGEE CB, 1995, J GEOPHYS RES-SOL EA, V100, P17725, DOI 10.1029/95JB00049; [Anonymous], J SOLID STATE CHEM; Brearley A. J., 1998, REV MINERAL GEOCHEM, V36, P1; Chen M, 1996, SCIENCE, V271, P1570, DOI 10.1126/science.271.5255.1570; DOWNS RT, 1995, AM MINERAL, V80, P937; ElGoresy A, 1997, METEORIT PLANET SCI, V32, pA38; HEMLEY RJ, 1986, PHYS CHEM MINER, V13, P285, DOI 10.1007/BF00308345; HOLLAND TJB, 1980, AM MINERAL, V65, P129; LIU LG, 1978, EARTH PLANET SC LETT, V37, P438, DOI 10.1016/0012-821X(78)90059-6; MADON M, 1989, NATURE, V342, P422, DOI 10.1038/342422a0; Richet P, 1997, EUR J MINERAL, V9, P907; RINGWOOD AE, 1967, ACTA CRYSTALLOGR, V23, P1093, DOI 10.1107/S0365110X6700430X; SEIFERT F, 1982, AM MINERAL, V67, P696; Sharp TG, 1997, SCIENCE, V277, P352, DOI 10.1126/science.277.5324.352; STOFFLER D, 1991, GEOCHIM COSMOCHIM AC, V55, P3845, DOI 10.1016/0016-7037(91)90078-J; Stoffler D., 1988, METEORITES EARLY SOL, P165; Tomioka N, 1997, SCIENCE, V277, P1084, DOI 10.1126/science.277.5329.1084; VANDERHILST R, 1995, NATURE, V374, P154, DOI 10.1038/374154a0; YAGI A, 1994, PHYS CHEM MINER, V21, P12; ZHANG JM, 1993, AM MINERAL, V78, P493	20	132	143	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1633	1636		10.1126/science.287.5458.1633	http://dx.doi.org/10.1126/science.287.5458.1633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698734				2022-12-28	WOS:000085628200032
J	Winkler, KE; Swenson, KI; Kornbluth, S; Means, AR				Winkler, KE; Swenson, KI; Kornbluth, S; Means, AR			Requirement of the prolyl isomerase Pin1 for the replication checkpoint	SCIENCE			English	Article							CELL-CYCLE; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; EGG EXTRACTS; MITOSIS; XENOPUS; COMPLETION; MATURATION; SEQUENCE; PROTEIN	The peptidyl-prolyl isomerase Pin1 has been implicated in regulating cell cycle progression. Pin1 was found to be required for the DNA replication checkpoint in Xenopus laevis, Egg extracts depleted of Pin1 inappropriately transited from the G(2) to the M phase of the cell cycle in the presence of the DNA replication inhibitor aphidicolin. This defect in replication checkpoint function was reversed after the addition of recombinant wild-type Pin1, but not an isomerase-inactive mutant, to the depleted extract. Premature mitotic entry in the absence of Pin1 was accompanied by hyperphosphorylation of Cdc25, activation of Cdc2/cyclin B, and generation of epitopes recognized by the mitotic phosphoprotein antibody, MPM-2. Therefore, Pin1 appears to be required for the checkpoint delaying the onset of mitosis in response to incomplete replication.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Means, AR (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.				NATIONAL CANCER INSTITUTE [R01CA082845] Funding Source: NIH RePORTER; NCI NIH HHS [CA 82845] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albert A, 1999, J CELL SCI, V112, P2493; BLOW JJ, 1993, J CELL BIOL, V122, P993, DOI 10.1083/jcb.122.5.993; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; Hani J, 1999, J BIOL CHEM, V274, P108, DOI 10.1074/jbc.274.1.108; HANI J, 1995, FEBS LETT, V365, P198, DOI 10.1016/0014-5793(95)00471-K; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; KORNBLUTH S, 1994, MOL BIOL CELL, V5, P273, DOI 10.1091/mbc.5.3.273; KUANG J, 1989, P NATL ACAD SCI USA, V86, P4982, DOI 10.1073/pnas.86.13.4982; KUMAGAI A, 1995, MOL BIOL CELL, V6, P199, DOI 10.1091/mbc.6.2.199; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Maleszka R, 1996, P NATL ACAD SCI USA, V93, P447, DOI 10.1073/pnas.93.1.447; Morris DP, 1999, J BIOL CHEM, V274, P31583, DOI 10.1074/jbc.274.44.31583; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; SCHLEGEL R, 1987, P NATL ACAD SCI USA, V84, P9025, DOI 10.1073/pnas.84.24.9025; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; WILCOX C, UNPUB; WINKLER K, UNPUB; WU XT, COMMUNICATION; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957	33	148	153	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1644	1647		10.1126/science.287.5458.1644	http://dx.doi.org/10.1126/science.287.5458.1644			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698738				2022-12-28	WOS:000085628200036
J	Tello, J; Bossano, J				Tello, J; Bossano, J			Varicella gangrenosa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Lake Charles Mem Hosp, Lake Charles, LA 70601 USA		Tello, J (corresponding author), Lake Charles Mem Hosp, Lake Charles, LA 70601 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					634	634		10.1056/NEJM200003023420905	http://dx.doi.org/10.1056/NEJM200003023420905			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10699163				2022-12-28	WOS:000085575500005
J	Bagshawe, KD				Bagshawe, KD			Limitations of tests for human chorionic gonadotropin	LANCET			English	Editorial Material									Imperial Coll Sch Med, Dept Med Oncol, London W6 8RF, England	Imperial College London	Bagshawe, KD (corresponding author), Imperial Coll Sch Med, Dept Med Oncol, Charing Cross Campus, London W6 8RF, England.							BAGSHAWE KD, 1986, LANCET, V2, P673; BOSCATO LM, 1988, CLIN CHEM, V34, P27; *WHO, 1983, WHO TECH REP SER, V692; WILDE CE, 1965, NATURE, V205, P191, DOI 10.1038/205191a0; ZONDEK B, 1929, ENDOKRINOLOGIE, V5, P425; 1999, ACB NEWS	6	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					671	671		10.1016/S0140-6736(00)00066-0	http://dx.doi.org/10.1016/S0140-6736(00)00066-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703795				2022-12-28	WOS:000085615600004
J	Heaney, AP; Singson, R; McCabe, CJ; Nelson, V; Nakashima, M; Melmed, S				Heaney, AP; Singson, R; McCabe, CJ; Nelson, V; Nakashima, M; Melmed, S			Expression of pituitary-tumour transforming gene in colorectal tumours	LANCET			English	Article							FIBROBLAST GROWTH-FACTOR; IDENTIFICATION; TUMORIGENESIS; INVASION; CANCERS; COLON; CELLS	Background Basic fibroblast growth factor promotes angiogenesis and mitogenesis in colon carcinomas. Pituitary tumour transforming gene (PTTG(1)) causes in-vitro and in-vivo transformation, regulates secretion of basic fibroblast growth factor. and inhibits chromatid separation. Most normal tissues show little or no PTTG(1) expression but cancer cells express the gene abundantly. We postulated that PTTG(2) expression in colorectal tumours is related to tumour invasiveness. Methods PTTG(1) gene and protein expression were assessed in 68 colorectal tumours and compared with invasive characteristics, such as lymph-node invasion. evidence of metastases, tumour Vessel density, and expression of basic fibroblast growth factor. PTTG(1) expression is given in terms of the fold-increase over that in normal-adjacent colorectal tissue. Findings PTTG(1) was overexpressed in all of 48 colon carcinomas (median fold-increase 2.2 [IQR 1.8-3.3]) and in 19 of 20 colonic polyps (2.2 [1.6-3.1]) compared with normal colonic tissue. Invasion of surrounding lymph nodes was associated with higher PTTG(1) expression than in carcinomas limited to the bowel wall (3.4 [2.1-5.9] vs 1.9 [1.7-2.4], p=0.007), and higher PTTG(1) expression was seen in more vascular than in less vascular tumours (2.6 [1.9-5.1] vs 1.9 [1.8-2.5], p=0.04). Interpretation Increased tumour PTTG(1) expression may be a marker of invasive colorectal carcinoma and could represent a new therapeutic target.	Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Dept Med, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Dept Pathol, Los Angeles, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Melmed, S (corresponding author), Cedars Sinai Med Ctr, Acad Affairs, 8700 Beverly Blvd,B-2015, Los Angeles, CA 90048 USA.				NATIONAL CANCER INSTITUTE [R01CA075979] Funding Source: NIH RePORTER; NCI NIH HHS [CA 75979] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; BOSARI S, 1992, HUM PATHOL, V23, P755, DOI 10.1016/0046-8177(92)90344-3; BOSS JL, 1987, NATURE, V327, P293; DEMILIA J, 1989, ONCOGENE, V4, P1233; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FINLEY GG, 1989, ONCOGENE, V4, P963; Folkman J, 1992, Semin Cancer Biol, V3, P65; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Galzie Z, 1997, INT J CANCER, V71, P390, DOI 10.1002/(SICI)1097-0215(19970502)71:3<390::AID-IJC15>3.0.CO;2-K; GRAHAM CH, 1994, AM J PATHOL, V145, P510; GULDI AJ, 1994, J NATL CANCER I, V86, P614; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; JAYSON GC, 1994, CANCER RES, V54, P5718; MURGUE B, 1994, CANCER RES, V54, P5206; Nakata S, 1998, INT J CANCER, V79, P179, DOI 10.1002/(SICI)1097-0215(19980417)79:2<179::AID-IJC14>3.0.CO;2-5; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Orr-Weaver TL, 1999, SCIENCE, V285, P344; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Prezant TR, 1999, J CLIN ENDOCR METAB, V84, P1149, DOI 10.1210/jc.84.3.1149; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WEIDNER N, 1992, NEW ENGL J MED, V324, P1; WILKINSON MC, 1993, INT J ONCOL, V3, P933; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zhang X, 1999, J CLIN ENDOCR METAB, V84, P761, DOI 10.1210/jc.84.2.761; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	30	197	222	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					716	719		10.1016/S0140-6736(99)10238-1	http://dx.doi.org/10.1016/S0140-6736(99)10238-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703804				2022-12-28	WOS:000085615600014
J	Aubin, F; Cahn, JY; Ferrand, C; Angonin, R; Humbert, P; Tiberghien, P				Aubin, F; Cahn, JY; Ferrand, C; Angonin, R; Humbert, P; Tiberghien, P			Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase	LANCET			English	Article								Most patients with frontotemporal dementia do not have tau-pathology as shown by immunohistochemistry. The use of the term tauopathy to classify frontotemporal dementia is inappropriate.	Univ Hosp, ETS Franche Comte, Dept Dermatol, F-25030 Besancon, France; Univ Hosp, ETS Franche Comte, Dept Pathol, F-25030 Besancon, France; Univ Hosp, ETS Franche Comte, Dept Haematol, F-25030 Besancon, France; Univ Hosp, ETS Franche Comte, Cell & Gene Therapy Unit, F-25030 Besancon, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon	Aubin, F (corresponding author), Univ Hosp, ETS Franche Comte, Dept Dermatol, 2 Pl St Jacques, F-25030 Besancon, France.		Tiberghien, Pierre/AAH-5878-2019; Aubin, François/AAB-5824-2022; Aubin, François/ABE-1236-2021	Aubin, François/0000-0002-1421-4996; Aubin, François/0000-0002-1421-4996; Tiberghien, Pierre/0000-0002-9310-8322				CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; Johnsen ML, 1998, J AM ACAD DERMATOL, V38, P369, DOI 10.1016/S0190-9622(98)70495-5; Kawakami Y, 1998, J IMMUNOTHER, V21, P237, DOI 10.1097/00002371-199807000-00001; Tiberghien P, 1997, HUM GENE THER, V8, P615, DOI 10.1089/hum.1997.8.5-615; Tiberghien P, 1998, Curr Opin Hematol, V5, P478, DOI 10.1097/00062752-199811000-00021	5	17	18	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					626	627		10.1016/S0140-6736(99)04215-4	http://dx.doi.org/10.1016/S0140-6736(99)04215-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696989				2022-12-28	WOS:000085615400020
J	Mulshine, JL; Henschke, CI				Mulshine, JL; Henschke, CI			Prospects for lung-cancer screening	LANCET			English	Editorial Material							DIAGNOSIS; LESIONS		NCI, Med Branch, Bethesda, MD 20892 USA; Cornell Univ, Weill Med Coll, Ithaca, NY 14853 USA; New York Presbyterian Hosp, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; NewYork-Presbyterian Hospital	Mulshine, JL (corresponding author), NCI, Med Branch, 8900 Rockville Pike, Bethesda, MD 20892 USA.							Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Bonelli FS, 1998, AM J ROENTGENOL, V170, P1507, DOI 10.2214/ajr.170.6.9609163; FIELD JK, 1999, LUNG TUMOURS FUNDAME, P287; Fielding P, 1999, CLIN CANCER RES, V5, P4048; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; HUNG J, 1995, JAMA-J AM MED ASSOC, V273, P558, DOI 10.1001/jama.273.7.558; KANEKO M, IN PRESS CANCER; KANEKO M, 1998, INT C PREV EARL DIAG, P144; KISHIMOTO Y, 1995, JNCI-J NATL CANCER I, V87, P1224, DOI 10.1093/jnci/87.16.1224; MAO L, 1994, P NATL ACAD SCI USA, V91, P9871, DOI 10.1073/pnas.91.21.9871; MAO L, 1994, CANCER RES, V54, P1634; Mao L, 1997, J NATL CANCER I, V89, P857, DOI 10.1093/jnci/89.12.857; Smith IE, 1999, LANCET, V354, P86, DOI 10.1016/S0140-6736(99)00228-7; SUNDARESAN V, 1992, ONCOGENE, V7, P1989; TOCKMAN MS, 1988, J CLIN ONCOL, V6, P1685, DOI 10.1200/JCO.1988.6.11.1685; Tockman MS, 1997, CLIN CANCER RES, V3, P2237; Wistuba II, 1999, ONCOGENE, V18, P643, DOI 10.1038/sj.onc.1202349	17	28	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					592	593		10.1016/S0140-6736(99)00398-0	http://dx.doi.org/10.1016/S0140-6736(99)00398-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696976				2022-12-28	WOS:000085615400006
J	Gilbertson, L; Langhorne, P; Walker, A; Allen, A; Murray, GD				Gilbertson, L; Langhorne, P; Walker, A; Allen, A; Murray, GD			Domiciliary occupational therapy for patients with stroke discharged from hospital: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							REHABILITATION	Objective To establish if a brief programme of domiciliary occupational therapy could improve the recovery of patients with stroke discharged from hospital. Design Single blind randomised controlled trial. Setting Two hospital sites within a UK teaching hospital. Subjects 138 patients with stroke with a definite plan for discharge home from hospital. Intervention Six week domiciliary occupational therapy or routine follow up. Main outcome measures Nottingham extended activities of daily living score and "global outcome" (deterioration according to the Barthel activities of daily living index, or death). Results By eight weeks the mean Nottingham extended activities of daily living score in the intervention group was 4.8 points (95% confidence interval -0.5 to 10.0, P = 0.08) greater than that of the control group. Overall, 16 (24%) intervention patients had a poor global outcome compared with 30 (42%) control patients (odds ratio 0.43, 0.21 to 0.89, P = 0.02). These patterns persisted at six months but were not statistically significant Patients in the intervention group were more likely to report satisfaction with a range of aspects of services. Conclusion The functional outcome and satisfaction of patients with stroke can be improved by a brief occupational therapy programme carried out in the patient's home immediately after discharge. Major benefits may not, however, be sustained.	Glasgow Royal Infirm, Acad Sect Geriatr Med, Glasgow G4 0SF, Lanark, Scotland; Glasgow Royal Infirm, Dept Occupat Therapy, Glasgow G4 0SF, Lanark, Scotland; Greater Glasgow Hlth Board, Glasgow G3 8YU, Lanark, Scotland; Univ Edinburgh, Dept Community Hlth Sci, Med Stat Unit, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland	University of Glasgow; University of Glasgow; University of Edinburgh	Langhorne, P (corresponding author), Glasgow Royal Infirm, Acad Sect Geriatr Med, Glasgow G4 0SF, Lanark, Scotland.			Murray, Gordon/0000-0001-9866-4734				Corr S, 1995, CLIN REHABIL, V9, P291; Dennis M, 1997, BRIT MED J, V314, P1071, DOI 10.1136/bmj.314.7087.1071; Drummond A, 1995, CLIN REHABIL, V9, P283, DOI DOI 10.1177/026921559500900402; FORSTER A, 1992, BRIT MED J, V305, P1446, DOI 10.1136/bmj.305.6867.1446; GILBERTSON L, 1998, THESIS U GLASGOW; Gladman J, 1996, BRIT MED J, V312, P1623, DOI 10.1136/bmj.312.7047.1623; Logan PA, 1997, CLIN REHABIL, V11, P107, DOI 10.1177/026921559701100203; Rodgers H, 1997, CLIN REHABIL, V11, P280, DOI 10.1177/026921559701100403; Rudd AG, 1997, BMJ-BRIT MED J, V315, P1039, DOI 10.1136/bmj.315.7115.1039; Wade DT., 1992, MEASUREMENT NEUROLOG; Walker MF, 1999, LANCET, V354, P278, DOI 10.1016/S0140-6736(98)11128-5	11	88	90	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					603	606		10.1136/bmj.320.7235.603	http://dx.doi.org/10.1136/bmj.320.7235.603			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698876	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-28	WOS:000085742600022
J	Cluzel, P; Surette, M; Leibler, S				Cluzel, P; Surette, M; Leibler, S			An ultrasensitive bacterial motor revealed by monitoring signaling proteins in single cells	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; FLAGELLAR ROTATION; ESCHERICHIA-COLI; CHEMOTAXIS; SWITCH; PHOSPHORYLATION; DIAGNOSTICS; ADAPTATION; MOLECULES; DIRECTION	Understanding biology at the single-cell Level requires simultaneous measurements of biochemical parameters and behavioral characteristics in individual cells. Here, the output of individual flagellar motors in Escherichia coli was measured as a function of the intracellular concentration of the chemotactic signaling protein. The concentration of this molecule, fused to green fluorescent protein, was monitored with fluorescence correlation spectroscopy. Motors from different bacteria exhibited an identical steep input-output relation, suggesting that they actively contribute to signal amplification in chemotaxis. This experimental approach can be extended to quantitative in vivo studies of other biochemical networks.	Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	Princeton University; Princeton University; University of Calgary	Cluzel, P (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	phcluzel@phoenix.princeton.edu						Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; BARAK R, 1992, BIOCHEMISTRY-US, V31, P1821, DOI 10.1021/bi00121a034; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Blat Y, 1998, J MOL BIOL, V284, P1191, DOI 10.1006/jmbi.1998.2224; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Brock R, 1999, P NATL ACAD SCI USA, V96, P10123, DOI 10.1073/pnas.96.18.10123; CLUZEL P, UNPUB; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; ISHIHARA A, 1983, J BACTERIOL, V155, P228, DOI 10.1128/JB.155.1.228-237.1983; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; KUO SC, 1989, J BACTERIOL, V171, P6279, DOI 10.1128/jb.171.11.6279-6287.1989; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; Levin MD, 1998, BIOPHYS J, V74, P175, DOI 10.1016/S0006-3495(98)77777-X; MACNAB RM, 1995, 2 COMPONENT SIGNAL T, P181; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; RIGLER R, 1992, FLUORESCENCE SPECTRO, P13; Scharf BE, 1998, J BACTERIOL, V180, P5123, DOI 10.1128/JB.180.19.5123-5128.1998; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Spiro PA, 1997, P NATL ACAD SCI USA, V94, P7263, DOI 10.1073/pnas.94.14.7263; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; WELCH M, 1994, BIOCHEMISTRY-US, V33, P10470, DOI 10.1021/bi00200a031; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; Zhao RB, 1996, J BACTERIOL, V178, P258, DOI 10.1128/jb.178.1.258-265.1996	31	459	464	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2000	287	5458					1652	1655		10.1126/science.287.5458.1652	http://dx.doi.org/10.1126/science.287.5458.1652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698740				2022-12-28	WOS:000085628200038
J	Fink, SL				Fink, SL			Physician groups and the war in Kosovo: Ethics, neutrality, and interventionism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif Berkeley, Human Rights Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Fink, SL (corresponding author), Univ Calif Berkeley, Human Rights Ctr, Berkeley, CA 94720 USA.							Agovino T, 1997, LANCET, V350, P1757; Agovino T, 1998, LANCET, V352, P1687, DOI 10.1016/S0140-6736(05)61465-1; *INT CRIS GROUP, 1998, KOS LONG HOT SUMM BR; RUBENSTEIN LS, 1999, PHR CALLS GROUND TRO; Russbach R., 1994, MED GLOBAL SURVIVAL, V1, P188; World Medical Association, 1983, INT COD MED ETH	6	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1200	1200		10.1001/jama.283.9.1200	http://dx.doi.org/10.1001/jama.283.9.1200			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703787	hybrid			2022-12-28	WOS:000085424100034
J	Bodenheimer, T				Bodenheimer, T			Disease management in the American market	BRITISH MEDICAL JOURNAL			English	Article							HEART-FAILURE; CARE; SYSTEM		Univ Calif San Francisco, Sch Med, Dept Family & Community Med, San Francisco, CA 94110 USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, Sch Med, Dept Family & Community Med, 1580 Valencia St,Suite 201, San Francisco, CA 94110 USA.							Anders G., 1996, HLTH WEALTH HMOS BRE; Anderson GF, 1999, AM J MANAG CARE, V5, P853; Blendon RJ, 1998, HEALTH AFFAIR, V17, P80, DOI 10.1377/hlthaff.17.4.80; Bodenheimer T, 1999, NEW ENGL J MED, V340, P1202, DOI 10.1056/NEJM199904153401511; Bodenheimer T, 1998, NEW ENGL J MED, V338, P1003, DOI 10.1056/NEJM199804023381422; Burns H, 1996, LANCET, V347, P1021, DOI 10.1016/S0140-6736(96)90151-8; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; *FAM US FDN, 1998, PREM PAY 2 CORP COMP; FREUDENHEIM M, 1998, NY TIMES        0110, P1; Ginzberg E, 1997, NEW ENGL J MED, V336, P1018, DOI 10.1056/NEJM199704033361411; Hunter DJ, 1997, BRIT MED J, V315, P50, DOI 10.1136/bmj.315.7099.50; Iezzoni LI, 1998, NEW ENGL J MED, V339, P1933, DOI 10.1056/NEJM199812243392613; *NAT HLTH INF, 1999, 1999 DIS MAN DIR GUI; Neuman P, 1999, HEALTH AFFAIR, V18, P150, DOI 10.1377/hlthaff.18.1.150; Rice TT, 1997, HOSP HEALTH NETWORK, V71, P34; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; ROBINSON JC, 1991, JAMA-J AM MED ASSOC, V266, P2719, DOI 10.1001/jama.266.19.2719; Rubin RJ, 1998, J CLIN ENDOCR METAB, V83, P2635, DOI 10.1210/jc.83.8.2635; Schulman KA, 1996, ANN INTERN MED, V124, P906, DOI 10.7326/0003-4819-124-10-199605150-00008; West JA, 1997, AM J CARDIOL, V79, P58, DOI 10.1016/S0002-9149(96)00676-5	20	59	61	1	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					563	566		10.1136/bmj.320.7234.563	http://dx.doi.org/10.1136/bmj.320.7234.563			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688566	Green Published			2022-12-28	WOS:000085624000027
J	Gottlieb, S				Gottlieb, S			Screening changes recommended for osteoporosis and diabetes	BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					532	532						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688546				2022-12-28	WOS:000085624000009
J	Treanor, JJ; Hayden, FG; Vrooman, PS; Barbarash, R; Bettis, R; Riff, D; Singh, S; Kinnersley, N; Ward, P; Mills, RG				Treanor, JJ; Hayden, FG; Vrooman, PS; Barbarash, R; Bettis, R; Riff, D; Singh, S; Kinnersley, N; Ward, P; Mills, RG		US Oral Neuraminidase Study Grp	Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	38th Interscience Conference on Antimicrobial Agents and Chemotherapy	SEP 24-28, 1998	SAN DIEGO, CALIFORNIA				A VIRUS; RIMANTADINE HYDROCHLORIDE; ACTIVE-SITE; B-VIRUS; AMANTADINE; RESISTANT; INFECTION; IMPACT; ADULTS; POPULATION	Context Previous studies have shown oseltamivir, a neuraminidase inhibitor, to be effective in preventing influenza and treating experimental influenza. Objective To evaluate the efficacy and safety of oseltamivir in the treatment of naturally acquired influenza infection. Design Randomized, placebo-controlled, double-blind study conducted January through March 1998. Setting Sixty primary care and university health centers throughout the United States. Participants A total of 629 healthy nonimmunized adults aged 18 to 65 years with febrile respiratory illness of no more than 36 hours' duration with temperature of 38 degrees C or more plus at least 1 respiratory symptom and 1 constitutional symptom. Interventions Individuals were randomized to 1 of 3 treatment groups with identical appearing pills: oral oseltamivir phosphate, 75 mg twice daily (n =211) or 150 mg (n = 209) twice daily, or placebo (n = 209). Main Outcome Measures Duration and severity of illness in individuals infected with influenza. Results Two individuals withdrew before receiving medication and were excluded from further analyses, A total of 374 individuals (59.6%) were infected with influenza. Their duration of illness was reduced by more than 30% with both oseltamivir, 75 mg twice daily (median, 71.5 hours; P < .001), and oseltamivir, 150 mg twice daily (median, 69.9 hours; P = .006), compared with placebo (median, 103.3 hours). Severity of illness was reduced by 38% (median score, 597 score-hours; P < .001) with oseltamivir, 75 mg twice daily, and by 35% (median score, 626 score-hours; P < .001) with oseitamivir, 150 mg twice daily, vs placebo (median score, 963 score-hours). Oseltamivir treatment reduced the duration of fever and oseltamivir recipients returned to usual activities 2 to 3 days earlier than placebo recipients (P less than or equal to .05). Secondary complications such as bronchitis and sinusitis occurred in 15% of placebo recipients compared with 7% of combined oseltamivir recipients (P = .03). Among all 629 subjects, oseltamivir reduced illness duration (76.3 hours and 74.3 hours for 75 mg and 150 mg, respectively, vs 97.0 hours for placebo; P = .004 for both comparisons) and illness severity (686 score-hours and 629 score-hours for 75 mg and 150 mg, respectively, vs 887 score-hours for placebo; P < .001 for both comparisons). Nausea and vomiting occurred more frequently in both oseltamivir groups (combined, 18.0% and 14.1%, respectively; P = .002) than in the placebo group (7.4% and 3.4%; P < .001). Conclusions Our data suggest that oral oseltamivir treatment reduces the duration and severity of acute influenza in healthy adults and may decrease the incidence of secondary complications.	Univ Rochester, Infect Dis Unit, Rochester, NY 14642 USA; Univ Virginia, Charlottesville, VA USA; PW Clin Res, Winston Salem, NC USA; Hill Top Res, St Louis, MO USA; Edmonds Family Med Clin, Edmonds, WA USA; Adv Clin Res Inst, Anaheim, CA USA; SARC Res Ctr, Fresno, CA USA; Roche Global Dev, Welwyn, England; Gilead Sci Inc, Foster City, CA 94404 USA	University of Rochester; University of Virginia; Roche Holding; Gilead Sciences	Treanor, JJ (corresponding author), Univ Rochester, Infect Dis Unit, Box 689,601 Elmwood Ave, Rochester, NY 14642 USA.			Ward, Penelope/0000-0002-7585-4313				[Anonymous], [No title captured]; AOKI FY, 1998, 38 INT C ANT AG CHEM; BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; BROWN LE, 1996, OPTIONS CONTROL INFL, P17; CALFEE DP, 1998, 38 INT C ANT AG CHEM; DEGELAU J, 1992, ARCH INTERN MED, V152, P390, DOI 10.1001/archinte.152.2.390; GALBRAIT.AW, 1969, B WORLD HEALTH ORGAN, V41, P677; GALBRAITH AW, 1971, LANCET, V1, P113; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; HAYDEN FG, 1991, ANTIMICROB AGENTS CH, V35, P1741, DOI 10.1128/AAC.35.9.1741; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; HAYDEN FG, 1989, NEW ENGL J MED, V321, P1696, DOI 10.1056/NEJM198912213212502; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; HAYDEN FG, 1986, ANTIMICROB AGENTS CH, V29, P339, DOI 10.1128/AAC.29.2.339; HAYDEN FG, 1981, ANTIMICROB AGENTS CH, V19, P226, DOI 10.1128/AAC.19.2.226; KAISER L, 1999, 39 ANN INT C ANT AG; KAVET J, 1977, AM J PUBLIC HEALTH, V67, P1063, DOI 10.2105/AJPH.67.11.1063; Keech M, 1998, OCCUP MED-OXFORD, V48, P85, DOI 10.1093/occmed/48.2.85; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; LENETTE EH, 1979, DIAGNOSTIC PROCEDURE, P603; Mahy B.W., 1996, VIROLOGY METHODS MAN, P25; Mendel DB, 1998, ANTIMICROB AGENTS CH, V42, P640, DOI 10.1128/AAC.42.3.640; *MIST STUD GROUP, 1998, LANCET, V352, P1877; MONTO AS, 1992, CLIN INFECT DIS, V15, P362, DOI 10.1093/clinids/15.2.362; Monto AS, 1999, J INFECT DIS, V180, P254, DOI 10.1086/314904; National Institutes of Health, 1993, NIH PUBL; SCHOENBAUM SC, 1987, AM J MED, V82, P26, DOI 10.1016/0002-9343(87)90557-2; SMITH AP, 1993, BRIT MED J, V306, P760, DOI 10.1136/bmj.306.6880.760; SULLIVAN KM, 1993, AM J PUBLIC HEALTH, V83, P1712, DOI 10.2105/AJPH.83.12.1712; TOGO Y, 1970, J AMER MED ASSOC, V211, P1149, DOI 10.1001/jama.211.7.1149; VANVORIS LP, 1981, JAMA-J AM MED ASSOC, V245, P1128, DOI 10.1001/jama.245.11.1128; WILTSHIRE HR, 1998, DISTRIBUTION INFLUEN; WOOD ND, 1997, TOLERABILITY PHARMAC; YOUNKIN SW, 1983, ANTIMICROB AGENTS CH, V23, P577, DOI 10.1128/AAC.23.4.577	38	752	814	1	42	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					1016	1024		10.1001/jama.283.8.1016	http://dx.doi.org/10.1001/jama.283.8.1016			9	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284AM	10697061	Bronze			2022-12-28	WOS:000085308600030
J	Christensen, SK; Dagenais, N; Chory, J; Weigel, D				Christensen, SK; Dagenais, N; Chory, J; Weigel, D			Regulation of auxin response by the protein kinase PINOID	CELL			English	Article							ARABIDOPSIS GENE MONOPTEROS; TRANSCRIPTION FACTOR; VASCULAR DEVELOPMENT; AUX/IAA PROTEINS; POLAR TRANSPORT; THALIANA; MUTANTS; EXPRESSION; ENCODES; EMBRYO	Arabidopsis plants carrying mutations in the PINOID (PID) gene have a pleiotropic shoot phenotype that mimics that of plants grown on auxin transport inhibitors or of plants mutant for the auxin efflux carrier PINFORMED (PIN), with defects in the formation of cotyledons, flowers, and floral organs. We have cloned PID and find that it is transiently expressed in the embryo and in initiating floral anlagen, demonstrating a specific role for PID in promoting primordium development. Constitutive expression of PID causes a phenotype in both shoots and roots that is similar to that of auxin-insensitive plants, implying that PID, which encodes a serine-threonine protein kinase, negatively regulates auxin signaling.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963				Aloni Roni, 1995, P531; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; BERLETH T, 1993, DEVELOPMENT, V118, P575; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; CELENZA JL, 1995, GENE DEV, V9, P2131, DOI 10.1101/gad.9.17.2131; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Davies Peter J., 1995, P1; Ephritikhine G, 1999, PLANT J, V18, P303, DOI 10.1046/j.1365-313X.1999.00454.x; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Fischer C, 1996, PLANT J, V9, P659, DOI 10.1046/j.1365-313X.1996.9050659.x; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Guilfoyle T, 1998, PLANT PHYSIOL, V118, P341, DOI 10.1104/pp.118.2.341; Hadfi K, 1998, DEVELOPMENT, V125, P879; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; JURGENS G, 1993, COLOUR ATLAS DEV EMB, P7; Kaufman Peter B., 1995, P547; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Lee I, 1997, CURR BIOL, V7, P95, DOI 10.1016/S0960-9822(06)00053-4; Lehman A, 1996, CELL, V85, P183, DOI 10.1016/S0092-8674(00)81095-8; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; LIU CM, 1993, PLANT CELL, V5, P621, DOI 10.1105/tpc.5.6.621; Long JA, 1998, DEVELOPMENT, V125, P3027; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; MAHER EP, 1980, BIOCHEM GENET, V18, P1041, DOI 10.1007/BF00484337; MANSFIELD SG, 1991, CAN J BOT, V69, P461, DOI 10.1139/b91-063; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Mattsson J, 1999, DEVELOPMENT, V126, P2979; MIZOGUCHI T, 1994, PLANT J, V5, P111, DOI 10.1046/j.1365-313X.1994.5010111.x; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nilsson O, 1998, PLANT J, V15, P799, DOI 10.1046/j.1365-313X.1998.00260.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Przemeck GKH, 1996, PLANTA, V200, P229, DOI 10.1007/BF00208313; Reed RC, 1998, PLANT PHYSIOL, V118, P1369, DOI 10.1104/pp.118.4.1369; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; SCIAVONE FM, 1987, CELL DIFFER, V21, P53; SESSIONS RA, 1995, DEVELOPMENT, V121, P1519; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Tian Q, 1999, DEVELOPMENT, V126, P711; TIMPTE C, 1995, PLANT J, V8, P561, DOI 10.1046/j.1365-313X.1995.8040561.x; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 2000, IN PRESS PLANT PHYSL	63	353	382	4	55	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					469	478		10.1016/S0092-8674(00)80682-0	http://dx.doi.org/10.1016/S0092-8674(00)80682-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693763	Bronze			2022-12-28	WOS:000085446900009
J	Mao, YX; Nickitenko, A; Duan, XQ; Lloyd, TE; Wu, MN; Bellen, H; Quiocho, FA				Mao, YX; Nickitenko, A; Duan, XQ; Lloyd, TE; Wu, MN; Bellen, H; Quiocho, FA			Crystal structure of the VHS and FYVE tandem domains of Hrs, a protein involved in membrane trafficking and signal transduction	CELL			English	Article							ZINC-FINGER DOMAIN; ADAPTER MOLECULE; CELL-GROWTH; MOLSCRIPT; BINDING; PROGRAM; MOTIF; STAM; EEA1	We have determined the 2 Angstrom X-ray structure of the 219-residue N-terminal VHS and MIE tandem domain unit of Drosophila Hrs. The unit assumes a pyramidal structure in which the much larger YHS domain (residues 1-153) forms a rectangular base and the FYVE domain occupies the apical end. The VHS domain is comprised of an unusual "superhelix" of eight alpha helices, and the MIE domain is mainly built of loops, two double-stranded antiparallel sheets, and a helix stabilized by two tetrahedrally coordinated zinc atoms. The two-domain structure forms an exact 2-fold-related homodimer through antiparallel association of mainly FYVE domains. Dimerization creates two identical pockets designed for binding ligands with multiple negative charges such as citrate or phosphatidylinositol 3-phosphate.	Baylor Coll Med, Struct & Computat Biol & Mol Biophys Grad Program, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Quiocho, FA (corresponding author), Baylor Coll Med, Struct & Computat Biol & Mol Biophys Grad Program, Houston, TX 77030 USA.			Lloyd, Thomas/0000-0003-4756-3700; Bellen, Hugo/0000-0001-5992-5989; Mao, Yuxin/0000-0002-5064-1397				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Carbone R, 1997, CANCER RES, V57, P5498; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Lohi O, 1998, J BIOL CHEM, V273, P21408, DOI 10.1074/jbc.273.33.21408; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; RAAG R, 1988, J MOL BIOL, V200, P553, DOI 10.1016/0022-2836(88)90542-6; Sack JS, 1997, METHOD ENZYMOL, V277, P158, DOI 10.1016/S0076-6879(97)77011-3; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Strickland CL, 1998, BIOCHEMISTRY-US, V37, P16601, DOI 10.1021/bi981197z; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; THUNNISSEN AMWH, 1994, NATURE, V367, P750, DOI 10.1038/367750a0; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; [No title captured]	39	137	138	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					447	456		10.1016/S0092-8674(00)80680-7	http://dx.doi.org/10.1016/S0092-8674(00)80680-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693761	Bronze			2022-12-28	WOS:000085446900007
J	Donovan, A; Brownlie, A; Zhou, Y; Shepard, J; Pratt, SJ; Moynihan, J; Paw, BH; Drejer, A; Barut, B; Zapata, A; Law, TC; Brugnara, C; Kingsley, PD; Palis, J; Fleming, MD; Andrews, NC; Zon, LI				Donovan, A; Brownlie, A; Zhou, Y; Shepard, J; Pratt, SJ; Moynihan, J; Paw, BH; Drejer, A; Barut, B; Zapata, A; Law, TC; Brugnara, C; Kingsley, PD; Palis, J; Fleming, MD; Andrews, NC; Zon, LI			Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter	NATURE			English	Article							DANIO-RERIO; GENE; HEMATOPOIESIS; TRANSPORTER; MUTATION; DEFECTS; ANEMIA; MAP	Defects in iron absorption and utilization lead to iron deficiency and overload disorders. Adult mammals absorb iron through the duodenum, whereas embryos obtain iron through placental transport. Iron uptake from the intestinal lumen through the apical surface of polarized duodenal enterocytes is mediated by the divalent metal transporter, DMT1 (refs 1-3). A second transporter has been postulated to export iron across the basolateral surface to the circulation. Here we have used positional cloning to identify the gene responsible for the hypochromic anaemia of the zebrafish mutant weissherbst. The gene, ferroportin1, encodes a multiple-transmembrane domain protein, expressed in the yolk sac, that is a candidate for the elusive iron exporter. Zebrafish ferroportin1 is required for the transport of iron from maternally derived yolk stores to the circulation and functions as an iron exporter when expressed in Xenopus oocytes. Human Ferroportin1 is found at the basal surface of placental syncytiotrophoblasts, suggesting that it also transports iron from mother to embryo. Mammalian Ferroportin1 is expressed at the basolateral surface of duodenal enterocytes and could export cellular iron into the circulation. We propose that Ferroportin1 function may be perturbed in mammalian disorders of iron deficiency or overload.	Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA; Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Canc, Rochester, NY 14642 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Washington University (WUSTL); Complutense University of Madrid; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; University of Rochester; University of Rochester	Zon, LI (corresponding author), Childrens Hosp, Dept Med, Div Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	zon@rascal.med.harvard.edu	Brugnara, Carlo/A-8041-2010	Brugnara, Carlo/0000-0001-8192-8713; Paw, Barry/0000-0002-0492-1419; Fleming, Mark/0000-0003-0948-4024; Zapata, Agustin G/0000-0003-0576-2672; Cutts, Alison/0000-0002-4986-573X; Andrews, Nancy/0000-0003-0243-4462; Palis, James/0000-0001-7324-1049				ALADHAMI MA, 1977, DEV GROWTH DIFFER, V19, P171; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BANNERMAN RM, 1976, FED PROC, V35, P2281; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; CRAIK JCA, 1986, COMP BIOCHEM PHYS A, V83, P515, DOI 10.1016/0300-9629(86)90138-6; DUMONT JN, 1978, J EXP ZOOL, V204, P193, DOI 10.1002/jez.1402040208; Einstein RS, 1998, J NUTR, V128, P2295, DOI 10.1093/jn/128.12.2295; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haffter P, 1996, DEVELOPMENT, V123, P1; JOHNSON SL, 1995, GENETICS, V139, P1727; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KINGSTON PJ, 1978, BRIT J HAEMATOL, V40, P265, DOI 10.1111/j.1365-2141.1978.tb03663.x; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; PALIS J, 1995, MOL REPROD DEV, V42, P19, DOI 10.1002/mrd.1080420104; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Ransom DG, 1999, METHOD CELL BIOL, V60, P195; Ransom DG, 1996, DEVELOPMENT, V123, P311; Richards MP, 1997, POULTRY SCI, V76, P152, DOI 10.1093/ps/76.1.152; RIEB J-P, 1973, Annales d'Embryologie et de Morphogenese, V6, P43; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Westerfield M, 1993, ZEBRAFISH BOOK; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585	29	1243	1322	7	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					776	781		10.1038/35001596	http://dx.doi.org/10.1038/35001596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693807				2022-12-28	WOS:000085423100054
J	Ward, WR; Canup, RM				Ward, WR; Canup, RM			Origin of the Moon's orbital inclination from resonant disk interactions	NATURE			English	Article							SINGLE IMPACT HYPOTHESIS; GENERATED DISK; SATELLITE; ACCRETION; EVOLUTION; SYSTEM	The Moon is generally believed to have formed from the debris disk created by a large body colliding with the early Earth(1,2) Recent models of this process predict that the orbit of the newly formed Moon should be in, or very near, the Earth's equatorial plane(3,4). This prediction, however, is at odds with the known history of the lunar orbit: the orbit is currently expanding, but can be traced back in time to reveal that, when the Moon formed, its orbital inclination relative to the Earth's equator was I approximate to 10 degrees (refs 5, 6). The cause of this initial inclination has been a mystery for over 30 years, as most dynamical processes (such as those that act to flatten Saturn's rings) will tend to decrease orbital inclinations. Here we show that the Moon's substantial orbital inclination is probably a natural result of its formation from an impact-generated disk. The mechanism involves a gravitational resonance between the Moon and accretion-disk material, which can increase orbital inclinations up to similar to 15 degrees.	SW Res Inst, Boulder, CO 80302 USA		Ward, WR (corresponding author), SW Res Inst, 1050 Walnut St,Suite 426, Boulder, CO 80302 USA.			Canup, Robin/0000-0002-2342-3458				BORDERIES N, 1984, ASTROPHYS J, V284, P429, DOI 10.1086/162423; BOSS AP, 1986, ORIGIN MOON; Brahic A., 1984, IAU C, V75, P513; Brouwer D., 1961, METHODS CELESTIAL ME; Cameron A. G. W., 1976, LUNAR SCI, V7, P120; CAMERON AGW, 1991, ICARUS, V92, P204, DOI 10.1016/0019-1035(91)90046-V; Cameron AGW, 1997, ICARUS, V126, P126, DOI 10.1006/icar.1996.5642; CAMERON AGW, 1998, LUNAR PLANET SCI, V29, P1062; Canup RM, 1996, ICARUS, V119, P427, DOI 10.1006/icar.1996.0028; Elliot JL, 1984, PLANETARY RINGS, P25; GOLDREIC.P, 1966, REV GEOPHYS, V4, P411, DOI 10.1029/RG004i004p00411; Ida S, 1997, NATURE, V389, P353, DOI 10.1038/38669; KOKUBO E, UNPUB ICARUS; MEYERVERNET N, 1987, ICARUS, V69, P157, DOI 10.1016/0019-1035(87)90011-X; THOMPSON C, 1983, ASTROPHYS J, V333, P542; TOUMA J, 1994, ASTRON J, V108, P1943, DOI 10.1086/117209; Touma J, 1998, ASTRON J, V115, P1653, DOI 10.1086/300312; Tremaine S, 1998, ASTRON J, V116, P2015, DOI 10.1086/300567; Ward W.R., 1978, LPSC, V9, P1205; WARD WR, 1994, ICARUS, V110, P95, DOI 10.1006/icar.1994.1109; Ward WR, 1998, SCIENCE, V280, P2104, DOI 10.1126/science.280.5372.2104	23	30	31	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					741	743		10.1038/35001516	http://dx.doi.org/10.1038/35001516			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693796				2022-12-28	WOS:000085423100043
J	Drummond, SPA; Brown, GG; Gillin, JC; Stricker, JL; Wong, EC; Buxton, RB				Drummond, SPA; Brown, GG; Gillin, JC; Stricker, JL; Wong, EC; Buxton, RB			Altered brain response to verbal learning following sleep deprivation	NATURE			English	Article							PERFORMANCE; MEMORY; TOMOGRAPHY; LANGUAGE; HUMANS; FMRI	The effects of sleep deprivation on the neural substrates of cognition are poorly understood. Here we used functional magnetic resonance imaging to measure the effects of 35 hours of sleep deprivation on cerebral activation during verbal learning in normal young volunteers. On the basis of a previous hypothesis', we predicted that the prefrontal cortex (PFC) would be less responsive to cognitive demands following sleep deprivation. Contrary to our expectations, however, the PFC was more responsive after one night of sleep deprivation than after normal sleep. Increased subjective sleepiness in sleep-deprived subjects correlated significantly with activation of the PFC. The temporal lobe was activated after normal sleep but not after sleep deprivation; in contrast, the parietal lobes were not activated after normal sleep but were activated after sleep deprivation. Although sleep deprivation significantly impaired free recall compared with the rested state, better free recall in sleep-deprived subjects was associated with greater parietal lobe activation, These findings show that there are dynamic, compensatory changes in cerebral activation during verbal learning after sleep deprivation and implicate the PFC and parietal lobes in this compensation.	Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92120 USA; Vet Adm San Diego Healthcare Syst, Psychiat Serv 116A, La Jolla, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego	Gillin, JC (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jgillin@ucsd.edu	Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604; Drummond, Sean/0000-0002-9815-626X				BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Brown GG, 1999, J INT NEUROPSYCH SOC, V5, P308, DOI 10.1017/S1355617799544020; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dinges DF., 1991, SLEEP SLEEPINESS PER, P97; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRACKOWIAK RSJ, 1994, TRENDS NEUROSCI, V17, P109, DOI 10.1016/0166-2236(94)90119-8; Harrison Y, 1997, SLEEP, V20, P871, DOI 10.1093/sleep/20.10.871; Harrison Y, 1998, J SLEEP RES, V7, P95, DOI 10.1046/j.1365-2869.1998.00104.x; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HORNE JA, 1988, SLEEP, V11, P528, DOI 10.1093/sleep/11.6.528; HORNE JA, 1993, BRIT J PSYCHIAT, V162, P413, DOI 10.1192/bjp.162.3.413; LUBIN A, 1976, PSYCHOPHYSIOLOGY, V13, P334, DOI 10.1111/j.1469-8986.1976.tb03086.x; PIETAU C, 1998, J SLEEP RES, V7, P208; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; POLZELLA DJ, 1975, J EXP PSYCHOL-HUM L, V104, P194; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Portas CM, 1998, J NEUROSCI, V18, P8979; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Talairach J., 1988, COPLANAR STEREOTAXIC; THOMAS ML, 1993, J CEREBR BLOOD FLOW, V13, pS531; Werth E, 1996, NEUROREPORT, V8, P123, DOI 10.1097/00001756-199612200-00025; WILLIAMS HL, 1966, PERCEPT MOTOR SKILL, V23, P1287, DOI 10.2466/pms.1966.23.3f.1287; WOLFE N, 1995, ARCH NEUROL-CHICAGO, V52, P257, DOI 10.1001/archneur.1995.00540270049018; WONG EC, 1992, P SOC MAGN RESON MED, V1, P105; WU JC, 1991, SLEEP, V14, P155	30	378	390	4	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					655	657		10.1038/35001068	http://dx.doi.org/10.1038/35001068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	283RD	10688201				2022-12-28	WOS:000085288200053
J	Williams, AG; Rayson, MP; Jubb, M; World, M; Woods, DR; Hayward, M; Martin, J; Humphries, SE; Montgomery, HE				Williams, AG; Rayson, MP; Jubb, M; World, M; Woods, DR; Hayward, M; Martin, J; Humphries, SE; Montgomery, HE			Physiology - The ACE gene and muscle performance	NATURE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MUSCULAR EFFICIENCY; HUMAN HEART; POLYMORPHISM		Optimal Preformance, Farnham GU9 7EB, Surrey, England; Rayne Inst, RFUCLMS, Ctr Cardiovasc Genet, British Heart Fdn, London WC1E 6JJ, England	University of London; King's College London; University College London	Williams, AG (corresponding author), Optimal Preformance, 93-94 West St, Farnham GU9 7EB, Surrey, England.		Williams, Alun G/B-6817-2008; Humphries, Stephen E/C-5075-2008; Montgomery, Hugh/L-1229-2019; Montgomery, Hugh/C-2592-2008	Williams, Alun G/0000-0002-8052-8184; Montgomery, Hugh/0000-0001-8797-5019; Jubb, Michael/0000-0001-5639-473X				BALL SG, 1993, LANCET, V342, P821; Boss O, 1998, FASEB J, V12, P335, DOI 10.1096/fasebj.12.3.335; CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010; COYLE EF, 1992, MED SCI SPORT EXER, V24, P782; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; DRAGOVIC T, 1996, DIABETES S1, V45, P34; GAESSER GA, 1975, J APPL PHYSIOL, V38, P1132, DOI 10.1152/jappl.1975.38.6.1132; Kemp GJ, 1996, HEART, V76, P35, DOI 10.1136/hrt.76.1.35; KULKARNI RN, 1992, ANN HUM BIOL, V19, P421, DOI 10.1080/03014469200002272; McArdle W., 2014, EXERCISE PHYSL ENERG, P253; Montgomery H, 1999, LANCET, V353, P541, DOI 10.1016/S0140-6736(98)07131-1; Montgomery HE, 1997, CIRCULATION, V96, P741; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Morris SD, 1997, J AM COLL CARDIOL, V29, P1599, DOI 10.1016/S0735-1097(97)00087-9; Spurr GB, 1998, EUR J CLIN NUTR, V52, P17, DOI 10.1038/sj.ejcn.1600504; Zhao G, 1999, CORONARY ARTERY DIS, V10, P315, DOI 10.1097/00019501-199907000-00007	16	209	226	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					614	614		10.1038/35001141	http://dx.doi.org/10.1038/35001141			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688186	Green Accepted			2022-12-28	WOS:000085288200038
J	Cane, DE				Cane, DE			Biosynthetic pathways - Biosynthesis meets bioinformatics	SCIENCE			English	Editorial Material							CLAVULANIC ACID; 1-DEOXY-D-XYLULOSE 5-PHOSPHATE; PRECURSOR; PYRIDOXOL; THIAMIN; ENZYME		Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University	Cane, DE (corresponding author), Brown Univ, Dept Chem, Box H, Providence, RI 02912 USA.	David_Cane@brown.edu						Baggaley KH, 1997, NAT PROD REP, V14, P309, DOI 10.1039/np9971400309; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; ELSON SW, 1978, J ANTIBIOT, V31, P586, DOI 10.7164/antibiotics.31.586; Jensen SE, 1999, ANTON LEEUW INT J G, V75, P125, DOI 10.1023/A:1001755724055; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Khaleeli N, 1999, J AM CHEM SOC, V121, P9223, DOI 10.1021/ja9923134; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P4509, DOI 10.1016/S0040-4039(98)00802-8; Lloyd MD, 1999, TETRAHEDRON, V55, P10201, DOI 10.1016/S0040-4020(99)00547-5; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Perez-Redondo R, 1999, J BACTERIOL, V181, P6922; Pitlik J, 1997, CHEM COMMUN, P225, DOI 10.1039/a607078g; Rohdich F, 1999, P NATL ACAD SCI USA, V96, P11758, DOI 10.1073/pnas.96.21.11758; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857	14	15	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2000	287	5454					818	819		10.1126/science.287.5454.818	http://dx.doi.org/10.1126/science.287.5454.818			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10691559				2022-12-28	WOS:000085136400035
J	Kazemi-Esfarjani, P; Benzer, S				Kazemi-Esfarjani, P; Benzer, S			Genetic suppression of polyglutamine toxicity in Drosophila	SCIENCE			English	Article							DNA-BINDING PROTEIN; CELL FATES; J-DOMAIN; LOCALIZATION; DEGENERATION; EXPRESSION; PHENOTYPES; INCLUSIONS; HSP70; EYE	A Drosophila model for Huntington's and other polyglutamine diseases was used to screen for genetic factors modifying the degeneration caused by expression of polyglutamine in the eye. Among 7000 P-element insertions, several suppressor strains were isolated, two of which Led to the discovery of the suppressor genes described here. The predicted product of one, dHDJ1, is homologous to human heat shock protein 40/HDJ1. That of the second, dTPR2, is homologous to the human tetratricopeptide repeat protein 2. Each of these molecules contains a chaperone-related J domain. Their suppression of polyglutamine toxicity was verified in transgenic flies.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Kazemi-Esfarjani, P (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Hata M, 1996, GENOMICS, V38, P446, DOI 10.1006/geno.1996.0653; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kim TW, 1998, NEURON, V21, P657, DOI 10.1016/S0896-6273(00)80581-4; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Murthy AE, 1996, DNA CELL BIOL, V15, P727, DOI 10.1089/dna.1996.15.727; PIRROTTA V, 1986, CLONING DROSOPHILA G, P83; RAABE T, 1991, NUCLEIC ACIDS RES, V19, P6645, DOI 10.1093/nar/19.23.6645; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; SEROUDE L, UNPUB; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Stubdal H, 1997, MOL CELL BIOL, V17, P4979, DOI 10.1128/MCB.17.9.4979; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Weiss B, 1999, AM J MED GENET, V89, P14, DOI 10.1002/(SICI)1096-8628(19990326)89:1<14::AID-AJMG5>3.3.CO;2-W	30	453	478	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1837	1840		10.1126/science.287.5459.1837	http://dx.doi.org/10.1126/science.287.5459.1837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710314				2022-12-28	WOS:000085775300046
J	Michota, FA				Michota, FA			Update in hospital medicine	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; DEEP-VEIN THROMBOSIS; VENA-CAVA FILTERS; UNFRACTIONATED HEPARIN; VENOUS THROMBOSIS; ENTEROCOCCUS; INFECTIONS; BACTEREMIA; MANAGEMENT; OUTCOMES		Cleveland Clin Fdn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Michota, FA (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Altkorn D, 1999, ANN INTERN MED, V131, P199, DOI 10.7326/0003-4819-131-3-199908030-00007; BECKER DM, 1992, ARCH INTERN MED, V152, P1985, DOI 10.1001/archinte.152.10.1985; FINCH R, 1993, BRIT J HOSP MED, V49, P346; Fine MJ, 1997, ARCH INTERN MED, V157, P36, DOI 10.1001/archinte.157.1.36; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; GARIBALDI RA, 1985, AM J MED, V78, P32, DOI 10.1016/0002-9343(85)90361-4; Greenberger NJ, 1999, ANN INTERN MED, V131, P445, DOI 10.7326/0003-4819-131-6-199909210-00010; GULLBERG RM, 1989, REV INFECT DIS, V11, P74; GUNTUPALLI KK, 1999, ANN INTERN MED, V131, P28; Hirsh J, 1996, CIRCULATION, V93, P2212, DOI 10.1161/01.CIR.93.12.2212; HYERS TM, 1995, CHEST, V108, pS335, DOI 10.1378/chest.108.4_Supplement.335S; JOLLEY AE, 1992, RESP MED, V86, P503, DOI 10.1016/S0954-6111(96)80011-4; Karnik AM, 1999, ANN INTERN MED, V131, P596, DOI 10.7326/0003-4819-131-8-199910190-00009; Katz PR, 1996, J AM GERIATR SOC, V44, P1118; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Lave JR, 1996, J GEN INTERN MED, V11, P415, DOI 10.1007/BF02600189; Leizorovicz A, 1996, DRUGS, V52, P30, DOI 10.2165/00003495-199600527-00006; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; MAGNANT JG, 1992, J VASC SURG, V16, P701; MOELLERING RC, 1992, CLIN INFECT DIS, V14, P1173, DOI 10.1093/clinids/14.6.1173; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; NOSKIN GA, 1995, CLIN INFECT DIS, V20, P296, DOI 10.1093/clinids/20.2.296; PATTERSON JA, 1995, J AM GERIATR SOC, V43, P919, DOI 10.1111/j.1532-5415.1995.tb05538.x; Rahal JJ, 1998, JAMA-J AM MED ASSOC, V280, P1233, DOI 10.1001/jama.280.14.1233; Rawlins MD, 1991, TXB ADVERSE DRUG REA; *WHO, 1966, TECHN REP SER WHO, V425; 1997, HLTH CARE FINANC R S, V18, P73	27	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2000	132	5					384	390		10.7326/0003-4819-132-5-200003070-00008	http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KY	10691589				2022-12-28	WOS:000085563000007
J	Quill, TE; Byock, IR				Quill, TE; Byock, IR		ACP-ASIM End Life Care Consensus P	Responding to intractable terminal suffering: The role of terminal sedation and voluntary refusal of food and fluids	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN-ASSISTED SUICIDE; SLOW EUTHANASIA; ACTIVE EUTHANASIA; PATIENT REQUESTS; SUPREME-COURT; UNITED-STATES; DEATH; CARE; LIFE; MANAGEMENT	When provided by a skilled, multidisciplinary team, palliative care is highly effective at addressing the physical, psychological, social, and spiritual needs of dying patients and their families. However, some patients who have witnessed harsh death want reassurance that they can escape if their suffering becomes intolerable. In addition, a small percentage of terminally ill patients receiving comprehensive care reach a point at which their suffering becomes severe and unacceptable despite unrestrained palliative efforts; some of these patients request that death be hastened. This paper presents terminal sedation and voluntary refusal of hydration and nutrition as potential last resorts that can be used to address the needs of such patients. These two practices allow clinicians to address a much wider range of intractable end-of-life suffering than physician-assisted suicide (even if it were legal) and can also provide alternatives for patients, families, and clinicians who are morally opposed to physician-assisted suicide. This paper will define the two practices, distinguish them from more standard palliative care interventions and from physician-assisted suicide, illustrate them with a real clinical scenario, provide potential guidelines and practicalities, and explore their moral and legal status. Although medicine cannot sanitize dying or provide perfect answers for all challenging end-of-life clinical problems, terminal sedation and voluntary refusal of hydration and nutrition substantially increase patients' choices at this inherently challenging time.			Quill, TE (corresponding author), Care Of Snyder L, Amer Coll Phys, Amer Soc Internal Med, Ctr Eth & Professionalism, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; American Board of Internal Medicine, 1996, CAR DYING ID PROM PH; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BERNAT JL, 1993, ARCH INTERN MED, V153, P2723, DOI 10.1001/archinte.153.24.2723; Billings JA, 1996, J PALLIAT CARE, V12, P21, DOI 10.1177/082585979601200404; BLOCH SD, 1994, ARCH INTERN MED, V154, P2039, DOI 10.1001/archinte.154.18.2039; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; BRODY H, 1993, J CLIN ETHIC, V4, P112; Brody H, 1997, NEW ENGL J MED, V336, P652, DOI 10.1056/NEJM199702273360910; Brody H, 1996, J PALLIATIVE CARE, V12, P38, DOI 10.1177/082585979601200406; Burt RA, 1997, NEW ENGL J MED, V337, P1234, DOI 10.1056/NEJM199710233371712; Byock I, 1995, Am J Hosp Palliat Care, V12, P9; BYOCK I, 1997, DYING WELL PROSPECTS; Byock I R, 1993, J Palliat Care, V9, P25; Byock I R, 1994, J Palliat Care, V10, P8; Byock IR, 1996, CLIN GERIATR MED, V12, P237; CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Cherny N I, 1994, J Palliat Care, V10, P31; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; Coyle N, 1990, J Pain Symptom Manage, V5, P83; DOYLE D, 1998, OXFORD TXB PALLIATIV, P945; DUNLOP RJ, 1989, PALLIATIVE MED, V3, P65; EDDY DM, 1994, JAMA-J AM MED ASSOC, V272, P179, DOI 10.1001/jama.272.3.179; ENCK RE, 1994, MED CARE TERMINALLY; ENCK RE, 1994, MED CARE TERMINALLY, P166; Field MJ, 1997, APPROACHING DEATH IM; FOLEY KM, 1995, PAIN FORUM, V4, P163; Frankel V. E., 1955, DOCTOR SOUL PSYCHOTH; GREENE WR, 1991, SOUTHERN MED J, V84, P332, DOI 10.1097/00007611-199103000-00009; Ingham JM, 1996, HEMATOL ONCOL CLIN N, V10, P21, DOI 10.1016/S0889-8588(05)70325-7; JADAD AR, 1995, JAMA-J AM MED ASSOC, V274, P1870, DOI 10.1001/jama.274.23.1870; Karlawish JHT, 1999, ANN INTERN MED, V130, P835, DOI 10.7326/0003-4819-130-10-199905180-00018; KASTING GA, 1994, PHYSICIAN ASSISTED D, P25; KATHOL RG, 1990, PSYCHOSOMATICS, V31, P434, DOI 10.1016/S0033-3182(90)72140-8; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; Lynn J, 1997, J AM GERIATR SOC, V45, P489, DOI 10.1111/j.1532-5415.1997.tb05176.x; MAX MB, 1995, JAMA-J AM MED ASSOC, V274, P1874, DOI 10.1001/jama.1995.03530230060032; MCCANN RM, 1994, JAMA-J AM MED ASSOC, V272, P1263, DOI 10.1001/jama.272.16.1263; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Miller FG, 1998, ANN INTERN MED, V128, P559, DOI 10.7326/0003-4819-128-7-199804010-00007; Mount B, 1996, J PALLIAT CARE, V12, P31, DOI 10.1177/082585979601200405; Moyle J, 1995, J PAIN SYMPTOM MANAG, V10, P643, DOI 10.1016/0885-3924(95)00125-5; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2229; PRINTZ LA, 1992, ARCH INTERN MED, V152, P697, DOI 10.1001/archinte.152.4.697; Quill T, 1996, MIDWIFE DYING PROCES; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Quill TE, 1998, ANN INTERN MED, V128, P552, DOI 10.7326/0003-4819-128-7-199804010-00006; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; QUILL TE, 1993, NEW ENGL J MED, V329, P1039, DOI 10.1056/NEJM199309303291414; QUILL TE, 1995, ARCH INTERN MED, V155, P1250, DOI 10.1001/archinte.155.12.1250; RHYMES J, 1990, JAMA-J AM MED ASSOC, V264, P369, DOI 10.1001/jama.264.3.369; Saunders C., 1993, MANAGEMENT TERMINAL, P1; SEALE CF, 1989, SOC SCI MED, V28, P551, DOI 10.1016/0277-9536(89)90249-9; Stone P, 1997, PALLIATIVE MED, V11, P140, DOI 10.1177/026921639701100208; TRUOG RD, 1992, NEW ENGL J MED, V327, P1678, DOI 10.1056/NEJM199212033272311; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; VANDERMAAS PJ, 1992, EUTHANASIA OTHER MED, V2; Ventafridda V, 1990, J Palliat Care, V6, P7; WALLSTON KA, 1988, MED CARE, V26, P177, DOI 10.1097/00005650-198802000-00008	61	195	198	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2000	132	5					408	414		10.7326/0003-4819-132-5-200003070-00012	http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	288KY	10691593				2022-12-28	WOS:000085563000011
J	Weiler, JM; Bloomfield, JR; Woodworth, GG; Grant, AR; Layton, TA; Brown, TL; McKenzie, DR; Baker, TW; Watson, GS				Weiler, JM; Bloomfield, JR; Woodworth, GG; Grant, AR; Layton, TA; Brown, TL; McKenzie, DR; Baker, TW; Watson, GS			Effects of fexofenadine, diphenhydramine, and alcohol on driving performance - A randomized, placebo-controlled trial in the Iowa Driving Simulator	ANNALS OF INTERNAL MEDICINE			English	Article						rhinitis, allergic; fexofenadine; diphenhydramine; antihistamines; automobile driving	PSYCHOMOTOR PERFORMANCE; MENTAL PERFORMANCE; ALLERGIC RHINITIS; ANTIHISTAMINES; DROWSINESS; SAFETY; DRUGS	Background: Sedating antihistamines may impair driving performance as seriously as alcohol. Objective: To compare the effects of fexofenadine, diphenhydramine, alcohol, and placebo on driving performance. Design: Randomized, double-blind, double-dummy, four-treatment, four-period crossover trial. Setting: The lowa Driving Simulator. Participants: 40 licensed drivers with seasonal allergic rhinitis who were 25 to 44 years of age. Intervention: One dose of fexofenadine (60 mg), diphenhydramine (50 mg), alcohol (approximately 0.1 % blood alcohol concentration), or placebo, given at weekly intervals before participants drove for 1 hour in the lowa Driving Simulator. Measurements: The primary end point was coherence, a continuous measure of participants' ability to match the varying speed of a vehicle that they were following. Secondary end points were drowsiness and other driving measures, including lane keeping and response to a vehicle that unexpectedly blocked the lane ahead. Results: Participants had significantly better coherence after taking alcohol or fexofenadine than after taking diphenhydramine. Lane keeping (steering instability and crossing the center line) was impaired after alcohol and diphenhydramine use compared with fexofenadine use. Mean response time to the blocking vehicle was slowest after alcohol use (2.21 seconds) compared with fexofenadine use (1.95 seconds). Self-reported drowsiness did not predict lack of coherence and was weakly associated with minimum following distance, steering instability, and left-lane excursion. Conclusions: Participants had similar performance when treated with fexofenadine or placebo. After alcohol use, participants performed the primary task well but not the secondary tasks; as a result, overall driving performance was poorer. After participants took diphenhydramine, driving performance was poorest, indicating that diphenhydramine had a greater impact on driving than alcohol did. Drowsiness ratings were not a good predictor of impairment, suggesting that drivers cannot use drowsiness to indicate when they should not drive.	Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Hoechst Marion Roussel Inc, Kansas City, MO USA	University of Iowa	Weiler, JM (corresponding author), Univ Iowa, Dept Internal Med, 200 Hawkins Dr,T307GH, Iowa City, IA 52242 USA.	john-weiler@uiowa.edu			NCRR NIH HHS [M01-RR-59] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BROOKHUIS KA, 1993, BRIT J CLIN PHARMACO, V36, P67, DOI 10.1111/j.1365-2125.1993.tb05894.x; CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244; CHOW SC, 1998, DESIGN ANAL CLIN TRI, P183; CHOW SC, 1998, DESIGN ANAL CLIN TRI, P531; CIMBURA G, 1982, J FORENSIC SCI, V27, P855; FREEMAN JS, SAE TECHNICAL PAPER; Gelman A, 1996, Stat Methods Med Res, V5, P339, DOI 10.1177/096228029600500402; GENGO F, 1989, CLIN PHARMACOL THER, V45, P15, DOI 10.1038/clpt.1989.3; GENGO FM, 1990, J ALLERGY CLIN IMMUN, V86, P1034, DOI 10.1016/S0091-6749(05)80250-7; GENGO FM, 1990, ANN ALLERGY, V64, P520; GENGO FM, 1987, ANN ALLERGY, V59, P53; HORNE JA, 1991, ERGONOMICS, V34, P1377, DOI 10.1080/00140139108964878; Kerr JS, 1998, HUM PSYCHOPHARM CLIN, V13, P1; KUHL J, 1995, COMPUTER, V28, P35, DOI 10.1109/2.391039; LANDAUER AA, 1983, ERGONOMICS, V26, P647, DOI 10.1080/00140138308963386; Malone DC, 1997, J ALLERGY CLIN IMMUN, V99, P22, DOI 10.1016/S0091-6749(97)81040-8; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007, DOI 10.1017/S0033291700009934; *MED EC, 1998, RED BOOK, P609; MESZAROS L, 1996, MANAGED HEALTHCARE, V6, P532; MOSKOWITZ H, 1974, ALCOHOL DRUGS TRAFFI, P295; *NAT HIGHW TRAFF S, 1996, DIG STAT ALC HIGHW S; OHANLON JF, 1995, ALLERGY, V50, P234, DOI 10.1111/j.1398-9995.1995.tb01140.x; PHILPOT EE, 1993, MIL MED, V158, P654, DOI 10.1093/milmed/158.10.654; *SAS I, 1997, SAS STAT SOFTW CHANG, P221; *SAS I INC, 1997, SAS STAT SOFTW CHANG, P571; Slavin RG, 1998, ALLERGY ASTHMA PROC, V19, P277, DOI 10.2500/108854198778557700; SMITH EA, 1998, DRUG TOPICS, V142, P60; SPIELHALTER DJ, 1999, WINBUGS VERSION 1 2; STARMER G, 1985, ACCIDENT ANAL PREV, V17, P311, DOI 10.1016/0001-4575(85)90032-6; Vermeeren A, 1998, J ALLERGY CLIN IMMUN, V101, P306, DOI 10.1016/S0091-6749(98)70240-4; Weisberg S., 1985, APPL LINEAR REGRESSI; WITEK TJ, 1995, ANN ALLERG ASTHMA IM, V74, P419; 1996, MANAGED PHARM REPORT, V3, P7	33	198	207	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2000	132	5					354	+		10.7326/0003-4819-132-5-200003070-00004	http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	288KY	10691585				2022-12-28	WOS:000085563000003
J	Plugge, B; Gazzarrini, S; Nelson, M; Cerana, R; Van Etten, JL; Derst, C; DiFrancesco, D; Moroni, A; Thiel, G				Plugge, B; Gazzarrini, S; Nelson, M; Cerana, R; Van Etten, JL; Derst, C; DiFrancesco, D; Moroni, A; Thiel, G			A potassium channel protein encoded by chlorella virus PBCV-1	SCIENCE			English	Article							XENOPUS OOCYTES; K+ CHANNELS; SEQUENCE	The Large chlorella virus PBCV-1, which contains double-stranded DNA (dsDNA), encodes a 94-codon open reading frame (ORF) that contains a motif resembling the signature sequence of the pore domain of potassium channel proteins. Phylogenetic analyses of the encoded protein, Kcv, indicate a previously unidentified type of potassium channel. The messenger RNA encoded by the ORF Leads to functional expression of a potassium-selective conductance in Xenopus laevis oocytes. The channel blockers amantadine and barium, but not cesium, inhibit this conductance, in addition to virus plaque formation. Thus, PBCV-1 encodes the first known viral protein that functions as a potassium-selective channel and is essential in the virus Life cycle.	Univ Gottingen, Albrecht von Haller Inst Pflanzenwissensch, D-37073 Gottingen, Germany; Univ Milan, I-20133 Milan, Italy; Megabase Res Prod, Lincoln, NE 68604 USA; Univ Milano Bicocca, DISAT, I-20126 Milan, Italy; Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; Univ Marburg, Inst Physiol, D-35033 Marburg, Germany	University of Gottingen; University of Milan; University of Milano-Bicocca; University of Nebraska System; University of Nebraska Lincoln; Philipps University Marburg	Thiel, G (corresponding author), Univ Gottingen, Albrecht von Haller Inst Pflanzenwissensch, D-37073 Gottingen, Germany.		moroni, anna/H-2097-2014; DiFrancesco, Dario/G-8408-2017; Ebert, Barbara/E-5709-2012	moroni, anna/0000-0002-1860-406X; DiFrancesco, Dario/0000-0002-7322-1790; Thiel, Gerhard/0000-0002-2335-1351; Ebert, Barbara/0000-0003-3328-6693; gazzarrini, sabrina/0000-0003-3062-7536	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032441] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32441, GM41333] Funding Source: Medline; Telethon [971] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon)		Bauer CK, 1996, PFLUG ARCH EUR J PHY, V432, P812, DOI 10.1007/s004240050203; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Derst C, 1998, J EXP BIOL, V201, P2791; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hille B., 1992, IONIC CHANNELS EXCIT; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; KUSANO K, 1982, J PHYSIOL-LONDON, V328, P143, DOI 10.1113/jphysiol.1982.sp014257; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lamb RA, 1997, VIROLOGY, V229, P1, DOI 10.1006/viro.1997.8451; Landstein D, 1995, VIROLOGY, V214, P413, DOI 10.1006/viro.1995.0051; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Owen JM, 1999, EXP PHYSIOL, V84, P471, DOI 10.1017/S0958067099018060; Papazian DM, 1999, NEURON, V23, P7, DOI 10.1016/S0896-6273(00)80746-1; Sabirov RZ, 1997, J GEN PHYSIOL, V110, P665, DOI 10.1085/jgp.110.6.665; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shieh RC, 1998, BIOPHYS J, V75, P2313, DOI 10.1016/S0006-3495(98)77675-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Etten JL, 1999, ANNU REV MICROBIOL, V53, P447, DOI 10.1146/annurev.micro.53.1.447; VANETTEN JL, 1983, VIROLOGY, V126, P117, DOI 10.1016/0042-6822(83)90466-X; VANETTEN JL, UNPUB; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Yellen G, 1999, CURR OPIN NEUROBIOL, V9, P267, DOI 10.1016/S0959-4388(99)80039-7	26	143	154	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1641	1644		10.1126/science.287.5458.1641	http://dx.doi.org/10.1126/science.287.5458.1641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698737	Green Published			2022-12-28	WOS:000085628200035
J	Lee, SH; Wolf, PL; Escudero, R; Deutsch, R; Jamieson, SW; Thistlethwaite, PA				Lee, SH; Wolf, PL; Escudero, R; Deutsch, R; Jamieson, SW; Thistlethwaite, PA			Early expression of angiogenesis factors in acute myocardial ischemia and infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1; PHENOL-CHLOROFORM EXTRACTION; FACTOR MESSENGER-RNA; SINGLE-STEP METHOD; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; O-2 HOMEOSTASIS; FACTOR 1-ALPHA; DNA-BINDING	Background: When the myocardium is deprived of blood, a process of ischemia, infarction, and myocardial remodeling is initiated. Hypoxia-inducible factor 1 (HIF-1) is a transcriptional activator of vascular endothelial growth factor (VEGF) and is critical for initiating early cellular responses to hypoxia. We investigated the temporal and spatial patterns of expression of the alpha subunit of HIF-1 (HIF-1 alpha) and VEGF in specimens of human heart tissue to elucidate the early molecular responses to myocardial hypoxia. Methods: Ventricular-biopsy specimens from 37 patients undergoing coronary bypass surgery were collected. The specimens were examined by microscopy for evidence of ischemia, evolving infarction, or a normal histologic appearance. The specimens were also analyzed with the reverse-transcriptase polymerase chain reaction for HIF-1 alpha and VEGF messenger RNA (mRNA) expression and by immunohistochemical analysis for the location of the HIF-1 alpha and VEGF proteins. Results: HIF-1 alpha mRNA was detected in myocardial specimens with pathological evidence of acute ischemia (onset, <48 hours before surgery) or early infarction (onset, <24 hours before surgery). In contrast, VEGF transcripts were seen in specimens with evidence of acute ischemia or evolving infarction (onset, 24 to 120 hours before surgery). Patients with normal ventricles or evidence of infarction in the distant past had no detectable levels of either VEGF mRNA or HIF-1 alpha mRNA. HIF-1 alpha immunoreactivity was detected in the nuclei of myocytes and endothelial cells, whereas VEGF immunoreactivity was found in the cytoplasm of endothelial cells lining capillaries and arterioles. Conclusions: An increase in the level of HIF-1 alpha is an early response to myocardial ischemia or infarction. This response defines, at a molecular level, one of the first adaptations of human myocardium to a deprivation of blood. HIF-1 alpha is a useful temporal marker of acutely jeopardized myocardium. (N Engl J Med 2000;342:626-33.) (C)2000, Massachusetts Medical Society.	Univ Calif San Diego, Div Cardiothorac Surg 8892, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; Univ Calif San Diego, Gen Clin Res Ctr, San Diego, CA 92103 USA; Vet Affairs Med Ctr, Dept Pathol, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Thistlethwaite, PA (corresponding author), Univ Calif San Diego, Div Cardiothorac Surg 8892, 200 W Arbor Dr, San Diego, CA 92103 USA.	pthistlethwaite@ucsd.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR 0827] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COTRAN RS, 1999, ROBBINS PATHOLOGIC B, P554; Deindl E, 1998, MOL CELL BIOCHEM, V186, P43, DOI 10.1023/A:1006853432678; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hashimoto Etsuo, 1994, American Journal of Physiology, V267, pH1948; Hearse DJ, 1998, MOL CELL BIOCHEM, V186, P177, DOI 10.1023/A:1006808507605; Heusch G, 1998, MOL CELL BIOCHEM, V186, P185, DOI 10.1023/A:1006816725351; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; LADOUX A, 1993, BIOCHEM BIOPH RES CO, V195, P1005, DOI 10.1006/bbrc.1993.2144; Levy AP, 1996, J BIOL CHEM, V271, P25492, DOI 10.1074/jbc.271.41.25492; LEVY AP, 1995, CIRC RES, V76, P758, DOI 10.1161/01.RES.76.5.758; Martin C, 1998, AM J OBSTET GYNECOL, V178, P527, DOI 10.1016/S0002-9378(98)70433-8; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Palmer LA, 1998, AM J PHYSIOL-LUNG C, V274, pL212, DOI 10.1152/ajplung.1998.274.2.L212; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; SABIA PJ, 1992, NEW ENGL J MED, V327, P1825, DOI 10.1056/NEJM199212243272601; Salceda S, 1996, ARCH BIOCHEM BIOPHYS, V334, P389, DOI 10.1006/abbi.1996.0469; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger RH, 1997, KIDNEY INT, V51, P560, DOI 10.1038/ki.1997.79; Wenger RH, 1997, BIOL CHEM, V378, P609; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818; [No title captured]	36	569	635	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					626	633		10.1056/NEJM200003023420904	http://dx.doi.org/10.1056/NEJM200003023420904			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10699162				2022-12-28	WOS:000085575500004
J	Birk, OS; Casiano, DE; Wassif, CA; Cogliati, T; Zhao, LP; Zhao, YG; Grinberg, A; Huang, SP; Kreidberg, JA; Parker, KL; Porter, FD; Westphal, H				Birk, OS; Casiano, DE; Wassif, CA; Cogliati, T; Zhao, LP; Zhao, YG; Grinberg, A; Huang, SP; Kreidberg, JA; Parker, KL; Porter, FD; Westphal, H			The LIM homeobox gene Lhx9 is essential for mouse gonad formation	NATURE			English	Article							SEXUAL-DIFFERENTIATION; EXPRESSION	During mammalian embryonic development, the ovaries and testes develop from somatic cells of the urogenital ridges as indifferent gonads, harbouring primordial germ cells that have migrated there. After sex determination of the gonads, the testes produce testosterone and anti-Mullerian hormone which mediate male sexual differentiation, and the female developmental pathway ensues in their absence(1-3). Here we show that transcripts of the LIM homeobox gene Lhx9 are present in urogenital ridges of mice at embryonic day 9.5; later they localize to the interstitial region as morphological differentiation occurs. In mice lacking Lhx9 function, germ cells migrate normally, but somatic cells of the genital ridge fail to proliferate and a discrete gonad fails to form. In the absence of testosterone and anti-Mullerian hormone, genetically male mice are phenotypically female. The expression of steroidogenic factor 1 (Sf1), a nuclear receptor essential for gonadogenesis2, is reduced to minimal levels in the Lhx9-deficient genital ridge, indicating that Lhx9 may lie upstream of Sf1 in a developmental cascade. Unlike mice lacking other genes that mediate early stages of gonadogenesis(4-6), Lhx9 mutants do not exhibit additional major developmental defects. Thus, LHX9 mutations may underlie certain forms of isolated gonadal agenesis in humans.	NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA; NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; NCI, Dept Genet, Med Branch, NIH, Bethesda, MD 20889 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Boston Children's Hospital	Westphal, H (corresponding author), NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA.			Birk, Ohad/0000-0003-1430-1296; Wassif, Christopher/0000-0002-2524-1420	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000139, ZIAHD000071] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000071, Z01HD000139] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Bertuzzi S, 1999, MECH DEVELOP, V81, P193, DOI 10.1016/S0925-4773(98)00233-0; Capel B, 1998, ANNU REV PHYSIOL, V60, P497, DOI 10.1146/annurev.physiol.60.1.497; FUJII T, 1994, DEV DYNAM, V199, P73, DOI 10.1002/aja.1001990108; Gilbert S., 1997, DEV BIOL; Goodfellow PN, 1999, CELL MOL LIFE SCI, V55, P857, DOI 10.1007/PL00013201; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; JOST A, 1953, RECENT PROG HORM RES, V8, P379; KAUFMAN MH, 1999, ANATOMICAL BASIS MOU, P117; Koopman P, 1999, CELL MOL LIFE SCI, V55, P839; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KUNIEDA T, 1992, BIOL REPROD, V46, P692, DOI 10.1095/biolreprod46.4.692; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Parker KL, 1999, ANNU REV PHYSIOL, V61, P417, DOI 10.1146/annurev.physiol.61.1.417; Porter FD, 1997, DEVELOPMENT, V124, P2935; Retaux S, 1999, J NEUROSCI, V19, P783; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Warne GL, 1998, ENDOCRIN METAB CLIN, V27, P945, DOI 10.1016/S0889-8529(05)70049-9; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155	23	255	264	0	25	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					909	913		10.1038/35002622	http://dx.doi.org/10.1038/35002622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706291				2022-12-28	WOS:000085559200062
J	Jupp, T; Schultz, A				Jupp, T; Schultz, A			A thermodynamic explanation for black smoker temperatures	NATURE			English	Article							HYDROTHERMAL SYSTEMS; WATER SUBSTANCE; TRANSPORT-PROPERTIES; VISCOSITY; EQUATION; STATE; CONVECTION; EVOLUTION; PRESSURE; MODELS	There is a remarkable difference between the maximum temperature of black smoker effluent (350 degrees C-400 degrees C) and the temperature of the solidifying magma which heats it (similar to 1,200 degrees C)(1-3). It has been suspected(4) for some time that the nonlinear thermodynamic properties of water(5) might be responsible for this discrepancy. Here, we translate this hypothesis into a physical model, by examining the internal temperature structure of convection cells in a porous medium. We demonstrate that, at pressures appropriate to seafloor crust, plumes of pure water form naturally at similar to 400 degrees C for any heat source with temperature greater than similar to 500 degrees C. Higher temperatures are confined to a boundary layer at the base of the convection cell, where the flow is horizontal. The phenomenon is explained analytically using the thermodynamic properties of water, and is illustrated by numerical simulations. Our model predicts the existence of the high-temperature 'reaction zone' found in ophiolites" and suggests that vent temperatures will remain steady as magma chambers solidify and cool(7).	Univ Cambridge, Dept Earth Sci, Inst Theoret Geophys, Cambridge CB2 3EQ, England	University of Cambridge	Jupp, T (corresponding author), Univ Cambridge, Dept Earth Sci, Inst Theoret Geophys, Cambridge CB2 3EQ, England.		Schultz, Adam/K-7394-2012	Jupp, Timothy/0000-0002-2036-9476; Schultz, Adam/0000-0003-1663-1547				ANDERKO A, 1993, GEOCHIM COSMOCHIM AC, V57, P1657, DOI 10.1016/0016-7037(93)90105-6; BISCHOFF JL, 1985, AM J SCI, V285, P725, DOI 10.2475/ajs.285.8.725; DICKSON P, 1995, HYDROTHERMAL VENTS P, V87, P145; DUNN JC, 1981, J VOLCANOL GEOTH RES, V11, P189, DOI 10.1016/0377-0273(81)90022-6; ELDER JE, 1981, GEOTHERMAL SYSTEMS, P180; FAUST CR, 1979, WATER RESOUR RES, V15, P23, DOI 10.1029/WR015i001p00023; FOURNIER RO, 1991, GEOPHYS RES LETT, V18, P955, DOI 10.1029/91GL00966; GERMANOVICH LN, 1992, SCIENCE, V255, P1564, DOI 10.1126/science.255.5051.1564; Gillis KM, 1999, EARTH PLANET SC LETT, V169, P227, DOI 10.1016/S0012-821X(99)00087-4; HAAR L, 1984, NBS NRC STEAM TABLES, P1; INGEBRITSEN SE, 1994, GEOPHYS RES LETT, V21, P2199, DOI 10.1029/94GL02002; JOHNSON JW, 1991, AM J SCI, V291, P541, DOI 10.2475/ajs.291.6.541; LAPWOOD ER, 1948, P CAMB PHILOS SOC, V44, P508, DOI 10.1017/S030500410002452X; LISTER CRB, 1995, GEOPHYS J INT, V120, P45; LISTER CRB, 1974, GEOPHYS J ROY ASTR S, V39, P465, DOI 10.1111/j.1365-246X.1974.tb05468.x; LOWELL RP, 1993, SCIENCE, V260, P192, DOI 10.1126/science.260.5105.192; LOWELL RP, 1994, J GEOPHYS RES-SOL EA, V99, P565, DOI 10.1029/93JB02568; LOWELL RP, 1995, J GEOPHYS RES-SOL EA, V100, P327, DOI 10.1029/94JB02222; NORTON D, 1977, AM J SCI, V277, P937, DOI 10.2475/ajs.277.8.937; PASCOE AR, 1995, HYDROTHERMAL VENTS P, V87, P159; PHILLIPS OM, 1991, FLOW REACTIONS PERME, P245; SENGERS JV, 1984, J PHYS CHEM REF DATA, V13, P185, DOI 10.1063/1.555708; SENGERS JV, 1986, J PHYS CHEM REF DATA, V15, P1291, DOI 10.1063/1.555763; STRAUS JM, 1977, J GEOPHYS RES, V82, P325, DOI 10.1029/JB082i002p00325; WATSON JTR, 1980, J PHYS CHEM REF DATA, V9, P1255, DOI 10.1063/1.555631; Wilcock WSD, 1998, J GEOPHYS RES-SOL EA, V103, P2585, DOI 10.1029/97JB03252; [No title captured]	27	94	99	1	27	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					880	883		10.1038/35002552	http://dx.doi.org/10.1038/35002552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706282				2022-12-28	WOS:000085559200053
J	Walter, MJ				Walter, MJ			Earth science - A shear pathway to the core	NATURE			English	Editorial Material							HIGH-PRESSURE		Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan	Okayama University	Walter, MJ (corresponding author), Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan.							Benz W., 1990, ORIGIN EARTH, P61; Bruhn D, 2000, NATURE, V403, P883, DOI 10.1038/35002558; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; Minarik WG, 1996, SCIENCE, V272, P530, DOI 10.1126/science.272.5261.530; Shannon MC, 1996, GEOPHYS RES LETT, V23, P2717, DOI 10.1029/96GL02817; WETHERILL GW, 1985, SCIENCE, V228, P877, DOI 10.1126/science.228.4701.877	6	3	3	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					839	840		10.1038/35002698	http://dx.doi.org/10.1038/35002698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706264				2022-12-28	WOS:000085559200032
J	Kew, MC				Kew, MC			Serum aminotransferase concentration as evidence of hepatocellular damage	LANCET			English	Editorial Material							ASPARTATE-AMINOTRANSFERASE; LIVER		Univ Witwatersrand, Sch Med, Dept Med, ZA-2193 Johannesburg, South Africa	University of Witwatersrand	Kew, MC (corresponding author), Univ Witwatersrand, Sch Med, Dept Med, ZA-2193 Johannesburg, South Africa.							BATZAKIS KG, 1979, INTREPRETIVE ENZYMOL; COHEN GA, 1976, ANN INTERN MED, V84, P275, DOI 10.7326/0003-4819-84-3-275; COHEN JA, 1979, DIGEST DIS SCI, V24, P835, DOI 10.1007/BF01324898; DAVIS GL, 1982, MAYO CLIN PROC, V57, P303; ELLIS G, 1978, AM J CLIN PATHOL, V70, P248; NALPAS B, 1984, HEPATOLOGY, V4, P893, DOI 10.1002/hep.1840040517; PATWARDHAN RV, 1987, ARCH INTERN MED, V147, P1249, DOI 10.1001/archinte.147.7.1249; REJ R, 1978, CLIN CHEM, V24, P1971; SCHMIDT E, 1979, ADV CLIN ENZYMOL, V1, P239; Whitehead MW, 1999, GUT, V45, P129, DOI 10.1136/gut.45.1.129	10	180	202	3	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					591	592		10.1016/S0140-6736(99)00219-6	http://dx.doi.org/10.1016/S0140-6736(99)00219-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696975				2022-12-28	WOS:000085615400005
J	Lyons, RA; Wareham, K; Hutchings, HA; Major, E; Ferguson, B				Lyons, RA; Wareham, K; Hutchings, HA; Major, E; Ferguson, B			Population requirement for adult critical-care beds: a prospective quantitative and qualitative study	LANCET			English	Article								Background The provision of adult critical-care facilities is not based on a rational or scientific assessment of need. We aimed to define the numbers of adult critical-care beds required for a population of 500 000. Methods In five hospitals in Wales, UK, we classified patients who might be suitable for critical care in intensive-care or high-dependency units. On every 12th day for 1 calendar year, we counted the numbers of such patients admitted in a defined geographical population. A panel of ten intensivists made consensus decisions about whether individual patients were in the appropriate unit. The data were used to predict the numbers of beds and units required for the population. Findings 4058 patients were suitable for critical care, of whom 3028 lived in the study area. 56.4% were in general wards, 22.3% in high-dependency units, and 21.3% in intensive-care units. The mean risk of death was 22.0% and the in-hospital death rate 17.3%. According to the masked consensus, 41.3% of patients required high-dependency beds and 21.5% intensive-care beds. Mean risk of death increased from general wards (14.7%) to high-dependency units (19.2%) to intensive care (37.0%). Based on the consensus decisions, the average daily requirement of intensive-care beds was 21 and of high-dependency beds 43; to meet needs 95% of times required 30 and 55 beds, respectively, in a single critical-care unit. Interpretation We estimated, scientifically, numbers of adult critical-care beds required to meet population needs. Studies are necessary periodically to track changes in admissions requiring critical care.	Univ Wales Coll Med, Dept Epidemiol & Publ Hlth, Swansea SA1 1LT, W Glam, Wales; Morriston Hosp, Sch Postgrad Studies Med & Hlth Care, Clin Res Unit, Swansea, W Glam, Wales; Prince Wales Hosp, Bridgend, Wales	Cardiff University; Morriston Hospital; Swansea University	Lyons, RA (corresponding author), Univ Wales Coll Med, Dept Epidemiol & Publ Hlth, Swansea SA1 1LT, W Glam, Wales.		Hutchings, Hayley A/C-9944-2013; Lyons, Ronan/G-7741-2012	Lyons, Ronan/0000-0001-5225-000X; Hutchings, Hayley Anne/0000-0003-4155-1741				Audit Commission, 1999, CRIT SUCC PLAC EFF E; Goldhill DR, 1998, CRIT CARE MED, V26, P1337, DOI 10.1097/00003246-199808000-00017; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; METCALF A, 1993, STUDY PROVISION INTE; *NAT HLTH SERV WAL, 1999, CLIN IND NHS 1995 19; Townsend PP., 1988, HLTH DEPRIVATION INE; *WORK GROUP GUID A, 1996, DISCH INT CAR HIGH D	7	61	61	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					595	598		10.1016/S0140-6736(00)01265-4	http://dx.doi.org/10.1016/S0140-6736(00)01265-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696978				2022-12-28	WOS:000085615400009
J	Greer, JM; Puetz, J; Thomas, KR; Capecchi, MR				Greer, JM; Puetz, J; Thomas, KR; Capecchi, MR			Maintenance of functional equivalence during paralogous Hox gene evolution	NATURE			English	Article							STEM-CELLS; TARGETED DISRUPTION; MICE; TRANSFORMATIONS; VERTEBRAE; HINDBRAIN; REVEAL; RESCUE; THYMUS	Biological diversity is driven mainly by gene duplication followed by mutation and selection. This divergence in either regulatory or protein-coding sequences can result in quite different biological functions for even closely related genes. This concept is exemplified by the mammalian Hox gene complex, a group of 39 genes which are located on 4 linkage groups, dispersed on 4 chromosomes(1-4). The evolution of this complex bee;an with amplification in cis of a primordial Hox gene to produce 13 members, followed by duplications in tuans of much of the entire unit. As a consequence, Hox genes that occupy the same relative position along the 5' to 3' chromosomal coordinate (trans-paralogous genes) share more similarity in sequence and expression pattern than do adjacent Hox genes on the same chromosome. Studies in mice indicate that although individual family members may have unique biological roles, they also share overlapping functions with their paralogues(5-12). Here we show that the proteins encoded by the paralogous genes, Hoxa3 and Hoxd3, can carry out identical biological functions, and that the different roles attributed to these genes are the result of quantitative modulations in gene expression.	Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.	mario.capecchi@genetics.utah.edu						Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; CONDIE BG, 1993, DEVELOPMENT, V119, P579; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; FITZGERALD K, 1993, DEVELOPMENT, V119, P1019; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gavalas A, 1998, DEVELOPMENT, V125, P1123; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; HUNT P, 1991, DEVELOPMENT, P63; KAPPEN C, 1989, P NATL ACAD SCI USA, V86, P5459, DOI 10.1073/pnas.86.14.5459; LONAI P, 1987, DNA-J MOLEC CELL BIO, V6, P409, DOI 10.1089/dna.1987.6.409; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Manley NR, 1997, DEV BIOL, V192, P274, DOI 10.1006/dbio.1997.8765; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; ROSSEL M, IN PRESS DEVELOPMENT, V126; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SCOTT MP, 1992, CELL, V71, P551, DOI 10.1016/0092-8674(92)90588-4; SHAM MH, 1992, EMBO J, V11, P1825, DOI 10.1002/j.1460-2075.1992.tb05234.x; Studer M, 1998, DEVELOPMENT, V125, P1025; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Zakany J, 1996, DEV BIOL, V176, P325, DOI 10.1006/dbio.1996.0137	30	208	211	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					661	665		10.1038/35001077	http://dx.doi.org/10.1038/35001077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688203				2022-12-28	WOS:000085288200055
J	Jackson, R				Jackson, R			Updated New Zealand cardiovascular disease risk-benefit prediction guide	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Auckland, Dept Community Hlth, Auckland, New Zealand	University of Auckland	Jackson, R (corresponding author), Univ Auckland, Dept Community Hlth, Auckland, New Zealand.	rt.jackson@auckland.ac.nz		Jackson, Rod/0000-0001-5914-6934				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; MACMAHON S, 1993, J VASC MED BIOL, V4, P265; Mann JI, 1996, NEW ZEAL MED J, V109, P224; MULROW CD, 1994, JAMA-J AM MED ASSOC, V272, P1932, DOI 10.1001/jama.272.24.1932; National Health Committee, 1995, GUID MAN MILDL RAIS; Shepherd J, 1996, LANCET, V348, P1339	7	177	180	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					709	710		10.1136/bmj.320.7236.709	http://dx.doi.org/10.1136/bmj.320.7236.709			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710588	Green Published			2022-12-28	WOS:000085895300029
J	Mangrum, JM; DiMarco, JP				Mangrum, JM; DiMarco, JP			Primary care: The evaluation and management of bradycardia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SICK-SINUS SYNDROME; 24-HOUR AMBULATORY ELECTROCARDIOGRAPHY; PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; HEART-RATE; ATRIAL-FIBRILLATION; OPERATIONAL DEFINITION; ACC/AHA GUIDELINES; PACEMAKER THERAPY; SLEEP-APNEA		Univ Virginia Hlth Syst, Dept Med, Div Cardiovasc, Cardiac Electrophysiol Lab, Charlottesville, VA 22908 USA	University of Virginia	DiMarco, JP (corresponding author), Univ Virginia Hlth Syst, Dept Med, Div Cardiovasc, Cardiac Electrophysiol Lab, Box 158, Charlottesville, VA 22908 USA.							ABBOTT JA, 1977, AM J MED, V62, P330, DOI 10.1016/0002-9343(77)90829-4; Andersen HR, 1997, LANCET, V350, P1210, DOI 10.1016/S0140-6736(97)03425-9; Benditt DG, 1996, J AM COLL CARDIOL, V28, P263, DOI 10.1016/0735-1097(96)00236-7; Benditt DG, 1997, PACE, V20, P832, DOI 10.1111/j.1540-8159.1997.tb03916.x; Bergfeldt L, 1996, J CARDIOVASC ELECTR, V7, P95, DOI 10.1111/j.1540-8167.1996.tb00504.x; BERNSTEIN AD, 1992, AM J CARDIOL, V69, P331, DOI 10.1016/0002-9149(92)90229-R; BOUMAN LN, 1986, EUR HEART J, V7, P94, DOI 10.1093/oxfordjournals.eurheartj.a062047; BRODSKY M, 1977, AM J CARDIOL, V39, P390, DOI 10.1016/S0002-9149(77)80094-5; CLARKE M, 1991, BRIT HEART J, V66, P185; CORBELLI R, 1990, PACE, V13, P179, DOI 10.1111/j.1540-8159.1990.tb05068.x; Crawford MH, 1999, J AM COLL CARDIOL, V34, P912, DOI 10.1016/S0735-1097(99)00354-X; DEMOULIN JC, 1978, BRIT HEART J, V40, P1384; DICKINSON DF, 1984, BRIT HEART J, V51, P179; DIMARCO JP, 1990, ANN INTERN MED, V113, P53, DOI 10.7326/0003-4819-113-1-53; ELLESTAD MH, 1975, CIRCULATION, V51, P363, DOI 10.1161/01.CIR.51.2.363; EVANS R, 1977, BRIT HEART J, V39, P778; Farshi R, 1999, J AM COLL CARDIOL, V33, P304, DOI 10.1016/S0735-1097(98)00561-0; FERRER MI, 1968, J AMER MED ASSOC, V206, P645, DOI 10.1001/jama.206.3.645; FLEG JL, 1982, CHEST, V81, P302, DOI 10.1378/chest.81.3.302; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Gregoratos G, 1998, J AM COLL CARDIOL, V31, P1175; GUILLEMINAULT C, 1983, AM J CARDIOL, V52, P490, DOI 10.1016/0002-9149(83)90013-9; HANNEPAPARO N, 1976, CARDIOLOGY, V61, P267, DOI 10.1159/000169770; HOLDEN W, 1978, BRIT HEART J, V40, P923; JOSE AD, 1970, CARDIOVASC RES, V4, P160, DOI 10.1093/cvr/4.2.160; KANTELIP JP, 1986, AM J CARDIOL, V57, P398, DOI 10.1016/0002-9149(86)90760-5; Krahn AD, 1999, CIRCULATION, V99, P406, DOI 10.1161/01.CIR.99.3.406; LEV M, 1954, J GERONTOL, V9, P1; NORTHCOTE RJ, 1989, BRIT HEART J, V61, P155; PITCHER D, 1986, BRIT MED J, V292, P594, DOI 10.1136/bmj.292.6520.594; POLLAK A, 1993, AM HEART J, V125, P824, DOI 10.1016/0002-8703(93)90177-B; RASMUSSEN K, 1981, EUR HEART J, V2, P455, DOI 10.1093/oxfordjournals.eurheartj.a061236; RUBENSTEIN JJ, 1972, CIRCULATION, V46, P5, DOI 10.1161/01.CIR.46.1.5; SCHEINMAN MM, 1982, AM J CARDIOL, V50, P1316, DOI 10.1016/0002-9149(82)90469-6; SCHEINMAN MM, 1979, J ELECTROCARDIOL, V12, P211, DOI 10.1016/S0022-0736(79)80031-X; SCOTT O, 1980, BRIT HEART J, V44, P304; SHAW DB, 1987, BRIT HEART J, V58, P598; SOUTHALL DP, 1981, BRIT HEART J, V45, P281; SPODICK DH, 1992, AM J CARDIOL, V69, P1245, DOI 10.1016/0002-9149(92)90947-W; SPODICK DH, 1993, AM J CARDIOL, V72, P487, DOI 10.1016/0002-9149(93)91153-9; Spodick DH, 1996, SOUTHERN MED J, V89, P666, DOI 10.1097/00007611-199607000-00003; Stegman SS, 1996, PACE, V19, P899, DOI 10.1111/j.1540-8159.1996.tb03385.x; VIITASALO MT, 1982, BRIT HEART J, V47, P213; WIENS RD, 1984, AM J CARDIOL, V54, P74, DOI 10.1016/0002-9149(84)90306-0; Zimetbaum PJ, 1999, ANN INTERN MED, V130, P848, DOI 10.7326/0003-4819-130-10-199905180-00020; ZIPES DP, 1995, CIRCULATION, V92, P673	46	159	167	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2000	342	10					703	709		10.1056/NEJM200003093421006	http://dx.doi.org/10.1056/NEJM200003093421006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ZW	10706901				2022-12-28	WOS:000085708800006
J	Katzan, IL; Furlan, AJ; Lloyd, LE; Frank, JI; Harper, DL; Hinchey, JA; Hammel, JP; Qu, A; Sila, CA				Katzan, IL; Furlan, AJ; Lloyd, LE; Frank, JI; Harper, DL; Hinchey, JA; Hammel, JP; Qu, A; Sila, CA			Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COOPERATIVE ACUTE STROKE; FIRST-LINE TREATMENT; THROMBOLYTIC THERAPY; INTRAVENOUS THROMBOLYSIS; T-PA; QUALITY; MORTALITY; ICD-9-CM; CARE	Context Little is known regarding outcomes after intravenous tissue-type plasminogen activator (IV tPA) therapy for acute ischemic stroke outside a trial setting. Objective To assess the rate of IV tPA use, the incidence of symptomatic intracerebral hemorrhage (ICH), and in-hospital patient outcomes throughout a large urban community. Design Historical prospective cohort study conducted from July 1997 through June 1998. Setting Twenty-nine hospitals in the Cleveland, Ohio, metropolitan area. Patients A total of 3948 patients admitted to a study hospital with a primary diagnosis of ischemic stroke (International Classification of Diseases, Ninth Revision, Clinical Modification code 434 or 436). Main Outcome Measures Rate of IV tPA use and occurrence of symptomatic ICH among patients treated with tPA; proportion of patients receiving tPA whose treatment deviated from national guidelines; in-hospital mortality among patients receiving tPA compared with that among ischemic stroke patients not receiving tPA and with mortality predicted by a model. Results Seventy patients (1.8%) admitted with ischemic stroke received IV tPA. Of those, 11 patients (15.7%; 95% confidence interval [CI], 8.1%-26.4%) had a symptomatic ICH (of which 6 were fatal) and 50% (95% CI, 37.8%-62.2%) had deviations from national treatment guidelines. In-hospital mortality was significantly higher among patients treated with tPA (15.7%) compared with patients not receiving tPA (5.1%, P<.001) and compared with the model's prediction (7.9%; P<.006). Conclusions A small proportion of patients admitted with acute ischemic stroke in Cleveland received tPA; they experienced a high rate of ICH. Cleveland community experience with tPA for acute ischemic stroke may differ from that reported in clinical trials.	Cleveland Clin Fdn, Cerebrovasc Ctr, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA; Qual Informat Management Corp, Cleveland, OH USA; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; Univ Chicago, Dept Surg, Chicago, IL 60637 USA; Univ Rochester, Dept Neurol, Rochester, NY USA; Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Chicago; University of Chicago; University of Rochester; Oregon State University	Katzan, IL (corresponding author), Cleveland Clin Fdn, Cerebrovasc Ctr, S91,9500 Euclid Ave, Cleveland, OH 44195 USA.							*ACEP, 1996, ACEP NEWS, P15; Adams HP, 1996, CIRCULATION, V94, P1167, DOI 10.1161/01.CIR.94.5.1167; Adams HP, 1996, NEUROLOGY, V47, P835; ALBERS WA, 1999, 51 ANN M AM AC NEUR; Benesch C, 1997, NEUROLOGY, V49, P660, DOI 10.1212/WNL.49.3.660; Brott T, 1996, ARCH NEUROL-CHICAGO, V53, P1305, DOI 10.1001/archneur.1996.00550120117025; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Caplan LR, 1997, NEW ENGL J MED, V337, P1309; Chiu D, 1998, STROKE, V29, P18, DOI 10.1161/01.STR.29.1.18; CUMMINS RO, 1997, ADV CARDIAC LIFE SUP, P1; Demchuk AM, 1999, STROKE, V30, P34, DOI 10.1161/01.STR.30.1.34; Fagan SC, 1998, NEUROLOGY, V50, P883, DOI 10.1212/WNL.50.4.883; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Grond M, 1998, STROKE, V29, P1544, DOI 10.1161/01.STR.29.8.1544; Grotta J, 1997, NEW ENGL J MED, V337, P1310; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HANSON SK, 1998, 50 ANN M AM AC NEUR; Hinchey JA, 1998, NEUROLOGY, V50, P619, DOI 10.1212/WNL.50.3.619; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; KARBALAI H, 1999, 24 AM HEART ASS INT; Larrue V, 1997, STROKE, V28, P957, DOI 10.1161/01.STR.28.5.957; Lopez-Yunez AM, 1999, STROKE, V30, P264, DOI 10.1161/01.STR.30.11.2495; MANLY BF, 1998, RANDOMIZATION BOOTST, pCH3; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MARLER JR, 1997, NIH PUBLICATION; Rosenthal G E, 1997, Am J Med Qual, V12, P103, DOI 10.1177/0885713X9701200204; ROSENTHAL GE, 1994, JOINT COMM J QUAL IM, V20, P425, DOI 10.1016/S1070-3241(16)30088-8; Rosenthal GE, 1997, JAMA-J AM MED ASSOC, V278, P485, DOI 10.1001/jama.278.6.485; Scott PA, 1999, STROKE, V30, P244; Tanne D, 1999, NEUROLOGY, V53, P424, DOI 10.1212/WNL.53.2.424; Tanne D, 1999, STROKE, V30, P248; Tilley BC, 1997, ARCH NEUROL-CHICAGO, V54, P1466, DOI 10.1001/archneur.1997.00550240020008; Zweifler RM, 1998, NEUROLOGY, V50, P501, DOI 10.1212/WNL.50.2.501	34	479	493	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1151	1158		10.1001/jama.283.9.1151	http://dx.doi.org/10.1001/jama.283.9.1151			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703777	Bronze			2022-12-28	WOS:000085424100024
J	Khwaja, A; Connolly, JO; Hendry, BM				Khwaja, A; Connolly, JO; Hendry, BM			Prenylation inhibitors in renal disease	LANCET			English	Article							MESANGIAL CELLS; RAS; PROLIFERATION; LOVASTATIN; PROGRESSION	Members of the superfamily of Ras GTPase signalling proteins (monomeric G proteins) require post-translational carboxy-terminal prenylation to function. Prenylation is the covalent attachment of a hydrophobic prenyl group (either farnesyl or geranylgeranyl), which localises the GTPase to cell membranes. Ras proteins exert substantial control on cell proliferation and gene-transcription events, and prenylation inhibitors are now included in clinical trials for cancer. Many renal diseases are highly proliferative and are driven by a range of profibrotic cytokines. We hypothesise that inhibition of prenylation could be of substantial therapeutic benefit in such diseases, providing greater selectivity against abnormal cytokine-driven proliferation and fibrogenesis than current treatments available to nephrologists.	Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Renal Med, London SE5 9PJ, England	University of London; King's College London	Hendry, BM (corresponding author), Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Renal Med, Bessemer Rd, London SE5 9PJ, England.	bruce.hendry@kcl.ac.uk		Khwaja, Arif/0000-0002-4690-3649				Adnane J, 1998, MOL CELL BIOL, V18, P6962, DOI 10.1128/MCB.18.12.6962; Augeri DJ, 1999, BIOORG MED CHEM LETT, V9, P1069, DOI 10.1016/S0960-894X(99)00144-4; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; Downward J, 1997, CURR BIOL, V7, pR258, DOI 10.1016/S0960-9822(06)00116-3; ElNahas AM, 1997, INT J BIOCHEM CELL B, V29, P55, DOI 10.1016/S1357-2725(96)00119-7; Ferrante K, 1999, CANCER CHEMOTH PHARM, V43, pS61, DOI 10.1007/s002800051100; Grone H. J., 1992, Journal of the American Society of Nephrology, V3, P739; Guijarro C, 1996, NEPHROL DIAL TRANSPL, V11, P990; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Johnson BF, 1997, ASM NEWS, V63, P2; JOHNSON RJ, 1994, KIDNEY INT, V45, P1769, DOI 10.1038/ki.1994.230; Katznelson S, 1996, TRANSPLANTATION, V61, P1469, DOI 10.1097/00007890-199605270-00010; Katznelson S, 1999, KIDNEY INT, V56, pS117, DOI 10.1046/j.1523-1755.1999.07129.x; KOHL NE, 1995, NAT MED, V1, P792, DOI 10.1038/nm0895-792; Lanoix J, 1996, ONCOGENE, V13, P1153; Lebowitz PF, 1998, ONCOGENE, V17, P1439, DOI 10.1038/sj.onc.1202175; Magee T, 1999, CELL, V98, P9, DOI 10.1016/S0092-8674(00)80601-7; Massy ZA, 1999, KIDNEY INT, V56, pS80, DOI 10.1038/sj.ki.4495407; McGuire TF, 1996, J BIOL CHEM, V271, P27402, DOI 10.1074/jbc.271.44.27402; MILLER AC, 1995, INT J CANCER, V60, P249; Nabeshima K, 1997, CONTRIB NEPHROL, V120, P153; ODONNELL MP, 1993, J CLIN INVEST, V91, P83, DOI 10.1172/JCI116204; Paul LC, 1999, KIDNEY INT, V56, P783, DOI 10.1046/j.1523-1755.1999.00611.x; Sebti Said, 1997, Current Opinion in Oncology, V9, P557, DOI 10.1097/00001622-199711000-00011; SEBTI SM, 1991, CANC COMM, V60, P249; SEBTI SM, 1997, PHARMACOL THERAPEUT, V1, P103; SOMA MR, 1993, ARTERIOSCLER THROMB, V13, P571, DOI 10.1161/01.ATV.13.4.571; Stark WW, 1998, AM J PHYSIOL-LUNG C, V275, pL55, DOI 10.1152/ajplung.1998.275.1.L55; SUN J, 1995, CANCER RES, V55, P5302; Vrtovsnik F, 1999, KIDNEY INT, V56, pS92, DOI 10.1046/j.1523-1755.1999.07123.x; Weiss RH, 1999, J AM SOC NEPHROL, V10, P1880	32	47	55	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2000	355	9205					741	744		10.1016/S0140-6736(99)08347-6	http://dx.doi.org/10.1016/S0140-6736(99)08347-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703816				2022-12-28	WOS:000085615600043
J	Sandin, RH; Enlund, G; Samuelsson, P; Lennmarken, C				Sandin, RH; Enlund, G; Samuelsson, P; Lennmarken, C			Awareness during anaesthesia: a prospective case study	LANCET			English	Article							GENERAL-ANESTHESIA; RECALL; PROPOFOL	Background Patients who are given general anaesthesia are not guaranteed to remain unconscious during surgery. Knowledge about the effectiveness of current protective measures is scarce, as is our understanding of patients' responses to this complication. We did a prospective case study to assess conscious awareness during anaesthesia. Methods 11 785 patients who had undergone general anaesthesia were interviewed for awareness on three occasions: before they left the post-anaesthesia care unit, and 1-3 days and 7-14 days after the operation. Findings We identified 18 cases of awareness and one case of inadvertent muscle blockade that had occurred before unconsciousness. Incidence of awareness was 0.18% in cases in which neuromuscular blocking drugs were used, and 0.10% in the absence of such drugs. 17 cases of awareness were identified at the final interview, but no more than 11 would have been detected if an interview had been done only when the patients left the post-anaesthesia care unit. Four non-paralysed patients recalled intraoperative events, but none had anxiety during wakefulness or had delayed neurotic symptoms. This finding contrasts with anaesthesia with muscle relaxants, during which 11 of 14 patients had pain, anxiety, or delayed neurotic symptoms, After repeated discussion and information, the delayed neurotic symptoms resolved within 3 weeks in all patients. Analysis of individual cases suggests that a reduced incidence of recall of intraoperative events would not be achieved by monitoring of end-tidal anaesthetic gas concentration or by more frequent use of benzodiazepines. Interpretation The inability to prevent awareness by conventional measures may advocate monitoring of cerebral activity by neurophysiological techniques. However, the sensitivity of such techniques is not known, and in the light of our findings, at least 861 patients would need to be monitored to avoid one patient from suffering due to awareness during relaxant anaesthesia.	Lanssjukhuset, Dept Anaesthesia & Intens Care, S-39185 Kalmar, Sweden; Vrinnevisjukhuset, Dept Anaesthesia & Intens Care, Norrkoping, Sweden		Sandin, RH (corresponding author), Lanssjukhuset, Dept Anaesthesia & Intens Care, S-39185 Kalmar, Sweden.	rolfs@ltkalmar.se	garcia, waynice np/K-3914-2015					BRICE DD, 1970, BRIT J ANAESTH, V42, P535, DOI 10.1093/bja/42.6.535; Klafta JM, 1996, ANESTH ANALG, V83, P1314, DOI 10.1097/00000539-199612000-00031; LIU WHD, 1991, ANAESTHESIA, V46, P435, DOI 10.1111/j.1365-2044.1991.tb11677.x; Myles PS, 2000, BRIT J ANAESTH, V84, P6, DOI 10.1093/oxfordjournals.bja.a013383; Nordstrom O, 1996, BRIT J ANAESTH, V76, P699, DOI 10.1093/bja/76.5.699; Nordstrom O, 1997, ACTA ANAESTH SCAND, V41, P978, DOI 10.1111/j.1399-6576.1997.tb04823.x; Pomfrett CJD, 1999, BRIT J ANAESTH, V82, P659, DOI 10.1093/bja/82.5.659; QUASHA AL, 1980, ANESTHESIOLOGY, V53, P315, DOI 10.1097/00000542-198010000-00008; Ranta SOV, 1998, ANESTH ANALG, V86, P1084, DOI 10.1097/00000539-199805000-00035	9	417	449	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2000	355	9205					707	711		10.1016/S0140-6736(99)11010-9	http://dx.doi.org/10.1016/S0140-6736(99)11010-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703802				2022-12-28	WOS:000085615600012
J	Martin, TE; Martin, PR; Olson, CR; Heidinger, BJ; Fontaine, JJ				Martin, TE; Martin, PR; Olson, CR; Heidinger, BJ; Fontaine, JJ			Parental care and clutch sizes in North and South American birds	SCIENCE			English	Article							LIFE-HISTORY EVOLUTION; NEST PREDATION; BREEDING BIOLOGY; PASSERINE BIRDS; SUCCESS; HYPOTHESIS; BEHAVIOR	The evolutionary causes of small clutch sizes in tropical and Southern Hemisphere regions are poorly understood. Alexander Skutch proposed 50 years ago that higher nest predation in the south constrains the rate at which parent birds can deliver food to young and thereby constrains clutch size by Limiting the number of young that parents can feed. This hypothesis for explaining differences in clutch size and parental behaviors between latitudes has remained untested. Here, a detailed study of bird species in Arizona and Argentina shows that Skutch's hypothesis explains clutch size variation within North and South America. However, neither Skutch's hypothesis nor two major alternatives explain differences between latitudes.	Univ Montana, US Geol Survey, Biol Resources Div, Missoula, MT 59812 USA; Univ Montana, Avian Studies Program, Montana Cooperat Wildlife Res Unit, Missoula, MT 59812 USA	United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana; University of Montana System; University of Montana	Martin, TE (corresponding author), Univ Montana, US Geol Survey, Biol Resources Div, Missoula, MT 59812 USA.	tmartin@selway.umt.edu	Fontaine, Joseph J/F-6557-2010; olson, Christopher/ABC-3812-2020; Martin, Thomas E/F-6016-2011	Fontaine, Joseph J/0000-0002-7639-9156; olson, Christopher/0000-0002-8351-0633; Martin, Thomas E/0000-0002-4028-4867				ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Briskie JV, 1999, P ROY SOC B-BIOL SCI, V266, P2153, DOI 10.1098/rspb.1999.0902; Clutton-Brock T. H., 1991, EVOLUTION PARENTAL C; CODY ML, 1966, EVOLUTION, V20, P174, DOI 10.1111/j.1558-5646.1966.tb03353.x; DYRCZ A, 1994, EMU, V94, P17, DOI 10.1071/MU9940017; FORD HA, 1991, EMU, V91, P53, DOI 10.1071/MU9910053; GIBBS JP, 1991, OIKOS, V60, P155, DOI 10.2307/3544861; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HASKELL D, 1994, P ROY SOC B-BIOL SCI, V257, P161, DOI 10.1098/rspb.1994.0110; HENSLER GL, 1981, WILSON BULL, V93, P42; KULESZA G, 1990, IBIS, V132, P407, DOI 10.1111/j.1474-919X.1990.tb01059.x; Lack D., 1968, pvii; Lack D., 1954, P343; LACK D, 1948, IBIS, V90, P25, DOI 10.1111/j.1474-919X.1948.tb01399.x; MACLEAN G L, 1974, Cimbebasia Series A, V2, P163; MAJOR RE, 1994, OIKOS, V69, P364, DOI 10.2307/3545849; MAJOR RE, 1991, EMU, V91, P236, DOI 10.1071/MU9910236; Martin T.E., 1992, Current Ornithology, V9, P163; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; Martin TE, 1996, J AVIAN BIOL, V27, P263, DOI 10.2307/3677257; Martin TE, 1996, NATURE, V380, P338, DOI 10.1038/380338a0; MARTIN TE, 1993, J FIELD ORNITHOL, V64, P507; Martin TE, 1996, AM NAT, V147, P1028, DOI 10.1086/285891; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin TE, 1999, AM NAT, V153, P131, DOI 10.1086/303153; MOLLER AP, 1994, EVOLUTION, V48, P1089, DOI 10.1111/j.1558-5646.1994.tb05296.x; NOSKE RA, 1991, EMU, V91, P73, DOI 10.1071/MU9910073; OATLEY TB, 1982, OSTRICH, V53, P206, DOI 10.1080/00306525.1982.9634575; ONIKI Y, 1979, BIOTROPICA, V11, P60, DOI 10.2307/2388174; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; RICKLEFS RE, 1992, P NATL ACAD SCI USA, V89, P4722, DOI 10.1073/pnas.89.10.4722; ROBINSON D, 1990, EMU, V90, P40, DOI 10.1071/MU9900040; Roff Derek A., 1992; Roper JJ, 1997, J AVIAN BIOL, V28, P111, DOI 10.2307/3677304; ROWLEY I, 1991, EMU, V91, P197, DOI 10.1071/MU9910197; ROWLEY I, 1991, BIRD POPULATION STUD, P00022; SARGENT S, 1993, WILSON BULL, V105, P285; Skutch A.F., 1985, ORNITHOLOGICAL MONOG, V36, P575, DOI [10.2307/40168306, DOI 10.2307/40168306]; SKUTCH AF, 1949, IBIS, V91, P430, DOI 10.1111/j.1474-919X.1949.tb02293.x; Skutch AF, 1967, PUBL NUTTALL ORNITHO, V7; Skutch AF, 1960, PACIFIC COAST AVIFAU; SKUTCH AF, 1981, PUBL NUTTALL ORNITHO, V19; SKUTCH AF, 1972, PUBL NUTTALL ORNITHO, V10; SLAGSVOLD T, 1982, OECOLOGIA, V54, P159, DOI 10.1007/BF00378388; SNOW D W, 1978, Journal fuer Ornithologie, V119, P227, DOI 10.1007/BF01644591; Taylor LNH, 1998, WILDLIFE RES, V25, P587, DOI 10.1071/WR98034; Terborgh J, 1997, ECOLOGY, V78, P1494, DOI 10.1890/0012-9658(1997)078[1494:BCITTL]2.0.CO;2; TOV YY, 1994, IBIS, V136, P131; Woinarski J.C.Z., 1985, Proceedings of the Ecological Society of Australia, V14, P159	49	339	355	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1482	1485		10.1126/science.287.5457.1482	http://dx.doi.org/10.1126/science.287.5457.1482			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688796	Green Submitted			2022-12-28	WOS:000085531600050
J	Meng, XJ; Lindahl, M; Hyvonen, ME; Parvinen, M; de Rooij, DG; Hess, MW; Raatikainen-Ahokas, A; Sainio, K; Rauvala, H; Lakso, M; Pichel, JG; Westphal, H; Saarma, M; Sariola, H				Meng, XJ; Lindahl, M; Hyvonen, ME; Parvinen, M; de Rooij, DG; Hess, MW; Raatikainen-Ahokas, A; Sainio, K; Rauvala, H; Lakso, M; Pichel, JG; Westphal, H; Saarma, M; Sariola, H			Regulation of cell fate decision of undifferentiated spermatogonia by GDNF	SCIENCE			English	Article							ENTERIC NERVOUS-SYSTEM; ACID RECEPTOR-ALPHA; MICE LACKING GDNF; NEUROTROPHIC FACTOR; IN-VIVO; MOTOR-NEURONS; EXPRESSION; TESTIS; SPERMATOGENESIS; MOUSE	The molecular control of self-renewal and differentiation of stem cells has remained enigmatic. Transgenic Loss-of-function and overexpression models now show that the dosage of glial cell Line-derived neurotrophic factor (GDNF), produced by Sertoli cells, regulates cell fate decisions of undifferentiated spermatogonial cells that include the stem cells for spermatogenesis. Gene-targeted mice with one GDNF-null allele show depletion of stem cell reserves, whereas mice overexpressing GDNF show accumulation of undifferentiated spermatogonia. They are unable to respond properly to differentiation signals and undergo apoptosis upon retinoic acid treatment. Nonmetastatic testicular tumors are regularly formed in older GDNF-overexpressing mice. Thus, GDNF contributes to paracrine regulation of spermatogonial self-renewal and differentiation.	Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Res Program Dev Biol, FIN-00014 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Res Program Mol Neurobiol, FIN-00014 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, Transgen Unit, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland; Univ Turku, Dept Anat, FIN-20520 Turku, Finland; Univ Utrecht, Med Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Hosp Merida, Unidad Invest, Badajoz 06800, Spain; NICHHD, Bethesda, MD 20892 USA	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Turku; Utrecht University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sariola, H (corresponding author), Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Res Program Dev Biol, POB 56,Viikinkaari 9, FIN-00014 Helsinki, Finland.		Lindahl, Maria/AHE-1252-2022; Pichel, Jose G/AAF-2255-2019; Hess, Michael/AAE-1985-2019; de Rooij, D.G./AAW-1195-2021	Pichel, Jose G/0000-0001-8580-0952; Hess, Michael/0000-0002-5154-3553; Lindahl, Maria/0000-0002-5674-8830; Rauvala, Heikki/0000-0001-7809-9811; de Rooij, Dirk/0000-0003-3932-4419				Akmal KM, 1998, ENDOCRINOLOGY, V139, P1239, DOI 10.1210/en.139.3.1239; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; CLERMONT Y, 1963, AM J ANAT, V112, P35, DOI 10.1002/aja.1001120103; de Rooij DG, 1999, BIOL REPROD, V61, P842, DOI 10.1095/biolreprod61.3.842; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Eddy EM, 1996, ENDOCRINOLOGY, V137, P4796, DOI 10.1210/en.137.11.4796; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Furuchi T, 1996, DEVELOPMENT, V122, P1703; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Hellmich HL, 1996, MECH DEVELOP, V54, P95, DOI 10.1016/0925-4773(95)00464-5; Hu J, 1999, ENDOCRINOLOGY, V140, P3416, DOI 10.1210/en.140.8.3416; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; Kokaia Z, 1999, EUR J NEUROSCI, V11, P1202, DOI 10.1046/j.1460-9568.1999.00513.x; KOSHIMIZU U, 1995, MOL REPROD DEV, V40, P221, DOI 10.1002/mrd.1080400211; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; MENG XK, UNPUB; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Parvinen M, 1997, HISTOCHEM CELL BIOL, V108, P77, DOI 10.1007/s004180050148; PELLETIER RM, 1992, MICROSC RES TECHNIQ, V20, P3, DOI 10.1002/jemt.1070200104; PESCOVITZ OH, 1994, TRENDS ENDOCRIN MET, V5, P126, DOI 10.1016/1043-2760(94)90094-9; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Saarma M, 1999, MICROSC RES TECHNIQ, V45, P292, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8; Sainio K, 1997, DEVELOPMENT, V124, P4077; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Widenfalk J, 1997, J NEUROSCI, V17, P8506; Wilkinson D. G., 1990, POSTIMPLANTATION MAM, P155; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1756; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689	39	982	1083	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1489	1493		10.1126/science.287.5457.1489	http://dx.doi.org/10.1126/science.287.5457.1489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688798				2022-12-28	WOS:000085531600052
J	Young, FE				Young, FE			A time for restraint	SCIENCE			English	Editorial Material								The debate on the use of human embryos for research will be one of the more important issues of the 21st century. Unlike recombinant DNA technology, embryonic stem cell research most probably will result in the destruction of living embryos. Many people consider this research immoral, illegal, and unnecessary. Therefore, it is imperative to proceed cautiously. Federal funding of research using human embryos or pluripotent cells derived from them would be inappropriate until further resolution of the ethical issues has been achieved.	Fourth Presbyterian Church, Reformed Theol Seminary, Bethesda, MD 20816 USA		Young, FE (corresponding author), Fourth Presbyterian Church, Reformed Theol Seminary, 5500 River Rd, Bethesda, MD 20816 USA.							CAMPBELL CS, 1997, CLONING HUMAN BEINGS, V2, pD3; Chan AWS, 2000, SCIENCE, V287, P317, DOI 10.1126/science.287.5451.317; FORSYTHE CD, 1998, VALPARAISO U LAW REV, V32, P491; Frisen J, 1998, CELL MOL LIFE SCI, V54, P935, DOI 10.1007/s000180050224; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kuhn HG, 1999, BIOESSAYS, V21, P625, DOI 10.1002/(SICI)1521-1878(199908)21:8<625::AID-BIES1>3.0.CO;2-6; Lanza RP, 1999, SCIENCE, V283, P1849; Luquin MR, 1999, NEURON, V22, P743, DOI 10.1016/S0896-6273(00)80733-3; *NBAC, 1999, EX SUMM ETH ISS HUM; ROBERTSON JA, 1978, SOUTHERN CALIF LAW R, V51, P1203; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; 1986, FED REG, V51, P23302	12	37	46	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1424	1424		10.1126/science.287.5457.1424	http://dx.doi.org/10.1126/science.287.5457.1424			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688779				2022-12-28	WOS:000085531600033
J	Bruhn, D; Groebner, N; Kohlstedt, DL				Bruhn, D; Groebner, N; Kohlstedt, DL			An interconnected network of core-forming melts produced by shear deformation	NATURE			English	Article							SIDEROPHILE ELEMENTS; HIGH-PRESSURE; EARTH; MANTLE; DIFFERENTIATION; CONSTRAINTS; EQUILIBRIUM; OLIVINE	The formation mechanism of terrestrial planetary cores is still poorly understood, and has been the subject of numerous experimental studies(1-3). Several mechanisms have been proposed by which metal-mainly iron with some nickel-could have been extracted from a silicate mantle to form the core. Most recent models involve gravitational sinking of molten metal or metal sulphide through a partially or fully molten mantle(4,5) that is often referred to as a 'magma ocean'. Alternative models invoke percolation of molten metal along an interconnected network (that is, porous flow) through a solid silicate matrix(6,7). But experimental studies performed at high pressures(1-3) have shown that, under hydrostatic conditions, these melts do not form an interconnected network, leading to the widespread assumption that formation of metallic cores requires a magma ocean. In contrast, here we present experiments which demonstrate that shear deformation to large strains can interconnect a significant fraction of initially isolated pockets of metal and metal sulphide melts in a solid matrix of polycrystalline olivine. Therefore, in a dynamic (nonhydrostatic) environment, percolation remains a viable mechanism for the segregation and migration of core-forming melts in a solid silicate mantle.	Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Bruhn, D (corresponding author), Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA.		Bruhn, David F/A-9160-2009	Bruhn, David F/0000-0003-0228-3553				AGEE CB, 1992, WORKSH PHYS CHEM MAG; Arculus R. J., 1990, ORIGIN EARTH, P251; Ballhaus C, 1996, EARTH PLANET SC LETT, V143, P137, DOI 10.1016/0012-821X(96)00135-5; Benz W., 1990, ORIGIN EARTH, P61; BRETT R, 1984, GEOCHIM COSMOCHIM AC, V48, P1183, DOI 10.1016/0016-7037(84)90054-1; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Daines MJ, 1997, J GEOPHYS RES-SOL EA, V102, P10257, DOI 10.1029/97JB00393; ELASSER WM, 1963, EARTH SCI METEORITES, P1; Gaetani GA, 1997, GEOCHIM COSMOCHIM AC, V61, P1829, DOI 10.1016/S0016-7037(97)00033-1; Hanks T. C., 1969, PHYS EARTH PLANET IN, V2, P19; Jurewicz S, 1995, P LUNAR PLANET SCI C, V26, P709; Karato S, 1997, PHYS EARTH PLANET IN, V100, P61, DOI 10.1016/S0031-9201(96)03232-3; Karato S, 1998, PURE APPL GEOPHYS, V151, P589, DOI 10.1007/s000240050131; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; Minarik WG, 1996, SCIENCE, V272, P530, DOI 10.1126/science.272.5261.530; MURTHY VR, 1991, SCIENCE, V253, P303, DOI 10.1126/science.253.5017.303; O'Neill H.S.C., 1998, EARTHS MANTLE COMPOS, P3; Righter K, 1999, EARTH PLANET SC LETT, V171, P383, DOI 10.1016/S0012-821X(99)00156-9; Shannon MC, 1996, GEOPHYS RES LETT, V23, P2717, DOI 10.1029/96GL02817; STEVENSON DJ, 1985, WORKSH EARL EARTH IN, P76; Stevenson DJ., 1990, ORIGIN EARTH, P231; VONBARGEN N, 1986, J GEOPHYS RES-SOLID, V91, P9261, DOI 10.1029/JB091iB09p09261; Walter M, 1996, NATURE, V381, P646, DOI 10.1038/381646a0; WETHERILL GW, 1990, ANNU REV EARTH PL SC, V18, P205, DOI 10.1146/annurev.ea.18.050190.001225; ZHANG SQ, 1995, NATURE, V375, P774, DOI 10.1038/375774a0; Zimmerman ME, 1999, GEOPHYS RES LETT, V26, P1505, DOI 10.1029/1999GL900259; [No title captured]	27	83	86	0	28	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					883	886		10.1038/35002558	http://dx.doi.org/10.1038/35002558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706283				2022-12-28	WOS:000085559200054
J	Miller, RJ; Roos, RP				Miller, RJ; Roos, RP			What happens when mutant neuroserpins get into bad shape	LANCET			English	Editorial Material									Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Miller, RJ (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.							Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Davis RL, 1999, AM J PATHOL, V155, P1901, DOI 10.1016/S0002-9440(10)65510-1; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Tran PB, 1999, TRENDS NEUROSCI, V22, P194, DOI 10.1016/S0166-2236(99)01409-5	8	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					590	591		10.1016/S0140-6736(99)00457-2	http://dx.doi.org/10.1016/S0140-6736(99)00457-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696974				2022-12-28	WOS:000085615400004
J	Huang, SP; Pollack, HN; Shen, PY				Huang, SP; Pollack, HN; Shen, PY			Temperature trends ever the past five centuries reconstructed from borehole temperatures	NATURE			English	Article							CLIMATE-CHANGE; RESOLUTION	For an accurate assessment of the relative roles of natural variability and anthropogenic influence in the Earth's climate, reconstructions of past temperatures from the pre-industrial as well as the industrial period are essential. But instrumental records are typically available for no more than the past 150 years. Therefore reconstructions of pre-industrial climate rely principally on traditional climate proxy records(1-5), each with particular strengths and limitations in representing climatic variability. Subsurface temperatures comprise an independent archive of past surface temperature changes that is complementary to both the instrumental record and the climate proxies. Here we use present-day temperatures in 616 boreholes from all continents except Antarctica to reconstruct century-long trends in temperatures over the past 500 years at global, hemispheric and continental scales. The results confirm the unusual warming of the twentieth century revealed by the instrumental record(6), but suggest that the cumulative change over the past five centuries amounts to about 1 K, exceeding recent estimates from conventional climate proxies(2-5). The strength of temperature reconstructions from boreholes lies in the detection of long-term trends, complementary to conventional climate proxies, but to obtain a complete picture of past warming, the differences between the approaches need to be investigated in detail.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Univ Western Ontario, Dept Earth Sci, London, ON N6A 5B7, Canada	University of Michigan System; University of Michigan; Western University (University of Western Ontario)	Pollack, HN (corresponding author), Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA.	hpollack@umich.edu	Huang, Shaopeng/GZG-9834-2022	Huang, Shaopeng/0000-0002-5428-9853				BELTRAMI H, 1995, GLOBAL PLANET CHANGE, V11, P57, DOI 10.1016/0921-8181(95)00002-9; BIRCH F, 1948, AM J SCI, V246, P729; Briffa KR, 1999, SCIENCE, V284, P926, DOI 10.1126/science.284.5416.926; Briffa KR, 1998, NATURE, V393, P450, DOI 10.1038/30943; CERMAK V, 1971, PALAEOGEOGR PALAEOCL, V10, P1, DOI 10.1016/0031-0182(71)90043-5; CHAPMAN DS, 1992, GLOBAL PLANET CHANGE, V98, P269; CLOW GD, 1992, GLOBAL PLANET CHANGE, V98, P81; Harris RN, 1998, J GEOPHYS RES-SOL EA, V103, P7363, DOI 10.1029/97JB03297; Huang S., 1998, IGBP PAGES WORLD DAT, V1998-044; Huang SP, 1996, GEOPHYS RES LETT, V23, P257, DOI 10.1029/96GL00020; Jones P, 1998, SCIENCE, V280, P544, DOI 10.1126/science.280.5363.544; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; JONES PD, 1994, J CLIMATE, V7, P1794, DOI 10.1175/1520-0442(1994)007<1794:HSATVA>2.0.CO;2; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; LACHENBRUCH AH, 1986, SCIENCE, V234, P689, DOI 10.1126/science.234.4777.689; Lewis T, 1998, GLOBAL PLANET CHANGE, V18, P1, DOI 10.1016/S0921-8181(97)00011-8; Majorowicz JA, 1997, GLOBAL PLANET CHANGE, V15, P79, DOI 10.1016/S0921-8181(97)00005-2; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Pollack HN, 1998, SCIENCE, V282, P279, DOI 10.1126/science.282.5387.279; SHEN PY, 1991, J GEOPHYS RES-SOL EA, V96, P19965, DOI 10.1029/91JB01883; SHEN PY, 1995, J GEOPHYS RES-SOL EA, V100, P6383, DOI 10.1029/94JB03136	23	334	359	7	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					756	758		10.1038/35001556	http://dx.doi.org/10.1038/35001556			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693801	Green Published			2022-12-28	WOS:000085423100048
J	Naeem, S; Hahn, DR; Schuurman, G				Naeem, S; Hahn, DR; Schuurman, G			Producer-decomposer co-dependency influences biodiversity effects	NATURE			English	Article							ECOSYSTEM PROCESSES; PLANT; DIVERSITY; NITROGEN; PRODUCTIVITY; BIOMASS; CARBON	Producers, such as plants and algae, acquire nutrients from inorganic sources that are supplied primarily by decomposers whereas decomposers, mostly fungi and bacteria, acquire carbon from organic sources that are supplied primarily by producers. This producer-decomposer co-dependency is important in governing ecosystem processes(1-4), which implies that the impacts of declining biodiversity on ecosystem functioning(5-7) should be strongly infuenced by this process. Here we show, by simultaneously manipulating producer (green algal) and decomposer (heterotrophic bacterial) diversity in freshwater microcosms, that algal biomass production varies considerably among microcosms (0.0-0.67 mg ml(-1)), but that neither algal nor bacterial diversity by itself can explain this variation. Instead, production is a joint function of both algal and bacterial diversity. Furthermore, the range in algal production in microscosms in which bacterial diversity was manipulated was nearly double (1.82 times) that of microcosms in which bacterial diversity was not manipulated. Measures of organic carbon use by bacteria in these microcosms indicate that carbon usage is the mechanism responsible for these results. Because both producer(8) and microbial diversity(9) respond to disturbance and habitat modification, the main causes of biodiversity loss(8), these results suggest that ecosystem response to changing biodiversity is likely to be more complex than other studies(5-7) have shown.	Univ Washington, Dept Zool, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Naeem, S (corresponding author), Univ Washington, Dept Zool, 24 Kincaid Hall,Boc 351800, Seattle, WA 98195 USA.							Allsopp D., 1995, MICROBIAL DIVERSITY; BERMAN T, 1974, MAR BIOL, V28, P305, DOI 10.1007/BF00388498; Berman-Frank I, 1999, BIOSCIENCE, V49, P29, DOI 10.2307/1313491; BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Griffiths BS, 1997, MICROBIAL COMMUNITIES, P1; HARTE J, 1993, AM NAT, V141, P839; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; JONES AK, 1982, MICROBIAL INTERACTIO, P189; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Mulder CPH, 1999, ECOL LETT, V2, P237; Naeem S, 1998, ECOLOGY, V79, P2603, DOI 10.1890/0012-9658(1998)079[2603:CSRAAB]2.0.CO;2; Naeem S, 1996, OIKOS, V76, P259, DOI 10.2307/3546198; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; PRITCHARD PH, 1995, MICROBIAL DIVERSITY AND ECOSYSTEM FUNCTION, P161; Schlesinger WH, 1997, BIOGEOCHEMISTRY; Smalla K, 1998, APPL ENVIRON MICROB, V64, P1220; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wall DH, 1999, BIOSCIENCE, V49, P109, DOI 10.2307/1313536; Wetzel R. G., 1991, LIMNOLOGICAL ANAL; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; WOOD A M, 1990, Marine Microbial Food Webs, V4, P103; ZAK DR, 1990, BIOGEOCHEMISTRY, V11, P111, DOI 10.1007/BF00002062; ZAK DR, 1991, OECOLOGIA, V88, P189, DOI 10.1007/BF00320810	30	166	180	5	101	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					762	764		10.1038/35001568	http://dx.doi.org/10.1038/35001568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693803				2022-12-28	WOS:000085423100050
J	Ensrud, KE; Duong, T; Cauley, JA; Heaney, RP; Wolf, RL; Harris, E; Cummings, SR				Ensrud, KE; Duong, T; Cauley, JA; Heaney, RP; Wolf, RL; Harris, E; Cummings, SR		Study Osteoporot Fractures Res Grp	Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake	ANNALS OF INTERNAL MEDICINE			English	Article						calcium; calcium, dietary; osteoporosis; hip fractures; intestinal absorption	VITAMIN-D SUPPLEMENTATION; DIETARY CALCIUM; PHYSICAL-ACTIVITY; INVOLUTIONAL OSTEOPOROSIS; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; PROXIMAL FEMUR; ELDERLY WOMEN; D METABOLISM; BONE LOSS	Background: Decreased ability to absorb calcium with age limits adaptation to low calcium intake and is thought to lead to secondary hyperparathyroidism and increased risk for hip and other fractures. However, the associations between fractional calcium absorption, dietary calcium intake, and risk for fracture have never been studied. Objective: To determine whether low fractional calcium absorption in women with low calcium intake increases the risk for subsequent hip and other nonspine fractures. Design: Prospective cohort study. Setting: Four clinical centers in Baltimore County, Maryland; Portland, Oregon; Minneapolis, Minnesota; and the Monongahela Valley, Pennsylvania. Derv participants: 5452 nonblack women 69 years of age or and subsequent older participating in the fourth examination of the Study studied. of Osteoporotic Fractures. Measurements: Fractional calcium absorption was measured by using a 3-hour single isotope (Ca-45) technique. Incident fractures were identified prospectively and were confirmed by radiographic report, Results: During an average of 4.8 years, 729 women (13%) experienced at least one nonspine fracture; 153 of these women had hip fractures. After adjustment for age, women with lower fractional calcium absorption were at increased risk for hip fracture (relative risk per 1-SD [7.7%] decrease in fractional calcium absorption, 1.24 [95% CI, 1.05 to 1.48]). Women with low fractional calcium absorption and low calcium intake were at greatest risk for subsequent hip fracture; among women whose dietary calcium intake was less than 400 mg/d, those who had fractional calcium absorption at or below the median value of 32.3% had a 2.5-fold (CI, 1.29-fold to 4.69-fold) increase in risk for hip fracture compared with those who had greater absorption efficiency. Fractional calcium absorption was not related to risk for other nonspine fractures (relative risk per 1-SD [7.7%] decrease in fractional calcium absorption, 1.05 [CI, 0.96 to 1.14]). Conclusions: In elderly women, low fractional calcium absorption in the setting of low calcium intake increases the risk for hip fracture. Our findings support the hypothesis of type II osteoporosis, which postulates that decreased calcium absorption is an important risk factor for hip fracture in older persons.	Vet Affairs Med Ctr, Minneapolis, MN 55417 USA; Univ Calif San Francisco, San Francisco, CA 94105 USA; Univ Pittsburgh, Pittsburgh, PA 15261 USA; Creighton Univ, Omaha, NE 68178 USA; Kaiser Permanente Ctr Hlth Res, Portland, OR 97227 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Creighton University; Kaiser Permanente	Ensrud, KE (corresponding author), Vet Affairs Med Ctr, 1 Vet Dr, Minneapolis, MN 55417 USA.	ensru001@tc.umn.edu	Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408; Ensrud, Kristine/0000-0002-9069-3036	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035582] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR35582] Funding Source: Medline; NIA NIH HHS [AG05407, AG05394] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALEVIZAKI CC, 1973, J NUCL MED, V14, P760; ARJANDI BH, 1993, BONE MINER, V21, P63; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; BULLAMORE JR, 1970, LANCET, V2, P535; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; CHAPUY MC, 1983, J GERONTOL, V38, P19, DOI 10.1093/geronj/38.1.19; COOPER C, 1988, BRIT MED J, V297, P1443, DOI 10.1136/bmj.297.6661.1443; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; CUMMING RG, 1994, AM J EPIDEMIOL, V139, P493, DOI 10.1093/oxfordjournals.aje.a117032; Cumming RG, 1997, AM J EPIDEMIOL, V145, P926, DOI 10.1093/oxfordjournals.aje.a009052; Cummings SR, 1998, NEW ENGL J MED, V339, P733, DOI 10.1056/NEJM199809103391104; CUMMINGS SR, 1987, AM J EPIDEMIOL, V126, P796, DOI 10.1093/oxfordjournals.aje.a114716; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; EASTELL R, 1991, J BONE MINER RES, V6, P125; EBELING PR, 1994, CALCIFIED TISSUE INT, V55, P330, DOI 10.1007/BF00299309; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; Feskanich D, 1997, AM J PUBLIC HEALTH, V87, P992, DOI 10.2105/AJPH.87.6.992; GALLAGHER JC, 1979, J CLIN INVEST, V64, P729, DOI 10.1172/JCI109516; HEANEY RP, 1990, J BONE MINER RES, V5, P1135; HEANEY RP, 1985, ANN INTERN MED, V103, P516, DOI 10.7326/0003-4819-103-4-516; HEANEY RP, 1989, J BONE MINER RES, V4, P469; HEANEY RP, 1986, AM J CLIN NUTR, V43, P299, DOI 10.1093/ajcn/43.2.299; HEANEY RP, 1988, ANN INTERN MED, V108, P905, DOI 10.7326/0003-4819-108-6-905_2; HOLBROOK TL, 1988, LANCET, V2, P1046, DOI 10.1016/S0140-6736(88)90065-7; JAGLAL SB, 1993, AM J EPIDEMIOL, V138, P107, DOI 10.1093/oxfordjournals.aje.a116833; JOHNELL O, 1995, J BONE MINER RES, V10, P1802, DOI 10.1002/jbmr.5650101125; KREIGER N, 1992, INT J EPIDEMIOL, V21, P953, DOI 10.1093/ije/21.5.953; LAU E, 1988, BRIT MED J, V297, P1441, DOI 10.1136/bmj.297.6661.1441; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Lohman TG, 1988, ANTHROPOMETRIC STAND, P177, DOI DOI 10.1002/AJHB.1310040323; LOOKER AC, 1993, OSTEOPOROSIS INT, V3, P177, DOI 10.1007/BF01623673; MEYER HE, 1995, OSTEOPOROSIS INT, V5, P239, DOI 10.1007/BF01774013; MICHAELSSON K, 1995, INT J EPIDEMIOL, V24, P771, DOI 10.1093/ije/24.4.771; MORRIS HA, 1991, CALCIFIED TISSUE INT, V49, P240, DOI 10.1007/BF02556211; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; NIEVES JW, 1992, OSTEOPOROSIS INT, V2, P122, DOI 10.1007/BF01623818; NORDIN BE, 1961, LANCET, V1, P1011; Paganini-Hill A, 1991, Epidemiology, V2, P16; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; RIGGS BL, 1983, AM J MED, V75, P899, DOI 10.1016/0002-9343(83)90860-4; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; STEIGER P, 1992, J BONE MINER RES, V7, P625; TSAI KS, 1984, J CLIN INVEST, V73, P1668, DOI 10.1172/JCI111373; WICKHAM CAC, 1989, BMJ-BRIT MED J, V299, P889, DOI 10.1136/bmj.299.6704.889; WOOTTON R, 1979, CLIN SCI, V57, P93, DOI 10.1042/cs0570093	46	112	116	2	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2000	132	5					345	+		10.7326/0003-4819-132-5-200003070-00003	http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KY	10691584				2022-12-28	WOS:000085563000002
J	Callahan, D				Callahan, D			Death and the research imperative.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hastings Ctr, Garrison, NY 10524 USA		Callahan, D (corresponding author), Hastings Ctr, Garrison, NY 10524 USA.							AMUNDSEN DW, 1978, HASTINGS CENT REP, V8, P23, DOI 10.2307/3560974; Aries P, 1981, HOUR OUR DEATH; FISHER LM, 1999, NY TIMES        0829; Larson E. J., 1997, WAKE FOREST LAW REV, V32, P349; SCHWARTZ WB, 1998, LIFE DIS PURSUIT MED; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506	6	104	114	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					654	656		10.1056/NEJM200003023420910	http://dx.doi.org/10.1056/NEJM200003023420910			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10699168				2022-12-28	WOS:000085575500010
J	McCluskey, PJ; Towler, HMA; Lightman, S				McCluskey, PJ; Towler, HMA; Lightman, S			Regular review - Management of chronic uveitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SUSTAINED-RELEASE; CYCLOSPORINE; DISEASE		Moorfields Eye Hosp, Inst Ophthalmol, Dept Clin Ophthalmol, London EC1V 2PD, England; St Vincents Hosp, Dept Ophthalmol, Sydney, NSW 2010, Australia; Whipps Cross Hosp & Chest Clin, London E11 1NR, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; St Vincents Hospital Sydney; University of London; Queen Mary University London	Lightman, S (corresponding author), Moorfields Eye Hosp, Inst Ophthalmol, Dept Clin Ophthalmol, City Rd, London EC1V 2PD, England.	s.lightman@ucl.ac.uk	McCluskey, Peter J/H-7607-2013	McCluskey, Peter J/0000-0002-8177-1637				BOKE W, 1992, DEV OPHTHALMOL, V23, P20; Bouza E, 1997, MEDICINE, V76, P53, DOI 10.1097/00005792-199701000-00005; Enyedi LB, 1996, CURR EYE RES, V15, P549, DOI 10.3109/02713689609000766; FORRESTER JV, 1990, BRIT J OPHTHALMOL, V74, P620, DOI 10.1136/bjo.74.10.620; HEMADY R, 1991, SURV OPHTHALMOL, V35, P369, DOI 10.1016/0039-6257(91)90186-J; JABS DA, 1986, AM J OPHTHALMOL, V102, P297, DOI 10.1016/0002-9394(86)90001-2; Jaffe GJ, 1998, OPHTHALMOLOGY, V105, P46, DOI 10.1016/S0161-6420(98)91176-9; Larkin G, 1999, OPHTHALMOLOGY, V106, P370, DOI 10.1016/S0161-6420(99)90078-7; LIGHTMAN S, 1991, Eye (London), V5, P294; Nussenblatt RB, 1997, AM J OPHTHALMOL, V123, P583, DOI 10.1016/S0002-9394(14)71070-0; Nussenblatt RB, 1999, P NATL ACAD SCI USA, V96, P7462, DOI 10.1073/pnas.96.13.7462; NUSSENBLATT RB, 1976, NAT I HLTH REP NAT A; Okhravi N, 1999, OPHTHALMOLOGY, V106, P710, DOI 10.1016/S0161-6420(99)90155-0; PRIEM HA, 1988, BRIT J OPHTHALMOL, V72, P646, DOI 10.1136/bjo.72.9.646; RIORDANEVA P, 1994, EYE, V8, P66, DOI 10.1038/eye.1994.12; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; SHAH SS, 1992, OPHTHALMOLOGY, V99, P1419; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; Towler H M, 1995, Ocul Immunol Inflamm, V3, P163, DOI 10.3109/09273949509069109; TOWLER HMA, 1995, INT OPHTHALMOL CLIN, V35, P31, DOI 10.1097/00004397-199503520-00005; WAKEFIELD D, 1991, SURV OPHTHALMOL, V36, P223, DOI 10.1016/0039-6257(91)90005-Z; WEINER A, 1991, AM J OPHTHALMOL, V112, P151, DOI 10.1016/S0002-9394(14)76694-2	22	61	64	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2000	320	7234					555	558		10.1136/bmj.320.7234.555	http://dx.doi.org/10.1136/bmj.320.7234.555			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688564	Green Published			2022-12-28	WOS:000085624000025
J	Cowburn, RP; Welland, ME				Cowburn, RP; Welland, ME			Room temperature magnetic quantum cellular automata	SCIENCE			English	Article								All computers process information electronically, A processing method based on magnetism is reported here, in which networks of interacting submicrometer magnetic dots are used to perform logic operations and propagate information at room temperature. The logic states are signaled by the magnetization direction of the single-domain magnetic dots; the dots couple to their nearest neighbors through magnetostatic interactions. Magnetic solitons carry information through the networks, and an applied oscillating magnetic field feeds energy into the system and serves as a clock. These networks offer a several thousandfold increase in integration density and a hundredfold reduction in power dissipation over current microelectronic technology.	Univ Cambridge, Dept Engn, Nanoscale Sci Lab, Cambridge CB2 1PZ, England	University of Cambridge	Cowburn, RP (corresponding author), Univ Cambridge, Dept Engn, Nanoscale Sci Lab, Trumpington St, Cambridge CB2 1PZ, England.	rpc12@cam.ac.uk	Cowburn, Russell/D-5820-2015	Cowburn, Russell/0000-0003-0867-8900				Ahmed H, 1996, MICROELECTRON ENG, V32, P297, DOI 10.1016/0167-9317(95)00179-4; Amlani I, 1999, SCIENCE, V284, P289, DOI 10.1126/science.284.5412.289; COMPANO R, 1999, TECHNOLOGY ROADMAP E, P12; Cowburn RP, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/316; Cowburn RP, 1998, APPL PHYS LETT, V73, P3947, DOI 10.1063/1.122945; Cowburn RP, 1999, PHYS REV LETT, V83, P1042, DOI 10.1103/PhysRevLett.83.1042; Gallagher William Joseph, 1997, US Patent, Patent No. [5,640,343, 5640343]; HUBERT A, 1998, MAGNETIC DOMAINS, P24; Lent CS, 1997, P IEEE, V85, P541, DOI 10.1109/5.573740; Pohm AV, 1999, J APPL PHYS, V85, P4771, DOI 10.1063/1.370476; Porod W, 1999, INT J ELECTRON, V86, P549, DOI 10.1080/002072199133265; Prinz GA, 1999, SCIENCE, V283, P330; Russek SE, 1999, J APPL PHYS, V85, P4773, DOI 10.1063/1.370477; Schaller RR, 1997, IEEE SPECTRUM, V34, P52, DOI 10.1109/6.591665; Schulz M, 1999, NATURE, V399, P729, DOI 10.1038/21526; *SEM, 1999, SEM IND ASS INT TECH; Smith CG, 1999, SCIENCE, V284, P274, DOI 10.1126/science.284.5412.274; Stamps RL, 1999, APPL PHYS LETT, V75, P1143, DOI 10.1063/1.124623	18	826	866	3	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1466	1468		10.1126/science.287.5457.1466	http://dx.doi.org/10.1126/science.287.5457.1466			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688790				2022-12-28	WOS:000085531600044
J	During, MJ; Symes, CW; Lawlor, PA; Lin, J; Dunning, J; Fitzsimons, HL; Poulsen, D; Leone, P; Xu, RA; Dicker, BL; Lipski, J; Young, D				During, MJ; Symes, CW; Lawlor, PA; Lin, J; Dunning, J; Fitzsimons, HL; Poulsen, D; Leone, P; Xu, RA; Dicker, BL; Lipski, J; Young, D			An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy	SCIENCE			English	Article							BLOOD-BRAIN-BARRIER; GLUTAMIC-ACID DECARBOXYLASE; GLYCINE-BINDING-SITE; D-ASPARTATE RECEPTOR; STIFF-MAN SYNDROME; STATUS EPILEPTICUS; RAT; AUTOANTIBODIES; SUBUNIT; MK-801	The brain is generally considered immunoprivileged, although increasing examples of immunological responses to brain antigens, neuronal expression of major histocompatibility class I genes, and neurological autoimmunity have been recognized. An adeno-associated virus (AAV) vaccine generated autoantibodies that targeted a specific brain protein, the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor. After peroral administration of the AAV vaccine, transgene expression persisted for at least 5 months and was associated with a robust humoral response in the absence of a significant cell-mediated response. This single-dose vaccine was associated with strong anti-epileptic and neuroprotective activity in rats for both a kainate-induced seizure model and also a middle cerebral artery occlusion stroke model at 1 to 5 months following vaccination. Thus, a vaccination strategy targeting brain proteins is feasible and may have therapeutic potential for neurological disorders.	Univ Auckland, Sch Med, Dept Mol Med, Auckland, New Zealand; Univ Auckland, Sch Med, Dept Physiol, Auckland, New Zealand; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Jefferson Med Coll, Dept Neurosurg, Philadelphia, PA 19107 USA	University of Auckland; University of Auckland; Jefferson University; Jefferson University	During, MJ (corresponding author), Univ Auckland, Sch Med, Dept Mol Med, Auckland, New Zealand.	matthew.during@mail.tju.edu	During, Matthew/AAC-1388-2020; Dicker, Bridget/F-8770-2019	Dicker, Bridget/0000-0002-8151-7356; Lipski, Janusz/0000-0001-6109-8724; Fitzsimons, Helen/0000-0001-7825-3911; Young, Deborah/0000-0003-1085-2824; Lin, John/0000-0002-1723-4597				AIHARA N, 1994, J COMP NEUROL, V342, P481, DOI 10.1002/cne.903420402; Albayrak S, 1997, ACTA NEUROPATHOL, V94, P158, DOI 10.1007/s004010050688; BARAN H, 1994, BRAIN RES, V652, P195, DOI 10.1016/0006-8993(94)90227-5; Beal M F, 1992, Curr Opin Neurobiol, V2, P657, DOI 10.1016/0959-4388(92)90035-J; BEAR MF, 1990, J NEUROSCI, V10, P909; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Butcher SP, 1997, J NEUROSCI, V17, P6939; CARLSSON M, 1990, LIFE SCI, V47, P1729, DOI 10.1016/0024-3205(90)90346-S; Darnell RB, 1996, P NATL ACAD SCI USA, V93, P4529, DOI 10.1073/pnas.93.10.4529; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Dinkel K, 1998, ANN NEUROL, V44, P194, DOI 10.1002/ana.410440209; DRAGUNOW M, 1995, MOL BRAIN RES, V32, P279, DOI 10.1016/0169-328X(95)00088-A; During MJ, 1998, NAT MED, V4, P1131, DOI 10.1038/2625; DURING MJ, UNPUB; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gusev EI, 1996, ZH NEVROPATOL PSIKH, V96, P68; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; LOTHMAN EW, 1993, EPILEPSIA, V34, pS59, DOI 10.1111/j.1528-1157.1993.tb05907.x; Mayhan WG, 1996, STROKE, V27, P965, DOI 10.1161/01.STR.27.5.965; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; POSNER JB, 1990, RES P ARNMD, V68, P187; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; Schehr RS, 1996, NAT BIOTECHNOL, V14, P1549, DOI 10.1038/nbt1196-1549; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SHALABY WSW, 1995, CLIN IMMUNOL IMMUNOP, V74, P127, DOI 10.1006/clin.1995.1019; SHARKEY J, 1995, J NEUROSCI METH, V60, P125, DOI 10.1016/0165-0270(95)00003-D; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SOLIMENA M, 1988, NEW ENGL J MED, V318, P1012, DOI 10.1056/NEJM198804213181602; STEINBERG GK, 1995, NEUROSCIENCE, V64, P99, DOI 10.1016/0306-4522(94)00374-E; TWYMAN RE, 1995, NEURON, V14, P755, DOI 10.1016/0896-6273(95)90219-8; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; Wood MW, 1997, J BIOL CHEM, V272, P3532, DOI 10.1074/jbc.272.6.3532; WOZNIAK DF, 1990, PSYCHOPHARMACOLOGY, V101, P47, DOI 10.1007/BF02253717; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; ZUCKER DK, 1983, EXP NEUROL, V79, P422, DOI 10.1016/0014-4886(83)90223-6	38	183	218	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1453	1460		10.1126/science.287.5457.1453	http://dx.doi.org/10.1126/science.287.5457.1453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688787				2022-12-28	WOS:000085531600041
J	Wang, BL; Fallon, JF; Beachy, PA				Wang, BL; Fallon, JF; Beachy, PA			Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb	CELL			English	Article							PROTEIN-KINASE-A; GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; TERMINAL CLEAVAGE PRODUCT; VENTRAL NEURAL-TUBE; SONIC-HEDGEHOG; FLOOR PLATE; CUBITUS-INTERRUPTUS; SIGNALING PATHWAY; TRANSCRIPTION FACTOR; PATTERNING ACTIVITY	Ci/Gli zinc finger proteins mediate the transcriptional effects of Hedgehog protein signals. In Drosophila, Ci action as transcriptional repressor or activator is contingent upon Hedgehog-regulated, PKA-dependent proteolytic processing. We demonstrate that PKA-dependent processing of vertebrate Gli3 in developing limb similarly generates a potent repressor in a manner antagonized by apparent long-range signaling from posteriorly localized Sonic hedgehog protein. The resulting anterior/posterior Gli3 repressor gradient can be perturbed by mutations of Gli3 in human genetic syndromes or by misregulation of Gli3 processing in the chicken mutant talpid(2), producing a range of limb patterning malformations. The high relative abundance and potency of Gli3 repressor suggest specialization of Gli3 and its products for negative Hedgehog pathway regulation.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	Howard Hughes Medical Institute; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.				NICHD NIH HHS [HD32551] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032551] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; Borycki AG, 1998, DEVELOPMENT, V125, P777; Buscher D, 1998, MAMM GENOME, V9, P676, DOI 10.1007/s003359900845; Caruccio NC, 1999, DEV BIOL, V212, P137, DOI 10.1006/dbio.1999.9321; CHANG DT, 1994, DEVELOPMENT, V120, P3339; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1998, P NATL ACAD SCI USA, V95, P2349, DOI 10.1073/pnas.95.5.2349; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DANIELS K, 1998, METHOD CELL BIOL, P237; Ding Q, 1998, DEVELOPMENT, V125, P2533; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Hughes DC, 1997, GENOMICS, V39, P205, DOI 10.1006/geno.1996.4468; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Lee J, 1997, DEVELOPMENT, V124, P2537; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; MARTI E, 1995, DEVELOPMENT, V121, P2537; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mo R, 1997, DEVELOPMENT, V124, P113; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tatusova TA, 1999, FEMS MICROBIOL LETT, V177, P187, DOI 10.1111/j.1574-6968.1999.tb13730.x; Ungar AR, 1996, DEV BIOL, V178, P186, DOI 10.1006/dbio.1996.0209; VORTKAMP A, 1992, MAMM GENOME, V3, P461, DOI 10.1007/BF00356157; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang BL, 1996, ONCOGENE, V12, P1921; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979; Yang Y, 1997, DEVELOPMENT, V124, P4393; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zou H, 1997, COLD SPRING HARB SYM, V62, P269	57	787	815	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					423	434		10.1016/S0092-8674(00)80678-9	http://dx.doi.org/10.1016/S0092-8674(00)80678-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693759	Bronze			2022-12-28	WOS:000085446900005
J	Markel, H				Markel, H			The University of Michigan Medical School, 1850-2000 - "An example worthy of imitation"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								The 150th anniversary of the University of Michigan Medical School affords occasion for both celebration and reflection, not just in Ann Arbor but throughout the world, as we consider its contributions to medical education, research, and health care over the past century and a half. This article explores the medical school's origins as a frontier medical outpost and describes the vital reforms in medical education implemented in Ann Arbor long before the landmark Flexner Report on Medical Education of 1910, It also depicts how and why the medical school developed as it did and what features are distinctive or typical about the school during this period.	Univ Michigan, Sch Med, Hist Ctr Hlth Sci, Simpson Mem Inst 100, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Hist, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Sch Med, Hist Ctr Hlth Sci, Simpson Mem Inst 100, Box 0725,102 Observ, Ann Arbor, MI 48109 USA.							ANDERSON F, 1951, DOCTORS 3 FLAGS; Bonner TN., 1992, ENDS EARTH WOMENS SE; BONNER TN, 1995, BECOMING PHYSICIAN M, P224; Bordin Ruth, 1999, WOMEN MICHIGAN DANGE; BURR CB, 1930, MED HIST MICHIGAN; CABOT H, 1935, DOCTORS BILL; DAVENPORT HW, 1993, U MICHIGAN MONOGRAPH, V3, P61; DAVENPORT HW, 1996, U MICHIGAN MONOGRAPH, V4, P1; Davenport HW, 1987, DOCTOR DOCK TEACHING; DAVENPORT HW, 1999, NOT JUST ANY MED SCH, P1; DEKRUIF P, 1962, SWEEPING WIND MEMOIR, P73; DOCK G, NOTES MED CLIN TAUGH; FLEXNER A, 1910, MED ED US CANADA, P243; Hamilton A., 1943, EXPLORING DANGEROUS; HOWELL J, 1993, MED LIVES SCI MED MI, P13; Lewis S., 1925, ARROWSMITH; LEWISJOHNSON GJ, 1994, BLACK MED GRADUATES; Ludmerer Kenneth M., 1985, LEARNING HEAL DEV AM; MARANTZSANCHEZ RM, 1985, SYMPATHY SCI WOMEN P; MARKEL H, 1987, AM J PUBLIC HEALTH, V77, P219, DOI 10.2105/AJPH.77.2.219; MCGUIGAN DG, 1970, DANGEROUS EXPT 100 Y, P37; NOVY FG, 1908, PHYSICIAN SURG, V30, P49; OSLER W, 1904, AEQUANIMITAS OTHER A, P327; PARASCONDOLA J, 1992, DEV AM PHARM JJ ABEL; Peckham Howard H., 1994, MAKING U MICHIGAN 18, P1; PITCHER Z, 1848, P BOARD REG U MICH 1, P390; PRATT JH, 1949, YEAR OSLER 1896 1897; SHAW WB, 1951, U MICHIGAN ENCY SURV, V2, P773; STENECK NH, 1995, U MICHIGAN MONOGRAPH, V1, P17; TUFTS CW, 1876, COMMUNICATION   1001; *U MICH, 1930, P BOARD REG U MICH F, P169; *U MICH, 1912, GEN CAT OFF STUD U M; *U MICH, 1920, P BOARD REG U MICH J, P811; VAUGHAN VC, 1926, DOCTORS MEMORIES, P97; WIGGERS CJ, 1928, PRESSURE PULSES CARD; WILLIAMS BA, 1995, U MICH BENTLEY HIST, V42; 1930, WASHTENAW TRIBU 0207, V1, P1	37	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2000	283	7					915	920		10.1001/jama.283.7.915	http://dx.doi.org/10.1001/jama.283.7.915			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	281WT	10685717				2022-12-28	WOS:000085185000031
J	Banfield, JF; Marshall, CR				Banfield, JF; Marshall, CR			Earth science and evolution - Genomics and the geosciences	SCIENCE			English	Editorial Material									Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard University	Banfield, JF (corresponding author), Univ Wisconsin, Dept Geol & Geophys, 1215 W Dayton St, Madison, WI 53706 USA.	jill@geology.wisc.edu; marshall@eps.harvard.edu		Banfield, Jill/0000-0001-8203-8771				Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; DAVIDSON EH, 1995, SCIENCE, V270, P1319, DOI 10.1126/science.270.5240.1319; Edwards KJ, 1999, APPL ENVIRON MICROB, V65, P3627; Fitz-Gibbon ST, 1999, NUCLEIC ACIDS RES, V27, P4218, DOI 10.1093/nar/27.21.4218; Hieter P, 1997, SCIENCE, V278, P601, DOI 10.1126/science.278.5338.601; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Nealson KH, 1997, REV MINERAL, V35, P5; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Valentine JW, 1999, DEVELOPMENT, V126, P851; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	12	13	16	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					605	606		10.1126/science.287.5453.605	http://dx.doi.org/10.1126/science.287.5453.605			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10691543				2022-12-28	WOS:000084989400034
J	Robson, J; Boomla, K; Hart, B; Feder, G				Robson, J; Boomla, K; Hart, B; Feder, G			Estimating cardiovascular risk for primary prevention: outstanding questions for primary care	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; GUIDELINES; FRAMINGHAM; PROFILE; TRIAL		Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, London E1 4NS, England; Chrisp St Hlth Ctr, London E14 6PG, England	University of London; Queen Mary University London	Robson, J (corresponding author), Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, Mile End Rd, London E1 4NS, England.		Robson, John/H-3904-2014	Robson, John/0000-0001-6889-0415; Feder, Gene/0000-0002-7890-3926				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; FIELD K, 1995, BRIT MED J, V310, P1109, DOI 10.1136/bmj.310.6987.1109; Gotto AM, 1997, JAMA-J AM MED ASSOC, V277, P595, DOI 10.1001/jama.277.7.595; Gregory J., 1990, DIETARY NUTR SURVEY; GROVER SA, 1995, JAMA-J AM MED ASSOC, V274, P801, DOI 10.1001/jama.274.10.801; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; GUEFFIYER F, 1997, ANN INTERN MED, V126, P761; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; HAQ IU, 1997, HEART, V77, P36; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; JACKSON R, 1998, 5 YEAR CARDIOVASCULA; Messerli FH, 1998, LANCET, V352, P1006, DOI 10.1016/S0140-6736(05)60073-6; *MRS GEN PRACT RES, 1998, LANCET, V315, P233; ODELL PM, 1994, J CLIN EPIDEMIOL, V47, P583, DOI 10.1016/0895-4356(94)90206-2; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; ROBSON J, 1997, FRAMINGHAM RISK SCOR; Unwin N, 1998, BMJ-BRIT MED J, V317, P1125; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312; Wood D, 1998, HEART, V80, pS1	24	25	28	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					702	704		10.1136/bmj.320.7236.702	http://dx.doi.org/10.1136/bmj.320.7236.702			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710585	Green Published			2022-12-28	WOS:000085895300027
J	Lindsey, C; Braun, DC				Lindsey, C; Braun, DC			Seismic images of the far side of the Sun	SCIENCE			English	Article							P-MODES; SUNSPOTS; OSCILLATIONS; ABSORPTION	Images of an active region on the far side of the sun were derived by applying seismic holography to recent helioseismic observations from space. Active regions are the centers of energetic phenomena such as solar flares and coronal mass ejections, whose resulting electromagnetic and particle radiation interfere with telecommunications and power transmissions on Earth and can pose significant hazards to astronauts and spacecraft. Synoptic seismic imaging of far-side solar activity will now allow anticipation of the appearance of Large active regions more than a week ahead of their arrival on the east solar Limb.	Solar Phys Res Corp, Tucson, AZ 85718 USA; NorthWest Res Associates Inc, Colorado Res Associates Div, Boulder, CO 80301 USA	NorthWest Research Associates	Lindsey, C (corresponding author), Solar Phys Res Corp, Tucson, AZ 85718 USA.	lindsey@sprc.com	Braun, Douglas C/T-3856-2017	Braun, Douglas C/0000-0001-6840-2717; Lindsey, Charles/0000-0002-5658-5541				BOGDAN TJ, 1993, ASTROPHYS J, V406, P723, DOI 10.1086/172483; Braun DC, 1998, ASTROPHYS J, V502, P968, DOI 10.1086/305933; BRAUN DC, 1995, ASTROPHYS J, V451, P859, DOI 10.1086/176272; BRAUN DC, 1992, ASTROPHYS J, V392, P739, DOI 10.1086/171477; BRAUN DC, 1988, ASTROPHYS J, V335, P1015, DOI 10.1086/166988; BRAUN DC, IN PRESS SOL PHYS; Cally PS, 1997, ASTROPHYS J, V486, pL67, DOI 10.1086/310833; CALLY PS, IN PRESS SOL PHYS; CHRISTENSENDALSGAARD J, 1993, ASTROPHYS J, V403, pL75, DOI 10.1086/186725; DUVALL TL, 1993, NATURE, V362, P430, DOI 10.1038/362430a0; Duvall TL, 1996, NATURE, V379, P235, DOI 10.1038/379235a0; HINDMAN BW, IN PRESS SOL PHYS; Howe R, 1999, ASTROPHYS J, V524, P1084, DOI 10.1086/307851; Lindsey C, 1998, ASTROPHYS J, V499, pL99, DOI 10.1086/311340; LINDSEY C, 1990, SOL PHYS, V126, P101, DOI 10.1007/BF00158301; Lindsey C, 1997, ASTROPHYS J, V485, P895, DOI 10.1086/304445; LINDSEY C, 1993, ASTR SOC P, V42, P81; LINDSEY C, IN PRESS SOL PHYS; RODDIER F, 1975, CR HEBD ACAD SCI, V281, P993; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429	20	113	114	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1799	1801		10.1126/science.287.5459.1799	http://dx.doi.org/10.1126/science.287.5459.1799			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710304				2022-12-28	WOS:000085775300036
J	Tettelin, H; Saunders, NJ; Heidelberg, J; Jeffries, AC; Nelson, KE; Eisen, JA; Ketchum, KA; Hood, DW; Peden, JF; Dodson, RJ; Nelson, WC; Gwinn, ML; DeBoy, R; Peterson, JD; Hickey, EK; Haft, DH; Salzberg, SL; White, O; Fleischmann, RD; Dougherty, BA; Mason, T; Ciecko, A; Parksey, DS; Blair, E; Cittone, H; Clark, EB; Cotton, MD; Utterback, TR; Khouri, H; Qin, HY; Vamathevan, J; Gill, J; Scarlato, V; Masignani, V; Pizza, M; Grandi, G; Sun, L; Smith, HO; Fraser, CM; Moxon, ER; Rappuoli, R; Venter, JC				Tettelin, H; Saunders, NJ; Heidelberg, J; Jeffries, AC; Nelson, KE; Eisen, JA; Ketchum, KA; Hood, DW; Peden, JF; Dodson, RJ; Nelson, WC; Gwinn, ML; DeBoy, R; Peterson, JD; Hickey, EK; Haft, DH; Salzberg, SL; White, O; Fleischmann, RD; Dougherty, BA; Mason, T; Ciecko, A; Parksey, DS; Blair, E; Cittone, H; Clark, EB; Cotton, MD; Utterback, TR; Khouri, H; Qin, HY; Vamathevan, J; Gill, J; Scarlato, V; Masignani, V; Pizza, M; Grandi, G; Sun, L; Smith, HO; Fraser, CM; Moxon, ER; Rappuoli, R; Venter, JC			Complete genome sequence of Neisseria meningitidis serogroup B strain MC58	SCIENCE			English	Article							ESCHERICHIA-COLI; HELICOBACTER-PYLORI; PATHOGENIC BACTERIA; INSERTION-SEQUENCE; ENDOTHELIAL-CELLS; DNA-SEQUENCE; GENE; EXPRESSION; IDENTIFICATION; GONORRHOEAE	The 2,272,351-base pair genome of Neisseria meningitidis strain MC58 (serogroup B), a causative agent of meningitis and septicemia, contains 2158 predicted coding regions, 1158 (53.7%) of which were assigned a biological role. Three major islands of horizontal DNA transfer were identified; two of these contain genes encoding proteins involved in pathogenicity, and the third island contains coding sequences only for hypothetical proteins. Insights into the commensal and virulence behavior of N, meningitidis can be gleaned from the genome, in which sequences for structural proteins of the pilus are clustered and several coding regions unique to serogroup B capsular polysaccharide synthesis can be identified. Finally, N. meningitidis contains more genes that undergo phase variation than any pathogen studied to date, a mechanism that controls their expression and contributes to the evasion of the host immune system.	Inst Genom Res, Rockville, MD 20850 USA; Univ Oxford, Inst Mol Med, Oxford OX3 9DS, England; Chiron SpA, Immunol Res Inst Siena, I-53100 Siena, Italy	J. Craig Venter Institute; University of Oxford; Novartis	Tettelin, H (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019; Scarlato, Vincenzo/B-8558-2019; Nelson, William C/E-9263-2016; Eisen, Jonathan A./H-2706-2019; Saunders, Nigel J/W-6745-2019	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432; Scarlato, Vincenzo/0000-0003-4227-677X; Nelson, William C/0000-0002-1873-3929; Eisen, Jonathan A./0000-0002-0159-2197; Vamathevan, Jessica/0000-0003-2016-9754; Grandi, Guido/0000-0001-9724-2185; Heidelberg, John/0000-0003-0673-3224				Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSON RP, 1978, COLD SPRING HARB SYM, V43, P1083; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Cao P, 1997, J BACTERIOL, V179, P2852, DOI 10.1128/jb.179.9.2852-2856.1997; Carrick CS, 1998, GENE, V220, P21, DOI 10.1016/S0378-1119(98)00424-7; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; CORREIA FF, 1986, J BACTERIOL, V167, P1009, DOI 10.1128/jb.167.3.1009-1015.1986; DIAZ JL, 1984, FEMS MICROBIOL LETT, V21, P181; DOBSON SRM, 1992, INFECT IMMUN, V60, P618, DOI 10.1128/IAI.60.2.618-622.1992; DURBIN R, 1991, C ELEGANS DATABASE; Ehrmann MA, 1998, FEMS MICROBIOL LETT, V169, P81, DOI 10.1016/S0378-1097(98)00467-4; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; FROSCH M, 1989, P NATL ACAD SCI USA, V86, P1669, DOI 10.1073/pnas.86.5.1669; FROSCH M, 1991, MOL MICROBIOL, V5, P1251, DOI 10.1111/j.1365-2958.1991.tb01899.x; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; *GENB, D90911; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; GOTSCHLICH EC, 1969, J EXP MED, V129, P349; GOTSCHLICH EC, 1969, J EXP MED, V129, P1369; HAAS R, 1986, CELL, V44, P107, DOI 10.1016/0092-8674(86)90489-7; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; HILL CW, 1988, GENETICS, V119, P771; HOLTEN E, 1976, ACTA PATH MICRO IM B, V84, P9; JENNINGS HJ, 1987, J EXP MED, V165, P1207, DOI 10.1084/jem.165.4.1207; Jennings MP, 1995, MOL MICROBIOL, V18, P729, DOI 10.1111/j.1365-2958.1995.mmi_18040729.x; JONES D, 1995, MENINGOCOCCAL DIS, P147; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; Klein NJ, 1996, J INFECT DIS, V173, P172, DOI 10.1093/infdis/173.1.172; KNIGHT AI, 1992, MOL MICROBIOL, V6, P1565, DOI 10.1111/j.1365-2958.1992.tb00878.x; KROLL JS, 1991, MOL MICROBIOL, V5, P1549, DOI 10.1111/j.1365-2958.1991.tb00802.x; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MARRS CF, 1990, J BACTERIOL, V172, P4370, DOI 10.1128/jb.172.8.4370-4377.1990; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; MORSE SA, 1978, INFECT IMMUN, V21, P87, DOI 10.1128/IAI.21.1.87-95.1978; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; NEUBAUER H, 1994, J BACTERIOL, V176, P3007, DOI 10.1128/JB.176.10.3007-3012.1994; PINNER RW, 1991, INFECT IMMUN, V59, P3169, DOI 10.1128/IAI.59.9.3169-3175.1991; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; RASMUSSEN JL, 1987, J BACTERIOL, V169, P3573, DOI 10.1128/jb.169.8.3573-3580.1987; RAYNER CFJ, 1995, J INFECT DIS, V171, P113, DOI 10.1093/infdis/171.1.113; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Salzberg SL, 1998, GENE, V217, P57, DOI 10.1016/S0378-1119(98)00374-6; SAUNDERS N, UNPUB; Saunders NJ, 1998, MOL MICROBIOL, V27, P1091, DOI 10.1046/j.1365-2958.1998.00768.x; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; SCHWARTZ B, 1989, CLIN MICROBIOL REV, V2, pS118, DOI 10.1128/CMR.2.Suppl.S118-S124.1989; SHIMIZU R, AB015669 GENB; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Wainwright LA, 1997, NUCLEIC ACIDS RES, V25, P1362, DOI 10.1093/nar/25.7.1362; WAINWRIGHT LA, 1994, MOL MICROBIOL, V13, P75, DOI 10.1111/j.1365-2958.1994.tb00403.x; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; WOOLDRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325, DOI 10.1016/0168-6445(93)90011-W; YOON H, 1989, J GEN MICROBIOL, V135, P245; Zhu PX, 1999, MOL MICROBIOL, V33, P635, DOI 10.1046/j.1365-2958.1999.01514.x	68	902	1601	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1809	1815		10.1126/science.287.5459.1809	http://dx.doi.org/10.1126/science.287.5459.1809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710307				2022-12-28	WOS:000085775300039
J	Lenoir, N				Lenoir, N			Europe confronts the embryonic stem cell research challenge	SCIENCE			English	Editorial Material								Europe's historic plurality and the Lack of a commonly accepted definition of the moral status of the embryo have led to varying regulation in European countries. Council of Europe and European Union Legislation, based on fundamental ethical principles, does exist for specific issues, such as prohibition against producing embryos solely for research. Such principles have recently been elucidated by the European Group on Ethics in Science and New Technologies. Newly emerging research techniques are beginning to cause reconsideration of the regulation of embryo research in Europe.	Conseil Constitut, F-75001 Paris, France		Lenoir, N (corresponding author), Conseil Constitut, 2 Rue Montpensier, F-75001 Paris, France.							Deutsch E, 1993, Med Law, V12, P535; KNOPPERS M, HUMAN DIGNITY GENETI; Marshall E, 1998, SCIENCE, V282, P1014, DOI 10.1126/science.282.5391.1014; McLaren Angus, 1990, HIST CONTRACEPTION; Noonan John T., 1965, CONTRACEPTION HIST I; RABELAIS F, 1991, GARGANTUA PANTAGRUEL	6	56	63	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1425	1427		10.1126/science.287.5457.1425	http://dx.doi.org/10.1126/science.287.5457.1425			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688780				2022-12-28	WOS:000085531600034
J	van der Kooy, D; Weiss, S				van der Kooy, D; Weiss, S			Why stem cells?	SCIENCE			English	Review							PRIMORDIAL GERM-CELLS; MAMMALIAN FOREBRAIN; MOUSE EMBRYOS; IN-VIVO; CULTURE; DIFFERENTIATION; PROGENITORS; MIGRATION; NEURONS; SYSTEM	Stem cells are viewed from the perspectives of their function, evolution, development, and cause. Counterintuitively, most stem cells may arise Late in development, to act principally in tissue renewal, thus ensuring an organism's Long-term survival, Surprisingly, recent reports suggest that tissue-specific adult stem cells have the potential to contribute to replenishment of multiple adult tissues.	Univ Toronto, Fac Med, Dept Anat & Cell Biol, Toronto, ON M5S 1A8, Canada; Univ Calgary, Fac Med, Dept Cell Biol & Anat, Genes & Dev Res Grp, Calgary, AB T2N 4N1, Canada	University of Toronto; University of Calgary	van der Kooy, D (corresponding author), Univ Toronto, Fac Med, Dept Anat & Cell Biol, Toronto, ON M5S 1A8, Canada.							Benfey PN, 1999, CURR BIOL, V9, pR171, DOI 10.1016/S0960-9822(99)80105-5; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bode HR, 1996, J CELL SCI, V109, P1155; Bonifer C, 1998, IMMUNOL TODAY, V19, P236, DOI 10.1016/S0167-5699(98)01259-6; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Dodeman VL, 1997, J EXP BOT, V48, P1493, DOI 10.1093/jexbot/48.313.1493; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dzierzak E, 1998, IMMUNOL TODAY, V19, P228, DOI 10.1016/S0167-5699(98)01258-4; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Geiger H, 1998, CELL, V93, P1055, DOI 10.1016/S0092-8674(00)81210-6; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; KORN A P, 1973, Experimental Hematology (Charlottesville), V1, P362; Lin HF, 1997, ANNU REV GENET, V31, P455, DOI 10.1146/annurev.genet.31.1.455; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Martens DJ, 2000, J NEUROSCI, V20, P1085, DOI 10.1523/JNEUROSCI.20-03-01085.2000; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Peterson KJ, 1997, BIOESSAYS, V19, P623, DOI 10.1002/bies.950190713; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Slack J, 1983, EGG EMBRYO; STENT GS, 1985, CELL, V40, P1, DOI 10.1016/0092-8674(85)90299-5; STEWARD FC, 1958, AM J BOT, V45, P705, DOI 10.2307/2439728; STEWART CL, 1994, DEV BIOL, V161, P626, DOI 10.1006/dbio.1994.1058; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; VASIL V, 1965, SCIENCE, V150, P889, DOI 10.1126/science.150.3698.889; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	40	192	212	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1439	1441		10.1126/science.287.5457.1439	http://dx.doi.org/10.1126/science.287.5457.1439			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688784				2022-12-28	WOS:000085531600038
J	Eeva, T; Lehikoinen, E				Eeva, T; Lehikoinen, E			Pollution - Recovery of breeding success in wild birds	NATURE			English	Article							FICEDULA-HYPOLEUCA; PIED FLYCATCHERS; METAL POLLUTION; PARUS-MAJOR; PASSERINES; GRADIENT; FINLAND		Univ Turku, Dept Biol, Sect Ecol, FIN-20014 Turku, Finland	University of Turku	Eeva, T (corresponding author), Univ Turku, Dept Biol, Sect Ecol, FIN-20014 Turku, Finland.		Eeva, Tapio/V-8922-2018; Lehikoinen, Esa/I-6128-2013	Eeva, Tapio/0000-0002-0395-1536; Lehikoinen, Esa/0000-0002-6932-3604				Eeva T, 1997, ECOLOGY, V78, P1120, DOI 10.1890/0012-9658(1997)078[1120:PRVIFS]2.0.CO;2; Eeva T, 1996, OECOLOGIA, V108, P631, DOI 10.1007/BF00329036; EEVA T, 1995, OECOLOGIA, V102, P312, DOI 10.1007/BF00329798; FRITZE H, 1989, BIOL FERT SOILS, V8, P87, DOI 10.1007/BF00260522; GRAVELAND J, 1994, NATURE, V368, P446, DOI 10.1038/368446a0; Heliovaara K, 1990, ACIDIFICATION FINLAN, P447; HYNNINEN V, 1986, ANN BOT FENN, V23, P83; Jussila I, 1997, SYKESARJA B, V12, P1; Nyholm NEI, 1998, ARCH ENVIRON CON TOX, V35, P632, DOI 10.1007/s002449900425	9	59	59	0	22	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					851	852		10.1038/35002672	http://dx.doi.org/10.1038/35002672			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706274				2022-12-28	WOS:000085559200045
J	Dawkins, MS; Woodington, A				Dawkins, MS; Woodington, A			Pattern recognition and active vision in chickens	NATURE			English	Article							ORIENTATION FLIGHTS; WASPS	Recognition of objects or environmental landmarks is problematic because appearance can vary widely depending on illumination, viewing distance, angle of view and so on(1). Storing a separate image or 'template' for every possible view requires vast numbers to be stored and scanned, has a high probability of recognition error and appears not to be the solution adopted by primates(2-3). However, some invertebrate template matching systems can achieve recognition by 'active vision' in which the animal's own behaviour is used to achieve a fit between template and object(4), for example by repeatedly following a set path(5-7). Recognition is thus limited to views from the set path but achieved with a minimal number of templates. Here we report the first evidence of similar active vision in a bird, in the form of locomotion and individually distinct head movements that give the eyes a similar series of views on different occasions. The hens' ability to recognize objects is also found to decrease when their normal paths are altered.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Dawkins, MS (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	marian.dawkins@zoo.ox.ac.uk						Andrew R.J., 1993, VISION BRAIN BEHAV B, P319; Baker R. R., 1978, EVOLUTIONARY ECOLOGY; COLLETT TS, 1992, PHILOS T R SOC B, V337, P295, DOI 10.1098/rstb.1992.0107; COLLETT TS, 1995, J COMP PHYSIOL A, V177, P737, DOI 10.1007/BF00187632; Dawkins MS, 1996, BEHAVIOUR, V133, P663, DOI 10.1163/156853996X00413; Edelman S, 1997, TRENDS COGN SCI, V1, P296, DOI 10.1016/S1364-6613(97)01090-5; Land MF, 1997, FROM LIVING EYES TO SEEING MACHINES, P16; PRATT DW, 1982, J EXP BIOL, V97, P217; ROLLS ET, 1994, BEHAV PROCESS, V33, P113, DOI 10.1016/0376-6357(94)90062-0; TURKEL J, 1977, NEUR ABSTR, V3, P158; Ullman S., 1996, HIGH LEVEL VISION OB; Wallman Josh, 1993, P245; ZEIL J, 1993, J COMP PHYSIOL A, V172, P189, DOI 10.1007/BF00189396	13	47	47	0	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					652	655		10.1038/35001064	http://dx.doi.org/10.1038/35001064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688200				2022-12-28	WOS:000085288200052
J	Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH				Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH			Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?	BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE		N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England; N Staffordshire Hosp, Dept Epidemiol, Stoke On Trent ST4 7PA, Staffs, England; Univ Newcastle Upon Tyne, Dept Med Stat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Royal Free Hosp, Dept Endocrinol, London NW3 2QG, England	Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust; Newcastle University - UK; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Neary, RH (corresponding author), N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England.							COLLINS R, 1994, BRIT MED BULL, V50, P272, DOI 10.1093/oxfordjournals.bmb.a072892; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Meade TW, 1998, LANCET, V351, P233; Shepherd J, 1996, LANCET, V348, P1339; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001	5	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					677	679		10.1136/bmj.320.7236.677	http://dx.doi.org/10.1136/bmj.320.7236.677			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710575	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000085895300019
J	Bower, P; Sibbald, B				Bower, P; Sibbald, B			Systematic review of the effect of on-site mental health professionals on the clinical behaviour of general practitioners	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED TRIAL; PRIMARY-CARE PATIENTS; OUTPATIENT GERIATRIC EVALUATION; SOMATIZATION DISORDER PATIENTS; COMMUNITY PSYCHIATRIC-NURSES; MAJOR DEPRESSIVE DISORDER; PROBLEM-SOLVING TREATMENT; COGNITIVE THERAPY; PSYCHOLOGICAL TREATMENT; POSTNATAL DEPRESSION	Objectives To review the published literature concerning the effects of on-site mental health professionals on general practitioners' management of mental health. Design Systgematic review of controlled trials. Setting Primary care. Participants General practitioners and menial health professionals. Main outcome measures Consultation rates, prescribing of psychotropics, and referrals to secondary care mental health services by general practitioners. Results The effect of on-site mental health professionals on consultation rates was inconsistent. Referral to a mental health professional reduced the likelihood of a patient receiving a prescription for psychotropics or being referred to secondary care, although the effects were nor consistent An on-site mental health professional did not alter prescribing and referral behaviour towards patients in the wider practice population. Conclusions The secondary effects of mental health professionals on the clinical behaviour of general practitioners are comparatively modest and inconsistent and seem to be restricted to patients directly under the care of the mental health professional.	Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England	University of Manchester	Bower, P (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Williamson Bldg, Manchester M13 9PL, Lancs, England.	peter.bower@man.ac.uk	Sandall, Jane/D-4146-2009; Bower, Peter/A-1508-2011	Sandall, Jane/0000-0003-2000-743X; Bower, Peter/0000-0001-9558-3349				Appleby L, 1997, BRIT MED J, V314, P932, DOI 10.1136/bmj.314.7085.932; ASHURST P, 1983, EVALUATION COUNSELLI; ASHWORTH M, MENTAL HLTH WORKERS; Baker R, 1998, BRIT J GEN PRACT, V48, P1049; BAKER R, 1996, DORSET PRIMARY CARE; BALESTRIER M, 1988, PSYCHOL MED, V18, P711, DOI 10.1017/S0033291700008400; BANNERJEE S, 1996, BMJ-BRIT MED J, V313, P1058; BASLER H, 1996, J PSYCHOSOM RES, V29, P383; BASLER HD, 1990, PSYCHOL HEALTH, V4, P293; BENSON P, 1988, J ROY COLL GEN PRACT, V38, P539; Bernal i Cercos A, 1995, Aten Primaria, V15, P499; BLACKBURN I, 1981, BRIT J PSYCHIAT, V171, P328; BLACKBURN IM, 1986, J AFFECT DISORDERS, V10, P67, DOI 10.1016/0165-0327(86)90050-9; BLAKEY R, 1986, J ROY COLL GEN PRACT, V36, P209; BLANCHARD MR, 1995, INT J GERIATR PSYCH, V10, P289, DOI 10.1002/gps.930100405; BLOWERS C, 1987, BEHAV RES THER, V25, P493, DOI 10.1016/0005-7967(87)90057-X; BOOT D, 1994, PATIENT EDUC COUNS, V24, P79, DOI 10.1016/0738-3991(94)90028-0; BOWER P, 1998, COCHRANE LIB; Brantley P J, 1986, Fam Med, V18, P351; BRODATY H, 1983, BRIT J PSYCHIAT, V143, P11, DOI 10.1192/bjp.143.1.11; BROOKER C, 1994, BRIT J PSYCHIAT, V165, P222, DOI 10.1192/bjp.165.2.222; Brown C, 1996, AM J PSYCHIAT, V153, P1293; BROWN JSL, 1998, BEHAV COGN PSYCHOTH, V26, P219; Bruce J, 1998, BRIT J GEN PRACT, V48, P1419; BUSCH C, 1996, PRIMARY CARE PSYCHIA, V2, P59; BUTLER G, 1987, BRIT J PSYCHIAT, V151, P535, DOI 10.1192/bjp.151.4.535; BUTLER G, 1991, J CONSULT CLIN PSYCH, V59, P167, DOI 10.1037/0022-006X.59.1.167; CALLAHAN CM, 1994, J AM GERIATR SOC, V42, P839, DOI 10.1111/j.1532-5415.1994.tb06555.x; Carr VJ, 1997, AUST NZ J PSYCHIAT, V31, P85, DOI 10.3109/00048679709073804; CATALAN J, 1984, BRIT J PSYCHIAT, V144, P593, DOI 10.1192/bjp.144.6.593; CATALAN J, 1984, BRIT J PSYCHIAT, V144, P603, DOI 10.1192/bjp.144.6.603; CATALAN J, 1991, PSYCHOL MED, V21, P1013, DOI 10.1017/S0033291700030002; Chalder T, 1997, BRIT J HEALTH PSYCH, V2, P189, DOI 10.1111/j.2044-8287.1997.tb00535.x; CHILVERS C, RANDOMISED CONTROLLE; COE N, 1996, COST EFFECTIVENESS I; Cook T.C., 1979, QUASIEXPERIMENTATION; COOPER B, 1975, PSYCHOL MED, V5, P372, DOI 10.1017/S0033291700056993; Cooper Peter J., 1997, P201; CORNEY R, RANDOMISED CONTROLLE; CORNEY RH, 1984, PSYCHOL MED, P1; Coulehan JL, 1997, ARCH INTERN MED, V157, P1113, DOI 10.1001/archinte.157.10.1113; CULLEN KJ, 1976, J PEDIATR-US, V88, P662, DOI 10.1016/S0022-3476(76)80032-7; DONNAN P, 1990, BRIT J GEN PRACT, V40, P498; Earll L, 1982, J R Coll Gen Pract, V32, P32; EAYRS CB, 1984, BEHAV PSYCHOTHER, V12, P117, DOI 10.1017/S0141347300009794; FINNEY J, BEHAV THER, V20, P283; FINNEY JW, 1991, J PEDIATR PSYCHOL, V16, P447, DOI 10.1093/jpepsy/16.4.447; Friedli K, 1997, LANCET, V350, P1662, DOI 10.1016/S0140-6736(97)05298-7; FRIEDLI K, 2000, IN PRESS BR J GEN PR; Gask L, 1997, BRIT J PSYCHIAT, V170, P6, DOI 10.1192/bjp.170.1.6; Gater R, 1997, PSYCHOL MED, V27, P1325, DOI 10.1017/S0033291797005631; GINSBERG G, 1984, PSYCHOL MED, V14, P683, DOI 10.1017/S0033291700015294; Goldberg D, 1996, PSYCHOL MED, V26, P487, DOI 10.1017/S003329170003556X; GOURNAY K, 1995, J ADV NURS, V22, P769, DOI 10.1046/j.1365-2648.1995.22040769.x; GOURNAY K, 1994, BRIT J PSYCHIAT, V165, P231, DOI 10.1192/bjp.165.2.231; GRAVES RL, 1981, PROF PSYCHOL, V12, P426, DOI 10.1037/0735-7028.12.4.426; Harvey I, 1998, BRIT J GEN PRACT, V48, P1043; HEBERT R, 1994, ARCH GERONTOL GERIAT, V18, P1, DOI 10.1016/0167-4943(94)90043-4; HELLMAN CJC, 1990, BEHAV MED, V16, P165, DOI 10.1080/08964289.1990.9934605; Hemmings A, 1997, PATIENT EDUC COUNS, V32, P219, DOI 10.1016/S0738-3991(97)00035-9; HEMMINGS A, 1993, NONPHARMACOLOGICAL M; HIRSCH T, 1997, EFFECTS BENZODIAZEPE; HOLDEN JM, 1989, BRIT MED J, V298, P223, DOI 10.1136/bmj.298.6668.223; Holdsworth N, 1996, J MENTAL HLTH, V5, P195, DOI DOI 10.1080/09638239650037081; Horowitz CR, 1996, JOINT COMM J QUAL IM, V22, P734, DOI 10.1016/S1070-3241(16)30279-6; Hunter D, 1983, Health Bull (Edinb), V41, P78; Hunter MS, 1995, J REPROD INFANT PSYC, V13, P147, DOI DOI 10.1080/02646839508403244; Huygen F, 1983, FAMILY SYSTEMS MED, V1, P23; JACKSON G, 1993, BRIT J PSYCHIAT, V162, P375, DOI 10.1192/bjp.162.3.375; JENKINS D, 1994, INT J GERIATR PSYCH, V9, P461, DOI 10.1002/gps.930090604; Jones, 1990, HLTH TRENDS, V22, P164; Karlberg L, 1998, SOC SCI MED, V46, P397, DOI 10.1016/S0277-9536(97)00169-X; KASHNER TM, 1992, MED CARE, V30, P811, DOI 10.1097/00005650-199209000-00005; KASHNER TM, 1995, PSYCHOSOMATICS, V36, P462, DOI 10.1016/S0033-3182(95)71627-9; KATON W, 1992, MED CARE, V30, P67, DOI 10.1097/00005650-199201000-00007; KATON W, 1992, GEN HOSP PSYCHIAT, V14, P86, DOI 10.1016/0163-8343(92)90033-7; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; KIELY BG, 1986, J ROY COLL GEN PRACT, V36, P307; KING M, 1994, BRIT J GEN PRACT, V44, P229; KLERMAN G, 1996, MED CARE, V25, P1078; Kupshik GA, 1999, BRIT J GEN PRACT, V49, P47; Lave JR, 1998, ARCH GEN PSYCHIAT, V55, P645, DOI 10.1001/archpsyc.55.7.645; Lewis G, 1996, FAM PRACT, V13, P120, DOI 10.1093/fampra/13.2.120; Lidbeck J, 1997, ACTA PSYCHIAT SCAND, V96, P14, DOI 10.1111/j.1600-0447.1997.tb09899.x; Lin EHB, 1997, MED CARE, V35, P831, DOI 10.1097/00005650-199708000-00008; LINDSAY WR, 1987, BRIT J CLIN PSYCHOL, V26, P3, DOI 10.1111/j.2044-8260.1987.tb00718.x; Lofvander M, 1997, SCAND J PRIM HEALTH, V15, P123, DOI 10.3109/02813439709018501; Lynch DJ, 1997, J FAM PRACTICE, V44, P293; LYON D, 1997, HLTH DIRECT, V30, P11; Mann AH, 1998, BRIT J GEN PRACT, V48, P875; MARKS I, 1985, BMJ-BRIT MED J, V290, P1181, DOI 10.1136/bmj.290.6476.1181; MARTIN E, 1985, FAM PRACT, V2, P241, DOI 10.1093/fampra/2.4.241; McKechnie A A, 1981, J R Coll Gen Pract, V31, P611; McLeod CC, 1997, GEN HOSP PSYCHIAT, V19, P251, DOI 10.1016/S0163-8343(97)00047-9; MILNE D, 1988, J ROY COLL GEN PRACT, V38, P457; MILNE D, 1988, HLTH ED J, V47, P67; MIRANDA J, 1994, PSYCHOSOM MED, V56, P136, DOI 10.1097/00006842-199403000-00009; MUNOZ RF, 1995, AM J COMMUN PSYCHOL, V23, P199, DOI 10.1007/BF02506936; MynorsWallis L, 1997, BRIT J PSYCHIAT, V170, P113, DOI 10.1192/bjp.170.2.113; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; Nazareth I, 1996, BRIT J PSYCHIAT, V169, P475, DOI 10.1192/bjp.169.4.475; Neira-Munoz E, 1998, Health Serv J, V108, P26; ODonnell JC, 1997, J AGING HEALTH, V9, P473, DOI 10.1177/089826439700900403; ONYETT SR, 1988, BEHAV PSYCHOTHER, V16, P297, DOI 10.1017/S0141347300014154; PATRICK DL, 1978, MED CARE, V16, P47, DOI 10.1097/00005650-197801000-00004; PAYKEL ES, 1982, BRIT J PSYCHIAT, V140, P573, DOI 10.1192/bjp.140.6.573; Peveler R, 1999, BRIT MED J, V319, P612, DOI 10.1136/bmj.319.7210.612; PHAROAH P, 1996, PRIMARY CARE PSYCHIA, V1, P263; PINCUS HA, 1987, GEN HOSP PSYCHIAT, V9, P95, DOI 10.1016/0163-8343(87)90020-X; POWER KG, 1989, BEHAV PSYCHOTHER, V17, P1, DOI 10.1017/S0141347300015597; POWER KG, 1990, J ANXIETY DISORD, V4, P267, DOI 10.1016/0887-6185(90)90026-6; POWER KG, 1990, BRIT J GEN PRACT, V40, P289; RAPHAEL B, 1977, ARCH GEN PSYCHIAT, V34, P1450; ROBSON MH, 1984, BRIT MED J, V288, P1805, DOI 10.1136/bmj.288.6433.1805; ROSS M, 1985, J ROY COLL GEN PRACT, V35, P239; ROST K, 1994, GEN HOSP PSYCHIAT, V16, P381, DOI 10.1016/0163-8343(94)90113-9; Roth A., 1996, WHAT WORKS WHOM CRIT; SAARIJARVI S, 1991, J PSYCHOSOM RES, V35, P671, DOI 10.1016/0022-3999(91)90117-7; SAARIJARVI S, 1991, J PSYCHOSOM RES, V35, P265, DOI 10.1016/0022-3999(91)90080-8; Schulberg HC, 1998, J CONSULT CLIN PSYCH, V66, P932, DOI 10.1037/0022-006X.66.6.932; Schulberg HC, 1996, ARCH GEN PSYCHIAT, V53, P913; SCOTT AIF, 1992, BRIT MED J, V304, P883, DOI 10.1136/bmj.304.6831.883; Scott C, 1997, BRIT J PSYCHIAT, V171, P131, DOI 10.1192/bjp.171.2.131; SCOTT J, 1994, BRIT J PSYCHIAT, V164, P410, DOI 10.1192/bjp.164.3.410; Sibbald B, 1996, BRIT J GEN PRACT, V46, P63; SIBBALD B, 1993, BMJ-BRIT MED J, V306, P29, DOI 10.1136/bmj.306.6869.29; SMITH GR, 1986, NEW ENGL J MED, V314, P1407, DOI 10.1056/NEJM198605293142203; SMITH GR, 1995, ARCH GEN PSYCHIAT, V52, P238; SORBY NGD, 1991, BRIT J GEN PRACT, V41, P417; STANTON R, 1998, EFFECTIVENESS COUNSE; TARRIER N, 1983, BRIT J CLIN SOC PSYC, V2, P85; TEASDALE JD, 1984, BRIT J PSYCHIAT, V144, P400, DOI 10.1192/bjp.144.4.400; Toseland RW, 1997, GERONTOLOGIST, V37, P324, DOI 10.1093/geront/37.3.324; Toseland RW, 1996, MED CARE, V34, P624, DOI 10.1097/00005650-199606000-00011; TREPKA C, 1986, J ROY COLL GEN PRACT, V36, P114; TUDIVER F, 1995, CAN FAM PHYSICIAN, V41, P392; TUDIVER F, 1992, EVAL HEALTH PROF, V15, P147, DOI 10.1177/016327879201500202; TYRER P, 1984, BRIT J PSYCHIAT, V145, P15, DOI 10.1192/bjp.145.1.15; TYRER P, 1990, ACTA PSYCHIAT SCAND, V81, P359, DOI 10.1111/j.1600-0447.1990.tb05464.x; Von Korff M, 1998, PSYCHOSOM MED, V60, P143, DOI 10.1097/00006842-199803000-00005; WALKER F, 1989, NEW ZEAL MED J, V102, P504; WARNER RW, 1993, BRIT J GEN PRACT, V43, P507; White J, 1995, BEHAV COGN PSYCHOTH, V23, P89, DOI DOI 10.1017/51352465800014363; *White J., 1998, BEHAV COGN PSYCHOTH, V26, P237, DOI 10.1017/S1352465898000253; White J, 1998, BEHAV COGN PSYCHOTH, V26, P133; Wickberg B, 1996, J AFFECT DISORDERS, V39, P209, DOI 10.1016/0165-0327(96)00034-1; WILKINSON G, 1993, PSYCHOL MED, V23, P229, DOI 10.1017/S0033291700039027; WILLIAMS P, 1989, BRIT J PSYCHIAT, V154, P67, DOI 10.1192/bjp.154.1.67; WINKLER R, 1989, SOC SCI MED, V29, P213, DOI 10.1016/0277-9536(89)90169-X; WOOD K, 1995, AUST NZ J PSYCHIAT, V29, P223, DOI 10.1080/00048679509075914; 1995, FUNDHOLDING, V4, P23	152	29	29	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2000	320	7235					614	617		10.1136/bmj.320.7235.614	http://dx.doi.org/10.1136/bmj.320.7235.614			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	291NH	10698881	Green Published, Bronze			2022-12-28	WOS:000085742600027
J	Horvath, A; Berry, EA; Maslov, DA				Horvath, A; Berry, EA; Maslov, DA			Translation of the edited mRNA for cytochrome b in trypanosome mitochondria	SCIENCE			English	Article							CRITHIDIA-FASCICULATA; C-OXIDASE; MESSENGER-RNA; KINETOPLASTID MITOCHONDRIA; SUBUNIT-II; BRUCEI; OXIDOREDUCTASE; NUCLEOTIDES; TRANSCRIPT; MECHANISM	The type of RNA editing found in the kinetoplast-mitochondria of trypanosomes and related protozoa, involving uridylate insertions and deletions, creates translatable messenger RNAs (mRNAs) out of nonsense pre-edited RNAs by correcting encoded defects that vary from simple frameshifts to Large "cryptic" regions. However, any evidence for translation of these mRNAs in the kinetoplast has been missing for decades. We identified a kinetoplast-encoded protein, apocytochrome b, whose mRNA is edited in the 5' region. The determined amino-terminal sequence of the protein coincides with the predicted sequence derived from the edited region, demonstrating that the cognate apocytochrome b mRNA is translated into a functional protein. This finding represents the first direct evidence for a functional translation system in the kinetoplasts.	Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Univ Calif Berkeley, Div Struct Biol, Berkeley, CA 94720 USA	University of California System; University of California Riverside; University of California System; University of California Berkeley	Maslov, DA (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.		Horvath, Anton/I-3626-2014; Horvath, Anton/V-1097-2018	Horvath, Anton/0000-0003-0785-4204	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044842] Funding Source: NIH RePORTER; NIAID NIH HHS [R29AI40634] Funding Source: Medline; NIDDK NIH HHS [R01DK44842] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alfonzo JD, 1997, NUCLEIC ACIDS RES, V25, P3751, DOI 10.1093/nar/25.19.3751; AVILA HA, COMMUNICATION; Beattie DS, 1996, EUR J BIOCHEM, V241, P888, DOI 10.1111/j.1432-1033.1996.00888.x; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BERRY EA, 1991, J BIOL CHEM, V266, P9064; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Breek CKD, 1997, BIOL CHEM, V378, P837, DOI 10.1515/bchm.1997.378.8.837; Cruz-Reyes J, 1998, MOL CELL, V1, P401, DOI 10.1016/S1097-2765(00)80040-4; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; Kable ML, 1996, SCIENCE, V273, P1189, DOI 10.1126/science.273.5279.1189; MARRES CAM, 1977, BIOCHIM BIOPHYS ACTA, V462, P531, DOI 10.1016/0005-2728(77)90099-8; PRIEST JW, 1992, J BIOL CHEM, V267, P20188; SHAW JM, 1989, P NATL ACAD SCI USA, V86, P6220, DOI 10.1073/pnas.86.16.6220; Simpson L, 1998, NUCLEIC ACIDS RES, V26, P170, DOI 10.1093/nar/26.1.170; Speijer D, 1997, MOL BIOCHEM PARASIT, V85, P171, DOI 10.1016/S0166-6851(96)02823-X; Speijer D, 1996, MOL BIOCHEM PARASIT, V79, P47, DOI 10.1016/0166-6851(96)02648-5; STEFFENS GJ, 1979, H-S Z PHYSIOL CHEM, V360, P613	18	58	62	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1639	1640		10.1126/science.287.5458.1639	http://dx.doi.org/10.1126/science.287.5458.1639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698736				2022-12-28	WOS:000085628200034
J	Nduati, R; John, G; Mbori-Ngacha, D; Richardson, B; Overbaugh, J; Mwatha, A; Ndinya-Achola, J; Bwayo, J; Onyango, FE; Hughes, J; Kreiss, J				Nduati, R; John, G; Mbori-Ngacha, D; Richardson, B; Overbaugh, J; Mwatha, A; Ndinya-Achola, J; Bwayo, J; Onyango, FE; Hughes, J; Kreiss, J			Effect of breastfeeding and formula feeding on transmission of HIV-1 - A randomized clinical trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CHILD TRANSMISSION; VITAMIN-A-DEFICIENCY; POSTNATAL TRANSMISSION; MOTHER; IMMUNOSUPPRESSION; ASSOCIATION; COHORT; INFANT; RISK	Context Transmission of human immunodeficiency virus type 1 (HIV-1) is known to occur through breastfeeding, but the magnitude of risk has not been precisely defined. Whether breast milk HIV-1 transmission risk exceeds the potential risk of formula-associated diarrheal mortality in developing countries is unknown. Objectives To determine the frequency of breast milk transmission of HIV-1 and to compare mortality rates and HIV-1-free survival in breastfed and formula-fed infants. Design and Setting Randomized clinical trial conducted from November 1992 to July 1998 in antenatal clinics in Nairobi, Kenya, with a median follow-up period of 24 months. Participants Of 425 HIV-1-seropositive, antiretroviral-naive pregnant women enrolled, 401 mother-infant pairs were included in the analysis of trial end points. Interventions Mother-infant pairs were randomized to breastfeeding (n = 212) vs formula feeding arms (n = 213). Main Outcome Measures Infant HIV-1 infection and death during the first 2 years of life, compared between the 2 intervention groups. Results Compliance with the assigned feeding modality was 96% in the breastfeeding arm and 70% in the formula arm (P<.001). Median duration of breastfeeding was 17 months. Of the 401 infants included in the analysis, 94% were followed up to HIV-1 infection or mortality end points: 83% for the HIV-1 infection end point and 93% to the mortality end point. The cumulative probability of HIV-1 infection at 24 months was 36.7% (95% confidence interval [CI], 29.4%-44.0%) in the breastfeeding arm and 20.5% (95% CI, 14.0%-27.0%) in the formula arm (P=.001). The estimated rate of breast milk transmission was 16.2% (95% CI, 6.5%-25.9%). Forty-four percent of HIV-1 infection in the breastfeeding arm was attributable to breast milk. Most breast milk transmission occurred early, with 75% of the risk difference between the 2 arms occurring by 6 months, although transmission continued throughout the duration of exposure. The 2-year mortality rates in both arms were similar (breastfeeding arm, 24.4% [95% CI, 18.2%-30.7%] vs formula feeding arm, 20.0% [95% CI, 14.4%-25.6%]; P=.30). The rate of HIV-1-free survival at 2 years was significantly lower in the breastfeeding arm than in the formula feeding arm (58.0% vs 70.0%, respectively; P=.02). Conclusions The frequency of breast milk transmission of HIV-1 was 16.2% in this randomized clinical trial, and the majority of infections occurred early during breastfeeding. The use of breast milk substitutes prevented 44% of infant infections and was associated with significantly improved HIV-1-free survival.	Univ Nairobi, Dept Paediat, Nairobi, Kenya; Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Nairobi; University of Nairobi; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kreiss, J (corresponding author), Harborview Med Ctr, Box 359931,325 9th Ave, Seattle, WA 98104 USA.		John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019		FIC NIH HHS [D43-TW00007, T22-TW00001] Funding Source: Medline; NICHD NIH HHS [R01 HD023412, NICHD-23412] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023412] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [T22TW000001, D43TW000007] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Bobat R, 1997, AIDS, V11, P1627, DOI 10.1097/00002030-199713000-00012; BOERMA JT, 1998, AIDS S1, V12, P53; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; DATTA P, 1994, J INFECT DIS, V170, P1134, DOI 10.1093/infdis/170.5.1134; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; FRIEDMAN LM, 1998, FUNDAMENTALS CLIN TR, P284; Global Program on AIDS Consensus statement from the WHO/UNICEF consultation on HIV and breastfeeding, 1992, WKLY EPIDEMIOL REC, V67, P177; HUGHES JP, 1993, INTRO BOOTSTRAP, P141; John GC, 1997, J INFECT DIS, V175, P57, DOI 10.1093/infdis/175.1.57; *JOINT UN PROGR HI, 1996, WKLY EPIDEMIOL REC, V71, P289; *JOINT UN PROGR HI, 1998, REP GLOB HIV AIDS EP; National Council for Population and Development - NCPD/Kenya Central Bureau of Statistics - CBS/Kenya and Macro International, 1999, KEN DEM HLTH SURV 19; NDUATI RW, 1995, J INFECT DIS, V172, P1461, DOI 10.1093/infdis/172.6.1461; Neilson JR, 1999, J VIROL, V73, P4393, DOI 10.1128/JVI.73.5.4393-4403.1999; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Panteleeff DD, 1999, J CLIN MICROBIOL, V37, P350, DOI 10.1128/JCM.37.2.350-353.1999; SIMONON A, 1994, J ACQ IMMUN DEF SYND, V7, P952; Tess BH, 1998, AIDS, V12, P513, DOI 10.1097/00002030-199805000-00013; VANDEPERRE P, 1991, NEW ENGL J MED, V325, P593, DOI 10.1056/NEJM199108293250901; *WHO, 1987, WHOSPAINF878 WHO; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; ZIEGLER JB, 1985, LANCET, V1, P896; 1985, MMWR MORB MORTAL WKL, V34, P721	24	629	645	2	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1167	1174		10.1001/jama.283.9.1167	http://dx.doi.org/10.1001/jama.283.9.1167			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703779	Bronze			2022-12-28	WOS:000085424100026
J	Gavrilova, O; Marcus-Samuels, B; Leon, LR; Vinson, C; Reitman, ML				Gavrilova, O; Marcus-Samuels, B; Leon, LR; Vinson, C; Reitman, ML			Hormones - Leptin and diabetes in lipoatrophic mice	NATURE			English	Article							ADIPOSE-TISSUE; OBESITY		NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA; NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gavrilova, O (corresponding author), NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA.	mlr@helix.nih.gov	Reitman, Marc/B-4448-2013	Reitman, Marc/0000-0002-0426-9475	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK047031] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Burant CF, 1997, J CLIN INVEST, V100, P2900, DOI 10.1172/JCI119839; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; FOSTER DW, 1994, HARRISONS PRINCIPLES, P2131; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213	9	63	65	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					850	850		10.1038/35002663	http://dx.doi.org/10.1038/35002663			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706272				2022-12-28	WOS:000085559200042
J	Landis, GA				Landis, GA			Avatars in space - Why bother to colonize space when electronic devices do it so much better?	NATURE			English	Editorial Material																			0	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					833	833		10.1038/35002684	http://dx.doi.org/10.1038/35002684			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706260	Bronze			2022-12-28	WOS:000085559200028
J	Reinhart, BJ; Slack, FJ; Basson, M; Pasquinelli, AE; Bettinger, JC; Rougvie, AE; Horvitz, HR; Ruvkun, G				Reinhart, BJ; Slack, FJ; Basson, M; Pasquinelli, AE; Bettinger, JC; Rougvie, AE; Horvitz, HR; Ruvkun, G			The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; HETEROCHRONIC MUTANTS; GENE; NEMATODE; PROTEIN; LIN-14; ENCODES; SWITCH; REGION	The C. elegans heterochronic gene pathway consists of a cascade of regulatory genes that are temporally controlled to specify the timing of developmental events(1). Mutations in heterochronic genes cause temporal transformations in cell fates in which stage-specific events are omitted or reiterated(2). Here we show that let-7 is a heterochronic switch gene. Loss of let-7 gene activity causes reiteration of larval cell fates during the adult stage, whereas increased let-7 gene dosage causes precocious expression of adult fates during larval stages. let-7 encodes a temporally regulated 21-nucleotide RNA that is complementary to elements in the 3' untranslated regions of the heterochronic genes lin-14, lin-28, lin-41, lin-42 and daf-12, indicating that expression of these genes may be directly controlled by let-7. A reporter gene bearing the lin-41 3' untranslated region is temporally regulated in a let-7-dependent manner. A second regulatory RNA, lin-4, negatively regulates lin-14 and lin-28 through RNA-RNA interactions with their 3' untranslated regions(3,4). We propose that the sequential stage-specific expression of the lin-4 and let-7 regulatory RNAs triggers transitions in the complement of heterochronic regulatory proteins to coordinate developmental timing.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, St Paul, MN 55108 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Minnesota System; University of Minnesota Twin Cities	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.			Slack, Frank/0000-0001-8263-0409	NIAMS NIH HHS [P30 AR046032] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abrahante JE, 1998, GENETICS, V149, P1335; AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Bettinger JC, 1996, DEVELOPMENT, V122, P2517; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; KENNEDY BP, 1993, J MOL BIOL, V229, P890, DOI 10.1006/jmbi.1993.1094; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LIU Z, 1990, THESIS HARVARD U; MENEELY PM, 1979, GENETICS, V92, P99; Moore DD, 1995, GLOB MOB SURV; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; ROUGVIE AE, 1995, DEVELOPMENT, V121, P2491; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; TRENT C, 1983, GENETICS, V104, P619; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; YEH WY, 1991, THESIS U MISSOURI CO; ZUCKERAPRISON E, 1989, J MOL EVOL, V28, P487, DOI 10.1007/BF02602929	21	3224	3765	17	447	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					901	906		10.1038/35002607	http://dx.doi.org/10.1038/35002607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706289				2022-12-28	WOS:000085559200060
J	Bui, JD; Calbo, S; Hayden-Martinez, K; Kane, LP; Gardner, P; Hedrick, SM				Bui, JD; Calbo, S; Hayden-Martinez, K; Kane, LP; Gardner, P; Hedrick, SM			A role for CaMKII in T cell memory	CELL			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; STAPHYLOCOCCAL ENTEROTOXIN-B; II MUTANT MICE; TRANSGENIC MICE; MOLECULAR MECHANISM; POSITIVE SELECTION; ANTIGEN RECEPTOR; EXPRESSION; CALCIUM	In order to study the role of calcium/calmodulin kinase II (CaMKII) in T cells, we generated transgenic mice expressing CaMKII gamma B* (T287D), a partially calcium-independent mutant of CaMKII gamma B. In these mice, the size of the thymus was increased 1.5- to 2-fold, at least in part due to an increase in the lifespan of double-positive (DP) thymocytes. More importantly, there was an increase in the number of T cells in the secondary lymphoid organs that had acquired an antigen-dependent memory phenotype. These T cells were bonafide memory cells as assessed by a variety of criteria. In addition, T cells from wild-type mice acquired calcium-independent CaMKII activity after several rounds of antigen-stimulated division. We propose that CaMKII controls a distinct process of activation-induced cellular differentiation.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Stanford Univ, Dept Mol Pharmacol & Med, Stanford, CA 94305 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University	Hedrick, SM (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.	shedrick@ucsd.edu	Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751; Kane, Lawrence/0000-0001-5198-516X	NIAID NIH HHS [R01AI21372-15] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021372] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Deisseroth K, 1995, CURR BIOL, V5, P1334, DOI 10.1016/S0960-9822(95)00262-4; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; ERNST DN, 1993, J IMMUNOL, V151, P575; Fukunaga K, 1996, NEUROCHEM INT, V28, P343, DOI 10.1016/0197-0186(95)00097-6; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Heist EK, 1998, CELL CALCIUM, V23, P103; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; LEE WT, 1990, J IMMUNOL, V144, P3288; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McConkey DJ, 1997, BIOCHEM BIOPH RES CO, V239, P357, DOI 10.1006/bbrc.1997.7409; MCCORMACK JE, 1993, J IMMUNOL, V150, P3785; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; NGHIEM P, 1993, J BIOL CHEM, V268, P5471; NGHIEM P, 1994, NATURE, V371, P347, DOI 10.1038/371347a0; NISHIMOTO I, 1991, NEURON, V6, P547, DOI 10.1016/0896-6273(91)90057-7; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Petschner F, 1998, EUR J IMMUNOL, V28, P560, DOI 10.1002/(SICI)1521-4141(199802)28:02<560::AID-IMMU560>3.0.CO;2-Q; Philpott NJ, 1996, BLOOD, V87, P2244, DOI 10.1182/blood.V87.6.2244.bloodjournal8762244; PICKER LJ, 1995, BLOOD, V86, P1408, DOI 10.1182/blood.V86.4.1408.bloodjournal8641408; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SMITH MK, 1992, J BIOL CHEM, V267, P1761; SODERLING TR, 1993, MOL CELL BIOCHEM, V128, P93, DOI 10.1007/BF01076760; Sprent J, 1997, IMMUNOL REV, V156, P79, DOI 10.1111/j.1600-065X.1997.tb00960.x; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TAO W, 1994, J EXP MED, V179, P145, DOI 10.1084/jem.179.1.145; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Vasseur F, 1999, J IMMUNOL, V162, P5164; WEBB SR, 1994, J IMMUNOL, V152, P586; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	69	54	54	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2000	100	4					457	467		10.1016/S0092-8674(00)80681-9	http://dx.doi.org/10.1016/S0092-8674(00)80681-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693762	Bronze			2022-12-28	WOS:000085446900008
J	Prober, DA; Edgar, BA				Prober, DA; Edgar, BA			Ras1 promotes cellular growth in the Drosophila wing	CELL			English	Article							EGF RECEPTOR GENE; SACCHAROMYCES-CEREVISIAE; TYROSINE KINASE; CYCLE MACHINERY; PROTO-ONCOGENE; LOCUS ENCODES; EXPRESSION; DIVISION; PATHWAY; PROLIFERATION	The Ras GTPase links extracellular mitogens to intracellular mechanisms that control cell proliferation. To understand how Ras regulates proliferation in vivo, we activated or inactivated Ras in cell clones in the developing Drosophila wing. Cells lacking Ras were smaller, had reduced growth rates, accumulated in G1, and underwent apoptosis due to cell competition. Conversely, activation of Ras increased cell size and growth rates and promoted G1/S transitions. Ras upregulated the growth driver dMyc, and both Pas and dMyc increased levels of cyclin E posttranscriptionally. We propose that Pas primarily promotes growth and that growth is coupled to G1/S progression via cyclin E. Interestingly, upregulation of growth by Pas did not deregulate G2/M progression or a developmentally regulated cell cycle exit.	Fred Hutchinson Canc Res Ctr, Mol & Cellular Biol Program, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Program Dev Biol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Mol & Cellular Biol Program, Seattle, WA 98109 USA.				NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NCI NIH HHS [5P30CA15704-26] Funding Source: Medline; NIGMS NIH HHS [GM51186] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON S, 1994, GENETICS, V137, P513; Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; BIGGS WH, 1994, EMBO J, V13, P1628, DOI 10.1002/j.1460-2075.1994.tb06426.x; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; CLIFFORD RJ, 1989, GENETICS, V123, P771; Dang CV, 1999, MOL CELL BIOL, V19, P1; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; Downward J, 1997, CURR BIOL, V7, P258; FAIN MJ, 1982, DEV BIOL, V92, P247, DOI 10.1016/0012-1606(82)90169-5; Fan JG, 1997, ONCOGENE, V14, P2595, DOI 10.1038/sj.onc.1201105; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GRAVES BJ, 1982, DEV BIOL, V93, P104, DOI 10.1016/0012-1606(82)90243-3; Guichard A, 1999, DEVELOPMENT, V126, P2663; Hall DD, 1998, EMBO J, V17, P4370, DOI 10.1093/emboj/17.15.4370; HAY BA, 1994, DEVELOPMENT, V120, P2121; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Karim FD, 1998, DEVELOPMENT, V125, P1; KATAOKA T, 1985, CELL, V40, P19, DOI 10.1016/0092-8674(85)90304-6; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee T, 1996, DEVELOPMENT, V122, P409; Lehman DA, 1999, DEVELOPMENT, V126, P1793; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; LIVNEH E, 1985, CELL, V40, P599, DOI 10.1016/0092-8674(85)90208-9; LU XY, 1993, GENE DEV, V7, P621, DOI 10.1101/gad.7.4.621; MADHAVAN MM, 1977, ROUX ARCH DEV BIOL, V183, P269, DOI 10.1007/BF00848459; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Mittnacht S, 1997, CURR BIOL, V7, P219, DOI 10.1016/S0960-9822(97)70094-0; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; NEUMANSILBERBERG FS, 1984, CELL, V37, P1027; NISHIDA Y, 1988, EMBO J, V7, P775, DOI 10.1002/j.1460-2075.1988.tb02875.x; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Pignoni F, 1997, DEVELOPMENT, V124, P271; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; RICHARDSON HE, 1993, DEVELOPMENT, V119, P673; Rommel C, 1998, CURR OPIN GENET DEV, V8, P412, DOI 10.1016/S0959-437X(98)80111-1; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Schnorr JD, 1996, GENETICS, V144, P1545; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Simcox A, 1997, MECH DEVELOP, V62, P41, DOI 10.1016/S0925-4773(96)00643-0; Simcox AA, 1996, DEV BIOL, V177, P475, DOI 10.1006/dbio.1996.0179; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; STURTEVANT MA, 1995, DEVELOPMENT, V121, P785; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Winston JT, 1996, ONCOGENE, V12, P127; XU T, 1993, DEVELOPMENT, V117, P1223	64	233	238	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					435	446		10.1016/S0092-8674(00)80679-0	http://dx.doi.org/10.1016/S0092-8674(00)80679-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693760	Green Accepted, Bronze			2022-12-28	WOS:000085446900006
J	Abbott, A				Abbott, A			CERN claims first experimental creation of quark-gluon plasma	NATURE			English	News Item																		Wilczek F, 1998, NATURE, V391, P330, DOI 10.1038/34778; 1999, NATURE, V400, P303	2	3	3	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					581	581		10.1038/35001196	http://dx.doi.org/10.1038/35001196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688162	Bronze			2022-12-28	WOS:000085288200003
J	Gierasch, PJ; Ingersoll, AP; Banfield, D; Ewald, SP; Helfenstein, P; Simon-Miller, A; Vasavada, A; Breneman, HH; Senske, DA				Gierasch, PJ; Ingersoll, AP; Banfield, D; Ewald, SP; Helfenstein, P; Simon-Miller, A; Vasavada, A; Breneman, HH; Senske, DA		Galileo Imaging Team	Observation of moist convection in Jupiter's atmosphere	NATURE			English	Article							GALILEO	The energy source driving Jupiter's active meteorology is not understood(1). There are two main candidates: a poorly understood internal heat source and sunlight. Here we report observations of an active storm system possessing both lightning and condensation of water. The storm has a vertical extent of at least 50 km and a length of about 4,000 km. Previous observations(2,3) of lightning on Jupiter have revealed both its frequency of occurrence and its spatial distribution, but they did not permit analysis of the detailed cloud structure and its dynamics. The present observations reveal the storm (on the day side of the planet) at the same location and within just a few hours of a lightning detection (on the night side). We estimate that the total vertical transport of heat by storms like the one observed here is of the same order as the planet's internal heat source. We therefore conclude that moist convection-similar to large clusters of thunderstorm cells on the Earth-is a dominant factor in converting heat flow into kinetic energy in the jovian atmosphere.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90025 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Cornell University; California Institute of Technology; University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Gierasch, PJ (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.		Simon, Amy/C-8020-2012; Banfield, Don J/I-3523-2018	Simon, Amy/0000-0003-4641-6186; Banfield, Don J/0000-0003-2664-0164				Banfield D, 1998, ICARUS, V135, P230, DOI 10.1006/icar.1998.5985; Beebe R. F., 1989, NASA, V494, P245; EMANUEL K, 1984, ATMOSPHERIC CONVECTI; Houze R. A., 1993, CLOUD DYNAMICS; INGERSOLL AP, 1990, SCIENCE, V248, P308, DOI 10.1126/science.248.4953.308; INGERSOLL AP, 1984, SATURN, P195; LEWIS JS, 1969, ICARUS, V10, P365, DOI 10.1016/0019-1035(69)90091-8; LIMAYE SS, 1986, ICARUS, V65, P335, DOI 10.1016/0019-1035(86)90142-9; Little B, 1999, ICARUS, V142, P306, DOI 10.1006/icar.1999.6195; MADDOX RA, 1980, B AM METEOROL SOC, V61, P1374, DOI 10.1175/1520-0477(1980)061<1374:MCC>2.0.CO;2; MAGALHAES JA, 1991, NATURE, V349, P311, DOI 10.1038/349311a0; SMITH BA, 1979, SCIENCE, V204, P951, DOI 10.1126/science.204.4396.951; Vasavada AR, 1998, ICARUS, V135, P265, DOI 10.1006/icar.1998.5984; WEST RA, 1986, ICARUS, V65, P161, DOI 10.1016/0019-1035(86)90135-1	15	153	154	2	20	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					628	630		10.1038/35001017	http://dx.doi.org/10.1038/35001017			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688191				2022-12-28	WOS:000085288200043
J	Johnson, KA; Ashcroft, NW				Johnson, KA; Ashcroft, NW			Structure and bandgap closure in dense hydrogen	NATURE			English	Article							SOLID MOLECULAR-HYDROGEN; MEGABAR PRESSURES; CRYSTAL-STRUCTURE; METALLIZATION; STATE; TRANSITIONS; ABSORPTION; EQUATION; PHASE; METAL	The possibility that steadily compressed hydrogen might undergo a transition from a proton-paired insulator to a monatomic metal was first suggested in 1935 (ref, 1). But experimental realization of metallic hydrogen in solid form has remained elusive, despite studies at pressures as high as 342 GPa (ref. 2). The pairing structure is known to be robust (from the persistence of its associated vibron mode(3)), leading to the suggestion of an alternative route to the metallic state, involving a band-overlap transition in which the pairing is preserved(4). Here we report density functional calculations within the local density approximation that predict a range of densities for hydrogen where a paired or molecular metallic state may be energetically preferred. The transition to this metallic state is naturally associated with the closing of an overall bandgap; but the pressures required to effect the transition are shown to change significantly when the gaps are corrected by approximate inclusion of many-electron effects. The implication is that a complete resolution of the structural and phase problem in dense hydrogen may require methods beyond the local density approximation.	Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; Cornell Univ, Cornell Ctr Mat Res, Ithaca, NY 14853 USA	Cornell University; Cornell University	Ashcroft, NW (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	nwa@ccmr.cornell.edu						BARBEE TW, 1989, PHYS REV LETT, V62, P1150, DOI 10.1103/PhysRevLett.62.1150; CEPERLEY DM, 1987, PHYS REV B, V36, P2092, DOI 10.1103/PhysRevB.36.2092; CHACHAM H, 1991, PHYS REV LETT, V66, P64, DOI 10.1103/PhysRevLett.66.64; Edwards B, 1996, EUROPHYS LETT, V34, P519, DOI 10.1209/epl/i1996-00489-5; Edwards B, 1997, NATURE, V388, P652, DOI 10.1038/41645; EDWARDS B, 1997, SOLID HYDROGEN HIGH; EGGERT JH, 1991, PHYS REV LETT, V66, P193, DOI 10.1103/PhysRevLett.66.193; Evans WJ, 1998, PHYS REV B, V57, P14105, DOI 10.1103/PhysRevB.57.14105; HANFLAND M, 1993, PHYS REV LETT, V70, P3760, DOI 10.1103/PhysRevLett.70.3760; HEDIN L, 1965, PHYS REV, V139, pA796, DOI 10.1103/PhysRev.139.A796; HEMLEY RJ, 1988, PHYS REV LETT, V61, P857, DOI 10.1103/PhysRevLett.61.857; HEMLEY RJ, 1991, NATURE, V350, P488, DOI 10.1038/350488a0; JOHNSON K, 1998, ELECT STRUCTURE BAND; Johnson KA, 1998, PHYS REV B, V58, P15548, DOI 10.1103/PhysRevB.58.15548; KAXIRAS E, 1991, PHYS REV LETT, V67, P1138, DOI 10.1103/PhysRevLett.67.1138; Kohanoff J, 1997, PHYS REV LETT, V78, P2783, DOI 10.1103/PhysRevLett.78.2783; Kohanoff J, 1999, PHYS REV LETT, V83, P4097, DOI 10.1103/PhysRevLett.83.4097; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Loubeyre P, 1996, NATURE, V383, P702, DOI 10.1038/383702a0; Mazin II, 1997, PHYS REV LETT, V78, P1066, DOI 10.1103/PhysRevLett.78.1066; MAZIN II, 1995, PHYS REV B, V52, pR8597, DOI 10.1103/PhysRevB.52.R8597; Nagao K, 1997, PHYS REV B, V56, P2295, DOI 10.1103/PhysRevB.56.2295; Narayana C, 1998, NATURE, V393, P46, DOI 10.1038/29949; NATOLI V, 1995, PHYS REV LETT, V74, P1601, DOI 10.1103/PhysRevLett.74.1601; NATOLI V, 1993, PHYS REV LETT, V70, P1952, DOI 10.1103/PhysRevLett.70.1952; Richardson CF, 1997, PHYS REV LETT, V78, P118, DOI 10.1103/PhysRevLett.78.118; Ruoff A. L., 1993, Modern Physics Letters B, V7, P907, DOI 10.1142/S0217984993000904; STERNE PA, 1984, J PHYS C SOLID STATE, V17, P1497, DOI 10.1088/0022-3719/17/9/008; STRAUSS DM, 1997, PHYS REV LETT, V38, P415; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Wigner E, 1935, J CHEM PHYS, V3, P764, DOI 10.1063/1.1749590	31	166	171	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					632	635		10.1038/35001024	http://dx.doi.org/10.1038/35001024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688193				2022-12-28	WOS:000085288200045
J	Parkhill, J; Wren, BW; Mungall, K; Ketley, JM; Churcher, C; Basham, D; Chillingworth, T; Davies, RM; Feltwell, T; Holroyd, S; Jagels, K; Karlyshev, AV; Moule, S; Pallen, MJ; Penn, CW; Quail, MA; Rajandream, MA; Rutherford, KM; van Vliet, AHM; Whitehead, S; Barrell, BG				Parkhill, J; Wren, BW; Mungall, K; Ketley, JM; Churcher, C; Basham, D; Chillingworth, T; Davies, RM; Feltwell, T; Holroyd, S; Jagels, K; Karlyshev, AV; Moule, S; Pallen, MJ; Penn, CW; Quail, MA; Rajandream, MA; Rutherford, KM; van Vliet, AHM; Whitehead, S; Barrell, BG			The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences	NATURE			English	Article							HELICOBACTER-PYLORI; GENES; VIRULENCE; IDENTIFICATION; BACTERIA; PROGRAM; CELLS	Campylobacter jejuni, from the delta-epsilon group of proteobacteria, is a microaerophilic, Gram-negative, flagellate, spiral bacterium-properties it shares with the related gastric pathogen Helicobacter pylori. It is the leading cause of bacterial food-borne diarrhoeal disease throughout the world(1). In addition, infection with C. jejuni is the most frequent antecedent to a form of neuromuscular paralysis known as Guillain-Barre syndrome(2). Here we report the genome sequence of C. jejuni NCTC11168. C. jejuni has a circular chromosome of 1,641,481 base pairs (30.6% G+C) which is predicted to encode 1,654 proteins and 54 stable RNA species. The genome is unusual in that there are virtually no insertion sequences or phage-associated sequences and very few repeat sequences. One of the most striking findings in the genome was the presence of hypervariable sequences. These short homopolymeric runs of nucleotides were commonly found in genes encoding the biosynthesis or modification of surface structures, or in closely linked genes of unknown function. The apparently high rate of variation of these homopolymeric tracts may be important in the survival strategy of C. jejuni.	Sanger Ctr, Cambridge CB10 1SA, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Queens Univ Belfast, Dept Microbiol & Immunobiol, Belfast BT12 6BN, Antrim, North Ireland; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Free Univ Amsterdam, Fac Med, Dept Med Microbiol, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Fac Med, Dept Gastroenterol, NL-1081 BT Amsterdam, Netherlands	Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University of Leicester; Queens University Belfast; University of Birmingham; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Parkhill, J (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.		van Vliet, Arnoud HM/B-5155-2013; Pallen, Mark J./E-7619-2011; Quail, michael/ABE-6131-2020; Parkhill, Julian/G-4703-2011; Karlyshev, Andrey/D-2797-2011; Rutherford, Kim/Y-7995-2018	Parkhill, Julian/0000-0002-7069-5958; Karlyshev, Andrey/0000-0003-3124-019X; Rutherford, Kim/0000-0001-6277-726X; Pallen, Mark/0000-0003-1807-3657; van Vliet, Arnoud/0000-0003-0203-1305; Davies, Robert/0000-0002-9983-1378				Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baillon MLA, 1999, J BACTERIOL, V181, P4798, DOI 10.1128/JB.181.16.4798-4804.1999; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; *CPHLS, 1999, COMMUNICAB DIS REP, V9, P11; Doig P, 1996, MOL MICROBIOL, V20, P885, DOI 10.1111/j.1365-2958.1996.tb02526.x; Domingo E, 1997, REV MED VIROL, V7, P87, DOI 10.1002/(SICI)1099-1654(199707)7:2<87::AID-RMV188>3.0.CO;2-0; Frishman D, 1998, NUCLEIC ACIDS RES, V26, P2941, DOI 10.1093/nar/26.12.2941; FRY B, IN PRESS CAMPYLOBACT; Guerry P, 1996, MOL MICROBIOL, V19, P369, DOI 10.1046/j.1365-2958.1996.369895.x; Hood DW, 1996, P NATL ACAD SCI USA, V93, P11121, DOI 10.1073/pnas.93.20.11121; Hughes NJ, 1998, J BACTERIOL, V180, P1119, DOI 10.1128/JB.180.5.1119-1128.1998; Jones AC, 1997, J BACTERIOL, V179, P5643, DOI 10.1128/jb.179.17.5643-5647.1997; Konkel ME, 1999, MOL MICROBIOL, V32, P691, DOI 10.1046/j.1365-2958.1999.01376.x; Lavitola A, 1999, MOL MICROBIOL, V33, P119, DOI 10.1046/j.1365-2958.1999.01454.x; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Wassenaar TM, 1997, CLIN MICROBIOL REV, V10, P466, DOI 10.1128/CMR.10.3.466; Wood AC, 1999, MICROBIOL-UK, V145, P379, DOI 10.1099/13500872-145-2-379; Wren BW, 1998, MICROBIOL-SGM, V144, P1205, DOI 10.1099/00221287-144-5-1205; Yao RJ, 1997, MOL MICROBIOL, V23, P1021, DOI 10.1046/j.1365-2958.1997.2861650.x; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	30	1536	2086	4	148	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					665	668		10.1038/35001088	http://dx.doi.org/10.1038/35001088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688204	Bronze			2022-12-28	WOS:000085288200056
J	Clyne, PJ; Warr, CG; Carlson, JR				Clyne, PJ; Warr, CG; Carlson, JR			Candidate taste receptors in Drosophila	SCIENCE			English	Article							POX-NEURO; GENE POXN; MELANOGASTER; ORGANS; BEHAVIOR	Little is known about the molecular mechanisms of taste perception in animals, particularly the initial events of taste signaling. A large and diverse family of seven transmembrane domain proteins was identified from the Drosophila genome database with a computer algorithm that identifies proteins on the basis of structure. Eighteen of 19 genes examined were expressed in the Drosophila labellum, a gustatory organ of the proboscis. Expression was not detected in a variety of other tissues. The genes were not expressed in the labellum of a Drosophila mutant, pox-neuro(70), in which taste neurons are eliminated. Tissue specificity of expression of these genes, along with their structural similarity, supports the possibility that the family encodes a Large and divergent family of taste receptors.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.			Warr, Coral/0000-0002-5289-3950	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-02174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; CHAPMAN RF, 1991, J EXP BIOL, V158, P241; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; DETHIER VG, 1955, Q REV BIOL, V30, P348, DOI 10.1086/401030; Dethier VG, 1976, HUNGRY FLY; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; Glendinning JI, 1997, J NEUROPHYSIOL, V78, P734, DOI 10.1152/jn.1997.78.2.734; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; NOTTEBOHM E, 1992, NATURE, V359, P829, DOI 10.1038/359829a0; NOTTEBOHM E, 1994, NEURON, V12, P25, DOI 10.1016/0896-6273(94)90149-X; PERIN MS, 1991, J BIOL CHEM, V266, P615; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; SHIRAISHI A, 1970, J GEN PHYSIOL, V56, P768, DOI 10.1085/jgp.56.6.768; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TOMPKINS L, 1979, P NATL ACAD SCI USA, V76, P884, DOI 10.1073/pnas.76.2.884; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431, DOI 10.1177/002215549904700402	20	438	490	10	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1830	1834		10.1126/science.287.5459.1830	http://dx.doi.org/10.1126/science.287.5459.1830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710312				2022-12-28	WOS:000085775300044
J	Morris, AH				Morris, AH			Developing and implementing computerized protocols for standardization of clinical decisions	ANNALS OF INTERNAL MEDICINE			English	Review							INVERSE RATIO VENTILATION; PULMONARY-ARTERY CATHETER; ELECTRONIC PATIENT RECORD; PRACTICE GUIDELINES; ADVANCE DIRECTIVES; MEDICAL-PRACTICE; SUPPORT SYSTEMS; CARE; QUALITY; PHYSICIANS	Humans have only a limited ability to incorporate information in decision making. In certain situations, the mismatch between this limitation and the availability of extensive information contributes to the varying performance and high error rate of clinical decision makers. Variation in clinical practice is due in part to clinicians' poor compliance with guidelines and recommended therapies. The use of decision-support tools is a response to both the information revolution and poor compliance. Computerized protocols used to deliver decision support can be configured to contain much more detail than textual guidelines or paper-based flow diagrams. Such protocols can generate patient-specific instructions for therapy that can be carried out with little interclinician variability; however, clinicians must be willing to modify personal styles of clinical management. Protocols need not be perfect. Several defensible and reasonable approaches are available for clinical problems. However, one of these reasonable approaches must be chosen and incorporated into the protocol to promote consistent clinical decisions. This reasoning is the basis of an explicit method of decision support that allows the rigorous evaluation of interventions, including use of the protocols themselves. Computerized protocols for mechanical ventilation and management of intravenous fluid and hemodynamic factors in patients with the acute respiratory distress syndrome provide case studies for this discussion.	Latter Day St Hosp, Div Pulm, Salt Lake City, UT 84143 USA; Univ Utah, Sch Med, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah	Morris, AH (corresponding author), Latter Day St Hosp, Div Pulm, 8th Ave & C St, Salt Lake City, UT 84143 USA.	ldamorri@ihc.com			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006594] Funding Source: NIH RePORTER; DIVISION OF LUNG DISEASES [N01HR046062] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036787] Funding Source: NIH RePORTER; AHRQ HHS [HS 06594] Funding Source: Medline; NHLBI NIH HHS [R01-HL-36787, N01-HR-46062] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAMSON NS, 1980, JAMA-J AM MED ASSOC, V244, P1582, DOI 10.1001/jama.244.14.1582; [Anonymous], 1982, CRITERIA STANDARDS Q; Arkes H., 1986, JUDGMENT DECISION MA, P582; ATKINS HJB, 1958, BRIT MED J, V2, P1547, DOI 10.1136/bmj.2.5112.1547; AUDET AM, 1990, ANN INTERN MED, V113, P709, DOI 10.7326/0003-4819-113-9-709; BANKOWITZ RA, 1989, ANN INTERN MED, V110, P824, DOI 10.7326/0003-4819-110-10-824; Beauchamp T, 1989, PRINCIPLES BIOMEDICA; CANNON SR, 1980, COMPUT BIOMED RES, V13, P399, DOI 10.1016/0010-4809(80)90037-3; CHAN LS, 1993, COMPUT BIOMED RES, V26, P582, DOI 10.1006/cbmr.1993.1041; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; CHASSIN MR, 1986, NEW ENGL J MED, V314, P285, DOI 10.1056/NEJM198601303140505; COCHRANE GM, 1998, EUR RESPIR REV, V8, P239; COOPER M, 1999, DARTMOUTH ATLAS HLTH; Deming EW., 1986, OUT CRISIS; Deming W. E, 1982, QUALITY PRODUCTIVITY; DON H, 1985, DECISION MAKING CRIT; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; East T., 1995, TXB CRITICAL CARE, V3 ed, P895; EAST T, 1999, 1999 AMM MED INF ASS; East T D, 1995, Proc Annu Symp Comput Appl Med Care, P243; East T. D., 1989, Proceedings: The Thirteenth Annual Symposium on Computer Applications in Medical Care (Cat. No.89TH0286-5), P583; East T D, 1995, Crit Care Nurs Clin North Am, V7, P203; EAST TD, 1991, INT J CLIN MONIT COM, V8, P263, DOI 10.1007/BF01739127; EAST TD, 1992, CHEST, V101, P697, DOI 10.1378/chest.101.3.697; EAST TD, 1990, P 14 ANN S COMP APPL, P564; Eddy D M, 1984, Health Aff (Millwood), V3, P74, DOI 10.1377/hlthaff.3.2.74; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Field MJ, 1990, CLIN PRACTICE GUIDEL; FLETCHER RH, 1990, ANN INTERN MED, V113, P645, DOI 10.7326/0003-4819-113-9-645; FRIDSMA D, 1996, 1996 AM MED INF ASS, P597; Garibaldi RA, 1998, NEW ENGL J MED, V338, P259, DOI 10.1056/NEJM199801223380411; GIGERENZA G, 1989, EMPIRE CHANCE; Gnaegi A, 1997, CRIT CARE MED, V25, P213, DOI 10.1097/00003246-199702000-00003; Goodman K.W., 1998, ETHICS COMPUTING MED; GRECO PJ, 1993, NEW ENGL J MED, V329, P1271, DOI 10.1056/NEJM199310213291714; GRIMM RH, 1975, NEW ENGL J MED, V292, P507, DOI 10.1056/NEJM197503062921005; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; GUYATT G, 1986, SOC SCI MED, V22, P393, DOI 10.1016/0277-9536(86)90046-8; HADORN DC, 1992, JAMA-J AM MED ASSOC, V267, P3311, DOI 10.1001/jama.267.24.3311; HENDERSON S, 1991, INT J CLIN MONIT COM, V8, P271, DOI 10.1007/BF01739128; Horn S, 1994, CLIN PRACTICE IMPROV; Hulley S., 2007, DESIGNING CLIN RES E; IBERTI TJ, 1994, CRIT CARE MED, V22, P1674; IBERTI TJ, 1990, JAMA-J AM MED ASSOC, V264, P2928, DOI 10.1001/jama.264.22.2928; Jennings D. L., 1982, JUDGMENT UNCERTAINTY, P211; JOHNSTON ME, 1994, ANN INTERN MED, V120, P135, DOI 10.7326/0003-4819-120-2-199401150-00007; Jones P.W., 1998, EUR RESPIR REV, V8, P243; Jonsen AR, 1992, CLIN ETHICS PRACTICA; KARLINSKY J, 1991, DECISION MAKING PULM; KINDER A, 1993, P 17 ANN S COMP APPL, P888; KIRWAN J, 1986, JUDGM DECIS MAK, P364; Kuperman GJ, 1991, HELP DYNAMIC HOSP IN; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEVINE M, 1992, ACP J CLUB, V116, pA12; LO B, 1995, JAMA-J AM MED ASSOC, V274, P1634, DOI 10.1001/jama.274.20.1634; Lobach DF, 1997, AM J MED, V102, P89, DOI 10.1016/S0002-9343(96)00382-8; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; Marinker M., 1998, EUR RESPIR REV, V8, P235; Matthews JR., 1995, QUANTIFICATION QUEST, DOI 10.1515/9781400821808; McClave SA, 1999, CRIT CARE MED, V27, P1252, DOI 10.1097/00003246-199907000-00003; MCDONALD CJ, 1992, M D COMPUT, V9, P304; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; MCDONALD CJ, 1980, JAMA-J AM MED ASSOC, V244, P1579, DOI 10.1001/jama.244.14.1579; MCDONALD CJ, 1984, ANN INTERN MED, V100, P130, DOI 10.7326/0003-4819-100-1-130; MCDONALD CJ, 1994, JAMA-J AM MED ASSOC, V271, P872, DOI 10.1001/jama.271.11.872; MCDONALD CJ, 1989, ANN INTERN MED, V110, P333, DOI 10.7326/0003-4819-110-5-333; MCGUIRE LB, 1990, ANN INTERN MED, V113, P705, DOI 10.7326/0003-4819-113-9-705; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; MILLER PL, 1995, J AM MED INFORM ASSN, V2, P238, DOI 10.1136/jamia.1995.96010392; MILLER R, 1998, COMPUTING MED INFORM, P102; MORRIS A, 1998, PRINCIPLES PRACTICE, P1355; MORRIS A, 1995, CRITICAL CARE MONITO, P413; Morris A H, 1985, Cardiologia, V30, P941; Morris A.H., 1998, PHYSL BASIS VENTILAT; MORRIS AH, 1984, CRIT CARE MED, V12, P164, DOI 10.1097/00003246-198403000-00003; MORRIS AH, 1994, J AM MED INFORM ASSN, P501; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; MORRIS AH, 1988, T AM SOC ART INT ORG, V34, P48; *NAT HEART LUNG BL, 1994, NHLBIHR9405 NIH; Nelson EC, 1998, ANN INTERN MED, V128, P460, DOI 10.7326/0003-4819-128-6-199803150-00007; Ohno-Machado L, 1998, J AM MED INFORM ASSN, V5, P357, DOI 10.1136/jamia.1998.0050357; Patel VL, 1998, J AM MED INFORM ASSN, V5, P467, DOI 10.1136/jamia.1998.0050467; PETTY TL, 1988, AM REV RESPIR DIS, V138, P475, DOI 10.1164/ajrccm/138.2.475; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Pryor T A, 1983, J Med Syst, V7, P87, DOI 10.1007/BF00995116; RABENECK L, 1992, ARCH INTERN MED, V152, P507, DOI 10.1001/archinte.152.3.507; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; REDMAN BK, 1994, J CLIN ETHIC, V5, P303; RIND DM, 1994, ARCH INTERN MED, V154, P1511, DOI 10.1001/archinte.154.13.1511; Rubenfeld GD, 1999, AM J RESP CRIT CARE, V160, P358, DOI 10.1164/ajrccm.160.1.9807118; Safran C, 1996, M D COMPUT, V13, P46; Safran C, 1996, M D COMPUT, V13, P55; Schulz EB, 1998, J AM MED INFORM ASSN, V5, P337, DOI 10.1136/jamia.1998.0050337; Sharpe V.A., 1998, MED HARM HIST CONCEP; SHEWART W, 1931, EC CONTROL QUALTIY M; Shojania KG, 1998, J AM MED INFORM ASSN, V5, P554, DOI 10.1136/jamia.1998.0050554; SILVERMAN WA, 1993, ANN NY ACAD SCI, V703, P5, DOI 10.1111/j.1749-6632.1993.tb26328.x; Singer MV, 1998, INFECT CONT HOSP EP, V19, P248; Starfield B, 1998, JAMA-J AM MED ASSOC, V280, P1006, DOI 10.1001/jama.280.11.1006; Teno J, 1997, J AM GERIATR SOC, V45, P513, DOI 10.1111/j.1532-5415.1997.tb05180.x; Teno JM, 1997, J AM GERIATR SOC, V45, P508, DOI 10.1111/j.1532-5415.1997.tb05179.x; TIERNEY WM, 1995, J AM MED INFORM ASSN, V2, P316, DOI 10.1136/jamia.1995.96073834; TIERNEY WM, 1996, 1996 AM MED INF ASS, P459; Walton Mary, 1986, DEMING MANAGEMENT ME; Warren K, 1993, DOING MORE GOOD HARM; Weinstein MC, 1980, CLIN DECISION ANAL; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Wennberg J E, 1984, Health Manage Q, P6, DOI 10.1377/hlthaff.3.2.6; WENNBERG JE, 1989, NEW ENGL J MED, V321, P1168, DOI 10.1056/NEJM198910263211706; WILLIAMSON JW, 1979, MED PRACTICE INFORMA; WIRTSCHAFTER DD, 1981, COMPUT BIOMED RES, V14, P78, DOI 10.1016/0010-4809(81)90042-2; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193; Zielstorff RD, 1998, J AM MED INFORM ASSN, V5, P227, DOI 10.1136/jamia.1998.0050227; 1998, JAMA, V280, P958; [No title captured]; [No title captured], DOI DOI 10.1017/CBO9780511809477	118	148	149	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2000	132	5					373	383		10.7326/0003-4819-132-5-200003070-00007	http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	288KY	10691588				2022-12-28	WOS:000085563000006
J	MacAuley, D				MacAuley, D			Interactive skeleton: Kinetic and sports edition	BRITISH MEDICAL JOURNAL			English	Software Review									Hillhead Family Practice, Belfast, Antrim, North Ireland		MacAuley, D (corresponding author), Hillhead Family Practice, Belfast, Antrim, North Ireland.								0	0	0	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					654	654		10.1136/bmj.320.7235.654	http://dx.doi.org/10.1136/bmj.320.7235.654			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698905	Green Published			2022-12-28	WOS:000085742600073
J	Schlichting, I; Berendzen, J; Chu, K; Stock, AM; Maves, SA; Benson, DE; Sweet, BM; Ringe, D; Petsko, GA; Sligar, SG				Schlichting, I; Berendzen, J; Chu, K; Stock, AM; Maves, SA; Benson, DE; Sweet, BM; Ringe, D; Petsko, GA; Sligar, SG			The catalytic pathway of cytochrome P450cam at atomic resolution	SCIENCE			English	Article							PEROXIDASE COMPOUND-I; PSEUDOMONAS-PUTIDA CYTOCHROME-P-450; CRYSTAL-STRUCTURE; OXYGEN ACTIVATION; C PEROXIDASE; CRYSTALLOGRAPHY; HYDROXYLATION; P-450CAM; INTERMEDIATE; SPECTROSCOPY	Members of the cytochrome P450 superfamily catalyze the addition of molecular oxygen to nonactivated hydrocarbons at physiological temperature-a reaction that requires high temperature to proceed in the absence of a catalyst. Structures were obtained for three intermediates in the hydroxylation reaction of camphor by P450cam with trapping techniques and cryocrystallography. The structure of the ferrous dioxygen adduct of P450cam was determined with 0.91 angstrom wavelength x-rays; irradiation with 1.5 angstrom x-rays results in breakdown of the dioxygen molecule to an intermediate that would be consistent with an oxyferryl species. The structures show conformational changes in several important residues and reveal a network of bound water molecules that may provide the protons needed for the reaction.	Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; Los Alamos Natl Lab, Biophys Grp, Los Alamos, NM 87545 USA; Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA	Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory; Rutgers State University New Brunswick; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Brookhaven National Laboratory; Brandeis University	Schlichting, I (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, Otto Hahn Str 11, D-44227 Dortmund, Germany.	ilme.schlichting@mpi-dortmund.mpg.de	Petsko, Gregory/AAO-7962-2020; Schlichting, Ilme/I-1339-2013	Stock, Ann/0000-0002-0446-8079; Berendzen, Joel/0000-0002-9454-9074	NIGMS NIH HHS [GM33775, GM31756] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031756, R01GM033775, R37GM031756] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIKENS J, 1994, J AM CHEM SOC, V116, P1143, DOI 10.1021/ja00082a051; Benson DE, 1997, BIOCHEMISTRY-US, V36, P5104, DOI 10.1021/bi963170q; Borman S, 1999, CHEM ENG NEWS, V77, P31, DOI 10.1021/cen-v077n049.p031; BREWER CB, 1986, ARCH BIOCHEM BIOPHYS, V249, P515, DOI 10.1016/0003-9861(86)90029-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, X PLOR SYSTEM CRYSTA; CAPDEVILA JH, 1992, FASEB J, V6, P731, DOI 10.1096/fasebj.6.2.1537463; CHANCE B, 1980, FEBS LETT, V112, P178, DOI 10.1016/0014-5793(80)80174-8; Contzen J, 1999, BIOCHEMISTRY-US, V38, P16253, DOI 10.1021/bi991759u; DAVYDOV R, 1991, FEBS LETT, V295, P113, DOI 10.1016/0014-5793(91)81398-R; DAWSON JH, 1986, J AM CHEM SOC, V108, P8114, DOI 10.1021/ja00285a052; de Montellano PR Ortiz, 1995, CYTOCHROME P450 STRU; DEWITT JG, 1991, J AM CHEM SOC, V113, P9219, DOI 10.1021/ja00024a031; EDWARDS SL, 1987, BIOCHEMISTRY-US, V26, P1503, DOI 10.1021/bi00380a002; Eriksson M, 1998, BIOCHEMISTRY-US, V37, P13359, DOI 10.1021/bi981380s; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FULOP V, 1994, STRUCTURE, V2, P201, DOI 10.1016/S0969-2126(00)00021-6; GERBER NC, 1994, J BIOL CHEM, V269, P4260; GERBER NC, 1992, J AM CHEM SOC, V114, P8742, DOI 10.1021/ja00048a081; Gouet P, 1996, NAT STRUCT BIOL, V3, P951, DOI 10.1038/nsb1196-951; Groves John T., 1995, P3; GROVES JT, 1984, J AM CHEM SOC, V106, P2177, DOI 10.1021/ja00319a044; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; HAJDU J, 1993, ANNU REV BIOPH BIOM, V22, P467, DOI 10.1146/annurev.bb.22.060193.002343; Harris D, 1998, J AM CHEM SOC, V120, P4308, DOI 10.1021/ja974110q; Harris DL, 1996, J AM CHEM SOC, V118, P6377, DOI 10.1021/ja954101m; HEDEGAARD J, 1965, J BIOL CHEM, V240, P4038; Honeychurch MJ, 1999, FEBS LETT, V451, P351, DOI 10.1016/S0014-5793(99)00610-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KIMATA Y, 1995, BIOCHEM BIOPH RES CO, V208, P96, DOI 10.1006/bbrc.1995.1310; KOBAYASHI K, 1990, BIOCHIM BIOPHYS ACTA, V1037, P297, DOI 10.1016/0167-4838(90)90028-E; KUBOTA M, 1991, J BIOCHEM-TOKYO, V110, P232, DOI 10.1093/oxfordjournals.jbchem.a123562; LI HY, 1995, J AM CHEM SOC, V117, P6297, DOI 10.1021/ja00128a019; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; LIPSCOMB JD, 1976, J BIOL CHEM, V251, P1116; LOIDA PJ, 1993, BIOCHEMISTRY-US, V32, P11530, DOI 10.1021/bi00094a009; MARTINIS SA, 1989, J AM CHEM SOC, V111, P9252, DOI 10.1021/ja00208a031; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MILLER VP, 1992, J BIOL CHEM, V267, P8936; Mueller Ernest J., 1995, P83; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEWCOMB M, IN PRESS J AM CHEM S; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4342, DOI 10.1021/bi00013a024; PETSKO GA, 1992, PHILOS T ROY SOC A, V340, P323, DOI 10.1098/rsta.1992.0070; PORTER TD, 1991, J BIOL CHEM, V266, P13469; POULOS TL, 1982, J BIOL CHEM, V257, P427; POULOS TL, 1992, FASEB J, V6, P674, DOI 10.1096/fasebj.6.2.1537455; POULOS TL, 1985, J BIOL CHEM, V260, P6122; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; RAAG R, 1989, BIOCHEMISTRY-US, V28, P7586, DOI 10.1021/bi00445a013; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; RINGE D, 1992, PHILOS T R SOC A, V340, P273, DOI 10.1098/rsta.1992.0066; Schlichting I, 1997, METHOD ENZYMOL, V277, P467, DOI 10.1016/S0076-6879(97)77026-5; SCHLICHTING I, UNPUB; SHARROCK M, 1976, BIOCHIM BIOPHYS ACTA, V420, P8, DOI 10.1016/0005-2795(76)90340-8; SHIMADA H, 1994, CYTOCHROME P450, P299; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; SLIGAR SG, 1974, BIOCHEM BIOPH RES CO, V61, P290, DOI 10.1016/0006-291X(74)90565-8; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stoddard BL, 1996, PHARMACOL THERAPEUT, V70, P215, DOI 10.1016/0163-7258(96)00058-7; TYSON CA, 1972, J BIOL CHEM, V247, P5777; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f; WATANABE R, 1995, INT J RADIAT BIOL, V68, P113, DOI 10.1080/09553009514551011; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531	66	1123	1137	7	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2000	287	5458					1615	1622		10.1126/science.287.5458.1615	http://dx.doi.org/10.1126/science.287.5458.1615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698731				2022-12-28	WOS:000085628200028
J	Gilden, DH; Kleinschmidt-DeMasters, BK; LaGuardia, JJ; Mahalingam, R; Cohrs, RJ				Gilden, DH; Kleinschmidt-DeMasters, BK; LaGuardia, JJ; Mahalingam, R; Cohrs, RJ			Neurologic complications of the reactivation of varicella-zoster virus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN TRIGEMINAL GANGLIA; POST-HERPETIC NEURALGIA; SO-BENIGN VIRUS; POSTHERPETIC NEURALGIA; SINE HERPETE; CONTRALATERAL HEMIPLEGIA; CHANGING CONCEPTS; THORACIC GANGLIA; FATAL VARICELLA; NATURAL-HISTORY		Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gilden, DH (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Neurol, Mailstop B182,4200 E 9th Ave, Denver, CO 80262 USA.	don.gilden@uchsc.edu	Hug, Balthasar L./G-1568-2010		NIA NIH HHS [AG06127] Funding Source: Medline; NINDS NIH HHS [NS07321, NS32623] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS032623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG006127, R01AG006127] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aitken RS, 1933, LANCET, V1, P19; AMLIELEFOND C, 1995, ANN NEUROL, V37, P784, DOI 10.1002/ana.410370612; AmlieLefond C, 1996, J NEUROVIROL, V2, P136, DOI 10.3109/13550289609146547; ARNOLD DG, 1941, J INT COLL SURG, V4, P66; BOWSHER D, 1994, DRUG AGING, V5, P411, DOI 10.2165/00002512-199405060-00003; BROWN GR, 1976, SOUTHERN MED J, V69, P576, DOI 10.1097/00007611-197605000-00028; CARROLL WM, 1979, NEUROLOGY, V29, P726, DOI 10.1212/WNL.29.5.726; CLARKE P, 1995, J VIROL, V69, P8151, DOI 10.1128/JVI.69.12.8151-8154.1995; Cohrs RJ, 1996, J VIROL, V70, P2789, DOI 10.1128/JVI.70.5.2789-2796.1996; CRABTREE JA, 1968, LARYNGOSCOPE, V78, P1853, DOI 10.1288/00005537-196811000-00003; CROEN KD, 1988, P NATL ACAD SCI USA, V85, P9773, DOI 10.1073/pnas.85.24.9773; DEMORAGAS JM, 1957, ARCH DERMATOL, V75, P193, DOI 10.1001/archderm.1957.01550140037006; Denny-Brown D., 1944, ARCH NEUROL AND PSYCHIAT, V51, P216; deSilva SM, 1996, NEUROLOGY, V47, P929, DOI 10.1212/WNL.47.4.929; DEVINSKY O, 1991, BRAIN, V114, P1181, DOI 10.1093/brain/114.3.1181; DUELAND AN, 1991, ANN NEUROL, V29, P569, DOI 10.1002/ana.410290520; DUELAND AN, 1995, ARCH VIROL, V140, P2055, DOI 10.1007/BF01322692; EAGLSTEIN WH, 1970, J AMER MED ASSOC, V211, P1681, DOI 10.1001/jama.211.10.1681; EASTON HG, 1970, LANCET, V2, P1065; EFSTATHIOU S, 1986, J VIROL, V57, P446, DOI 10.1128/JVI.57.2.446-455.1986; EIDE PK, 1995, PAIN, V61, P221, DOI 10.1016/0304-3959(94)00182-E; ELBLE RJ, 1983, ANN NEUROL, V14, P591, DOI 10.1002/ana.410140518; ESMANN V, 1987, LANCET, V2, P126; FUKUMOTO S, 1986, STROKE, V17, P1024, DOI 10.1161/01.STR.17.5.1024; GALBRAITH AW, 1983, BRIT J CLIN PRACT, V37, P304; GARTY BZ, 1985, J PEDIATR-US, V106, P71, DOI 10.1016/S0022-3476(85)80469-8; GELB LD, 1987, J INFECT DIS, V155, P633, DOI 10.1093/infdis/155.4.633; GENY C, 1991, NEUROLOGY, V41, P1846, DOI 10.1212/WNL.41.11.1846; Gilden DH, 1996, NEUROLOGY, V47, P1441, DOI 10.1212/WNL.47.6.1441; GILDEN DH, 1994, NEUROLOGY, V44, P1818, DOI 10.1212/WNL.44.10.1818; GILDEN DH, 1983, NATURE, V306, P478, DOI 10.1038/306478a0; GILDEN DH, 1991, NEUROLOGY, V41, P1215, DOI 10.1212/WNL.41.8.1215; GILDEN DH, 1994, ANN NEUROL, V35, P530, DOI 10.1002/ana.410350505; GILDEN DH, 1987, ANN NEUROL, V22, P377, DOI 10.1002/ana.410220315; Gilden DH, 1998, J NEUROL SCI, V159, P140, DOI 10.1016/S0022-510X(98)00153-1; GILDEN DH, 1988, VIRUS GENES, V2, P299; GUESS HA, 1985, PEDIATRICS, V76, P512; HALL S, 1983, ANN NEUROL, V13, P217, DOI 10.1002/ana.410130226; HART MN, 1975, J NEUROL NEUROSUR PS, V38, P585, DOI 10.1136/jnnp.38.6.585; HILT DC, 1983, ANN NEUROL, V14, P543, DOI 10.1002/ana.410140509; HOGAN EL, 1973, ARCH NEUROL-CHICAGO, V29, P309, DOI 10.1001/archneur.1973.00490290049004; Hope-Simpson R E, 1975, J R Coll Gen Pract, V25, P571; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; HORTEN B, 1981, ANN NEUROL, V9, P251, DOI 10.1002/ana.410090308; HYMAN RW, 1983, LANCET, V2, P814; KECZKES K, 1980, BRIT J DERMATOL, V102, P551, DOI 10.1111/j.1365-2133.1980.tb07654.x; Kennedy PGE, 1998, P NATL ACAD SCI USA, V95, P4658, DOI 10.1073/pnas.95.8.4658; KERNBAUM S, 1981, JAMA-J AM MED ASSOC, V246, P132; KING RB, 1993, ARCH NEUROL-CHICAGO, V50, P1046, DOI 10.1001/archneur.1993.00540100041012; Kleinschmidt-DeMasters BK, 1998, J NEUROL SCI, V159, P213, DOI 10.1016/S0022-510X(98)00171-3; KleinschmidtDeMasters BK, 1996, HUM PATHOL, V27, P927, DOI 10.1016/S0046-8177(96)90220-8; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; KUROIWA Y, 1981, NEUROLOGY, V31, P1030, DOI 10.1212/WNL.31.8.1030; LaGuardia JJ, 1999, J VIROL, V73, P8571, DOI 10.1128/JVI.73.10.8571-8577.1999; LAPRESLE J, 1986, BRAIN, V109, P207, DOI 10.1093/brain/109.1.207; Levin MJ, 1998, J INFECT DIS, V178, pS109, DOI 10.1086/514264; LEWIS GW, 1958, BMJ-BRIT MED J, V2, P418, DOI 10.1136/bmj.2.5093.418; Lungu O, 1998, P NATL ACAD SCI USA, V95, P7080, DOI 10.1073/pnas.95.12.7080; LUNGU O, 1995, P NATL ACAD SCI USA, V92, P10980, DOI 10.1073/pnas.92.24.10980; MAHALINGAM R, 1993, J VIROL, V67, P2381, DOI 10.1128/JVI.67.4.2381-2384.1993; MAHALINGAM R, 1995, J NEUROVIROL, V1, P130, DOI 10.3109/13550289509111018; MAHALINGAM R, 1990, NEW ENGL J MED, V323, P627, DOI 10.1056/NEJM199009063231002; Mahalingam R, 1996, P NATL ACAD SCI USA, V93, P2122, DOI 10.1073/pnas.93.5.2122; MANZ HJ, 1986, SOUTHERN MED J, V79, P1026, DOI 10.1097/00007611-198608000-00028; MAYBERG MR, 1984, J COMP NEUROL, V223, P46, DOI 10.1002/cne.902230105; MAYO DR, 1989, ARCH NEUROL-CHICAGO, V46, P313, DOI 10.1001/archneur.1989.00520390079020; MCCORMICK WF, 1969, ARCH NEUROL-CHICAGO, V21, P559, DOI 10.1001/archneur.1969.00480180015001; MCKENDRICK MW, 1989, BRIT MED J, V298, P431, DOI 10.1136/bmj.298.6671.431; MEIER JL, 1993, J VIROL, V67, P7573, DOI 10.1128/JVI.67.12.7573-7581.1993; Melanson M, 1996, NEUROLOGY, V47, P569, DOI 10.1212/WNL.47.2.569; MELLERICK DM, 1987, VIROLOGY, V158, P265, DOI 10.1016/0042-6822(87)90198-X; MERIGAN TC, 1978, NEW ENGL J MED, V298, P981, DOI 10.1056/NEJM197805042981801; MORGELLO S, 1988, ARCH PATHOL LAB MED, V112, P173; Nau R, 1998, NEUROLOGY, V51, P914, DOI 10.1212/WNL.51.3.914; Osaki Y, 1995, NEUROLOGY, V45, P2293; PLOTKIN SA, 1977, ANN NEUROL, V2, P249, DOI 10.1002/ana.410020313; PORTENOY RK, 1986, ANN NEUROL, V20, P651, DOI 10.1002/ana.410200602; RAWLINSON WD, 1991, MED J AUSTRALIA, V155, P344, DOI 10.5694/j.1326-5377.1991.tb142297.x; REIMER LG, 1981, ARCH NEUROL-CHICAGO, V38, P668, DOI 10.1001/archneur.1981.00510100096020; ROGERS RS, 1971, J AM GERIATR SOC, V19, P495, DOI 10.1111/j.1532-5415.1971.tb01208.x; ROSS MH, 1991, NEUROLOGY, V41, P1685, DOI 10.1212/WNL.41.10.1685; RYDER JW, 1986, ANN NEUROL, V19, P182, DOI 10.1002/ana.410190212; Segal AZ, 1996, NEUROLOGY, V46, P1175, DOI 10.1212/WNL.46.4.1175; SHOPE TC, 1982, YALE J BIOL MED, V55, P321; SKLAR SH, 1985, JAMA-J AM MED ASSOC, V253, P1427, DOI 10.1001/jama.253.10.1427; SMITH FP, 1978, SURG NEUROL, V10, P50; STEFFEN R, 1972, MED J AUSTRALIA, V1, P227, DOI 10.5694/j.1326-5377.1972.tb46771.x; STOWASSER M, 1990, MED J AUSTRALIA, V153, P555, DOI 10.5694/j.1326-5377.1990.tb126199.x; TAKASHIMA S, 1979, ARCH PATHOL LAB MED, V103, P209; TAKO J, 1965, ARCH NEUROL-CHICAGO, V12, P610, DOI 10.1001/archneur.1965.00460300058007; THOMAS JE, 1972, NEUROLOGY, V22, P459, DOI 10.1212/WNL.22.5.459; TYRING S, 1993, 33RD INT C ANT AG CH, P400; VAFAI A, 1988, GERONTOLOGY, V34, P242, DOI 10.1159/000212962; VARTDAL F, 1982, J NEUROL SCI, V57, P121, DOI 10.1016/0022-510X(82)90116-2; WATSON CPN, 1991, PAIN, V44, P105, DOI 10.1016/0304-3959(91)90124-G; WATSON CPN, 1993, PAIN RES CLIN MANAGE, V8; WELLER TH, 1983, NEW ENGL J MED, V309, P1362, DOI 10.1056/NEJM198312013092205; WOLF SM, 1974, ARCH NEUROL-CHICAGO, V30, P109, DOI 10.1001/archneur.1974.00490310111020; WOOD MJ, 1994, NEW ENGL J MED, V330, P896, DOI 10.1056/NEJM199403313301304	99	510	543	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					635	645		10.1056/NEJM200003023420906	http://dx.doi.org/10.1056/NEJM200003023420906			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10699164				2022-12-28	WOS:000085575500006
J	Hariharan, S; Johnson, CP; Bresnahan, BA; Taranto, SE; McIntosh, MJ; Stablein, D				Hariharan, S; Johnson, CP; Bresnahan, BA; Taranto, SE; McIntosh, MJ; Stablein, D			Improved graft survival after renal transplantation in the United States, 1988 to 1996.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the American-Society-of-Transplantation	MAY 15-19, 1999	CHICAGO, ILLINOIS	Amer Soc Transplantat			ALLOGRAFT SURVIVAL; ACUTE REJECTION; CYCLOSPORINE ERA; RISK-FACTORS; RECIPIENTS; PREDICTORS; IMPACT; RACE	Background: The introduction of cyclosporine has resulted in improvement in the short-term outcome of renal transplantation, but its effect on the long-term survival of kidney transplants is not known. Methods: We analyzed the influence of demographic characteristics (age, sex, and race), transplant-related variables (living or cadaveric donor, panel-reactive antibody titer, extent of HLA matching, and cold-ischemia time), and post-transplantation variables (presence or absence of acute rejection, delayed graft function, and therapy with mycophenolate mofetil and tacrolimus) on graft survival for all 93,934 renal transplantations performed in the United States between 1988 and 1996. A regression analysis adjusted for these variables was used to estimate the risk of graft failure within the first year and more than one year after transplantation. Results: From 1988 to 1996, the one-year survival rate for grafts from living donors increased from 88.8 to 93.9 percent, and the rate for cadaveric grafts increased from 75.7 to 87.7 percent. The half-life for grafts from living donors increased steadily from 12.7 to 21.6 years, and that for cadaveric grafts increased from 7.9 to 13.8 years. After censoring of data for patients who died with functioning grafts, the half-life for grafts from living donors increased from 16.9 years to 35.9 years, and that for cadaveric grafts increased from 11.0 years to 19.5 years. The average yearly reduction in the relative hazard of graft failure after one year was 4.2 percent for all recipients (P<0.001), 0.4 percent for those who had acute rejection (P=0.57), and 6.3 percent for those who did not have acute rejection (P<0.001). Conclusions: Since 1988, there has been a substantial increase in short-term and long-term survival of kidney grafts from both living and cadaveric donors. (N Engl J Med 2000;342:605-12.) (C)2000, Massachusetts Medical Society.	Med Coll Wisconsin, Div Nephrol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Div Transplant Surg, Milwaukee, WI 53226 USA; United Network Organ Sharing, Richmond, VA USA; EMMES Corp, Potomac, MD USA	Medical College of Wisconsin; Medical College of Wisconsin; United Network for Organ Sharing; Emmes Corporation	Hariharan, S (corresponding author), Med Coll Wisconsin, Div Nephrol, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.				NIAID NIH HHS [N01-AI-25132] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025132] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER JW, 1994, TRANSPLANTATION, V57, P871, DOI 10.1097/00007890-199403270-00018; ALMOND PS, 1993, TRANSPLANTATION, V55, P752, DOI 10.1097/00007890-199304000-00013; BURKE JF, 1994, NEW ENGL J MED, V331, P358, DOI 10.1056/NEJM199408113310604; Cho S, 1999, AM J KIDNEY DIS, V34, P296; COLE E, 1995, CLIN TRANSPLANT, V9, P282; Cosio FG, 1997, TRANSPLANTATION, V63, P1611, DOI 10.1097/00007890-199706150-00013; GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337; Hariharan S, 1996, CLIN TRANSPLANT, V10, P186; Hariharan S, 1997, TRANSPLANTATION, V64, P1748, DOI 10.1097/00007890-199712270-00022; HARIHARAN S, 1993, CLIN TRANSPLANT, V7, P235; Hariharan S, 1996, CLIN TRANSPLANT, V10, P538; HUME DM, 1955, J CLIN INVEST, V34, P327, DOI 10.1172/JCI103085; Jindal RM, 1999, NEPHRON, V83, P13, DOI 10.1159/000045468; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KASISKE BL, 1991, NEW ENGL J MED, V324, P302, DOI 10.1056/NEJM199101313240505; KERMAN RH, 1991, TRANSPLANTATION, V51, P338, DOI 10.1097/00007890-199102000-00013; MERION RM, 1984, NEW ENGL J MED, V310, P148, DOI 10.1056/NEJM198401193100303; MORRIS PJ, 1994, BRIT J SURG, V81, P635, DOI 10.1002/bjs.1800810503; PAUL LC, 1995, KIDNEY INT, V47, P1491, DOI 10.1038/ki.1995.211; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Rush D, 1998, J AM SOC NEPHROL, V9, P2129; RUSH DN, 1995, TRANSPLANTATION, V59, P511; SCHROEDER TJ, 1995, TRANSPLANT P, V27, P837; SOLLINGER HW, 1995, TRANSPLANTATION, V60, P225, DOI 10.1097/00007890-199508000-00003; SUMRANI N, 1993, TRANSPLANT P, V25, P2259; Tejani A, 1996, J AM SOC NEPHROL, V7, P550; Tejani A, 1996, TRANSPLANTATION, V61, P1054, DOI 10.1097/00007890-199604150-00011; TESI RJ, 1993, CLIN TRANSPLANT, V7, P345; THIEL G, 1994, TRANSPLANT P, V26, P2493; *USRDS, 1998, NIH PUBL, P39; Valente JF, 1997, CLIN TRANSPLANT, V11, P231	31	1496	1579	0	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					605	612		10.1056/NEJM200003023420901	http://dx.doi.org/10.1056/NEJM200003023420901			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10699159	Bronze			2022-12-28	WOS:000085575500001
J	Simini, B				Simini, B			Awareness of awareness during general anaesthesia	LANCET			English	Editorial Material							ANESTHESIA; RECALL		Ospedale, I-55100 Lucca, Italy		Simini, B (corresponding author), Ospedale, I-55100 Lucca, Italy.							Aitkenhead AR, 1996, CAN J ANAESTH, V43, P206, DOI 10.1007/BF03011735; Bailey AR, 1997, ANAESTHESIA, V52, P460, DOI 10.1111/j.1365-2044.1997.133-az0134.x; BRIGHOUSE D, 1992, BRIT MED J, V304, P1327, DOI 10.1136/bmj.304.6838.1327; LEVINSON BW, 1965, BRIT J ANAESTH, V37, P544, DOI 10.1093/bja/37.7.544; LIU WHD, 1991, ANAESTHESIA, V46, P435, DOI 10.1111/j.1365-2044.1991.tb11677.x; Peduto V A, 1994, Minerva Anestesiol, V60, P1; Ranta SOV, 1998, ANESTH ANALG, V86, P1084, DOI 10.1097/00000539-199805000-00035; REYNOLDS F, 1986, ANAESTHESIA, V41, P652, DOI 10.1111/j.1365-2044.1986.tb13069.x; SANDIN R, 1993, BRIT J ANAESTH, V71, P782, DOI 10.1093/bja/71.6.782; Schwender D, 1998, BRIT J ANAESTH, V80, P133, DOI 10.1093/bja/80.2.133; 1986, LANCET, V2, P1019; 1973, LANCET, V2, P1305	12	4	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					672	674		10.1016/S0140-6736(00)00080-5	http://dx.doi.org/10.1016/S0140-6736(00)00080-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703797				2022-12-28	WOS:000085615600006
J	Tunstall-Pedoe, H; Vanuzzo, D; Hobbs, M; Mahonen, M; Cepaitis, Z; Kuulasmaa, K; Keil, U				Tunstall-Pedoe, H; Vanuzzo, D; Hobbs, M; Mahonen, M; Cepaitis, Z; Kuulasmaa, K; Keil, U		WHO MONICA Project	Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CLINICAL-TRIALS; UNSTABLE ANGINA; CASE-FATALITY; REINFARCTION; MANAGEMENT; GUIDELINES; PREVENTION; DECLINE; FAILURE	Background The revolution in coronary care in the mid-1980s to mid-1990s corresponded with monitoring of coronary heart disease (CHD) in 31 populations of the WHO MONICA Project. We studied the impact of this revolution on coronary endpoints. Methods Case fatality, coronary-event rates, and CHD mortality were monitored in men and women aged 35-64 years in two separate 3-4-year periods. In each period, we recorded percentage use of eight treatments: coronary-artery reperfusion before, thrombolytics during, and beta-blockers, antiplatelet drugs, and angiotensin-converting-enzyme (ACE) inhibitors before and during non-fatal myocardial infarction. Values were averaged to produce treatment scores. We correlated changes across populations, and regressed changes in coronary endpoints on changes in treatment scores. Findings Treatment changes correlated positively with each other but inversely with change in coronary endpoints. By regression, for the common average treatment change of 20, case fatality fell by 19% (95% CI 12-26) in men and 16% (5-27) in women; coronary-event rates fell by 25% (16-35) and 23% (7-39); and CHD mortality rates fell by 42% (31-53) and 34% (17-50). The regression model explained an estimated 61% and 41% of variance for men and women in trends for case fatality, 52% and 30% for coronary-event rates, and 72% and 56% for CHD mortality. Interpretation Changes in coronary care and secondary prevention were strongly linked with declining coronary endpoints. Scores and benefits followed a geographical east-to-west gradient. The apparent effects of the treatment might be exaggerated by other changes in economically successful populations, so their specificity needs further assessment.	Univ Dundee, Ninewells Hosp & Med Sch, Cardiovasc Epidemiol Unit, MONICA Qual Control Ctr Event Registrat, Dundee DD1 9SY, Scotland; Ctr Malattie Cardiovasc, ASS4 Medio Friuli, Udine, Italy; Univ Western Australia, Dept Publ Hlth, Perth, WA 6009, Australia; Natl Publ Hlth Inst, KTL, MONICA Data Ctr, Dept Epidemiol & Hlth Promot, Helsinki, Finland; Univ Munster, Dept Epidemiol & Social Med, D-4400 Munster, Germany	University of Dundee; University of Western Australia; Finland National Institute for Health & Welfare; University of Munster	Tunstall-Pedoe, H (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Cardiovasc Epidemiol Unit, MONICA Qual Control Ctr Event Registrat, Dundee DD1 9SY, Scotland.	h.tunstallpedoe@dundee.ac.uk	Zikic, Milorad/Q-6630-2019	Paluzie, Guillermo/0000-0002-5808-6041; Kuulasmaa, Kari/0000-0003-2165-1411				[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; [Anonymous], 1986, LANCET, V2, P57; *ANT TRIAL COLL, 1988, BMJ-BRIT MED J, V196, P320; BEAGLEHOLE R, 1986, BMJ-BRIT MED J, V292, P33, DOI 10.1136/bmj.292.6512.33; Bots M L, 1996, J Cardiovasc Risk, V3, P271, DOI 10.1097/00043798-199606000-00002; Chambless L, 1997, CIRCULATION, V96, P3849; COLLINS R, 1995, LANCET, V345, P669; DEVITA C, 1994, LANCET, V343, P1115; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; FRYE RL, 1982, CIRCULATION, V65, P111; Fuller W.A., 2009, MEASUREMENT ERROR MO; FURBERG CD, 1985, AM J CARDIOL, V55, P1110, DOI 10.1016/0002-9149(85)90756-8; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; GUNNAR RM, 1990, J AM COLL CARDIOL, V16, P249, DOI 10.1016/0735-1097(90)90575-A; HELD PH, 1989, BMJ-BRIT MED J, V299, P1187, DOI 10.1136/bmj.299.6709.1187; HJALMARSON A, 1981, LANCET, V2, P823; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; KUULASMAA K, 1997, B INT STAT I, P295; MICHELS KB, 1995, CIRCULATION, V91, P476, DOI 10.1161/01.CIR.91.2.476; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; NORRIS RM, 1969, LANCET, V1, P274; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; PEDERSEN TR, 1994, LANCET, V344, P1383; PEEL AAF, 1962, BRIT HEART J, V24, P745; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; RYAN TJ, 1988, CIRCULATION, V78, P486, DOI 10.1161/01.CIR.78.2.486; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TUNSTALL-PEDOE H, 1988, Journal of Clinical Epidemiology, V41, P105; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; YUSUF S, 1985, EUR HEART J, V6, P556, DOI 10.1093/oxfordjournals.eurheartj.a061905; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2259, DOI 10.1001/jama.260.15.2259	39	346	360	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2000	355	9205					688	700		10.1016/S0140-6736(99)11181-4	http://dx.doi.org/10.1016/S0140-6736(99)11181-4			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703800				2022-12-28	WOS:000085615600010
J	Mitka, M				Mitka, M			Whose news is it, anyway?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					992	992		10.1001/jama.283.8.992	http://dx.doi.org/10.1001/jama.283.8.992			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284AM	10697047				2022-12-28	WOS:000085308600004
J	Antson, AA; Burns, JE; Moroz, OV; Scott, DJ; Sanders, CM; Bronstein, IB; Dodson, GG; Wilson, KS; Maitland, NJ				Antson, AA; Burns, JE; Moroz, OV; Scott, DJ; Sanders, CM; Bronstein, IB; Dodson, GG; Wilson, KS; Maitland, NJ			Structure of the intact transactivation domain of the human papillomavirus E2 protein	NATURE			English	Article							DNA-BINDING DOMAIN; FUNCTIONAL INTERACTION; AMINO-ACIDS; REPLICATION; ACTIVATION; DIMERS	Papillomaviruses cause warts and proliferative lesions in skin and other epithelia. In a minority of papillomavirus types ('high risk'. including human papillomaviruses 16, 18, 31, 33, 45 and 56), further transformation of the wart lesions can produce tumours'. The papillomavirus E2 protein controls primary transcription and replication of the viral genome(2). Both activities are governed by a similar to 200 amino-acid amino-terminal module (E2NT) which is connected to a DNA-binding carboxy-terminal module by a flexible linker. Here we describe the crystal structure of the complete E2NT module from human papillomavirus 16. The E2NT module forms a dimer both in the crystal and in solution. Amino acids that are necessary for transactivation are located at the dimer interface, indicating that the dimer structure may be important in the interactions of E2NT with viral and cellular transcription factors. We propose that dimer formation may contribute to the stabilization of DNA loops(3) which may serve to relocate distal DNA-binding transcription factors to the site of human papillomavirus transcription initiation.	Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; Univ York, Dept Biol, YCR Canc Res Unit, York YO10 5DD, N Yorkshire, England; Natl Inst Med Res, London NW7 1AA, England	University of York - UK; University of York - UK; MRC National Institute for Medical Research	Wilson, KS (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.		Antson, Alfred/N-2551-2016	Antson, Alfred/0000-0002-4533-3816; Moroz, Olga/0000-0002-0354-6119; Wilson, Keith/0000-0002-3581-2194; Maitland, Norman/0000-0003-1607-9035; Scott, David/0000-0002-6726-2078; Burns, Julie/0000-0003-1238-8826				Abroi A, 1996, J VIROL, V70, P6169, DOI 10.1128/JVI.70.9.6169-6179.1996; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Breiding DE, 1997, MOL CELL BIOL, V17, P7208, DOI 10.1128/MCB.17.12.7208; Brokaw JL, 1996, J VIROL, V70, P23, DOI 10.1128/JVI.70.1.23-29.1996; Burns JE, 1998, ACTA CRYSTALLOGR D, V54, P1471, DOI 10.1107/S0907444998010889; Chao SF, 1999, BIOCHEMISTRY-US, V38, P4586, DOI 10.1021/bi982616v; COLLETTI V, 1994, SKULL BASE SURG, V4, P1, DOI 10.1055/s-2008-1058981; Cooper CS, 1998, VIROLOGY, V241, P312, DOI 10.1006/viro.1997.8941; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Desaintes C, 1996, SEMIN CANCER BIOL, V7, P339, DOI 10.1006/scbi.1996.0043; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Foguel D, 1998, J BIOL CHEM, V273, P9050, DOI 10.1074/jbc.273.15.9050; GAUTHIER JM, 1991, NEW BIOL, V3, P498; Harris SF, 1999, SCIENCE, V284, P1673, DOI 10.1126/science.284.5420.1673; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; KNIGHT JD, 1991, P NATL ACAD SCI USA, V88, P3204, DOI 10.1073/pnas.88.8.3204; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; MCBRIDE AA, 1997, HUMAN PAPILLOMAVIRUS, P54; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MOHR IJ, 1990, SCIENCE, V250, P1694, DOI 10.1126/science.2176744; Mok YK, 1996, PROTEIN SCI, V5, P310; OLDFIELD TJ, 1994, P CCP4 STUD WEEK 1 M, P15; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sengchanthalangsy LL, 1999, J MOL BIOL, V289, P1029, DOI 10.1006/jmbi.1999.2823; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Yao JM, 1998, J VIROL, V72, P1013, DOI 10.1128/JVI.72.2.1013-1019.1998; zur Hausen H, 1994, Curr Top Microbiol Immunol, V186, P131	29	88	93	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					805	809		10.1038/35001638	http://dx.doi.org/10.1038/35001638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693813				2022-12-28	WOS:000085423100060
J	Brazma, A; Robinson, A; Cameron, G; Ashburner, M				Brazma, A; Robinson, A; Cameron, G; Ashburner, M			One-stop shop for microarray data - Is a universal, public DNA-microarray database a realistic goal?	NATURE			English	Editorial Material									European Bioinformat Inst, Wellcome Trust Genome, Cambridge CB10 1SD, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Brazma, A (corresponding author), European Bioinformat Inst, Wellcome Trust Genome, Campus, Cambridge CB10 1SD, England.	brazma@ebi.ac.uk		Brazma, Alvis/0000-0001-5988-7409				*CHIPP FOR, 1999, NATURE GENET S, V21; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Kaiser J, 1999, SCIENCE, V284, P410; Pennisi E, 1999, SCIENCE, V286, P449, DOI 10.1126/science.286.5439.449; 1999, NATURE GENET, V22, P211	5	101	106	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					699	700		10.1038/35001676	http://dx.doi.org/10.1038/35001676			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693778				2022-12-28	WOS:000085423100020
J	Kitov, PI; Sadowska, JM; Mulvey, G; Armstrong, GD; Ling, H; Pannu, NS; Read, RJ; Bundle, DR				Kitov, PI; Sadowska, JM; Mulvey, G; Armstrong, GD; Ling, H; Pannu, NS; Read, RJ; Bundle, DR			Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands	NATURE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI; RECEPTOR; BINDING; IDENTIFICATION; PATHOGENESIS; GLYCOSIDES; TYPE-1; MICE	The diseases caused by Shiga and cholera toxins account for the loss of millions of lives each year(1). Both belong to the clinically significant subset of bacterial AB(5) toxins consisting of an enzymatically active A subunit that gains entry to susceptible mammalian cells after oligosaccharide recognition by the B-5 homopentamer(2,3), Therapies might target the obligatory oligosaccharide-toxin recognition event(4), but the low intrinsic affinity of carbohydrate-protein interactions hampers the development of low-molecular-weight inhibitors(5). The toxins circumvent low affinity by binding simultaneously to five or more cell-surface carbohydrates(6), Here we demonstrate the use of the crystal structure of the B-5 subunit Of Escherichia coli O157:H7 Shiga-like toxin I (SLT-I) in complex with an analogue of its carbohydrate receptor(6) to design an oligovalent, water-soluble carbohydrate ligand (named STARFISH), with subnanomolar inhibitory activity. The in vitro inhibitory activity is 1-10-million-fold higher than that of univalent ligands and is by far the highest molar activity of any inhibitor yet reported for Shiga-like toxins I and II. Crystallography of the STARFISH/Shiga-like toxin I complex explains this activity. Two trisaccharide receptors at the tips of each of five spacer arms simultaneously engage all five B subunits of two toxin molecules.	Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England	University of Alberta; University of Alberta; University of Alberta; University of Cambridge	Bundle, DR (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.		Ling, Hong/E-3729-2010; Kitov, Pavel/J-3714-2014; Read, Randy J/L-1418-2013	Read, Randy J/0000-0001-8273-0047				ARMSTRONG GD, 1991, J INFECT DIS, V164, P1160, DOI 10.1093/infdis/164.6.1160; ARONSON M, 1979, J INFECT DIS, V139, P329, DOI 10.1093/infdis/139.3.329; Bast DJ, 1999, MOL MICROBIOL, V32, P953, DOI 10.1046/j.1365-2958.1999.01405.x; BOYD B, 1989, NEPHRON, V51, P207, DOI 10.1159/000185286; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CIMOLAI N, 1990, J PEDIATR-US, V116, P589, DOI 10.1016/S0022-3476(05)81609-9; DEGRANDIS S, 1987, J BACTERIOL, V169, P4313, DOI 10.1128/jb.169.9.4313-4319.1987; Dubber M, 1998, CARBOHYD RES, V310, P35, DOI 10.1016/S0008-6215(98)00155-4; FUCHS G, 1986, INFECT IMMUN, V53, P372, DOI 10.1128/IAI.53.2.372-377.1986; HOLMGREN J, 1992, GASTROENTEROL CLIN N, V21, P283; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Kitov PI, 1998, CARBOHYD RES, V307, P361, DOI 10.1016/S0008-6215(98)00053-6; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MERRITT EA, 1995, CURR OPIN STRUC BIOL, V5, P165, DOI 10.1016/0959-440X(95)80071-9; Mulvey G, 1998, J MICROBIOL METH, V32, P247, DOI 10.1016/S0167-7012(98)00028-1; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nyholm PG, 1996, CHEM BIOL, V3, P263, DOI 10.1016/S1074-5521(96)90106-4; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Read RJ, 1997, METHOD ENZYMOL, V277, P110, DOI 10.1016/S0076-6879(97)77009-5; Shimizu H, 1998, BIOCHEMISTRY-US, V37, P11078, DOI 10.1021/bi980946+; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; STHILAIRE PM, 1994, BIOCHEMISTRY-US, V33, P14452, DOI 10.1021/bi00252a011; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993	30	731	758	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					669	672		10.1038/35001095	http://dx.doi.org/10.1038/35001095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688205				2022-12-28	WOS:000085288200057
J	Donnelly, R; Hinwood, D; London, NJM				Donnelly, R; Hinwood, D; London, NJM			ABC of arterial and venous disease - Non-invasive methods of arterial and venous assessment	BRITISH MEDICAL JOURNAL			English	Review									Univ Nottingham, Nottingham NG7 2RD, England; So Derbyshire Acute Hosp NHS Trust, Derby, England; Univ Leicester, Leicester, Leics, England	University of Nottingham; University of Leicester	Donnelly, R (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.								0	43	43	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					698	701		10.1136/bmj.320.7236.698	http://dx.doi.org/10.1136/bmj.320.7236.698			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710584	Green Published			2022-12-28	WOS:000085895300026
J	Shaw, PJ; Cirelli, C; Greenspan, RJ; Tononi, G				Shaw, PJ; Cirelli, C; Greenspan, RJ; Tononi, G			Correlates of sleep and waking in Drosophila melanogaster	SCIENCE			English	Article							RATS; EXPRESSION; LOCUS; DEPRIVATION; COCKROACH; NEURONS; LESIONS; CYCLE	Drosophila exhibits a circadian rest-activity cycle, but it is not known whether fly rest constitutes sleep or is mere inactivity. it is shown here that, like mammalian sleep, rest in Drosophila is characterized by an increased arousal threshold and is homeostatically regulated independently of the circadian clock. As in mammals, rest is abundant in young flies, is reduced in older flies, and is modulated by stimulants and hypnotics. Several molecular markers modulated by sleep and waking in mammals are modulated by rest and activity in Drosophila, including cytochrome oxidase C, the endoplasmic reticulum chaperone protein BiP, and enzymes implicated in the catabolism of monoamines. Flies Lacking one such enzyme, arylalkylamine N-acetyltransferase, show increased rest after rest deprivation. These results implicate the catabolism of monoamines in the regulation of sleep and waking in the fly and suggest that Drosophila may serve as a model system for the genetic dissection of sleep.	Inst Neurosci, San Diego, CA 92121 USA		Tononi, G (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.							Aronstein K, 1996, INVERTEBR NEUROSCI, V2, P115, DOI 10.1007/BF02214114; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BRIDGES C. B., 1937, Cytologia, P745, DOI 10.1508/cytologia.FujiiJubilaei.745; Brodbeck D, 1998, DNA CELL BIOL, V17, P621, DOI 10.1089/dna.1998.17.621; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Cirelli C, 1998, MOL BRAIN RES, V56, P293, DOI 10.1016/S0169-328X(98)00057-6; CIRELLI C, 1999, SLEEP S, V22, P113; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; Dunkov BC, 1996, MOL GEN GENET, V251, P290, DOI 10.1007/s004380050169; EDGAR DM, 1993, J NEUROSCI, V13, P1065; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; Hartmann E.L., 1973, FUNCTIONS SLEEP; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; KAISER W, 1983, NATURE, V301, P707, DOI 10.1038/301707a0; KAISER W, 1988, J COMP PHYSIOL A, V163, P565, DOI 10.1007/BF00603841; KUHL D, 1992, J CELL BIOL, V119, P1069, DOI 10.1083/jcb.119.5.1069; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; MISTLBERGER RE, 1983, SLEEP, V6, P217, DOI 10.1093/sleep/6.3.217; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; RUBIN DM, 1993, GENE, V128, P155, DOI 10.1016/0378-1119(93)90558-K; SIEGEL JM, 1988, BRAIN RES REV, V13, P213, DOI 10.1016/0165-0173(88)90007-0; Stone W S, 1989, Clin Geriatr Med, V5, P363; TOBLER I, 1992, J SLEEP RES, V1, P231, DOI 10.1111/j.1365-2869.1992.tb00044.x; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; TOBLER I, 1988, J COMP PHYSIOL A, V163, P227, DOI 10.1007/BF00612431; TOBLER I, 1983, BEHAV BRAIN RES, V8, P351, DOI 10.1016/0166-4328(83)90180-8; YANIK G, 1987, BRAIN RES, V403, P177, DOI 10.1016/0006-8993(87)90141-7; Yehuda S, 1998, PEPTIDES, V19, P407, DOI 10.1016/S0196-9781(97)00295-7; ZEPELIN H, 1974, BRAIN BEHAV EVOLUT, V10, P425, DOI 10.1159/000124330	29	811	833	7	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1834	1837		10.1126/science.287.5459.1834	http://dx.doi.org/10.1126/science.287.5459.1834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710313				2022-12-28	WOS:000085775300045
J	Kmietowicz, Z				Kmietowicz, Z			Better coronary care reduces deaths from heart disease	BRITISH MEDICAL JOURNAL			English	News Item																		Grover SA, 2000, LANCET, V355, P668, DOI 10.1016/S0140-6736(00)00016-7; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4	3	0	0	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					600	600		10.1136/bmj.320.7235.600	http://dx.doi.org/10.1136/bmj.320.7235.600			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698868	Green Published			2022-12-28	WOS:000085742600012
J	Salisbury, C; Trivella, M; Bruster, S				Salisbury, C; Trivella, M; Bruster, S			Demand for and supply of out of hours care from general practitioners in England and Scotland: observational study based on routinely collected data	BRITISH MEDICAL JOURNAL			English	Article							OUT-OF-HOURS; DEPUTIZING SERVICES; TELEPHONE ADVICE; HOURS WORKLOAD; HOURS CALLS; NIGHT; DEPRIVATION; DENMARK; RATES	Objectives To determine the level of demand and supply of out of hours care from a nationally representative sample of general practice cooperatives. Design Observational study based on routinely collected data on telephone calls, patient population data from general practices, and information about cooperatives from interviews with managers. Setting 20 cooperatives in England and Scotland selected after stratification by region and by size. Subjects 899 657 out of hours telephone calls aver 12 months. Main outcome measures Numbers and age and sex specific rates of calls; variation in demand and activity in relation to characteristics of the population; timing of calls; proportion of patients consulting at home, at a primary care centre, or on the telephone: response times; hospital admission rates. Results The out of hours call rate (excluding bank holidays) was 159 calls per 1000 patients/year, with rates in children aged under 5 years four times higher than for adults. Little variation occurred by day of the week or seasonally. Cooperatives in Scotland experienced higher demand than those in England. Patients living in deprived areas made 70% more calls than those in non-deprived areas, but this had little effect on the overall variation in demand. 45.4% (408 407) of calls were handled by telephone advice. 23.6% (212 550) by a home visit and 29.8% (267 663) at a centre. Cooperatives responded to 60'%, of calls within 30 minutes and to 83% within one hour: Hospital admission followed 5.5% (30 743/554 179) of out of hours calls (8 admissions per 1000 patients/year). Conclusions This project provides national baseline data for the planning of services and the analysis of future changes.	Univ Bristol, Div Primary Hlth Care, Bristol BS8 2PR, Avon, England; Inst Hlth Sci, CRF Med Stat Grp, Oxford OX3 7LF, England; Picker Europe, London W1R 6LP, England	University of Bristol; University of Oxford	Salisbury, C (corresponding author), Univ Bristol, Div Primary Hlth Care, Bristol BS8 2PR, Avon, England.		Salisbury, Chris/C-6724-2008	Salisbury, Chris/0000-0002-4378-3960; Trivella, Marialena/0000-0003-4492-1760				BAIN DJG, 1984, BRIT MED J, V289, P471, DOI 10.1136/bmj.289.6443.471; Bain J, 1997, BRIT J GEN PRACT, V47, P573; BAKER D, 1991, BRIT MED J, V303, P225, DOI 10.1136/bmj.303.6796.225; Beecham L, 1999, BRIT MED J, V318, P1097, DOI 10.1136/bmj.318.7191.1097b; Brogan C, 1998, BRIT MED J, V316, P524, DOI 10.1136/bmj.316.7130.524; Carlisle R, 1998, BRIT MED J, V316, P520, DOI 10.1136/bmj.316.7130.520; CARLISLE RD, 1993, BRIT MED J, V306, P1383, DOI 10.1136/bmj.306.6889.1383; Christensen MB, 1998, BMJ-BRIT MED J, V316, P1502, DOI 10.1136/bmj.316.7143.1502; Cragg DK, 1997, BMJ-BRIT MED J, V314, P187, DOI 10.1136/bmj.314.7075.187; DIXON RA, 1977, BRIT MED J, V1, P560, DOI 10.1136/bmj.1.6060.560; Hansen BL, 1998, BRIT J GEN PRACT, V48, P1497; Heaney D J, 1996, Health Bull (Edinb), V54, P495; JARMAN B, 1983, BRIT MED J, V286, P1705, DOI 10.1136/bmj.286.6379.1705; Jessopp L, 1997, BRIT MED J, V314, P199, DOI 10.1136/bmj.314.7075.199; LIVINGSTONE AE, 1989, BRIT MED J, V299, P368, DOI 10.1136/bmj.299.6695.368; MAJEED FA, 1995, BRIT J GEN PRACT, V45, P531; MARSH GN, 1987, J ROY COLL GEN PRACT, V37, P301; MCCARTHY M, 1990, BRIT J GEN PRACT, V40, P19; Pencheon D, 1998, BRIT MED J, V316, P215; PITTS J, 1990, BRIT MED J, V300, P1113, DOI 10.1136/bmj.300.6732.1113; ROBINSON G, 1993, BRIT MED J, V306, P1068, DOI 10.1136/bmj.306.6884.1068-a; SALISBURY C, 1993, BRIT MED J, V306, P762, DOI 10.1136/bmj.306.6880.762; Salisbury C, 1997, BRIT MED J, V314, P182, DOI 10.1136/bmj.314.7075.182; Salisbury C, 1997, BRIT MED J, V314, P1598, DOI 10.1136/bmj.314.7094.1598; SOLER M, 1991, Health Bulletin (Edinburgh), V49, P40; VANDUIJN NP, 1998, EUR J GEN PRACT, V4, P69; Vehvilainen AT, 1996, FAM PRACT, V13, P373, DOI 10.1093/fampra/13.4.373; Whynes DK, 1996, FAM PRACT, V13, P174, DOI 10.1093/fampra/13.2.174	28	47	47	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					618	621		10.1136/bmj.320.7235.618	http://dx.doi.org/10.1136/bmj.320.7235.618			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698882	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000085742600028
J	Beniaminovitz, A; Itescu, S; Lietz, K; Donovan, M; Burke, EM; Groff, BD; Edwards, N; Mancini, DM				Beniaminovitz, A; Itescu, S; Lietz, K; Donovan, M; Burke, EM; Groff, BD; Edwards, N; Mancini, DM			Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; HEART-TRANSPLANTATION; ALLOGRAFT VASCULOPATHY; MYCOPHENOLATE-MOFETIL; RISK-FACTORS; RECIPIENTS; TAC; THERAPY; TRIAL; TOLERANCE	Background: Alloantigen-activated T cells express the high-affinity interleukin-2 receptor. Specific blockade of this receptor with the human IgG1 monoclonal antibody daclizumab may prevent rejection of allografts after cardiac transplantation without inducing global immunosuppression. Methods: We randomly assigned 55 nonsensitized patients undergoing a first cardiac transplantation to receive either induction therapy with daclizumab (1.0 mg per kilogram of body weight), given intravenously within 24 hours after cardiac transplantation and every two weeks thereafter, for a total of five doses, or generalized immunosuppressive therapy. Concomitant immunosuppression was achieved in both groups with cyclosporine, mycophenolate mofetil, and prednisone. The primary end points were the incidence and severity of acute rejection, and the length of time to a first episode of biopsy-confirmed rejection. Results: Of the 55 patients in the study, 28 were randomly assigned to receive daclizumab and 27 served as the control group. During induction therapy, the mean frequency of acute rejection episodes (defined as a histologic grade of 2 or higher according to the classification of the International Society of Heart and Lung Transplants) was 0.64 per patient in the control group and 0.19 per patient in the daclizumab group (P=0.02). Acute rejection developed in 17 of 27 patients in the control group (63 percent), as compared with 5 of 28 patients in the daclizumab group (18 percent; relative risk, 2.8; 95 percent confidence interval, 1.1 to 7.4; P=0.04). Throughout follow-up, there were nine patients with episodes of acute rejection of histologic grade 3 in the control group, as compared with two in the daclizumab group (P=0.03), and the time to a first episode of rejection was significantly longer in the daclizumab group (P=0.04). There were no adverse reactions to daclizumab and no significant differences between the groups in the incidence of infection or cancer during follow-up. Conclusions: Induction therapy with daclizumab safely reduces the frequency and severity of cardiac-allograft rejection during the induction period. (N Engl J Med 2000;342:613-9.) (C)2000, Massachusetts Medical Society.	Columbia Presbyterian Med Ctr, Div Cardiol, New York, NY 10032 USA; Columbia Presbyterian Med Ctr, Div Circulatory Physiol, New York, NY 10032 USA; Columbia Presbyterian Med Ctr, Dept Surg, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Beniaminovitz, A (corresponding author), 177 Ft Washington Ave,MHB 5-435, New York, NY 10032 USA.	ab49@columbia.edu	Mattos, Beatriz A/D-2432-2011					ANASETTI C, 1994, BLOOD, V84, P1320; ARNOLD B, 1993, IMMUNOL TODAY, V14, P12, DOI 10.1016/0167-5699(93)90317-E; Billingham M E, 1990, J Heart Transplant, V9, P587; BOURGE RC, 1993, J HEART LUNG TRANSPL, V12, P549; BROWN PS, 1991, P NATL ACAD SCI USA, V88, P2663, DOI 10.1073/pnas.88.7.2663; COSTANZONORDIN MR, 1992, J HEART LUNG TRANSPL, V11, pS90; Fisher PE, 1995, J HEART LUNG TRANSPL, V14, P1156; HAKIMI J, 1991, J IMMUNOL, V147, P1352; Hakimi J., 1997, ANTIBODY THERAPEUTIC, P277; HAMMOND EH, 1992, J HEART LUNG TRANSPL, V11, pS111; Itescu S, 1998, LANCET, V352, P263, DOI 10.1016/S0140-6736(98)09475-6; JOHNSON MR, 1994, AM J CARDIOL, V74, P261, DOI 10.1016/0002-9149(94)90368-9; Kabelitz D, 1998, TRANSPLANTATION, V65, P869, DOI 10.1097/00007890-199804150-00003; Kobashigawa J, 1998, TRANSPLANTATION, V66, P507, DOI 10.1097/00007890-199808270-00016; KUBO SH, 1995, J HEART LUNG TRANSPL, V14, P409; LIU Z, 1993, J EXP MED, V177, P1643, DOI 10.1084/jem.177.6.1643; MAMULA MJ, 1993, IMMUNOL TODAY, V14, P151, DOI 10.1016/0167-5699(93)90274-O; Morris RE, 1996, KIDNEY INT, V49, pS26; NORMAN DJ, 1993, TRANSPLANTATION, V55, P44, DOI 10.1097/00007890-199301000-00009; Reed EF, 1996, TRANSPLANTATION, V61, P566, DOI 10.1097/00007890-199602270-00009; ROSE EA, 1992, J HEART LUNG TRANSPL, V11, pS120; SOLLINGER HW, 1995, TRANSPLANTATION, V60, P225, DOI 10.1097/00007890-199508000-00003; Stock PG, 1996, TRANSPLANT P, V28, P915; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Tugulea S, 1997, TRANSPLANTATION, V64, P842, DOI 10.1097/00007890-199709270-00009; URETSKY BF, 1987, CIRCULATION, V76, P827, DOI 10.1161/01.CIR.76.4.827; Vanderlugt CJ, 1996, CURR OPIN IMMUNOL, V8, P831, DOI 10.1016/S0952-7915(96)80012-4; VENTURA HO, 1995, AM HEART J, V129, P791, DOI 10.1016/0002-8703(95)90331-3; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; 1996, J CLIN INVEST, V98, P1150	30	167	236	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					613	619		10.1056/NEJM200003023420902	http://dx.doi.org/10.1056/NEJM200003023420902			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10699160	Bronze			2022-12-28	WOS:000085575500002
J	Wu, GD				Wu, GD			A nuclear receptor to prevent colon cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLORECTAL-CANCER; SULINDAC SULFIDE; APOPTOSIS; DRUGS; APC		Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Wu, GD (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.							He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; PIAZZA GA, 1995, CANCER RES, V55, P3110; Prescott SM, 1996, CELL, V87, P783, DOI 10.1016/S0092-8674(00)81983-2; SHIFF SJ, 1995, J CLIN INVEST, V96, P491, DOI 10.1172/JCI118060; Smalley W E, 1997, Adv Pharmacol, V39, P1, DOI 10.1016/S1054-3589(08)60067-8	8	32	34	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					651	653		10.1056/NEJM200003023420909	http://dx.doi.org/10.1056/NEJM200003023420909			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10699167				2022-12-28	WOS:000085575500009
J	Berger, A				Berger, A			Cirrhosis may be amenable to telomerase treatment	BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					536	536						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688556				2022-12-28	WOS:000085624000018
J	Watt, FM; Hogan, BLM				Watt, FM; Hogan, BLM			Out of Eden: Stem cells and their niches	SCIENCE			English	Review							TRUNCATED BETA-CATENIN; PROGENITOR CELLS; GERM-CELLS; MICE; MOUSE; DERIVATION; DIVISION; DIFFERENTIATION; MORPHOGENESIS; MAINTENANCE	Stem cells are currently in the news for two reasons: the successful cultivation of human embryonic stem cell Lines and reports that adult stem cells can differentiate into developmentally unrelated cell types, such as nerve cells into blood cells. Both intrinsic and extrinsic signals regulate stem cell fate and some of these signals have now been identified. Certain aspects of the stem cell microenvironment, or niche, are conserved between tissues, and this can be exploited in the application of stem cells to tissue replacement therapy.	Imperial Canc Res Fund, Keratinocyte Lab, London WC2A 3PX, England; Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Howard Hughes Med Inst, Nashville, TN 37232 USA	Cancer Research UK; Vanderbilt University; Howard Hughes Medical Institute; Vanderbilt University	Watt, FM (corresponding author), Imperial Canc Res Fund, Keratinocyte Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.		Watt, Fiona/AHB-0226-2022	Watt, Fiona/0000-0001-9151-5154				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Cross MA, 1997, CURR OPIN GENET DEV, V7, P609, DOI 10.1016/S0959-437X(97)80007-X; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dyson S, 1998, CELL, V93, P557, DOI 10.1016/S0092-8674(00)81185-X; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FLEMING TP, 1988, ANNU REV CELL BIOL, V4, P459, DOI 10.1146/annurev.cellbio.4.1.459; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Greaves M, 1996, TRENDS GENET, V12, P127, DOI 10.1016/0168-9525(96)30016-4; GURDON JB, 1988, NATURE, V336, P772, DOI 10.1038/336772a0; HALL PA, 1989, DEVELOPMENT, V106, P619; Hatzopoulos AK, 1998, DEVELOPMENT, V125, P1457; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kedinger M, 1998, PHILOS T R SOC B, V353, P847, DOI 10.1098/rstb.1998.0249; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Lin HF, 1998, CURR OPIN CELL BIOL, V10, P687, DOI 10.1016/S0955-0674(98)80108-7; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; North T, 1999, DEVELOPMENT, V126, P2563; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Shea KS, 1999, ANAT RECORD, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2; Peifer M, 1999, NATURE, V400, P213, DOI 10.1038/22214; Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Potten C. S., 1997, STEM CELLS; Quesenberry PJ, 1998, P NATL ACAD SCI USA, V95, P15155, DOI 10.1073/pnas.95.26.15155; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SLACK JMW, 1985, J THEOR BIOL, V114, P463, DOI 10.1016/S0022-5193(85)80179-X; SOBIS H, 1982, DEV BIOL, V92, P553, DOI 10.1016/0012-1606(82)90201-9; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tavian M, 1999, DEVELOPMENT, V126, P793; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zhu AJ, 1999, DEVELOPMENT, V126, P2285; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	58	1260	1443	3	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1427	1430		10.1126/science.287.5457.1427	http://dx.doi.org/10.1126/science.287.5457.1427			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688781				2022-12-28	WOS:000085531600035
J	Bellamy, R				Bellamy, R			Evidence of gene-environment interaction in development of tuberculosis	LANCET			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; GAMMA-INTERFERON; HUMAN-MONOCYTES; PROLIFERATION; METABOLITES; VITAMIN-D3; CELLS		Univ Wales Hosp, Dept Infect Dis, Cardiff CF14 4XW, S Glam, Wales	Cardiff University	Bellamy, R (corresponding author), Univ Wales Hosp, Dept Infect Dis, Cardiff CF14 4XW, S Glam, Wales.							Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614; CADRANEL J, 1988, AM REV RESPIR DIS, V138, P984, DOI 10.1164/ajrccm/138.4.984; DAVIES PDO, 1985, THORAX, V40, P187, DOI 10.1136/thx.40.3.187; DENIS M, 1991, CLIN EXP IMMUNOL, V84, P200, DOI 10.1111/j.1365-2249.1991.tb08149.x; DOWLING GB, 1946, LANCET, V250, P919; GRANGE JM, 1985, TUBERCLE, V66, P187, DOI 10.1016/0041-3879(85)90035-2; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Riggs BL, 1997, NEW ENGL J MED, V337, P125, DOI 10.1056/NEJM199707103370210; ROOK GAW, 1987, IMMUNOLOGY, V62, P229; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; STRACHAN DP, 1995, THORAX, V50, P175, DOI 10.1136/thx.50.2.175; TSOUKAS CD, 1984, SCIENCE, V224, P1438, DOI 10.1126/science.6427926	12	22	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					588	589		10.1016/S0140-6736(99)00426-2	http://dx.doi.org/10.1016/S0140-6736(99)00426-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696972				2022-12-28	WOS:000085615400002
J	Jeffcoate, W				Jeffcoate, W			Can growth hormone therapy cause diabetes?	LANCET			English	Editorial Material							REPLACEMENT THERAPY; ADULTS		City Hosp, Dept Endocrinol & Diabet, Nottingham NG5 1PB, England	University of Nottingham	Jeffcoate, W (corresponding author), City Hosp, Dept Endocrinol & Diabet, Nottingham NG5 1PB, England.							Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; BESHYAH SA, 1995, J CLIN ENDOCR METAB, V80, P356, DOI 10.1210/jc.80.2.356; Best JD, 1998, BAILLIERE CLIN ENDOC, V12, P199, DOI 10.1016/S0950-351X(98)80018-9; Borch-Johnsen K, 1999, LANCET, V354, P617; Chipman JJ, 1997, CLIN ENDOCRINOL, V46, P473, DOI 10.1046/j.1365-2265.1997.1660984.x; Chrisoulidou A, 1998, BAILLIERE CLIN ENDOC, V12, P261, DOI 10.1016/S0950-351X(98)80022-0; Holly J, 1998, LANCET, V351, P1373, DOI 10.1016/S0140-6736(05)79438-1; Maison P, 1998, BRIT MED J, V316, P1132, DOI 10.1136/bmj.316.7138.1132; Murray RD, 1999, CLIN ENDOCRINOL, V50, P749; Vance ML, 1999, NEW ENGL J MED, V341, P1206, DOI 10.1056/NEJM199910143411607	11	11	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					589	590		10.1016/S0140-6736(99)00325-6	http://dx.doi.org/10.1016/S0140-6736(99)00325-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696973				2022-12-28	WOS:000085615400003
J	Pan, SH; Hudson, EW; Lang, KM; Eisaki, H; Uchida, S; Davis, JC				Pan, SH; Hudson, EW; Lang, KM; Eisaki, H; Uchida, S; Davis, JC			Imaging the effects of individual zinc impurity atoms on superconductivity in Bi2Sr2CaCu2O8+delta	NATURE			English	Article							D-WAVE SUPERCONDUCTORS; SCANNING-TUNNELING-MICROSCOPY; STATES; PROBE; SUBSTITUTION; TRANSITION; MOMENTS; GAP; NMR; CU	Although the crystal structures of the copper oxide high-temperature superconductors are complex and diverse, they all contain some crystal planes consisting of only copper and oxygen atoms in a square lattice: superconductivity is believed to originate from strongly interacting electrons in these CuO2 planes, Substituting a single impurity atom for a copper atom strongly perturbs the surrounding electronic environment and can therefore be used to probe high-temperature superconductivity at the atomic scale. This has provided the motivation for several experimental(1-8) and theoretical studies(9-20). Scanning tunnelling microscopy (STM) is an ideal technique for the study of such effects at the atomic scale, as it has been used very successfully to probe individual impurity atoms in several other systems(21-25). Here we use STM to investigate the effects of individual zinc impurity atoms in the high-temperature superconductor Bi2Sr2CaCu2O8+delta. We find intense quasiparticle scattering resonances(26) at the Zn sites, coincident with strong suppression of superconductivity within similar to 15 Angstrom of the scattering sites. Imaging of the spatial dependence of the quasiparticle density of states in the vicinity of the impurity atoms reveals the long-sought four-fold symmetric quasiparticle 'cloud' aligned with the nodes of the d-wave superconducting gap which is believed to characterize superconductivity in these materials.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Tokyo, Dept Superconduct, Tokyo 1138656, Japan; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of Tokyo; Stanford University	Davis, JC (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.		Hudson, Eric/C-2746-2008; Hudson, Eric/C-4170-2017; Eisaki, Hiroshi/F-6317-2018	Hudson, Eric/0000-0001-7064-0351; Hudson, Eric/0000-0001-7064-0351; Eisaki, Hiroshi/0000-0002-8299-6416				ANDERSEN OK, 1994, PHYS REV B, V49, P4145, DOI 10.1103/PhysRevB.49.4145; Atkinson WA, 1999, SCIENCE, V285, P57, DOI 10.1126/science.285.5424.57; BALATSKY AV, 1995, PHYS REV B, V51, P15547, DOI 10.1103/PhysRevB.51.15547; Basov DN, 1998, PHYS REV LETT, V81, P2132, DOI 10.1103/PhysRevLett.81.2132; BONN DA, 1994, PHYS REV B, V50, P4051, DOI 10.1103/PhysRevB.50.4051; BYERS JM, 1993, PHYS REV LETT, V71, P3363, DOI 10.1103/PhysRevLett.71.3363; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; Flatte ME, 1999, SOLID STATE PHYS, V52, P137, DOI 10.1016/S0081-1947(08)60019-3; Fong HF, 1999, PHYS REV LETT, V82, P1939, DOI 10.1103/PhysRevLett.82.1939; Franz M, 1996, PHYS REV B, V54, pR6897, DOI 10.1103/PhysRevB.54.R6897; Fukuzumi Y, 1996, PHYS REV LETT, V76, P684, DOI 10.1103/PhysRevLett.76.684; Hirschfeld PJ, 1996, PHYS REV LETT, V77, P3909, DOI 10.1103/PhysRevLett.77.3909; Hudson EW, 1999, SCIENCE, V285, P88, DOI 10.1126/science.285.5424.88; ISHIDA K, 1991, PHYSICA C, V179, P29, DOI 10.1016/0921-4534(91)90007-L; LEE PA, 1993, PHYS REV LETT, V71, P1887, DOI 10.1103/PhysRevLett.71.1887; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; MAEDA A, 1990, PHYS REV B, V41, P4112, DOI 10.1103/PhysRevB.41.4112; MAHAJAN AV, 1994, PHYS REV LETT, V72, P3100, DOI 10.1103/PhysRevLett.72.3100; MOTOHIRA N, 1989, NIPPON SERAM KYO GAK, V97, P1009, DOI 10.2109/jcersj.97.1009; Nachumi B, 1996, PHYS REV LETT, V77, P5421, DOI 10.1103/PhysRevLett.77.5421; Nagaosa N, 1997, PHYS REV LETT, V79, P3755, DOI 10.1103/PhysRevLett.79.3755; Salkola MI, 1997, PHYS REV B, V55, P12648, DOI 10.1103/PhysRevB.55.12648; Salkola MI, 1996, PHYS REV LETT, V77, P1841, DOI 10.1103/PhysRevLett.77.1841; SALKOLA MI, 1998, PHYS REV B, V58, P5952; SUN Y, 1995, PHYS REV B, V51, P6059, DOI 10.1103/PhysRevB.51.6059; Tsuchiura H, 1999, J PHYS SOC JPN, V68, P2510, DOI 10.1143/JPSJ.68.2510; WELLS BO, 1992, PHYS REV B, V46, P11830, DOI 10.1103/PhysRevB.46.11830; WHITE PJ, 1999, ZN IMPURITIES BI2SR2; Wittneven C, 1998, PHYS REV LETT, V81, P5616, DOI 10.1103/PhysRevLett.81.5616; Yazdani A, 1999, PHYS REV LETT, V83, P176, DOI 10.1103/PhysRevLett.83.176; Yazdani A, 1997, SCIENCE, V275, P1767, DOI 10.1126/science.275.5307.1767; ZHENG JF, 1994, PHYS REV LETT, V72, P1490, DOI 10.1103/PhysRevLett.72.1490	32	686	689	1	153	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					746	750		10.1038/35001534	http://dx.doi.org/10.1038/35001534			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693798	Green Submitted			2022-12-28	WOS:000085423100045
J	Yan, H; Papadopoulos, N; Marra, G; Perrera, C; Jiricny, J; Boland, CR; Lynch, HT; Chadwick, RB; de la Chapelle, A; Berg, K; Eshleman, JR; Yuan, WS; Markowitz, S; Laken, SJ; Lengauer, C; Kinzler, KW; Vogelstein, B				Yan, H; Papadopoulos, N; Marra, G; Perrera, C; Jiricny, J; Boland, CR; Lynch, HT; Chadwick, RB; de la Chapelle, A; Berg, K; Eshleman, JR; Yuan, WS; Markowitz, S; Laken, SJ; Lengauer, C; Kinzler, KW; Vogelstein, B			Conversion of diploidy to haploidy - Individuals susceptible to multigene disorders may now be spotted more easily.	NATURE			English	Article							MONOALLELIC MUTATION ANALYSIS; HYBRIDS; GENES; MICE		Johns Hopkins Univ, Howard Hughes Med Inst, Ctr Oncol, Dept Math Sci, Baltimore, MD 21231 USA; Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA; Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Inst Med Radiobiol, CH-8008 Zurich, Switzerland; Univ Calif San Diego, La Jolla, CA 92093 USA; Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; Case Western Reserve Univ, Howard Hughes Med Inst, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Columbia University; University of California System; University of California San Diego; Creighton University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Case Western Reserve University; Howard Hughes Medical Institute; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Yan, H (corresponding author), Johns Hopkins Univ, Howard Hughes Med Inst, Ctr Oncol, Dept Math Sci, Baltimore, MD 21231 USA.		Papadopoulos, Nickolas/K-7272-2012					ANDERSON MJ, 1993, FASEB J, V7, P826, DOI 10.1096/fasebj.7.10.8344482; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HARRIS H, 1985, J CELL SCI, V79, P83; IMREH S, 1994, GENE CHROMOSOME CANC, V11, P237, DOI 10.1002/gcc.2870110406; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Lynch HT, 1999, J MED GENET, V36, P801; McDaniel LD, 1997, HUM MUTAT, V10, P317, DOI 10.1002/(SICI)1098-1004(1997)10:4<317::AID-HUMU8>3.3.CO;2-J; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; PATERSON D, 1982, ANN NY ACAD SCI, V396, P69; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; SCHULTZ RA, 1987, P NATL ACAD SCI USA, V84, P4176, DOI 10.1073/pnas.84.12.4176; Warthin AS, 1913, ARCH INTERN MED, V12, P546; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795; Yuan ZQ, 1999, J MED GENET, V36, P790	15	209	222	0	9	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					723	724		10.1038/35001659	http://dx.doi.org/10.1038/35001659			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693791				2022-12-28	WOS:000085423100038
J	Bilder, D; Perrimon, N				Bilder, D; Perrimon, N			Localization of apical epithelial determinants by the basolateral PDZ protein Scribble	NATURE			English	Article							LEUCINE-RICH REPEATS; TIGHT JUNCTIONS; PLASMA-MEMBRANE; DROSOPHILA; CRUMBS; DOMAINS; CELLS; EXPRESSION; ENCODES; FAMILY	The generation of membrane domains with distinct protein constituents is a hallmark of cell polarization. In epithelia, segregation of membrane proteins into epical and basolateral compartments is critical for cell morphology, tissue physiology and cell signalling. Drosophila proteins that confer apical membrane identity have been found(1,2), but the mechanisms that restrict these determinants to the apical cell surface are unknown. Here we show that a laterally localized protein is required for the apical confinement of polarity determinants. Mutations in Drosophila scribble (scrib), which encodes a multi-PDZ (PSD-95, Discs-large and ZO-1) and leucine-rich-repeat protein, cause aberrant cell shapes and loss of the monolayer organization of embryonic epithelia. Scrib is localized to the epithelial septate junction, the analogue of the vertebrate tight junction(3), at the boundary of the apical and basolateral cell surfaces. Loss of scrib function results in the misdistribution of apical proteins and adherens junctions to the basolateral cell surface, but basolateral protein localization remains intact. These phenotypes can be accounted for by mislocalization of the apical determinant Crumbs. Ow results show that the lateral domain of epithelia, particularly the septate junction, functions in restricting apical membrane identity and correctly placing adherens junctions.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Bilder, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.			Perrimon, Norbert/0000-0001-7542-472X; Bilder, David/0000-0002-1842-4966				Apperson ML, 1996, J NEUROSCI, V16, P6839; Balda MS, 1998, J CELL SCI, V111, P541; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 1998, DEVELOPMENT, V125, P1781; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Bryant PJ, 1997, DEV GENET, V20, P75, DOI 10.1002/(SICI)1520-6408(1997)20:2<75::AID-DVG1>3.3.CO;2-G; CAMPOSORGEGA JA, 1997, EMBRYONIC DEV DROSOP; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; DRAGSTEN PR, 1981, NATURE, V294, P718, DOI 10.1038/294718a0; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Grawe F, 1996, DEVELOPMENT, V122, P951; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Nagase T, 1995, DNA Res, V2, P167, DOI 10.1093/dnares/2.4.167; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Salzberg A, 1997, GENETICS, V147, P1723; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Spradling AC, 1999, GENETICS, V153, P135; SUZUKI N, 1990, P NATL ACAD SCI USA, V87, P8711, DOI 10.1073/pnas.87.22.8711; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 1997, BIOESSAYS, V19, P673, DOI 10.1002/bies.950190807; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73	29	548	557	2	34	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					676	680		10.1038/35001108	http://dx.doi.org/10.1038/35001108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688207				2022-12-28	WOS:000085288200059
J	Dalton, R				Dalton, R			International science council names first female president	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					582	582		10.1038/35001201	http://dx.doi.org/10.1038/35001201			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688164	Bronze			2022-12-28	WOS:000085288200005
J	ten Brink, GJ; Arends, IWCE; Sheldon, RA				ten Brink, GJ; Arends, IWCE; Sheldon, RA			Green, catalytic oxidation of alcohols in water	SCIENCE			English	Article							MOLECULAR-OXYGEN; AEROBIC OXIDATION; ATOM ECONOMY; ALDEHYDES; KETONES; 1,10-PHENANTHROLINE; 2,2'-BIPYRIDINE; EFFICIENT; COMPLEXES	Alcohol oxidations are typically performed with stoichiometric reagents that generate heavy-metal waste and are usually run in chlorinated solvents. A water-soluble palladium(ll) bathophenanthroline complex is a stable recyclable catalyst for the selective aerobic oxidation of a wide range of alcohols to aldehydes, ketones, and carboxylic acids in a biphasic water-alcohol system. The use of water as a solvent and air as the oxidant makes the reaction interesting from both an economic and environmental point of view.	Delft Univ Technol, Organ Chem & Catalysis Lab, NL-2628 BL Delft, Netherlands	Delft University of Technology	Sheldon, RA (corresponding author), Delft Univ Technol, Organ Chem & Catalysis Lab, Julianalaan 136, NL-2628 BL Delft, Netherlands.	R.A.Sheldon@tnw.tudelft.nl	Sheldon, Roger Arthur/ADM-3421-2022; Arends, Isabel/AAH-8785-2020; Arends, Isabel/Y-7459-2018	Arends, Isabel/0000-0002-1015-4682; 				BACKVALL JE, 1991, J CHEM SOC CHEM COMM, P473, DOI 10.1039/c39910000473; BILGRIEN C, 1987, J AM CHEM SOC, V109, P3786, DOI 10.1021/ja00246a049; BLACKBURN TF, 1977, J CHEM SOC CHEM COMM, P157, DOI 10.1039/c39770000157; CAINELLI G, 1984, CHROMIUM OXIDANTS OR; Dijksman A, 1999, CHEM COMMUN, P1591, DOI 10.1039/a902594d; GRATE JH, 1994, CHEM INDUST, V53, P213; Hanyu A, 1998, TETRAHEDRON LETT, V39, P5557, DOI 10.1016/S0040-4039(98)01119-8; Lenz R, 1997, J CHEM SOC PERK T 1, P3291, DOI 10.1039/a707339i; Ley S. V., 1991, COMPREHENSIVE ORGANI, P251, DOI DOI 10.1016/B978-0-08-052349-1.09002-8; MALLAT T, 1994, CATAL TODAY, V19, P247, DOI 10.1016/0920-5861(94)80187-8; Marko IE, 1996, SCIENCE, V274, P2044, DOI 10.1126/science.274.5295.2044; Marko IE, 1997, J AM CHEM SOC, V119, P12661, DOI 10.1021/ja973227b; MUKAIYAMA T, 1993, ACTIVATION OF DIOXYGEN AND HOMOGENEOUS CATALYTIC OXIDATION, P133; Nishimura T, 1998, TETRAHEDRON LETT, V39, P6011, DOI 10.1016/S0040-4039(98)01235-0; Peterson KP, 1998, J ORG CHEM, V63, P3185, DOI 10.1021/jo971268k; Sato K, 1998, SCIENCE, V281, P1646, DOI 10.1126/science.281.5383.1646; TANG R, 1978, J CHEM SOC CHEM COMM, P562, DOI 10.1039/c39780000562; ten Brink GJ, 2000, APPL CATAL A-GEN, V194, P435; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; TROST BM, 1995, ANGEW CHEM INT EDIT, V34, P259, DOI 10.1002/anie.199502591; WIMMER S, 1989, J CHEM SOC DALTON, P403, DOI 10.1039/dt9890000403; WIMMER S, 1988, INORG CHIM ACTA, V142, P13, DOI 10.1016/S0020-1693(00)80648-9	22	1029	1035	6	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1636	1639						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	289NE	10698735				2022-12-28	WOS:000085628200033
J	Grover, SA				Grover, SA			Role of WHO-MONICA Project in unravelling of the cardiovascular puzzle	LANCET			English	Editorial Material							GUIDELINES; PREVENTION; DISEASE; RISK		Montreal Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3G 1A4, Canada	McGill University	Grover, SA (corresponding author), Montreal Gen Hosp, Div Clin Epidemiol, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.							Abbott RD, 1987, FRAMINGHAM STUDY EPI; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; ANDRADE SE, 1995, NEW ENGL J MED, V332, P1125, DOI 10.1056/NEJM199504273321703; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Durrington PN, 1999, LANCET, V353, P278, DOI 10.1016/S0140-6736(98)04027-6; Frolkis JP, 1998, CIRCULATION, V98, P851, DOI 10.1161/01.CIR.98.9.851; FURINO A, 1991, JAMA-J AM MED ASSOC, V265, P255; Grover S, 1999, LANCET, V353, P254, DOI 10.1016/S0140-6736(05)74941-2; Grover SA, 1998, ARCH INTERN MED, V158, P655, DOI 10.1001/archinte.158.6.655; GROVER SA, 1995, JAMA-J AM MED ASSOC, V274, P801, DOI 10.1001/jama.274.10.801; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; PEDERSEN TR, 1994, LANCET, V344, P1383; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; WIKSTRAND J, 1988, JAMA-J AM MED ASSOC, V259, P1976, DOI 10.1001/jama.259.13.1976	15	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2000	355	9205					668	669		10.1016/S0140-6736(00)00016-7	http://dx.doi.org/10.1016/S0140-6736(00)00016-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703793				2022-12-28	WOS:000085615600002
J	Midgley, R; Kerr, D				Midgley, R; Kerr, D			Towards post-genomic investigation of colorectal cancer	LANCET			English	Editorial Material							PREDICTION		Univ Birmingham, CRC, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Midgley, R (corresponding author), Univ Birmingham, CRC, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England.			Kerr, Rachel/0000-0002-7240-3269				Bottaci L, 1997, LANCET, V350, P469, DOI 10.1016/S0140-6736(96)11196-X; Burke HB, 1997, CANCER, V79, P857, DOI 10.1002/(SICI)1097-0142(19970215)79:4<857::AID-CNCR24>3.0.CO;2-Y; McLeod HL, 1999, BRIT J CANCER, V79, P191, DOI 10.1038/sj.bjc.6690033; Tortola S, 1999, J CLIN ONCOL, V17, P1375, DOI 10.1200/JCO.1999.17.5.1375	4	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					669	670		10.1016/S0140-6736(00)00078-7	http://dx.doi.org/10.1016/S0140-6736(00)00078-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703794				2022-12-28	WOS:000085615600003
J	Bjorkman, J; Nagaev, I; Berg, OG; Hughes, D; Andersson, DI				Bjorkman, J; Nagaev, I; Berg, OG; Hughes, D; Andersson, DI			Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance	SCIENCE			English	Article							ESCHERICHIA-COLI; RIBOSOMES; GROWTH	Most types of antibiotic resistance impose a biological cost on bacterial fitness. These costs can be compensated, usually without Loss of resistance, by second-site mutations during the evolution of the resistant bacteria in an experimental host or in a Laboratory medium. Different fitness-compensating mutations were selected depending on whether the bacteria evolved through serial passage in mice or in a Laboratory medium. This difference in mutation spectra was caused by either a growth condition-specific formation or selection of the compensated mutants. These results suggest that bacterial evolution to reduce the costs of antibiotic resistance can take different trajectories within and outside a host.	Swedish Inst Infect Dis Control, Dept Bacteriol, S-17182 Solna, Sweden; Uppsala Univ, Ctr Biomed, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Uppsala Univ, Ctr Biomed, Dept Mol Evolut, S-75123 Uppsala, Sweden	Swedish Institute for Infectious Disease Control; Uppsala University; Uppsala University	Andersson, DI (corresponding author), Swedish Inst Infect Dis Control, Dept Bacteriol, S-17182 Solna, Sweden.	Dan.Andersson@smi.ki.se	Hughes, Diarmaid/A-9487-2014; Nagaev, Ivan/B-7269-2008	Hughes, Diarmaid/0000-0002-7456-9182; Andersson, Dan/0000-0001-6640-2174				Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Bjorkman J, 1999, MOL MICROBIOL, V31, P53, DOI 10.1046/j.1365-2958.1999.01142.x; Bjorkman J, 1998, P NATL ACAD SCI USA, V95, P3949, DOI 10.1073/pnas.95.7.3949; BOHMAN K, 1984, MOL GEN GENET, V198, P90, DOI 10.1007/BF00328706; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; DEBOER JG, 1984, P NATL ACAD SCI-BIOL, V81, P5528; DRAKE JW, 1991, ANNU REV GENET, V25, P125, DOI 10.1146/annurev.ge.25.120191.001013; Johanson U, 1996, J MOL BIOL, V258, P420, DOI 10.1006/jmbi.1996.0259; Kurland C.G., 1996, ESCHERICHIA COLI SAL, P979; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; Levin BR, 1997, CLIN INFECT DIS, V24, pS9, DOI 10.1093/clinids/24.Supplement_1.S9; LEVIN BR, 1996, IN PRESS GENETICS, V272, P1641; MACVANIN M, IN PRESS MOL MICROBI; McCormick JB, 1998, CURR OPIN MICROBIOL, V1, P125, DOI 10.1016/S1369-5274(98)80152-5; MCDERMOTT PJ, 1993, LETT APPL MICROBIOL, V17, P139, DOI 10.1111/j.1472-765X.1993.tb01443.x; MIKKOLA R, 1992, MOL BIOL EVOL, V9, P394; MODI RI, 1991, EVOLUTION, V45, P656, DOI 10.1111/j.1558-5646.1991.tb04336.x; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; Schrag SJ, 1996, NATURE, V381, P120, DOI 10.1038/381120b0	20	321	341	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1479	1482		10.1126/science.287.5457.1479	http://dx.doi.org/10.1126/science.287.5457.1479			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688795				2022-12-28	WOS:000085531600049
J	Annane, D; Sebille, V; Troche, G; Raphael, JC; Gajdos, P; Bellissant, E				Annane, D; Sebille, V; Troche, G; Raphael, JC; Gajdos, P; Bellissant, E			A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEPSIS SYNDROME; ADRENOCORTICAL RESPONSIVENESS; HEMODYNAMIC IMPROVEMENT; ADRENAL INSUFFICIENCY; REPLACEMENT; SURVIVAL; ILLNESS; SERUM; MULTICENTER; MORTALITY	Context The hypothalamic-pituitary-adrenal axis is a major determinant of the host response to stress. The relationship between its activation and patient outcome is not known. Objective To evaluate the prognostic Value of cortisol levels and a short corticotropin stimulation test in patients with septic shock. Design and Setting Prospective inception cohort study conducted between October 1991 and September 1995 in 2 teaching hospital adult intensive care units in France. Participants A total of 189 consecutive patients who met clinical criteria for septic shock. Intervention A short corticotropin stimulation test was performed in all patients by intravenously injecting 0.25 mg of tetracosactrin; blood samples were taken immediately before the test (T0) and 30 (T30) and 60 (T60) minutes afterward, Main Outcome Measures Twenty-eight-day mortality as a function of variables collected at the onset of septic shock, including cortisol levels before the corticotropin test and the cortisol response to corticotropin (Delta max, defined as the difference between T0 and the highest value between T30 and T60). Results The 28-day mortality was 58% (95% confidence interval [CI], 51%-65%)and median time to death was 17 days (95% CI, 14-27 days). In multivariate analysis, independent predictors of death (P less than or equal to.001 for all) were McCabe score greater than 0, organ system failure score greater than 2, arterial lactate level greater than 2.8 mmol/L, ratio of PaO2 to fraction of inspired oxygen no more than 160 mm Hg, cortisol level at T0 greater than 34 mu g/dL and Delta max no more than 9 mu g/dL. Three groups of patient prognoses were identified: good (cortisol level at T0 less than or equal to 34 mu g/dL and Delta max >9 mu g/dL; 28-day mortality rate, 26%), intermediate (cortisol level at T0 34 mu g/dL and Delta max less than or equal to 9 mu g/dL or cortisol level at T0 >34 mu g/dL and Delta max >9 Delta g/dL; 28-day mortality rate, 67%), and poor (cortisol level at T0 >34 mu g/dL and Delta max less than or equal to 9 mu g/dL; 28-day mortality rate, 82%). Conclusion Our data suggest that a short corticotropin test has a good prognostic value and could be helpful in identifying patients with septic shock at high risk for death.	Hop Raymond Poincare, Serv Reanimat Med, Dept Intens Care Unit, Sch Med Paris Ouest, F-92380 Garches, France; Hosp Antoine Beclerc, Dept Intens Care Unit, Clamart, France; Univ Rennes 1, Hosp Pontchaillou, Dept Pharmacol, Rennes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; CHU Rennes; Universite de Rennes	Annane, D (corresponding author), Hop Raymond Poincare, Serv Reanimat Med, Dept Intens Care Unit, Sch Med Paris Ouest, 104 Blvd Raymond Poincare, F-92380 Garches, France.	djillali.annane@rpc.ap-hop-paris.fr	Annane, Djillali/R-7947-2019; Sebille, Veronique/I-3309-2015	Troche, Gilles/0000-0002-8150-6630; Sebille, Veronique/0000-0002-0780-7742				Annane D, 1998, BRIT J CLIN PHARMACO, V46, P589; Annane D, 1996, CRIT CARE MED, V24, P899, DOI 10.1097/00003246-199605000-00035; ANNANE D, 1996, BR J INTENS CARE, V6, P260; Aygen B, 1997, EXP CLIN ENDOCR DIAB, V105, P182, DOI 10.1055/s-0029-1211749; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BONE RC, 1991, JAMA-J AM MED ASSOC, V266, P1686, DOI 10.1001/jama.266.12.1686; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BONE RC, 1989, CRIT CARE MED, V17, P389, DOI 10.1097/00003246-198905000-00002; BOUACHOUR G, 1995, INTENS CARE MED, V21, P57, DOI 10.1007/BF02425155; BRIEGEL J, 1992, INTENS CARE MED, V18, P318, DOI 10.1007/BF01706486; BRIEGEL J, 1991, LANCET, V338, P507, DOI 10.1016/0140-6736(91)90575-A; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; CALANDRA T, 1990, J INFECT DIS, V161, P982, DOI 10.1093/infdis/161.5.982; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; CLEMMER TP, 1992, CRIT CARE MED, V20, P1395, DOI 10.1097/00003246-199210000-00006; DRUCKER D, 1985, CRIT CARE MED, V13, P477, DOI 10.1097/00003246-198506000-00007; FINLAY WEI, 1982, LANCET, V1, P1414; FIRSCHEIN HE, 1957, ENDOCRINOLOGY, V60, P347, DOI 10.1210/endo-60-3-347; FRIDERICHSEN C, 1918, JB KINDERHEILKUNDE, P87; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOSMER DW, 1989, APPL LOGISTIC REGRES; JURNEY TH, 1987, CHEST, V92, P292, DOI 10.1378/chest.92.2.292; KNAUS WA, 1993, JAMA-J AM MED ASSOC, V270, P1233, DOI 10.1001/jama.270.10.1233; KNAUS WA, 1985, ANN SURG, V202, P685, DOI 10.1097/00000658-198512000-00004; KREGER BE, 1980, AM J MED, V68, P344, DOI 10.1016/0002-9343(80)90102-3; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Matot I, 1998, CRIT CARE MED, V26, P627, DOI 10.1097/00003246-199804000-00002; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; MCKEE JI, 1983, LANCET, V1, P484; MELBY JC, 1958, J CLIN INVEST, V37, P1791, DOI 10.1172/JCI103772; MORAN JL, 1994, INTENS CARE MED, V20, P489, DOI 10.1007/BF01711901; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; PUGEAT M, 1989, CLIN CHEM, V35, P1675; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; ROTHWELL PM, 1995, CRIT CARE MED, V23, P78, DOI 10.1097/00003246-199501000-00015; SCHEIN RMH, 1990, CRIT CARE MED, V18, P259, DOI 10.1097/00003246-199003000-00002; SCHNEIDER AJ, 1991, INTENS CARE MED, V17, P436, DOI 10.1007/BF01720688; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; SIBBALD WJ, 1977, ANN SURG, V186, P29, DOI 10.1097/00000658-197707000-00005; SONI A, 1995, AM J MED, V98, P266, DOI 10.1016/S0002-9343(99)80373-8; SPAN LFR, 1992, INTENS CARE MED, V18, P93, DOI 10.1007/BF01705039; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; WADE CE, 1988, J CLIN ENDOCR METAB, V67, P223, DOI 10.1210/jcem-67-2-223; Waterhouse R, 1911, LANCET, V1, P577; Zeni F, 1997, CRIT CARE MED, V25, P1095, DOI 10.1097/00003246-199707000-00001	46	680	743	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					1038	1045		10.1001/jama.283.8.1038	http://dx.doi.org/10.1001/jama.283.8.1038			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284AM	10697064				2022-12-28	WOS:000085308600033
J	Delbanco, T; Hartman, EE				Delbanco, T; Hartman, EE			A 75-year-old man with congestive heart failure, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Guyatt G, 1999, JAMA-J AM MED ASSOC, V281, P2321, DOI 10.1001/jama.281.24.2321	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					1054	1054		10.1001/jama.283.8.1054	http://dx.doi.org/10.1001/jama.283.8.1054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284AM	10697066				2022-12-28	WOS:000085308600035
J	Zeng, WL; Wharton, KA; Mack, JA; Wang, K; Gadbaw, M; Suyama, K; Klein, PS; Scott, MP				Zeng, WL; Wharton, KA; Mack, JA; Wang, K; Gadbaw, M; Suyama, K; Klein, PS; Scott, MP			Naked cuticle encodes an inducible antagonist of Wnt signalling	NATURE			English	Article							DROSOPHILA EMBRYOS; IMAGINAL DISKS; CELL FATES; WINGLESS; POLARITY; GENE; EXPRESSION; XENOPUS; EPIDERMIS; INDUCTION	During animal development, cells have to respond appropriately to localized secreted signals. Proper responses to Hedgehog, transforming growth factor-beta, epidermal growth factor and fibroblast growth factor/Ras signals require cognate inducible antagonists such as Patched, Dad, Argos and Sprouty(1). Wnt signals are crucial in development and neoplasia(2). Here we show that naked cuticle (nkd), a Drosophila segment-polarity gene, encodes an inducible antagonist for the Wnt signal Wingless (Wg). In fly embryos and imaginal discs nkd transcription is induced by Wg. In embryos, decreased nkd function has an effect similar to excess Wg; at later stages such a decrease appears to have no effect. Conversely, overproduction of Nkd in Drosophila and misexpression of Nkd in the vertebrate Xenopus laevis result in phenotypes resembling those of loss of Wg/Wnt function. nkd encodes a protein with a single EF hand (a calcium-binding motif) that is most similar to the recoverin family of myristoyl switch proteins. Nkd may therefore Link ion fluxes to the regulation of the potency, duration or distribution of Wnt signals. Signal-inducible feedback antagonists such as nkd may limit the effects of Wnt proteins in development and disease.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr B300,Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr B300,Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr B300,Dept Pathol, Stanford, CA 94305 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Internal Med, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; University of Pennsylvania	Scott, MP (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr B300,Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.			Wang, Kevin/0000-0002-5305-6791	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BAKER NE, 1988, DEVELOPMENT, V102, P489; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; COUSO JP, 1993, SCIENCE, V259, P484, DOI 10.1126/science.8424170; COUSO JP, 1994, DEVELOPMENT, V120, P621; Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; DOUGAN S, 1992, NATURE, V360, P347, DOI 10.1038/360347a0; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Itoh K, 1999, GENE DEV, V13, P2328, DOI 10.1101/gad.13.17.2328; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; MA CY, 1995, DEVELOPMENT, V121, P2279; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Moline MM, 1999, DEVELOPMENT, V126, P4375; Moon RT, 1997, CELL, V88, P725, DOI 10.1016/S0092-8674(00)81915-7; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; Pai LM, 1997, DEVELOPMENT, V124, P2255; Pazdera TM, 1998, DEVELOPMENT, V125, P3427; Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; Shirras AD, 1996, DEV BIOL, V175, P24, DOI 10.1006/dbio.1996.0092; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Steitz MC, 1998, DEV BIOL, V197, P218, DOI 10.1006/dbio.1998.8884	30	176	186	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					789	795		10.1038/35001615	http://dx.doi.org/10.1038/35001615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693810				2022-12-28	WOS:000085423100057
J	Altamirano, MM; Blackburn, JM; Aguayo, C; Fersht, AR				Altamirano, MM; Blackburn, JM; Aguayo, C; Fersht, AR			RETRACTED: Directed evolution of new catalytic activity using the alpha/beta-barrel scaffold (Retracted article. See vol 417, pg 468, 2002)	NATURE			English	Article; Retracted Publication							PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; INDOLEGLYCEROL-PHOSPHATE SYNTHASE; IN-VITRO RECOMBINATION; MUCONATE LACTONIZING ENZYME; BETA-SHEET BARRELS; ESCHERICHIA-COLI; MOLECULAR EVOLUTION; BIFUNCTIONAL ENZYME; TRYPTOPHAN BIOSYNTHESIS; MANDELATE RACEMASE	In biological systems, enzymes catalyse the efficient synthesis of complex molecules under benign conditions, but widespread industrial use of these biocatalysts depends crucially on the development of new enzymes with useful catalytic functions. The evolution of enzymes in biological systems often involves the acquisition of new catalytic or binding properties by an existing protein scaffold. Here we mimic this strategy using the most common fold in enzymes, the alpha/beta-barrel, as the scaffold. By combining an existing binding site for structural elements of phosphoribosylanthranilate with a catalytic template required for isomerase activity, we are able to evolve phosphoribosylanthranilate isomerase activity from the scaffold of indole-3-glycerolphosphate synthase, We find that targeting the catalytic template for in vitro mutagenesis and recombination, followed by in vivo selection, results in a new phosphoribosylanthranilate isomerase that has catalytic properties similar to those of the natural enzyme, with an even higher specificity constant. Our demonstration of divergent evolution and the widespread occurrence of the alpha/beta-barrel suggest that this scaffold may be a fold of choice for the directed evolution of new biocatalysts.	Cambridge Ctr Prot Engn, Cambridge CB2 2QH, England; Univ Cambridge, Chem Lab, MRC Ctr, Cambridge CB2 2QH, England; Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico	University of Cambridge; MRC Laboratory Molecular Biology; University of Cambridge; Universidad Nacional Autonoma de Mexico	Fersht, AR (corresponding author), Cambridge Ctr Prot Engn, Hills Rd, Cambridge CB2 2QH, England.	arf10@cam.ac.uk	Fersht, Alan R/B-2189-2008					Altamirano MM, 1997, P NATL ACAD SCI USA, V94, P3576, DOI 10.1073/pnas.94.8.3576; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; BISSWANGER H, 1979, BIOCHEMISTRY-US, V18, P5946, DOI 10.1021/bi00593a029; Branden C., 1999, INTRO PROTEIN STRUCT; Branden CI, 1991, CURR OPIN STRUC BIOL, V1, P978, DOI 10.1016/0959-440X(91)90094-A; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; CLARKE L, 1980, P NATL ACAD SCI-BIOL, V77, P2173, DOI 10.1073/pnas.77.4.2173; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Crameri A, 1996, NAT MED, V2, P100, DOI 10.1038/nm0196-100; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Darimont B, 1998, PROTEIN SCI, V7, P1221, DOI 10.1002/pro.5560070518; EBERHARD M, 1995, BIOCHEMISTRY-US, V34, P5419, DOI 10.1021/bi00016a013; Gerlt JA, 1998, CURR OPIN CHEM BIOL, V2, P607, DOI 10.1016/S1367-5931(98)80091-4; Giver L, 1998, CURR OPIN CHEM BIOL, V2, P335, DOI 10.1016/S1367-5931(98)80006-9; Hasson MS, 1998, P NATL ACAD SCI USA, V95, P10396, DOI 10.1073/pnas.95.18.10396; Henikoff S, 1997, SCIENCE, V278, P609, DOI 10.1126/science.278.5338.609; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; HOMMEL U, 1995, BIOCHEMISTRY-US, V34, P5429, DOI 10.1021/bi00016a014; Kauffman S. A., 1993, ORIGINS ORDER; KIRSCHNER K, 1987, METHOD ENZYMOL, V142, P386; Knochel TR, 1996, J MOL BIOL, V262, P502, DOI 10.1006/jmbi.1996.0531; LUGER K, 1989, SCIENCE, V243, P206, DOI 10.1126/science.2643160; MURZIN AG, 1994, J MOL BIOL, V236, P1382, DOI 10.1016/0022-2836(94)90065-5; MURZIN AG, 1994, J MOL BIOL, V236, P1369, DOI 10.1016/0022-2836(94)90064-7; NEIDHART DJ, 1990, NATURE, V347, P692, DOI 10.1038/347692a0; Patthy Laszlo, 1999, PROTEIN EVOLUTION; Shao ZX, 1998, NUCLEIC ACIDS RES, V26, P681, DOI 10.1093/nar/26.2.681; Stehlin C, 1997, FEBS LETT, V403, P268, DOI 10.1016/S0014-5793(97)00066-5; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; STERNBERG N, 1995, P NATL ACAD SCI USA, V92, P1609, DOI 10.1073/pnas.92.5.1609; Sterner R, 1996, PROTEIN SCI, V5, P2000, DOI 10.1002/pro.5560051006; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; WILMANNS M, 1991, BIOCHEMISTRY-US, V30, P9161, DOI 10.1021/bi00102a006; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; YANOFSKY C, 1994, J BACTERIOL, V176, P6245, DOI 10.1128/jb.176.20.6245-6254.1994; YANOFSKY C, 1971, J AMER MED ASSOC, V218, P1026, DOI 10.1001/jama.218.7.1026; YANOFSKY C, 1971, GENETICS, V69, P409; Zhao HM, 1997, NUCLEIC ACIDS RES, V25, P1307, DOI 10.1093/nar/25.6.1307; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258	42	147	162	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					617	622		10.1038/35001001	http://dx.doi.org/10.1038/35001001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688189				2022-12-28	WOS:000085288200041
J	Porath, D; Bezryadin, A; de Vries, S; Dekker, C				Porath, D; Bezryadin, A; de Vries, S; Dekker, C			Direct measurement of electrical transport through DNA molecules	NATURE			English	Article							DISTANCE	Attempts to infer DNA electron transfer from fluorescence quenching measurements(1-9) on DNA strands doped with donor and acceptor molecules have spurred intense debate(10,11) over the question of whether or not this important biomolecule is able to conduct electrical charges. More recently, first electrical transport measurements on micrometre-long DNA 'ropes'(12), and also on large numbers of DNA molecules in films(13), have indicated that DNA behaves as a good linear conductor. Here we present measurements of electrical transport through individual 10.4-nm-long, double-stranded poly(G)-poly(C) DNA molecules connected to two metal nanoelectrodes, that indicate, by contrast, large-bandgap semiconducting behaviour. We obtain nonlinear current-voltage curves that exhibit a voltage gap at low applied bias. This is observed in air as well as in vacuum down to cryogenic temperatures. The voltage dependence of the differential conductance exhibits a peak structure, which is suggestive of the charge carrier transport being mediated by the molecular energy bands of DNA.	Delft Univ Technol, Dept Appl Sci, NL-2628 CJ Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Dept Appl Sci, POB 5046, NL-2628 CJ Delft, Netherlands.	dekker@qt.tn.tudelft.nl	Bezryadin, Alexey/H-1815-2016	Bezryadin, Alexey/0000-0002-4822-6960; Dekker, Cees/0000-0001-6273-071X				Arkin MR, 1996, SCIENCE, V273, P475, DOI 10.1126/science.273.5274.475; BAKHSHI AK, 1994, PROG BIOPHYS MOL BIO, V61, P187, DOI 10.1016/0079-6107(94)90001-9; BARBARA PF, 1999, ADV CHEM PHYS, V107, pCH13; Beratan DN, 1997, CHEM BIOL, V4, P3, DOI 10.1016/S1074-5521(97)90230-1; Bezryadin A, 1997, J VAC SCI TECHNOL B, V15, P793, DOI 10.1116/1.589411; Bezryadin A, 1997, APPL PHYS LETT, V71, P1273, DOI 10.1063/1.119871; Datta S, 1997, PHYS REV LETT, V79, P2530, DOI 10.1103/PhysRevLett.79.2530; ELEY DD, 1962, T FARADAY SOC, V58, P411, DOI 10.1039/tf9625800411; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; GRABERT H, 1992, SINGLE CHARGE TUNNEL; Grozema FC, 1999, INT J QUANTUM CHEM, V75, P1009, DOI 10.1002/(SICI)1097-461X(1999)75:6<1009::AID-QUA5>3.0.CO;2-A; Henderson PT, 1999, P NATL ACAD SCI USA, V96, P8353, DOI 10.1073/pnas.96.15.8353; Hutter M, 1996, J AM CHEM SOC, V118, P7574, DOI 10.1021/ja953370+; Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; LADIK J, 1971, INT J QUANTUM CHEM, V4, P307; Lewis FD, 1997, SCIENCE, V277, P673, DOI 10.1126/science.277.5326.673; Meggers E, 1998, J AM CHEM SOC, V120, P12950, DOI 10.1021/ja983092p; Okahata Y, 1998, J AM CHEM SOC, V120, P6165, DOI 10.1021/ja980165w; Taubes G, 1997, SCIENCE, V275, P1420, DOI 10.1126/science.275.5305.1420; VANLITH D, 1986, J CHEM SOC FARAD T 1, V82, P2933, DOI 10.1039/f19868202933; Wan CZ, 1999, P NATL ACAD SCI USA, V96, P6014, DOI 10.1073/pnas.96.11.6014; WILSON EK, 1998, CHEM ENG NEWS, P2751	22	1532	1596	8	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					635	638		10.1038/35001029	http://dx.doi.org/10.1038/35001029			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688194				2022-12-28	WOS:000085288200046
J	Zhong, TP; Rosenberg, M; Mohideen, MAPK; Weinstein, B; Fishman, MC				Zhong, TP; Rosenberg, M; Mohideen, MAPK; Weinstein, B; Fishman, MC			gridlock, an HLH gene required for assembly of the aorta in zebrafish	SCIENCE			English	Article							REPRESSION; RECEPTOR; HOMOLOG; DOMAIN; CLOCHE; ACTS	The first artery and vein of the vertebrate embryo assemble in the trunk by migration and coalescence of angioblasts to form endothelial tubes. The gridlock (grl) mutation in zebrafish selectively perturbs assembly of the artery (the aorta). Here it is shown that grl encodes a basic helix-loop-helix (bHLH) protein belonging to the Hairy/Enhancer of the split family of bHLH proteins. The grl gene is expressed in Lateral plate mesoderm before vessel formation, and thereafter in the aorta and not in the vein. These results suggest that the arterial endothelial identity is established even before the onset of blood flow and implicate the grl gene in assignment of vessel-specific cell fate.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Fishman, MC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, 149 13th St,4th Floor, Boston, MA 02129 USA.	fishman@cvrc.mgh.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055383] Funding Source: NIH RePORTER; NCRR NIH HHS [R01RR0888] Funding Source: Medline; NHLBI NIH HHS [T32HL07208] Funding Source: Medline; NIDDK NIH HHS [R01DK55383] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMEMIYA CT, 1999, ZEBRAFISH GENETICS G, P236; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Burge CB, 1998, N COMP BIOC, V32, P129; Carmeliet P, 1999, NATURE, V401, P657, DOI 10.1038/44304; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Liao W, 1997, DEVELOPMENT, V124, P381; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; PIERPONT MEM, 1986, GENETICS CARDIOVASCU, P13; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhong TP, 1998, GENOMICS, V48, P136, DOI 10.1006/geno.1997.5155	24	323	332	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2000	287	5459					1820	1824		10.1126/science.287.5459.1820	http://dx.doi.org/10.1126/science.287.5459.1820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710309				2022-12-28	WOS:000085775300041
J	Villaveces, A; Cummings, P; Espitia, VE; Koepsell, TD; McKnight, B; Kellermann, AL				Villaveces, A; Cummings, P; Espitia, VE; Koepsell, TD; McKnight, B; Kellermann, AL			Effect of a ban on carrying firearms on homicide rates in 2 Colombian cities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REGRESSION	Context Homicide is a leading cause of death in Colombia, with much of the fatal interpersonal violence concentrated in the country's largest cities. Firearms are involved in as much as 80% of homicides in Colombia. Objective To evaluate the effect of an intermittent police-enforced ban on carrying firearms on the incidence of homicide in urban Colombia. Design Interrupted time-series study with multiple replications. Setting Cali, Colombia, during 1993 and 1994 and Bogota, Colombia, from 1995 through August 1997. Participants The populations of Cali and Bogota. Intervention Carrying of firearms was banned on weekends after paydays, on holidays, and on election days, Enforcement included establishment of police checkpoints and searching of individuals during traffic stops and other routine law enforcement activity. Main Outcome Measure Homicide rates during intervention days were compared with rates during similar days without the intervention; estimates were based on comparisons within the same month, day of week, and time of day. Results There were 4078 homicides in Cali during 1993 and 1994 (114.6 per 100 000 person-years). In Bogota, 9106 homicides occurred from 1995 through August 1997 (61 per 100 000 person-years). The incidence of homicide was lower during periods when the firearm-carrying ban was in effect compared with other periods (multivariate-adjusted rate ratio, 0.86 [95% confidence interval {CI}, 0.76-0.97] for Cali, and 0.87 [95% CI, 0.77-0.98] for Bogota). Conclusion An intermittent citywide ban on the carrying of firearms in 2 Colombian cities was associated with a reduction in homicide rates for both cities.	Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98104 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Hlth Serv, Seattle, WA 98104 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98104 USA; Emory Univ, Rollins Sch Publ Hlth, Dept Int Hlth, Atlanta, GA 30322 USA; Emory Univ, Emory Ctr Injury Control, Dept Int Hlth, Atlanta, GA 30322 USA; Univ Valle, Alcaldia Municipal Cali, Programa DESEPAZ, Cali, Colombia	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University; Rollins School Public Health; Emory University; Universidad del Valle	Villaveces, A (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Box 359960,325 9th Ave, Seattle, WA 98104 USA.	avillav@u.washington.edu		Villaveces, Andres/0000-0002-3725-2741				[Anonymous], INTRO TIME SERIES MO; [Anonymous], 1996, GLOBAL BURDEN DIS CO; CONCHA ACF, 1994, CIUDAD VIOLENCIAS AM, P92; *CTR REF NAC VIOL, 1994, REP COMP LES FAT FAT, P135; ESPITIA VE, 1995, FOCALIZACION VIOLENC; *FED BUR INV, 1994, FBI CRIM US, P13; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; HOSMER DW, 1989, APPL LOGISTIC REGRES, P216; LITTLE RJA, 1987, STAT ANAL MISSING DA, P255; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; *PAN AM HLTH ASS, 1994, HLTH COND AM, P135; *POL METR CAL, 1994, B INF DIAR; *PROGR DEV SEC PEA, 1995, CONS PAR DES SEG PAZ; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P41; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Rubin DB, 1987, MULTIPLE IMPUTATION, P75; SCHAFER JL, 1997, ANAL INCOMPLETE MULT, P109; SHERMAN LW, 1995, KANSAS CITY GUN EXPE, P1; SINGH GK, 1995, MONTHLY VITAL STAT R, V4; *STAT CORP, 1997, STAT REF MAN VERS 6, P797; ZAWITZ MW, 1995, GUNS USED CRIME FIRE, P1; 1995, MMWR MORB MORTAL WKL, V44, P734; 1996, PLAN DESARME	23	69	72	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1205	1209		10.1001/jama.283.9.1205	http://dx.doi.org/10.1001/jama.283.9.1205			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703790				2022-12-28	WOS:000085424100037
J	Odenbreit, S; Puls, J; Sedlmaier, B; Gerland, E; Fischer, W; Haas, R				Odenbreit, S; Puls, J; Sedlmaier, B; Gerland, E; Fischer, W; Haas, R			Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion	SCIENCE			English	Article							VACUOLATING CYTOTOXIN; SHUTTLE MUTAGENESIS; VIRULENCE FACTORS; SYSTEM; PROTEIN; STRAINS; TRANSFORMATION; EXPRESSION	The Gram-negative bacterium Helicobacter pylori is a causative agent of gastritis and peptic ulcer disease in humans. Strains producing the CagA antigen (cagA(+)) induce strong gastric inflammation and are strongly associated with gastric adenocarcinoma and MALT Lymphoma. We show here that such strains translocate the bacterial protein CagA into gastric epithelial cells by a type IV secretion system, encoded by the cag pathogenicity island. CagA is tyrosine-phosphorylated and induces changes in the tyrosine phosphorylation state of distinct cellular proteins. Modulation of host cells by bacterial protein translocation adds a new dimension to the chronic Helicobacter infection with yet unknown consequences.	Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany	University of Munich	Haas, R (corresponding author), Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, Pettenkoferstr 9A, D-80336 Munich, Germany.							Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Blaser MJ, 1996, SCI AM, V274, P104, DOI 10.1038/scientificamerican0296-104; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Fullner KJ, 1996, SCIENCE, V273, P1107, DOI 10.1126/science.273.5278.1107; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Heuermann D, 1998, MOL GEN GENET, V257, P519, DOI 10.1007/s004380050677; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Kahrs AF, 1995, GENE, V167, P53, DOI 10.1016/0378-1119(95)00671-0; POHLNER J, 1993, GENE, V130, P121, DOI 10.1016/0378-1119(93)90354-6; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; Segal ED, 1996, P NATL ACAD SCI USA, V93, P1259, DOI 10.1073/pnas.93.3.1259; Segal ED, 1997, P NATL ACAD SCI USA, V94, P7595, DOI 10.1073/pnas.94.14.7595; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winans SC, 1996, TRENDS MICROBIOL, V4, P64, DOI 10.1016/0966-842X(96)81513-7; XIANG ZY, 1995, INFECT IMMUN, V63, P94, DOI 10.1128/IAI.63.1.94-98.1995	18	983	1040	4	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1497	1500		10.1126/science.287.5457.1497	http://dx.doi.org/10.1126/science.287.5457.1497			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688800				2022-12-28	WOS:000085531600054
J	Over, H; Kim, YD; Seitsonen, AP; Wendt, S; Lundgren, E; Schmid, M; Varga, P; Morgante, A; Ertl, G				Over, H; Kim, YD; Seitsonen, AP; Wendt, S; Lundgren, E; Schmid, M; Varga, P; Morgante, A; Ertl, G			Atomic-scale structure and catalytic reactivity of the RuO2(110) surface	SCIENCE			English	Article							ADSORBATE INTERACTIONS; CARBON-MONOXIDE; CO OXIDATION; RU(0001); OXYGEN; DIFFRACTION; EQUILIBRIUM; KINETICS	The structure of RuO2(110) and the mechanism for catalytic carbon monoxide oxidation on this surface were studied by Low-energy electron diffraction, scanning tunneling microscopy, and density-functional calculations. The RuO2(110) surface exposes bridging oxygen atoms and ruthenium atoms not capped by oxygen, The Latter act as coordinatively unsaturated sites-a hypothesis introduced Long ago to account for the catalytic activity of oxide surfaces-onto which carbon monoxide can chemisorb and from where it can react with neighboring Lattice-oxygen to carbon dioxide, Under steady-state conditions, the consumed Lattice-oxygen is continuously restored by oxygen uptake from the gas phase. The results provide atomic-scale verification of a general mechanism originally proposed by Mars and van Krevelen in 1954 and are likely to be of general relevance for the mechanism of catalytic reactions at oxide surfaces.	Max Planck Gesell, Fritz Haber Inst, Dept Chem Phys, D-14195 Berlin, Germany; Univ La Sapienza, Dipartimento Fis, Ist Nazl Fis Mat, Unita Roma, I-00185 Rome, Italy; Vienna Tech Univ, Inst Allgemeine Phys, A-1040 Vienna, Austria; Univ Trieste, Dipartmento Fis, I-34127 Trieste, Italy; TASC INFM Lab, I-34012 Trieste, Italy	Max Planck Society; Fritz Haber Institute of the Max Planck Society; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Sapienza University Rome; Technische Universitat Wien; University of Trieste	Over, H (corresponding author), Max Planck Gesell, Fritz Haber Inst, Dept Chem Phys, Faradayweg 4-6, D-14195 Berlin, Germany.		Varga, Peter/K-6377-2013; Lundgren, Edvin/F-5551-2010; Seitsonen, Ari P/B-1552-2009; Kim, Young Dok/ABG-8998-2021; Morgante, Alberto/ABF-5813-2020; Morgante, Alberto/C-5199-2010	Seitsonen, Ari P/0000-0003-4331-0650; Morgante, Alberto/0000-0001-9021-2944; Morgante, Alberto/0000-0001-9021-2944; Schmid, Michael/0000-0003-3373-9357				BLYHOLDER G, 1964, J PHYS CHEM-US, V68, P2772, DOI 10.1021/j100792a006; Bonn M, 1999, SCIENCE, V285, P1042, DOI 10.1126/science.285.5430.1042; Bottcher A, 1997, J PHYS CHEM B, V101, P11185, DOI 10.1021/jp9726899; Bottcher A, 1999, PHYS REV B, V60, P14396, DOI 10.1103/PhysRevB.60.14396; Bottcher A, 1999, J PHYS CHEM B, V103, P6267, DOI 10.1021/jp990503v; BRUNO F, UNPUB; CANT NW, 1978, J CATAL, V54, P372, DOI 10.1016/0021-9517(78)90085-4; Charlton G, 1997, PHYS REV LETT, V78, P495, DOI 10.1103/PhysRevLett.78.495; CUNNINGHAM SL, 1974, PHYS REV B, V10, P4988, DOI 10.1103/PhysRevB.10.4988; Diebold U, 1998, SURF SCI, V411, P137, DOI 10.1016/S0039-6028(98)00356-2; Ertl G., 1997, HDB HETEROGENEOUS CA; GLASSFORD KM, 1993, PHYS REV B, V47, P1732, DOI 10.1103/PhysRevB.47.1732; HEINZ K, 1995, REP PROG PHYS, V58, P637, DOI 10.1088/0034-4885/58/6/003; Henrich V.E., 1996, SURFACE SCI METAL OX; HIRSHFELD FL, 1977, ISRAEL J CHEM, V16, P226; LEE HI, 1980, J CATAL, V63, P261, DOI 10.1016/0021-9517(80)90078-0; Mars P., 1954, CHEM ENG SCI, V3, P41; NEUGEBAUER J, 1992, PHYS REV B, V46, P16067, DOI 10.1103/PhysRevB.46.16067; Over H, 1998, PROG SURF SCI, V58, P249, DOI 10.1016/S0079-6816(98)00029-X; OVER H, 1993, PHYS REV LETT, V70, P315, DOI 10.1103/PhysRevLett.70.315; PEDEN CHF, 1986, J PHYS CHEM-US, V90, P1360, DOI 10.1021/j100398a031; PEDEN CHF, 1992, ACS SYM SER, V483, P143; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; PFNUR H, 1983, J CHEM PHYS, V79, P4613, DOI 10.1063/1.446378; SAVCHENKO VI, 1984, KINET CATAL+, V24, P983; SEITSONEN A, 2000, THESIS TU BERLIN; Somorjai G.A., 2010, INTRO SURFACE CHEM C; Stampfl C, 1996, PHYS REV LETT, V77, P3371, DOI 10.1103/PhysRevLett.77.3371; Taylor K.C., 1969, ADV CATAL, V20, P1; Troullier N., 1991, PHYS REV B, V43, P1993; VANHOVE MA, 1985, LOW ENERGY ELECT DIF; Wintterlin J, 1997, SURF SCI, V394, P159, DOI 10.1016/S0039-6028(97)00604-3	32	789	800	19	436	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1474	1476		10.1126/science.287.5457.1474	http://dx.doi.org/10.1126/science.287.5457.1474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688793				2022-12-28	WOS:000085531600047
J	Neda, Z; Ravasz, E; Brechet, Y; Vicsek, T; Barabasi, AL				Neda, Z; Ravasz, E; Brechet, Y; Vicsek, T; Barabasi, AL			The sound of many hands clapping - Tumultuous applause can transform itself into waves of synchronized clapping	NATURE			English	Article									Univ Babes Bolyai, Dept Theoret Phys, RO-3400 Cluj Napoca, Romania; INP Grenoble, ENSEEG, LTPCM, St Martin Dheres, France; Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	Babes Bolyai University from Cluj; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Eotvos Lorand University; University of Notre Dame	Neda, Z (corresponding author), Univ Babes Bolyai, Dept Theoret Phys, Str Kogalniceanu 1, RO-3400 Cluj Napoca, Romania.		Vicsek, Tamas/A-3305-2009; Regan, Erzsébet Ravasz/AAG-8989-2019; Néda, Zoltán/C-3754-2011; Barabasi, Albert-Laszlo/S-6474-2017	Regan, Erzsébet Ravasz/0000-0002-8663-3153; Barabasi, Albert/0000-0002-4028-3522				Bottani S, 1996, PHYS REV E, V54, P2334, DOI 10.1103/PhysRevE.54.2334; Glass L, 1988, CLOCKS CHAOS RHYTHMS; KURAMOTO Y, 1987, J STAT PHYS, V49, P569, DOI 10.1007/BF01009349; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; STROGATZ SH, 1997, SCI AM, V54, P2334; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3	6	438	457	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					849	850		10.1038/35002660	http://dx.doi.org/10.1038/35002660			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706271	Green Submitted			2022-12-28	WOS:000085559200041
J	Larson, EB; Delbanco, T				Larson, EB; Delbanco, T			An 80-year-old man with memory loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALZHEIMERS-DISEASE; DRUG TREATMENTS; COGNITIVE IMPAIRMENT; ELDERLY OUTPATIENTS; DEMENTIA PATIENTS; CONTROLLED TRIAL; SILENT EPIDEMIC; CLINICAL-TRIAL; NURSING-HOME; DOUBLE-BLIND		Univ Washington, Med Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Larson, EB (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,LY318, Boston, MA 02215 USA.							ALEXANDER EM, 1995, J AM GERIATR SOC, V43, P138, DOI 10.1111/j.1532-5415.1995.tb06378.x; BECK JC, 1982, ANN INTERN MED, V97, P231, DOI 10.7326/0003-4819-97-2-231; Birge SJ, 1997, NEUROLOGY, V48, pS36, DOI 10.1212/WNL.48.5_Suppl_7.36S; BREITNER JCS, 1995, EPIDEMIOL REV, V17, P39, DOI 10.1093/oxfordjournals.epirev.a036184; CEDARBAUM JM, 1986, ADV NEUROL, V45, P469; COOPER PJ, 1993, J SAFETY RES, V24, P9, DOI 10.1016/0022-4375(93)90047-Q; DRINKA TJK, 1987, J AM GERIATR SOC, V35, P522, DOI 10.1111/j.1532-5415.1987.tb01398.x; EVANS DA, 1990, MILBANK Q, V68, P267, DOI 10.2307/3350099; Fazel S, 1999, LANCET, V354, P48, DOI 10.1016/S0140-6736(99)01911-X; Graves AB, 1996, AM J EPIDEMIOL, V144, P760, DOI 10.1093/oxfordjournals.aje.a009000; JAGUST WJ, 1987, ARCH NEUROL-CHICAGO, V44, P258, DOI 10.1001/archneur.1987.00520150014011; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Kelly CA, 1997, BRIT MED J, V314, P693, DOI 10.1136/bmj.314.7082.693; KUKULL WA, 1990, NEUROLOGY, V40, P1364, DOI 10.1212/WNL.40.9.1364; KUKULL WA, 1995, AM J EPIDEMIOL, V141, P1059, DOI 10.1093/oxfordjournals.aje.a117370; LARSON EB, 1986, ARCH INTERN MED, V146, P1917, DOI 10.1001/archinte.146.10.1917; Larson EB, 1998, J AM GERIATR SOC, V46, P1576, DOI 10.1111/j.1532-5415.1998.tb01546.x; LARSON EB, 1984, ANN INTERN MED, V100, P417, DOI 10.7326/0003-4819-100-3-417; LARSON EB, 1987, ANN INTERN MED, V107, P169, DOI 10.7326/0003-4819-107-2-169; Larson EB, 1999, HOSP PRACT, V34, P137, DOI 10.1080/21548331.1999.11443935; Larson EB, 1998, ARCH INTERN MED, V158, P941, DOI 10.1001/archinte.158.9.941; LeBars PL, 1997, JAMA-J AM MED ASSOC, V278, P1327, DOI 10.1001/jama.278.16.1327; LEILSON C, 1999, J AM GERIATR SOC, V47, P864; Lim A, 1999, J AM GERIATR SOC, V47, P564, DOI 10.1111/j.1532-5415.1999.tb02571.x; Lovestone S, 1997, LANCET, V350, P232, DOI 10.1016/S0140-6736(05)62221-0; LUI HC, 1997, NEUROEPIDEMIOLOGY, P60; MACE NL, 1981, 36 HOUR DAY; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; MCCORMICK WC, 1994, J AM GERIATR SOC, V42, P517, DOI 10.1111/j.1532-5415.1994.tb04974.x; MCCORMICK WC, 1995, J GEN INTERN MED, V10, P187, DOI 10.1007/BF02600253; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; Moceri VM, 2000, NEUROLOGY, V54, P415, DOI 10.1212/WNL.54.2.415; Mortimer JA, 1995, ALZHEIMERS RES, V1, P67; OKAGAKI JF, 1994, NEUROLOGY, V44, P2203; PEARSON JL, 1993, AM J ALZHEIMERS DISE, V8, P15; Post SG, 1997, JAMA-J AM MED ASSOC, V277, P832, DOI 10.1001/jama.277.10.832; RABINS PV, 1982, JAMA-J AM MED ASSOC, V848, P333; REIFLER BV, 1982, AM J PSYCHIAT, V139, P623; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Ross GW, 1997, JAMA-J AM MED ASSOC, V277, P800, DOI 10.1001/jama.277.10.800; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Shadlen MF, 1999, POSTGRAD MED, V105, P109, DOI 10.3810/pgm.1999.01.500; SNOWDEN MB, 1995, J GERIATR PSYCH NEUR, V8, P154, DOI 10.1177/089198879500800302; Teri L, 1999, J GERONTOL A-BIOL, V54, pM348, DOI 10.1093/gerona/54.7.M348; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; *US C OFF TECHN AS, 1987, LOS MILL MINDS CONFR; WELCH HG, 1992, J AM GERIATR SOC, V40, P221, DOI 10.1111/j.1532-5415.1992.tb02072.x; 1991, CAN CONS C ASS DEM	51	8	7	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					1046	1053		10.1001/jama.283.8.1046	http://dx.doi.org/10.1001/jama.283.8.1046			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284AM	10697065				2022-12-28	WOS:000085308600034
J	de Costa, CM				de Costa, CM			A matter of choice	LANCET			English	Article									Univ Queensland, Cairns Base Hosp, N Queensland Clin Sch, Dept Obstet & Gynaecol, Cairns, Qld 4870, Australia	University of Queensland	de Costa, CM (corresponding author), Univ Queensland, Cairns Base Hosp, N Queensland Clin Sch, Dept Obstet & Gynaecol, POB 902, Cairns, Qld 4870, Australia.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					649	650		10.1016/S0140-6736(99)11158-9	http://dx.doi.org/10.1016/S0140-6736(99)11158-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696998				2022-12-28	WOS:000085615400043
J	Balatsky, AV				Balatsky, AV			Superconductivity - From obscurity to impurity	NATURE			English	Editorial Material							MAGNETIC-IMPURITIES		Univ Calif Los Alamos Natl Lab, Div Theory, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Balatsky, AV (corresponding author), Univ Calif Los Alamos Natl Lab, Div Theory, MS B 262, Los Alamos, NM 87545 USA.							Atkinson WA, 1999, SCIENCE, V285, P57, DOI 10.1126/science.285.5424.57; Balatsky AV, 1999, PHYSICA B, V259-61, P446, DOI 10.1016/S0921-4526(98)00750-9; BALATSKY AV, 1995, PHYS REV B, V51, P15547, DOI 10.1103/PhysRevB.51.15547; Balatsky AV, 1998, PHYS REV LETT, V80, P1972, DOI 10.1103/PhysRevLett.80.1972; BYERS JM, 1993, PHYS REV LETT, V71, P3363, DOI 10.1103/PhysRevLett.71.3363; Pan SH, 2000, NATURE, V403, P746, DOI 10.1038/35001534; STAMP PCE, 1987, J MAGN MAGN MATER, V63-4, P429, DOI 10.1016/0304-8853(87)90628-7; Yazdani A, 1997, SCIENCE, V275, P1767, DOI 10.1126/science.275.5307.1767; Yazdani A, 1999, NATURE, V401, P227, DOI 10.1038/45709	9	23	23	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					717	718		10.1038/35001703	http://dx.doi.org/10.1038/35001703			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693786				2022-12-28	WOS:000085423100033
J	Hofmann, HA; Stevenson, PA				Hofmann, HA; Stevenson, PA			Flight restores fight in crickets	NATURE			English	Article									Univ Leipzig, Inst Zool, D-04103 Leipzig, Germany	Leipzig University	Hofmann, HA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.		Hofmann, Hans A/E-4538-2016; Hofmann, Hans A/A-1437-2008; Stevenson, Paul A/A-2048-2010	Hofmann, Hans A/0000-0002-3335-330X; 				Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CAREW TJ, 1998, MECH RELATIONSHIPS D; CHENG MF, 1992, ANIM BEHAV, V43, P1035, DOI 10.1016/0003-3472(92)90016-3; FRANCIS RC, 1993, P NATL ACAD SCI USA, V90, P7794, DOI 10.1073/pnas.90.16.7794; Hofmann H, 1996, BIOL ZBL, V115, P206; Huber F., 1955, Zeitschrift fuer Tierpsychologie Berlin, V12, P12; KRAVITZ EA, 1988, SCIENCE, V241, P1775, DOI 10.1126/science.2902685; Lorenz Konrad, 1981, FDN ETHOLOGY; STEVENSON PA, 1987, J COMP PHYSIOL A, V161, P115, DOI 10.1007/BF00609460; WU JC, 1990, AM J PSYCHIAT, V147, P14; Yeh SR, 1996, SCIENCE, V271, P366, DOI 10.1126/science.271.5247.366	11	84	88	8	117	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					613	613		10.1038/35001137	http://dx.doi.org/10.1038/35001137			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688185	Bronze			2022-12-28	WOS:000085288200037
J	Gartner, S				Gartner, S			AIDS - HIV infection and dementia	SCIENCE			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; COLONY-STIMULATING FACTOR; EARLY SIV ENCEPHALOPATHY; BONE-MARROW MACROPHAGES; MYELODYSPLASTIC SYNDROMES; CEREBROSPINAL-FLUID; NONHUMAN-PRIMATES; POSITIVE PATIENTS; MONOCYTE SUBSET; BRAIN		Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Gartner, S (corresponding author), Johns Hopkins Univ Hosp, Dept Neurol, Meyer Bldg 6-181,600 N Wolfe St, Baltimore, MD 21287 USA.	sgartner@jhmi.edu						BELL JE, 1993, J INFECT DIS, V168, P818, DOI 10.1093/infdis/168.4.818; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; BUDKA H, 1987, ACTA NEUROPATHOL, V75, P185, DOI 10.1007/BF00687080; CHAKRABARTI L, 1991, AM J PATHOL, V139, P1273; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; DONALDSON YK, 1994, LANCET, V343, P382, DOI 10.1016/S0140-6736(94)91222-X; Dore GJ, 1999, AIDS, V13, P1249, DOI 10.1097/00002030-199907090-00015; Dunne J, 1996, BRIT J BIOMED SCI, V53, P263; GALLO P, 1990, J NEUROIMMUNOL, V29, P105, DOI 10.1016/0165-5728(90)90152-D; GARTNER S, 1999, 6 C RETR OPP INF CHI; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; GOSZTONYI G, 1994, J NEUROPATH EXP NEUR, V53, P521, DOI 10.1097/00005072-199409000-00012; HIRSCH VM, 1991, J INFECT DIS, V163, P976, DOI 10.1093/infdis/163.5.976; HURTREL B, 1991, J MED PRIMATOL, V20, P159; HURTREL B, 1993, RES VIROLOGY, V144, P41, DOI 10.1016/S0923-2516(06)80010-5; KALOUTSI V, 1994, AM J CLIN PATHOL, V101, P123, DOI 10.1093/ajcp/101.2.123; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; KITAGAWA M, 1991, AM J PATHOL, V138, P921; Lane JH, 1996, J NEUROVIROL, V2, P423, DOI 10.3109/13550289609146909; LIU Y, IN PRESS J NEUROVIRO; MANDELL CP, 1995, LAB INVEST, V72, P323; MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245; Munn DH, 1996, BLOOD, V88, P1215, DOI 10.1182/blood.V88.4.1215.bloodjournal8841215; MUNN DH, 1990, BLOOD, V75, P2042; Nottet HSLM, 1996, J IMMUNOL, V156, P1284; Otani I, 1998, AIDS RES HUM RETROV, V14, P1181, DOI 10.1089/aid.1998.14.1181; PANG S, 1990, NATURE, V343, P85, DOI 10.1038/343085a0; Persidsky Y, 1997, J IMMUNOL, V158, P3499; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; SALEH MN, 1995, BLOOD, V85, P2910, DOI 10.1182/blood.V85.10.2910.bloodjournal85102910; Sasseville VG, 1996, AM J PATHOL, V149, P1459; SASSEVILLE VG, 1992, AM J PATHOL, V141, P1021; Schmidtmayerova H, 1996, P NATL ACAD SCI USA, V93, P700, DOI 10.1073/pnas.93.2.700; SCHNEIDER DR, 1985, AM J CLIN PATHOL, V84, P144, DOI 10.1093/ajcp/84.2.144; SHAW GM, 1985, SCIENCE, V227, P177, DOI 10.1126/science.2981429; SINCLAIR E, 1994, J NEUROPATH EXP NEUR, V53, P43, DOI 10.1097/00005072-199401000-00006; Teo I, 1997, J VIROL, V71, P2928, DOI 10.1128/JVI.71.4.2928-2933.1997; TITIUS BR, 1994, ACTA HAEMATOL-BASEL, V91, P144; VAZEUX R, 1991, PATHOBIOLOGY, V59, P214, DOI 10.1159/000163648; Weiser B, 1996, AIDS RES HUM RETROV, V12, P1551, DOI 10.1089/aid.1996.12.1551; WILLIAMS K, 1999, 6 C RETR OPP INF CHI; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999	43	272	284	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					602	604		10.1126/science.287.5453.602	http://dx.doi.org/10.1126/science.287.5453.602			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10691542				2022-12-28	WOS:000084989400032
J	Gourevitch, D				Gourevitch, D			The history of medical teaching	LANCET			English	Article									Ecole Prat Hautes Etud, IVe Sect, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Gourevitch, D (corresponding author), Ecole Prat Hautes Etud, IVe Sect, 45-47 Rue Ecoles, F-75005 Paris, France.								0	10	11	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	DEC	1999	354			S			33	33		10.1016/S0140-6736(99)90376-8	http://dx.doi.org/10.1016/S0140-6736(99)90376-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267DT	10691445				2022-12-28	WOS:000084342100034
J	Anderson, MM; Lauring, AS; Burns, CC; Overbaugh, J				Anderson, MM; Lauring, AS; Burns, CC; Overbaugh, J			Identification of a cellular cofactor required for infection by feline leukemia virus	SCIENCE			English	Article							IMMUNODEFICIENCY DISEASE; RECEPTOR; INTERFERENCE; CELLS; RETROVIRUS; CLONING	Retroviral infection involves continued genetic variation, Leading to phenotypic and immunological selection for more fit virus variants in the host. For retroviruses that cause immunodeficiency, pathogenesis is linked to the emergence of T cell-tropic, cytopathic viruses. Here we show that an immunodeficiency-inducing, T cell-tropic feline Leukemia virus (FeLV) has evolved such that it cannot infect cells unless both a classic multiple membrane-spanning receptor molecule (Pit1) and a second coreceptor or entry factor are present. This second receptor component, which we call FeLIX, was identified as an endogenously expressed protein that is similar to a portion of the FeLV envelope protein. This cellular protein can function either as a transmembrane protein or as a soluble component to facilitate infection.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Overbaugh, J (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.							ALLAN JS, 1990, SCIENCE, V247, P1084, DOI 10.1126/science.2309120; Boomer S, 1997, J VIROL, V71, P8116, DOI 10.1128/JVI.71.11.8116-8123.1997; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; DONAHUE PR, 1991, J VIROL, V65, P4461, DOI 10.1128/JVI.65.8.4461-4469.1991; EGLITIS MA, 1993, J VIROL, V67, P5472, DOI 10.1128/JVI.67.9.5472-5477.1993; JOHANN SV, 1992, J VIROL, V66, P1635, DOI 10.1128/JVI.66.3.1635-1640.1992; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; KUMAR DV, 1989, J VIROL, V63, P2379, DOI 10.1128/JVI.63.5.2379-2384.1989; MCDOUGALL AS, 1994, J VIROL, V68, P2151, DOI 10.1128/JVI.68.4.2151-2160.1994; Moser M, 1998, VIROLOGY, V242, P366, DOI 10.1006/viro.1997.9008; OVERBAUGH J, 1988, SCIENCE, V239, P906, DOI 10.1126/science.2893454; OVERBAUGH J, 1988, NATURE, V332, P731, DOI 10.1038/332731a0; Quigley JG, 2000, BLOOD, V95, P1093, DOI 10.1182/blood.V95.3.1093.003k01_1093_1099; Rasko JEJ, 1999, P NATL ACAD SCI USA, V96, P2129, DOI 10.1073/pnas.96.5.2129; Rohn JL, 1998, J VIROL, V72, P2686, DOI 10.1128/JVI.72.4.2686-2696.1998; SARMA PS, 1971, VIROLOGY, V44, P352, DOI 10.1016/0042-6822(71)90266-2; SOMMERFELT MA, 1990, VIROLOGY, V176, P58, DOI 10.1016/0042-6822(90)90230-O; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; TAKEUCHI Y, 1992, J VIROL, V66, P1219, DOI 10.1128/JVI.66.2.1219-1222.1992; Weiss R, 1985, RNA TUMOR VIRUSES; WEISS RA, 1995, CELL, V82, P531, DOI 10.1016/0092-8674(95)90024-1; [No title captured]	23	95	96	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1828	1830		10.1126/science.287.5459.1828	http://dx.doi.org/10.1126/science.287.5459.1828			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710311				2022-12-28	WOS:000085775300043
J	Dyer, C				Dyer, C			UK home secretary faces new problems over Pinochet	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					532	532		10.1136/bmj.320.7234.532	http://dx.doi.org/10.1136/bmj.320.7234.532			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688545	Green Published			2022-12-28	WOS:000085624000008
J	Gage, FH				Gage, FH			Mammalian neural stem cells	SCIENCE			English	Review							FIBROBLAST GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; ADULT-MOUSE BRAIN; RAT CEREBRAL-CORTEX; DENTATE GYRUS; SUBVENTRICULAR ZONE; HIPPOCAMPAL-NEURONS; ADHESION MOLECULE; OLFACTORY-BULB; IN-VITRO	Neural stem cells exist not only in the developing mammalian nervous system but also in the adult nervous system of all mammalian organisms, including humans. Neural stem cells can also be derived from more primitive embryonic stem cells. The location of the adult stem cells and the brain regions to which their progeny migrate in order to differentiate remain unresolved, although the number of viable Locations is Limited in the adult. The mechanisms that regulate endogenous stem cells are poorly understood. Potential uses of stem cells in repair include transplantation to repair missing cells and the activation of endogenous cells to provide "self-repair." Before the full potential of neural stem cells can be realized, we need to Learn what controls their proliferation, as well as the various pathways of differentiation available to their daughter cells.	Salk Inst Lab Genet, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Lab Genet, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu			NINDS NIH HHS [N01-NS-6-2348] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [N01NS062348] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Altman J. B. S., 1995, ATLAS PRENATAL RAT B; ALVARADO AS, 1998, WOUND REPAIR REGEN, V6, P413; AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; BONFANTI L, 1994, NEUROSCIENCE, V62, P291, DOI 10.1016/0306-4522(94)90333-6; Brasted PJ, 1999, P NATL ACAD SCI USA, V96, P10524, DOI 10.1073/pnas.96.18.10524; Brustle O, 1997, P NATL ACAD SCI USA, V94, P14809, DOI 10.1073/pnas.94.26.14809; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Craig CG, 1996, J NEUROSCI, V16, P2649; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Doe CQ, 1998, J NEUROBIOL, V36, P111, DOI 10.1002/(SICI)1097-4695(199808)36:2<111::AID-NEU2>3.0.CO;2-4; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gaiano N, 1998, J NEUROBIOL, V36, P152, DOI 10.1002/(SICI)1097-4695(199808)36:2<152::AID-NEU4>3.0.CO;2-0; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gritti A, 1999, J NEUROSCI, V19, P3287; Gritti A, 1996, J NEUROSCI, V16, P1091; Hoshimaru M, 1996, P NATL ACAD SCI USA, V93, P1518, DOI 10.1073/pnas.93.4.1518; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; Markakis EA, 1999, J COMP NEUROL, V406, P449; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Noble M, 1999, METH MOL B, V97, P139, DOI 10.1385/1-59259-270-8:139; OLSSON M, 1998, EUR J NEUROSCI, V10, P1040; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; OVERTURF KM, 1997, AM J PATHOL, V151, P1078; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; Parent JM, 1997, J NEUROSCI, V17, P3727; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; PRICE J, 1988, DEVELOPMENT, V104, P473; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; STANFIELD BB, 1988, EXP BRAIN RES, V72, P399; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tao Y, 1996, J COMP NEUROL, V376, P653, DOI 10.1002/(SICI)1096-9861(19961223)376:4<653::AID-CNE11>3.0.CO;2-N; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; van der Kooy D, 2000, SCIENCE, V287, P1439, DOI 10.1126/science.287.5457.1439; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029	87	3632	4144	14	609	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1433	1438		10.1126/science.287.5457.1433	http://dx.doi.org/10.1126/science.287.5457.1433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688783				2022-12-28	WOS:000085531600037
J	Dillon, RJ; Vennard, CT; Charnley, AK				Dillon, RJ; Vennard, CT; Charnley, AK			Pheromones - Exploitation of gut bacteria in the locust	NATURE			English	Article							DESERT LOCUST; SCHISTOCERCA-GREGARIA; METARHIZIUM-ANISOPLIAE; INHIBITION; FLORA		Univ Bath, Dept Biol & Biochem, Microbial Pathogen Grp, Bath BA2 7AY, Avon, England	University of Bath	Dillon, RJ (corresponding author), Univ Bath, Dept Biol & Biochem, Microbial Pathogen Grp, Bath BA2 7AY, Avon, England.			Dillon, Rod/0000-0002-3551-0030				BYERS JA, 1991, BIOL REV, V66, P347, DOI 10.1111/j.1469-185X.1991.tb01146.x; CHARNLEY AK, 1985, J INSECT PHYSIOL, V31, P477, DOI 10.1016/0022-1910(85)90096-4; CRAWFORD RL, 1978, APPL ENVIRON MICROB, V36, P539, DOI 10.1128/AEM.36.4.539-543.1978; Dillon R.J., 1991, P129; DILLON RJ, 1988, CAN J MICROBIOL, V34, P1075, DOI 10.1139/m88-189; DILLON RJ, 1986, J INVERTEBR PATHOL, V47, P350, DOI 10.1016/0022-2011(86)90106-0; DILLON RJ, 1995, J INVERTEBR PATHOL, V66, P72, DOI 10.1006/jipa.1995.1063; FUZEAUBRAESCH S, 1988, J CHEM ECOL, V14, P1023, DOI 10.1007/BF01018790; HUNT J, 1981, J INVERTEBR PATHOL, V38, P378, DOI 10.1016/0022-2011(81)90105-1; LYSENKO O, 1985, ANNU REV MICROBIOL, V39, P673; OBENGOFORI D, 1994, J CHEM ECOL, V20, P2077, DOI 10.1007/BF02066244; STEEDMAN A, 1988, LOCUST HDB, P2	12	155	168	2	49	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					851	851		10.1038/35002669	http://dx.doi.org/10.1038/35002669			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706273				2022-12-28	WOS:000085559200044
J	Lappe, M; Awater, H; Krekelberg, B				Lappe, M; Awater, H; Krekelberg, B			Postsaccadic visual references generate presaccadic compression of space	NATURE			English	Article							EYE-MOVEMENTS; DISPLACEMENT; LOCALIZATION; SACCADES	With every rapid gaze shift (saccade), our eyes experience a different view of the world. Stable perception of visual space requires that points in the new image are associated with corresponding points in the previous image. The brain may use an extraretinal eye position signal to compensate for gaze changes(1,2), or, alternatively, exploit the image contents to determine associated locations(3,4). Support for a uniform extraretinal signal comes from findings that the apparent position of objects briefly flashed around the time of a saccade is often shifted in the direction of the saccade(5-9). This view is challenged, however, by observations that the magnitude(4,10) and direction(11) of the displacement varies across the visual field. Led by the observation that non-uniform displacements typically occurred in studies conducted in slightly illuminated rooms(4,7,10-13), here we determine the dependence of perisaccadic mislocalization on the availability of visual spatial references at various times around a saccade. We find that presaccadic compression(11) occurs only if visual references are available immediately after, rather than before or during, the saccade. Our findings indicate that the visual processes of transsaccadic spatial localization use mainly postsaccadic visual information.	Ruhr Univ Bochum, Dept Zool & Neurobiol, D-44780 Bochum, Germany	Ruhr University Bochum	Lappe, M (corresponding author), Ruhr Univ Bochum, Dept Zool & Neurobiol, D-44780 Bochum, Germany.		Krekelberg, Bart/N-7938-2019	Krekelberg, Bart/0000-0003-1083-6103				BISCHOF N, 1968, PSYCHOL FORSCH, V32, P185, DOI 10.1007/BF00418660; Bockisch CJ, 1999, VISION RES, V39, P1025, DOI 10.1016/S0042-6989(98)00205-3; Cai RH, 1997, NATURE, V386, P601, DOI 10.1038/386601a0; DASSONVILLE P, 1995, VISION RES, V35, P2191, DOI 10.1016/0042-6989(94)00317-3; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; HONDA H, 1993, VISION RES, V33, P709, DOI 10.1016/0042-6989(93)90190-8; Krekelberg B, 2000, VISION RES, V40, P201, DOI 10.1016/S0042-6989(99)00168-6; MACKAY DM, 1970, NATURE, V227, P731, DOI 10.1038/227731a0; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; Miller JM, 1997, NATURE, V386, P550, DOI 10.1038/386550a0; OREGAN JK, 1984, PERCEPT PSYCHOPHYS, V36, P1, DOI 10.3758/BF03206348; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; von Helmholtz H, 1896, HDB PHYSL OPTIK; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503	17	205	205	0	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					892	895		10.1038/35002588	http://dx.doi.org/10.1038/35002588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706286				2022-12-28	WOS:000085559200057
J	Lee, PY; Tse, HF				Lee, PY; Tse, HF			Transient ischaemic attack in a young woman	LANCET			English	Article							NONBACTERIAL THROMBOTIC ENDOCARDITIS; CANCER-PATIENTS; COAGULATION		Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Tse, HF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China.		Tse, Hung-Fat/C-4426-2009	Tse, Hung-Fat/0000-0002-9578-7808				BEDIKIAN A, 1978, MED PEDIATR ONCOL, V4, P149, DOI 10.1002/mpo.2950040211; Edoute Y, 1997, AM J MED, V102, P252, DOI 10.1016/S0002-9343(96)00457-3; KIM HS, 1977, ARCH PATHOL LAB MED, V101, P65; LOPEZ JA, 1987, AM HEART J, V113, P773, DOI 10.1016/0002-8703(87)90719-8; ROSEN P, 1973, AM J MED, V54, P23, DOI 10.1016/0002-9343(73)90079-X	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					622	622		10.1016/S0140-6736(99)11115-2	http://dx.doi.org/10.1016/S0140-6736(99)11115-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696984				2022-12-28	WOS:000085615400015
J	Dahmann, C; Basler, K				Dahmann, C; Basler, K			Opposing transcriptional outputs of hedgehog signaling and engrailed control compartmental cell sorting at the Drosophila A/P boundary	CELL			English	Article							CUBITUS-INTERRUPTUS PROTEIN; KINESIN-RELATED PROTEIN; GENE; EXPRESSION; ADHESION; RECEPTOR; ENCODES; COMPLEX; PATTERN; COSTAL2	The wing imaginal disc is subdivided into two nonintermingling sets of cells, the anterior (A)I and posterior (P) compartments. Anterior cells require reception of the Hedgehog (Hh) signal to segregate from P cells. We provide evidence that Hh signaling controls A/P cell segregation not by directly modifying structural components but by a Cubitus interruptus (Ci)-mediated transcriptional response. A shift in the balance between repressor and activator forms of Ci toward the activator form is necessary and sufficient to define "A-type" cell sorting behavior. Moreover, we show that Engrailed (En), in the absence of Ci, is sufficient to specify "P-type" sorting. We propose that the opposing transcriptional activities of Ci and En control cell segregation at the A/P boundary by regulating a single cell adhesion molecule.	Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Biol, Wintherthurerstr 190, CH-8057 Zurich, Switzerland.	basler@molbio.unizh.ch	Dahmann, Christian/B-5841-2017	Basler, Konrad/0000-0003-3534-1529				Alcedo J, 1997, BIOL CHEM, V378, P583; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BLAIR SS, 1992, DEVELOPMENT, V115, P21; BLAIR SS, 1995, BIOESSAYS, V17, P299, DOI 10.1002/bies.950170406; Blair SS, 1997, DEVELOPMENT, V124, P4053; BRAND AH, 1993, DEVELOPMENT, V118, P401; COLEMAN KG, 1987, GENE DEV, V1, P19, DOI 10.1101/gad.1.1.19; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; FRIEDLANDER DR, 1989, P NATL ACAD SCI USA, V86, P7043, DOI 10.1073/pnas.86.18.7043; Garcia-Bellido A, 1975, Ciba Found Symp, V0, P161; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gustavson E, 1996, GENETICS, V142, P893; HAMA C, 1990, GENE DEV, V4, P1079, DOI 10.1101/gad.4.7.1079; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; LAWRENCE PA, 1982, EMBO J, V1, P827, DOI 10.1002/j.1460-2075.1982.tb01255.x; Lawrence PA, 1997, NATURE, V389, P546, DOI 10.1038/39188; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Pignoni F, 1997, DEVELOPMENT, V124, P271; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Sokal RR, 1995, BIOMETRY; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; TABATA T, 1995, DEVELOPMENT, V121, P3359; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Vincent JP, 1998, INT J DEV BIOL, V42, P311; XU T, 1993, DEVELOPMENT, V117, P1223; ZECCA M, 1995, DEVELOPMENT, V121, P2265	50	127	130	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2000	100	4					411	422		10.1016/S0092-8674(00)80677-7	http://dx.doi.org/10.1016/S0092-8674(00)80677-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693758	Green Accepted, Bronze			2022-12-28	WOS:000085446900004
J	Ivessa, AS; Zhou, JQ; Zakian, VA				Ivessa, AS; Zhou, JQ; Zakian, VA			The Saccharomyces Pif1p DNA helicase and the highly related Rrm3p have opposite effects on replication fork progression in ribosomal DNA	CELL			English	Article							TELOMERIC HETEROCHROMATIN; S-CEREVISIAE; GENE-PRODUCT; CELL-CYCLE; YEAST RDNA; RNA GENES; RECOMBINATION; TRANSCRIPTION; ORIGINS; PROTEIN	Replication of Saccharomyces ribosomal DNA (rDNA) proceeds bidirectionally from origins in a subset of the similar to 150 tandem repeats, but the leftward-moving fork stops when it encounters the replication fork barrier (RFB). The Pif1p helicase and the highly related Rrm3p were rDNA associated in vivo. Both proteins affected rDNA replication but had opposing effects on fork progression. Pif1p helped maintain the RFB. Rrm8p appears to be the replicative helicase for rDNA as it acted catalytically to promote fork progression throughout the rDNA. Loss of Rrm3p increased rDNA breakage and accumulation of rDNA circles, whereas breakage and circles were less common in pif1 cells. These data support a model in which replication fork pausing causes breakage and recombination in the rDNA.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Ivessa, Andreas/0000-0002-7578-1337	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026938, R01GM026938] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26938] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BORST P, 1978, CELL, V15, P705, DOI 10.1016/0092-8674(78)90257-X; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1991, BIOESSAYS, V13, P317, DOI 10.1002/bies.950130702; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Bussiere DE, 1999, MOL MICROBIOL, V31, P1611, DOI 10.1046/j.1365-2958.1999.01287.x; CHRISTMAN MF, 1993, P NATL ACAD SCI USA, V90, P7637, DOI 10.1073/pnas.90.16.7637; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; CRAMER JH, 1980, MOL GEN GENET, V177, P199; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345; Gangloff S, 1996, EMBO J, V15, P1715, DOI 10.1002/j.1460-2075.1996.tb00517.x; Gerber JK, 1997, CELL, V90, P559, DOI 10.1016/S0092-8674(00)80515-2; Gotta M, 1997, EMBO J, V16, P3243, DOI 10.1093/emboj/16.11.3243; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; HARTWELL LH, 1985, GENETICS, V110, P381; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; HERNANDEZ P, 1993, EMBO J, V12, P1475, DOI 10.1002/j.1460-2075.1993.tb05791.x; HUBERMAN JA, 1987, CELL, V51, P473, DOI 10.1016/0092-8674(87)90643-X; KEIL RL, 1993, GENETICS, V135, P711; KIM RA, 1989, CELL, V57, P975, DOI 10.1016/0092-8674(89)90336-X; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LIN YH, 1991, GENETICS, V127, P31; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; Lopez-Estrano C, 1998, J MOL BIOL, V277, P249, DOI 10.1006/jmbi.1997.1607; MARTINPARRAS L, 1992, J BIOL CHEM, V267, P22496; Mizushima T, 1998, J BIOL CHEM, V273, P20847, DOI 10.1074/jbc.273.33.20847; PECK LJ, 1983, P NATL ACAD SCI-BIOL, V80, P6206, DOI 10.1073/pnas.80.20.6206; Rose MD., 1990, METHODS YEAST GENETI; Sanchez JA, 1998, EXP CELL RES, V238, P220, DOI 10.1006/excr.1997.3835; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.3.CO;2-V; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SKRYABIN KG, 1984, NUCLEIC ACIDS RES, V12, P2955, DOI 10.1093/nar/12.6.2955; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; ZAKIAN VA, 1982, PLASMID, V8, P15, DOI 10.1016/0147-619X(82)90037-3	43	217	220	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					479	489		10.1016/S0092-8674(00)80683-2	http://dx.doi.org/10.1016/S0092-8674(00)80683-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693764	Bronze			2022-12-28	WOS:000085446900010
J	Baldo, MA; Thompson, ME; Forrest, SR				Baldo, MA; Thompson, ME; Forrest, SR			High-efficiency fluorescent organic light-emitting devices using a phosphorescent sensitizer	NATURE			English	Article							THIN-FILMS	To obtain the maximum luminous efficiency from an organic material, it is necessary to harness both the spin-symmetric and anti-symmetric molecular excitations (bound electron-hole pairs, or excitons) that result from electrical pumping. This is possible if the material is phosphorescent, and high efficiencies have been observed in phosphorescent(1,2) organic light-emitting devices(3), However, phosphorescence in organic molecules is rare at room temperature. The alternative radiative process of fluorescence is more common, but it is approximately 75% less efficient, due to the requirement of spin-symmetry conservation(4) Here, we demonstrate that this deficiency can be overcome by using a phosphorescent sensitizer to excite a fluorescent dye. The mechanism for energetic coupling between phosphorescent and fluorescent molecular species is a long-range, non-radiative energy transfer: the internal efficiency of fluorescence can be as high as 100%. As an example, we use this approach to nearly quadruple the efficiency of a fluorescent red organic light-emitting device.	Princeton Univ, Dept Elect Engn, Ctr Photon & Optoelectron Mat, Princeton, NJ 08544 USA; Princeton Univ, Princeton Mat Inst, Princeton, NJ 08544 USA; Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	Princeton University; Princeton University; University of Southern California	Forrest, SR (corresponding author), Princeton Univ, Dept Elect Engn, Ctr Photon & Optoelectron Mat, Princeton, NJ 08544 USA.		Thompson, Mark/F-4062-2018	Thompson, Mark/0000-0002-7764-4096				Baldo MA, 1999, PHYS REV B, V60, P14422, DOI 10.1103/PhysRevB.60.14422; Baldo MA, 1999, APPL PHYS LETT, V75, P4, DOI 10.1063/1.124258; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; Berggren M, 1997, NATURE, V389, P466; BRACKMANN U, 1997, LAMBDACHROME LASER D; Bulovic V, 1998, CHEM PHYS LETT, V287, P455, DOI 10.1016/S0009-2614(98)00168-7; Bulovic V, 1999, CHEM PHYS LETT, V308, P317, DOI 10.1016/S0009-2614(99)00580-1; Chen C.H., 1997, MACROMOL S, V125, P49; CHEN TQ, 1997, PHOSPHORUS SULFUR, V125, P1; Cleave V, 1999, ADV MATER, V11, P285, DOI 10.1002/(SICI)1521-4095(199903)11:4<285::AID-ADMA285>3.0.CO;2-N; ERMOLAEV VL, 1963, DOKL AKAD NAUK SSSR+, V149, P1295; FORSTER T, 1959, DISCUSS FARADAY SOC, P7; Garbuzov DZ, 1996, CHEM PHYS LETT, V249, P433, DOI 10.1016/0009-2614(95)01424-1; Klessinger M., 1995, EXCITED STATES PHOTO; O'Brien DF, 1999, APPL PHYS LETT, V74, P442, DOI 10.1063/1.123055; TANG CW, 1989, J APPL PHYS, V65, P3610, DOI 10.1063/1.343409; Van Slyke S. A, 1985, U.S. Patent, Patent No. [US4539507, 4539507]; VANDERDONCKT E, 1994, B SOC CHIM BELG, V103, P207	18	1927	2144	23	504	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					750	753		10.1038/35001541	http://dx.doi.org/10.1038/35001541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693799				2022-12-28	WOS:000085423100046
J	Millonig, JH; Millen, KJ; Hatten, ME				Millonig, JH; Millen, KJ; Hatten, ME			The mouse Dreher gene Lmx1a controls formation of the roof plate in the vertebrate CNS	NATURE			English	Article							MUTANT MOUSE; LIM DOMAIN; PROTEIN; CELLS; EXPRESSION	In the vertebrate central nervous system (CNS), a cascade of signals that originates in the ectoderm adjacent to the neural tube is propagated by the roof plate to dorsalize the neural tube(1). Here we report that the phenotype of the spontaneous neurological mutant mouse dreher (dr)(2-5) results from a failure of the roof plate to develop. Dorsalization of the neural tube is consequently affected: dorsal interneurons in the spinal cord and granule neurons in the cerebellar cortex are lost, and the dorsal vertebral neural arches fail to form. Positional cloning of dreher indicates that the LIM homeodomain protein, Lmx1a, is affected in three different alleles of dreher. Lmx1a is expressed in the roof plate dong the neuraxis during development of the CNS. Thus, Lmx1a is required for development of the roof plate and, in turn, for specification of dorsal cell fates in the CNS and developing vertebrae.	Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA	Rockefeller University	Hatten, ME (corresponding author), Rockefeller Univ, Dev Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.			Millen, Kathleen/0000-0001-9978-675X				Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; ALMASAN A, 1994, GENOMICS, V20, P397, DOI 10.1006/geno.1994.1193; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bergstrom DE, 1999, GENOMICS, V59, P291, DOI 10.1006/geno.1999.5873; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Konrat R, 1997, J BIOL CHEM, V272, P12001, DOI 10.1074/jbc.272.18.12001; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LYONS M, 1996, GENETIC VARIANTS LAB, P195; Millen Kathleen J., 1996, P339; Millonig JH, 1996, MAMM GENOME, V7, P616, DOI 10.1007/s003359900183; PARR BA, 1993, DEVELOPMENT, V119, P247; PEREZALVARADO GC, 1994, NAT STRUCT BIOL, V1, P388, DOI 10.1038/nsb0694-388; PerezAlvarado GC, 1996, J MOL BIOL, V257, P153, DOI 10.1006/jmbi.1996.0153; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; SEKIGUCHI M, 1992, DEV BRAIN RES, V67, P105, DOI 10.1016/0165-3806(92)90030-Z; SEKIGUCHI M, 1994, DEV BRAIN RES, V77, P37, DOI 10.1016/0165-3806(94)90211-9; SIDMAN RL, 1983, GENETICS NEUROLOGICA, P19; WALSTEN D, 1983, J HERED, V74, P421	25	215	222	1	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					764	769		10.1038/35001573	http://dx.doi.org/10.1038/35001573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693804				2022-12-28	WOS:000085423100051
J	Bartlett, RH; Roloff, DW; Custer, JR; Younger, JG; Hirschl, RB				Bartlett, RH; Roloff, DW; Custer, JR; Younger, JG; Hirschl, RB			Extracorporeal life support - The University of Michigan experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE RESPIRATORY-FAILURE; MEMBRANE-OXYGENATION; ADULT PATIENTS; CO2 REMOVAL; VENTILATION; NEWBORN	The University of Michigan experience with extracorporeal life support (ECLS) in 1000 consecutive patients between 1980 and 1998 is the largest series at one institution in the world. Among this patient population, survival to hospital discharge in moribund patients with respiratory failure was 88% in 586 neonates, 70% in 132 children, and 56% in 146 adults. Survival in moribund patients with cardiac failure was 48% in 105 children and 33% in 31 adults. This article describes the University of Michigan's overall ECLS patient experience, the progression of ECLS from laboratory experiments to clinical application at the bedside, the expansion of the technology to other centers, and current ECLS technology and outcomes. Despite the challenges faced in clinical research in this field, our experience and that of others has shown that ECLS saves lives of patients with acute cardiac or pulmonary failure in a variety of clinical settings.	Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bartlett, RH (corresponding author), Univ Michigan, Med Ctr, Dept Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.			Younger, John/0000-0002-0820-0635; Gadepalli, Samir/0000-0001-8268-8723	NICHD NIH HHS [R01 HD15434] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD015434] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON H, 1993, SURGERY, V114, P161; ANDERSON HL, 1990, J THORAC CARDIOV SUR, V99, P1011; ANDERSON HL, 1989, T AM SOC ART INT ORG, V35, P650; BARTLETT R H, 1969, Surgical Forum (Chicago), V20, P152; BARTLETT RH, 1985, PEDIATRICS, V76, P479; BARTLETT RH, 1969, J THORAC CARDIOV SUR, V58, P795, DOI 10.1016/S0022-5223(19)42526-9; BARTLETT RH, 1974, ANN SURG, V180, P850, DOI 10.1097/00000658-197412000-00010; BARTLETT RH, 1982, SURGERY, V92, P425; BARTLETT RH, 1986, CHEST, V89, P684, DOI 10.1378/chest.89.5.684; BARTLETT RH, 1990, EXTRACORPOREAL LIFE, V27; CILLEY RE, 1988, J PEDIATR SURG, V23, P306, DOI 10.1016/S0022-3468(88)80194-5; Conrad SA, 1998, ASAIO J, V44, P848, DOI 10.1097/00002480-199811000-00016; CORNELL RG, 1986, COMMUN STAT THEORY, V15, P159, DOI 10.1080/03610928608829113; DELIUS RE, 1992, CRIT CARE MED, V20, P1216, DOI 10.1097/00003246-199209000-00007; DRINKER PA, 1969, SURGERY, V66, P775; Field D, 1996, LANCET, V348, P75; FOLEY D, IN PRESS ASAIO J; GATTINONI L, 1986, JAMA-J AM MED ASSOC, V256, P881, DOI 10.1001/jama.256.7.881; GERMAN JC, 1980, J PEDIATR SURG, V15, P378, DOI 10.1016/S0022-3468(80)80740-8; Geven W B, 1990, Ned Tijdschr Geneeskd, V134, P2200; GILLE JP, 1976, T AM SOC ART INT ORG, V22, P102; Green TP, 1996, CRIT CARE MED, V24, P323, DOI 10.1097/00003246-199602000-00023; HILL JD, 1972, NEW ENGL J MED, V286, P629, DOI 10.1056/NEJM197203232861204; Kolla S, 1997, ANN SURG, V226, P544, DOI 10.1097/00000658-199710000-00015; Kolla S, 1996, ASAIO J, V42, pM809, DOI 10.1097/00002480-199609000-00103; LEWANDOWSKI K, 1995, ECMO EXTRACORPOREAL, P415; Macha M, 1996, ASAIO J, V42, pM841, DOI 10.1097/00002480-199609000-00109; MOLER FW, 1994, J PEDIATR-US, V124, P875, DOI 10.1016/S0022-3476(05)83174-9; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; OROURKE PP, 1989, PEDIATRICS, V84, P957; Rich PB, 1998, J CRIT CARE, V13, P26, DOI 10.1016/S0883-9441(98)90026-0; Schumacher R E, 1993, ASAIO J, V39, P873, DOI 10.1097/00002480-199310000-00010; SHANLEY CJ, 1994, ANN SURG, V220, P269, DOI 10.1097/00000658-199409000-00004; Toomasian JM., 1988, T AM SOC ART INT ORG, V34, P140; WRIGHT L, 1993, DIFFUSION HIGH TECH; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193; Zwischenberger JB., 1995, EXTRACORPOREAL CARDI	37	241	251	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2000	283	7					904	908		10.1001/jama.283.7.904	http://dx.doi.org/10.1001/jama.283.7.904			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	281WT	10685715				2022-12-28	WOS:000085185000029
J	Radajewski, S; Ineson, P; Parekh, NR; Murrell, JC				Radajewski, S; Ineson, P; Parekh, NR; Murrell, JC			Stable-isotope probing as a tool in microbial ecology	NATURE			English	Article							BACTERIA; POPULATIONS; SOIL	Microorganisms are responsible for driving the biogeochemical cycling of elements on Earth. Despite their importance and vast diversity(1), the taxonomic identity of the microorganisms involved in any specific process has usually been confined to that small fraction of the microbiota that has been isolated and cultivated. The recent coupling of molecular biological methods with stable-isotope abundance in biomarkers has provided a cultivation-independent means of linking the identity of bacteria with their function in the environment(2,3). Here we show that C-13-DNA, produced during the growth of metabolically distinct microbial groups on a C-13-enriched carbon source, can be resolved from C-12- DNA by density-gradient centrifugation. DNA isolated from the target group of microorganisms can be characterized taxonomically and functionally by gene probing and sequence analysis. Application of this technique to investigate methanol-utilizing microorganisms in soil demonstrated the involvement of members of two phylogenetically distinct groups of eubacteria; the alpha-proteobacterial and Acidobacterium lineages. Stable-isotope probing thus offers a powerful new technique for identifying microorganisms that are actively involved in specific metabolic processes under conditions which approach those occurring in situ.	Univ Warwick, Dept Sci Biol, Coventry CV4 7AL, W Midlands, England; Inst Terr Ecol, Merlewood Res Stn, Grange Sands LA11 6JU, Cumbria, England	University of Warwick; UK Centre for Ecology & Hydrology (UKCEH)	Murrell, JC (corresponding author), Univ Warwick, Dept Sci Biol, Coventry CV4 7AL, W Midlands, England.		Murrell, John C/B-1443-2012					AMANN RI, 1992, APPL ENVIRON MICROB, V58, P614, DOI 10.1128/AEM.58.2.614-623.1992; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Boschker HTS, 1998, NATURE, V392, P801, DOI 10.1038/33900; Dedysh SN, 1998, SCIENCE, V282, P281, DOI 10.1126/science.282.5387.281; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; KISHIMOTO N, 1991, CURR MICROBIOL, V22, P1, DOI 10.1007/BF02106205; Lee N, 1999, APPL ENVIRON MICROB, V65, P1289; Lidstrom M. E., 1992, The prokaryotes: a handbook on the biology of bacteria: ecophysiology, isolation, identification, applications, vol.I., P431; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; McDonald IR, 1997, APPL ENVIRON MICROB, V63, P3218, DOI 10.1128/AEM.63.8.3218-3224.1997; MESELSON M, 1958, P NATL ACAD SCI USA, V44, P671, DOI 10.1073/pnas.44.7.671; MOFFAT AJ, 1990, SOIL USE MANAGE, V6, P46, DOI 10.1111/j.1475-2743.1990.tb00797.x; MURRELL JC, 1992, METHANE METHANOL UTI; Nogales B, 1999, ENVIRON MICROBIOL, V1, P199, DOI 10.1046/j.1462-2920.1999.00024.x; Nold SC, 1999, FEMS MICROBIOL ECOL, V29, P81, DOI 10.1111/j.1574-6941.1999.tb00600.x; Ouverney CC, 1999, APPL ENVIRON MICROB, V65, P1746; Roslev P, 1999, APPL ENVIRON MICROB, V65, P4064; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Sambrook J., 2002, MOL CLONING LAB MANU; Starr M. P., 1981, PROKARYOTES; Stein JL, 1996, J BACTERIOL, V178, P591, DOI 10.1128/jb.178.3.591-599.1996; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Yeates C, 1998, LETT APPL MICROBIOL, V27, P49, DOI 10.1046/j.1472-765X.1998.00383.x	26	835	910	15	648	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					646	649		10.1038/35001054	http://dx.doi.org/10.1038/35001054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688198				2022-12-28	WOS:000085288200050
J	Snyderman, R; Holmes, EW				Snyderman, R; Holmes, EW			Medical research - Oversight mechanisms for clinical research	SCIENCE			English	Article									Duke Univ, Hlth Syst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Durham, NC 27710 USA; Duke Univ, Sch Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Snyderman, R (corresponding author), Duke Univ, Hlth Syst, DUMC 3701, Durham, NC 27710 USA.	snyde001@mc.duke.edu	Holmes, Edward/GVR-9499-2022					Eichenwald Kurt, 1999, N Y Times Web, pA16; Kaplan S, 1999, US News World Rep, V127, P34; Kass NE, 1996, KENNEDY INST ETHIC J, V6, P271; Mandel HG, 1999, SCIENCE, V285, P1674; SNYDERMAN R, 2000, REPORT AAMC TASK FOR, V1; Varmus H, 1997, NEW ENGL J MED, V337, P1003, DOI 10.1056/NEJM199710023371411	6	16	17	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					595	+		10.1126/science.287.5453.595	http://dx.doi.org/10.1126/science.287.5453.595			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10691540				2022-12-28	WOS:000084989400028
J	Baker, S; Priest, P; Jackson, R				Baker, S; Priest, P; Jackson, R			Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; DRUG-TREATMENT; NEW-ZEALAND; GUIDELINES; MANAGEMENT; TRIALS; METAANALYSIS; DYSLIPIDEMIA; FRAMINGHAM	Objective To estimate the impact of using thresholds based on absolute risk of cardiovascular disease to target drug treatment to lower blood pressure in the community. Design Modelling of three thresholds of treatment for hypertension based on the absolute risk of cardiovascular disease. 5 year risk of disease was estimated for each participant using an equation to predict risk. Net predicted impact of the thresholds on the number of people treated and the number of disease events averted over 5 years was calculated Setting Auckland, New Zealand. Participants 2158 men and women aged 35-79 veers randomly sampled from the general electoral rolls. Main outcome measures Predicted 5 year risk of cardiovascular disease event estimated number of people for whom treatment would be recommended and disease events averted over 5 years at different treatment thresholds. Results 46 374 (12%) Auckland residents aged 35-79 receive drug treatment to lower their blood pressure, averting an estimated 1689 disease events: over 5 years. Restricting treatment to individuals with blood pressure greater than or equal to 170/100 mm Hg and those with blood pressure between 150/90-169/99 mm Hg who have a predicted 5 year risk of disease greater than or equal to 10% would increase the net number for whom treatment would be recommended by 19 401. This 42% relative increase is predicted to avert 1139/1689 (68%) additional disease events overall over 5 years compared with current treatment. If the threshold for 5 year risk of disease is set at 15% the number recommended for treatment increases by < 10% but about 620/1689 (37%) additional events can be averted. A 20% threshold decreases the net number of patients recommended fur treatment by about 10% but averts 204/1689 (12%) more disease events than current treatment. Conclusions Implementing treatment guidelines that use treatment thresholds based on absolute risk could significantly improve the efficiency of drug treatment to lower blood pressure in primary care.	Univ Auckland, Fac Med & Hlth Sci, Dept Community Hlth, Auckland 1, New Zealand; Univ Oxford Wolfson Coll, Oxford OX2 6UD, England; Hlth Funding Author, Auckland, New Zealand	University of Auckland; University of Oxford	Jackson, R (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Community Hlth, Private Bag 92019, Auckland 1, New Zealand.	rt.jackson@auckland.co.nz		Jackson, Rod/0000-0001-5914-6934				ALLAIN CC, 1974, CLIN CHEM, V20, P470; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; BRAND RJ, 1976, CIRCULATION, V53, P348, DOI 10.1161/01.CIR.53.2.348; *COR SERV COMM, 1995, GUID MAN RAIS BLOOD; Fahey TP, 1996, BMJ-BRIT MED J, V313, P93, DOI 10.1136/bmj.313.7049.93; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; INSUA JT, 1994, ANN INTERN MED, V121, P355, DOI 10.7326/0003-4819-121-5-199409010-00008; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; JOHANNESSON M, 1994, MED DECIS MAKING, V14, P236, DOI 10.1177/0272989X9401400305; LEAVERTON PE, 1987, J CHRON DIS, V40, P775, DOI 10.1016/0021-9681(87)90129-9; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; MACMAHON S, 1993, J VASC MED BIOL, V4, P265; Mann JI, 1996, NEW ZEAL MED J, V109, P224; MANN JI, 1993, NEW ZEAL MED J, V106, P133; MCGEE D, 1976, FRAMINGHAM STUDY EPI; MULROW CD, 1994, JAMA-J AM MED ASSOC, V272, P1932, DOI 10.1001/jama.272.24.1932; North D, 1996, NEW ZEAL MED J, V109, P134; *NZ GUID GROUP, 2000, MAN RAIS BLOOD PRESS; PEDERSEN TR, 1994, LANCET, V344, P1383; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X; Wood D, 1998, HEART, V80, pS1	28	40	40	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					680	685		10.1136/bmj.320.7236.680	http://dx.doi.org/10.1136/bmj.320.7236.680			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710577	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000085895300021
J	Kastan, DJ; Burke, TH				Kastan, DJ; Burke, TH			Retroperitoneal hemorrhage.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Henry Ford Hosp, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Kastan, DJ (corresponding author), Henry Ford Hosp, Detroit, MI 48202 USA.								0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2000	342	10					702	702		10.1056/NEJM200003093421005	http://dx.doi.org/10.1056/NEJM200003093421005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ZW	10706900				2022-12-28	WOS:000085708800005
J	Albers, GW; Bates, VE; Clark, WM; Bell, R; Verro, P; Hamilton, SA				Albers, GW; Bates, VE; Clark, WM; Bell, R; Verro, P; Hamilton, SA			Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE ISCHEMIC STROKE; THROMBOLYSIS; PA	Context Tissue-type plasminogen activator (tPA) is the only therapy for acute ischemic stroke approved by the Food and Drug Administration. Objective To assess the safety profile and to document clinical outcomes and adverse events in patients treated with intravenous tPA for acute stroke in clinical practice. Design and Setting Prospective, multicenter study of consecutive patients enrolled between February 1997 and December 1998 at 57 medical centers in the United States (24 academic and 33 community). Intervention Intravenous tPA (recombinant alteplase). Patients Three hundred eighty-nine patients with a mean age of 69 years (range, 28-100 years); 55% were men. Main Outcome Measures Time intervals between stroke symptom onset, hospital arrival, and treatment with tPA; pretreatment computed tomographic scan results, intracerebral hemorrhage, and major systemic bleeding. The modified Rankin Scale score was used to assess clinical outcomes at 30 days. Results Median time from stroke onset to treatment was 2 hours 44 minutes, and the median baseline National Institutes of Health Stroke Scale score was 13. The 30-day mortality rate was 13%. At 30 days after treatment, 35% of patients had very favorable outcomes (modified Rankin score, 0-1) and 43% were functionally independent (modified Ran kin score, 0-2). Thirteen patients (3.3%) experienced symptomatic intracerebral hemorrhage, including 7 who died. Twenty-eight patients (8.2%) had asymptomatic intracerebral hemorrhage within 3 days of treatment with tPA. Protocol violations were reported for 127 patients (32.6%), and included treatment with tPA more than 3 hours after symptom onset in 13.4%, treatment with anticoagulants within 24 hours of tPA administration in 9.3%, and tPA administration despite systolic blood pressure exceeding 185 mm Hg in 6.7%. A multivariate analysis found predictors of favorable outcome to be a less severe baseline National Institutes of Health Stroke Scale score, absence of specific abnormalities (effacement or hypodensity of >33% of the middle cerebral artery territory or a hyperdense middle cerebral artery) on the baseline computed tomographic scan, an age of 85 years or younger, and a lower mean arterial pressure at baseline. Conclusions This study, conducted at multiple institutions throughout the United States, suggests that favorable clinical outcomes and low rates of symptomatic intracerebral hemorrhage can be achieved using tPA for stroke treatment.	Stanford Univ, Med Ctr, Stanford Stroke Ctr, Palo Alto, CA 94304 USA; Millard Fillmore Hosp, Dent Neurol Inst, Buffalo, NY USA; Oregon Hlth & Sci Univ, Oregon Stroke Ctr, Portland, OR 97201 USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Seton Hall Univ, Edison, NJ USA; Genentech Inc, San Francisco, CA 94080 USA	Stanford University; State University of New York (SUNY) System; Oregon Health & Science University; Jefferson University; Seton Hall University; Roche Holding; Genentech	Albers, GW (corresponding author), Stanford Univ, Med Ctr, Stanford Stroke Ctr, 701 Welch Rd,B325, Palo Alto, CA 94304 USA.	albers@leland.stanford.edu		Albers, Gregory/0000-0003-0263-4632				Adams HP, 1996, CIRCULATION, V94, P1167, DOI 10.1161/01.CIR.94.5.1167; Adams HP, 1996, NEUROLOGY, V47, P835; Albers GW, 1998, CHEST, V114, p683S, DOI 10.1378/chest.114.5_Supplement.683S; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Brott T, 1997, STROKE, V28, P2119, DOI 10.1161/01.STR.28.11.2119; Chiu D, 1998, STROKE, V29, P18, DOI 10.1161/01.STR.29.1.18; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Grond M, 1998, STROKE, V29, P1544, DOI 10.1161/01.STR.29.8.1544; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Katzan IL, 1999, STROKE, V30, P266; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Lopez-Yunez AM, 1999, STROKE, V30, P264, DOI 10.1161/01.STR.30.11.2495; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Marler JR, 1999, STROKE, V30, P244; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Villar-Cordova C, 1998, NEUROLOGY, V50, P1491, DOI 10.1212/WNL.50.5.1491; Wang DZ, 2000, STROKE, V31, P77, DOI 10.1161/01.STR.31.1.77; Zweifler RM, 1998, NEUROLOGY, V50, P501, DOI 10.1212/WNL.50.2.501	19	508	529	2	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1145	1150		10.1001/jama.283.9.1145	http://dx.doi.org/10.1001/jama.283.9.1145			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703776	Bronze			2022-12-28	WOS:000085424100023
J	Breedveld, FC				Breedveld, FC			Therapeutic monoclonal antibodies	LANCET			English	Article							NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; RANDOMIZED TRIAL; CROHNS-DISEASE; REDUCTION; PLACEBO; CA2	The therapeutic potential of monoclonal antibodies (mAb) was quickly realised after the hybridoma technique allowed their development in the mid 1970s. Chimeric humanised and fully humanised mAb can now be made by recombinant engineering. About a quarter of all biotech drugs in development are mAb, and around 30 products are in use or being investigated. Licensed products are available for inhibition of alloimmune and autoimmune reactivity, and for antitumour, antiplatelet, or antiviral therapy. short-term side-effects are tolerable and as expected, although long-term safety remains to be elucidated. The cost-effectiveness and quality-of-life benefits of the use of mAb in patients who are usually seriously and chronically ill also needs studying. The therapeutic use of mAb is now established, and is perhaps the first example of how the "new biology" and the understanding of underlying molecular mechanisms has benefited patients.	Leiden Univ, Med Ctr, Dept Rheumatol C4 R, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Breedveld, FC (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol C4 R, POB 9600, NL-2300 RC Leiden, Netherlands.							ALEGRE ML, 1992, J IMMUNOL, V148, P3461; Baselga J, 1999, SEMIN ONCOL, V26, P78; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Breedveld F, 1998, EUR CYTOKINE NETW, V9, P233; Choy EHS, 1996, ARTHRITIS RHEUM, V39, P52, DOI 10.1002/art.1780390107; Czuczman MS, 1999, J CLIN ONCOL, V17, P268, DOI 10.1200/JCO.1999.17.1.268; de Geus B, 1998, RES IMMUNOL, V149, P533, DOI 10.1016/S0923-2494(98)80001-1; Dyer MJS, 1999, SEMIN ONCOL, V26, P52; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Feldmann M, 1997, ADV IMMUNOL, V64, P283, DOI 10.1016/S0065-2776(08)60891-3; GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Kahan BD, 1999, TRANSPLANTATION, V67, P276, DOI 10.1097/00007890-199901270-00016; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LAUGHLIN P, 1998, J CLIN ONCOL, V16, P2824; Lipsky P, 1999, ARTHRITIS RHEUM, V42, pS401; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Malley R, 1998, J INFECT DIS, V178, P1555, DOI 10.1086/314523; Nashan B, 1997, LANCET, V350, P1193, DOI 10.1016/S0140-6736(97)09278-7; Nashan B, 1999, TRANSPLANTATION, V67, P110, DOI 10.1097/00007890-199901150-00019; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Simoons ML, 1997, LANCET, V349, P1429; SLAMON D, 1998, P AN M AM SOC CLIN, V17, P98; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; TOPOL EJ, 1994, LANCET, V343, P881, DOI 10.1016/S0140-6736(94)90007-8; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Vallhonrat H, 1999, TRANSPLANTATION, V67, P253, DOI 10.1097/00007890-199901270-00011; VanDeventer SJH, 1997, GUT, V40, P443, DOI 10.1136/gut.40.4.443; Vincenti F, 1997, TRANSPLANTATION, V63, P33, DOI 10.1097/00007890-199701150-00007; Waldmann H, 1998, ANNU REV IMMUNOL, V16, P619, DOI 10.1146/annurev.immunol.16.1.619; Weiner LM, 1999, SEMIN ONCOL, V26, P41	33	213	246	1	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					735	740		10.1016/S0140-6736(00)01034-5	http://dx.doi.org/10.1016/S0140-6736(00)01034-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703815				2022-12-28	WOS:000085615600042
J	Jadad, AR; Moher, M; Browman, GP; Booker, L; Sigouin, C; Fuentes, M; Stevens, R				Jadad, AR; Moher, M; Browman, GP; Booker, L; Sigouin, C; Fuentes, M; Stevens, R			Systematic reviews and meta-analyses on treatment of asthma: critical evaluation	BRITISH MEDICAL JOURNAL			English	Article							ACUTE CHILDHOOD ASTHMA; INHALED CORTICOSTEROIDS; CONTROLLED TRIALS; CLINICAL-TRIALS; METAANALYSIS; EFFICACY; QUALITY; SALMETEROL; ARTICLES; THERAPY	Objective To evaluate the clinical, methodological, and reporting aspects of systematic reviews and meta-analyses on the treatment of asthma and to compare those published by the Cochrane Collaboration with those published in paper based journals. Design. Analysis of studies identified from Medline, CINAHL. HealthSTAR, EMBASE, Cochrane Library, personal collections, and reference lists. Studies Articles describing a systematic review or a meta-analysis of the treatment of asthma that were published as a full report, in any language or format, in a peer reviewed journal or the Cochrane Library. Main outcome measures General characteristics of studies reviewed and methodological characteristics (sources of articles; language restrictions; format, design and publication status of studies included; type of data synthesis; and methodological quality). Results 50 systematic reviews and meta-analyses were included. More than half were published in the past two years. Twelve reviews were published in the Cochrane Library and 38 were published in 2 peer reviewed journals. Forced expiratory volume in one second was the most frequently used outcome, but few reviews evaluated the effect of treatment on costs or patient preferences. Forty reviews were judged to have serious or extensive nd rvs. All six reviews associated with industry were in this group. Seven of the 10 most rigorous reviews were published in the Cochrane Library. Conclusions Most reviews published in peer reviewed journals or funded by industry have serious methodological flaws that limit their value to guide decisions. Cochrane reviews are more rigorous and better reported than those published in peer reviewed journals.	McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; Univ Oxford, Inst Hlth Sci, Oxford OX3 7LF, England; Foresight Consultants, Dundas, ON L9H 2R5, Canada	McMaster University; University of Oxford	Jadad, AR (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada.							ABRAMSON MJ, 1995, AM J RESP CRIT CARE, V151, P969; ABRAMSON MJ, ALLERGEN SPECIFIC IM; ABRAMSON MJ, 1998, COCHRANE LIB; ALLEN DB, 1994, J ALLERGY CLIN IMMUN, V93, P967, DOI 10.1016/S0091-6749(94)70043-5; Amirav I, 1997, ARCH PEDIAT ADOL MED, V151, P876, DOI 10.1001/archpedi.1997.02170460014003; ASSENDELFT WJJ, 1995, JAMA-J AM MED ASSOC, V274, P1942, DOI 10.1001/jama.274.24.1942; BARNES CL, 1993, ANN PHARMACOTHER, V27, P464; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Barnes N, 1998, J ALLERGY CLIN IMMUN, V101, pS460, DOI 10.1016/S0091-6749(98)70160-5; Barnes NC, 1998, RESP MED, V92, P95, DOI 10.1016/S0954-6111(98)90039-7; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; BERNARDBONNIN AC, 1995, J ALLERGY CLIN IMMUN, V95, P34, DOI 10.1016/S0091-6749(95)70150-8; Bero LA, 1996, INT J TECHNOL ASSESS, V12, P209, DOI 10.1017/S0266462300009582; BIELORY L, 1994, ANN ALLERGY, V73, P89; Calpin C, 1997, J ALLERGY CLIN IMMUN, V100, P452, DOI 10.1016/S0091-6749(97)70134-9; CATES CJ, COMP HOLDING CHAMBER; Davies B, 1998, RESP MED, V92, P256, DOI 10.1016/S0954-6111(98)90105-6; DAVIES H, 1998, COCHRANE LIB; DAVIES H, METHOTREXATE STEROID; Devine EC, 1996, RES NURS HEALTH, V19, P367, DOI 10.1002/(SICI)1098-240X(199610)19:5<367::AID-NUR1>3.0.CO;2-O; Droogan J, 1997, Nurs Times, V93, P45; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GIBSON PG, 1998, COCHRANE LIB; GIBSON PG, EFFECTS SELF MANAGEM; GIBSON PG, EFFECTS LTD INFORMAT; Goodman DC, 1996, PEDIATR PULM, V21, P211, DOI 10.1002/(SICI)1099-0496(199604)21:4<211::AID-PPUL2>3.0.CO;2-R; Gosselink HA, 1993, J REHABILITATION SCI, V6, P66; Grunfeld A.F, 1996, CAN RESPIR J, V3, P322, DOI [10.1155/1996/254627, DOI 10.1155/1996/254627]; HAMMARQUIST C, HOUSE DUST MITE CONT; HAMMERQUIST C, 1998, COCHRANE LIB; HATOUM HT, 1994, ANN PHARMACOTHER, V28, P1285; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Jadad AR, 1996, J CLIN EPIDEMIOL, V49, P235, DOI 10.1016/0895-4356(95)00062-3; Jadad AR, 1998, MED DECIS MAKING, V18, P2, DOI 10.1177/0272989X9801800102; Kelloway JS, 1997, ANN PHARMACOTHER, V31, P1012, DOI 10.1177/106002809703100912; Kelly HW, 1998, ANN PHARMACOTHER, V32, P220, DOI 10.1345/aph.17014; LARSEN JS, 1993, ANN PHARMACOTHER, V27, P898, DOI 10.1177/106002809302700718; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; LINDE K, ACUPUNCTURE TREATMEN; LINDE K, HOMEOPATHY CHRONIC A; LITTENBERG B, 1988, JAMA-J AM MED ASSOC, V259, P1678, DOI 10.1001/jama.259.11.1678; Marin MG, 1997, CHEST, V112, P29, DOI 10.1378/chest.112.1.29; MEYER JM, 1993, ANN PHARMACOTHER, V27, P1478, DOI 10.1177/106002809302701214; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; MOHER D, 1999, QUOROM GROUP IMPROVI; Moore RH, 1998, CHEST, V113, P1095, DOI 10.1378/chest.113.4.1095; MULLEN M, 1993, JAMA-J AM MED ASSOC, V270, P1842, DOI 10.1001/jama.270.15.1842; MULROW CD, 1995, SYSTEMATIC REV, P1; Negro J M, 1997, Allergol Immunopathol (Madr), V25, P209; OByrne PM, 1997, ANN INTERN MED, V127, P472, DOI 10.7326/0003-4819-127-6-199709150-00009; OBYRNE PM, 1995, J AEROSOL MED, V8, pS39; OSMOND MH, 1995, ACAD EMERG MED, V2, P651, DOI 10.1111/j.1553-2712.1995.tb03607.x; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; OXMAN AD, 1988, CAN MED ASSOC J, V138, P687; PANTON J, FAMILY THERAPY TREAT; PARISH RC, 1993, ANN PHARMACOTHER, V27, P599, DOI 10.1177/106002809302700515; Petticrew M, 1997, Nurs Times, V93, P53; PLOTNICK LH, 1998, COCHRANE LIB; PLOTNICK LH, EFFICACY SAFETY COMB; ROWE BH, 1992, AM J EMERG MED, V10, P301, DOI 10.1016/0735-6757(92)90007-K; ROWE BH, 1998, COCHRANE LIB; ROWE BH, EFFECTIVENESS CORTIC; Sacks HS, 1996, MT SINAI J MED, V63, P216; SACKS HS, 1992, MED USES STATISTICS, P427; Self T H, 1992, J Am Board Fam Pract, V5, P281; SHEA B, 1999, 7 COCHR C; Smith LJ, 1996, ARCH INTERN MED, V156, P2181, DOI 10.1001/archinte.156.19.2181; SPOONER CH, 1998, COCHRANE LIB; SPOONER CH, NEDOCROMIL SODIUM SI; Turner MO, 1997, ARCH INTERN MED, V157, P1736, DOI 10.1001/archinte.157.15.1736; Van der Palen J, 1998, RESP MED, V92, P668, DOI 10.1016/S0954-6111(98)90516-9; VANDERKUY PHM, 1993, PHARM WEEKBLAD, V128, P1293; VanGanse E, 1997, EUR RESPIR J, V10, P2216, DOI 10.1183/09031936.97.10102216; Verberne AAPH, 1998, RESP MED, V92, P777, DOI 10.1016/S0954-6111(98)90012-9; Vickers A. J., 1997, COMPLEMENTARY THERAP, V5, P202	75	161	171	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					537	540D		10.1136/bmj.320.7234.537	http://dx.doi.org/10.1136/bmj.320.7234.537			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688558	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000085624000020
J	Millane, T; Jackson, G; Gibbs, CR; Lip, GYH				Millane, T; Jackson, G; Gibbs, CR; Lip, GYH			ABC of heart failure - Acute and chronic management strategies	BRITISH MEDICAL JOURNAL			English	Article									City Hosp, Birmingham, W Midlands, England; Guys & St Thomas Hosp, London SE1 9RT, England	University of Birmingham; Guy's & St Thomas' NHS Foundation Trust	Millane, T (corresponding author), City Hosp, Birmingham, W Midlands, England.							DARGIE HJ, 1994, BMJ-BRIT MED J, V308, P321, DOI 10.1136/bmj.308.6924.321; Hunt SA, 1998, JAMA-J AM MED ASSOC, V280, P1692, DOI 10.1001/jama.280.19.1692; Remme WJ, 1997, EUR HEART J, V18, P736; WILLIAMS JF, 1995, J AM COLL CARDIOL, V26, P1376	4	25	28	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					559	562		10.1136/bmj.320.7234.559	http://dx.doi.org/10.1136/bmj.320.7234.559			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688565	Green Published			2022-12-28	WOS:000085624000026
J	Chu, K; Vojtchovsky, J; McMahon, BH; Sweet, RM; Berendzen, J; Schlichting, I				Chu, K; Vojtchovsky, J; McMahon, BH; Sweet, RM; Berendzen, J; Schlichting, I			Structure of a ligand-binding intermediate in wild-type carbonmonoxy myoglobin	NATURE			English	Article							MOLECULAR-DYNAMICS; PROTEINS; RELAXATION; MUTANTS; STATES; XENON; SITE	Small molecules such as NO, O-2, CO or H-2 are important biological ligands that bind to metalloproteins to function crucially in processes such as signal transduction, respiration and catalysis. A key issue for understanding the regulation of reaction mechanisms in these systems is whether ligands gain access to the binding sites through specific channels and docking sites, or by random diffusion through the protein matrix. A model system for studying this issue is myoglobin, a simple haem protein. Myoglobin has been studied extensively by spectroscopy, crystallography, computation and theory(1-11). It serves as an aid to oxygen diffusion but also binds carbon mono nide, a byproduct of endogenous haem catabolism. Molecular dynamics simulations(3-5), random mutagenesis(6) and flash photolysis studies(7-10) indicate that ligand migration occurs through a limited number of pathways involving docking sites. Here we report the 1.4 Angstrom resolution crystal structure of a ligand-binding intermediate in carbonmonoxy myoglobin that may have far-reaching implications for understanding the dynamics of ligand binding and catalysis.	Univ Calif Los Alamos Natl Lab, Biophys Grp P21, Los Alamos, NM 87545 USA; Univ Vermont, Dept Phys, Burlington, VT 05405 USA; Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; Univ Calif Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Vermont; Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory	Chu, K (corresponding author), Univ Calif Los Alamos Natl Lab, Biophys Grp P21, MS-D454, Los Alamos, NM 87545 USA.		Schlichting, Ilme/I-1339-2013	Berendzen, Joel/0000-0002-9454-9074				ABADAN Y, 1995, BIOPHYS J, V68, P2497, DOI 10.1016/S0006-3495(95)80432-7; AHMED AM, 1991, CHEM PHYS, V158, P329, DOI 10.1016/0301-0104(91)87076-8; ALBEN JO, 1982, P NATL ACAD SCI-BIOL, V79, P3744, DOI 10.1073/pnas.79.12.3744; Anfinrud P, 1999, P NATL ACAD SCI USA, V96, P8328, DOI 10.1073/pnas.96.15.8328; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; BRUNGER AT, 1992, X PLOR SYSTEM CRYSTA; Brunori M, 1999, TRENDS BIOCHEM SCI, V24, P253, DOI 10.1016/S0968-0004(99)01421-8; Carlson ML, 1996, BIOCHEMISTRY-US, V35, P1125, DOI 10.1021/bi951767k; CHU K, 1995, PHYS REV LETT, V74, P2607, DOI 10.1103/PhysRevLett.74.2607; ELBER R, 1987, SCIENCE, V235, P318, DOI 10.1126/science.3798113; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; GIBSON QH, 1992, J BIOL CHEM, V267, P22022; Hartmann H, 1996, P NATL ACAD SCI USA, V93, P7013, DOI 10.1073/pnas.93.14.7013; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473; Lim MH, 1997, NAT STRUCT BIOL, V4, P209, DOI 10.1038/nsb0397-209; MCMAHON BH, 1997, THESIS U ILLINOIS UR; Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523; POWERS L, 1987, BIOCHEMISTRY-US, V26, P4785, DOI 10.1021/bi00389a028; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; TENG TY, 1994, NAT STRUCT BIOL, V1, P701, DOI 10.1038/nsb1094-701; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; TILTON RF, 1986, J MOL BIOL, V192, P443, DOI 10.1016/0022-2836(86)90374-8; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6	30	230	234	0	21	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					921	923		10.1038/35002641	http://dx.doi.org/10.1038/35002641			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706294				2022-12-28	WOS:000085559200065
J	Matthews, BW				Matthews, BW			Paul Sigler (1934-2000) - Obituary	NATURE			English	Biographical-Item									Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon; University of Oregon	Matthews, BW (corresponding author), Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA.								0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					848	848		10.1038/35002722	http://dx.doi.org/10.1038/35002722			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706270				2022-12-28	WOS:000085559200040
J	Farnham, FR; James, DV				Farnham, FR; James, DV			Patients' attitudes to psychiatric hospital admission	LANCET			English	Editorial Material							VOLUNTARY; COERCION		UCL Royal Free & Univ Coll Med Sch, Dept Psychiat & Behav Sci, London NW3 2PF, England	University of London; University College London; UCL Medical School	Farnham, FR (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Psychiat & Behav Sci, London NW3 2PF, England.							*DEP HLTH, 1999, STAT B, V25; Department of Health, 1999, NAT SERV FRAM MENT H; Hoge SK, 1997, INT J LAW PSYCHIAT, V20, P167, DOI 10.1016/S0160-2527(97)00001-0; Johnson S., 1997, LONDONS MENTAL HLTH; ROGERS A, 1993, BEHAV SCI LAW, V11, P259, DOI 10.1002/bsl.2370110304; Royal College of Psychiatrists, 1998, CR62 ROYAL COLL PSYC; SZASZ T, 1972, NEW ENGL J MED, V287, P590	7	20	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					594	594		10.1016/S0140-6736(00)00077-5	http://dx.doi.org/10.1016/S0140-6736(00)00077-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	289HX	10696977				2022-12-28	WOS:000085615400007
J	Willoughby, DA; Moore, AR; Colville-Nash, PR				Willoughby, DA; Moore, AR; Colville-Nash, PR			COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease	LANCET			English	Article							NITRIC-OXIDE SYNTHASE; RECEPTOR-GAMMA; CYCLOOXYGENASE; DRUGS	A new generation of non-steroidal anti-inflammatory drugs has been described that selectively targets the inducible isoform of cyclo-oxygenase, cyclo-oxygenase 2 (COX-5). This isoform is expressed at sites of inflammation, which has fed to the speculation that its inhibition could provide all the benefits of current nonsteroidal anti-inflammatory drugs, but without their major side-effects on the gastrointestinal system (which are due to inhibition of COX-1). We have shown that COX-2 (identified by use of specific antibodies) is induced during the resolution of an inflammatory response, inhibition of COX-2 resulting in persistence of the inflammation due to the prevention of the synthesis of a range of anti-inflammatory prostanoids. We propose that there is a third isoform of this enzyme family, COX-3, a proposal that will have implication for the prescription of both existing and new generation anti-inflammatory drugs, and might represent a new therapeutic target.	St Bartholomews & Royal London Hosp Sch Med, William Harvey Res Inst, Dept Expt Pathol, London EC1M 6BQ, England; St Bartholomews & Royal London Hosp Sch Dent, William Harvey Res Inst, Dept Expt Pathol, London EC1M 6BQ, England	Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London	Willoughby, DA (corresponding author), St Bartholomews & Royal London Hosp Sch Med, William Harvey Res Inst, Dept Expt Pathol, Charterhouse Sq, London EC1M 6BQ, England.							Colville-Nash PR, 1998, J IMMUNOL, V161, P978; DIROSA M, 1971, J PATHOL, V104, P15, DOI 10.1002/path.1711040103; Gilroy DW, 1998, EUR J PHARMACOL, V355, P211, DOI 10.1016/S0014-2999(98)00508-1; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; MASFERRER JL, 1992, P NATL ACAD SCI USA, V89, P3917, DOI 10.1073/pnas.89.9.3917; MASFERRER JL, 1990, J CLIN INVEST, V86, P1375, DOI 10.1172/JCI114850; RASHAD S, 1989, LANCET, V2, P519; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Simmons DL, 1999, P NATL ACAD SCI USA, V96, P3275, DOI 10.1073/pnas.96.6.3275; VANE J, 1994, NATURE, V367, P215, DOI 10.1038/367215a0; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P547; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692	18	216	243	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					646	648		10.1016/S0140-6736(99)12031-2	http://dx.doi.org/10.1016/S0140-6736(99)12031-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696997				2022-12-28	WOS:000085615400042
J	Lee, KJ; Dietrich, P; Jessell, TM				Lee, KJ; Dietrich, P; Jessell, TM			Genetic ablation reveals that the roof plate is essential for dorsal interneuron specification	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; AVIAN NEURAL CREST; SPINAL-CORD; TRANSGENIC MICE; FLOOR PLATE; COMMISSURAL INTERNEURONS; MOUSE DEVELOPMENT; TOXIN GENE; EXPRESSION; CELL	During neural development in vertebrates, a spatially ordered array of neurons is generated in response to inductive signals derived from localized organizing centres, One organizing centre that has been proposed to have a role in the control of neural patterning is the roof plate, To define the contribution of signals derived from the roof plate to the specification of neuronal cell types in the dorsal neural tube, we devised a genetic strategy to ablate the roof plate selectively in mouse embryos, Embryos without a roof plate lack all the interneuron subtypes that are normally generated in the dorsal third of the neural tube. Using a genetically based lineage analysis and in vitro assays, we show that the loss of these neurons results from the elimination of nonautonomous signals provided by the roof plate, These results reveal that the roof plate is essential for specifying multiple classes of neurons in the mammalian central nervous system.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Jessell, TM (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA.	tmj1@columbia.edu		Lee, Kevin/0000-0001-9823-0952				AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Arkell R, 1997, DEVELOPMENT, V124, P1; Beattie CE, 1997, DEV BIOL, V187, P171, DOI 10.1006/dbio.1997.8604; Bei M, 1998, DEVELOPMENT, V125, P4325; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; CHRISTIANS E, 1995, DEVELOPMENT, V121, P113; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; DIETRICH P, IN PRESS MAMM GENOME; Ding Q, 1998, DEVELOPMENT, V125, P2533; Dodd J, 1998, SCIENCE, V282, P1654, DOI 10.1126/science.282.5394.1654; Dudley AT, 1997, DEV DYNAM, V208, P349; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Grieshammer U, 1998, DEV BIOL, V197, P234, DOI 10.1006/dbio.1997.8859; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Helms AW, 1998, DEVELOPMENT, V125, P919; HILL RE, 1989, GENE DEV, V3, P26, DOI 10.1101/gad.3.1.26; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; JONES CM, 1991, DEVELOPMENT, V111, P531; Labosky PA, 1998, MECH DEVELOP, V76, P185, DOI 10.1016/S0925-4773(98)00105-1; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Matise MP, 1998, DEVELOPMENT, V125, P2759; MAXWELL IH, 1986, CANCER RES, V46, P4660; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PARR BA, 1993, DEVELOPMENT, V119, P247; Pearse RV, 1998, J EXP ZOOL, V282, P677, DOI 10.1002/(SICI)1097-010X(19981215)282:6<677::AID-JEZ4>3.0.CO;2-F; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; ROBERT B, 1989, EMBO J, V8, P91, DOI 10.1002/j.1460-2075.1989.tb03352.x; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Shamim H, 1999, DEVELOPMENT, V126, P945; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5	50	219	222	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					734	740		10.1038/35001507	http://dx.doi.org/10.1038/35001507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693795				2022-12-28	WOS:000085423100042
J	Ingersoll, AP; Gierasch, PJ; Banfield, D; Vasavada, AR				Ingersoll, AP; Gierasch, PJ; Banfield, D; Vasavada, AR		Galileo Imaging Team	Moist convection as an energy source for the large-scale motions in Jupiter's atmosphere	NATURE			English	Article							GREAT RED SPOT; JOVIAN ATMOSPHERE; ZONAL JETS; BETA-PLANE; CLOUD; TURBULENCE; GENERATION; VORTICES; MODEL	lJupiter's dominant large-scale weather patterns (dimensions similar to 10,000 km) are zonal jets and long-lived ovals. The jets have been flowing east and west at constant speeds of up to 180 m s(-1) for over 100 years(1-3). These jets receive energy from small-scale eddies, which pump(1) eastward momentum into the eastward jets and westward momentum into the westward jets. This momentum transfer was predicted by numerical models(4) before it was observed on Jupiter(1). The large ovals roll between the jets in an anticyclonic direction(5)-clockwise in the northern hemisphere and counterclockwise in the southern hemisphere-where they regularly assimilate small anticyclonic eddies(5,6). But from where the eddies receive their; energy has been an open question. Here we argue that the eddies, which ultimately drive both the jets and the ovals, receive their energy from moist convection. This hypothesis is consistent with observations of jovian lightning(7-9), which is an indicator of moist convection(10,11) It also explains the anticyclonic rotation and poleward drift of the eddies', and suggests patterns of upwelling and downwelling that resemble the patterns of large-scale axisymmetric overturning in the Earth's atmosphere.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	California Institute of Technology; Cornell University; University of California System; University of California Los Angeles	Ingersoll, AP (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	api@gps.caltech.edu	Muller, Jan-Peter/Q-8886-2019; Banfield, Don J/I-3523-2018	Muller, Jan-Peter/0000-0002-5077-3736; Banfield, Don J/0000-0003-2664-0164				ACHTERBERG RK, 1994, J ATMOS SCI, V51, P541, DOI 10.1175/1520-0469(1994)051<0541:NSOBJV>2.0.CO;2; Banfield D, 1998, ICARUS, V135, P230, DOI 10.1006/icar.1998.5985; Cho JYK, 1996, SCIENCE, V273, P335, DOI 10.1126/science.273.5273.335; DOWLING TE, 1989, J ATMOS SCI, V46, P3256, DOI 10.1175/1520-0469(1989)046<3256:JGRSAA>2.0.CO;2; Folkner WM, 1998, J GEOPHYS RES-PLANET, V103, P22847, DOI 10.1029/98JE01635; GIBBARD S, 1995, NATURE, V378, P592, DOI 10.1038/378592a0; Gill AE, 1982, ATMOSPHERE OCEAN DYN; Holton J. R., 1992, INTRO DYNAMIC METEOR; Huang HP, 1998, J ATMOS SCI, V55, P611, DOI 10.1175/1520-0469(1998)055<0611:TDTAPZ>2.0.CO;2; HUNT GE, 1982, NATURE, V295, P491, DOI 10.1038/295491a0; INGERSOLL AP, 1981, J GEOPHYS RES-SPACE, V86, P8733, DOI 10.1029/JA086iA10p08733; Ingersoll AP, 1995, SPACE SCI S, P613; LeBeau RP, 1998, ICARUS, V132, P239, DOI 10.1006/icar.1998.5918; LIMAYE SS, 1986, ICARUS, V65, P335, DOI 10.1016/0019-1035(86)90142-9; Little B, 1999, ICARUS, V142, P306, DOI 10.1006/icar.1999.6195; LOW MMM, 1986, ICARUS, V65, P353, DOI 10.1016/0019-1035(86)90143-0; MALTRUD ME, 1991, J FLUID MECH, V228, P321, DOI 10.1017/S0022112091002720; MCWILLIAMS JC, 1979, J PHYS OCEANOGR, V9, P1155, DOI 10.1175/1520-0485(1979)009<1155:OTEOIN>2.0.CO;2; Niemann HB, 1998, J GEOPHYS RES-PLANET, V103, P22831, DOI 10.1029/98JE01050; PANETTA RL, 1993, J ATMOS SCI, V50, P2073, DOI 10.1175/1520-0469(1993)050<2073:ZJIWBU>2.0.CO;2; RHINES PB, 1975, J FLUID MECH, V69, P417, DOI 10.1017/S0022112075001504; Vasavada AR, 1998, ICARUS, V135, P265, DOI 10.1006/icar.1998.5984; WEST RA, 1986, ICARUS, V65, P161, DOI 10.1016/0019-1035(86)90135-1; WILLIAMS GP, 1978, J ATMOS SCI, V35, P1399, DOI 10.1175/1520-0469(1978)035<1399:PCBROJ>2.0.CO;2; YAIR Y, 1995, ICARUS, V115, P421, DOI 10.1006/icar.1995.1108	27	129	129	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					630	632		10.1038/35001021	http://dx.doi.org/10.1038/35001021			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688192				2022-12-28	WOS:000085288200044
J	Lemieux, C; Otis, C; Turmel, M				Lemieux, C; Otis, C; Turmel, M			Ancestral chloroplast genome in Mesostigma viride reveals an early branch of green plant evolution	NATURE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CHLOROPHYLL; PHYLOGENY; ALGA	Sequence comparisons suggest that all living green plants belong to one of two major phyla(1-3): Streptophyta(4) (land plants and their closest green algal relatives, the charophytes); and Chlorophyta(5) (the rest of green algae). Because no green algae are known that pre-date the Streptophyta/Chlorophyta split, and also because the earliest diverging green algae show considerable morphological variation, the nature of the unicellular flagellate ancestor of the two green plant phyla is unknown(1,6,7). Here we report that the flagellate Mesostigma viride belongs to the earliest diverging green plant lineage discovered to date. We have sequenced the entire chloroplast DNA (118,360 base pairs) of this green alga and have conducted phylogenetic analyses of sequences derived from this genome. Mesostigma represents a lineage that emerged before the divergence of the Streptophyta and Chlorophyta, a position that is supported by several features of its chloroplast DNA. The structure and gene organization of this genome indicate that chloroplast DNA architecture has been extremely well conserved in the line leading to land plants.	Univ Laval, Dept Biochem & Microbiol, Quebec City, PQ G1K 7P4, Canada	Laval University	Lemieux, C (corresponding author), Univ Laval, Dept Biochem & Microbiol, Quebec City, PQ G1K 7P4, Canada.	clemieux@bcm.ulaval.ca	Lemieux, Claude/L-8831-2015; Turmel, Monique/AAC-9752-2020	Lemieux, Claude/0000-0001-9580-8042; Turmel, Monique/0000-0001-7060-035X				Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Bhattacharya D, 1998, J MOL EVOL, V47, P544, DOI 10.1007/PL00006410; BREMER K, 1985, Cladistics, V1, P369, DOI 10.1111/j.1096-0031.1985.tb00434.x; Chapman R. L., 1998, MOL SYSTEMATICS PLAN, P508; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; FELSENSTEIN J, 1995, PHYLIP VERSION 3 5; Friedl T, 1997, PLANT SYST EVOL, P87; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kowallik KV, 1995, PLANT MOL BIOL REP, V13, P336, DOI 10.1007/BF02669188; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Lockhart PJ, 1999, MOL BIOL EVOL, V16, P573, DOI 10.1093/oxfordjournals.molbev.a026139; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; MELKONIAN M, 1989, PLANT SYST EVOL, V164, P93, DOI 10.1007/BF00940432; MELKONIAN M, 1995, B SOC ZOOL FR, V120, P191; Melkonian M., 1990, P600; Melkonian M., 1995, BIODIVERSITY EVOLUTI, P153; Nakayama T, 1998, PROTIST, V149, P367, DOI 10.1016/S1434-4610(98)70043-4; O'Kelly C.J., 1992, P315; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Palmer J.D., 1998, MOL SYSTEMATICS PLAN, P375, DOI [10.1007/978-1-4615-5419-6_13, DOI 10.1007/978-1-4615-5419-6_13]; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; SLUIMAN HJ, 1985, PLANT SYST EVOL, V149, P217, DOI 10.1007/BF00983308; Stirewalt VL, 1995, PLANT MOL BIOL REP, V13, P327, DOI 10.1007/BF02669186; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turmel M, 1999, P NATL ACAD SCI USA, V96, P10248, DOI 10.1073/pnas.96.18.10248; Wakasugi T, 1997, P NATL ACAD SCI USA, V94, P5967, DOI 10.1073/pnas.94.11.5967	30	198	320	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					649	652		10.1038/35001059	http://dx.doi.org/10.1038/35001059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688199	hybrid			2022-12-28	WOS:000085288200051
J	Uetz, P; Giot, L; Cagney, G; Mansfield, TA; Judson, RS; Knight, JR; Lockshon, D; Narayan, V; Srinivasan, M; Pochart, P; Qureshi-Emili, A; Li, Y; Godwin, B; Conover, D; Kalbfleisch, T; Vijayadamodar, G; Yang, MJ; Johnston, M; Fields, S; Rothberg, JM				Uetz, P; Giot, L; Cagney, G; Mansfield, TA; Judson, RS; Knight, JR; Lockshon, D; Narayan, V; Srinivasan, M; Pochart, P; Qureshi-Emili, A; Li, Y; Godwin, B; Conover, D; Kalbfleisch, T; Vijayadamodar, G; Yang, MJ; Johnston, M; Fields, S; Rothberg, JM			A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae	NATURE			English	Article							SPINDLE CHECKPOINT; COMPLEX-FORMATION; 3-HYBRID SYSTEM; BUDDING YEAST; RECOMBINATION; GENES; CYTOPLASM; VACUOLE; ASSOCIATION; AUTOPHAGY	Two large-scale yeast two-hybrid screens were undertaken to identify protein-protein interactions between full-length open reading frames predicted from the Saccharomyces cerevisiae genome sequence. In one approach, we constructed a protein array of about 6,000 yeast transformants, with each transformant expressing one of the open reading frames as a fusion to an activation domain. This array was screened by a simple and automated procedure for 192 yeast proteins, with positive responses identified by their positions in the array, In a second approach, we pooled cells expressing one of about 6,000 activation domain fusions to generate a library. We used a high-throughput screening procedure to screen nearly all of the 6,000 predicted yeast proteins, expressed as Gal4 DNA-binding domain fusion proteins, against the library, and characterized positives by sequence analysis. These approaches resulted in the detection of 957 putative interactions involving 1,004 S. cerevisiae proteins, These data reveal interactions that place functionally unclassified proteins in a biological context, interactions between proteins involved in the same biological function, and interactions that link biological functions together into larger cellular processes. The results of these screens are shown here.	CuraGen Corp, New Haven, CT 06511 USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL)	Rothberg, JM (corresponding author), CuraGen Corp, 555 Long Wharf Dr,11th Floor, New Haven, CT 06511 USA.		Uetz, Peter/A-7119-2012; Johnston, Mark/R-6156-2019; Kalbfleisch, Theodore/AAN-5407-2021; Johnston, Mark/K-3543-2019; Cagney, Gerard/A-4648-2009	Uetz, Peter/0000-0001-6194-4927; Johnston, Mark/0000-0002-4932-7229; Judson, Richard/0000-0002-2348-9633; Cagney, Gerard/0000-0001-7189-9496; Kalbfleisch, Theodore/0000-0002-2370-8189				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Boeck R, 1998, MOL CELL BIOL, V18, P5062, DOI 10.1128/MCB.18.9.5062; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Flores A, 1999, P NATL ACAD SCI USA, V96, P7815, DOI 10.1073/pnas.96.14.7815; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Funakoshi T, 1997, GENE, V192, P207, DOI 10.1016/S0378-1119(97)00031-0; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GUENETTE S, 1995, J CELL SCI, V108, P1195; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hudson JR, 1997, GENOME RES, V7, P1169, DOI 10.1101/gr.7.12.1169; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; James P, 1996, GENETICS, V144, P1425; KADOWAKI T, 1994, J CELL BIOL, V126, P649, DOI 10.1083/jcb.126.3.649; KADOWAKI T, 1994, J CELL BIOL, V126, P1627; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; LEGRAIN P, 1994, NUCLEIC ACIDS RES, V22, P3241, DOI 10.1093/nar/22.15.3241; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Licitra EJ, 1996, P NATL ACAD SCI USA, V93, P12817, DOI 10.1073/pnas.93.23.12817; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Nasmyth K, 1993, CURR OPIN CELL BIOL, V5, P166, DOI 10.1016/0955-0674(93)90099-C; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; RAMESH V, 1991, MOL BIOL MED, V8, P81; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scott SV, 1998, CURR OPIN CELL BIOL, V10, P523, DOI 10.1016/S0955-0674(98)80068-9; Seeley TW, 1999, BIOCHEM BIOPH RES CO, V257, P589, DOI 10.1006/bbrc.1999.0514; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Sherman F., 1986, METHODS YEAST GENETI; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0	42	3619	3818	7	523	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					623	627		10.1038/35001009	http://dx.doi.org/10.1038/35001009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688190				2022-12-28	WOS:000085288200042
J	Aridor, M; Balch, WE				Aridor, M; Balch, WE			Drug delivery - Regulating export of ER cargo	SCIENCE			English	Editorial Material							ENDOPLASMIC-RETICULUM; COPII; TRANSPORT; ERGIC-53; PATHWAY		Scripps Res Inst, Dept Cellular & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Aridor, M (corresponding author), Scripps Res Inst, Dept Cellular & Mol Biol, 10550 N Torrey Pines Rd,IMM11, La Jolla, CA 92037 USA.							Aridor M, 1996, TRENDS CELL BIOL, V6, P315, DOI 10.1016/0962-8924(96)10027-1; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Herrmann JM, 1999, TRENDS CELL BIOL, V9, P5, DOI 10.1016/S0962-8924(98)01414-7; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9	17	11	14	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					816	817		10.1126/science.287.5454.816	http://dx.doi.org/10.1126/science.287.5454.816			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10691557				2022-12-28	WOS:000085136400033
J	Khorana, HG				Khorana, HG			A life in science	SCIENCE			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Khorana, HG (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.								0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					810	810		10.1126/science.287.5454.810	http://dx.doi.org/10.1126/science.287.5454.810			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10691555				2022-12-28	WOS:000085136400028
J	Berger, A				Berger, A			Scientists find a new way around blood clotting disorders	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					670	670		10.1136/bmj.320.7236.670	http://dx.doi.org/10.1136/bmj.320.7236.670			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710571	Green Published			2022-12-28	WOS:000085895300015
J	Gibbon, KL; Goldsmith, P; Salisbury, JA; Bewley, AP				Gibbon, KL; Goldsmith, P; Salisbury, JA; Bewley, AP			Lesson of the week - Unnecessary surgical treatment of fungal kerions in children	BRITISH MEDICAL JOURNAL			English	Review							SOUTH-EAST LONDON; TINEA-CAPITIS; INFECTION		Whipps Cross Hosp, Dept Dermatol, London E11 1NR, England; Whittington Hosp, Dept Dermatol, London N19 5NF, England	University of London; University College London	Gibbon, KL (corresponding author), Whipps Cross Hosp, Dept Dermatol, London E11 1NR, England.							Elewski BE, 1999, J AM ACAD DERMATOL, V40, pS27, DOI 10.1016/S0190-9622(99)70394-4; Fuller LC, 1997, BRIT J DERMATOL, V136, P139, DOI 10.1111/j.1365-2133.1997.tb08771.x; Gupta AK, 1999, PEDIATR DERMATOL, V16, P171, DOI 10.1046/j.1525-1470.1999.00050.x; Hay RJ, 1996, BRIT J DERMATOL, V135, P955, DOI 10.1046/j.1365-2133.1996.d01-1101.x; Leeming JG, 1995, BRIT J DERMATOL, V133, P929, DOI 10.1111/j.1365-2133.1995.tb06928.x; NANDWANI R, 1995, J INFECTION, V31, P79, DOI 10.1016/S0163-4453(95)91705-5; NAROTAM PK, 1994, NEUROSURGERY, V34, P409, DOI 10.1227/00006123-199403000-00004; Sohnle P. G., 1989, Immunology of the fungal diseases., P1	8	5	5	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					696	697		10.1136/bmj.320.7236.696	http://dx.doi.org/10.1136/bmj.320.7236.696			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710583	Green Published			2022-12-28	WOS:000085895300025
J	Towse, A; Sussex, J				Towse, A; Sussex, J			"Getting UK health care expenditure up to the European Union mean" - what does that mean?	BRITISH MEDICAL JOURNAL			English	Article									Off Hlth Econ, London SW1A 2DY, England		Towse, A (corresponding author), Off Hlth Econ, 12 Whitehail, London SW1A 2DY, England.		Sussex, Jon/J-5049-2014; Towse, Adrian/M-3760-2014	Sussex, Jon/0000-0001-8970-4546; 				[Anonymous], 1998, CM4011; Besley T., 1996, PRIVATE HLTH INSURAN; Ferriman A, 2000, BRIT MED J, V320, P205, DOI 10.1136/bmj.320.7229.205; Hansen P, 1996, J HEALTH ECON, V15, P127, DOI 10.1016/0167-6296(95)00017-8; *I FISC STUD, 2000, IFS GREEN BUDG 2000; *LAING BUISS, 1998, LAINGS HEALTHC MARK; Loux A, 2000, BRIT MED J, V320, P5, DOI 10.1136/bmj.320.7226.5; Mossialos E, 2000, BMJ-BRIT MED J, V320, P197, DOI 10.1136/bmj.320.7229.197; *OFF NAT STAT, 2000, UK EC ACC 1999 3 Q; *OFF NAT STAT, 1999, FAM SPEND REP 1998 9; *ORG EC COOP DEV, 1999, OECD HLTH DAT 99 COM; Royal Commission on Long Term Care, 1999, RESP OLD AG LONG TER; SALTMAN R. B., 1998, CRITICAL CHALLENGES; TREASURY HM, 2000, GDP DEFLATORS USERS; TREASURY HM, 1999, FORECASTS UK EC COMP; 1999, CM4023	16	12	12	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					640	642		10.1136/bmj.320.7235.640	http://dx.doi.org/10.1136/bmj.320.7235.640			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698890	Green Published			2022-12-28	WOS:000085742600034
J	Boudaiffa, B; Cloutier, P; Hunting, D; Huels, MA; Sanche, L				Boudaiffa, B; Cloutier, P; Hunting, D; Huels, MA; Sanche, L			Resonant formation of DNA strand breaks by low-energy (3 to 20 eV) electrons	SCIENCE			English	Article							ATTACHMENT; DAMAGE; BASES; RADIATION; YIELDS; FILMS; WATER; O-2	Most of the energy deposited in cells by ionizing radiation is channeled into the production of abundant free secondary electrons with ballistic energies between 1 and 20 electron volts. Here it is shown that reactions of such electrons, even at energies well below ionization thresholds, induce substantial yields of single- and double-strand breaks in DNA, which are caused by rapid decays of transient molecular resonances Localized on the DNA's basic components. This finding presents a fundamental challenge to the traditional notion that genotoxic damage by secondary electrons can only occur at energies above the onset of ionization, or upon solvation when they become a slowly reacting chemical species.	Univ Sherbrooke, Fac Med, Dept Med Nucl & Radiobiol, Canadian Med Res Council,Grp Radiat Sci, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Huels, MA (corresponding author), Univ Sherbrooke, Fac Med, Dept Med Nucl & Radiobiol, Canadian Med Res Council,Grp Radiat Sci, Sherbrooke, PQ J1H 5N4, Canada.							Aflatooni K, 1998, J PHYS CHEM A, V102, P6205, DOI 10.1021/jp980865n; Antic D, 1999, J PHYS CHEM B, V103, P6611, DOI 10.1021/jp990686l; Bass AD, 1998, J CHEM PHYS, V109, P8635, DOI 10.1063/1.477530; Bass AD, 1998, RADIAT ENVIRON BIOPH, V37, P243, DOI 10.1007/s004110050125; Christophorou L. G., 1994, LINKING GASEOUS COND; Cobut V, 1998, RADIAT PHYS CHEM, V51, P229, DOI 10.1016/S0969-806X(97)00096-0; COLSON AO, 1992, J PHYS CHEM-US, V96, P9787, DOI 10.1021/j100203a039; FOLKARD M, 1993, INT J RADIAT BIOL, V64, P651, DOI 10.1080/09553009314551891; FUCIARELLI AF, 1995, RAD DAMAGE DNA STRUC; Hendricks JH, 1998, J CHEM PHYS, V108, P8, DOI 10.1063/1.475360; HIEDA K, 1994, INT J RADIAT BIOL, V66, P561, DOI 10.1080/09553009414551631; HUELS MA, 1994, J CHEM PHYS, V100, P3940, DOI 10.1063/1.466329; Huels MA, 1998, J CHEM PHYS, V108, P1309, DOI 10.1063/1.475503; Huels MA, 1997, CHEM PHYS LETT, V279, P223, DOI 10.1016/S0009-2614(97)01026-9; International Commission on Radiation Units and Measurements, 1979, 31 ICRU; MICHAEL BD, 1995, RADIATION DAMAGE IN DNA: STRUCTURE/FUNCTION RELATIONSHIPS AT EARLY TIMES, P251; PIMBLOTT SM, 1976, AGING CARCINOGENESIS, P3; ROWNTREE P, 1991, J PHYS CHEM-US, V95, P4902, DOI 10.1021/j100165a054; ROWNTREE P, 1991, J CHEM PHYS, V94, P8570, DOI 10.1063/1.460090; SANCHE L, 1995, SCANNING MICROSCOPY, V9, P619; SANCHE L, UNPUB; Sieger MT, 1998, NATURE, V394, P554, DOI 10.1038/29015; SRDOC D, 1995, IAEA CRP ATOMIC MOL, pCH8; Stepanovic M, 1999, J CHEM PHYS, V110, P11376, DOI 10.1063/1.479078; SWARTS SG, 1992, RADIAT RES, V129, P333, DOI 10.2307/3578034; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; Ward J.F., 1975, ADV RAD BIOL, P181; Yamamoto O., 1976, AGING CARCINOGENESIS, P165	28	1817	1834	7	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1658	1660		10.1126/science.287.5458.1658	http://dx.doi.org/10.1126/science.287.5458.1658			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698742				2022-12-28	WOS:000085628200040
J	Christoffel, KK; Spivak, H; Witwer, M				Christoffel, KK; Spivak, H; Witwer, M			Youth violence prevention: The physician's role	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUN OWNERSHIP; HOMICIDE; INJURY; SUICIDE; HOME		Northwestern Univ, Sch Med, HELP Network, Childrens Mem Med Ctr, Chicago, IL 60611 USA; New England Med Ctr, Boston, MA 02111 USA	Northwestern University; Tufts Medical Center	Christoffel, KK (corresponding author), Northwestern Univ, Sch Med, HELP Network, Childrens Mem Med Ctr, Chicago, IL 60611 USA.							*AM AC PED CTR PRE, 1996, KEEP YOUR FAM SAF FI; *AM ASS SUIC, 1997, PERC YOUTH SUIC FIR; *AM MED ASS, 1998, PHYS FIR SAF GUID; ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; Blumstein A, 1998, J CRIM LAW CRIM, V88, P1175, DOI 10.2307/1144254; Cassel CK, 1998, ANN INTERN MED, V128, P224, DOI 10.7326/0003-4819-128-3-199802010-00009; *CDCP, 2000, COMPR MORT REP DEATH; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P101; CHRISTOFFEL KK, 1994, AM J PUBLIC HEALTH, V84, P539, DOI 10.2105/AJPH.84.4.539; CHRISTOFFEL KK, 1997, CHILDREN VIOLENT SOC, P48; CHRISTOFFEL KK, 1999, AM HOSP ASS NEW 0823, P6; CHRISTOFFEL KK, 1999, AM HOSP ASS NEW 0823, P1; *FED BUR INV, 1997, CRIM US 1996 UN CRIM; GOINS WA, 1992, J NATL MED ASSOC, V84, P431; Hawkins G., 1997, CRIME IS NOT PROBLEM; Hoyert DL, 1999, NATL VITAL STAT REPO, V47, P27; *I MED, 1995, RED BURD INJ ADV PRE, pCH5; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; KILLIAS M, 1993, CAN MED ASSOC J, V148, P1721; Krug Etienne G., 1996, World Health Statistics Quarterly, V49, P230; Mercy JA, 1998, AM J PREV MED, V15, P6, DOI 10.1016/S0749-3797(98)00060-9; Osofsky J. D., 1997, CHILDREN VIOLENT SOC; POOLE GV, 1993, SURGERY, V113, P608; RIENER DS, 1990, AM SURGEON, V56, P556; SLOAN JH, 1988, NEW ENGL J MED, V319, P1256, DOI 10.1056/NEJM198811103191905; Spivak H, 1999, PEDIATRICS, V103, P173; SPIVAK H, 1994, PEDIATRICS, V94, P576; Wintemute GJ, 1999, JAMA-J AM MED ASSOC, V282, P475, DOI 10.1001/jama.282.5.475; WINTEMUTE GJ, 1988, LANCET, V2, P1136	30	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1202	1203		10.1001/jama.283.9.1202	http://dx.doi.org/10.1001/jama.283.9.1202			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703789				2022-12-28	WOS:000085424100036
J	Simon, GE; VonKorff, M; Rutter, C; Wagner, E				Simon, GE; VonKorff, M; Rutter, C; Wagner, E			Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care	BRITISH MEDICAL JOURNAL			English	Article							COLLABORATIVE MANAGEMENT; COST-EFFECTIVENESS; MAJOR DEPRESSION; MENTAL-DISORDERS; CHRONIC ILLNESS; PHYSICIANS; REMINDERS; OUTCOMES	Objective To test the effectiveness of two programmes to improve the treatment of acute depression in primary care. Design Randomised trial. Setting Primary care clinics in Seattle. Patients 613 patients starting antidepressant treatment Intervention Patients were randomly assigned to continued usual care or one of two interventions: feedback only and feedback plus care management Feedback only comprised feedback and algorithm based recommendations to doctors on the basis of data from computerised records of pharmacy and visits. Feedback plus care management included systematic follow up by telephone, sophisticated treatment recommendations, and practice support by a care manager. Main outcome measures Blinded interviews by telephone 3 and 6 months after the initial prescription included a 20 item depression scale from the Hopkins symptom checklist and the structured clinical interview for the current DSM-IV depression module. Visits, antidepressant prescriptions, and overall use of health care were assessed from computerised records. Results Compared with usual care, feedback only had no significant effect on treatment received or patient outcomes. Patients receiving feedback plus cafe management had a higher probability of both receiving at least moderate doses of antidepressants (odds ratio 1.99, 95% confidence interval 1.23 to 3.22) and a 50% improvement in depression scores on the symptom checklist (2.22, 1.31 to 3.75), lower mean depression scores on the symptom checklist at follow up, and a lower probability of major depression at follow up (0.46, 0.24 to 0.86). The incremental cost of feedback plus care management was about $80 (pound 50) per patient. Conclusions Monitoring and feedback to doctors yielded no significant benefits for patients in primary care starting antidepressant treatment A programme of systematic follow up and care management by telephone, however, significantly improved outcomes at modest cost.	Grp Hlth Cooperat, Ctr Hlth Studies, Seattle, WA 98101 USA	Group Health Cooperative	Simon, GE (corresponding author), Grp Hlth Cooperat, Ctr Hlth Studies, Seattle, WA 98101 USA.		Rutter, Carolyn/AAZ-3677-2021	VonKorff, Michael/0000-0001-5386-8477	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051338] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH051338, MH51338] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AG HLTH POL RES, 1993, AHCPR PUBL; Balas EA, 1996, ARCH FAM MED, V5, P271, DOI 10.1001/archfami.5.5.271; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; CURRY SJ, 1995, J CONSULT CLIN PSYCH, V63, P1005, DOI 10.1037/0022-006X.63.6.1005; DEROGATIS I, 1974, PSYCHOL MEASUREMENTS, P79; DOWRICK C, 1995, BMJ-BRIT MED J, V311, P1274, DOI 10.1136/bmj.311.7015.1274; First M. B., 1997, STRUCTURED CLIN INTE; Goldberg H I, 1998, Jt Comm J Qual Improv, V24, P130; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Lave JR, 1998, ARCH GEN PSYCHIAT, V55, P645, DOI 10.1001/archpsyc.55.7.645; LITZELMAN DK, 1993, J GEN INTERN MED, V8, P311, DOI 10.1007/BF02600144; MCDONALD CJ, 1984, ANN INTERN MED, V100, P130, DOI 10.7326/0003-4819-100-1-130; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741; Schulberg HC, 1996, ARCH GEN PSYCHIAT, V53, P913; Simon GE, 1995, J GEN INTERN MED, V10, P663, DOI 10.1007/BF02602759; Simon GE, 1996, JAMA-J AM MED ASSOC, V275, P1897, DOI 10.1001/jama.275.24.1897; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Von Korff M, 1998, PSYCHOSOM MED, V60, P143, DOI 10.1097/00006842-199803000-00005; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WASSON J, 1992, JAMA-J AM MED ASSOC, V267, P1788, DOI 10.1001/jama.267.13.1788; WEINBERGER M, 1993, ARTHRITIS RHEUM, V36, P243, DOI 10.1002/art.1780360216	24	425	429	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					550	554		10.1136/bmj.320.7234.550	http://dx.doi.org/10.1136/bmj.320.7234.550			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688563	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000085624000024
J	Rollenhagen, JE; Olson, CR				Rollenhagen, JE; Olson, CR			Mirror-image confusion in single neurons of the macaque inferotemporal cortex	SCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; ORIENTATION DISCRIMINATION	Humans and animals confuse Lateral mirror images, such as the Letters "b" and "d," more often than vertical mirror images, such as the Letters "b" and "p," Experiments were performed to find a neural correlate of this phenomenon. Visually responsive pattern-selective neurons in the inferotemporal cortex of macaque monkeys responded more similarly to members of a Lateral mirror-image pair than to members of a vertical mirror-image pair. The phenomenon developed within 20 milliseconds of the onset of the visual response and persisted to its end. It occurred during presentation of stimuli both at the fovea and in the periphery.	Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Olson, CR (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003631] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008098, R01EY011831] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR03631] Funding Source: Medline; NEI NIH HHS [EY08098, R01-EY11831] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BIEDERMAN I, 1991, PERCEPTION, V20, P585, DOI 10.1068/p200585; BORNSTEIN MH, 1978, COGNITION, V6, P89, DOI 10.1016/0010-0277(78)90017-3; CORBALLIS MC, 1970, PSYCHOL REV, V77, P451, DOI 10.1037/h0029805; CORBALLIS MC, 1976, PSYCHOL RIGHT LEFT; DESIMONE R, 1984, J NEUROSCI, V4, P2051; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; GROSS CG, 1977, BRAIN RES, V131, P227, DOI 10.1016/0006-8993(77)90517-0; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; GROSS CG, 1978, LEONARDO, V11, P29, DOI DOI 10.2307/1573500; HAMILTON CR, 1973, BRAIN RES, V64, P241, DOI 10.1016/0006-8993(73)90181-9; HUTTENLOCHER J, 1967, CHILD DEV, V38, P1169, DOI 10.1111/j.1467-8624.1967.tb04392.x; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Olson CR, 1999, J NEUROPHYSIOL, V81, P2340, DOI 10.1152/jn.1999.81.5.2340; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; RIOPELLE AJ, 1964, PERCEPT MOTOR SKILL, V19, P383, DOI 10.2466/pms.1964.19.2.383; RUDEL RG, 1963, J COMP PHYSIOL PSYCH, V56, P892, DOI 10.1037/h0046592; SEKULER RW, 1968, Q J EXP PSYCHOL, V20, P204, DOI 10.1080/14640746808400151; SERPELL R, 1971, J COMP PHYSIOL PSYCH, V75, P312, DOI 10.1037/h0030832; SUTHERLAND NS, 1960, BRIT J PSYCHOL, V51, P9, DOI 10.1111/j.2044-8295.1960.tb00719.x; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; TODRIN DC, 1983, PERCEPT PSYCHOPHYS, V34, P397, DOI 10.3758/BF03203053; VOGELS R, 1994, J NEUROPHYSIOL, V71, P1428, DOI 10.1152/jn.1994.71.4.1428; VOGELS R, 1994, EUR J NEUROSCI, V6, P1680, DOI 10.1111/j.1460-9568.1994.tb00560.x	25	105	108	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1506	1508		10.1126/science.287.5457.1506	http://dx.doi.org/10.1126/science.287.5457.1506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	287WZ	10688803				2022-12-28	WOS:000085531600057
J	Braine, J; Lisenfeld, U; Due, PA; Leon, S				Braine, J; Lisenfeld, U; Due, PA; Leon, S			Formation of molecular gas in the tidal debris of violent galaxy-galaxy interactions	NATURE			English	Article							COLD DUST; DWARF GALAXIES; SYSTEM ARP-105; LINE EMISSION; H-I; SEQUENCE	In many gravitational interactions between galaxies, gas and stars that have been torn from the precursor galaxies can collect in tidal 'tails'. Star formation begins anew in some of these regions, producing tidal dwarf galaxies(1-4). Observations of these new galaxies provides insight into processes relevant to galaxy formation more generally, because the timescale of the interaction is well defined. But tracking the star formation process has hitherto been difficult because the tidal dwarf galaxies with young stars showed no evidence of the molecular gas out of which those young stars formed(5-8). Here we report the discovery of molecular hydrogen (traced by carbon monoxide emission) in two tidal dwarf galaxies. In both cases, the concentration of molecular gas peaks at the same location as the maximum in atomic-hydrogen density, unlike the situation in most gas-rich galaxies. We infer from this that the molecular gas formed from the atomic hydrogen, rather than being torn in molecular form from the interacting galaxies. Star formation in the tidal dwarf galaxies therefore appears to mimic the process in normal spiral galaxies like our own.	Observ Bordeaux, UMR 5804, CNRS, INSU, F-33270 Floirac, France; Inst Radioastron Millimetr, Granada 18012, Spain; Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; CNRS, F-91191 Gif Sur Yvette, France; CEA, DSM, DAPNIA, Serv Astrophys, F-91191 Gif Sur Yvette, France; Acad Sinica, ASIAA, Taipei 115, Taiwan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Academia Sinica - Taiwan	Braine, J (corresponding author), Observ Bordeaux, UMR 5804, CNRS, INSU, BP89, F-33270 Floirac, France.	Jonathan.Braine@observ.u-bordeaux.fr	Lisenfeld, Ute/A-1637-2015; Lisenfeld, Ute/AAF-4987-2019	Lisenfeld, Ute/0000-0002-9471-5423; 				ARP H, 1966, ASTROPHYS J, VS 14, P1, DOI 10.1086/190147; BARNES JE, 1992, NATURE, V360, P715, DOI 10.1038/360715a0; BRAINE J, 1993, ASTRON ASTROPHYS, V280, P451; Braine J, 1997, ASTRON ASTROPHYS, V326, P963; BROUILLET N, 1992, ASTRON ASTROPHYS, V262, pL5; Duc PA, 1997, ASTRON ASTROPHYS, V326, P537; DUC PA, 1994, ASTRON ASTROPHYS, V289, P83; DUC PA, UNPUB ASTRON J; DUC PA, 1997, GALAXY INTERACTIONS, P61; Dumke M, 1997, ASTRON ASTROPHYS, V325, P124; FRITZEVALVENSLE.U, 1998, MAGELLANIC CLOUDS OT, P141; GUELIN M, 1993, ASTRON ASTROPHYS, V279, pL37; Hibbard JE, 1996, ASTRON J, V111, P655, DOI 10.1086/117815; HOLLENBACH D, 1989, ASTROPHYS J, V342, P306, DOI 10.1086/167595; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; MIRABEL IF, 1992, ASTRON ASTROPHYS, V256, pL19; Neininger N, 1996, ASTRON ASTROPHYS, V310, P725; SAGE LJ, 1990, ASTRON ASTROPHYS, V239, P125; SCHWEIZER F, 1978, STRUCTURE PROPERTIES, P279; SMITH BJ, 1994, ASTRON J, V108, P837, DOI 10.1086/117115; Smith BJ, 1999, ASTRON J, V117, P1237, DOI 10.1086/300785; Taylor CL, 1998, ASTRON J, V116, P2746, DOI 10.1086/300655; Walter F, 1999, ASTROPHYS J, V519, pL69, DOI 10.1086/312097; ZWICKY F, 1956, ERG EXAKT NATURWISS, V29, P344, DOI 10.1007/BFb0118841	25	56	56	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					867	869		10.1038/35002521	http://dx.doi.org/10.1038/35002521			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706277				2022-12-28	WOS:000085559200048
J	Jones, JA; Vedral, V; Ekert, A; Castagnoli, G				Jones, JA; Vedral, V; Ekert, A; Castagnoli, G			Geometric quantum computation using nuclear magnetic resonance	NATURE			English	Article							IMPLEMENTATION; SPECTROSCOPY; PHASE	A significant development in computing has been the discovery(1) that the computational power of quantum computers exceeds that of Turing machines. Central to the experimental realization of quantum information processing is the construction of fault-tolerant quantum logic gates. Their operation requires conditional quantum dynamics, in which one sub-system undergoes a coherent evolution that depends on the quantum state of another sub-system(2); in particular, the evolving sub-system may acquire a conditional phase shift. Although conventionally dynamic in origin, phase shifts can also be geometric(3,4) Conditional geometric (or 'Berry') phases depend only on the geometry of the path executed, and are therefore resilient to certain types of errors; this suggests the possibility of an intrinsically fault-tolerant way of performing quantum gate operations. Nuclear magnetic resonance techniques have already been used to demonstrate both simple quantum information processing(5-9) and geometric phase shifts(10-12). Here we combine these ideas by performing a nuclear magnetic resonance experiment in which a conditional Berry phase is implemented, demonstrating a controlled phase shift gate.	Univ Oxford, Clarendon Lab, Ctr Quantum Computat, Oxford OX1 3PU, England; Oxford Ctr Mol Sci, New Chem Lab, Oxford OX1 3QT, England; Elsag, I-1615 Genoa, Italy	University of Oxford; University of Oxford	Jones, JA (corresponding author), Univ Oxford, Clarendon Lab, Ctr Quantum Computat, Parks Rd, Oxford OX1 3PU, England.		Jones, Jonathan/AAD-9414-2020; vedral, vlatko/P-1712-2014; Vedral, Vlatko/L-3270-2016; Jones, Jonathan/E-4585-2011; Ekert, Artur K/P-1420-2014	Jones, Jonathan/0000-0003-1862-587X; Vedral, Vlatko/0000-0002-8588-2940; Jones, Jonathan/0000-0003-1862-587X; 				Averin DV, 1998, SOLID STATE COMMUN, V105, P659, DOI 10.1016/S0038-1098(97)10001-1; BARENCO A, 1995, PHYS REV LETT, V74, P4083, DOI 10.1103/PhysRevLett.74.4083; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Chuang IL, 1998, PHYS REV LETT, V80, P3408, DOI 10.1103/PhysRevLett.80.3408; Cory DG, 1998, PHYSICA D, V120, P82, DOI 10.1016/S0167-2789(98)00046-3; Cory DG, 1997, P NATL ACAD SCI USA, V94, P1634, DOI 10.1073/pnas.94.5.1634; DEUTSCH D, 1995, P R SOC-MATH PHYS SC, V449, P669, DOI 10.1098/rspa.1995.0065; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350; Goldman M, 1996, J MAGN RESON SER A, V118, P11, DOI 10.1006/jmra.1996.0003; Jones JA, 1998, J MAGN RESON, V135, P353, DOI 10.1006/jmre.1998.1606; Jones JA, 1997, J CHEM PHYS, V106, P3007, DOI 10.1063/1.473046; Jones JA, 1999, J MAGN RESON, V141, P322, DOI 10.1006/jmre.1999.1890; Jones JA, 1998, J CHEM PHYS, V109, P1648, DOI 10.1063/1.476739; KITAEV AY, FAULT TOLERANT QUANT; PELLIZZARI T, 1995, PHYS REV LETT, V75, P3788, DOI 10.1103/PhysRevLett.75.3788; PRESKILL J, FAULT TOLERANT QUANT; Shapere A., 1989, GEOMETRIC PHASES PHY; Shor PW, 1999, SIAM REV, V41, P303, DOI 10.1137/S0036144598347011; SORENSEN OW, 1983, PROG NUCL MAG RES SP, V16, P163; SUTER D, 1987, MOL PHYS, V61, P1327, DOI 10.1080/00268978700101831	21	645	659	0	58	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					869	871		10.1038/35002528	http://dx.doi.org/10.1038/35002528			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706278	Green Submitted			2022-12-28	WOS:000085559200049
J	Yu, FW; Morin, X; Cai, Y; Yang, XH; Chia, W				Yu, FW; Morin, X; Cai, Y; Yang, XH; Chia, W			Analysis of partner of inscuteable, a novel player of Drosophila asymmetric divisions, reveals two distinct steps in inscuteable apical localization	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; GANGLION MOTHER CELLS; CAENORHABDITIS-ELEGANS; ADAPTER PROTEIN; MAMMALIAN NUMB; PROSPERO GENE; DAUGHTER CELL; FATES; NOTCH; MITOSIS	Asymmetric localization is a prerequisite for inscuteable (insc) to function in coordinating and mediating asymmetric cell divisions in Drosophila. We show here that Partner of Inscuteable (Pins), a new component of asymmetric divisions, is required for Inscuteable to asymmetrically localize. In the absence of pins, Inscuteable becomes cytoplasmic and asymmetric divisions of neuroblasts and mitotic domain 9 cells show defects reminiscent of insc mutants. Pins colocalizes with Insc and interacts with the region necessary and sufficient for directing its asymmetric localization. Analyses of pins function in neuroblasts reveal two distinct steps for Insc apical cortical localization: A pins-independent, bazooka-dependent initiation step during delamination (interphase) and a later maintenance step during which Baz, Pins, and Insc localization are interdependent.	Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Chia, W (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.	mcbwchia@imcb.nus.edu.sg	morin, xavier/AAI-3306-2020; Cai, Yu/R-7737-2019	Cai, Yu/0000-0003-2044-3290; Yu, Fengwei/0000-0003-0268-199X; Morin, Xavier/0000-0001-9999-0355				Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; CamposOrtega JA, 1996, NEURON, V17, P1, DOI 10.1016/S0896-6273(00)80274-3; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Doe CQ, 1996, CURR OPIN GENET DEV, V6, P562, DOI 10.1016/S0959-437X(96)80084-0; Dye CA, 1998, DEVELOPMENT, V125, P1845; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Gomez MR, 1997, DEVELOPMENT, V124, P4857; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Hung TJ, 1999, DEVELOPMENT, V126, P127; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; MATSUZAKI F, 1992, BIOCHEM BIOPH RES CO, V182, P1326, DOI 10.1016/0006-291X(92)91878-T; Matsuzaki F, 1998, DEVELOPMENT, V125, P4089; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shapiro L, 1997, SCIENCE, V276, P712, DOI 10.1126/science.276.5313.712; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; Skeath JB, 1998, DEVELOPMENT, V125, P1857; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3187; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tio M, 1999, J CELL SCI, V112, P1541; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	55	297	305	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2000	100	4					399	409		10.1016/S0092-8674(00)80676-5	http://dx.doi.org/10.1016/S0092-8674(00)80676-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693757	Bronze			2022-12-28	WOS:000085446900003
J	Overpeck, JT				Overpeck, JT			Climate change - The hole record	NATURE			English	Editorial Material							TEMPERATURE; CENTURIES		Univ Arizona, Inst Study Planet Earth, Tucson, AZ 85721 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Overpeck, JT (corresponding author), Univ Arizona, Inst Study Planet Earth, Tucson, AZ 85721 USA.	jto@u.arizona.edu						Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; Briffa KR, 1999, SCIENCE, V284, P926, DOI 10.1126/science.284.5416.926; Briffa KR, 1998, NATURE, V393, P450, DOI 10.1038/30943; Crowley TJ, 1999, GEOPHYS RES LETT, V26, P1901, DOI 10.1029/1999GL900347; DEAN JS, 1994, CLIMATIC CHANGE, V26, P225, DOI 10.1007/BF01092416; Free M, 1999, J GEOPHYS RES-ATMOS, V104, P19057, DOI 10.1029/1999JD900233; Huang SP, 2000, NATURE, V403, P756, DOI 10.1038/35001556; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; MANN ME, IN PRESS EARTH INTER; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251	12	3	3	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					714	715		10.1038/35001697	http://dx.doi.org/10.1038/35001697			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693784				2022-12-28	WOS:000085423100031
J	Tessier-Lavigne, M; Goodman, CS				Tessier-Lavigne, M; Goodman, CS			Neurobiology - Regeneration in the Nogo Zone	SCIENCE			English	Editorial Material							MYELIN-ASSOCIATED GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; NEURITE GROWTH; AXONAL REGENERATION; INHIBITOR; IDENTIFICATION		Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.							CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Kandel E., 2000, PRINCIPLES NEURAL SC; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.3.CO;2-W; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spillmann AA, 1998, J BIOL CHEM, V273, P19283, DOI 10.1074/jbc.273.30.19283; VANDEVELDE HJK, 1994, J CELL SCI, V107, P2403	18	19	25	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					813	814		10.1126/science.287.5454.813	http://dx.doi.org/10.1126/science.287.5454.813			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10691556				2022-12-28	WOS:000085136400031
J	Tunstall-Pedoe, H				Tunstall-Pedoe, H			"Absolute" is inappropriate for quantitative risk estimation	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					723	723		10.1136/bmj.320.7236.723	http://dx.doi.org/10.1136/bmj.320.7236.723			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710607	Green Published			2022-12-28	WOS:000085895300065
J	[Anonymous]				[Anonymous]			Australian government attacked for tobacco funding	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					667	667		10.1136/bmj.320.7236.667	http://dx.doi.org/10.1136/bmj.320.7236.667			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710564				2022-12-28	WOS:000085895300008
J	Ma, HT; Patterson, RL; van Rossum, DB; Birnbaumer, L; Mikoshiba, K; Gill, DL				Ma, HT; Patterson, RL; van Rossum, DB; Birnbaumer, L; Mikoshiba, K; Gill, DL			Requirement of the inositol trisphosphate receptor for activation of store-operated Ca2+ channels	SCIENCE			English	Article							CAPACITATIVE CALCIUM-ENTRY; DEPLETION; CELLS; RELEASE; SIGNAL; INFLUX	The coupling mechanism between endoplasmic reticulum (ER) calcium ion (Ca2+) stores and plasma membrane (PM) store-operated channels (SOCs) is crucial to Ca2+ signaling but has eluded detection. SOCs may be functionally related to the TRP family of receptor-operated channels. Direct comparison of endogenous SOCs with stably expressed TRP3 channels in human embryonic kidney (HEK293) cells revealed that TRP3 channels differ in being store independent. However, condensed cortical F-actin prevented activation of both SOC and TRP3 channels, which suggests that ER-PM interactions underlie coupling of both channels. A cell-permeant inhibitor of inositol trisphosphate receptor (InsP(2)R) function, 2-aminoethoxydiphenyl berate, prevented both receptor-induced TRP3 activation and receptor-induced SOC activation. It is concluded that InsP(3)Rs mediate both SOC and TRP channel opening and that the InsP(3)R is essential for maintaining coupling between store emptying and physiological activation of SOCs.	Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Tokyo, Japan	University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of Tokyo	Gill, DL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	dgill@umaryland.edu	Mikoshiba, Katsuhiko/N-7943-2015	van Rossum, Damian/0000-0003-1011-2586	NHLBI NIH HHS [HL55426] Funding Source: Medline; NIAMS NIH HHS [AR07592] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Favre CJ, 1998, J BIOL CHEM, V273, P30855, DOI 10.1074/jbc.273.47.30855; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; MA HT, UNPUB; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Putney JW, 1999, BIOESSAYS, V21, P38; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; PUTNEY JW, 1993, CELL, V75, P199, DOI 10.1016/0092-8674(93)80061-I; Waldron RT, 1997, J BIOL CHEM, V272, P6440, DOI 10.1074/jbc.272.10.6440; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	23	508	523	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2000	287	5458					1647	1651		10.1126/science.287.5458.1647	http://dx.doi.org/10.1126/science.287.5458.1647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698739				2022-12-28	WOS:000085628200037
J	Pearson, GD; Veille, JC; Rahimtoola, S; Hsia, J; Oakley, CM; Hosenpud, JD; Ansari, A; Baughman, KL				Pearson, GD; Veille, JC; Rahimtoola, S; Hsia, J; Oakley, CM; Hosenpud, JD; Ansari, A; Baughman, KL			Peripartum cardiomyopathy - National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR FUNCTION; ENDOMYOCARDIAL BIOPSY; MYOCARDITIS; PREGNANCY; FAILURE; CELLS; CARVEDILOL; AMLODIPINE; DIAGNOSIS; MORBIDITY	Objective Peripartum cardiomyopathy (PPCM) is a rare life-threatening cardiomyopathy of unknown cause that occurs in the peripartum period in previously healthy women. In April 1997, the National Heart, Lung, and Blood Institute (NHLBI) and the Office of Rare Diseases of the National Institutes of Health (NIH) convened a Workshop on Peripartum Cardiomyopathy to foster a systematic review of information and to develop recommendations for research and education. Participants Fourteen workshop participants were selected by NHLBI staff and represented cardiovascular medicine, obstetrics, immunology, and pathology. A representative subgroup of 8 participants and NHLBI staff formed the writing group for this article and updated the literature on which the conclusions were based. The workshop was an open meeting, consistent with NIH policy. Evidence Data presented at the workshop were augmented by a MEDLINE search for English-language articles published from 1966 to July 1999, using the terms peripartum cardiomyopathy, cardiomyopathy, and pregnancy. Articles on the epidemiology, pathogenesis, pathophysiology, diagnosis, treatment, and prognosis of PPCM were included. Recommendation Process After discussion of data presented, workshop participants agreed on a standardized definition of PPCM, a general clinical approach, and the need for a registry to provide an infrastructure for future research. Conclusions Peripartum cardiomyopathy is a rare lethal disease about which little is known. Diagnosis is confined to a narrow period and requires echocardiographic evidence of left ventricular systolic dysfunction. Symptomatic patients should receive standard therapy for heart failure, managed by a multidisciplinary team. If subsequent pregnancies occur, they should be managed in collaboration with a high-risk perinatal center. Systematic data collection is required to answer important questions about incidence, treatment, and prognosis.	NHLBI, Div Heart & Vasc Dis, NIH, Bethesda, MD 20892 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Obstet & Gynecol, Winston Salem, NC 27103 USA; Univ So Calif, Div Cardiol, Los Angeles, CA USA; George Washington Univ, Sch Med & Hlth Sci, Div Cardiol, Washington, DC 20052 USA; Imperial Coll Med Sch, London, England; Med Coll Wisconsin, Div Cardiovasc Med, Milwaukee, WI 53226 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wake Forest University; Wake Forest Baptist Medical Center; University of Southern California; George Washington University; Imperial College London; Medical College of Wisconsin; Emory University; Johns Hopkins University	Pearson, GD (corresponding author), NHLBI, Div Heart & Vasc Dis, NIH, 6701 Rockledge Dr,Room 9146,MSC 7940, Bethesda, MD 20892 USA.							ANSARI AA, 1993, CLIN IMMUNOL IMMUNOP, V68, P208, DOI 10.1006/clin.1993.1120; Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Bozkurt B, 1999, J AM COLL CARDIOL, V34, P177, DOI 10.1016/S0735-1097(99)00161-8; Ceci O, 1998, EUR J OBSTET GYN R B, V76, P29, DOI 10.1016/S0301-2115(97)00148-6; CHOW LH, 1989, J AM COLL CARDIOL, V14, P915, DOI 10.1016/0735-1097(89)90465-8; COSTANZONORDIN MR, 1989, PROG CARDIOL, V2, P225; Coulson CC, 1996, OBSTET GYNECOL, V87, P610, DOI 10.1016/0029-7844(95)00493-9; CUNNINGHAM FG, 1986, OBSTET GYNECOL, V67, P157; DEMAKIS JG, 1971, CIRCULATION, V44, P964, DOI 10.1161/01.CIR.44.5.964; DEMAKIS JG, 1971, CIRCULATION, V44, P1053, DOI 10.1161/01.CIR.44.6.1053; FARBER PA, 1970, AM HEART J, V80, P96, DOI 10.1016/0002-8703(70)90042-6; Frishman WH, 1998, NEW ENGL J MED, V339, P1759, DOI 10.1056/NEJM199812103392407; Geva T, 1997, AM HEART J, V133, P53, DOI 10.1016/S0002-8703(97)70247-3; Goulet B, 1937, AM J MED SCI, V194, P185; HAUCK AJ, 1989, MAYO CLIN PROC, V64, P1235, DOI 10.1016/S0025-6196(12)61286-5; JULIAN DG, 1985, PROG CARDIOVASC DIS, V27, P223, DOI 10.1016/0033-0620(85)90007-6; KEOGH A, 1994, J HEART LUNG TRANSPL, V13, P202; KOTHARI SS, 1977, INT J CARDIOL, V60, P111; LAMPERT MB, 1995, AM HEART J, V130, P860, DOI 10.1016/0002-8703(95)90089-6; Lampert MB, 1997, AM J OBSTET GYNECOL, V176, P189, DOI 10.1016/S0002-9378(97)80034-8; LUDWIG P, 1997, AUST N Z J OBSTET GY, V37, P156; LYDEN DC, 1984, CELL IMMUNOL, V87, P462, DOI 10.1016/0008-8749(84)90015-7; Mann Douglas L., 1996, Cytokine and Growth Factor Reviews, V7, P341, DOI 10.1016/S1359-6101(96)00043-3; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; MASSAD LS, 1993, OBSTET GYNECOL, V81, P886; MELVIN KR, 1982, NEW ENGL J MED, V307, P731, DOI 10.1056/NEJM198209163071207; MIDEI MG, 1990, CIRCULATION, V81, P922, DOI 10.1161/01.CIR.81.3.922; Mohler ER, 1997, J AM COLL CARDIOL, V30, P35, DOI 10.1016/S0735-1097(97)00145-9; Mone SM, 1996, CIRCULATION, V94, P667, DOI 10.1161/01.CIR.94.4.667; Nelson J L, 1998, J Am Med Womens Assoc (1972), V53, P31; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; OCONNELL JB, 1986, J AM COLL CARDIOL, V8, P52, DOI 10.1016/S0735-1097(86)80091-2; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PEARL W, 1995, AM HEART J, V129, P421, DOI 10.1016/0002-8703(95)90032-2; Pierce JA, 1962, ARCH INTERN MED, V111, P163; Rahimtoola S H, 1996, Curr Probl Cardiol, V21, P781, DOI 10.1016/S0146-2806(96)80001-6; SUTTON MS, 1991, AM HEART J, V121, P1776; VEILLE JC, 1984, AM J OBSTET GYNECOL, V148, P805, DOI 10.1016/0002-9378(84)90572-6; Ventura S J, 1997, Mon Vital Stat Rep, V46, P1; Witlin AG, 1997, AM J OBSTET GYNECOL, V176, P182, DOI 10.1016/S0002-9378(97)80033-6	43	532	572	0	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1183	1188		10.1001/jama.283.9.1183	http://dx.doi.org/10.1001/jama.283.9.1183			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703781	Bronze			2022-12-28	WOS:000085424100028
J	Donovan, JL; Blake, DR				Donovan, JL; Blake, DR			Qualitative study of interpretation of reassurance among patients attending rheumatology clinics: "just a touch of arthritis, doctor?"	BRITISH MEDICAL JOURNAL			English	Article							DECISION-MAKING; LAY BELIEFS; CONSULTATION; EDUCATION; DISEASE	Objectives To examine commonly used methods of reassurance by clinicians and explore their effect on patients. Design Qualitative study of tape recordings of in-depth, semistructured interviews with patients before and after consultation and of their consultations with doctors. Setting NHS specialist rheumatology clinics in two large British cities. Participants 35 patients selected by consultant rheumatologists from general practitioner referral letters (28 women, 7 men; 24 with inflammatory arthropathies, ii other rheumatological complaints). Main outcome measures Patients' perceptions of reassurance. Results Reassurance was an important part of consultations, whether the diagnosis was clear or uncertain. Clinicians tried to reduce anxiety by emphasising the mildness, early stage, or non-seriousness of the disorder and the likelihood that patients would recover. Patients interpreted reassurance in the context of their own views and perceptions. Doctors' emphasis on the mildness or earliness of the condition raised the spectre of future pain and disability rather than providing reassurance. Patients who felt;hat their problems were properly acknowledged felt more reassured. Conclusions Typical patterns of reassurance were not successful because of the differences in perspective of patients and doctors. A key to successful reassurance seemed to be the doctor's ability to acknowledge patients' perspectives of their difficulties.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England	University of Bristol; Royal National Hospital for Rheumatic Diseases (RNHRD)	Donovan, JL (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.							BARTLETT EE, 1984, J CHRON DIS, V37, P755, DOI 10.1016/0021-9681(84)90044-4; BLAXTER M, 1983, SOC SCI MED, V17, P59, DOI 10.1016/0277-9536(83)90356-8; DONOVAN J, 1991, ANN RHEUM DIS, V50, P418, DOI 10.1136/ard.50.Suppl_3.418; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; DONOVAN JL, 1989, BRIT J RHEUMATOL, V28, P58; DONOVAN JL, 1995, INT J TECHNOL ASSESS, V11, P443, DOI 10.1017/S0266462300008667; EYLES J, 1990, SOCIAL EFFECTS HLTH; Fitzpatrick R, 1996, BRIT MED J, V313, P311, DOI 10.1136/bmj.313.7053.311; FITZPATRICK R, 1981, J NEUROL NEUROSUR PS, V44, P1061, DOI 10.1136/jnnp.44.12.1061; FRANCIS V, 1969, NEW ENGL J MED, V280, P535, DOI 10.1056/NEJM196903062801004; Freidson E., 1970, PROFESSION MED STUDY; Glaser B.G., 1965, AWARENESS DYING; Hammersley M., 1983, ETHNOGRAPHY; HENBEST RJ, 1990, FAM PRACT, V7, P28, DOI 10.1093/fampra/7.1.28; KESSEL N, 1979, LANCET, V1, P1128; MAYOU R, 1976, BRIT J PSYCHIAT, V129, P55, DOI 10.1192/bjp.129.1.55; Mays N, 1996, QUALITATIVE RES HLTH; McDonald IG, 1996, BRIT MED J, V313, P329, DOI 10.1136/bmj.313.7053.329; Miles M., 2013, QUALITATIVE DATA ANA; Mishler EG, 1984, DISCOURSE MED DIALEC; PILOWSKY I, 1969, BRIT J MED PSYCHOL, V42, P347, DOI 10.1111/j.2044-8341.1969.tb02089.x; Silverman D., 1987, COMMUNICATION MED PR; Williams S, 1996, MODER MED LAY PERSPE; 1993, ANN PHARMACOTHERAPY, V27, pS5	24	97	98	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					541	544		10.1136/bmj.320.7234.541	http://dx.doi.org/10.1136/bmj.320.7234.541			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688559	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000085624000021
J	Greenbaum, L				Greenbaum, L			That's what it is	LANCET			English	Article									Indiana Internal Med, Beech Grove Off, Beech Grove, IN 46107 USA		Greenbaum, L (corresponding author), Indiana Internal Med, Beech Grove Off, Beech Grove, IN 46107 USA.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					745	+		10.1016/S0140-6736(99)11157-7	http://dx.doi.org/10.1016/S0140-6736(99)11157-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703817				2022-12-28	WOS:000085615600044
J	Razavi, B				Razavi, B			Reactive arthritis after Helicobacter pylori eradication	LANCET			English	Article							REITERS-SYNDROME		Univ Iowa Hosp & Clin, Dept Med, Iowa City, IA 52242 USA	University of Iowa	Razavi, B (corresponding author), Univ Iowa Hosp & Clin, Dept Med, Iowa City, IA 52242 USA.							ATKINSON MH, 1988, J RHEUMATOL, V15, P520; COPE A, 1992, EUR J CLIN MICROBIOL, V11, P40, DOI 10.1007/BF01971269; Kocar IH, 1998, SCAND J RHEUMATOL, V27, P357; PUTTERMAN C, 1993, SEMIN ARTHRITIS RHEU, V22, P420, DOI 10.1016/S0049-0172(05)80033-2; Shmerling RH, 1998, NEW ENGL J MED, V338, P1830, DOI 10.1056/NEJM199806183382508	5	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					720	720		10.1016/S0140-6736(99)12060-9	http://dx.doi.org/10.1016/S0140-6736(99)12060-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703805				2022-12-28	WOS:000085615600015
J	Hayashi, CY; Lewis, RV				Hayashi, CY; Lewis, RV			Molecular architecture and evolution of a modular spider silk protein gene	SCIENCE			English	Article							FIBROIN GENE; DRAGLINE SILK; ORGANIZATION; SEQUENCES; DRIVE	Spider flagelliform silk is one of the most elastic natural materials known. Extensive sequencing of spider silk genes has shown that the exons and introns of the flagelliform gene underwent intragenic concerted evolution. The intron sequences are more homogenized within a species than are the exons. This pattern can be explained by extreme mutation and recombination pressures on the internally repetitive exons. The iterated sequences within exons encode protein structures that are critical to the function of silks. Therefore, attributes that make silks exceptional biomaterials may also hinder the fixation of optimally adapted protein sequences.	Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Wyoming	Hayashi, CY (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.							Beckwitt R, 1998, INSECT BIOCHEM MOLEC, V28, P121, DOI 10.1016/S0965-1748(97)00083-0; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; DOVER GA, 1993, METHOD ENZYMOL, V224, P525, DOI 10.1016/0076-6879(93)24039-W; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; LASSNER M, 1986, NUCLEIC ACIDS RES, V14, P5499, DOI 10.1093/nar/14.13.5499; MANNING RF, 1980, J BIOL CHEM, V255, P9451; MITA K, 1994, J MOL EVOL, V38, P583; Osaki S, 1996, NATURE, V384, P419, DOI 10.1038/384419a0; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2; VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; ZIMMER EA, 1980, P NATL ACAD SCI-BIOL, V77, P2158, DOI 10.1073/pnas.77.4.2158	20	225	247	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1477	1479		10.1126/science.287.5457.1477	http://dx.doi.org/10.1126/science.287.5457.1477			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688794				2022-12-28	WOS:000085531600048
J	Slack, JMW				Slack, JMW			Stem cells in epithelial tissues	SCIENCE			English	Review							MOUSE INTESTINAL EPITHELIUM; TRANSGENIC MICE; SOMATIC MUTATION; RAT PANCREAS; DIFFERENTIATION; LIVER; CRYPT; ORGANIZATION; LINEAGE; REGENERATION	Most, if not all, epithelial tissues contain stem cells. They are responsible for normal tissue renewal or for regeneration following damage. Our present knowledge of their properties is limited and is mainly derived from studies of cell kinetics and from clonal analysis.	Univ Bath, Dept Biol & Biochem, Dev Biol Programme, Bath BA2 7AY, Avon, England	University of Bath	Slack, JMW (corresponding author), Univ Bath, Dept Biol & Biochem, Dev Biol Programme, Bath BA2 7AY, Avon, England.							ALBERTS B, 1994, MOL BIOL CELL, P1138; Alison M, 1998, PHILOS T R SOC B, V353, P877, DOI 10.1098/rstb.1998.0252; Alison M, 1997, J HEPATOL, V26, P343, DOI 10.1016/S0168-8278(97)80051-7; ANTONIOLI DA, 1975, AM J CLIN PATHOL, V64, P625; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1985, ANAT REC, V211, P420, DOI 10.1002/ar.1092110408; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; FORMAN D, 1980, NATURE, V286, P492, DOI 10.1038/286492a0; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; GORDON JI, 1992, FASEB J, V6, P3039, DOI 10.1096/fasebj.6.12.1521737; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; GU DL, 1993, DEVELOPMENT, V118, P33; GURDON JB, 1988, NATURE, V336, P772, DOI 10.1038/336772a0; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HERMISTON ML, 1995, AM J PHYSIOL-GASTR L, V268, pG813, DOI 10.1152/ajpgi.1995.268.5.G813; INOUE M, 1988, AM J PATHOL, V132, P49; Jensen UB, 1999, DEVELOPMENT, V126, P2409; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; KUSAKABE M, 1988, J CELL BIOL, V107, P257, DOI 10.1083/jcb.107.1.257; LATHJA LG, 1983, STEM CELLS, P1; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; LOEFFLER M, 1993, J THEOR BIOL, V160, P471, DOI 10.1006/jtbi.1993.1031; Lyle S, 1998, J CELL SCI, V111, P3179; MATSUKURA N, 1980, JNCI-J NATL CANCER I, V65, P231; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nomura S, 1998, DEV BIOL, V204, P124, DOI 10.1006/dbio.1998.9055; Nomura S, 1998, GUT, V42, P663, DOI 10.1136/gut.42.5.663; Percival AC, 1999, EXP CELL RES, V247, P123, DOI 10.1006/excr.1998.4322; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; POTTEN CS, 1978, STEM CELLS TISSUE HO, P317; RAO MS, 1989, AM J PATHOL, V134, P1069; ROSENBERG L, 1983, J SURG RES, V35, P63, DOI 10.1016/0022-4804(83)90127-0; ROTH KA, 1991, P NATL ACAD SCI USA, V88, P9407, DOI 10.1073/pnas.88.21.9407; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; SCHMIDT GH, 1987, DEVELOPMENT, V100, P535; Sengel P., 1976, MORPHOGENESIS SKIN; SHIOJIRI N, 1991, CANCER RES, V51, P2611; SIGAL SH, 1992, AM J PHYSIOL, V263, pG139, DOI 10.1152/ajpgi.1992.263.2.G139; SLACK JMW, 1985, J THEOR BIOL, V114, P463, DOI 10.1016/S0022-5193(85)80179-X; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; THORGEIRSSON SS, 1993, AM J PATHOL, V142, P1331; WAINSCOAT JS, 1990, CANCER RES, V50, P1355; WARD AM, 1971, VIRCHOWS ARCH A, V352, P296, DOI 10.1007/BF00542714; Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Wolpert L., 1998, PRINCIPLES DEV; Zhu AJ, 1999, DEVELOPMENT, V126, P2285	52	250	342	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1431	1433		10.1126/science.287.5457.1431	http://dx.doi.org/10.1126/science.287.5457.1431			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688782				2022-12-28	WOS:000085531600036
J	Goslar, T; Arnold, M; Tisnerat-Laborde, N; Czernik, J; Wieckowski, K				Goslar, T; Arnold, M; Tisnerat-Laborde, N; Czernik, J; Wieckowski, K			Variations of Younger Dryas atmospheric radiocarbon explicable without ocean circulation changes	NATURE			English	Article							ICE CORE; CALIBRATION; GREENLAND; C-14; CORALS; DEGLACIATION; INCREASE; RECORDS; EVENT; BE-10	The concentration of radiocarbon, C-14, in the atmosphere depends on its production rate by cosmic rays, and on the intensity of carbon exchange between the atmosphere and other reservoirs, for example the deep oceans. For the Holocene (the past similar to 11,500 years), it has been shown that fluctuations in atmospheric radiocarbon concentrations have been caused mostly by variations in the solar magnetic field(1-3). Recent progress in extending the radiocarbon record backwards in time(4-10) has indicated especially high atmospheric radiocarbon concentrations in the Younger Dryas cold period, between 12,700 and 11,500 years before the present. These high concentrations have been interpreted as a result of a reduced exchange with the deep-ocean reservoir, caused by a drastic weakening of the deep-ocean ventilation(7-9,11,12). Here we present a high-resolution reconstruction of atmospheric radiocarbon concentrations, derived from annually laminated sediments of two Polish lakes, Lake Gosciaz and Lake Perespilno. These records indicate that the maximum in atmospheric radiocarbon concentrations in the early Younger Dryas was smaller than previously believed, and might have been caused by variations in solar activity. If so, there is no indication that the deep-ocean ventilation in the Younger Dryas was significantly different from today's.	Silesian Tech Univ, Inst Phys, PL-44100 Gliwice, Poland; CEA, CNRS, Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; Polish Acad Sci, Inst Geog & Spatial Org, PL-00325 Warsaw, Poland	Silesian University of Technology; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Polish Academy of Sciences	Goslar, T (corresponding author), Silesian Tech Univ, Inst Phys, PL-44100 Gliwice, Poland.			Tisnerat Laborde, Nadine/0000-0002-7697-3605; Goslar, Tomasz/0000-0002-1346-3122				ALLEY RB, 1995, J GLACIOL, V41, P503, DOI 10.3189/S0022143000034845; ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; Bard E, 1998, GEOCHIM COSMOCHIM AC, V62, P2025, DOI 10.1016/S0016-7037(98)00130-6; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; Bard E, 1997, EARTH PLANET SC LETT, V150, P453, DOI 10.1016/S0012-821X(97)00082-4; BEER J, 1988, NATURE, V331, P675, DOI 10.1038/331675a0; Bjorck S, 1996, SCIENCE, V274, P1155, DOI 10.1126/science.274.5290.1155; Blunier T, 1997, GEOPHYS RES LETT, V24, P2683, DOI 10.1029/97GL02658; Brauer A, 1999, QUATERNARY SCI REV, V18, P321, DOI 10.1016/S0277-3791(98)00084-5; Broecker WS, 1990, GLOBAL BIOGEOCHEM CY, V4, P103, DOI 10.1029/GB004i001p00103; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; Finkel RC, 1997, J GEOPHYS RES-OCEANS, V102, P26699, DOI 10.1029/97JC01282; GOSLAR T, 1993, QUATERNARY SCI REV, V12, P287, DOI 10.1016/0277-3791(93)90037-M; Goslar T, 1999, QUATERNARY SCI REV, V18, P899, DOI 10.1016/S0277-3791(99)00004-9; Goslar T, 1999, CLIM DYNAM, V15, P29, DOI 10.1007/s003820050266; GOSLAR T, 1995, NATURE, V377, P414, DOI 10.1038/377414a0; HAMMER CU, 1998, STRATIGRAPHIC DATING; Hughen KA, 1998, NATURE, V391, P65, DOI 10.1038/34150; JOHNSEN SJ, 1992, NATURE, V359, P311, DOI 10.1038/359311a0; Kitagawa H, 1998, SCIENCE, V279, P1187, DOI 10.1126/science.279.5354.1187; MIKOLAJEWICZ U, 1996, 189 M PLANCK I MET; Spurk M, 1998, RADIOCARBON, V40, P1107, DOI 10.1017/S0033822200019159; Stocker TF, 1996, PALEOCEANOGRAPHY, V11, P773, DOI 10.1029/96PA02640; STUIVER M, 1980, SCIENCE, V207, P11, DOI 10.1126/science.207.4426.11; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123	27	73	79	2	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					877	880		10.1038/35002547	http://dx.doi.org/10.1038/35002547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706281				2022-12-28	WOS:000085559200052
J	Burnier, M; Brunner, HR				Burnier, M; Brunner, HR			Angiotensin II receptor antagonists	LANCET			English	Review							SPONTANEOUSLY HYPERTENSIVE RATS; TO-MODERATE HYPERTENSION; HEART-FAILURE; DOUBLE-BLIND; LOSARTAN POTASSIUM; HEALTHY-SUBJECTS; TYPE-1 RECEPTOR; BLOOD-PRESSURE; NORMOTENSIVE SUBJECTS; ENZYME-INHIBITION	Blockade of the renin-angiotensin system began as a way of studying the pathogenesis of cardiovascular disease with specific pharmacological probes. Oral activity, achieved by shortening the original peptide structures, transformed the probes into therapeutic agents, the angiotensin-converting enzyme (ACE) inhibitors. However, ACE is a non-specific target for blocking the renin-angiotensin enzymatic cascade. The availability of orally active drugs turned ACE inhibition into a therapeutic breakthrough but more specific blockade always seemed desirable. This goal has now been achieved with the orally active angiotensin II receptor antagonists; six are on the market and more are under development. This new class of drugs is equal in efficacy to ACE inhibitors, at least in hypertensive patients. Trials now underway will demonstrate whether angiotensin II receptor antagonists can prevent target-organ damage and reduce cardiovascular morbidity and mortality. If they do, these compounds might one day replace ACE inhibitors.	CHU Vaudois, Dept Med, Div Hypertens & Vasc Med, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Burnier, M (corresponding author), CHU Vaudois, Dept Med, Div Hypertens & Vasc Med, CH-1011 Lausanne, Switzerland.	Michel.Burnier@chuv.hospvd.ch						ACKER CG, 1995, NEW ENGL J MED, V333, P1572, DOI 10.1056/NEJM199512073332316; Andersson Ove K., 1998, Blood Pressure, V7, P53; Baruch L, 1999, CIRCULATION, V99, P2658, DOI 10.1161/01.CIR.99.20.2658; Benz J, 1997, J CLIN PHARMACOL, V37, P101, DOI 10.1002/j.1552-4604.1997.tb04767.x; BERGSMA DJ, 1992, BIOCHEM BIOPH RES CO, V183, P989, DOI 10.1016/S0006-291X(05)80288-8; Black HR, 1997, J HUM HYPERTENS, V11, P483, DOI 10.1038/sj.jhh.1000482; BRUNNER HR, 1973, LANCET, V2, P1045; BRUNNER HR, 1974, PROG CARDIOVASC DIS, V17, P87, DOI 10.1016/0033-0620(74)90024-3; Burnier M, 1996, KIDNEY INT, V49, P1787, DOI 10.1038/ki.1996.268; BURNIER M, 1995, HYPERTENSION, V25, P602, DOI 10.1161/01.HYP.25.4.602; Cao ZM, 1999, HYPERTENSION, V34, P408, DOI 10.1161/01.HYP.34.3.408; Chiolero A, 1998, Expert Opin Investig Drugs, V7, P1915, DOI 10.1517/13543784.7.11.1915; CONLIN PR, IN PRESS AM J HYPERT; Corea L, 1996, CLIN PHARMACOL THER, V60, P341, DOI 10.1016/S0009-9236(96)90061-2; CORVOL P, 1990, HYPERTENSION, V16, P1; CROZIER I, 1995, CIRCULATION, V91, P691, DOI 10.1161/01.CIR.91.3.691; Dahlof B, 1997, AM J HYPERTENS, V10, P705; DELACRETAZ E, 1995, HYPERTENSION, V25, P14, DOI 10.1161/01.HYP.25.1.14; Di Pasquale P, 1998, CARDIOVASC DRUG THER, V12, P211, DOI 10.1023/A:1007739412802; DICKSTEIN K, 1995, J AM COLL CARDIOL, V26, P438, DOI 10.1016/0735-1097(95)80020-H; Dickstein K, 1999, AM J CARDIOL, V83, P477, DOI 10.1016/S0002-9149(98)00898-4; Faulhaber HD, 1999, CURR THER RES CLIN E, V60, P170, DOI 10.1016/S0011-393X(00)88527-6; Fierens F, 1999, EUR J PHARMACOL, V367, P413, DOI 10.1016/S0014-2999(98)00965-0; Fierens FLP, 1999, EUR J PHARMACOL, V372, P199, DOI 10.1016/S0014-2999(99)00205-8; Fogari R, 1999, CURR THER RES CLIN E, V60, P195, DOI 10.1016/S0011-393X(00)88515-X; FORNES P, 1993, J CARDIOVASC PHARM, V22, P305, DOI 10.1097/00005344-199308000-00021; Fricker AF, 1998, KIDNEY INT, V54, P2089, DOI 10.1046/j.1523-1755.1998.00220.x; GANSEVOORT RT, 1994, KIDNEY INT, V45, P861, DOI 10.1038/ki.1994.113; GAVRAS H, 1977, JAMA-J AM MED ASSOC, V238, P880, DOI 10.1001/jama.238.8.880; Gillis JC, 1997, DRUGS, V54, P885, DOI 10.2165/00003495-199754060-00007; Goa KL, 1996, DRUGS, V51, P820, DOI 10.2165/00003495-199651050-00008; GOLDBERG AI, 1995, AM J CARDIOL, V75, P793, DOI 10.1016/S0002-9149(99)80413-5; GOTTLIEB SS, 1993, CIRCULATION, V88, P1602, DOI 10.1161/01.CIR.88.4.1602; GRADMAN AH, 1995, HYPERTENSION, V25, P1345, DOI 10.1161/01.HYP.25.6.1345; Hall WD, 1998, CLIN DRUG INVEST, V16, P203, DOI 10.2165/00044011-199816030-00004; Hamroff G, 1999, CIRCULATION, V99, P990, DOI 10.1161/01.CIR.99.8.990; Havranek EP, 1999, J AM COLL CARDIOL, V33, P1174, DOI 10.1016/S0735-1097(98)00695-0; Hayashi N, 1997, ARZNEIMITTELFORSCH, V47, P625; Hebert LA, 1999, AM J NEPHROL, V19, P1, DOI 10.1159/000013417; Hedner T, 1999, AM J HYPERTENS, V12, P414, DOI 10.1016/S0895-7061(99)00082-5; Hegner G, 1997, EUR J CLIN PHARMACOL, V52, P173, DOI 10.1007/s002280050270; Holm Ellen A., 1996, Blood Pressure, V5, P360, DOI 10.3109/08037059609078075; Julian BA, 1998, J AM SOC NEPHROL, V9, P1104; Kassler-Taub K, 1998, AM J HYPERTENS, V11, P445, DOI 10.1016/S0895-7061(97)00491-3; Lacourciere Y, 1999, INT J CLIN PRACT, V53, P99; LACOURCIERE Y, 1994, J HYPERTENS, V12, P1387; Lacourciere Y, 1999, AM J HYPERTENS, V12, p41A; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Li JS, 1998, HYPERTENSION, V31, P487, DOI 10.1161/01.HYP.31.1.487; MacKay JH, 1996, ARCH INTERN MED, V156, P278, DOI 10.1001/archinte.156.3.278; Mackenzie HS, 1998, AM J KIDNEY DIS, V31, P161, DOI 10.1053/ajkd.1998.v31.pm9428469; Mackenzie HS, 1997, KIDNEY INT, pS140; Maillon JM, 1999, J HUM HYPERTENS, V13, P657, DOI 10.1038/sj.jhh.1000925; MASSIE BM, 1998, LANCET S1, V352, pS129; Mazzolai L, 1999, HYPERTENSION, V33, P850, DOI 10.1161/01.HYP.33.3.850; Mazzolai L, 1999, DRUG SAFETY, V21, P23, DOI 10.2165/00002018-199921010-00003; McClellan KJ, 1998, DRUGS, V55, P713, DOI 10.2165/00003495-199855050-00011; McClellan KJ, 1998, DRUGS, V56, P1039, DOI 10.2165/00003495-199856060-00007; McInnes GT, 1997, J HUM HYPERTENS, V11, pS75; McKelvie RS, 1999, CIRCULATION, V100, P1056, DOI 10.1161/01.CIR.100.10.1056; Meffert S, 1996, MOL CELL ENDOCRINOL, V122, P59, DOI 10.1016/0303-7207(96)03873-7; Mimran A, 1998, J HUM HYPERTENS, V12, P203, DOI 10.1038/sj.jhh.1000591; Missouris CG, 1997, HEART, V77, P391, DOI 10.1136/hrt.77.4.391-b; MIZUNO K, 1994, LIFE SCI, V54, P1987, DOI 10.1016/0024-3205(94)90133-3; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; MULLER P, 1994, EUR J CLIN PHARMACOL, V47, P231, DOI 10.1007/BF02570503; MUNAFO A, 1992, CLIN PHARMACOL THER, V51, P513, DOI 10.1038/clpt.1992.56; NAKASHIMA M, 1992, EUR J CLIN PHARMACOL, V42, P333; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; NUSSBERGER J, 1989, CARDIOLOGY, V76, P11, DOI 10.1159/000174555; Ohkubo N, 1997, CIRCULATION, V96, P3954; Oparil S, 1998, CLIN THER, V20, P398, DOI 10.1016/S0149-2918(98)80051-9; Ostermann M, 1997, POSTGRAD MED J, V73, P105, DOI 10.1136/pgmj.73.856.105; Ots M, 1998, J AM SOC NEPHROL, V9, P224; Pechere-Bertschi A, 1998, J HYPERTENS, V16, P385, DOI 10.1097/00004872-199816030-00016; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; Pitt B, 1996, CIRCULATION, V94, P2497; Plouin PF, 1997, J HUM HYPERTENS, V11, pS65; Plum J, 1998, J AM SOC NEPHROL, V9, P2223; Pope JC, 1999, J AM SOC NEPHROL, V10, P2018; Reeves RA, 1998, HYPERTENSION, V31, P1311, DOI 10.1161/01.HYP.31.6.1311; Remuzzi A, 1998, EXP NEPHROL, V6, P28; Remuzzi A, 1999, AM J PHYSIOL-RENAL, V276, pF457, DOI 10.1152/ajprenal.1999.276.3.F457; Ribstein J., 1994, J HYPERTENS, V12, P131; Russo D, 1999, AM J KIDNEY DIS, V33, P851, DOI 10.1016/S0272-6386(99)70416-6; Saine DR, 1996, ANN INTERN MED, V124, P775, DOI 10.7326/0003-4819-124-8-199604150-00015; Schwarzbeck A, 1998, LANCET, V352, P286, DOI 10.1016/S0140-6736(05)60259-0; Sever P, 1997, J HUM HYPERTENS, V11, pS91; Smith DHG, 1998, ADV THER, V15, P229; Smith R D, 1994, Curr Opin Nephrol Hypertens, V3, P112, DOI 10.1097/00041552-199401000-00016; SOFFER BA, 1995, HYPERTENSION, V26, P112, DOI 10.1161/01.HYP.26.1.112; Spinale FG, 1997, CIRCULATION, V96, P2385; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Stumpe K. O., 1998, Blood Pressure, V7, P31; Swedberg K, 1999, J Card Fail, V5, P276, DOI 10.1016/S1071-9164(99)90013-1; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Thurmann PA, 1998, CIRCULATION, V98, P2037, DOI 10.1161/01.CIR.98.19.2037; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Toto R, 1998, HYPERTENSION, V31, P684, DOI 10.1161/01.HYP.31.2.684; van Rijnsoever EW, 1998, ARCH INTERN MED, V158, P2063, DOI 10.1001/archinte.158.18.2063; VONLUTTEROTTI N, 1992, J HYPERTENS, V10, P949; Willenheimer R, 1999, EUR HEART J, V20, P997, DOI 10.1053/euhj.1999.1547; Yerkes E, 1998, KIDNEY INT, V54, pS75, DOI 10.1046/j.1523-1755.1998.06715.x; Zanchetti A, 1997, J HUM HYPERTENS, V11, pS57	104	468	488	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					637	645		10.1016/S0140-6736(99)10365-9	http://dx.doi.org/10.1016/S0140-6736(99)10365-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696996				2022-12-28	WOS:000085615400041
J	Samuel, IDW; Beeby, A				Samuel, IDW; Beeby, A			Display technology - Sidestepping the selection rules	NATURE			English	Editorial Material							ORGANIC ELECTROLUMINESCENT DEVICES		Univ Durham, Dept Phys, Durham DH1 3LE, England; Univ Durham, Dept Chem, Durham DH1 3LE, England	Durham University; Durham University	Samuel, IDW (corresponding author), Univ Durham, Dept Phys, South Rd, Durham DH1 3LE, England.		Beeby, Andrew/G-2866-2012	Beeby, Andrew/0000-0002-2134-4668; Samuel, Ifor/0000-0001-7821-7208				Baldo MA, 1999, PHYS REV B, V60, P14422, DOI 10.1103/PhysRevB.60.14422; Baldo MA, 1999, APPL PHYS LETT, V75, P4, DOI 10.1063/1.124258; Baldo MA, 2000, NATURE, V403, P750, DOI 10.1038/35001541; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; Cleave V, 1999, ADV MATER, V11, P285, DOI 10.1002/(SICI)1521-4095(199903)11:4<285::AID-ADMA285>3.0.CO;2-N; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; Hoshino S, 1997, MOL CRYST LIQ CRYS A, V294, P313; McGehee MD, 1999, ADV MATER, V11, P1349, DOI 10.1002/(SICI)1521-4095(199911)11:16<1349::AID-ADMA1349>3.0.CO;2-W; Miyamoto Y, 1999, J LUMIN, V81, P159, DOI 10.1016/S0022-2313(98)00173-2; O'Brien DF, 1999, APPL PHYS LETT, V74, P442, DOI 10.1063/1.123055; Sheats JR, 1996, SCIENCE, V273, P884, DOI 10.1126/science.273.5277.884; Zhang XM, 1997, APPL PHYS LETT, V71, P2596, DOI 10.1063/1.119339	12	13	14	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					710	711		10.1038/35001688	http://dx.doi.org/10.1038/35001688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693782				2022-12-28	WOS:000085423100029
J	Reichhardt, T				Reichhardt, T			NASA review leaves projects on launch pad	NATURE			English	News Item																		2000, NATURE, V403, P232	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					583	583		10.1038/35001206	http://dx.doi.org/10.1038/35001206			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688165	Bronze			2022-12-28	WOS:000085288200007
J	Seiff, A				Seiff, A			Astronomy - Dynamics of Jupiter's atmosphere	NATURE			English	Editorial Material									San Jose State Univ Fdn, Moffett Field, CA 94035 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	California State University System; San Jose State University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Seiff, A (corresponding author), San Jose State Univ Fdn, Mail Stop 245-1, Moffett Field, CA 94035 USA.							Atkinson DH, 1998, J GEOPHYS RES-PLANET, V103, P22911, DOI 10.1029/98JE00060; BUSSE FH, 1976, ICARUS, V29, P255, DOI 10.1016/0019-1035(76)90053-1; GIERASCH PJ, 1976, ICARUS, V29, P445, DOI 10.1016/0019-1035(76)90064-6; INGERSOLL AP, 1981, J GEOPHYS RES-SPACE, V86, P8733, DOI 10.1029/JA086iA10p08733; LITTLE B, IN PRESS ICARUS	7	7	8	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					603	+		10.1038/35001171	http://dx.doi.org/10.1038/35001171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688179				2022-12-28	WOS:000085288200030
J	Meijers, JCM; Tekelenburg, WLH; Bouma, BN; Bertina, RM; Rosendaal, FR				Meijers, JCM; Tekelenburg, WLH; Bouma, BN; Bertina, RM; Rosendaal, FR			High levels of coagulation factor XI as a risk factor for venous thrombosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVATED PROTEIN-C; MOLECULAR-WEIGHT KININOGEN; DEEP-VEIN THROMBOSIS; LEIDEN THROMBOPHILIA; BLOOD-COAGULATION; FIBRINOLYSIS INHIBITOR; ASHKENAZI JEWS; HUMAN PLASMA; DEFICIENCY; CARBOXYPEPTIDASE	Background: Factor XI, a component of the intrinsic pathway of coagulation, contributes to the generation of thrombin, which is involved in both the formation of fibrin and protection against fibrinolysis. A deficiency of factor XI is associated with bleeding, but a role of high factor XI levels in thrombosis has not been investigated. Methods: We determined factor XI antigen levels in the patients enrolled in the Leiden Thrombophilia Study, a large population-based, case-control study (with a total of 474 patients and 474 controls) designed to estimate the contributions of genetic and acquired factors to the risk of deep venous thrombosis. Odds ratios were calculated as a measure of relative risk. Results: The age- and sex-adjusted odds ratio for deep venous thrombosis in subjects who had factor XI levels above the 90th percentile, as compared with those who had factor XI levels at or below that value, was 2.2 (95 percent confidence interval, 1.5 to 3.2). There was a dose-response relation between the factor XI level and the risk of venous thrombosis. Adjustment of the odds ratios for other risk factors such as oral-contraceptive use, homocysteine, fibrinogen, factor VIII, female sex, and older age did not alter the result. Also, when we excluded subjects who had known genetic risk factors for thrombosis (e.g., protein C or S deficiency, antithrombin deficiency, the factor V Leiden mutation, or the prothrombin G20210A mutation), the odds ratio remained the same, indicating that the risk of venous thrombosis associated with elevated levels of factor XI was not the result of one of the known risk factors for thrombosis. Conclusions: High levels of factor XI are a risk factor for deep venous thrombosis, with a doubling of the risk at levels that are present in 10 percent of the population. (N Engl J Med 2000;342:696-701.) (C)2000, Massachusetts Medical Society.	Univ Med Ctr, Dept Hematol, Thrombosis & Hemostasis Lab, Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, Utrecht, Netherlands; Leiden Univ, Med Ctr, Ctr Hemostasis & Thrombosis Res, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Meijers, JCM (corresponding author), Acad Med Ctr, Dept Vasc Med, G1-143,POB 22660, NL-1100 DD Amsterdam, Netherlands.		Bertina, Rogier/AGQ-5246-2022; Rosendaal, Frits/Q-3842-2017; Meijers, J.C.M./S-5981-2019	Rosendaal, Frits/0000-0003-2558-7496; Meijers, J.C.M./0000-0002-4198-6780				ASAKAI R, 1991, NEW ENGL J MED, V325, P153, DOI 10.1056/NEJM199107183250303; BERLINER S, 1992, BLOOD COAGUL FIBRIN, V3, P465, DOI 10.1097/00001721-199203040-00014; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BOUMA BN, 1983, BLOOD, V62, P1123; Bouma BN, 1998, THROMB HAEMOSTASIS, V80, P24; Cawthern KM, 1998, BLOOD, V91, P4581, DOI 10.1182/blood.V91.12.4581.412k12_4581_4592; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; EATON DL, 1991, J BIOL CHEM, V266, P21833; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; KOSTER T, 1995, BLOOD, V85, P2756, DOI 10.1182/blood.V85.10.2756.bloodjournal85102756; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; KOSTER T, 1994, THROMB HAEMOSTASIS, V71, P719; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Minnema MC, 1998, J CLIN INVEST, V101, P10, DOI 10.1172/JCI781; Minnema MC, 1998, J CLIN INVEST, V101, P917; NAITO K, 1991, J BIOL CHEM, V266, P7353; Nesheim M, 1997, THROMB HAEMOSTASIS, V78, P386; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Oliver JA, 1999, ARTERIOSCL THROM VAS, V19, P170, DOI 10.1161/01.ATV.19.1.170; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; RAPAPORT SI, 1961, BLOOD, V18, P149, DOI 10.1182/blood.V18.2.149.149; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P35; SELIGSOHN U, 1993, THROMB HAEMOSTASIS, V70, P68; SELIGSOHN U, 1978, BLOOD, V51, P1223; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; VONDEMBORNE PAK, 1994, THROMB HAEMOSTASIS, V72, P397; VONDEMBORNE PAK, 1995, BLOOD, V86, P3035; VondemBorne PAK, 1997, J CLIN INVEST, V99, P2323, DOI 10.1172/JCI119412; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; WANG W, 1994, J BIOL CHEM, V269, P15937; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; WUILLEMIN WA, 1995, BLOOD, V85, P1517, DOI 10.1182/blood.V85.6.1517.bloodjournal8561517	33	488	539	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2000	342	10					696	701		10.1056/NEJM200003093421004	http://dx.doi.org/10.1056/NEJM200003093421004			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ZW	10706899				2022-12-28	WOS:000085708800004
J	Berner, RA; Petsch, ST; Lake, JA; Beerling, DJ; Popp, BN; Lane, RS; Laws, EA; Westley, MB; Cassar, N; Woodward, FI; Quick, WP				Berner, RA; Petsch, ST; Lake, JA; Beerling, DJ; Popp, BN; Lane, RS; Laws, EA; Westley, MB; Cassar, N; Woodward, FI; Quick, WP			Isotope fractionation and atmospheric oxygen: Implications for phanerozoic O-2 evolution	SCIENCE			English	Article							GROWTH-RATE; CARBON; SULFUR; CYCLES; MODEL; DISCRIMINATION; PALEOCLIMATE; PLANTS; RISE; CO2	Models describing the evolution of the partial pressure of atmospheric oxygen over Phanerozoic time are constrained by the mass balances required between the inputs and outputs of carbon and sulfur to the oceans. This constraint has Limited the applicability of proposed negative feedback mechanisms for maintaining Levels of atmospheric O-2 at biologically permissable Levels. Here we describe a modeling approach that incorporates O-2-dependent carbon and sulfur isotope fractionation using data obtained from Laboratory experiments on carbon-13 discrimination by vascular Land plants and marine plankton. The model allows us to calculate a Phanerozoic O-2 history that agrees with independent models and with biological and physical constraints and supports the hypothesis of a high atmospheric O-2 content during the Carboniferous (300 million years ago), a time when insect gigantism was widespread.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA	Yale University; University of Sheffield; University of Hawaii System	Berner, RA (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.		Cassar, Nicolas/B-4260-2011; Woodward, Frank Ian/P-4530-2019; Beerling, David J/C-2840-2009; Woodward, Ian F/B-7762-2008	Cassar, Nicolas/0000-0003-0100-3783; Beerling, David J/0000-0003-1869-4314; Popp, Brian/0000-0001-7021-5478				Beerling D. J., 1998, STABLE ISOTOPES INTE, P347; Beerling DJ, 1998, PHILOS T R SOC B, V353, P131, DOI 10.1098/rstb.1998.0196; BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; Berner RA, 1998, SCIENCE, V282, P1426, DOI 10.1126/science.282.5393.1426; Berner RA, 1997, SCIENCE, V276, P544, DOI 10.1126/science.276.5312.544; BERNER RA, 1987, AM J SCI, V287, P177, DOI 10.2475/ajs.287.3.177; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; CHALONER WG, 1989, J GEOL SOC LONDON, V146, P171, DOI 10.1144/gsjgs.146.1.0171; CLOUD P, 1976, Paleobiology, V2, P351; Colman AS, 1997, SCIENCE, V275, P406, DOI 10.1126/science.275.5298.406; Dudley R, 1998, J EXP BIOL, V201, P1043; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P191, DOI 10.1071/PP9840191; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FRANCOIS LM, 1986, GEOCHIM COSMOCHIM AC, V50, P2289, DOI 10.1016/0016-7037(86)90083-9; Freeman KH, 1992, GLOBAL BIOGEOCHEM CY, V6, P185, DOI 10.1029/92GB00190; GARRELS RM, 1984, AM J SCI, V284, P989, DOI 10.2475/ajs.284.9.989; Gillon JS, 1997, PLANT CELL ENVIRON, V20, P1217, DOI 10.1046/j.1365-3040.1997.d01-24.x; GRAHAM JB, 1995, NATURE, V375, P117, DOI 10.1038/375117a0; Harrison JF, 1998, J EXP BIOL, V201, P1739; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; HOLLAND HD, 1994, EOS, V75, pOS96; Holland HD., 1984, CHEM EVOLUTION ATMOS; KUMP LR, 1986, AM J SCI, V286, P337, DOI 10.2475/ajs.286.5.337; LASAGA AC, 1989, AM J SCI, V289, P411, DOI 10.2475/ajs.289.4.411; Laws EA, 1997, LIMNOL OCEANOGR, V42, P1552, DOI 10.4319/lo.1997.42.7.1552; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; LENTON TM, 1998, THESIS U E ANGLIA NO; LINDH TB, 1984, THESIS U MIAMI MIAMI; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Paytan A, 1998, SCIENCE, V282, P1459, DOI 10.1126/science.282.5393.1459; Petsch ST, 1998, AM J SCI, V298, P246, DOI 10.2475/ajs.298.3.246; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; POPP BN, 1986, GEOL SOC AM BULL, V97, P1262, DOI 10.1130/0016-7606(1986)97<1262:BAIOOI>2.0.CO;2; Popp BN, 1998, GEOCHIM COSMOCHIM AC, V62, P69, DOI 10.1016/S0016-7037(97)00333-5; QUEBEDEAUX B, 1975, PLANT PHYSIOL, V55, P102, DOI 10.1104/pp.55.1.102; ROBINSON JM, 1989, GLOBAL PLANET CHANGE, V75, P223; SACKETT WM, 1965, SCIENCE, V148, P235, DOI 10.1126/science.148.3667.235; VanCappellen P, 1996, SCIENCE, V271, P493, DOI 10.1126/science.271.5248.493; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; WATSON A, 1978, BIOSYSTEMS, V10, P293, DOI 10.1016/0303-2647(78)90012-6	44	153	164	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2000	287	5458					1630	1633		10.1126/science.287.5458.1630	http://dx.doi.org/10.1126/science.287.5458.1630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698733				2022-12-28	WOS:000085628200031
J	Clark, NM; Gong, M				Clark, NM; Gong, M			Management of chronic disease by practitioners and patients: are we teaching the wrong things?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CLINICAL-TRIAL; ASTHMATIC-CHILDREN; ADULT ASTHMA; EDUCATION-PROGRAM; GENERAL-PRACTICE; HEALTH-CARE; SELF; ADHERENCE; PHYSICIANS; COMPUTER		Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Clark, NM (corresponding author), Univ Michigan, Sch Publ Hlth, 109 S Observ St, Ann Arbor, MI 48109 USA.	nmclark@umich.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044976] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-44976] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN RM, 1995, THORAX, V50, P731, DOI 10.1136/thx.50.7.731; BAILEY WC, 1990, ARCH INTERN MED, V150, P1664, DOI 10.1001/archinte.150.8.1664; BECKER MH, 1985, MED CARE, V23, P539, DOI 10.1097/00005650-198505000-00014; BOLTON MB, 1991, J GEN INTERN MED, V6, P401, DOI 10.1007/BF02598160; CHARLTON I, 1990, BRIT MED J, V301, P1355, DOI 10.1136/bmj.301.6765.1355; CLARK N M, 1990, Health Education Research, V5, P371, DOI 10.1093/her/5.3.371; CLARK NM, 1992, HEALTH EDUC QUART, V19, P341, DOI 10.1177/109019819201900306; Clark NM, 1997, HEALTH EDUC BEHAV, V24, P245, DOI 10.1177/109019819702400211; Clark NM, 1998, PEDIATRICS, V101, P831, DOI 10.1542/peds.101.5.831; CLARK NM, 1986, PATIENT EDUC COUNS, V8, P27, DOI 10.1016/0738-3991(86)90024-8; EVANS D, 1987, HLTH ED Q, V14, P367; FIREMAN P, 1981, PEDIATRICS, V68, P341; GARRETT J, 1994, THORAX, V49, P976, DOI 10.1136/thx.49.10.976; HILTON S, 1986, LANCET, V1, P26; HINDIALEXANDER MC, 1984, J ALLERGY CLIN IMMUN, V74, P505, DOI 10.1016/0091-6749(84)90386-5; HUGHES DM, 1991, PEDIATRICS, V87, P54; HUSS K, 1991, RES NURS HEALTH, V14, P259, DOI 10.1002/nur.4770140404; JENKINSON D, 1988, BRIT MED J, V297, P267, DOI 10.1136/bmj.297.6643.267; KOTSES H, 1995, J ALLERGY CLIN IMMUN, V95, P529, DOI 10.1016/S0091-6749(95)70315-2; LEBARON S, 1985, ANN ALLERGY, V55, P811; LEWIS CE, 1984, PEDIATRICS, V74, P478; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; MAIMAN LA, 1979, JAMA-J AM MED ASSOC, V241, P1919; MAYO PH, 1990, ANN INTERN MED, V112, P864, DOI 10.7326/0003-4819-112-11-864; MCINTOSH NA, 1994, J ASTHMA, V31, P453, DOI 10.3109/02770909409089487; MCNABB WL, 1985, AM J PUBLIC HEALTH, V75, P1219, DOI 10.2105/AJPH.75.10.1219; MESTERS I, 1994, J ASTHMA, V31, P347, DOI 10.3109/02770909409061314; MITCHELL EA, 1986, ARCH DIS CHILD, V61, P1184, DOI 10.1136/adc.61.12.1184; MOLDOFSKY H, 1979, CAN MED ASSOC J, V120, P669; OLEARY A, 1985, BEHAV RES THER, V23, P437, DOI 10.1016/0005-7967(85)90172-X; OSMAN LM, 1994, BRIT MED J, V308, P568, DOI 10.1136/bmj.308.6928.568; Parcel G S, 1980, J Dev Behav Pediatr, V1, P128; RAKOS RF, 1985, J PSYCHOSOM RES, V29, P101, DOI 10.1016/0022-3999(85)90014-5; RAND CS, 1992, AM REV RESPIR DIS, V146, P1559, DOI 10.1164/ajrccm/146.6.1559; RINGSBERG KC, 1990, EUR RESPIR J, V3, P33; ROBINSON LD, 1985, CHEST, V87, pS105, DOI 10.1378/chest.87.1.105S; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; RUBIN DH, 1986, PEDIATRICS, V77, P1; SNYDER SE, 1987, J ASTHMA, V24, P153, DOI 10.3109/02770908709070931; STAUDENMAYER H, 1981, J ASTHMA, V18, P1, DOI 10.3109/02770908109118301; WILSON SR, 1993, AM J MED, V94, P564, DOI 10.1016/0002-9343(93)90206-5; WILSON SR, 1994, CHEST, V106, pS197, DOI 10.1378/chest.106.4_Supplement.197S; WINDSOR RA, 1990, AM J PUBLIC HEALTH, V80, P1519, DOI 10.2105/AJPH.80.12.1519; YOON R, 1993, THORAX, V48, P1110, DOI 10.1136/thx.48.11.1110	44	129	132	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2000	320	7234					572	+		10.1136/bmj.320.7234.572	http://dx.doi.org/10.1136/bmj.320.7234.572			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	289LV	10688569	Green Published			2022-12-28	WOS:000085624000030
J	Gajiwala, KS; Chen, H; Cornille, F; Roques, BP; Reith, W; Mach, B; Burley, SK				Gajiwala, KS; Chen, H; Cornille, F; Roques, BP; Reith, W; Mach, B; Burley, SK			Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding	NATURE			English	Article							LINKER HISTONE H5; GLOBULAR DOMAIN; NUCLEOSOME BINDING; CRYSTAL-STRUCTURE; SITE; IDENTIFICATION; RECOGNITION; FAMILY; MOTIF; HEAD	Regulatory factor X (RFX) proteins are transcriptional activators that recognize X-boxes (DNA of the sequence 5'-GTNRCC(0-3N) RGYAAC-3', where N is any nucleotide, R is a purine and Y is a pyrimidine) using a highly conserved 76-residue DNA-binding domain (DBD). DNA-binding defects in the protein RFX5 cause bare lymphocyte syndrome or major histocompatibility antigen class II defciency(1), RFXI, -2 and -3 regulate expression of other medically important gene products (for example, interleukin-5 receptor alpha chain, IL-5R alpha)(2). Fusions of the ligand-binding domain of the oestrogen receptor with the DBD of RFX4 occur in some human breast tumours'. Here we present a 1.5 Angstrom-resolution structure of two copies of the DBD of human RFXI (hRFX1) binding cooperatively to a symmetrical X-box(4,5), hRFX1 is an unusual member of the winged-helix subfamily of helix-turn-helix proteins(6) because it uses a beta-hairpin (or wing) to recognize DNA instead of the recognition helix typical of helix-turn-helix proteins. A new model for interactions between linker histones and DNA is proposed.	Rockefeller Univ, Pels Family Ctr Biochem & Struct Biol, Labs Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; UFR Sci Pharmaceut & Biol, Dept Pharmacol Mol & Struct, CNRS,URA D1500, INSERM,U266, F-75720 Paris, France; Ctr Med Univ Geneva, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Geneva	Burley, SK (corresponding author), Rockefeller Univ, Pels Family Ctr Biochem & Struct Biol, Labs Mol Biophys, 1230 York Ave, New York, NY 10021 USA.			Burley, Stephen K./0000-0002-2487-9713				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCKLE RS, 1992, J MOL BIOL, V223, P651, DOI 10.1016/0022-2836(92)90981-O; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Cornille F, 1998, NUCLEIC ACIDS RES, V26, P2143, DOI 10.1093/nar/26.9.2143; DOTZLAW H, 1992, MOL ENDOCRINOL, V6, P773, DOI 10.1210/me.6.5.773; Emery P, 1996, MOL CELL BIOL, V16, P4486; Goytisolo FA, 1996, EMBO J, V15, P3421, DOI 10.1002/j.1460-2075.1996.tb00708.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Iwama A, 1999, MOL CELL BIOL, V19, P3940; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Jin CW, 1999, J MOL BIOL, V289, P683, DOI 10.1006/jmbi.1999.2819; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OSTAPCHUK P, 1989, MOL CELL BIOL, V9, P2787, DOI 10.1128/MCB.9.7.2787; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; REITH W, 1990, GENE DEV, V4, P1528, DOI 10.1101/gad.4.9.1528; THOMAS JO, 1986, EMBO J, V5, P3531, DOI 10.1002/j.1460-2075.1986.tb04679.x; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zhou YB, 1998, NATURE, V395, P402, DOI 10.1038/26521	25	261	272	0	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					916	921		10.1038/35002634	http://dx.doi.org/10.1038/35002634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706293				2022-12-28	WOS:000085559200064
J	Bochtler, M; Hartmann, C; Song, HK; Bourenkov, GP; Bartunik, HD; Huber, R				Bochtler, M; Hartmann, C; Song, HK; Bourenkov, GP; Bartunik, HD; Huber, R			The structures of HsIU and ATP-dependent protease HsIU-HsIV	NATURE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; UBIQUITIN SYSTEM; 20S PROTEASOME; P-LOOP; DEGRADATION; PROTEINS; BINDING; CHAPERONES; RESOLUTION	The degradation of cytoplasmic proteins is an ATP-dependent process'. Substrates are targeted to a single soluble protease, the 26S proteasome(2,3), in eukaryotes and to a number of unrelated proteases in prokaryotes(4,5). A surprising Link emerged with the discovery of the ATP-dependent protease HslVU (heat shock locus VU)(6-8) in Escherichia coli. Its protease component HsIV shares similar to 20% sequence similarity(6) and a conserved fold(9) with 20S proteasome beta-subunits. HslU is a member of the Hsp100 (Clp) family of ATPases. Here we report the crystal structures of free HslU and an 820,000 relative molecular mass complex of HslU and HslV-the first structure of a complete set of components of an ATP-dependent protease. HslV and HslU display sixfold symmetry, ruling out mechanisms of protease activation that require a symmetry mismatch between the two components. Instead, there is conformational flexibility and domain motion in HslU and a localized order-disorder transition in HslV. Individual subunits of HslU contain two globular domains in relative orientations that correlate with nucleotide bound and unbound states. They are surprisingly similar to their counterparts in N-ethylmaleimide-sensitive fusion protein(10,11), the prototype of an AAA-ATPase. A third, mostly a-helical domain in HslU mediates the contact with HslV and may be the structural equivalent of the amino-terminal domains in proteasomal AAA-ATPases.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Max Planck Gesell, Arbeitsgrp Strukturelle Mol Biol, D-22603 Hamburg, Germany	Max Planck Society; Max Planck Society	Bochtler, M (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	bochtler@bio-chem.mpg.de	Song, Hyun Kyu/D-6763-2016; Bochtler, Matthias/A-4514-2010; Bourenkov, Gleb P/C-7794-2017	Song, Hyun Kyu/0000-0001-5684-4059; Bourenkov, Gleb P/0000-0002-2617-5920; Bochtler, Matthias/0000-0001-7884-4463				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHUANG SE, 1993, GENE, V134, P1, DOI 10.1016/0378-1119(93)90167-2; Feng HP, 1998, CURR BIOL, V8, pR464, DOI 10.1016/S0960-9822(98)70294-5; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Huang HC, 1997, J BIOL CHEM, V272, P21364, DOI 10.1074/jbc.272.34.21364; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Levchenko I, 1997, CELL, V91, P939, DOI 10.1016/S0092-8674(00)80485-7; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; Missiakas D, 1996, EMBO J, V15, P6899, DOI 10.1002/j.1460-2075.1996.tb01082.x; Neuwald AF, 1999, GENOME RES, V9, P27; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	30	362	370	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					800	805		10.1038/35001629	http://dx.doi.org/10.1038/35001629			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693812				2022-12-28	WOS:000085423100059
J	Gylfe, A; Bergstrom, S; Lunstrom, J; Olsen, B				Gylfe, A; Bergstrom, S; Lunstrom, J; Olsen, B			Epidemiology - Reactivation of Borrelia infection in birds	NATURE			English	Article							BURGDORFERI SENSU-LATO		Umea Univ, Dept Microbiol, SE-90187 Umea, Sweden; Uppsala Univ, Dept Populat Biol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; Umea Univ, Dept Infect Dis, SE-90187 Umea, Sweden; Kalmar Cty Hosp, Dept Infect Dis, SE-39185 Kalmar, Sweden	Umea University; Uppsala University; Umea University	Gylfe, A (corresponding author), Umea Univ, Dept Microbiol, SE-90187 Umea, Sweden.	bjornol@ltkalmar.se		Olsen, Bjorn/0000-0002-4646-691X				Alerstam T, 1990, BIRD MIGRATION; Apanius V, 1998, ADV STUD BEHAV, V27, P133; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Holberton RL, 1996, AUK, V113, P558, DOI 10.2307/4088976; Hubalek Z, 1998, J MED MICROBIOL, V47, P929, DOI 10.1099/00222615-47-10-929; Humair PF, 1998, ZBL BAKT-INT J MED M, V287, P521, DOI 10.1016/S0934-8840(98)80194-1; Kurtenbach K, 1998, APPL ENVIRON MICROB, V64, P1169; OLSEN B, 1995, APPL ENVIRON MICROB, V61, P3082; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; WELTY JC, 1988, LIFE BIRDS, P119	11	134	138	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					724	725		10.1038/35001663	http://dx.doi.org/10.1038/35001663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693792				2022-12-28	WOS:000085423100039
J	Vazquez-Torres, A; Xu, YS; Jones-Carson, J; Holden, DW; Lucia, SM; Dinauer, MC; Mastroeni, P; Fang, FC				Vazquez-Torres, A; Xu, YS; Jones-Carson, J; Holden, DW; Lucia, SM; Dinauer, MC; Mastroeni, P; Fang, FC			Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase	SCIENCE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; III SECRETION SYSTEM; NITRIC-OXIDE; MYCOBACTERIUM-TUBERCULOSIS; SUPEROXIDE PRODUCTION; BACTERIAL VIRULENCE; RADICAL PRODUCTION; RESPIRATORY BURST; HOST-CELLS; TYPHIMURIUM	A type III protein secretion system encoded by Salmonella pathogenicity island 2 (SPI2) has been found to be required for virulence and survival within macrophages. Here, SPI2 was shown to allow Salmonella typhimurium to avoid NADPH oxidase-dependent killing by macrophages. The ability of SPI2-mutant bacteria to survive in macrophages and to cause Lethal infection in mice was restored by abrogation of the NADPH oxidase-dependent respiratory burst. Ultrastructural and immunofluorescence microscopy demonstrated efficient Localization of the NADPH oxidase in the proximity of vacuoles containing SPI2-mutant but not wild-type bacteria, suggesting that SPI2 interferes with trafficking of oxidase-containing vesicles to the phagosome.	Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Denver, CO 80262 USA; Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Infect Dis, London W12 0NN, England; Indiana Univ, Sch Med, Indianapolis, IN 46202 USA; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2BZ, England	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Imperial College London; Indiana University System; Indiana University-Purdue University Indianapolis; Imperial College London	Fang, FC (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA.		Timms, Andrew/K-2380-2019	Timms, Andrew/0000-0001-7439-1073; Mastroeni, Pietro/0000-0003-3838-4962; Fang, Ferric/0000-0002-3243-110X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044486, R01AI039557, R21AI039557] Funding Source: NIH RePORTER; NIAID NIH HHS [AI39557, AI44486] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; BRIGGS RT, 1975, J CELL BIOL, V67, P566, DOI 10.1083/jcb.67.3.566; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; COX JA, 1985, J CLIN INVEST, V76, P1932, DOI 10.1172/JCI112190; CURNUTTE JT, 1989, J CLIN INVEST, V83, P1236, DOI 10.1172/JCI114006; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DeGroote MA, 1996, SCIENCE, V272, P414, DOI 10.1126/science.272.5260.414; Dusi S, 1996, J IMMUNOL, V157, P4615; Fang FC, 1997, INFECT IMMUN, V65, P5371, DOI 10.1128/IAI.65.12.5371-5375.1997; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; JESAITIS AJ, 1990, J CLIN INVEST, V85, P821, DOI 10.1172/JCI114509; Kobayashi T, 1998, J CELL SCI, V111, P81; Li YB, 1998, J BIOL CHEM, V273, P2015, DOI 10.1074/jbc.273.4.2015; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MASTROENI P, UNPUB; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MOUY R, 1989, J PEDIATR-US, V114, P555, DOI 10.1016/S0022-3476(89)80693-6; OBRIEN S, 1991, MICROB PATHOGENESIS, V10, P199, DOI 10.1016/0882-4010(91)90054-E; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Taylor PD, 1998, INFECT IMMUN, V66, P3208, DOI 10.1128/IAI.66.7.3208-3217.1998; TSOLIS RM, 1995, J BACTERIOL, V177, P4628, DOI 10.1128/jb.177.16.4628-4637.1995; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Vaissiere C, 1999, J LEUKOCYTE BIOL, V65, P629, DOI 10.1002/jlb.65.5.629; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227; VAZQUEZTORRES A, UNPUB; WILES ME, 1995, LIFE SCI, V57, P1533, DOI 10.1016/0024-3205(95)02114-X; WOLFF DJ, 1995, ARCH BIOCHEM BIOPHYS, V316, P290, DOI 10.1006/abbi.1995.1040; WU J, 1991, J BACTERIOL, V173, P2864, DOI 10.1128/JB.173.9.2864-2871.1991; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	45	432	441	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1655	1658		10.1126/science.287.5458.1655	http://dx.doi.org/10.1126/science.287.5458.1655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698741				2022-12-28	WOS:000085628200039
J	Perng, GC; Jones, C; Ciacci-Zanella, J; Stone, M; Henderson, G; Yukht, A; Slanina, SM; Hofman, FM; Ghiasi, H; Nesburn, AB; Wechsler, SL				Perng, GC; Jones, C; Ciacci-Zanella, J; Stone, M; Henderson, G; Yukht, A; Slanina, SM; Hofman, FM; Ghiasi, H; Nesburn, AB; Wechsler, SL			Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; GENE MESSENGER-RNA; POLY(ADP-RIBOSE) POLYMERASE; SPONTANEOUS REACTIVATION; INFECTED NEURONS; TYPE-1; PROTEIN; CERAMIDE; ESTABLISHMENT; INDUCTION	Latent infections with periodic reactivation are a common outcome after acute infection with many viruses, The Latency-associated transcript (LAT) gene is required for wild-type reactivation of herpes simplex virus (HSV), However, the underlying mechanisms remain unclear. In rabbit trigeminal ganglia, extensive apoptosis occurred with LAT(-) virus but not with LAT(+) viruses. In addition, a plasmid expressing LAT blocked apoptosis in cultured cells. Thus, LAT promotes neuronal survival after HSV-1 infection by reducing apoptosis.	Cedars Sinai Med Ctr, Burns & Allen Res Inst, Ophthalmol Res Labs, Los Angeles, CA 90048 USA; Univ Nebraska, Ctr Biotechnol, Dept Vet & Biomed Sci, Lincoln, NE 68583 USA; Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90025 USA; Univ Calif Los Angeles, Sch Med, Dept Ophthalmol, Los Angeles, CA 90024 USA	Cedars Sinai Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wechsler, SL (corresponding author), Cedars Sinai Med Ctr, Burns & Allen Res Inst, Ophthalmol Res Labs, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	Wechsler@CSMC.edu	Zanella, Janice R/C-3632-2014; zanella, janice/AAV-9729-2020	zanella, janice/0000-0002-6259-6028; Perng, Oscar/0000-0001-7510-4486	NEI NIH HHS [EY07566, EY11629] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011629, R01EY007566] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aubert M, 1999, J VIROL, V73, P2803, DOI 10.1128/JVI.73.4.2803-2813.1999; Boesen-de Cock JGR, 1999, J BIOL CHEM, V274, P14255, DOI 10.1074/jbc.274.20.14255; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Ciacci-Zanella J, 1999, J VIROL, V73, P9734, DOI 10.1128/JVI.73.12.9734-9740.1999; Ciacci-Zanella JR, 1999, FOOD CHEM TOXICOL, V37, P703, DOI 10.1016/S0278-6915(99)00034-4; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; DIEKEN ES, 1992, MOL CELL BIOL, V12, P589, DOI 10.1128/MCB.12.2.589; Drolet BS, 1998, VIROLOGY, V242, P221, DOI 10.1006/viro.1997.9020; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Galvan V, 1999, J VIROL, V73, P3219, DOI 10.1128/JVI.73.4.3219-3226.1999; Galvan V, 1998, P NATL ACAD SCI USA, V95, P3931, DOI 10.1073/pnas.95.7.3931; Garber DA, 1997, J VIROL, V71, P5885, DOI 10.1128/JVI.71.8.5885-5893.1997; GORDON YJ, 1995, GRAEF ARCH CLIN EXP, V233, P649; HAINSWORTH JD, 1995, ANN ONCOL, V6, P325, DOI 10.1093/oxfordjournals.annonc.a059180; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Jones C, 1998, Adv Virus Res, V51, P81, DOI 10.1016/S0065-3527(08)60784-8; JONES C, IN PRESS ENV HLTH PE; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Leopardi R, 1997, P NATL ACAD SCI USA, V94, P7891, DOI 10.1073/pnas.94.15.7891; Mador N, 1998, J VIROL, V72, P5067, DOI 10.1128/JVI.72.6.5067-5075.1998; Mitchell IJ, 1998, NEUROSCIENCE, V84, P489, DOI 10.1016/S0306-4522(97)00534-4; Nip J, 1997, MOL CELL BIOL, V17, P1049, DOI 10.1128/MCB.17.3.1049; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Perng GC, 2000, J VIROL, V74, P1885, DOI 10.1128/JVI.74.4.1885-1891.2000; Perng GC, 1999, J VIROL, V73, P920, DOI 10.1128/JVI.73.2.920-929.1999; PERNG GC, 1994, J VIROL, V68, P8045, DOI 10.1128/JVI.68.12.8045-8055.1994; Perng GC, 1996, J VIROL, V70, P976, DOI 10.1128/JVI.70.2.976-984.1996; ROCK DL, 1987, J VIROL, V61, P3820, DOI 10.1128/JVI.61.12.3820-3826.1987; Saldeen J, 1998, MOL CELL ENDOCRINOL, V139, P99, DOI 10.1016/S0303-7207(98)00068-9; Sawtell NM, 1998, J VIROL, V72, P6888, DOI 10.1128/JVI.72.8.6888-6892.1998; Sawtell NM, 1998, J VIROL, V72, P5343, DOI 10.1128/JVI.72.7.5343-5350.1998; SAWTELL NM, 1992, J VIROL, V66, P2157, DOI 10.1128/JVI.66.4.2157-2169.1992; Sawtell NM, 1997, J VIROL, V71, P5423, DOI 10.1128/JVI.71.7.5423-5431.1997; Simbulan-Rosenthal CM, 1998, J BIOL CHEM, V273, P13703, DOI 10.1074/jbc.273.22.13703; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Thompson RL, 1997, J VIROL, V71, P5432, DOI 10.1128/JVI.71.7.5432-5440.1997; Wagner EK, 1997, CLIN MICROBIOL REV, V10, P419, DOI 10.1128/CMR.10.3.419; Wang H, 1996, P NATL ACAD SCI USA, V93, P3461, DOI 10.1073/pnas.93.8.3461	39	343	363	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1500	1503		10.1126/science.287.5457.1500	http://dx.doi.org/10.1126/science.287.5457.1500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688801	Green Submitted			2022-12-28	WOS:000085531600055
J	Schaffer, E; Thurn-Albrecht, T; Russell, TP; Steiner, U				Schaffer, E; Thurn-Albrecht, T; Russell, TP; Steiner, U			Electrically induced structure formation and pattern transfer	NATURE			English	Article							BLOCK-COPOLYMER MICROSTRUCTURE; FIELD; ALIGNMENT; FILMS	The wavelength of light represents a fundamental technological barrier(1) to the production of increasingly smaller features on integrated circuits. New technologies that allow the replication of patterns on scales less than 100 nm need to be developed if increases in computing power are to continue at the present rate(2). Here we report a simple electrostatic technique that creates and replicates lateral structures in polymer films on a submicrometre length scale. Our method is based on the fact that dielectric media experience a force in an electric field gradient(3). Strong field gradients can produce forces that overcome the surface tension in thin liquid films, inducing an instability that features a characteristic hexagonal order. In our experiments, pattern formation takes place in polymer films at elevated temperatures, and is fixed by cooling the sample to room temperature. The application of a laterally varying electric field causes the instability to be focused in the direction of the highest electric field. This results in the replication of a topographically structured electrode. We report patterns with lateral dimensions of 140 nm, but the extension of the technique to pattern replication on scales smaller than 100 nm seems feasible.	Univ Konstanz, Fak Phys, D-78457 Constance, Germany; Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; Univ Groningen, Dept Polymer Chem, NL-9747 AG Groningen, Netherlands	University of Konstanz; University of Massachusetts System; University of Massachusetts Amherst; University of Groningen	Steiner, U (corresponding author), Univ Konstanz, Fak Phys, D-78457 Constance, Germany.		Steiner, Ullrich/K-4777-2013; Schäffer, Erik/A-4664-2010; Russell, Thomas Paul/ADL-3689-2022	Steiner, Ullrich/0000-0001-5936-339X; Schäffer, Erik/0000-0001-7876-085X; Russell, Thomas Paul/0000-0001-6384-5826; Thurn-Albrecht, Thomas/0000-0002-7618-0218				AMUNDSON K, 1994, MACROMOLECULES, V27, P6559, DOI 10.1021/ma00100a047; AMUNDSON K, 1991, MACROMOLECULES, V24, P6546, DOI 10.1021/ma00024a030; AMUNDSON K, 1993, MACROMOLECULES, V26, P2698, DOI 10.1021/ma00063a010; BIYTHE AR, 1979, ELECT PROPERTIES; Chou SY, 1999, APPL PHYS LETT, V75, P1004, DOI 10.1063/1.124579; Chou SY, 1999, J VAC SCI TECHNOL B, V17, P3197, DOI 10.1116/1.590979; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; Herminghaus S, 1999, PHYS REV LETT, V83, P2359, DOI 10.1103/PhysRevLett.83.2359; Landau LD., 1984, ELECTRODYNAMICS CONT; Morkved TL, 1996, SCIENCE, V273, P931, DOI 10.1126/science.273.5277.931; REITER G, 1992, PHYS REV LETT, V68, P75, DOI 10.1103/PhysRevLett.68.75; *SEM IND ASS, 1997, NAT TECHN ROADM SEM; THURNALBRECHT T, UNPUB MACROMOLECULES; Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q	14	664	681	8	214	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					874	877		10.1038/35002540	http://dx.doi.org/10.1038/35002540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706280				2022-12-28	WOS:000085559200051
J	Rhymes, JA; McCullough, LB; Luchi, RJ; Teasdale, TA; Wilson, N				Rhymes, JA; McCullough, LB; Luchi, RJ; Teasdale, TA; Wilson, N			Withdrawing very low-burden interventions in chronically ill patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Rhymes, JA (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Plaza,M310, Houston, TX 77030 USA.							Beauchamp TL, 2009, PRINCIPLES BIOMEDICA; Brock D. W., 1995, ENCY BIOETHICS, P563; Garcia J. L. A., 1995, ENCY BIOETHICS, P636; Leplege A, 1997, JAMA-J AM MED ASSOC, V278, P47, DOI 10.1001/jama.278.1.47; WALTER JL, 1995, ENCY BIOETHICS, P1353	5	39	39	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					1061	1063		10.1001/jama.283.8.1061	http://dx.doi.org/10.1001/jama.283.8.1061			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284AM	10697070				2022-12-28	WOS:000085308600039
J	Albright, TD; Jessell, TM; Kandel, ER; Posner, MI				Albright, TD; Jessell, TM; Kandel, ER; Posner, MI			Neural science: A century of progress and the mysteries that remain	CELL			English	Review							OCULAR DOMINANCE COLUMNS; LONG-TERM-MEMORY; PRIMARY VISUAL-CORTEX; DEFICIT HYPERACTIVITY DISORDER; BINOCULAR IMPULSE BLOCKADE; CENTRAL-NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; GATED ION CHANNELS; FRAGILE-X SYNDROME; FUNCTIONAL ARCHITECTURE		Salk Inst Biol Studies, Howard Hughes Med Inst, San Diego, CA 92186 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Cornell Univ, Weill Med Coll, Dept Psychiat, Sackler Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Salk Institute; Columbia University; Columbia University; Howard Hughes Medical Institute; Cornell University	Albright, TD (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, San Diego, CA 92186 USA.							Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; ADRIAN, 1957, P ROY SOC MED, V50, P991, DOI 10.1177/003591575705001201; Albright T D, 1993, Rev Oculomot Res, V5, P177; ALBRIGHT TD, 1995, P NATL ACAD SCI USA, V92, P2433, DOI 10.1073/pnas.92.7.2433; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; [Anonymous], 1989, NEUROBIOLOGY SACCADI; [Anonymous], 1941, AM J OPHTHALMOL, DOI [10.1016/S0002-9394(41)91363-6, DOI 10.1016/S0002-9394(41)91363-6]; ANTONINI A, 1993, J NEUROSCI, V13, P3549; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; ATTARDI DG, 1963, EXP NEUROL, V7, P46, DOI 10.1016/0014-4886(63)90093-1; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; BARTHELS D, 1987, EMBO J, V6, P907, DOI 10.1002/j.1460-2075.1987.tb04837.x; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0; Benes FM, 1998, SCHIZOPHRENIA BULL, V24, P219, DOI 10.1093/oxfordjournals.schbul.a033322; Bennett M.V.L., 1972, P221; Bennett MVL, 2000, NAT NEUROSCI, V3, P7, DOI 10.1038/71082; BISIACH E, 1978, CORTEX, V14, P129, DOI 10.1016/S0010-9452(78)80016-1; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLOOM FE, 1988, BRAIN MIND BEHAV; Bock JB, 1999, P NATL ACAD SCI USA, V96, P12227, DOI 10.1073/pnas.96.22.12227; BOISTEL J, 1958, J PHYSL, V4, P176; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BOYD IA, 1956, J PHYSIOL-LONDON, V132, P74, DOI 10.1113/jphysiol.1956.sp005503; BRACKENBURY R, 1981, P NATL ACAD SCI-BIOL, V78, P387, DOI 10.1073/pnas.78.1.387; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Broadbent D.E., 1958, PERCEPTION COMMUNICA; BROCK LG, 1952, J PHYSIOL-LONDON, V117, P431, DOI 10.1113/jphysiol.1952.sp004759; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; BROWN RH, 1993, ANN NY ACAD SCI, V707, P305, DOI 10.1111/j.1749-6632.1993.tb38061.x; Bruer J., 1999, MYTH 1 3 YEARS NEW U; Brummendorf T, 1996, CURR OPIN NEUROBIOL, V6, P584, DOI 10.1016/S0959-4388(96)80089-4; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Byrne JH, 1996, J NEUROSCI, V16, P425; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Cajal S. R., 1911, HISTOLOGIE SYSTEME N, V2; Cajal S.R.y., 1894, P R SOC LOND, V55, P444; Cajal S. R. y, 1906, NOBEL LECT PHYSL MED, P220; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CAREW TJ, 1983, SCIENCE, V219, P397, DOI 10.1126/science.6681571; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CATTERALL WA, 2000, IN PRESS NEURON; Chan YM, 1999, CURR OPIN NEUROBIOL, V9, P582, DOI 10.1016/S0959-4388(99)00017-3; CHANGEUX JP, 1992, Q REV BIOPHYS, V25, P395, DOI 10.1017/S0033583500004352; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Coen L, 1997, P NATL ACAD SCI USA, V94, P9400, DOI 10.1073/pnas.94.17.9400; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cole KS, 1939, J GEN PHYSIOL, V22, P649, DOI 10.1085/jgp.22.5.649; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Colquhoun D, 1998, NEURON, V20, P381, DOI 10.1016/S0896-6273(00)80982-4; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Cooper L.A., 1973, VISUAL INFORM PROCES, P75, DOI [10.1016/B978-0-12-170150, 10.1016/b978-0-12-170150-5.50009-3, DOI 10.1016/B978-0-12-170150-5.50009-3]; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Cowan WM, 1998, NEURON, V20, P413, DOI 10.1016/S0896-6273(00)80985-X; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; Cowan WM, 1997, MOL CELLULAR APPROAC; COWAN WM, 1999, IN PRESS ANN REV NEU; COWAN WM, 2000, IN PRESS SYNAPSE; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; DAVINCI L, 1956, TREATISE PAINTING; De No RL, 1938, J NEUROPHYSIOL, V1, P207; Dehaene S., 1997, NUMBER SENSE; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DEMB JB, 1995, J NEUROSCI, V15, P5870; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Detwiler S. R., 1936, NEUROEMBRYOLOGY EXPT; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; EASTER SS, 1985, SCIENCE, V230, P507, DOI 10.1126/science.4048944; Eccles, 2013, PHYSL SYNAPSES; ECCLES JC, 1953, NEUROPHYSIOLOGICAL B; EDELMAN GM, 1983, SCIENCE, V219, P450, DOI 10.1126/science.6823544; Engel AK, 1999, CONSCIOUS COGN, V8, P128, DOI 10.1006/ccog.1999.0389; FARAH MT, 1995, VISUAL AGNOSIA; FATT P, 1951, J PHYSIOL-LONDON, V115, P320, DOI 10.1113/jphysiol.1951.sp004675; Fechner G.T., 1860, ELEMENTS PSYCHOPHYSI, V1; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; FISCHBACH GD, 1978, PHARMACOL REV, V30, P411; Forbes A, 1922, PHYSIOL REV, V2, P361, DOI 10.1152/physrev.1922.2.3.361; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frith C, 1998, CURR OPIN NEUROBIOL, V8, P259, DOI 10.1016/S0959-4388(98)80149-9; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; FURSHPAN EJ, 1957, NATURE, V180, P342, DOI 10.1038/180342a0; GALTON F, 1907, INQUIRY HUMAN FACULT; Galvani L., 1791, COMMENTARY EFFECT EL, VE; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GOLDBERG G, 1985, BEHAV BRAIN SCI, V8, P567, DOI 10.1017/S0140525X00045167; Goldberg JL, 2000, NATURE, V403, P369, DOI 10.1038/35000309; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Goodhill GJ, 1997, TRENDS NEUROSCI, V20, P375; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goridis C, 1999, CURR OPIN NEUROBIOL, V9, P47, DOI 10.1016/S0959-4388(99)80006-3; GRAY CM, 1989, SYNCHRONIZATION OSCI; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Green T, 1998, NEURON, V20, P427, DOI 10.1016/S0896-6273(00)80986-1; Grieshammer U, 1998, DEV BIOL, V197, P234, DOI 10.1006/dbio.1997.8859; Gross C. G., 1973, HDB SENSORY PHYSIOLO, P451; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Guthrie S, 1999, CURR BIOL, V9, pR432, DOI 10.1016/S0960-9822(99)80274-7; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; HAMBURGER V, 1993, J NEUROBIOL, V24, P893, DOI 10.1002/neu.480240702; Han EB, 1999, LEARN MEMORY, V6, P539, DOI 10.1101/lm.6.6.539; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; Hartline HK, 1932, J CELL COMPAR PHYSL, V1, P277, DOI 10.1002/jcp.1030010211; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hebb Donald O., 1949, ORG BEHAV; HERTTING G, 1961, NATURE, V192, P172, DOI 10.1038/192172a0; HEUSER JE, 1977, APPROACHES CELL BIOL, P215; Hille B, 1999, NAT MED, V5, P1105, DOI 10.1038/13415; Hodgkin AL, 1937, J PHYSIOL-LONDON, V90, P183, DOI 10.1113/jphysiol.1937.sp003507; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; Hodgkin AL, 1939, NATURE, V144, P710, DOI 10.1038/144710a0; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; HOFER M, 1994, PROG BRAIN RES, V102, P277; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; Holmes G, 1927, BRAIN, V50, P413, DOI 10.1093/brain/50.3-4.413; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; HUNT RK, 1990, BRAIN CIRCUITS FUNCT, P19; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Iversen L., 1967, UPTAKE STORAGE NORAD; IWASAKI S, 1993, COGNITION, V49, P211, DOI 10.1016/0010-0277(93)90005-G; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johns DC, 1999, J NEUROSCI, V19, P1691; Jones CM, 1999, METH MOL B, V97, P341, DOI 10.1385/1-59259-270-8:341; Kandel E., 2000, PRINCIPLES NEURAL SC; KANDEL ER, 1968, PHYSIOL REV, V48, P65, DOI 10.1152/physrev.1968.48.1.65; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Karni A, 1997, CURR OPIN NEUROBIOL, V7, P530, DOI 10.1016/S0959-4388(97)80033-5; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Katz B., 1969, RELEASE NEURAL TRANS; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kleiman RJ, 1996, CELL, V85, P461, DOI 10.1016/S0092-8674(00)81245-3; KOCHANSKA G, 1995, CHILD DEV, V66, P597, DOI 10.2307/1131937; Koffka K, 1935, PRINCIPLES GESTALT P; KOHLER W, 1929, ESTALT PSYCHOL; Konorski J., 1967, INTEGRATIVE ACTIVITY; Kosslyn S. M., 1980, IMAGE MIND; Kosslyn S. M., 1994, IMAGE BRAIN; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; Langley J N, 1897, J Physiol, V22, P215; Langley JN, 1906, P R SOC LOND B-CONTA, V78, P170, DOI 10.1098/rspb.1906.0056; LEE K, 2000, IN PRESS NATURE; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LEVI-MONTALCINI RITA, 1966, HARVEY LECT, V60, P217; LEWIS EB, 1985, COLD SPRING HARB SYM, V50, P155, DOI 10.1101/SQB.1985.050.01.021; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; MACH E, 1886, CONTRIBUTIONS ANAL S; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P197, DOI 10.1016/0010-0285(83)90009-9; Marr D., 1982, VISION COMPUTATIONAL, DOI [10.7551/mitpress/9780262514620.001.0001, DOI 10.7551/MITPRESS/9780262514620.001.0001]; Marrocco RT, 1998, ATTENTIVE BRAIN, P35; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McClelland JL., 1987, PARALLEL DISTRIBUTED, DOI [10.7551/mitpress/5237.001.0001, DOI 10.7551/MITPRESS/5237.001.0001]; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; MILLER KD, 1994, J NEUROSCI, V14, P409; Milner A. D., 1995, VISUAL BRAIN ACTION; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Milner B., 1965, COGNITIVE PROCESSES; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; MUNK H, 1881, FUNKTIONEN GROSSHIRN, P28; NAGEL T, 1993, CIBA F SYMP, V174, P1; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Nestler E. J., 1984, PROTEIN PHOSPHORYLAT; Newell A., 1972, HUMAN PROBLEM SOLVIN; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Nieuwkoop PD, 1997, CELL MOL LIFE SCI, V53, P305, DOI 10.1007/PL00000608; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; NUMA S, 1989, HARVEY LECT, V83, P121; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; OPPENHEIM RW, 1981, STUDIES DEV NEUROBIO; Panchision D, 1998, CURR OPIN CELL BIOL, V10, P727, DOI 10.1016/S0955-0674(98)80114-2; Parasuraman R., 1998, SELECTIVE ATTENTION; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Parsons LM, 1998, COGN NEUROPSYCHOL, V15, P583; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Picciotto MR, 1999, CRIT REV NEUROBIOL, V13, P103, DOI 10.1615/CritRevNeurobiol.v13.i2.10; Posner M.I., 1978, CHRONOMETRIC EXPLORA; Posner M. I., 1994, IMAGES MIND; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Posner MI, 1999, NEUROREPORT, V10, pR12; Posner MI, 1998, PHILOS T R SOC B, V353, P1915, DOI 10.1098/rstb.1998.0344; Posner MI, 1998, P NATL ACAD SCI USA, V95, P763, DOI 10.1073/pnas.95.3.763; Ptacek L, 1998, AM J MED, V105, P58, DOI 10.1016/S0002-9343(98)00123-5; Ptacek LJ, 1997, NEUROMUSCULAR DISORD, V7, P250, DOI 10.1016/S0960-8966(97)00046-1; Purves, 1985, PRINCIPLES NEURAL DE; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Ramon y Cajal S., 1911, HISTOLOGIE SYSTEME N; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; ROTHBART MK, 2000, IN PRESS J PERSONALI; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; RUTISHAUSER U, 1982, P NATL ACAD SCI-BIOL, V79, P685, DOI 10.1073/pnas.79.2.685; RYALLS J, 1996, BRAIN DAM B, P235; SALZMAN CD, 1990, OPHTHALMOL VIS SCI, V31, P238; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHAFER EA, 1888, BRAIN, V10, P362; SCHILLER F, 1992, P BROCA EXPLORER BRA; SCHWARTZ EL, 1980, VISION RES, V20, P645, DOI 10.1016/0042-6989(80)90090-5; Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SEARLE JR, 1993, CIBA F SYMP, V174, P61; SEARLE JR, 1998, UNDERSTANDING INTEGR, P379; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; SHATZ CJ, 1997, MOL CELLULAR APPROAC; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Shepherd GM, 1991, FDN NEURON DOCTRINE; Sherrington C, 1906, INTEGRATIVE ACTION N; Sherrington C. S., 1932, INHIBITION COORDINAT; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; SHERRINGTON CS, 1897, CENTRAL NERVOUS SYST, V3; SHERRINGTON CS, 1941, MAN HIST NATURE; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Singer W, 1998, PHILOS T ROY SOC B, V353, P1829, DOI 10.1098/rstb.1998.0335; Smalley SL, 1998, MOL PSYCHIATR, V3, P427, DOI 10.1038/sj.mp.4000457; Smith JC, 1989, CURR OPIN CELL BIOL, V1, P1061, DOI 10.1016/S0955-0674(89)80051-1; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Speidel CC, 1933, AM J ANAT, V52, P1, DOI 10.1002/aja.1000520102; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sperry RW, 1943, J EXP ZOOL, V92, P263, DOI 10.1002/jez.1400920303; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR., 1999, MEMORY MIND MOL; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; STEVENS CF, 1991, NATURE, V349, P657, DOI 10.1038/349657a0; STJOHNSTON D, 1992, CELL, V68, P201; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SWINDALE NV, 1980, PROC R SOC SER B-BIO, V208, P243, DOI 10.1098/rspb.1980.0051; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; Takeichi M, 1997, COLD SPRING HARB SYM, V62, P505; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TAKEUCHI A, 1960, J PHYSIOL-LONDON, V154, P52, DOI 10.1113/jphysiol.1960.sp006564; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tatagiba M, 1997, NEUROSURGERY, V40, P541, DOI 10.1097/00006123-199703000-00023; Teller DY, 1997, INVEST OPHTH VIS SCI, V38, P2183; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; van Essen D.C., 1985, P259; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; vonBekesy G., 1960, EXPT HEARING; VONDERMALSBURG C, 1981, 812 MPI BIOPH CHEM; VONHELMHOLTZ H, 1924, TREATISE PSYCHOL OPT, V2; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WARREN ST, 1995, ANNU REV NEUROSCI, V18, P77, DOI 10.1146/annurev.neuro.18.1.77; WASHBURN DA, 1994, PSYCHOL SCI, V5, P375, DOI 10.1111/j.1467-9280.1994.tb00288.x; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WEBER RJ, 1974, J EXP PSYCHOL, V102, P409, DOI 10.1037/h0035868; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEISS PAUL, 1941, COMPAR PSYCHOL MONOGR, V17, P1; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WERTHEIMER M, 1924, GESTALT THEORY; Wessells N., 1977, TISSUE INTERACTIONS; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; WUNDT W, 1902, PRINCIPLES PHYSL PSY; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6; [No title captured]	355	86	92	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2000	100			S			S1	S55						55	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	286LG	10698132				2022-12-28	WOS:000085447000001
J	Alexander, RB; Smith, RA; Schwarz, GE				Alexander, RB; Smith, RA; Schwarz, GE			Effect of stream channel size on the delivery of nitrogen to the Gulf of Mexico	NATURE			English	Article							COASTAL MARINE ECOSYSTEMS; MISSISSIPPI RIVER; WATER-QUALITY; FRESH-WATER; DENITRIFICATION; RESPONSES; EXCHANGE; BUDGET; SYSTEM	An increase in the flux of nitrogen from the Mississippi river during the latter half of the twentieth century has caused eutrophication and chronic seasonal hypoxia in the shallow waters of the Louisiana shelf in the northern Gulf of Mexico(1-5). This has led to reductions in species diversity, mortality of benthic communities and stress in fishery resources(4). There is evidence for a predominantly anthropogenic origin of the increased nitrogen flux(2,5-7), hut the location of the most significant sources in the Mississippi basin responsible for the delivery of nitrogen to the Gulf of Mexico have not been clearly identified, because the parameters influencing nitrogen-loss rates in rivers are not well known. Here we present an analysis of data from 374 US monitoring stations, including 123 along the six largest tributaries to the Mississippi, that shows a rapid decline in the average first-order rate of nitrogen loss with channel size-from 0.45 day(-1) in small streams to 0.005 day(-1) in the Mississippi river. Using stream depth as an explanatory variable, our estimates of nitrogen-loss rates agreed with values from earlier studies. We conclude that the proximity of sources to large streams and rivers is an important determinant of nitrogen delivery to the estuary in the Mississippi basin, and possibly also in other large river basins.	US Geol Survey, Natl Ctr 413, Reston, VA USA	United States Department of the Interior; United States Geological Survey	Alexander, RB (corresponding author), US Geol Survey, Natl Ctr 413, Reston, VA USA.	ralex@usgs.gov		Schwarz, Gregory/0000-0002-9239-4566				Alexander RB, 1998, WATER RESOUR RES, V34, P2401, DOI 10.1029/98WR01530; BAKER LA, 1988, WATER RESOUR RES, V24, P65, DOI 10.1029/WR024i001p00065; Behrendt H, 1996, WATER SCI TECHNOL, V33, P99, DOI 10.1016/0273-1223(96)00219-3; BILLEN G, 1989, BIOGEOCHEMISTRY, V8, P73, DOI 10.1007/BF02180168; BILLEN G, 1991, PHYS CH EAR, P19; BREZONIK PL, 1999, FED REGISTER, V64, P23834; Burns DA, 1998, BIOGEOCHEMISTRY, V40, P73, DOI 10.1023/A:1005916102026; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Goolsby D.A., 1999, FED REGISTER, V64, P23834; Harvey JW, 1996, WATER RESOUR RES, V32, P2441, DOI 10.1029/96WR01268; HILL AR, 1981, CAN GEOGR-GEOGR CAN, V25, P225, DOI 10.1111/j.1541-0064.1981.tb01643.x; HILL AR, 1979, NATURE, V281, P291, DOI 10.1038/281291a0; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; JOHNSTON CA, 1984, J ENVIRON QUAL, V13, P283, DOI 10.2134/jeq1984.00472425001300020022x; KELLY CA, 1987, BIOGEOCHEMISTRY, V3, P129, DOI 10.1007/BF02185189; Leopold L.B., 1953, HYDRAULIC GEOMETRY S, V252, P22; McMahon PB, 1996, J HYDROL, V186, P105, DOI 10.1016/S0022-1694(96)03037-5; Novotny V, 1994, TECHNOL ENG, DOI DOI 10.2134/JEQ1995.00472425002400020024; Preston S. D., 1999, 994054 US GEOL SURV; Rabalais NN, 1996, ESTUARIES, V19, P386, DOI 10.2307/1352458; Seaber P.R., 1987, HYDROLOGIC UNIT MAPS; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; Seitzinger SP, 1998, GLOBAL BIOGEOCHEM CY, V12, P93, DOI 10.1029/97GB03657; Sjodin AL, 1997, BIOGEOCHEMISTRY, V39, P327, DOI 10.1023/A:1005884117467; Smith RA, 1997, WATER RESOUR RES, V33, P2781, DOI 10.1029/97WR02171; TRISKA FJ, 1993, FRESHWATER BIOL, V29, P259, DOI 10.1111/j.1365-2427.1993.tb00762.x; TURNER RE, 1991, BIOSCIENCE, V41, P140, DOI 10.2307/1311453; TURNER RE, 1994, NATURE, V368, P619, DOI 10.1038/368619a0; TWIDWELL SR, 1987, 8704 IS TEX NAT RES; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431	30	855	911	6	386	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					758	761		10.1038/35001562	http://dx.doi.org/10.1038/35001562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693802				2022-12-28	WOS:000085423100049
J	Ellis, GFR				Ellis, GFR			Dennis Sciama (1926-99) - Obituary	NATURE			English	Biographical-Item									Univ Cape Town, Dept Math, ZA-7700 Rondebosch, South Africa	University of Cape Town	Ellis, GFR (corresponding author), Univ Cape Town, Dept Math, ZA-7700 Rondebosch, South Africa.							SCIAMA D, PUBLICATION LIST	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					722	722		10.1038/35001716	http://dx.doi.org/10.1038/35001716			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693790				2022-12-28	WOS:000085423100037
J	Naismith, JH				Naismith, JH			Don't let politics put diamond at risk	NATURE			English	Letter									Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland	University of St Andrews	Naismith, JH (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland.		Naismith, James Henderson/H-3408-2012; Naismith, James Henderson/AAB-8614-2020	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061				DIAMOND, 1999, NATURE, V402, P451	1	0	0	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					698	698		10.1038/35001757	http://dx.doi.org/10.1038/35001757			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693777	Bronze			2022-12-28	WOS:000085423100019
J	Edwards, KJ; Bond, PL; Gihring, TM; Banfield, JF				Edwards, KJ; Bond, PL; Gihring, TM; Banfield, JF			An archaeal iron-oxidizing extreme acidophile important in acid mine drainage	SCIENCE			English	Article							AQUEOUS PYRITE OXIDATION; FAM-NOV; GEN-NOV; ENVIRONMENT; DIVERSITY	A new species of Archaea grows at pH similar to 0.5 and similar to 40 degrees C in slime streamers and attached to pyrite surfaces at a sulfide ore body, Iron Mountain, California. This iron-oxidizing Archaeon is capable of growth at pH 0. This species represents a dominant prokaryote in the environment studied (slimes and sediments) and constituted up to 85% of the microbial community when solution concentrations were high (conductivity of 100 to 160 millisiemens per centimeter). The presence of this and other closely related Thermoplasmales suggests that these acidophiles are important contributors to acid mine drainage and may substantially impact iron and sulfur cycles.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA	Woods Hole Oceanographic Institution; University of Wisconsin System; University of Wisconsin Madison	Edwards, KJ (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.		Bond, Philip/C-6046-2009; Bond, Philip/N-6649-2017	Bond, Philip/0000-0002-9025-4797; Banfield, Jill/0000-0001-8203-8771				Barker WW, 1998, AM MINERAL, V83, P1551, DOI 10.2138/am-1998-11-1243; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Benson DA, 1998, NUCLEIC ACIDS RES, V26, P1, DOI 10.1093/nar/26.1.1; BOND P, UNPUB; Brimblecombe P, 1989, EVOLUTION GLOBAL BIO, P77; Edwards KJ, 1998, AM MINERAL, V83, P1444, DOI 10.2138/am-1998-11-1233; Edwards KJ, 1999, APPL ENVIRON MICROB, V65, P3627; EDWARDS KJ, 1999, THESIS WISCONSIN MAD; GOLYSHINA OV, IN PRESS INT J SYST; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LUTHER GW, 1987, GEOCHIM COSMOCHIM AC, V51, P3193, DOI 10.1016/0016-7037(87)90127-X; Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109; MOSES CO, 1987, GEOCHIM COSMOCHIM AC, V51, P1561, DOI 10.1016/0016-7037(87)90337-1; Nordstrom DK, 2000, ENVIRON SCI TECHNOL, V34, P254, DOI 10.1021/es990646v; Nordstrom DK, 1999, P NATL ACAD SCI USA, V96, P3455, DOI 10.1073/pnas.96.7.3455; Nordstrom DK, 1997, REV MINERAL, V35, P361; Schleper C, 1996, INT J SYST BACTERIOL, V46, P814, DOI 10.1099/00207713-46-3-814; SCHLEPER C, 1995, J BACTERIOL, V177, P7050, DOI 10.1128/jb.177.24.7050-7059.1995; Schrenk MO, 1998, SCIENCE, V279, P1519, DOI 10.1126/science.279.5356.1519; SILVERMAN M. P., 1964, Advances in Applied Microbiology, V6, P153, DOI 10.1016/S0065-2164(08)70626-9; Staley JT, 1999, ASM NEWS, V65, P681; van de Vossenberg JLCM, 1998, EXTREMOPHILES, V2, P163, DOI 10.1007/s007920050056; Vasquez M, 1999, FEMS MICROBIOL LETT, V173, P183, DOI 10.1016/S0378-1097(99)00070-1; WILLIAMSON MA, 1994, GEOCHIM COSMOCHIM AC, V58, P5443, DOI 10.1016/0016-7037(94)90241-0	26	390	423	6	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1796	1799		10.1126/science.287.5459.1796	http://dx.doi.org/10.1126/science.287.5459.1796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710303				2022-12-28	WOS:000085775300035
J	Steel, KP				Steel, KP			Science, medicine, and the future - New interventions in hearing impairment	BRITISH MEDICAL JOURNAL			English	Review							SENSORINEURAL DEAFNESS; MUTATIONS; GENE; MYOSIN; MICE; ISK		MRC, Inst Hearing Res, Nottingham NG7 2RD, England		Steel, KP (corresponding author), MRC, Inst Hearing Res, Univ Pk, Nottingham NG7 2RD, England.							DAVIS A, 1997, HLTH TECHNOL ASSESSM, V1; Davis AC, 1995, HEARING IN ADULTS; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Dixon MJ, 1999, HUM MOL GENET, V8, P1579, DOI 10.1093/hmg/8.8.1579; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; *OMIM, 1999, ONL MEND INH MAN; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Self T, 1998, DEVELOPMENT, V125, P557; Steel KP, 1998, SCIENCE, V279, P1870, DOI 10.1126/science.279.5358.1870; Steel KP, 1999, TRENDS GENET, V15, P207, DOI 10.1016/S0168-9525(99)01753-9; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; VANCAMP G, 1999, HEREDITARY HEARING L; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	22	29	45	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					622	625		10.1136/bmj.320.7235.622	http://dx.doi.org/10.1136/bmj.320.7235.622			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698884	Bronze, Green Published			2022-12-28	WOS:000085742600029
J	Holmes, JD; Johnston, KP; Doty, RC; Korgel, BA				Holmes, JD; Johnston, KP; Doty, RC; Korgel, BA			Control of thickness and orientation of solution-grown silicon nanowires	SCIENCE			English	Article							LIQUID-SOLID GROWTH; QUANTUM WIRES; OPTICAL-PROPERTIES; POROUS SILICON; LASER-ABLATION; 1ST-PRINCIPLES; NANOCRYSTALS; GAP	Bulk quantities of defect-free silicon (Si) nanowires with nearly uniform diameters ranging from 40 to 50 angstroms were grown to a length of several micrometers with a supercritical fluid solution-phase approach. Alkanethiol-coated gold nanocrystals (25 angstroms in diameter) were used as uniform seeds to direct one-dimensional Si crystallization in a solvent heated and pressurized above its critical point. The orientation of the Si nanowires produced with this method could be controlled with reaction pressure. Visible photoluminescence due to quantum confinement effects was observed, as were discrete optical transitions in the ultraviolet-visible absorbance spectra.	Univ Texas, Dept Chem Engn, Austin, TX 78712 USA; Univ Texas, Texas Mat Inst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Korgel, BA (corresponding author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.		Korgel, Brian A/I-5771-2013					Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; BRUS L, 1994, J PHYS CHEM-US, V98, P3575, DOI 10.1021/j100065a007; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; BUDA F, 1992, PHYS REV LETT, V69, P1272, DOI 10.1103/PhysRevLett.69.1272; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; HEATH JR, 1993, CHEM PHYS LETT, V208, P263, DOI 10.1016/0009-2614(93)89073-Q; Hu JT, 1999, ACCOUNTS CHEM RES, V32, P435, DOI 10.1021/ar9700365; Korgel BA, 1998, PHYS REV LETT, V80, P3531, DOI 10.1103/PhysRevLett.80.3531; MCHUGH M, 1993, SUPERCRITICAL FLUIDS; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Prokes SM, 1999, MRS BULL, V24, P13, DOI 10.1557/S0883769400052842; READ AJ, 1992, PHYS REV LETT, V69, P1232, DOI 10.1103/PhysRevLett.69.1232; SANDERS GD, 1992, PHYS REV B, V45, P9202, DOI 10.1103/PhysRevB.45.9202; SHEN MY, 1993, PHYS LETT A, V176, P254, DOI 10.1016/0375-9601(93)91045-7; Trentler TJ, 1997, J AM CHEM SOC, V119, P2172, DOI 10.1021/ja9640859; TRENTLER TJ, 1995, SCIENCE, V270, P1791, DOI 10.1126/science.270.5243.1791; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Westwater J, 1997, J VAC SCI TECHNOL B, V15, P554, DOI 10.1116/1.589291; Wolkin MV, 1999, PHYS REV LETT, V82, P197, DOI 10.1103/PhysRevLett.82.197; YEH CY, 1994, PHYS REV B, V50, P14405, DOI 10.1103/PhysRevB.50.14405; Yorikawa H, 1996, J APPL PHYS, V79, P3619, DOI 10.1063/1.361416; Zhang YF, 1998, APPL PHYS LETT, V72, P1835, DOI 10.1063/1.121199	23	1434	1593	5	462	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1471	1473		10.1126/science.287.5457.1471	http://dx.doi.org/10.1126/science.287.5457.1471			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688792				2022-12-28	WOS:000085531600046
J	Perry, D				Perry, D			Patients' voices: The powerful sound in the stem cell debate	SCIENCE			English	Editorial Material								Millions of patients may benefit from the applications of stem cell research, although there is disagreement about whether public funds should be used to develop the science. Patients have been key to winning political support. Acting as advocates, they have contended that public investment will speed the research and bring accountability to biomedical technology. A political dispute about the new research, which holds the potential for cures to devastating diseases and to foster healthy aging, shows the need to respect public sensibilities and to court public approval, as well as the importance of involving patients in debates where the methods of biomedical discoveries and ethical beliefs collide.	Alliance Aging Res, Washington, DC 20006 USA		Perry, D (corresponding author), Alliance Aging Res, 2021 K St NW,Suite 305, Washington, DC 20006 USA.							*ALL AG RES, 1999, 106 C CAN ACH HLTH I; Alliance for Aging Research, 1999, IND OLD AM INV OUR N; *AM ASS ADV SCI I, 1999, STEM CELL RES APPL M; DICKEY J, 1999, ROLL CALL       0603, P4; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; 1999, THEOLOGIANS 4 MAJOR	6	40	42	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1423	1423		10.1126/science.287.5457.1423	http://dx.doi.org/10.1126/science.287.5457.1423			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688778				2022-12-28	WOS:000085531600032
J	Mi, S; Lee, X; Li, XP; Veldman, GM; Finnerty, H; Racie, L; LaVallie, E; Tang, XY; Edouard, P; Howes, S; Keith, JC; McCoy, JM				Mi, S; Lee, X; Li, XP; Veldman, GM; Finnerty, H; Racie, L; LaVallie, E; Tang, XY; Edouard, P; Howes, S; Keith, JC; McCoy, JM			Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis	NATURE			English	Article							EXPRESSION; CELLS; VIRUS; GENE; SEQUENCE; GROWTH; ERV3	Many mammalian viruses have acquired genes from their hosts during their evolution(1). The rationale for these acquisitions is usually quite clear: the captured genes are subverted to provide a selective advantage to the virus. Here we describe the opposite situation, where a viral gene has been sequestered to serve an important function in the physiology of a mammalian host. This gene, encoding a protein that we have called syncytin, is the envelope gene of a recently identified human endogenous defective retrovirus, HERV-W-2. We find that the major sites of syncytin expression are placental syncytiotrophoblasts, multinucleated cells that originate from fetal trophoblasts. We show that expression of recombinant syncytin in a wide variety of cell types induces the formation of giant syncytia, and that fusion of a human trophoblastic cell line expressing endogenous syncytin can be inhibited by an anti-syncytin antiserum. Our data indicate that syncytin may mediate placental cytotrophoblast fusion in vivo, and thus may be important in human placental morphogenesis.	Genet Inst, Cambridge, MA 02140 USA		McCoy, JM (corresponding author), Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.							Baergen Rebecca N., 1997, General and Diagnostic Pathology, V143, P127; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; BOYD MT, 1993, VIROLOGY, V196, P905, DOI 10.1006/viro.1993.1556; CIANCIOLO GJ, 1985, SCIENCE, V230, P453, DOI 10.1126/science.2996136; COHEN M, 1985, VIROLOGY, V147, P449, DOI 10.1016/0042-6822(85)90147-3; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; FISCHER D, 1991, CHROMOSOMA, V101, P133, DOI 10.1007/BF00355363; Fox PT, 1997, HUM BRAIN MAPP, V5, P1, DOI 10.1002/(SICI)1097-0193(1997)5:1<1::AID-HBM1>3.0.CO;2-7; GATELY MK, 1996, CURRENT PROTOCOLS IM, V6, P16; HARRIS JR, 1991, FEBS LETT, V295, P3, DOI 10.1016/0014-5793(91)81370-N; HUNT JS, 1992, CURR OPIN IMMUNOL, V4, P591, DOI 10.1016/0952-7915(92)90032-A; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Kalter S S, 1975, Bibl Haematol, P391; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; KOHLER PO, 1971, J CLIN ENDOCR METAB, V32, P683, DOI 10.1210/jcem-32-5-683; KOVATS S, 1990, SCIENCE, V248, P20; Lala PK, 1996, PLACENTA, V17, P545, DOI 10.1016/S0143-4004(96)80071-3; LARSSON E, 1993, J CANC RES CLIN O S1, V119, P6; Larsson Erik, 1994, Upsala Journal of Medical Sciences, V99, P113; LIMJOCO TI, 1993, J VIROL, V67, P4163, DOI 10.1128/JVI.67.7.4163-4168.1993; Lin L, 1999, PLACENTA, V20, P109, DOI 10.1053/plac.1998.0337; LYDEN TW, 1993, PLACENTA, V14, P177, DOI 10.1016/S0143-4004(05)80259-0; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; PATTILLO RA, 1968, SCIENCE, V159, P1467, DOI 10.1126/science.159.3822.1467; PIJNENBORG R, 1981, PLACENTA, V2, P71, DOI 10.1016/S0143-4004(81)80042-2; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; SASSOON D, 1993, METHOD ENZYMOL, V225, P384; VENABLES PJW, 1995, VIROLOGY, V211, P589, DOI 10.1006/viro.1995.1442; YAMADA S, 1986, BIOCHEMISTRY-US, V25, P3703, DOI 10.1021/bi00360a034	30	1099	1153	4	104	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					785	789		10.1038/35001608	http://dx.doi.org/10.1038/35001608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693809				2022-12-28	WOS:000085423100056
J	Burke, P; Burne, SR				Burke, P; Burne, SR			Drug points - Allergy associated with ciprofloxacin	BRITISH MEDICAL JOURNAL			English	Letter																		BORCHERDING SM, 1993, ANTIMICROB AGENTS CH, V36, P1553; DAVIS H, 1989, ANN INTERN MED, V111, P1041, DOI 10.7326/0003-4819-111-12-1041; GAUNT PN, 1988, J ANTIMICROB CHEMOTH, V21, P489, DOI 10.1093/jac/21.4.489; Hastings L, 1997, Commun Dis Rep CDR Rev, V7, pR195	4	19	21	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					679	679		10.1136/bmj.320.7236.679	http://dx.doi.org/10.1136/bmj.320.7236.679			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710576	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000085895300020
J	Rosenfeld, D				Rosenfeld, D			Suppression of rain and snow by urban and industrial air pollution	SCIENCE			English	Article							CLOUDS; PRECIPITATION; PARTICLES	Direct evidence demonstrates that urban and industrial air pollution can completely shut off precipitation from clouds that have temperatures at their tops of about -10 degrees C over large areas. Satellite data reveal plumes of reduced cloud particle size and suppressed precipitation originating from major urban areas and from industrial facilities such as power plants. Measurements obtained by the Tropical Rainfall Measuring Mission satellite reveal that both cloud droplet coalescence and ice precipitation formation are inhibited in polluted clouds.	Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Rosenfeld, D (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel.	daniel@vms.huji.ac.il	Rosenfeld, Daniel/F-6077-2016; Rosenfeld, Daniel/AAJ-4617-2021	Rosenfeld, Daniel/0000-0002-0784-7656; Rosenfeld, Daniel/0000-0002-0784-7656				ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; BRAHAM RR, 1981, METEOROL MONOGR, V18, P141; Cerveny RS, 1998, NATURE, V394, P561, DOI 10.1038/29043; COAKLEY JA, 1987, SCIENCE, V237, P1020, DOI 10.1126/science.237.4818.1020; Duus A. L., 1992, Australian Meteorological Magazine, V40, P195; EAGAN RC, 1974, J APPL METEOROL, V13, P535, DOI 10.1175/1520-0450(1974)013<0535:PEFALK>2.0.CO;2; GATZ DF, 1979, J APPL METEOROL, V18, P1245, DOI 10.1175/1520-0450(1979)018<1245:AIOPSS>2.0.CO;2; GUNN R, 1957, J METEOROL, V14, P272, DOI 10.1175/1520-0469(1957)014<0272:AEIOTE>2.0.CO;2; Harasymiw B, 1993, SNOWY PRECIPITATION; HOBBS PV, 1969, SCIENCE, V163, P279, DOI 10.1126/science.163.3864.279; Jauregui E, 1996, ATMOS ENVIRON, V30, P3383, DOI 10.1016/1352-2310(96)00041-6; JOHNSON DB, 1982, J ATMOS SCI, V39, P448, DOI 10.1175/1520-0469(1982)039<0448:TROGAU>2.0.CO;2; JONAS PR, 1974, Q J ROY METEOR SOC, V100, P286, DOI 10.1002/qj.49710042503; Kaufman YJ, 1997, SCIENCE, V277, P1636, DOI 10.1126/science.277.5332.1636; MOSSOP SC, 1974, SCIENCE, V186, P632, DOI 10.1126/science.186.4164.632; Oki R, 1998, MAR TECHNOL SOC J, V32, P13; RADKE LF, 1989, SCIENCE, V246, P1146, DOI 10.1126/science.246.4934.1146; RANGNO AL, 1994, Q J ROY METEOR SOC, V120, P573, DOI 10.1002/qj.49712051705; Rosenfeld D, 1999, GEOPHYS RES LETT, V26, P3105, DOI 10.1029/1999GL006066; Rosenfeld D, 1998, B AM METEOROL SOC, V79, P2457, DOI 10.1175/1520-0477(1998)079<2457:SBIIPF>2.0.CO;2; Rosenfeld D, 1994, ATMOS RES, V34, P259, DOI 10.1016/0169-8095(94)90096-5; SQUIRES P, 1958, TELLUS, V10, P256, DOI 10.1111/j.2153-3490.1958.tb02011.x; Warner J., 1968, J APPL METEOROL, V7, P247, DOI [DOI 10.1175/1520-0450(1968)007<0247:ARIRAW>2.0.CO;2, 10.1175/1520-0450(1968)0070247:ARIRAW2.0.CO;2]	23	980	1105	6	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2000	287	5459					1793	1796		10.1126/science.287.5459.1793	http://dx.doi.org/10.1126/science.287.5459.1793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710302				2022-12-28	WOS:000085775300034
J	Hou, YM; Potts, R; Yuan, BY; Guo, ZT; Deino, A; Wang, W; Clark, J; Xie, GM; Huang, WW				Hou, YM; Potts, R; Yuan, BY; Guo, ZT; Deino, A; Wang, W; Clark, J; Xie, GM; Huang, WW			Mid-Pleistocene Acheulean-like stone technology of the Bose basin, South China	SCIENCE			English	Article							CHRONOLOGY; OLDOWAN; ASIA	Stone artifacts from the Bose basin, South China, are associated with tektites dated to 803,000 +/- 3000 years ago and represent the oldest known Large cutting tools (LCTs) in East Asia. Bose toolmaking is compatible with Mode 2 (Acheulean) technologies in Africa in its targeted manufacture and biased spatial distribution of LCTs, Large-scale flaking, and high flake scar counts. Acheulean-Like tools in the mid-Pleistocene of South China imply that Mode 2 technical advances were manifested in East Asia contemporaneously with handaxe technology in Africa and western Eurasia. Bose Lithic technology is associated with a tektite airfall and forest burning.	Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Chinese Acad Sci, Inst Geol & Geophys, Beijing 100029, Peoples R China; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Nat Hist Museum Guangxi Zhuang Autonomous Reg, Nanning 530012, Peoples R China; Hist Museum Guangxi Zhuang Autonomous Reg, Nanning 530022, Peoples R China	Smithsonian Institution; Smithsonian National Museum of Natural History; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Berkeley Geochronolgy Center	Potts, R (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA.		Guo, Zhengtang/B-6854-2008; Huang, WW/GXH-0977-2022; huang, wen/GXW-0661-2022; Wang, Wei/B-5617-2019	Guo, Zhengtang/0000-0003-2259-9715; Wang, Wei/0000-0002-5118-7093				BAI K, 1988, THESIS U CALIFORNIA; CALLOW P, 1994, OLDUVAI GORGE, V5, P235; CHEN TM, 1988, ARCHAEOMETRY, V30, P59; CLARK G, 1969, WORLD PREHISTORY; Clark J. D., 1994, INTEGRATIVE PATHS PA, P451; CLARK JD, 1992, PHILOS T ROY SOC B, V337, P201, DOI 10.1098/rstb.1992.0098; DECHARDIN PT, 1941, EARLY MAN CHINA; Guo SL, 1997, RADIAT MEAS, V28, P565, DOI 10.1016/S1350-4487(97)00140-6; GUO ZT, 1993, CHINESE SCI BULL, V38, P586; HAY RL, 1976, GEOLOGY OLDUVAL GORG; Huang W. W., 1990, ACTA ANTHR SINICA, V9, P105; Huang WeiWen, 1989, QUATERNARY RES, V28, P237; Hutterer K.L., 1977, SUNDA SAHUL, P31; Isaac G.L., 1977, OLORGESAILIE; IZETT GA, 1994, J GEOPHYS RES-SOL EA, V99, P2925, DOI 10.1029/93JB03085; Jones P.R., 1994, OLDUVAI GORGE, P254; Kunz J., 1995, LUNAR PLANET SCI, P809; Leakey M.D., 1971, OLDUVAI GORGE; LEAKEY MD, 1994, OLDUVAL GORGE, V5; LENG J, 1992, THESIS WASHINGTON U; Liu TS, 1999, QUATERNARY SCI REV, V18, P1205, DOI 10.1016/S0277-3791(98)00110-3; Movius H.L., 1949, T AM PHILOS SOC, V38, P330; MOVIUS HL, 1969, STUDIES PHYS ANTHR, V1, P17; Noll M. P., 2000, THESIS U ILLINOIS UR; POPE GG, 1988, PALAEOENVIRONMENT E, P1097; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; POTTS R, 1991, J ANTHROPOL RES, V47, P153, DOI 10.1086/jar.47.2.3630323; POTTS R, UNPUB OLDOWAN DEV OL; Ranov V, 1995, QUATERNARY SCI REV, V14, P731, DOI 10.1016/0277-3791(95)00055-0; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; Roberts MB., 1999, BOXGROVE MIDDLE PLEI; ROEBROECKS W, 1995, EARLIEST OCCUPATION; Schick K. D, 1994, INTEGRATIVE PATHS PA, P569; SCHNEIDER DA, 1992, EARTH PLANET SC LETT, V111, P395, DOI 10.1016/0012-821X(92)90192-X; SHARP W, 1996, EOS, V77, pF773; SINGER BS, 1996, EARTH PLANET SC LETT, V139, P41; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; Teilhard de Chardin P., 1935, B GEOLOGICAL SOC CHI, V14, P179; TOTH N, 1985, J ARCHAEOL SCI, V12, P101, DOI 10.1016/0305-4403(85)90056-1; TOTH N, 1992, TOOLS LANGUAGE COGNI, P346; WANG K, 1991, CHINESE SCI BULL, V36, P1721; Wang P.X., 1990, QUATERNARY SICENCES, V2, P111, DOI [10.3321/j.issn:1001-7410.1990.02.002, DOI 10.3321/J.ISSN:1001-7410.1990.02.002]; WATANABE H, 1985, J ANTHROPOL ARCHAEOL, V4, P1, DOI 10.1016/0278-4165(85)90011-X; Wynn T., 1989, EVOLUTION SPATIAL CO; YI S, 1983, CURR ANTHROPOL, V24, P181, DOI 10.1086/202964; Yuan B.Y., 1999, ACTA ANTHR SIN, V18, P215, DOI DOI 10.16359/J.CNKI.CN11-1963/Q.1999.03.005; ZHU Z, 1995, QUAT SCI, V8, P276	47	260	330	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1622	1626		10.1126/science.287.5458.1622	http://dx.doi.org/10.1126/science.287.5458.1622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	289NE	10698732				2022-12-28	WOS:000085628200029
J	Crosby, SS				Crosby, SS			A mother's prayer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Crosby, Sondra/0000-0002-1672-5407					0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1109	1110		10.1001/jama.283.9.1109	http://dx.doi.org/10.1001/jama.283.9.1109			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703762				2022-12-28	WOS:000085424100001
J	Henney, JE				Henney, JE			Revised labeling for cisapride	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	32	32	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1131	1131		10.1001/jama.283.9.1131	http://dx.doi.org/10.1001/jama.283.9.1131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703765				2022-12-28	WOS:000085424100006
J	Crawley, J; Waruiru, C; Mithwani, S; Mwangi, I; Watkins, W; Ouma, D; Winstanley, P; Peto, T; Marsh, K				Crawley, J; Waruiru, C; Mithwani, S; Mwangi, I; Watkins, W; Ouma, D; Winstanley, P; Peto, T; Marsh, K			Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study	LANCET			English	Article							STATUS EPILEPTICUS; KAINIC ACID; CHILDREN; BRAIN; PHARMACOKINETICS; CONVULSIONS; PHENYTOIN; DIAZEPAM	Background Seizures commonly complicate cerebral malaria and are associated with an increased risk of death and neurological sequelae. We undertook a randomised study to assess the efficacy of intramuscular phenobarbital in preventing seizures in childhood cerebral malaria. Methods Children with cerebral malaria admitted to one hospital in Kilifi, Kenya, were randomly assigned a single intramuscular dose of phenobarbital (20 mg/kg) or identical placebo. Clinical tolerance was assessed at the start of the trial, with particular reference to respiratory depression and hypotension. Seizures were timed and recorded, and treated in a standard way. Plasma phenobarbital concentrations were measured. Analyses were by intention to treat. Findings 440 children with cerebral malaria were admitted to the hospital; 100 were not recruited to the study. Of the remaining 340 170 received phenobarbital and 170 placebo. The drug was adequately absorbed and well tolerated. Seizure frequency was significantly lower in the phenobarbital group than in the placebo group (18 [11%] vs 46 [27%] children had three or more seizures of any duration; odds ratio 0.32 [95% CI 0.18-0.58]) but mortality was doubled (30 [18%] vs 14 [8%] deaths; 2.39 higher in the phenobarbital group than in the placebo group, and mortality was greatly increased in children who received phenobarbital plus three or more doses of diazepam (odds ratio 31.7 [1.2-814]). Interpretation In children with cerebral malaria, phenobarbital 20 mg/kg provides highly effective seizure prophylaxis but is associated with an unacceptable increase in mortality. Use of this dose cannot, therefore, be recommended.	Kenya Med Res Inst, Wellcome Trust Ctr Geog Med Res Coast, Kilifi, Kenya; Univ Oxford, Nuffield Dept Clin Med, Oxford, England; Wellcome Trust Res Labs, Nairobi, Kenya; Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England	Kenya Medical Research Institute; University of Oxford; University of Liverpool	Crawley, J (corresponding author), John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England.							Bone RC, 1993, JAMA-J AM MED ASSOC, V270, P854; BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7; Brzakovic B, 1997, CLIN DRUG INVEST, V14, P307, DOI 10.2165/00044011-199714040-00009; CRAWFORD TO, 1988, NEUROLOGY, V38, P1035, DOI 10.1212/WNL.38.7.1035; Crawley J, 1996, QJM-INT J MED, V89, P591; CRAWLEY J, 1999, CURR PAEDIAT, V9, P34; DODSON WE, 1984, EPILEPSIA, V25, P132; DULEY L, 1995, LANCET, V345, P1455; FAERO O, 1972, EPILEPSIA, V13, P279, DOI 10.1111/j.1528-1157.1972.tb05262.x; GOLDBERG MA, 1983, ADV NEUROL, P499; Jaffar S, 1997, AM J TROP MED HYG, V57, P20, DOI 10.4269/ajtmh.1997.57.20; MELDRUM BS, 1973, ARCH NEUROL-CHICAGO, V29, P82, DOI 10.1001/archneur.1973.00490260026003; MIKATI MA, 1994, ANN NEUROL, V36, P425, DOI 10.1002/ana.410360314; MOLYNEUX ME, 1989, Q J MED, V71, P441; Newton CRJC, 1997, ARCH DIS CHILD, V76, P219, DOI 10.1136/adc.76.3.219; PEARCE JL, 1977, PEDIATRICS, V60, P569; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; PRENSKY AL, 1967, NEW ENGL J MED, V276, P779, DOI 10.1056/NEJM196704062761404; RAMSAY RE, 1979, ARCH NEUROL-CHICAGO, V36, P535, DOI 10.1001/archneur.1979.00500450029003; RYLANCE GW, 1990, LANCET, V336, P488, DOI 10.1016/0140-6736(90)92025-D; SAWYER GT, 1968, JAMA-J AM MED ASSOC, V203, P111; SHANER DM, 1988, NEUROLOGY, V38, P202, DOI 10.1212/WNL.38.2.202; Shorvon S., 1994, STATUS EPILEPTICUS I, P218; SIMON RP, 1987, J CEREBR BLOOD F MET, V7, P783, DOI 10.1038/jcbfm.1987.134; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; STAFSTROM CE, 1993, EPILEPSIA, V34, P420, DOI 10.1111/j.1528-1157.1993.tb02582.x; SUTULA T, 1992, J NEUROSCI, V12, P4173; Treiman David M., 1992, Epilepsia, V33, P3; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; WHITE NJ, 1988, LANCET, V2, P64; WINSTANLEY PA, 1992, BRIT J CLIN PHARMACO, V33, P149, DOI 10.1111/j.1365-2125.1992.tb04017.x; WINSTANLEY PA, 1994, T ROY SOC TROP MED H, V88, P577, DOI 10.1016/0035-9203(94)90170-8; World Health Organization, 1997, Weekly Epidemiological Record, V72, P269	33	112	114	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					701	706		10.1016/S0140-6736(99)07148-2	http://dx.doi.org/10.1016/S0140-6736(99)07148-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703801				2022-12-28	WOS:000085615600011
J	Corkum, P				Corkum, P			Laser physics - Attosecond pulses at last	NATURE			English	Editorial Material									Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Corkum, P (corresponding author), Natl Res Council Canada, Steacie Inst Mol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.			Corkum, Paul/0000-0003-3394-5572					0	34	34	0	16	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					845	846		10.1038/35002711	http://dx.doi.org/10.1038/35002711			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706268				2022-12-28	WOS:000085559200037
J	Cruz, A; Green, BG				Cruz, A; Green, BG			Thermal stimulation of taste	NATURE			English	Article							TEMPERATURE-DEPENDENCE; RESPONSES; HAMSTER; NERVE	The first electrophysiological recordings from animal(1) and human(2) taste nerves gave clear evidence of thermal sensitivity, and studies have shown that as many as half of the neurons in mammalian taste pathways respond to temperature(3-6). Because temperature has never been shown to induce sensations of taste, it has been assumed that thermal stimulation in the gustatory system is somehow nulled(6). Here we show that heating or cooling small areas of the tongue can in fact cause sensations of taste: warming the anterior edge of the tongue (chorda tympani nerve) from a cold temperature can evoke sweetness, whereas cooling can evoke sourness and/or saltiness. Thermal taste also occurs on the rear of the tongue (glossopharyngeal nerve), but the relationship between temperature and taste is different there than on the front of the tongue. These observations indicate the human gustatory system contains several different types of thermally sensitive neurons that normally contribute to the sensory code for taste.	John B Pierce Fdn Lab, New Haven, CT 06519 USA; Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06519 USA	Yale University; The John B Pierce Laboratory, Inc; Yale University	Green, BG (corresponding author), John B Pierce Fdn Lab, 290 Congress Ave, New Haven, CT 06519 USA.	green@jbpierce.org						BARTOSHUK LM, 1982, PHYSIOL BEHAV, V28, P905, DOI 10.1016/0031-9384(82)90212-8; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; GREEN BG, 1987, CHEM SENSES, V12, P609, DOI 10.1093/chemse/12.4.609; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; MCBURNEY DH, 1973, PHYSIOL BEHAV, V11, P89, DOI 10.1016/0031-9384(73)90127-3; NAKAMURA M, 1988, BRAIN RES, V444, P159, DOI 10.1016/0006-8993(88)90923-7; OAKLEY B, 1985, CHEM SENSES, V10, P469, DOI 10.1093/chemse/10.4.469; OGAWA H, 1968, J PHYSIOL-LONDON, V199, P223, DOI 10.1113/jphysiol.1968.sp008650; SATO M, 1975, J GEN PHYSIOL, V66, P781, DOI 10.1085/jgp.66.6.781; TRAVERS SP, 1984, J GEN PHYSIOL, V84, P221, DOI 10.1085/jgp.84.2.221; VONBEKESY G, 1964, SCIENCE, V145, P834, DOI 10.1126/science.145.3634.834; WHITEHEAD MC, 1994, J COMP NEUROL, V340, P515, DOI 10.1002/cne.903400405; Whitehead MC, 1999, NEUROSCIENCE, V93, P931, DOI 10.1016/S0306-4522(99)00115-3; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zotterman Y, 1935, SKAND ARCH PHYSIOL, V72, P73, DOI 10.1111/j.1748-1716.1935.tb00412.x	16	170	174	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					889	892		10.1038/35002581	http://dx.doi.org/10.1038/35002581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706285				2022-12-28	WOS:000085559200056
J	Guo, HF; Tong, JY; Hannan, F; Luo, L; Zhong, Y				Guo, HF; Tong, JY; Hannan, F; Luo, L; Zhong, Y			A neurofibromatosis-1-regulated pathway is required for learning in Drosophila	NATURE			English	Article							PROTEIN-KINASE-A; ADENYLATE-CYCLASE; MUSHROOM BODIES; TERM-MEMORY; GENE; NF1; TYPE-1; RAS; MELANOGASTER; RUTABAGA	The tumour-suppressor gene Neurofibromatosis 1 (Nf1) encodes a Ras-specific GTPase activating protein (Ras-GAP)(1-5). In addition to being involved in tumour formation(6,7), NF1 has been reported to cause learning defects in humans(8-10) and Nf1 knockout mice(11) However, it remains to be determined whether the observed learning defect is secondary to abnormal development. The Drosophila NF1 protein is highly conserved, showing 60% identity of its 2,803 amino acids with human NF1 (ref. 12), Previous studies have suggested that Drosophila NF1 acts not only as a Ras-GAP but also as a possible regulator of the cAMP pathway that involves the rutabaga (rut)-encoded adenylyl cyclase(13). Because rut was isolated as a learning and short-term memory mutant(14,15), we have pursued the hypothesis that NF1 may affect learning through its control of the Rut-adenylyl cyclase/cAMP pathway. Here we show that NF1 affects learning and short-term memory independently of its developmental effects. We show that G-protein-activated adenylyl cyclase activity consists of NF1-independent and NF1-dependent components, and that the mechanism of the NF1-dependent activation of the Rut-adenylyl cyclase pathway is essential for mediating Drosophila learning and memory.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Guo, HF (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Zhong, Yi/0000-0002-7927-5976; Zhong, Yi/0000-0001-7810-9899				BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BERNARDS A, 1995, BBA-REV CANCER, V1242, P43, DOI 10.1016/0304-419X(95)00003-X; BERS DM, 1994, METHOD CELL BIOL, V40, P3; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CHEN CN, 1986, P NATL ACAD SCI USA, V86, P3599; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Ferner RE, 1996, J NEUROL SCI, V138, P125, DOI 10.1016/0022-510X(96)00022-6; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1985, P NATL ACAD SCI USA, V82, P5992, DOI 10.1073/pnas.82.17.5992; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MCCORMICK F, 1995, CURR OPIN GENET DEV, V5, P51, DOI 10.1016/S0959-437X(95)90053-5; MITTS MR, 1991, MOL CELL BIOL, V11, P4591, DOI 10.1128/MCB.11.9.4591; NORTH K, 1995, DEV MED CHILD NEUROL, V37, P427, DOI 10.1111/j.1469-8749.1995.tb12026.x; NORTH K, 1994, NEUROLOGY, V44, P878, DOI 10.1212/WNL.44.5.878; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	29	186	191	3	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					895	898		10.1038/35002593	http://dx.doi.org/10.1038/35002593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706287				2022-12-28	WOS:000085559200058
J	Abbott, A				Abbott, A			Europe's X-ray observatory defies the jinx ...	NATURE			English	News Item																		1999, NATURE, V401, P415	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					693	693		10.1038/35001737	http://dx.doi.org/10.1038/35001737			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693772	Bronze			2022-12-28	WOS:000085423100010
J	Varcoe, BTH; Brattke, S; Weidinger, M; Walther, H				Varcoe, BTH; Brattke, S; Weidinger, M; Walther, H			Preparing pure photon number states of the radiation field	NATURE			English	Article							ONE-ATOM MASER; MICROMASER; BEHAVIOR; CAVITY	The quantum mechanical description of a radiation field is based on states that are characterized by the number of photons in a particular mode; the most basic quantum states are those with fixed photon number, usually referred to as number (or Fock) states. Although Fock states of vibrational motion can be observed readily in ion traps', number states of the radiation field are very fragile and difficult to produce and maintain. Single photons in multi-mode fields have been generated using the technique of photon pairs(2,3). But in order to generate these states in a cavity, the mode in question must have minimal losses; moreover, additional sources of photon number fluctuations, such as the thermal field, must be eliminated. Here we observe the build-up of number states in a high-Q cavity, by investigating the interaction dynamics of a probe atom with the field. We employ a dynamical method of number state preparation that involves state reduction of highly excited atoms in a cavity, with a photon lifetime as high as 0.2 seconds. (This set-up is usually known as the one-atom maser or 'micromaser'.) Pure states containing up to two photons are measured unambiguously.	Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Univ Munich, Sekt Phys, D-85748 Garching, Germany	Max Planck Society; University of Munich	Walther, H (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.		Varcoe, Ben/A-3049-2013	Varcoe, Benjamin/0000-0001-7056-7238				BENSON O, 1994, PHYS REV LETT, V72, P3506, DOI 10.1103/PhysRevLett.72.3506; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; CUMMINGS FW, 1989, PHYS REV A, V39, P3414, DOI 10.1103/PhysRevA.39.3414; Englert BG, 1998, FORTSCHR PHYS, V46, P897, DOI 10.1002/(SICI)1521-3978(199811)46:6/8<897::AID-PROP897>3.0.CO;2-2; ENGLERT BG, 1993, OPT COMMUN, V100, P526, DOI 10.1016/0030-4018(93)90254-3; FEARN H, 1989, J OPT SOC AM B, V6, P917, DOI 10.1364/JOSAB.6.000917; FILLIPOWICZ P, 1986, PHYS REV A, V34, P3077; HONG CK, 1986, PHYS REV LETT, V56, P58, DOI 10.1103/PhysRevLett.56.58; JAYNES ET, 1963, P IEEE, V51, P89, DOI 10.1109/PROC.1963.1664; KRAUSE J, 1987, PHYS REV A, V36, P4547, DOI 10.1103/PhysRevA.36.4547; Maitre X, 1997, PHYS REV LETT, V79, P769, DOI 10.1103/PhysRevLett.79.769; MEYSTRE P, 1988, OPT LETT, V13, P1078, DOI 10.1364/OL.13.001078; Nogues G, 1999, NATURE, V400, P239, DOI 10.1038/22275; RAITHEL G, 1995, PHYS REV LETT, V75, P3446, DOI 10.1103/PhysRevLett.75.3446; REMPE G, 1987, PHYS REV LETT, V58, P353, DOI 10.1103/PhysRevLett.58.353; REMPE G, 1990, PHYS REV A, V42, P1650, DOI 10.1103/PhysRevA.42.1650; WEHNER E, 1994, OPT COMMUN, V110, P655, DOI 10.1016/0030-4018(94)90268-2; Weidinger M, 1999, PHYS REV LETT, V82, P3795, DOI 10.1103/PhysRevLett.82.3795	19	317	321	0	36	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					743	746		10.1038/35001526	http://dx.doi.org/10.1038/35001526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693797				2022-12-28	WOS:000085423100044
J	Minsky, M				Minsky, M			Time for an aspirin	NATURE			English	Letter									MIT, Media Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Minsky, M (corresponding author), MIT, Media Lab, 20 Ames St, Cambridge, MA 02139 USA.							1999, NATURE, V402, pC17	1	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					592	592		10.1038/35001234	http://dx.doi.org/10.1038/35001234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688174	Bronze			2022-12-28	WOS:000085288200019
J	Simpkins, PG; Kuck, VJ				Simpkins, PG; Kuck, VJ			Air entrapment in coatings by way of a tip-streaming meniscus	NATURE			English	Article							SURFACE; FLOW; DEFORMATION; INTERFACES; DYNAMICS; BREAKUP; DROPS	Entrapment of small air bubbles is a problem for continuous liquid-film coatings processes. The coating of any surface requires that the surrounding air in contact with it be displaced by an advancing liquid interface. Studies of dynamic wetting suggest that if the interface motion is too rapid, the air is not completely removed and it becomes entrained in the coating material(1). This process, which can lead to undesirable flaws in the form of bubbles, blemishes or voids, limits the speed at which the substrate can be moved in the production of uniform precision coatings. However, the entrapment process is not understood in detail. Here we report an experimental investigation of air entrapment in high-speed coating operations. Tip streaming-a phenomenon well known in emulsification technology(2), involving the ejection of a fine filament from the cusped interface between two immiscible fluids-is shown to be the precursor of air entrainnent. We demonstrate that tip-streaming air filaments emanating from the contact zone of a dynamic liquid interface give rise to minute (similar to 10 mu m) bubbles.	Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Simpkins, PG (corresponding author), Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA.	pgs@bell-labs.com						BENJAMIN DF, 1991, IND COATING RES, V1, P1; BLAKE TD, 1979, NATURE, V282, P489, DOI 10.1038/282489a0; BOLTON B, 1980, CHEM ENG SCI, V35, P597, DOI 10.1016/0009-2509(80)80008-X; DEBRUIJN RA, 1993, CHEM ENG SCI, V48, P277, DOI 10.1016/0009-2509(93)80015-I; DUSSAN EB, 1974, J FLUID MECH, V65, P71, DOI 10.1017/S0022112074001261; Eggers J, 1997, REV MOD PHYS, V69, P865, DOI 10.1103/RevModPhys.69.865; GHANNAM MT, 1990, AICHE J, V36, P1283, DOI 10.1002/aic.690360822; GRACE HP, 1982, CHEM ENG COMMUN, V14, P225, DOI 10.1080/00986448208911047; JEONG JT, 1992, J FLUID MECH, V241, P1, DOI 10.1017/S0022112092001927; JOSEPH DD, 1991, J FLUID MECH, V223, P383, DOI 10.1017/S0022112091001477; Kistler SF, 1993, WETTABILITY, P311; Pozrikidis C, 1998, J FLUID MECH, V357, P29, DOI 10.1017/S0022112097007866; SHERWOOD JD, 1984, J FLUID MECH, V144, P281, DOI 10.1017/S0022112084001609; Shikhmurzaev YD, 1998, J FLUID MECH, V359, P313, DOI 10.1017/S0022112098008532; Siegel M, 1999, SIAM J APPL MATH, V59, P1998, DOI 10.1137/S0036139997327435; SMITH PG, 1985, COLLOID SURFACE, V15, P191, DOI 10.1016/0166-6622(85)80071-8; STONE HA, 1994, ANNU REV FLUID MECH, V26, P65, DOI 10.1146/annurev.fluid.26.1.65; Taylor GI, 1934, P R SOC LOND A-CONTA, V146, P0501, DOI 10.1098/rspa.1934.0169	18	26	26	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					641	643		10.1038/35001043	http://dx.doi.org/10.1038/35001043			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688196				2022-12-28	WOS:000085288200048
J	Culler, TS; Becker, TA; Muller, RA; Renne, PR				Culler, TS; Becker, TA; Muller, RA; Renne, PR			Lunar impact history from 40Ar/39Ar dating of glass spherules	SCIENCE			English	Article							CALIBRATION	Lunar spherules are small glass beads that are formed mainly as a result of small impacts on the lunar surface; the ages of these impacts can be determined by the 40Ar/39Ar isochron technique. Here, 155 spherules separated from 1 gram of Apollo 14 soil were analyzed using this technique. The data show that over the Last similar to 3.5 billion years, the cratering rate decreased by a factor of 2 to 3 to a low about 500 to 600 million years ago, then increased by a factor of 3.7 +/- 1.2 in the last 400 million years. This latter period coincided with rapid biotic evolutionary radiation on Earth.	Univ Calif Berkeley, Dept Geol & Geophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Berkeley Geochronolgy Center	Renne, PR (corresponding author), Univ Calif Berkeley, Dept Geol & Geophys, Berkeley, CA 94720 USA.	prenne@bgc.org		Renne, Paul/0000-0003-1769-5235				Basaltic Volcanism Study Project (BVSP), 1981, BAS VOLC TERR PLAN; CHAO ECT, 1973, US GEOL SURV J RES, V1, P1; CULLER TS, UNPUB; DALRYMPLE GB, 1993, US GEOL SURV B, V2065, P20; Drozd R.J., 1977, P LUN SCI C, P3027; Eberhardt P., 1972, P LUNAR PLANET SCI C, P1821; FRONDEL C, 1970, P APOLLO 11 LUNAR SC, V1, P445; GLASS BP, 1982, INTRO PLANETARY GEOL; Grieve RAF, 1994, HAZARDS DUE COMETS A, P417; GROTZINGER JP, 1995, SCIENCE, V270, P598, DOI 10.1126/science.270.5236.598; GROTZINGER JP, 1997, AAPG BULL, V18, P1954; Hartmann W.K., 1980, LUNAR HIGHLANDS CRUS, P155; HARTMANN WK, 1972, ASTROPHYS SPACE SCI, V17, P48, DOI 10.1007/BF00642541; Heiken GH., 1991, LUNAR SOURCEBOOK; HORZ F, 1991, LUNAR SOURCEBOOK, P285; McEwen AS, 1997, J GEOPHYS RES-PLANET, V102, P9231, DOI 10.1029/97JE00114; MCGETCHIN TR, 1973, EARTH PLANET SC LETT, V20, P226, DOI [10.1016/0012-821X(73)90162-3, 10.1016/0012-821X(74)90115-0]; MCKAY DS, 1973, EOS T AM GEOPHYS UN, V54, P599; MORRIS RV, 1983, 19069 JSC LB JOHNS S; MULLER RA, 1993, LBL34168 L BERK NAT; Neukum G., 1994, HAZARDS DUE COMETS A, P359; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; RYDER G, 1991, GEOLOGY, V19, P143, DOI 10.1130/0091-7613(1991)019<0143:PAOAAC>2.3.CO;2; SAMSON SD, 1987, CHEM GEOL, V66, P27, DOI 10.1016/0168-9622(87)90025-X; SHOEMAKER EM, 1994, HAZARDS DUE COMETS A, P313; Shoemaker EM, 1963, ADV ASTRONAUT SCI, V8, p70 ; SHOEMAKER EM, 1990, 247 GEOL SOC AM, P155; STONE CD, 1982, P LUNAR PLANET SC S1, V13, pA182; Wilhelms D.E., 1987, US GEOLOGICAL SURVEY, DOI DOI 10.3133/PP1348	29	143	147	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2000	287	5459					1785	1788		10.1126/science.287.5459.1785	http://dx.doi.org/10.1126/science.287.5459.1785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710300				2022-12-28	WOS:000085775300032
J	Pepin, M; Schwarze, U; Superti-Furga, A; Byers, PH				Pepin, M; Schwarze, U; Superti-Furga, A; Byers, PH			Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIEXON DELETION; III COLLAGEN; COL3A1 GENE; PREGNANCY; COMPLICATIONS; PROCOLLAGEN; MUTATIONS; DNA; SUBSTITUTION; ALLELE	Background: Ehlers-Danlos syndrome type IV, the vascular type, results from mutations in the gene for type III procollagen (COL3A1). Affected patients are at risk for arterial, bowel, and uterine rupture, but the timing of these events, their frequency, and the course of the disease are not well documented. Methods: We reviewed the clinical and family histories of and medical and surgical complications in 220 index patients with biochemically confirmed Ehlers-Danlos syndrome type IV and 199 of their affected relatives. We identified the underlying COL3A1 mutation in 135 index patients. Results: Complications were rare in childhood; 25 percent of the index patients had a first complication by the age of 20 years, and more than 80 percent had had at least one complication by the age of 40. The calculated median survival of the entire cohort was 48 years. Most deaths resulted from arterial rupture. Bowel rupture, which often involved the sigmoid colon, accounted for about a quarter of complications but rarely led to death. Complications of pregnancy led to death in 12 of the 81 women who became pregnant. The types of complications were not associated with specific mutations in COL3A1. Conclusions: Although most affected patients survive the first and second major complications, Ehlers-Danlos syndrome type IV results in premature death. The diagnosis should be considered in young people who come to medical attention because of uterine rupture during pregnancy or arterial or visceral rupture. (N Engl J Med 2000;342:673-80.) (C)2000, Massachusetts Medical Society.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Zurich, Dept Pediat, Div Metab & Mol Dis, Zurich, Switzerland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Zurich	Byers, PH (corresponding author), Univ Washington, Dept Pathol, Box 357470, Seattle, WA 98195 USA.	pbyers@u.washington.edu	superti-furga, andrea/E-9162-2015	superti-furga, andrea/0000-0002-3543-7531; Byers, Peter H./0000-0001-7786-7030	NIAMS NIH HHS [AR 21557] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON P, 1993, MCKUSICKS HERITABLE; Bergqvist D, 1996, EUR J SURG, V162, P163; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; BRIGHOUSE D, 1992, BRIT J ANAESTH, V69, P517, DOI 10.1093/bja/69.5.517; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; DEPAEPE A, 1989, EUR J OBSTET GYN R B, V33, P189, DOI 10.1016/0028-2243(89)90214-1; Freeman RK, 1996, AM SURGEON, V62, P869; Gilchrist D, 1999, AM J MED GENET, V82, P305, DOI 10.1002/(SICI)1096-8628(19990212)82:4<305::AID-AJMG6>3.3.CO;2-3; JAMES LM, 1993, TERATOLOGY, V48, P707; KONTUSAARI S, 1992, AM J HUM GENET, V51, P497; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; MILEWICZ DM, 1993, AM J HUM GENET, V53, P62; NARCISI P, 1994, HUM MOL GENET, V3, P1617, DOI 10.1093/hmg/3.9.1617; *NAT CTR HLTH STAT, 1998, DHHS PUBL; North KN, 1995, ANN NEUROL, V38, P960, DOI 10.1002/ana.410380620; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PEACEMAN AM, 1987, OBSTET GYNECOL, V69, P428; Pope FM, 1996, BRIT J DERMATOL, V135, P163, DOI 10.1046/j.1365-2133.1996.d01-971.x; POPE FM, 1983, LANCET, V1, P249; RUDD NL, 1983, LANCET, V1, P50; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwarze U, 1997, AM J HUM GENET, V61, P1276, DOI 10.1086/301641; Steinmann Beat, 1993, P351; VENTURA SJ, 1995, MON VITAL STAT REP S, V44, P75; VISSING H, 1991, J BIOL CHEM, V266, P5244; WEINBAUM PJ, 1987, AM J PERINAT, V4, P134, DOI 10.1055/s-2007-999756	30	775	814	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2000	342	10					673	680		10.1056/NEJM200003093421001	http://dx.doi.org/10.1056/NEJM200003093421001			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ZW	10706896	Bronze			2022-12-28	WOS:000085708800001
J	Catto, GRD				Catto, GRD			Interface between university and medical school: the way ahead?	BRITISH MEDICAL JOURNAL			English	Article									Univ Aberdeen, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Catto, GRD (corresponding author), Univ Aberdeen, Aberdeen AB25 2ZD, Scotland.							Bett M., 1999, INDEPENDENT REV HIGH; *GEN MED COUNC, 1996, NEW DOCT; *GEN MED COUNC, 1998, GOOD MED PRACT; *GEN MED COUNC, 1999, DOCT TEACH; *GEN MED COUNC, 1996, STUD HLTH COND; General Medical Council, 1993, TOM DOCT; HAMPTON JR, 1999, J R SOC MED, V92, P319; Levinson W, 1999, NEW ENGL J MED, V341, P840, DOI 10.1056/NEJM199909093411111; *WELLC TRUST, 1998, MAPP LANDSC	9	16	16	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					633	636		10.1136/bmj.320.7235.633	http://dx.doi.org/10.1136/bmj.320.7235.633			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698888	Green Published			2022-12-28	WOS:000085742600032
J	Tosswill, JHC; Taylor, GP; Tedder, RS; Mortimer, PP				Tosswill, JHC; Taylor, GP; Tedder, RS; Mortimer, PP			HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests	BRITISH MEDICAL JOURNAL			English	Article									St Marys Hosp, Imperial Coll Sch Med, Dept Genitourinary Med & Communicable Dis, London W2 1PG, England; Cent Publ Hlth Lab, Virus Reference Div, London NW9 5HT, England; UCL, Royal Free & Univ Coll Med Sch, Dept Virol, London W1P 6DB, England	Imperial College London; Public Health England; University of London; University College London	Taylor, GP (corresponding author), St Marys Hosp, Imperial Coll Sch Med, Dept Genitourinary Med & Communicable Dis, Praed St, London W2 1PG, England.	g.p.taylor@ic.ac.uk						HASKEY J, 1997, POPULATION TRENDS, V88, P13; International Agency of Research on Cancer, 1996, IARC MON EV CARC RIS, V67; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Simms I, 1994, Commun Dis Rep CDR Rev, V4, pR65; Tynell E, 1998, BRIT MED J, V316, P1417, DOI 10.1136/bmj.316.7142.1417	5	28	28	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					611	612		10.1136/bmj.320.7235.611	http://dx.doi.org/10.1136/bmj.320.7235.611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698878	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000085742600024
J	Dudley, RA; Johansen, KL; Brand, R; Rennie, DJ; Milstein, A				Dudley, RA; Johansen, KL; Brand, R; Rennie, DJ; Milstein, A			Selective referral to high-volume hospitals - Estimating potentially avoidable deaths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK-STATE; ABDOMINAL AORTIC-ANEURYSMS; TRANSLUMINAL CORONARY ANGIOPLASTY; ACUTE MYOCARDIAL-INFARCTION; ARTERY BYPASS-SURGERY; SHORT-TERM MORTALITY; CAROTID ENDARTERECTOMY; SURGICAL VOLUME; OPERATIVE MORTALITY; PATIENT VOLUME	Context Evidence exists that high-volume hospitals (HVHs) have lower mortality rates than low-volume hospitals (LVHs) for certain conditions. However, few employers, health plans, or government programs have attempted to increase the number of patients referred to HVHs. Objectives To determine the difference in hospital mortality between HVHs and LVHs for conditions for which good quality data exist and to estimate how many deaths potentially would be avoided in California by referral to HVHs. Design, Setting, and Patients Literature in MEDLINE, Current Contents, and First-Search Social Abstracts databases from January 1, 1983, to December 31, 1998, was searched using the key words hospital, outcome, mortality, volume, risk, and quality. The highest-quality study assessing the mortality-volume relationship for each given condition was identified and used to calculate odds ratios (ORs) for in-hospital mortality for LVHs vs HVHs. These ORs were then applied to the 1997 California database of hospital discharges maintained by the California Office of Statewide Health Planning and Development to estimate potentially avoidable deaths. Main Outcome Measures Deaths that potentially could be avoided if patients with conditions for which a mortality-volume relationship had been treated at an HVH vs LVH. Results The articles identified in the literature search were grouped by condition, and predetermined criteria were applied to choose the best article for each condition. Mortality was significantly lower at HVHs for elective abdominal aortic aneurysm repair, carotid endarterectomy, lower extremity arterial bypass surgery, coronary artery bypass surgery, coronary angioplasty, heart transplantation, pediatric cardiac surgery, pancreatic cancer surgery, esophageal cancer surgery, cerebral aneurysm surgery, and treatment of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS). A total of 58 306 of 121 609 patients with these conditions were admitted to LVHs in California in 1997, After applying the calculated ORs to these patient populations, we estimated that 602 deaths (95% confidence interval, 304-830) at LVHs could be attributed to their low volume. Additional analyses were performed to take into account emergent admissions and distance traveled, but the impact of loss of continuity of care for some patients and reduction in the availability of specialists for patients remaining at LVHs could not be assessed. Conclusions Initiatives to facilitate referral of patients to HVHs have the potential to reduce overall hospital mortality in California for the conditions identified. Additional study is needed to determine the extent to which selective referral is feasible and to examine the potential consequences of such initiatives.	Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94118 USA; Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94118 USA; Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94118 USA; Pacific Business Grp Hlth, San Francisco, CA USA; William M Mercer Inc, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dudley, RA (corresponding author), Univ Calif San Francisco, Inst Hlth Policy Studies, Box 0936,3333 Calif St,Suite 265, San Francisco, CA 94118 USA.							AASS N, 1991, J CLIN ONCOL, V9, P818, DOI 10.1200/JCO.1991.9.5.818; ADAMS DF, 1973, CIRCULATION, V48, P609, DOI 10.1161/01.CIR.48.3.609; AMUNDSEN S, 1990, ACTA CHIR SCAND, V156, P323; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; BENNETT CL, 1989, JAMA-J AM MED ASSOC, V261, P2975, DOI 10.1001/jama.261.20.2975; Casale PN, 1998, J AM COLL CARDIOL, V32, P885, DOI 10.1016/S0735-1097(98)00325-8; Cebul RD, 1998, JAMA-J AM MED ASSOC, V279, P1282, DOI 10.1001/jama.279.16.1282; Chen H, 1996, SURGERY, V120, P948, DOI 10.1016/S0039-6060(96)80039-0; CULLER SD, 1995, MED CARE, V33, P1188, DOI 10.1097/00005650-199512000-00003; Dardik A, 1998, J VASC SURG, V28, P413, DOI 10.1016/S0741-5214(98)70126-0; DICKERSIN K, 1992, EPIDEMIOL REV, V14, P154, DOI 10.1093/oxfordjournals.epirev.a036084; EDWARDS WH, 1991, ANN SURG, V213, P433, DOI 10.1097/00000658-199105000-00008; FARLEY DE, 1992, MED CARE, V30, P77, DOI 10.1097/00005650-199201000-00009; Finlayson SRG, 1999, MED CARE, V37, P204, DOI 10.1097/00005650-199902000-00010; FISHER ES, 1989, AM J PUBLIC HEALTH, V79, P1617, DOI 10.2105/AJPH.79.12.1617; Glasgow RE, 1996, WESTERN J MED, V165, P294; GORDON TA, 1995, ANN SURG, V221, P43, DOI 10.1097/00000658-199501000-00005; Gordon TA, 1998, ANN SURG, V228, P71, DOI 10.1097/00000658-199807000-00011; Grassman ED, 1997, J AM COLL CARDIOL, V30, P201, DOI 10.1016/S0735-1097(97)00102-2; GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282; Hannan EL, 1998, STROKE, V29, P2292, DOI 10.1161/01.STR.29.11.2292; HANNAN EL, 1992, HEALTH SERV RES, V27, P517; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; HANNAN EL, 1991, MED CARE, V29, P1094, DOI 10.1097/00005650-199111000-00003; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Hannan EL, 1998, PEDIATRICS, V101, P963, DOI 10.1542/peds.101.6.963; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; Hofer TP, 1996, MED CARE, V34, P737, DOI 10.1097/00005650-199608000-00002; Hogg RS, 1998, CLIN INVEST MED, V21, P27; HOROWITZ MM, 1992, BLOOD, V79, P2771; HOSENPUD JD, 1994, JAMA-J AM MED ASSOC, V271, P1844, DOI 10.1001/jama.271.23.1844; HUGHES RG, 1987, MED CARE, V25, P489, DOI 10.1097/00005650-198706000-00004; Imperato P J, 1996, Am J Med Qual, V11, P193, DOI 10.1177/0885713X9601100407; JENKINS KJ, 1995, PEDIATRICS, V95, P323; Jollis JG, 1997, CIRCULATION, V95, P2485, DOI 10.1161/01.CIR.95.11.2485; JOLLIS JG, 1994, NEW ENGL J MED, V331, P1625, DOI 10.1056/NEJM199412153312406; Jones J, 1995, INT J TECHNOL ASSESS, V11, P762, DOI 10.1017/S0266462300009193; KAGAN RJ, 1994, AM SURGEON, V60, P394; Kantonen I, 1998, EUR J VASC ENDOVASC, V15, P155, DOI 10.1016/S1078-5884(98)80137-8; Karp HR, 1998, STROKE, V29, P46, DOI 10.1161/01.STR.29.1.46; Kazmers A, 1996, J VASC SURG, V23, P191, DOI 10.1016/S0741-5214(96)70263-X; KELLY JV, 1987, HEALTH SERV RES, V22, P369; KELLY JV, 1986, MED CARE, V24, P785, DOI 10.1097/00005650-198609000-00001; KIMMEL SE, 1995, JAMA-J AM MED ASSOC, V274, P1137, DOI 10.1001/jama.274.14.1137; KRAKAUER H, 1995, TRANSPLANTATION, V59, P840, DOI 10.1097/00007890-199503270-00007; Kreder HJ, 1997, J BONE JOINT SURG AM, V79A, P485, DOI 10.2106/00004623-199704000-00003; LAVERNIA CJ, 1995, J ARTHROPLASTY, V10, P133, DOI 10.1016/S0883-5403(05)80119-6; LIEBERMAN MD, 1995, ANN SURG, V222, P638, DOI 10.1097/00000658-199511000-00006; LUFT HS, 1987, HEALTH SERV RES, V22, P157; LUFT HS, 1996, CALIFORNIA HOSPITAL, V1; MAERKI SC, 1986, MED CARE, V24, P148, DOI 10.1097/00005650-198602000-00006; Manheim LM, 1998, J VASC SURG, V28, P45, DOI 10.1016/S0741-5214(98)70199-5; Moore J D Jr, 1997, Mod Healthc, V27, P155; MOORE JD, 1997, MOD HEALTHCARE, V27, P155; Neoptolemos JP, 1997, BRIT J SURG, V84, P1370; Patti M G, 1998, J Gastrointest Surg, V2, P186, DOI 10.1016/S1091-255X(98)80011-5; Perler BA, 1998, J VASC SURG, V27, P25, DOI 10.1016/S0741-5214(98)70288-5; Phibbs CS, 1996, JAMA-J AM MED ASSOC, V276, P1054, DOI 10.1001/jama.276.13.1054; PHILLIPS KA, 1995, MED CARE, V33, P502, DOI 10.1097/00005650-199505000-00005; PILCHER DB, 1980, AM J SURG, V139, P487, DOI 10.1016/0002-9610(80)90325-6; Riley G, 1985, Health Care Financ Rev, V7, P37; RITCHIE JL, 1993, CIRCULATION, V88, P2735, DOI 10.1161/01.CIR.88.6.2735; ROMANO PS, 1992, CHEST, V101, P1332, DOI 10.1378/chest.101.5.1332; Ronning P L, 1995, J Cardiovasc Manag, V6, P21; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Santner T., 1989, STAT ANAL DISCRETE D; SHOWSTACK JA, 1987, JAMA-J AM MED ASSOC, V257, P785, DOI 10.1001/jama.257.6.785; SHOWSTACK JA, 1987, JAMA-J AM MED ASSOC, V257, P2438; Shroyer ALW, 1996, ANN THORAC SURG, V61, P17, DOI 10.1016/0003-4975(95)00830-6; SLOAN FA, 1989, J HEALTH POLIT POLIC, V14, P115, DOI 10.1215/03616878-14-1-115; Solomon RA, 1996, STROKE, V27, P13, DOI 10.1161/01.STR.27.1.13; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; STILLER CA, 1989, ARCH DIS CHILD, V64, P657, DOI 10.1136/adc.64.5.657; STONE VE, 1992, JAMA-J AM MED ASSOC, V268, P2655, DOI 10.1001/jama.268.19.2655; Taylor CL, 1997, J NEUROSURG, V86, P583, DOI 10.3171/jns.1997.86.4.0583; Taylor HD, 1997, J ARTHROPLASTY, V12, P235, DOI 10.1016/S0883-5403(97)90018-8; Tepas JJ, 1998, J TRAUMA, V44, P827, DOI 10.1097/00005373-199805000-00014; Thomas JW, 1999, MED CARE, V37, P83, DOI 10.1097/00005650-199901000-00012; THORPE AC, 1994, BRIT J UROL, V74, P559, DOI 10.1111/j.1464-410X.1994.tb09184.x; Wen SW, 1996, J EPIDEMIOL COMMUN H, V50, P207, DOI 10.1136/jech.50.2.207; Wennberg DE, 1998, JAMA-J AM MED ASSOC, V279, P1278, DOI 10.1001/jama.279.16.1278; WILLIAMS RL, 1979, MED CARE, V17, P95, DOI 10.1097/00005650-197902000-00001; Zalkind DL, 1997, HOSP HEALTH SERV ADM, V42, P3; ZELEN J, 1991, NEW YORK STATE J MED, V91, P290	84	621	625	0	24	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1159	1166		10.1001/jama.283.9.1159	http://dx.doi.org/10.1001/jama.283.9.1159			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	286BQ	10703778				2022-12-28	WOS:000085424100025
J	Dobson, R				Dobson, R			Paediatricians "close to despair" over child protection laws	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					531	531						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688544				2022-12-28	WOS:000085624000007
J	Nakano, S; Chadalavada, DM; Bevilacqua, PC				Nakano, S; Chadalavada, DM; Bevilacqua, PC			General acid-base catalysis in the mechanism of a hepatitis delta virus ribozyme	SCIENCE			English	Article							METAL-ION CATALYSIS; GROUP-I RIBOZYME; ACTIVE-SITE; CRYSTAL-STRUCTURE; RNA; CLEAVAGE; HAIRPIN; HAMMERHEAD; DOMAIN; SPECIFICITY	Many protein enzymes use general acid-base catalysis as a way to increase reaction rates. The amino acid histidine is optimized for this function because it has a pK(a) (where K-a is the acid dissociation constant) near physiological pH. The RNA enzyme (ribozyme) from hepatitis delta virus catalyzes self-cleavage of a phosphodiester bond. Reactivity-pH profiles in monovalent or divalent cations, as well as distance to the Leaving-group oxygen, implicate cytosine 75 (C75) of the ribozyme as the general acid and ribozyme-bound hydrated metal hydroxide as the general base in the self-cleavage reaction. Moreover, C75 has a pK(a) perturbed to neutrality, making it "histidine-like." Anticooperative interaction is observed between protonated C75 and a metal ion, which serves to modulate the pK(a) of C75. General acid-base catalysis expands the catalytic repertoire of RNA and may provide improved rate acceleration.	Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bevilacqua, PC (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.		Chadalavada, Durga/A-5233-2011	Bevilacqua, Philip/0000-0001-8074-3434; Ghosh, Durga/0000-0003-1367-8198	NIGMS NIH HHS [GM58709] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058709] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASOLO R, 1988, MECHANISMS INORGANIC; Been MD, 1997, EUR J BIOCHEM, V247, P741, DOI 10.1111/j.1432-1033.1997.00741.x; Cate JH, 1996, STRUCTURE, V4, P1221, DOI 10.1016/S0969-2126(96)00129-3; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Cech TR, 1999, RNA WORLD, P321; CHADALAVADA D, UNPUB; CONNELL GJ, 1994, SCIENCE, V264, P1137, DOI 10.1126/science.7513905; DAHM SC, 1993, BIOCHEMISTRY-US, V32, P13040, DOI 10.1021/bi00211a013; DASILVA FJJ, 1993, BIOL CHEM ELEMENTS; Ferre-D'Amare AR, 2000, J MOL BIOL, V295, P541, DOI 10.1006/jmbi.1999.3398; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Fersht A., 1985, ENZYME STRUCTURE MEC; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Hampel A, 1997, CHEM BIOL, V4, P513, DOI 10.1016/S1074-5521(97)90323-9; Hampel KJ, 1998, BIOCHEMISTRY-US, V37, P14672, DOI 10.1021/bi981083n; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8312, DOI 10.1021/bi00083a035; Jencks W. P., 1987, CATALYSIS CHEM ENZYM, P163; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; KIRBY AJ, 1970, J CHEM SOC B, P1165, DOI 10.1039/j29700001165; KIRBY AJ, 1970, J CHEM SOC B, P510, DOI 10.1039/j29700000510; Legault P, 1997, J AM CHEM SOC, V119, P6621, DOI 10.1021/ja9640051; LEGAULT P, 1994, J AM CHEM SOC, V116, P8390, DOI 10.1021/ja00097a066; MAKINO S, 1987, NATURE, V329, P343, DOI 10.1038/329343a0; Misra VK, 1998, BIOPOLYMERS, V48, P113, DOI 10.1002/(SICI)1097-0282(1998)48:2<113::AID-BIP3>3.0.CO;2-Y; Murray JB, 1998, CHEM BIOL, V5, P587, DOI 10.1016/S1074-5521(98)90116-8; Narlikar GJ, 1997, ANNU REV BIOCHEM, V66, P19, DOI 10.1146/annurev.biochem.66.1.19; Nesbitt S, 1997, CHEM BIOL, V4, P619, DOI 10.1016/S1074-5521(97)90247-7; Oivanen M, 1998, CHEM REV, V98, P961, DOI 10.1021/cr960425x; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; Pontius BW, 1997, P NATL ACAD SCI USA, V94, P2290, DOI 10.1073/pnas.94.6.2290; Saenger W., 1984, PRINCIPLES NUCL ACID; SCHMIDT DE, 1971, BIOCHEMISTRY-US, V10, P1249; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Segel I.H, 1993, ENZYME KINETICS; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; Shih IH, 1999, RNA, V5, P1140, DOI 10.1017/S1355838299990763; Shim JH, 1999, BIOCHEMISTRY-US, V38, P10024, DOI 10.1021/bi9904609; Suga H, 1998, BIOCHEMISTRY-US, V37, P10118, DOI 10.1021/bi980432a; SUH YA, 1993, NUCLEIC ACIDS RES, V21, P3277, DOI 10.1093/nar/21.14.3277; THOMPSON JE, 1994, J AM CHEM SOC, V116, P5467, DOI 10.1021/ja00091a060; Wadkins TS, 1999, RNA, V5, P720, DOI 10.1017/S1355838299990209; Weinstein LB, 1997, NATURE, V388, P805, DOI 10.1038/42076; Yoshida A, 1999, NAT STRUCT BIOL, V6, P318; Young KJ, 1997, NUCLEIC ACIDS RES, V25, P3760, DOI 10.1093/nar/25.19.3760	48	352	368	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1493	1497		10.1126/science.287.5457.1493	http://dx.doi.org/10.1126/science.287.5457.1493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688799				2022-12-28	WOS:000085531600053
J	Macilwain, C				Macilwain, C			AAAS members fret over links with theological foundation	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					819	819		10.1038/35002753	http://dx.doi.org/10.1038/35002753			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706251	Bronze			2022-12-28	WOS:000085559200010
J	Reed, MB; Saliba, KJ; Caruana, SR; Kirk, K; Cowman, AF				Reed, MB; Saliba, KJ; Caruana, SR; Kirk, K; Cowman, AF			Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum	NATURE			English	Article							CHLOROQUINE RESISTANCE; P-GLYCOPROTEIN; PHYSICOCHEMICAL PROPERTIES; HALOFANTRINE RESISTANCE; MALARIA PARASITES; IN-VITRO; GENE; AMPLIFICATION; DRUG; TRANSFORMATION	Throughout the latter half of this century, the development and spread of resistance to most front-line antimalarial compounds used in the prevention and treatment of the most severe form of human malaria has given cause for grave clinical concern. Polymorphisms in pfmdr1, the gene encoding the P-glycoprotein homologue 1 (Pgh1) protein of Plasmodium falciparum, have been linked to chloroquine resistance(1); Pgh1 has also been implicated in resistance to mefloquine and halofantrine(2-5). However, conclusive evidence of a direct causal association between pfmdr1 and resistance to these antimalarials has remained elusive, and a single genetic cross has suggested that Pgh1 is not involved in resistance to chloroquine and mefloquine(6). Here we provide direct proof that mutations in Pgh1 can confer resistance to mefloquine, quinine and halofantrine. The same mutations influence parasite resistance towards chloroquine in a strain-specific manner and the level of sensitivity to the structurally unrelated compound, artemisinin, This has important implications for the development and efficacy of future antimalarial agents.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Australian Natl Univ, Fac Sci, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia	Walter & Eliza Hall Institute; Australian National University	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	cowman@wehi.edu.au	Saliba, Kevin J/C-9166-2009; Cowman, Alan F/C-7642-2013; Kirk, Kiaran/C-8299-2009	Saliba, Kevin J/0000-0003-3345-8440; Cowman, Alan F/0000-0001-5145-9004; Kirk, Kiaran/0000-0002-5613-2622				Bray PG, 1998, MOL PHARMACOL, V54, P170, DOI 10.1124/mol.54.1.170; Bray PG, 1999, J CELL BIOL, V145, P363, DOI 10.1083/jcb.145.2.363; Bray PG, 1996, MOL PHARMACOL, V50, P1559; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; Crabb BS, 1997, MOL BIOCHEM PARASIT, V90, P131, DOI 10.1016/S0166-6851(97)00143-6; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; CREMER G, 1995, EXP PARASITOL, V81, P1, DOI 10.1006/expr.1995.1086; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; DOURY JC, 1992, TROP MED PARASITOL, V43, P197; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; GEARY TG, 1990, BIOCHEM PHARMACOL, V40, P685, DOI 10.1016/0006-2952(90)90302-2; Hawley SR, 1996, BIOCHEM PHARMACOL, V52, P723, DOI 10.1016/0006-2952(96)00354-1; Kirkman LA, 1996, EXP PARASITOL, V83, P147, DOI 10.1006/expr.1996.0058; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; PEEL SA, 1993, AM J TROP MED HYG, V48, P385, DOI 10.4269/ajtmh.1993.48.385; PEEL SA, 1994, AM J TROP MED HYG, V51, P648, DOI 10.4269/ajtmh.1994.51.648; Ritchie GY, 1996, MOL BIOCHEM PARASIT, V83, P35, DOI 10.1016/S0166-6851(96)02746-6; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; WARD SA, 1995, ANN TROP MED PARASIT, V89, P121, DOI 10.1080/00034983.1995.11812942; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130	27	682	704	0	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					906	909		10.1038/35002615	http://dx.doi.org/10.1038/35002615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706290				2022-12-28	WOS:000085559200061
J	Ellerbrock, TV; Chiasson, MA; Bush, TJ; Sun, XW; Sawo, D; Brudney, K; Wright, TC				Ellerbrock, TV; Chiasson, MA; Bush, TJ; Sun, XW; Sawo, D; Brudney, K; Wright, TC			Incidence of cervical squamous intraepithelial lesions in HIV-infected women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; PAPANICOLAOU SMEAR; NEOPLASIA; RISK; HPV; ABNORMALITIES; PREVALENCE; DYSPLASIA; CANCER	Context Women infected with human immunodeficiency virus (HIV) are at increased risk for cervical squamous intraepithelial lesions (SILs), the precursors to invasive cervical cancer. However, little is known about the causes of this association. Objectives To compare the incidence of SILs in HIV-infected vs uninfected women and to determine the role of risk factors in the pathogenesis of such lesions. Design Prospective cohort study conducted from October 1, 1991, to June 30, 1996. Setting Urban clinics for sexually transmitted diseases, HIV infection, and methadone maintenance. Participants A total of 328 HIV-infected and 325 uninfected women with no evidence of SILs by Papanicolaou test or colposcopy at study entry. Main Outcome Measure Incident SILs confirmed by biopsy, compared by HIV status and risk factors. Results During about 30 months of follow-up, 67 (20%) HIV-infected and 16 (5%) uninfected women developed a SIL (incidence of 8.3 and 1.8 cases per 100 person-years in sociodemographically similar infected and uninfected women, respectively [P<.001]). Of incident SILs, 91% were low grade in HIV-infected women vs 75% in uninfected women. No invasive cervical cancers were identified. By multivariate analysis, significant risk factors for incident SILs were HIV infection (relative risk [RR], 3.2; 95% confidence interval [CI], 1.7-6.1), transient human papillomavirus (HPV) DNA detection (RR, 5.5, 95% CI, 1.4-21.9), persistent HPV DNA types other than 16 or 18 (RR, 7.6; 95% CI, 1.9-30.3), persistent HPV DNA types 16 and 18 (RR, 11.6; 95% CI, 2.7-50.7), and younger age (<37.5 years; RR, 2.1;95% CI, 1.3-3.4), Conclusions In our study, 1 in 5 HIV-infected women with no evidence of cervical disease developed biopsy-confirmed SILs within 3 years, highlighting the importance of cervical cancer screening programs in this population.	Columbia Univ Coll Phys & Surg, Dept Pathol, Room 16-402,630 W 168th St, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA; New York City Dept Hlth, Bur Dis Intervent Res, New York, NY 10013 USA	Columbia University; Columbia University; Centers for Disease Control & Prevention - USA; New York City Department of Health & Mental Hygiene	Wright, TC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, Room 16-402,630 W 168th St, New York, NY 10032 USA.	tcw1@columbia.edu						[Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; CHIASSON M, 1998, INCIDENCE INVASIVE C; Chin KM, 1998, OBSTET GYNECOL, V92, P83, DOI 10.1016/S0029-7844(98)00140-9; CONTI M, 1993, GYNECOL ONCOL, V49, P344, DOI 10.1006/gyno.1993.1137; FEINGOLD AR, 1990, J ACQ IMMUN DEF SYND, V3, P896; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; KORN AP, 1994, OBSTET GYNECOL, V83, P401; KOULOS JP, 1993, GYNECOL ONCOL, V48, P364, DOI 10.1006/gyno.1993.1064; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; KREISS JK, 1992, SEX TRANSM DIS, V19, P54, DOI 10.1097/00007435-199201000-00011; KURMAN RJ, 1994, BLAUSTEINS PATHOLOGY, P229; LAGA M, 1992, INT J CANCER, V50, P45, DOI 10.1002/ijc.2910500110; LUNGU O, 1992, MOL CELL PROBE, V6, P145, DOI 10.1016/0890-8508(92)90059-7; MAIMAN M, 1991, OBSTET GYNECOL, V78, P84; Maiman M, 1998, J Natl Cancer Inst Monogr, P43; MAIMAN M, 1988, JAMA-J AM MED ASSOC, V260, P2214, DOI 10.1001/jama.260.15.2214; MANDELL GL, 1997, ATLAS INFECT DIS, pCH12; MARTE C, 1992, AM J OBSTET GYNECOL, V166, P1232, DOI 10.1016/S0002-9378(11)90612-7; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; Six C, 1998, AIDS, V12, P1047, DOI 10.1097/00002030-199809000-00012; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; SUN XW, 1995, OBSTET GYNECOL, V85, P680, DOI 10.1016/0029-7844(95)00025-M; TWEDDEL G, 1994, GYNECOL ONCOL, V52, P161, DOI 10.1006/gyno.1994.1024; [U.S. Public Health Service (USPHS) Infectious Diseases Society of America (IDSA)], 1999, MMWR-MORBID MORTAL W, V48, p[1, 61]; VERNON SD, 1994, J INFECT DIS, V169, P1108, DOI 10.1093/infdis/169.5.1108; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; WILLIAMS AB, 1994, OBSTET GYNECOL, V83, P205; WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591; Wright TC, 1996, OBSTET GYN CLIN N AM, V23, P861, DOI 10.1016/S0889-8545(05)70280-1	33	332	347	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					1031	1037		10.1001/jama.283.8.1031	http://dx.doi.org/10.1001/jama.283.8.1031			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284AM	10697063				2022-12-28	WOS:000085308600032
J	Brown, MS; Ye, J; Rawson, RB; Goldstein, JL				Brown, MS; Ye, J; Rawson, RB; Goldstein, JL			Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans	CELL			English	Review							CLEAVAGE-ACTIVATING PROTEIN; BOUND TRANSCRIPTION FACTOR; ENDOPLASMIC-RETICULUM; ALZHEIMERS-DISEASE; TRANSMEMBRANE PROTEIN; REQUIRES; NUCLEUS; CLONING; KINASE; SREBPS		Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL20948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		An FY, 1999, J BACTERIOL, V181, P5915, DOI 10.1128/JB.181.19.5915-5921.1999; Annaert W, 1999, TRENDS NEUROSCI, V22, P439, DOI 10.1016/S0166-2236(99)01455-1; BROU C, 2000, IN PRESS MOL CELL; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Chan YM, 1999, NEURON, V23, P201, DOI 10.1016/S0896-6273(00)80771-0; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Dunny GM, 1997, ANNU REV MICROBIOL, V51, P527, DOI 10.1146/annurev.micro.51.1.527; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; FIRTH N, 1994, J BACTERIOL, V176, P5871, DOI 10.1128/JB.176.18.5871-5873.1994; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; HUBBARD SJ, 1994, PROTEIN SCI, V3, P757; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Lewis AP, 1999, PROTEIN SCI, V8, P439; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; MORI K, 1993, CELL, V74, P743; MUMM JS, 2000, IN PRESS MOL CELL; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973	55	1134	1172	1	48	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					391	398		10.1016/S0092-8674(00)80675-3	http://dx.doi.org/10.1016/S0092-8674(00)80675-3			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693756	Bronze			2022-12-28	WOS:000085446900002
J	Di Cristofano, A; Pandolfi, PP				Di Cristofano, A; Pandolfi, PP			The multiple roles of PTEN in tumor suppression	CELL			English	Review							GENE		Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Human Genet, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Human Genet, New York, NY 10021 USA.		Di Cristofano, Antonio/B-4148-2016; di cristofano, antonio/AAJ-3796-2020	di cristofano, antonio/0000-0003-2537-3228				Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies MA, 1999, CANCER RES, V59, P2551; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li DM, 1997, CANCER RES, V57, P2124; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maier D, 1999, CANCER RES, V59, P5479; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tamura M, 1999, JNCI-J NATL CANCER I, V91, P1820, DOI 10.1093/jnci/91.21.1820; Weng LP, 1999, CANCER RES, V59, P5808	20	949	974	0	57	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					387	390		10.1016/S0092-8674(00)80674-1	http://dx.doi.org/10.1016/S0092-8674(00)80674-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693755	Bronze			2022-12-28	WOS:000085446900001
J	Goodson, JL; Bass, AH				Goodson, JL; Bass, AH			Forebrain peptides modulate sexually polymorphic vocal circuitry	NATURE			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; TELEOST FISH; VASOTOCIN; VASOPRESSIN; AGGRESSION; OXYTOCIN; NEURONS; BRAIN; RATS; VERTEBRATES	The peptide arginine-vasopressin (mammals) and its evolutionary precursor arginine-vasotocin (non-mammals) modulate reproductive physiology and numerous related social behaviours, as do oxytocin (mammals) and its homologues mesotocin and isotocin (fish)(1). The distributions in the brain and/or the behavioural functions of these peptides often differ between the sexes(2-4), and between species with divergent social structures(3,5,6). Here we present neurophysiological evidence that males with vocal characteristics typical of females share a pattern of neuropeptide function with females rather than conspecific males. The plainfin midshipman fish (Porichthys notatus) has two male morphs with different reproductive tactics and vocalizations (a key species-typical behaviour which varies in its physical attributes and contextual usage, depending on the morph's social strategy)(7,8). Forebrain-evoked, rhythmic vocal-motor activity that precisely mimics natural vocalizations was modulated by arginine-vasotocin, isotocin and their antagonists delivered to the preoptic area-anterior hypothalamus, a primary site for behavioural integration in all vertebrates. Peptides had different effects in males that acoustically court females (arginine-vasotocin-sensitive) than in females and sneak-spawning males (isotocin-sensitive), showing that the neuromodulatory mechanisms that establish reproduction-related behaviour can be dissociated from gonadal sex.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Univ Calif Bodega, Marine Lab, Bodega Bay, CA 94923 USA	Cornell University	Goodson, JL (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	jlg14@cornell.edu						Bass AH, 1996, AM SCI, V84, P352; BASS AH, 1990, J NEUROBIOL, V21, P1155, DOI 10.1002/neu.480210802; BASS AH, 1994, J NEUROSCI, V14, P4025; Bass AH, 1997, BRAIN BEHAV EVOLUT, V50, P3, DOI 10.1159/000113351; BATTEN TFC, 1990, J COMP NEUROL, V302, P893, DOI 10.1002/cne.903020416; BLUTHE RM, 1990, BRAIN RES, V535, P301, DOI 10.1016/0006-8993(90)91613-L; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; Delville Y, 1998, J NEUROSCI, V18, P2667; Emerson SB, 1999, BRAIN BEHAV EVOLUT, V53, P187, DOI 10.1159/000006594; Everts HGJ, 1997, HORM BEHAV, V31, P136, DOI 10.1006/hbeh.1997.1375; FINE ML, 1994, J COMP PHYSIOL A, V174, P173; Floody OR, 1998, PEPTIDES, V19, P833, DOI 10.1016/S0196-9781(98)00029-1; Foran CM, 1998, GEN COMP ENDOCR, V111, P271, DOI 10.1006/gcen.1998.7113; Goodson JL, 1998, GEN COMP ENDOCR, V111, P233, DOI 10.1006/gcen.1998.7112; Goodson JL, 1998, HORM BEHAV, V34, P67, DOI 10.1006/hbeh.1998.1467; Grober MS, 1996, NEUROREPORT, V7, P2945, DOI 10.1097/00001756-199611250-00029; HAUSMANN H, 1995, FEBS LETT, V370, P227, DOI 10.1016/0014-5793(95)00832-T; MAHLMANN S, 1994, P NATL ACAD SCI USA, V91, P1342, DOI 10.1073/pnas.91.4.1342; MANNING M, 1989, J MED CHEM, V32, P382, DOI 10.1021/jm00122a016; Marler CA, 1999, HORM BEHAV, V36, P53, DOI 10.1006/hbeh.1999.1524; MOORE FL, 1992, ANN NY ACAD SCI, V652, P156, DOI 10.1111/j.1749-6632.1992.tb34352.x; MOORE FL, 1983, PEPTIDES, V4, P97, DOI 10.1016/0196-9781(83)90173-0; Moore FL, 1998, COMP BIOCHEM PHYS C, V119, P251, DOI 10.1016/S0742-8413(98)00014-0; Northcutt RG, 1980, COMP NEUROLOGY TELEN; Ota Y, 1999, GEN COMP ENDOCR, V116, P40, DOI [10.1006/gcen.1999.7344, 10.1006/gcen.1999.7343]; ROSE JD, 1995, NEUROENDOCRINOLOGY, V62, P406, DOI 10.1159/000127030; SWAAB DF, 1990, BRAIN RES, V537, P141, DOI 10.1016/0006-8993(90)90350-K; WINSLOW JT, 1993, EUR J PHARMACOL, V233, P101, DOI 10.1016/0014-2999(93)90354-K; YOUNG DS, 1975, CLIN CHEM, V21, pD1; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475	30	219	222	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					769	772		10.1038/35001581	http://dx.doi.org/10.1038/35001581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693805				2022-12-28	WOS:000085423100052
J	Groombridge, JJ; Jones, CG; Bruford, MW; Nichols, RA				Groombridge, JJ; Jones, CG; Bruford, MW; Nichols, RA			Conservation biology - 'Ghost' alleles of the Mauritius kestrel	NATURE			English	Article							POPULATIONS; BIRDS		Zool Soc London, Inst Zool, London NW1 4RY, England; Mauritius Wildlife Fdn, Black River, Mauritius; Queen Mary Univ London, Sch Biol Sci, London E1 4NS, England	Zoological Society of London; University of London; Queen Mary University London	Groombridge, JJ (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.		Bruford, Michael/Y-7463-2019; Nichols, Richard/B-7732-2008; Bruford, Michael W/D-3750-2009; Groombridge, Jim/G-8060-2011	Bruford, Michael/0000-0001-6357-6080; Nichols, Richard/0000-0002-4801-9312; Bruford, Michael W/0000-0001-6357-6080; 				Bataillon T, 2000, GENET RES, V75, P75, DOI 10.1017/S0016672399004048; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gilpin M.E., 1986, P19; JOHNSON TH, 1990, IBIS, V132, P167, DOI 10.1111/j.1474-919X.1990.tb01036.x; Jones C. G., 1987, STUDIES MASCARENE IS, P5; JONES CG, 1995, IBIS, V137, pS173, DOI 10.1111/j.1474-919X.1995.tb08439.x; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Saccheri IJ, 1996, EVOLUTION, V50, P2000, DOI 10.1111/j.1558-5646.1996.tb03587.x; Safford RJ, 1997, BIODIVERS CONSERV, V6, P1445, DOI 10.1023/A:1018350016327	11	131	135	1	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					616	616		10.1038/35001148	http://dx.doi.org/10.1038/35001148			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688188	Bronze			2022-12-28	WOS:000085288200040
J	Siegert, MJ; Kwok, R; Mayer, C; Hubbard, B				Siegert, MJ; Kwok, R; Mayer, C; Hubbard, B			Water exchange between the subglacial Lake Vostok and the overlying ice sheet	NATURE			English	Article							CENTRAL EAST-ANTARCTICA; STATION	It has now been known for several years that a 200-km-long lake, called Lake Vostok, lies beneath the ice sheet on which sits Vostok Station in Antarctica(1-5), The conditions at the base of the ice sheet above this subglacial lake can provide information about the environment within the lake, including the likelihood that it supports life(2). Here we present an analysis of the ice-sheet structure from airborne 60-MHz radar studies, which indicates that distinct zones of basal ice loss and accretion occur at the ice-water interface. Subglacial melting and net ice loss occur in the north of the lake and across its 200-km-long western margin, whereas about 150 m of ice is gained by subglacial freezing in the south. This indicates that significant quantities of water are exchanged between the base of the ice sheet and the lake waters, which will enrich the lake with gas hydrates, cause sediment deposition and encourage circulation of the lake water.	Univ Bristol, Sch Geol Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Alfred Wegener Inst Polar & Marine Res, Dept Geophys, Bremerhaven, Germany; Univ Wales, Inst Geog & Earth Sci, Ctr Glaciol, Aberystwyth SY23 3DB, Dyfed, Wales	University of Bristol; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Aberystwyth University	Siegert, MJ (corresponding author), Univ Bristol, Sch Geol Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England.		Kwok, Ronald/L-3968-2019; Siegert, Martin J/A-3826-2008; Siegert, Martin/M-9939-2019; Kwok, Ron/A-9762-2008	Kwok, Ronald/0000-0003-4051-5896; Siegert, Martin J/0000-0002-0090-4806; Siegert, Martin/0000-0002-0090-4806; Kwok, Ron/0000-0003-4051-5896; Hubbard, Bryn/0000-0002-3565-3875				Dowdeswell JA, 1999, GEOL SOC AM BULL, V111, P254, DOI 10.1130/0016-7606(1999)111<0254:TDATSO>2.3.CO;2; Fujita S, 1999, J GEOPHYS RES-SOL EA, V104, P13013, DOI 10.1029/1999JB900034; JENKINS A, 1991, J GEOPHYS RES-OCEANS, V96, P791, DOI 10.1029/90JC01952; Jouzel J, 1999, SCIENCE, V286, P2138, DOI 10.1126/science.286.5447.2138; Kapitsa AP, 1996, NATURE, V381, P684, DOI 10.1038/381684a0; Legrand M, 1997, REV GEOPHYS, V35, P219, DOI 10.1029/96RG03527; MAYER C, IN PRESS J GLACIOL; MILLAR DHM, 1981, NATURE, V292, P441, DOI 10.1038/292441a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; ROBIN GDQ, 1977, PHILOS T ROY SOC B, V279, P185, DOI 10.1098/rstb.1977.0081; Siegert MJ, 1998, J GEOPHYS RES-SOL EA, V103, P10195, DOI 10.1029/98JB00390; Siegert MJ, 1996, ANTARCT SCI, V8, P281, DOI 10.1017/S0954102096000405; UCHIDA T, 1994, J GLACIOL, V40, P79, DOI 10.3189/S0022143000003828	13	63	64	3	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					643	646		10.1038/35001049	http://dx.doi.org/10.1038/35001049			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688197				2022-12-28	WOS:000085288200049
J	Pizza, M; Scarlato, V; Masignani, V; Giuliani, MM; Arico, B; Comanducci, M; Jennings, GT; Baldi, L; Bartolini, E; Capecchi, B; Galeotti, CL; Luzzi, E; Manetti, R; Marchetti, E; Mora, M; Nuti, S; Ratti, G; Santini, L; Savino, S; Scarselli, M; Storni, E; Zuo, PJ; Broeker, M; Hundt, E; Knapp, B; Blair, E; Mason, T; Tettelin, H; Hood, DW; Jeffries, AC; Saunders, NJ; Granoff, DM; Venter, JC; Moxon, ER; Grandi, G; Rappuoli, R				Pizza, M; Scarlato, V; Masignani, V; Giuliani, MM; Arico, B; Comanducci, M; Jennings, GT; Baldi, L; Bartolini, E; Capecchi, B; Galeotti, CL; Luzzi, E; Manetti, R; Marchetti, E; Mora, M; Nuti, S; Ratti, G; Santini, L; Savino, S; Scarselli, M; Storni, E; Zuo, PJ; Broeker, M; Hundt, E; Knapp, B; Blair, E; Mason, T; Tettelin, H; Hood, DW; Jeffries, AC; Saunders, NJ; Granoff, DM; Venter, JC; Moxon, ER; Grandi, G; Rappuoli, R			Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing	SCIENCE			English	Article							OUTER-MEMBRANE PROTEIN; NEISSERIA-MENINGITIDIS; ESCHERICHIA-COLI; CAPSULAR POLYSACCHARIDE; HAEMOPHILUS-INFLUENZAE; POLYSIALIC ACID; DISEASE; RECOMBINATION; GENE; POPULATIONS	Neisseria meningitidis is a major cause of bacterial septicemia and meningitis. Sequence variation of surface-exposed proteins and cross-reactivity of the serogroup B capsular polysaccharide with human tissues have hampered efforts to develop a successful vaccine. To overcome these obstacles, the entire genome sequence bf a virulent serogroup B strain (MC58) was used to identify vaccine candidates. A total of 350 candidate antigens were expressed in Escherichia coli, purified. and used to immunize mice. The sera allowed the identification of proteins that are surface exposed, that are conserved in sequence across a range of strains, and that induce a bactericidal antibody response, a property known to correlate with vaccine efficacy in humans.	Chiron SpA, IRIS, I-53100 Siena, Italy; Chiron Behring, D-35006 Marburg, Germany; Inst Genom Res, Rockville, MD 20850 USA; John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DS, England; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Novartis; Novartis; J. Craig Venter Institute; University of Oxford; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Rappuoli, R (corresponding author), Chiron SpA, IRIS, Via Fiorentina 1, I-53100 Siena, Italy.		Scarlato, Vincenzo/B-8558-2019; Saunders, Nigel J/W-6745-2019	Scarlato, Vincenzo/0000-0003-4227-677X; Grandi, Guido/0000-0001-9724-2185				Bart A, 1999, INFECT IMMUN, V67, P3842, DOI 10.1128/IAI.67.8.3842-3846.1999; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; CAUGANT DA, 1987, J BACTERIOL, V169, P2781, DOI 10.1128/jb.169.6.2781-2792.1987; CHANYANGAM M, 1991, INFECT IMMUN, V59, P600, DOI 10.1128/IAI.59.2.600-608.1991; Coligan J.E., 1997, CURRENT PROTOCOLS PR; CONNOLLY M, 1997, SURVEILLANCE BACTERI, P6; DAVIES RL, 1991, J IMMUNOL METHODS, V134, P215; DEMPSEY JAF, 1991, J BACTERIOL, V173, P5476, DOI 10.1128/jb.173.17.5476-5486.1991; FINNE J, 1987, J IMMUNOL, V138, P4402; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOTSCHLICH EC, 1969, J EXP MED, V129, P1349, DOI 10.1084/jem.129.6.1349; GOTSCHLICH EC, 1969, J EXP MED, V129, P1367, DOI 10.1084/jem.129.6.1367; GRANOFF DM, 1997, INT J INFECT DIS, V1, P152; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAYRINEN J, 1995, J INFECT DIS, V171, P1481, DOI 10.1093/infdis/171.6.1481; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; JAFARI HS, 1997, MMWR-MORBID MORTAL W, V46, P1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lommatzsch J, 1997, J BACTERIOL, V179, P5465, DOI 10.1128/jb.179.17.5465-5470.1997; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MANDRELL RE, 1995, J INFECT DIS, V172, P1279, DOI 10.1093/infdis/172.5.1279; Martin D, 1997, J EXP MED, V185, P1173, DOI 10.1084/jem.185.7.1173; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; MORAES JC, 1992, LANCET, V340, P1074; NAESS A, 1994, ACTA NEUROL SCAND, V89, P139; Peeters CCAM, 1999, VACCINE, V17, P2702, DOI 10.1016/S0264-410X(99)00011-0; Peltola H, 1998, DRUGS, V55, P347, DOI 10.2165/00003495-199855030-00003; PIZZA M, UNPUB; POOLMAN JT, 1995, INFECT AGENT DIS, V4, P13; RELMAN DA, 1989, P NATL ACAD SCI USA, V86, P2637, DOI 10.1073/pnas.86.8.2637; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHOLTEN RJPM, 1993, CLIN INFECT DIS, V16, P237, DOI 10.1093/clind/16.2.237; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Seller A, 1996, MOL MICROBIOL, V19, P841, DOI 10.1046/j.1365-2958.1996.437970.x; Smith JM, 1998, MOL BIOL EVOL, V15, P590, DOI 10.1093/oxfordjournals.molbev.a025960; STEPHENS DS, 1991, INFECT IMMUN, V59, P4097, DOI 10.1128/IAI.59.11.4097-4102.1991; StGeme JW, 1996, J BACTERIOL, V178, P6281, DOI 10.1128/jb.178.21.6281-6287.1996; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; VANDERLEY P, 1992, INFECT IMMUN, V60, P3156, DOI 10.1128/IAI.60.8.3156-3161.1992; WANG JF, 1993, J INFECT DIS, V167, P1320, DOI 10.1093/infdis/167.6.1320; WUENSCHER MD, 1993, J BACTERIOL, V175, P3491, DOI 10.1128/jb.175.11.3491-3501.1993; Zollinger W.D., 1997, NEW GENERATION VACCI, V2nd ed., P469; MORB MORTAL WKLY REP, V46, P45	45	980	1113	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1816	1820		10.1126/science.287.5459.1816	http://dx.doi.org/10.1126/science.287.5459.1816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710308				2022-12-28	WOS:000085775300040
J	McCarthy, RE; Boehmer, JP; Hruban, RH; Hutchins, GM; Kasper, EK; Hare, JM; Baughman, KL				McCarthy, RE; Boehmer, JP; Hruban, RH; Hutchins, GM; Kasper, EK; Hare, JM; Baughman, KL			Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTRICULAR ASSIST DEVICE; ENDOMYOCARDIAL BIOPSY; LYMPHOCYTIC MYOCARDITIS; CIRCULATORY SUPPORT; FOLLOW-UP; DIAGNOSIS; FEATURES	Background: Lymphocytic myocarditis causes left ventricular dysfunction that may be persistent or reversible. There are no clinical criteria that predict which patients will recover ventricular function and which cases will progress to dilated cardiomyopathy. We hypothesized that patients with fulminant myocarditis may have a better long-term prognosis than those with acute (nonfulminant) myocarditis. Methods: We identified 147 patients considered to have myocarditis according to the findings on endomyocardial biopsy and the Dallas histopathological criteria. Fulminant myocarditis was diagnosed on the basis of clinical features at presentation, including the presence of severe hemodynamic compromise, rapid onset of symptoms, and fever. Patients with acute myocarditis did not have these features. The incidence of the end point of this study, death or heart transplantation, was ascertained by contact with the patient or the patient's family or by a search of the National Death Index. The average period of follow-up was 5.6 years. Results: A total of 15 patients met the criteria for fulminant myocarditis, and 132 met the criteria for acute myocarditis. Among the patients with fulminant myocarditis, 93 percent were alive without having received a heart transplant 11 years after biopsy (95 percent confidence interval, 59 to 99 percent), as compared with only 45 percent of those with acute myocarditis (95 percent confidence interval, 30 to 58 percent; P=0.05 by the log-rank test). Fulminant myocarditis was an independent predictor of survival after adjustments were made for age, histopathological findings, and hemodynamic variables. The rate of transplantation-free survival did not differ significantly between the patients considered to have borderline myocarditis and those considered to have active myocarditis according to the Dallas histopathological criteria. Conclusions: Fulminant myocarditis is a distinct clinical entity with an excellent long-term prognosis. Aggressive hemodynamic support is warranted for patients with this condition. (N Engl J Med 2000;342:690-5.) (C)2000, Massachusetts Medical Society.	Johns Hopkins Univ Hosp, Div Cardiol, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA; Milton S Hershey Med Ctr, Div Cardiol, Hershey, PA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Hare, JM (corresponding author), Johns Hopkins Univ Hosp, Div Cardiol, 600 N Wolfe St,Carnegie 568, Baltimore, MD 21287 USA.	jhare@mail.jhmi.edu		Boehmer, John/0000-0002-8024-1589	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003238] Funding Source: NIH RePORTER; NHLBI NIH HHS [KO8-HL03238] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; CHANG AC, 1992, CRIT CARE MED, V20, P712, DOI 10.1097/00003246-199205000-00028; CHOW LH, 1989, J AM COLL CARDIOL, V14, P915, DOI 10.1016/0735-1097(89)90465-8; DAVIS KB, 1985, CONTROL CLIN TRIALS, V6, P179, DOI 10.1016/0197-2456(85)90001-7; DEC GW, 1985, NEW ENGL J MED, V312, P885, DOI 10.1056/NEJM198504043121404; Eck M, 1997, AM J SURG PATHOL, V21, P1109, DOI 10.1097/00000478-199709000-00017; FENOGLIO JJ, 1983, NEW ENGL J MED, V308, P12, DOI 10.1056/NEJM198301063080103; GROGAN M, 1995, J AM COLL CARDIOL, V26, P80, DOI 10.1016/0735-1097(95)00148-S; HAUCK AJ, 1989, MAYO CLIN PROC, V64, P1235, DOI 10.1016/S0025-6196(12)61286-5; HERSKOWITZ A, 1993, AM J CARDIOL, V71, P982, DOI 10.1016/0002-9149(93)90918-3; JETT GK, 1992, J HEART LUNG TRANSPL, V11, P733; KHATIB R, 1980, J INFECT DIS, V141, P394, DOI 10.1093/infdis/141.3.394; LIEBERMAN EB, 1991, J AM COLL CARDIOL, V18, P1617, DOI 10.1016/0735-1097(91)90493-S; LUDMERER KM, 1985, AM J MED, V79, P245; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; McCarthy RE, 1998, CIRCULATION, V98, P296; MCCARTHY RE, 1997, CIRCULATION, V96, P321; NEMICKAS R, 1978, AM HEART J, V95, P766, DOI 10.1016/0002-8703(78)90509-4; PALLANSCH MA, 1988, COXSACKIEVIRUSES GEN, P399; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; PETERS NS, 1991, AM HEART J, V121, P942, DOI 10.1016/0002-8703(91)90221-3; QUIGLEY PJ, 1987, EUR HEART J, V8, P39, DOI 10.1093/eurheartj/8.suppl_J.39; ROCKMAN HA, 1991, AM HEART J, V121, P922, DOI 10.1016/0002-8703(91)90213-2; STRIKAS RA, 1986, J INFECT DIS, V153, P346, DOI 10.1093/infdis/153.2.346; WOODRUFF JF, 1980, AM J PATHOL, V101, P425; Yasu T, 1997, JPN CIRC J, V61, P1037, DOI 10.1253/jcj.61.1037; 1997, MMWR MORB MORTAL WKL, V46, P748	28	526	543	2	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2000	342	10					690	695		10.1056/NEJM200003093421003	http://dx.doi.org/10.1056/NEJM200003093421003			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ZW	10706898				2022-12-28	WOS:000085708800003
J	Schurch, B; Schmid, DM; Stohrer, M				Schurch, B; Schmid, DM; Stohrer, M			Treatment of neurogenic incontinence with botulinum toxin A.	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Univ Hosp Balgrist, CH-8008 Zurich, Switzerland; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Berufsgenossenschaftliche Unfallklin, D-8110 Murnau, Germany	University of Zurich; University of Zurich; University Zurich Hospital	Schurch, B (corresponding author), Univ Hosp Balgrist, CH-8008 Zurich, Switzerland.							Schurch B, 1996, J UROLOGY, V155, P1023, DOI 10.1016/S0022-5347(01)66376-6	1	149	152	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					665	665		10.1056/NEJM200003023420918	http://dx.doi.org/10.1056/NEJM200003023420918			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10702067	Bronze			2022-12-28	WOS:000085575500029
J	Kuulasmaa, K; Tunstall-Pedoe, H; Dobson, A; Fortmann, S; Sans, S; Tolonen, H; Evans, A; Ferrario, M; Tuomilehto, J				Kuulasmaa, K; Tunstall-Pedoe, H; Dobson, A; Fortmann, S; Sans, S; Tolonen, H; Evans, A; Ferrario, M; Tuomilehto, J		WHO MONICA Project	Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations	LANCET			English	Article							ISCHEMIC-HEART-DISEASE; SERUM-CHOLESTEROL CONCENTRATION; BLOOD-PRESSURE; CARDIOVASCULAR MORTALITY; MYOCARDIAL-INFARCTION; 38 POPULATIONS; AUTRES PAYS; ASSOCIATION; MEN; COUNTRIES	Background From the mid-1980s to mid-1990s, the WHO MONICA Project monitored coronary events and classic risk factors for coronary heart disease (CHD) in 38 populations from 21 countries. We assessed the extent to which changes in these risk factors explain the variation in the trends in coronary-event rates across the populations. Methods In men and women aged 35-64 years, non-fatal myocardial infarction and coronary deaths were registered continuously to assess trends in rates of coronary events. We carried out population surveys to estimate trends in risk factors. Trends in event rates were regressed on trends in risk score and in individual risk factors. Findings Smoking rates decreased in most male populations but trends were mixed in women; mean blood pressures and cholesterol concentrations decreased, body-mass index increased, and overall risk scores and coronary-event rates decreased. The model of trends in 10-year coronary-event rates against risk scores and single risk factors showed a poor fit, but this was improved with a 4-year time lag for coronary events. The explanatory power of the analyses was limited by imprecision of the estimates and homogeneity of trends in the study populations. Interpretation Changes in the classic risk factors seem to partly explain the variation in population trends in CHD. Residual variance is attributable to difficulties in measurement and analysis, including time lag, and to factors that were not included, such as medical interventions. The results support prevention policies based on the classic risk factors but suggest potential for prevention beyond these.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland; Univ Dundee, Ninewells Hosp & Med Sch, Cardiovasc Epidemiol Unit, MONICA Qual Control Ctr Event Registrat, Dundee DD1 9SY, Scotland; Univ Newcastle, Dept Stat, Newcastle, NSW 2308, Australia; Stanford Univ, Stanford Ctr Res Dis Prevent, Stanford, CA 94305 USA; Dept Hlth & Social Secur, Inst Hlth Studies, Barcelona, Spain; Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast, Antrim, North Ireland; Univ Milano Bicocca, Fac Med, Monza, Italy; Osped San Gerardo, Monza, Italy	Finland National Institute for Health & Welfare; University of Dundee; University of Newcastle; Stanford University; Queens University Belfast; University of Milano-Bicocca; San Gerardo Hospital	Kuulasmaa, K (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	kari.kuulasmaa@ktl.fi	Sans, Susana/ABD-5378-2021; Ferrario, Marco M./ABH-2115-2021; Dobson, Annette J/B-5273-2008	Sans, Susana/0000-0002-0400-5197; Paluzie, Guillermo/0000-0002-5808-6041; Ferrario, Marco M/0000-0003-2741-7124; Kuulasmaa, Kari/0000-0003-2165-1411; Tolonen, Hanna/0000-0003-3121-4303				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ARTAUDWILD SM, 1993, CIRCULATION, V88, P2771, DOI 10.1161/01.CIR.88.6.2771; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Borch-Johnsen K, 1999, LANCET, V354, P617; Chenet L, 1998, J EPIDEMIOL COMMUN H, V52, P772, DOI 10.1136/jech.52.12.772; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Dawber TR., 1980, FRAMINGHAM STUDY EPI, DOI DOI 10.4159/HARVARD.9780674492097; Dobson A, 1996, AM J EPIDEMIOL, V143, P1025; Dobson AJ, 1998, ANN MED, V30, P199, DOI 10.3109/07853899808999404; Dobson AJ, 1999, J CLIN EPIDEMIOL, V52, P761, DOI 10.1016/S0895-4356(99)00052-9; Dobson AJ, 1998, TOB CONTROL, V7, P14, DOI 10.1136/tc.7.1.14; DORING A, 1990, REV EPIDEMIOL SANTE, V38, P455; ERNST E, 1993, ANN INTERN MED, V118, P956, DOI 10.7326/0003-4819-118-12-199306150-00008; EVANS AE, 1995, QJM-INT J MED, V88, P469; Fuller W.A., 2009, MEASUREMENT ERROR MO; GEY KF, 1991, AM J CLIN NUTR, V53, pS326, DOI 10.1093/ajcn/53.1.326S; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; HAVLIK RJ, 1978, NIH PUBLICATION; Hense HW, 1995, J HUM HYPERTENS, V9, P935; KANNEL WB, 1986, AM HEART J, V112, P825, DOI 10.1016/0002-8703(86)90481-3; KEIL U, 1989, INT J EPIDEMIOL, V18, pS46; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; KUULASMAA K, 1997, B INT STAT I, P295; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LAW MR, 1994, BMJ-BRIT MED J, V308, P363, DOI 10.1136/bmj.308.6925.363; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MANSON JE, 1992, NEW ENGL J MED, V326, P1406, DOI 10.1056/NEJM199205213262107; Molarius A, 1997, J EPIDEMIOL COMMUN H, V51, P252, DOI 10.1136/jech.51.3.252; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; Pocock S J, 1981, J R Stat Soc Ser C Appl Stat, V30, P286; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; REID DD, 1976, LANCET, V2, P979; ROSE G, 1982, BRIT MED J, V284, P1600, DOI 10.1136/bmj.284.6329.1600; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sans S, 1997, EUR HEART J, V18, P1231; Schwartz S, 1999, AM J PUBLIC HEALTH, V89, P1175, DOI 10.2105/AJPH.89.8.1175; SIGFUSSON N, 1991, BRIT MED J, V302, P1371, DOI 10.1136/bmj.302.6789.1371; STAMLER R, 1979, J CHRON DIS, V32, P805, DOI 10.1016/0021-9681(79)90060-2; STEWART AW, 1994, INT J EPIDEMIOL, V23, P505; Tunstall-Pedoe H, 1999, LANCET, V354, P863, DOI 10.1016/S0140-6736(05)75932-8; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TUNSTALL-PEDOE H, 1988, Journal of Clinical Epidemiology, V41, P105; TUNSTALLPEDOE H, 1988, BRIT MED J, V297, P1559, DOI 10.1136/bmj.297.6663.1559; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; Waterhouse J, 1976, CANC INCIDENCE 5 CON; Wolf HK, 1997, J HUM HYPERTENS, V11, P733, DOI 10.1038/sj.jhh.1000531	52	686	719	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2000	355	9205					675	687		10.1016/S0140-6736(99)11180-2	http://dx.doi.org/10.1016/S0140-6736(99)11180-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703799				2022-12-28	WOS:000085615600009
J	Wagner, EH				Wagner, EH			The role of patient care teams in chronic disease management	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC ILLNESS; RANDOMIZED TRIAL; COLLABORATIVE MANAGEMENT; DIABETIC-PATIENTS; GENERAL-PRACTICE; OLDER ADULTS; HEALTH; ORGANIZATION; INTERVENTION; POPULATION		Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Inst Healthcare Innovat, Seattle, WA 98101 USA	Group Health Cooperative	Wagner, EH (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Inst Healthcare Innovat, 1730 Minor Ave,Suite 1290, Seattle, WA 98101 USA.	wagner.e@ghc.org						Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Beck A, 1997, J AM GERIATR SOC, V45, P543, DOI 10.1111/j.1532-5415.1997.tb03085.x; Becker DM, 1998, ARCH INTERN MED, V158, P1533, DOI 10.1001/archinte.158.14.1533; BECKER MH, 1974, J PEDIATR-US, V84, P599, DOI 10.1016/S0022-3476(74)80689-X; BERO LA, 2000, COCHRANE LIB, V1; Bogden PE, 1998, J GEN INTERN MED, V13, P740, DOI 10.1046/j.1525-1497.1998.00225.x; CALKINS E, 1998, NEW WAYS CARE OLDER; CHRISTIE D, 1984, COMMUNITY HEALTH ST, V8, P26; Corkery E, 1997, DIABETES CARE, V20, P254, DOI 10.2337/diacare.20.3.254; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; Delbanco TL, 1996, OBSTET GYNECOL, V88, pS41, DOI 10.1016/0029-7844(96)00243-8; FARMER A, 1990, BRIT J GEN PRACT, V40, P56; Friedman N M, 1998, Eff Clin Pract, V1, P5; Greineder DK, 1999, J ALLERGY CLIN IMMUN, V103, P436, DOI 10.1016/S0091-6749(99)70468-9; Hanlon JT, 1996, AM J MED, V100, P428, DOI 10.1016/S0002-9343(97)89519-8; HJORTDAHL P, 1992, BRIT MED J, V304, P1287, DOI 10.1136/bmj.304.6837.1287; Jolly K, 1999, BMJ-BRIT MED J, V318, P706; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; KOTTKE TE, 1993, MAYO CLIN PROC, V68, P785, DOI 10.1016/S0025-6196(12)60638-7; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403; Maisiak R, 1996, ARTHRITIS RHEUM-US, V39, P1391, DOI 10.1002/art.1780390818; McCulloch D K, 1998, Eff Clin Pract, V1, P12; MCCULLOCH DK, 1994, DIABETES CARE, V17, P765, DOI 10.2337/diacare.17.7.765; Navarro AM, 1998, AM J PREV MED, V15, P32, DOI 10.1016/S0749-3797(98)00023-3; NOLAN T, 1987, LANCET, V2, P411; PACALA JT, 1995, J AM GERIATR SOC, V43, P538, DOI 10.1111/j.1532-5415.1995.tb06102.x; Payne T H, 1995, HMO Pract, V9, P101; PEARSON P, 1994, BRIT MED J, V309, P1387, DOI 10.1136/bmj.309.6966.1387; Pritchard P, 1995, SHARED CARE FUTURE I; Retchin SM, 1997, JAMA-J AM MED ASSOC, V278, P119; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Starfield B., 1992, PRIMARY CARE CONCEPT; Taplin S, 1998, J Am Board Fam Pract, V11, P116; THORN PA, 1973, BRIT MED J, V2, P534, DOI 10.1136/bmj.2.5865.534; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner E H, 1998, Eff Clin Pract, V1, P2; WAGNER EH, 1995, PATIENT EDUC COUNS, V26, P225, DOI 10.1016/0738-3991(95)00761-N; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WAGNER EH, 1997, MANAGE CARE Q, P56; Wanger EH, 1998, ANN INTERN MED, V129, P654, DOI 10.7326/0003-4819-129-8-199810150-00015; WASSON J, 1992, JAMA-J AM MED ASSOC, V267, P1828; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; WEINBERGER M, 1993, J AM GERIATR SOC, V41, P153, DOI 10.1111/j.1532-5415.1993.tb02050.x; WITMER A, 1995, AM J PUBLIC HEALTH, V85, P1055, DOI 10.2105/AJPH.85.8_Pt_1.1055	48	617	627	0	45	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2000	320	7234					569	572		10.1136/bmj.320.7234.569	http://dx.doi.org/10.1136/bmj.320.7234.569			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	289LV	10688568	Green Published			2022-12-28	WOS:000085624000029
J	Windsor, R				Windsor, R			Facing the challenges of long term care	BRITISH MEDICAL JOURNAL			English	Editorial Material									Caring Matters, London, England		Windsor, R (corresponding author), Caring Matters, London, England.								0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					589	589		10.1136/bmj.320.7234.589	http://dx.doi.org/10.1136/bmj.320.7234.589			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688584	Green Published			2022-12-28	WOS:000085624000058
J	Cutfield, WS; Wilton, P; Bennmarker, H; Albertsson-Wikland, K; Chatelain, P; Ranke, MB; Price, DA				Cutfield, WS; Wilton, P; Bennmarker, H; Albertsson-Wikland, K; Chatelain, P; Ranke, MB; Price, DA			Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment	LANCET			English	Article							RISING INCIDENCE; INSULIN; IDDM	Background Growth hormone (GH) contributes to insulin resistance, but whether children treated with GH are at increased risk of diabetes has not been established. We undertook a retrospective analysis of data from an international pharmacoepidemiological survey of children treated with GH to find out the incidence of impaired glucose tolerance and types 1 and 2 diabetes mellitus. Methods Reports to the survey of abnormal glucose metabolism were investigated and classified. The incidence and age-distribution of type 1 diabetes were compared with values from a model of reference data. The incidence of type 2 diabetes was compared with data from two reports of children not treated with GH. Findings 85 (0.36%) of 23 333 children were reported with abnormal glucose metabolism. After investigation, 43 had confirmed glucose disorders (11 with type 1 diabetes, 18 with type 2 diabetes, and 14 with impaired glucose tolerance). The incidence and age at diagnosis of type 1 diabetes in children treated with GH did not differ from expected values. The incidence of type 2 diabetes was 34.4 cases per 100 000 years of GH treatment which was six-fold higher than reported in children not treated with GH. Type 2 diabetes did not resolve after GH therapy was stopped. Interpretation GH treatment did not affect the incidence of type 1 diabetes mellitus in any age group. We postulate that the higher than expected incidence of type 2 diabetes mellitus with GH treatment may be an acceleration of the disorder in predisposed individuals.	Univ Auckland, Dept Paediat, Auckland, New Zealand; Pharmacia & Upjohn Inc, Stockholm, Sweden; East Hosp, Dept Paediat, Gothenburg, Sweden; Univ Lyon 1, Serv Pediat Endocrinol & Diabetol Infantiles, Hop Debrousse, F-69365 Lyon, France; Univ Tubingen, Childrens Hosp, Tubingen, Germany; St Marys Hosp, Dept Paediat, Manchester M13 0JH, Lancs, England	University of Auckland; Pfizer; Pharmacia Corporation; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Manchester	Cutfield, WS (corresponding author), Univ Auckland, Dept Paediat, Private Bag 92019, Auckland, New Zealand.	waynec@ahsl.co.nz	Albertsson-Wikland, Kerstin/D-3843-2012					AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402; Blethen SL, 1996, J CLIN ENDOCR METAB, V81, P1704, DOI 10.1210/jc.81.5.1704; BOUGNERES PF, 1990, ACTA PAEDIATR SCAND, P38; CAPRIO S, 1992, HORM RES, V38, P47, DOI 10.1159/000182594; CUTFIELD WS, 1990, J CLIN ENDOCR METAB, V70, P1644, DOI 10.1210/jcem-70-6-1644; CZERNICHOW P, 1993, HORM RES, V39, P102; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; Gavin JR, 1997, DIABETES CARE, V20, P1183; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402; JADRESIC A, 1982, Q J MED, V51, P189; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; KITAGAWA T, 1994, DIABETES RES CLIN PR, V24, pS7, DOI 10.1016/0168-8227(94)90221-6; Neu A, 1997, DIABETES CARE, V20, P530, DOI 10.2337/diacare.20.4.530; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Rangasami JJ, 1997, ARCH DIS CHILD, V77, P210, DOI 10.1136/adc.77.3.210; REWERS M, 1988, World Health Statistics Quarterly, V41, P179; SHIZUME K, 1984, ENDOCRINOL JAPON, V31, P201; Smith TR, 1997, AM J PHYSIOL-ENDOC M, V272, pE1071, DOI 10.1152/ajpendo.1997.272.6.E1071; VERGE CF, 1994, DIABETES CARE, V17, P693, DOI 10.2337/diacare.17.7.693; WASS JAH, 1980, CLIN ENDOCRINOL, V12, P53, DOI 10.1111/j.1365-2265.1980.tb03132.x	22	211	220	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					610	613		10.1016/S0140-6736(99)04055-6	http://dx.doi.org/10.1016/S0140-6736(99)04055-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696981				2022-12-28	WOS:000085615400012
J	Grosman, C; Zhou, M; Auerbach, A				Grosman, C; Zhou, M; Auerbach, A			Mapping the conformational wave of acetylcholine receptor channel gating	NATURE			English	Article							FREE-ENERGY RELATIONSHIPS; ENGINEERED PROTEINS; MECHANISM; VOLTAGE; ENZYME	Allosteric transitions allow fast regulation of protein function in living systems. Even though the end points of such conformational changes are known for many proteins, the characteristics of the paths connecting these states remain largely unexplored. Rate-equilibrium linear free-energy relationships (LFERs) provide information about such pathways by relating changes in the free energy of the transition state to those of the ground states upon systematic perturbation of the system(1). Here we present an LFER analysis of the gating reaction pathway of the muscle acetylcholine receptor. We studied the closed reversible arrow open conformational change at the single-molecule level following perturbation by series of single-site mutations, agonists and membrane voltages. This method provided a snapshot of several regions of the receptor at the transition state in terms of their approximate positions along the reaction coordinate, on a scale from 0 (closed-like) to 1 (open-like). The resulting map reveals a spatial gradient of positional values, which suggests that the conformational change proceeds in a wave-like manner, with the low-to-high affinity change at the transmitter-binding sites preceding the complete opening of the pore.	SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Grosman, C (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall, Buffalo, NY 14214 USA.			Grosman, Claudio/0000-0001-8093-8362				Akk G, 1999, BIOPHYS J, V76, P207, DOI 10.1016/S0006-3495(99)77190-0; Akk G, 1996, J PHYSIOL-LONDON, V496, P185, DOI 10.1113/jphysiol.1996.sp021676; Auerbach A, 1996, J PHYSIOL-LONDON, V494, P155, DOI 10.1113/jphysiol.1996.sp021482; EATON WA, 1991, P NATL ACAD SCI USA, V88, P4472, DOI 10.1073/pnas.88.10.4472; Edelstein SJ, 1996, BIOL CYBERN, V75, P361, DOI 10.1007/s004220050302; ESTELL DA, 1986, SCIENCE, V233, P659, DOI 10.1126/science.233.4764.659; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; FERSHT AR, 1986, NATURE, V322, P284, DOI 10.1038/322284a0; FERSHT AR, 1995, CURR OPIN STRUC BIOL, V5, P79, DOI 10.1016/0959-440X(95)80012-P; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hammett L. P., 1972, ADV LINEAR FREE ENER, pvii; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; JACKSON MB, 1984, P NATL ACAD SCI-BIOL, V81, P3901, DOI 10.1073/pnas.81.12.3901; JAFFE HH, 1953, CHEM REV, V53, P191, DOI 10.1021/cr60165a003; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kirsch JF., 1972, ADV LINEAR FREE ENER, P369, DOI [10.1007/978-1-4615-8660-9_8, DOI 10.1007/978-1-4615-8660-9_8]; KYTE J, 1995, MECHANISM PROTEIN CH, P461; LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340; Leffler JE., 1989, RATES EQUILIBRIA ORG; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Onuchic JN, 1996, FOLD DES, V1, P441, DOI 10.1016/S1359-0278(96)00060-0; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Salamone FN, 1999, J PHYSIOL-LONDON, V516, P315, DOI 10.1111/j.1469-7793.1999.0315v.x; STRAUB JE, 1990, PROTEIN ENG, V3, P673, DOI 10.1093/protein/3.8.673; Sunderman ER, 1999, J GEN PHYSIOL, V113, P621, DOI 10.1085/jgp.113.5.621; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326; Yifrach O, 1998, J AM CHEM SOC, V120, P13262, DOI 10.1021/ja983136u; Zhou M, 1999, P NATL ACAD SCI USA, V96, P10466, DOI 10.1073/pnas.96.18.10466	31	280	282	1	16	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					773	776		10.1038/35001586	http://dx.doi.org/10.1038/35001586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693806				2022-12-28	WOS:000085423100053
J	Jones, G				Jones, G			Total internal reflection - The secret of the accidental immortals can now be made known.	NATURE			English	Editorial Material																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					707	707		10.1038/35001682	http://dx.doi.org/10.1038/35001682			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693780	Bronze			2022-12-28	WOS:000085423100027
J	Jacobson, PD; Pomfret, SD				Jacobson, PD; Pomfret, SD			ERISA litigation and physician autonomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE	The Employee Retirement Income Security Act (ERISA), enacted in 1974 to regulate pension and health benefit plans, is a complex statute that dominates the managed care environment. Physicians must understand ERISA's role in the relationship between themselves and managed care organizations (MCOs), including how it can influence clinical decision making and physician autonomy. This article describes ERISA's central provisions and how ERISA influences health care delivery in MCOs, We analyze ERISA litigation trends in 4 areas: professional liability, utilization management, state legislative initiatives, and compensation arrangements. This analysis demonstrates how courts have interpreted ERISA to limit physician autonomy and subordinate clinical decision making to MCOs' cost containment decisions. Physicians should support efforts to amend ERISA, thus allowing greater state regulatory oversight of MCOs and permitting courts to hold MCOs accountable for their role in medical decision making.	Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; Ropes & Gray, Boston, MA USA	University of Michigan System; University of Michigan	Jacobson, PD (corresponding author), Univ Michigan, Sch Publ Hlth, 109 Observ, Ann Arbor, MI 48109 USA.							CHIRBAMARTIN MA, 1994, HEALTH AFFAIR, V13, P142, DOI 10.1377/hlthaff.13.2.142; FREUDENHEIM M, 1999, NY TIMES        1109, pA1; GOSTIN LO, 1993, JAMA-J AM MED ASSOC, V269, P2527; HALL MA, 1988, U PENN LAW REV, V137, P431, DOI 10.2307/3312252; Jacobson PD, 1999, HEALTH AFFAIR, V18, P69, DOI 10.1377/hlthaff.18.4.69; JACOBSON PD, 1998, HOUSTON LAW REV, V35, P985; JORDAN KA, 1996, YALE J REGUL, V13, P255; LIGHT D, 1988, MILBANK Q, V66, P10, DOI 10.2307/3349912; Mariner WK, 1996, NEW ENGL J MED, V335, P1986, DOI 10.1056/NEJM199612263352610; MORREIM EH, 1998, U TENNESSEE LAW REV, V65, P511; PORNFRET SD, 1998, TORT INSUR LAW J, V34, P131	11	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2000	283	7					921	926		10.1001/jama.283.7.921	http://dx.doi.org/10.1001/jama.283.7.921			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	281WT	10685718				2022-12-28	WOS:000085185000032
J	Mermel, LA				Mermel, LA			Prevention of intravascular catheter-related infections	ANNALS OF INTERNAL MEDICINE			English	Review							CENTRAL VENOUS CATHETERS; BLOOD-STREAM INFECTIONS; PROSPECTIVE RANDOMIZED MULTICENTER; PULMONARY-ARTERY CATHETERS; INTRAVENOUS-ACCESS SYSTEM; SILVER-IMPREGNATED CUFF; CARE-UNIT PATIENTS; STAPHYLOCOCCUS-AUREUS; CONTROLLED TRIAL; BACTERIAL-COLONIZATION	Purpose: To review the literature on prevention of intravascular catheter-related infections. Data Sources: The MEDLINE database, conference proceedings, and bibliographies of review articles and book chapters were searched for relevant articles. Primary authors were contacted directly if data were incomplete. Study Selection: Studies met the following criteria unless otherwise stated: Trials were prospective and randomized; catheters were inserted into new sites, not into old sites over guidewires; catheter cultures were done by using semi-quantitative or quantitative methods; and, for prospective studies, catheter-related bloodstream infection was confirmed by microbial growth from percutaneously drawn blood cultures that matched catheter cultures. Data Extraction: Data on population, methods, preventive strategy, and outcome (measured as catheter-related bloodstream infections) were gathered. The quality of the data was graded by using preestablished criteria. Data Synthesis: The recommended preventive strategies with the strongest supportive evidence are full barrier precautions during central venous catheter insertion; subcutaneous tunneling short-term catheters inserted in the internal jugular or femoral veins when catheters are not used for drawing blood; contamination shields for pulmonary artery catheters; povidone-iodine ointment applied to insertion sites of hemodialysis catheters; specialized nursing teams caring for patients with short-term peripheral venous catheters, especially at institutions with a high incidence of catheter-related infection; no routine replacement of central venous catheters; antiseptic chamber-filled hub or hub-protective antiseptic sponge for central venous catheters; and use of chlorhexidine-silver sulfadiazine-im impregnated or minocycline-rifampin-impregnated short-term central venous catheters if the rate of infection is high despite adherence to other strategies that do not incorporate antimicrobial agents (for example, maximal barrier precautions). Conclusions: Simple interventions can reduce the risk for serious catheter-related infection. Adequately powered randomized trials are needed.	Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA; Brown Univ, Sch Med, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Mermel, LA (corresponding author), Rhode Isl Hosp, Div Infect Dis, 593 Eddy St, Providence, RI 02903 USA.	lmermel@lifespan.org	Mermel, Leonard/Z-1475-2019					Appelgren P, 1996, CRIT CARE MED, V24, P1482, DOI 10.1097/00003246-199609000-00009; Arduino MJ, 1997, AM J INFECT CONTROL, V25, P377, DOI 10.1016/S0196-6553(97)90081-X; Arepally G, 1998, CLIN REV ALLERG IMMU, V16, P237, DOI 10.1007/BF02737634; ARMSTRONG P, 1998, J HOSP INFECT SA, V40; ARNOW PM, 1993, CLIN INFECT DIS, V16, P778, DOI 10.1093/clind/16.6.778; Bach A, 1996, J ANTIMICROB CHEMOTH, V37, P315, DOI 10.1093/jac/37.2.315; BERN MM, 1990, ANN INTERN MED, V112, P423, DOI 10.7326/0003-4819-76-3-112-6-423; BOIDIN R, 1999, 9 ANN SCI M SOC HEAL, P50; BONAWITZ SC, 1991, AM SURGEON, V57, P618; Boraks P, 1998, BRIT J HAEMATOL, V101, P483, DOI 10.1046/j.1365-2141.1998.00732.x; BOYCE JM, 1999, 9 ANN SCI M SOC HEAL, P34; BRENNAN PJ, 1997, INFECT CONTROL HOS 2, V18, P20; Brown JD, 1997, J HOSP INFECT, V36, P181, DOI 10.1016/S0195-6701(97)90193-6; BYERS K, 1995, INFECT CONT HOSP E S, V16, P23; Casewell MW, 1998, J HOSP INFECT, V40, pS3, DOI 10.1016/S0195-6701(98)90199-2; Chang FY, 1998, INFECT CONT HOSP EP, V19, P328; CLEMENCE MA, 1995, AM J INFECT CONTROL, V23, P5, DOI 10.1016/0196-6553(95)90002-0; CLEMENTI E, 1991, 31 INT C ANT AG CHEM, P460; Cohen Y, 1998, AM J RESP CRIT CARE, V157, P284, DOI 10.1164/ajrccm.157.1.97-03067; COLLIGNON PJ, 1994, MED J AUSTRALIA, V161, P374, DOI 10.5694/j.1326-5377.1994.tb127491.x; Collin GR, 1999, CHEST, V115, P1632, DOI 10.1378/chest.115.6.1632; CONLY JM, 1989, J INFECT DIS, V159, P310, DOI 10.1093/infdis/159.2.310; Cook D, 1997, CRIT CARE MED, V25, P1417, DOI 10.1097/00003246-199708000-00033; Cookson ST, 1998, INFECT CONT HOSP EP, V19, P23; DAHLBERG PJ, 1995, INFECT CONT HOSP EP, V16, P506; DANZIG LE, 1995, JAMA-J AM MED ASSOC, V273, P1862, DOI 10.1001/jama.273.23.1862; Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DeMuri GP, 1996, J INFECT DIS, V174, P127, DOI 10.1093/infdis/174.1.127; Do AN, 1999, J INFECT DIS, V179, P442, DOI 10.1086/314592; DOSCANO CM, 1999, 9 ANN SCI M SOC HEAL, P49; DUTHOIT D, 1993, 33 INT C ANT AG CHEM, P1627; EGGIMANN P, 1999, 9 ANN SCI M SOC HEAL, P73; ELLIOTT TSJ, 1989, J HOSP INFECT, V14, P193, DOI 10.1016/0195-6701(89)90035-2; ENA J, 1992, INFECT CONT HOSP EP, V13, P15, DOI 10.2307/30146963; FALCHUK KH, 1985, NEW ENGL J MED, V312, P78, DOI 10.1056/NEJM198501103120203; FLOWERS RH, 1989, JAMA-J AM MED ASSOC, V261, P878, DOI 10.1001/jama.261.6.878; Fridkin SK, 1996, INFECT CONT HOSP EP, V17, P150; George SJ, 1997, EUR J ANAESTH, V14, P428, DOI 10.1046/j.1365-2346.1997.00168.x; Goetz AM, 1998, INFECT CONT HOSP EP, V19, P842; Goldschmidt H, 1995, ZBL BAKT-INT J MED M, V283, P215; GROEGER JS, 1993, ANN SURG, V218, P206, DOI 10.1097/00000658-199308000-00014; GROSS PA, 1994, CLIN INFECT DIS, V18, P421, DOI 10.1093/clinids/18.3.421; HALPIN DP, 1991, NUTRITION, V7, P33; HAMORY BH, 1984, 84 ANN M AM SOC MICR, P307; Hannan M, 1996, CLIN INTENSIVE CARE, V7, P56; Heard SO, 1998, ARCH INTERN MED, V158, P81, DOI 10.1001/archinte.158.1.81; HEISELMAN D, 1994, JAMA-J AM MED ASSOC, V272, P1819, DOI 10.1001/jama.272.23.1819; Hemmerlein JB, 1997, RADIOLOGY, V204, P363, DOI 10.1148/radiology.204.2.9240521; HERRMANN M, 1991, INFECT IMMUN, V59, P279, DOI 10.1128/IAI.59.1.279-288.1991; HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; HOFFMANN KK, 1992, JAMA-J AM MED ASSOC, V267, P2072, DOI 10.1001/jama.267.15.2072; HUMAR A, 1997, 37 INT C ANT AG CHEM, P302; JANSEN B, 1997, CATHETER RELATED INF, P41; Jarvis WR, 1998, AM J INFECT CONTROL, V26, P522; Kellerman S, 1996, J PEDIATR-US, V129, P711, DOI 10.1016/S0022-3476(96)70154-3; KONNER K, 1995, NEPHROL DIAL TRANSPL, V10, P1988; LEDERLE FA, 1992, ANN INTERN MED, V116, P737, DOI 10.7326/0003-4819-116-9-737; LEVIN A, 1991, KIDNEY INT, V40, P934, DOI 10.1038/ki.1991.297; Little JR, 1999, AM J MED, V107, P119, DOI 10.1016/S0002-9343(99)00197-7; LIU WK, 1993, J INFECTION, V27, P261, DOI 10.1016/0163-4453(93)92068-8; Ljungman P, 1997, SUPPORT CARE CANCER, V5, P485, DOI 10.1007/s005200050117; Logghe C, 1997, J HOSP INFECT, V37, P145, DOI 10.1016/S0195-6701(97)90184-5; Luebke MA, 1998, AM J INFECT CONTROL, V26, P437, DOI 10.1016/S0196-6553(98)70042-2; Maas A, 1998, J HOSP INFECT, V40, P211, DOI 10.1016/S0195-6701(98)90139-6; MAKI D, 1994, 34 INT C ANT AG CHEM, P195; MAKI DG, 1991, LANCET, V338, P339, DOI 10.1016/0140-6736(91)90479-9; MAKI DG, 1994, CRIT CARE MED, V22, P1729; MAKI DG, 1981, AM J MED, V70, P739, DOI 10.1016/0002-9343(81)90605-7; MAKI DG, 1988, AM J MED, V85, P307, DOI 10.1016/0002-9343(88)90579-7; Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001; MAKI DG, 1997, INFECT CONTROL HO S2, V18, P51; MAKI DG, 1986, 26 INT C ANT AG CHEM, P1041; MAKI DG, 1996, 36 INT C ANT AG CHEM, P230; MAKI DG, 1984, 24 INT C ANT AG CHEM, P230; MAKI DG, 1998, HOSP INFECT, P689; McDonald LC, 1998, INFECT CONT HOSP EP, V19, P772; MCKEE R, 1985, J HOSP INFECT, V6, P419, DOI 10.1016/0195-6701(85)90059-3; Mendelson MH, 1998, INFECT CONT HOSP EP, V19, P401; Mermel L, 1998, CRIT CARE MED, V26, P1315, DOI 10.1097/00003246-199808000-00011; MERMEL LA, 1991, AM J MED, V91, pS197, DOI 10.1016/0002-9343(91)90369-9; MERMEL LA, 1993, J INFECT DIS, V167, P920, DOI 10.1093/infdis/167.4.920; Mimoz O, 1996, CRIT CARE MED, V24, P1818, DOI 10.1097/00003246-199611000-00010; Nguyen MH, 1999, ANN INTERN MED, V130, P221, DOI 10.7326/0003-4819-130-3-199902020-00026; Nilsson M, 1998, INFECT IMMUN, V66, P2666, DOI 10.1128/IAI.66.6.2666-2673.1998; Oda T, 1997, ANESTHESIOLOGY, V87, P1242, DOI 10.1097/00000542-199711000-00031; PARENTI CM, 1994, ARCH INTERN MED, V154, P1829, DOI 10.1001/archinte.154.16.1829; Pearson ML, 1996, INFECT CONT HOSP EP, V17, P438; PELLIZZER G, 1995, 35 INT C ANT AG CHEM, P26; Pemberton LB, 1996, ARCH SURG-CHICAGO, V131, P986; PINHEIRO SM, 1997, AM J INFECT CONTROL, V25, P148; PITTET D, 1992, 32 INT C ANT AG CHEM, P411; Raad I, 1996, J INFECT DIS, V173, P495, DOI 10.1093/infdis/173.2.495; RAAD II, 1994, JAMA-J AM MED ASSOC, V271, P1014, DOI 10.1001/jama.271.13.1014; RAAD II, 1994, INFECT CONT HOSP EP, V15, P231; RADD I, 1993, J INFECT DIS, V168, P400, DOI 10.1093/infdis/168.2.400; Ramsay J, 1994, CRIT CARE MED, V22, pA115; Randolph AG, 1998, CHEST, V113, P165, DOI 10.1378/chest.113.1.165; Randolph AG, 1998, CRIT CARE MED, V26, P1452, DOI 10.1097/00003246-199808000-00038; Rao SP, 1997, PERITON DIALYSIS INT, V17, P410; Riu S, 1998, NEPHROL DIAL TRANSPL, V13, P1870, DOI 10.1093/ndt/13.7.1870; ROBINSON JF, 1995, ARCH INTERN MED, V155, P1225, DOI 10.1001/archinte.155.11.1225; Ruschman K L, 1993, J Intraven Nurs, V16, P304; SALZMAN MB, 1993, J CLIN MICROBIOL, V31, P475, DOI 10.1128/JCM.31.3.475-479.1993; SAMPATH L, 1999, 39 INT C ANT AG CHEM; Segura M, 1996, ANN SURG, V223, P363, DOI 10.1097/00000658-199604000-00004; Sesso R, 1998, J AM SOC NEPHROL, V9, P1085; SHEEHAN G, 1993, 33 INT C ANT AG CHEM, P1616; SHERETZ RJ, 1998, 8 ANN SCI M SOC HEAL, P252; Sieradzki K, 1998, LANCET, V351, P880, DOI 10.1016/S0140-6736(05)70291-9; Sieradzki K, 1999, NEW ENGL J MED, V340, P517, DOI 10.1056/NEJM199902183400704; Smith TL, 1999, NEW ENGL J MED, V340, P493, DOI 10.1056/NEJM199902183400701; Soifer NE, 1998, ARCH INTERN MED, V158, P473, DOI 10.1001/archinte.158.5.473; SPAFFORD PS, 1994, J PEDIATR-US, V125, P259, DOI 10.1016/S0022-3476(94)70208-X; STRAND CL, 1993, JAMA-J AM MED ASSOC, V269, P1004, DOI 10.1001/jama.269.8.1004; Sun Q, 1997, INFECT IMMUN, V65, P537, DOI 10.1128/IAI.65.2.537-543.1997; TABONE E, 1991, BIOMATERIALS, V12, P741, DOI 10.1016/0142-9612(91)90023-4; Tattawasart U, 1999, J HOSP INFECT, V42, P219, DOI 10.1053/jhin.1999.0591; Timsit JF, 1998, CHEST, V114, P207, DOI 10.1378/chest.114.1.207; Timsit JF, 1999, ANN INTERN MED, V130, P729, DOI 10.7326/0003-4819-130-9-199905040-00004; Timsit JF, 1996, JAMA-J AM MED ASSOC, V276, P1416, DOI 10.1001/jama.276.17.1416; TROTTIER SJ, 1995, CRIT CARE MED, V23, P52, DOI 10.1097/00003246-199501000-00011; vanHeerden PV, 1996, ANAESTH INTENS CARE, V24, P330, DOI 10.1177/0310057X9602400305; VASSALLO D, 1995, 35 INT C ANT AG CHEM, P259; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V281, P261, DOI 10.1001/jama.281.3.261; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V282, P554, DOI 10.1001/jama.282.6.554; VIALE P, 1998, J HOSP INFECT SA, V40; WEIST K, 1997, INFECT CONT HOSP EP, V18, P24; ZAKRZEWSKABODE A, 1995, J HOSP INFECT, V31, P189, DOI 10.1016/0195-6701(95)90065-9; Ziebuhr W, 1997, INFECT IMMUN, V65, P890, DOI 10.1128/IAI.65.3.890-896.1997; 1994, MMWR MORB MORTAL WKL, V44, P1; 1997, MMWR MORB MORTAL WKL, V46, P626	133	695	728	2	78	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2000	132	5					391	402		10.7326/0003-4819-132-5-200003070-00009	http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00009			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KY	10691590				2022-12-28	WOS:000085563000008
J	De Cock, KM; Fowler, MG; Mercier, E; de Vincenzi, I; Saba, J; Hoff, E; Alnwick, DJ; Rogers, M; Shaffer, N				De Cock, KM; Fowler, MG; Mercier, E; de Vincenzi, I; Saba, J; Hoff, E; Alnwick, DJ; Rogers, M; Shaffer, N			Prevention of mother-to-child HIV transmission in resource-poor countries - Translating research into policy and practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERINATAL TRANSMISSION; PREGNANT-WOMEN; CLINICAL-TRIAL; COTE-DIVOIRE; INFANT; TYPE-1; INFECTION; ABIDJAN; AFRICA	Each year, an estimated 590 000 infants acquire human immunodeficiency virus type 1 (HIV) infection from their mothers, mostly in developing countries that are unable to implement interventions now standard in the industrialized world. In resource-poor settings, the HIV pandemic has eroded hard-won gains in infant and child survival. Recent clinical trial results from international settings suggest that short-course antiretroviral regimens could significantly reduce perinatal HIV transmission worldwide if research findings could be translated into practice. This article reviews current knowledge of mother-to-child HIV transmission in developing countries, summarizes key findings from the trials, outlines future research requirements, and describes public health challenges of implementing perinatal HIV prevention interventions in resource-poor settings, Public health efforts must also emphasize primary prevention strategies to reduce incident HIV infections among adolescents and women of childbearing age. Successful implementation of available perinatal HIV interventions could substantially improve global child survival.	Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; UN Childrens Fund, Programme Div, New York, NY USA; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; WHO, Dept Policy Strategy & Res, Joint UN Programme HIV AIDS, CH-1211 Geneva, Switzerland	Centers for Disease Control & Prevention - USA; World Health Organization; World Health Organization	De Cock, KM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, CDC MS D-21,1600 Clifton Rd, Atlanta, GA 30333 USA.							Ammann AJ, 1996, NAT MED, V2, P490, DOI 10.1038/nm0596-490a; [Anonymous], 1998, Wkly Epidemiol Rec, V73, P313; Beckerman KP, 1999, NEW ENGL J MED, V341, P205; Bertolli J, 1996, J INFECT DIS, V174, P722, DOI 10.1093/infdis/174.4.722; Biggar RJ, 1996, LANCET, V347, P1647, DOI 10.1016/S0140-6736(96)91486-5; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; DECOCK KM, 1997, INT AIDS SOC NEWSLET, V8, P9; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; Ekpini ER, 1997, LANCET, V349, P1054, DOI 10.1016/S0140-6736(96)06444-6; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Graham WJ, 1999, LANCET, V353, P836, DOI 10.1016/S0140-6736(98)12374-7; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; *I MED, 1999, RED ODDS PREV PER TR; *JOINT UN PROGR HI, 1999, PREVENT HIV INFECT; *JOINT UN PROGR HI, 1997, HIV INF FEED POL STA; Kaplan JE, 1996, AM J TROP MED HYG, V55, P1; Landesman SH, 1996, NEW ENGL J MED, V334, P1617, DOI 10.1056/NEJM199606203342501; Leroy V, 1998, LANCET, V352, P597, DOI 10.1016/S0140-6736(98)01419-6; Lindegren ML, 1999, JAMA-J AM MED ASSOC, V282, P531, DOI 10.1001/jama.282.6.531; Lorenzi P, 1998, AIDS, V12, pF241, DOI 10.1097/00002030-199818000-00002; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Mbidde EK, 1998, NEW ENGL J MED, V338, P837; Minkoff H, 1998, JAMA-J AM MED ASSOC, V279, P1743, DOI 10.1001/jama.279.21.1743; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Mirochnick M, 1998, J INFECT DIS, V178, P368, DOI 10.1086/515641; Mock PA, 1999, AIDS, V13, P407, DOI 10.1097/00002030-199902250-00014; Mofenson LM, 1997, OBSTET GYN CLIN N AM, V24, P759, DOI 10.1016/S0889-8545(05)70343-0; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Msellati P, 1998, AIDS, V12, P1257, DOI 10.1097/00002030-199810000-00026; Musoke P, 1999, AIDS, V13, P479, DOI 10.1097/00002030-199903110-00006; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; NEWELL ML, 1992, LANCET, V339, P1007; Newell ML, 1998, AIDS, V12, P1571, DOI 10.1097/00002030-199813000-00003; NICOLL A, 1995, AIDS, V9, P107, DOI 10.1097/00002030-199509020-00001; SABA J, 1999, 2 C GLOB STRAT PREV; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Shaffer N, 1999, J INFECT DIS, V179, P590, DOI 10.1086/314641; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; SIMONON A, 1994, J ACQ IMMUN DEF SYND, V7, P952; SMITH M, 1999, 2 C GLOB STRAT PREV; Taha TE, 1997, BRIT MED J, V315, P216, DOI 10.1136/bmj.315.7102.216; *UNAIDS, 2000, GLOB HIV AIDS EP JUN; *UNAIDS, 2000, AIDS EP UPD DEC 1998; *US BUR CENS, 1999, REC HIV SER LEV COUN; VANDEPERRE P, 1991, NEW ENGL J MED, V325, P593, DOI 10.1056/NEJM199108293250901; Varmus H, 1997, NEW ENGL J MED, V337, P1003, DOI 10.1056/NEJM199710023371411; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001; *WHO, 1998, HIV INF FEED GUID DE; Wiktor S Z, 1997, AIDS, V11 Suppl B, pS79; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9	56	689	704	1	46	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1175	1182		10.1001/jama.283.9.1175	http://dx.doi.org/10.1001/jama.283.9.1175			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703780				2022-12-28	WOS:000085424100027
J	Henney, JE				Henney, JE			New drug for refractory cutaneous T-cell lymphoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	32	32	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1131	1131		10.1001/jama.283.9.1131	http://dx.doi.org/10.1001/jama.283.9.1131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703765				2022-12-28	WOS:000085424100005
J	Greenhalgh, T; Herxheimer, X; Isaacs, AJ; Beaman, M; Morris, J; Farrow, S				Greenhalgh, T; Herxheimer, X; Isaacs, AJ; Beaman, M; Morris, J; Farrow, S			Commercial partnerships in chronic disease management: proceeding with caution	BRITISH MEDICAL JOURNAL			English	Article									UCL, Sch Med, Dept Primary Care & Populat Sci, London N19 3UA, England; Barnet Hlth Author, Clin Effectiveness Rev Grp, London NW9, England	University of London; University College London; UCL Medical School	Greenhalgh, T (corresponding author), UCL, Sch Med, Dept Primary Care & Populat Sci, London N19 3UA, England.	p.greenhalgh@ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				Fairfield G, 1997, BRIT MED J, V314, P1895, DOI 10.1136/bmj.314.7098.1895; *NHS, 1994, 9494 EL NHS DEP HLTH; PRINGLE M, 1987, BRIT MED J, V295, P738, DOI 10.1136/bmj.295.6601.738; *ROYAL SOC, 1995, PEER REV ASS REC DEV, P1; 1999, CLIN EVIDENCE, P73	5	13	13	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					566	568		10.1136/bmj.320.7234.566	http://dx.doi.org/10.1136/bmj.320.7234.566			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688567	Green Published			2022-12-28	WOS:000085624000028
J	Hatzakis, A; Touloumi, G; Karanicolas, R; Karafoulidou, A; Mandalaki, T; Anastassopoulou, C; Zhang, L; Goedert, JJ; Ho, DD; Kostrikis, LG				Hatzakis, A; Touloumi, G; Karanicolas, R; Karafoulidou, A; Mandalaki, T; Anastassopoulou, C; Zhang, L; Goedert, JJ; Ho, DD; Kostrikis, LG			Effect of recent thymic emigrants on progression of HIV-1 disease	LANCET			English	Article							HEMOPHILIA COHORT; NATURAL-HISTORY; T-CELLS; INFECTION; CCR5; ALLELE; PLASMA; AIDS; GENE; SEROCONVERSION	Background The concentration of T-cell receptor-rearrangement excision DNA circles (TREC) in peripheral-blood T cells is a marker of recent thymic emigrant ap T cells. We studied the predictive ability of measurements of TREC for clinical outcome in HIV-1-infected individuals. Methods We measured TREC in peripheral-blood mononuclear cells with a real-time PCR assay. We studied 131 Greek participants in the Multicenter Hemophilia Cohort Study who had known HIV-1 seroconversion dates. The prognostic value of baseline TREC, CD4 T-cell count, and HIV-1 RNA concentration was assessed by Kaplan-Meier and Cox's regression analysis. Findings Four participants had progressed to AIDS by first blood sampling. Among the remaining 127 individuals, the median value of TREC per 10(6) cells was 6900 (IQR 2370-15 604). Baseline TREC values were lower in the 53 who progressed to AIDS than in those who did not (geometric mean 2843 [95% CI 1468-5504] vs 6560 [4723-9113] per 10(6) cells; p=0.017). The relative hazard of AIDS, adjusted for plasma viral load, CD4 T-cell count, and age at seroconversion was 1.44 (95% CI 1.04-2.01; p=0.031) per ten-fold increase in TREC; that for death was 1.52 (1.12-2.06; p=0.007). The adjusted relative hazards of death were 2.91 (1.91-4.44; p<0.001) per ten-fold increase in plasma HIV-1 RNA load and 1.20 (1.04-1.38; p=0.014) per 100-cell decrease in CD4 T-cell count. Interpretation The concentration of TREC in the peripheral T-cell pool complements HIV-1 RNA load and CD4 T-cell count in predicting the rate of HIV-1 disease progression. Recent thymic emigrants have a role in the pathogenesis of HIV-1 disease.	Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; Laikon Gen Hosp, Hemophilia Ctr, Athens, Greece; NCI, Viral Epidemiol Branch, Rockville, MD USA	Rockefeller University; Athens Medical School; National & Kapodistrian University of Athens; Laiko General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kostrikis, LG (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 1st Ave, New York, NY 10016 USA.	Ikostrik@adarc.org	KOSTRIKIS, LEONDIOS G/A-5330-2016; Anastassopoulou, Cleo/AAO-8539-2020	KOSTRIKIS, LEONDIOS G/0000-0002-5340-7109; Anastassopoulou, Cleo/0000-0001-7666-9198	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043868, R01AI040387, P30AI042848] Funding Source: NIH RePORTER; NIAID NIH HHS [AI42848, R01 AI40387, R01 AI43868] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BONYHADI ML, 1993, NATURE, V363, P728, DOI 10.1038/363728a0; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; EYSTER ME, 1987, ANN INTERN MED, V107, P1, DOI 10.7326/0003-4819-107-1-1; FUJIMOTO S, 1987, NATURE, V327, P242, DOI 10.1038/327242a0; Haynes BF, 1998, IMMUNOL RES, V18, P175, DOI 10.1007/BF02788778; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kong FK, 1998, IMMUNITY, V8, P97, DOI 10.1016/S1074-7613(00)80462-8; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Kostrikis LG, 1998, NAT MED, V4, P350, DOI 10.1038/nm0398-350; Livak F, 1996, MOL CELL BIOL, V16, P609; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; McCune JM, 1998, J CLIN INVEST, V101, P2301, DOI 10.1172/JCI2834; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; OBrien TR, 1996, JAMA-J AM MED ASSOC, V276, P105, DOI 10.1001/jama.276.2.105; OKAZAKI K, 1987, CELL, V49, P477, DOI 10.1016/0092-8674(87)90450-8; Riddler SA, 1997, AIDS, V11, pS141; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Touloumi G, 1998, AIDS, V12, P1691, DOI 10.1097/00002030-199813000-00018; Touloumi G, 1998, J ACQ IMMUN DEF SYND, V19, P89, DOI 10.1097/00042560-199809010-00014; Tyagi S, 1996, NAT BIOTECHNOL, V14, P947, DOI 10.1038/nbt0896-947b; Vigano' A, 1999, AIDS, V13, pF29, DOI 10.1097/00002030-199904010-00001; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	28	83	87	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					599	604		10.1016/S0140-6736(99)10311-8	http://dx.doi.org/10.1016/S0140-6736(99)10311-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696979				2022-12-28	WOS:000085615400010
J	Wilkinson, RJ; Llewelyn, M; Toossi, Z; Patel, P; Pasvol, G; Lalvani, A; Wright, D; Latif, M; Davidson, RN				Wilkinson, RJ; Llewelyn, M; Toossi, Z; Patel, P; Pasvol, G; Lalvani, A; Wright, D; Latif, M; Davidson, RN			Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study	LANCET			English	Article							BONE-MINERAL DENSITY; START CODON POLYMORPHISM; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; GENE; SUSCEPTIBILITY; INTERFERON; WOMEN; SERUM; RISK	Background Susceptibility to disease after infection by Mycobacterium tuberculosis is influenced by environmental and host genetic factors. Vitamin D metabolism leads to activation of macrophages and restricts the intracellular growth of M tuberculosis. This effect may be influenced by polymorphisms at three sites in the Vitamin D receptor (VDR) gene. We investigated the interaction between serum vitamin D (25-hydroxycholecalciferol) concentrations and VDR genotype on susceptibility to tuberculosis. Methods This study was a hospital-based case-control analysis of Asians of Gujarati origin, a mainly vegetarian immigrant population with a high rate of tuberculosis. We typed three VDR polymorphisms (defined by the presence of restriction endonuclease sites for Taq1, Bsm1, and Fok1) in 91 of 126 untreated patients with tuberculosis and 116 healthy contacts who had been sensitised to tuberculosis. Serum 25-hydroxycholecalciferol was recorded in 42 contacts and 103 patients. Findings 25-hydroxycholecalciferol deficiency was associated with active tuberculosis (odds ratio 2.9 [95% CI 1.3-6.5], p=0.008), and undetectable serum 25-hydroxycholecalciferol (<7 nmol/L) carried a higher risk of tuberculosis (9.9 [1.3-76.2], p=0.009). Although there was no significant independent association between VDR genotype and tuberculosis, the combination of genotype TT/Tt and 25-hydroxycholecalciferol deficiency was associated with disease (2.8 [1.2-6.5]) and the presence of genotype ff or undetectable serum 25-hydroxycholecalciferol was strongly associated with disease (5.1[1.4-18.4]). Interpretation 25-hydroxycholecalciferol deficiency may contribute to the high occurrence of tuberculosis in this population. Polymorphisms in the VDR gene also contribute to susceptibility when considered in combination with 25 hydroxycholecalciferol deficiency.	Northwick Pk Hosp & Clin Res Ctr, Imperial Coll Sch Med, Wellcome Ctr Clin Trop Med, Harrow HA1 3UJ, Middx, England; Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	Imperial College London; Case Western Reserve University; University of Oxford	Davidson, RN (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Imperial Coll Sch Med, Wellcome Ctr Clin Trop Med, Harrow HA1 3UJ, Middx, England.	r.n.davidson@ic.ac.uk	Pasvol, Geoffrey/B-7113-2009; Llewelyn, Martin/Y-1472-2019; Llewelyn, Martin/A-7194-2011	Llewelyn, Martin/0000-0002-6811-1124; Lalvani, Ajit/0000-0002-2396-246X; Wilkinson, Robert/0000-0002-2753-1800				Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614; Cippitelli M, 1998, EUR J IMMUNOL, V28, P3017, DOI 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.3.CO;2-Y; Compston JE, 1998, BRIT MED J, V317, P1466, DOI 10.1136/bmj.317.7171.1466; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Cooper GS, 1996, J BONE MINER RES, V11, P1841; DAVIES PDO, 1987, TUBERCLE, V68, P261, DOI 10.1016/0041-3879(87)90066-3; DAVIES PDO, 1985, THORAX, V40, P187, DOI 10.1136/thx.40.3.187; DAVIS P, 1994, HEALTH POLICY, V29, P113, DOI 10.1016/0168-8510(94)90010-8; Douglas AS, 1996, THORAX, V51, P944, DOI 10.1136/thx.51.9.944; FINCH PJ, 1991, THORAX, V46, P1, DOI 10.1136/thx.46.1.1; GRANGE JM, 1985, TUBERCLE, V66, P187, DOI 10.1016/0041-3879(85)90035-2; Gross C, 1996, J BONE MINER RES, V11, P1850; Gross C, 1998, J BONE MINER RES, V13, P1691, DOI 10.1359/jbmr.1998.13.11.1691; Harris SS, 1997, J BONE MINER RES, V12, P1043, DOI 10.1359/jbmr.1997.12.7.1043; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Lawson M, 1999, BRIT MED J, V318, P28, DOI 10.1136/bmj.318.7175.28; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Ormerod LP, 1998, THORAX, V53, P176, DOI 10.1136/thx.53.3.176; PREECE MA, 1974, CLIN CHIM ACTA, V54, P235, DOI 10.1016/0009-8981(74)90241-1; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; SHENDEROVA RJ, 1991, PROBL TUBERK, V3, P54; SINGH SPN, 1983, J INFECT DIS, V148, P676, DOI 10.1093/infdis/148.4.676; SPENCE DPS, 1993, BRIT MED J, V307, P759, DOI 10.1136/bmj.307.6907.759; STRACHAN DP, 1995, THORAX, V50, P175, DOI 10.1136/thx.50.2.175; Verbeek W, 1997, BIOCHEM BIOPH RES CO, V238, P77, DOI 10.1006/bbrc.1997.7239; WILKINSON RJ, 1995, J ROY COLL PHYS LOND, V29, P86; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863	32	583	622	0	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					618	621		10.1016/S0140-6736(99)02301-6	http://dx.doi.org/10.1016/S0140-6736(99)02301-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696983				2022-12-28	WOS:000085615400014
J	Short, RV				Short, RV			Where do babies come from? William Harvey spent a lifetime searching for the earliest moments of life.	NATURE			English	Editorial Material									Univ Melbourne, Royal Hosp Women, Dept Obstet & Gynaecol, Melbourne, Vic 3053, Australia	University of Melbourne	Short, RV (corresponding author), Univ Melbourne, Royal Hosp Women, Dept Obstet & Gynaecol, 132 Grattan St, Melbourne, Vic 3053, Australia.								0	1	1	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					705	705		10.1038/35001679	http://dx.doi.org/10.1038/35001679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693779	Bronze			2022-12-28	WOS:000085423100026
J	Stewart, I				Stewart, I			Mathematics - A gathering of groups	NATURE			English	Editorial Material									Univ Warwick, Dept Math, Coventry CV4 7AL, W Midlands, England	University of Warwick	Stewart, I (corresponding author), Univ Warwick, Dept Math, Coventry CV4 7AL, W Midlands, England.							BESCHE H, 1999, J SYMB COMPUT, V17, P405	1	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					719	720		10.1038/35001708	http://dx.doi.org/10.1038/35001708			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693788				2022-12-28	WOS:000085423100035
J	May, R				May, R			Epidemiology - Simple rules with complex dynamics	SCIENCE			English	Editorial Material									UK Govt, Off Sci & Technol, London SW1H 9ST, England		May, R (corresponding author), UK Govt, Off Sci & Technol, 94-98 Albany House, London SW1H 9ST, England.	robert.may@zoo.ox.ac.uk						ANDERSON R M, 1991; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; May R.M., 1986, Biomathematics (Berlin), V17, P405; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; *UK PARL OFF SCI T, 1999, 131 UK PARL OFF SCI	5	21	22	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					601	602						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10691541				2022-12-28	WOS:000084989400031
J	Diaz, PT; King, MA; Pacht, ER; Wewers, MD; Gadek, JE; Nagaraja, HN; Drake, J; Clanton, TL				Diaz, PT; King, MA; Pacht, ER; Wewers, MD; Gadek, JE; Nagaraja, HN; Drake, J; Clanton, TL			Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers	ANNALS OF INTERNAL MEDICINE			English	Article							CELLS; VIRUS; LUNG; PNEUMONITIS; EXPRESSION; INFECTION; DISEASE	Background: Previous uncontrolled reports have suggested that HIV-seropositive persons develop an accelerated form of emphysema. Objective: To characterize the risk for emphysema in a stable HIV-seropositive outpatient population. Design: Controlled, cross-sectional analysis. Setting: Midwestern urban community. Participants: HIV-seropositive persons (n = 114)without AIDS-related pulmonary complications and HIV-seronegative controls (n = 44), matched for age and smoking history. Measurements: Measurement of pulmonary function, bronchoalveolar lavage, and high-resolution computed tomography of the chest. Results: The incidence of emphysema was 15 % (17 of 114) in the HIV-seropositive group compared with 2 % (1 of 44) in the HIV-seronegative group (P = 0.025). The incidence of emphysema in participants with a smoking history of 12 pack-years or greater was 37% (14 of 38 persons) in the HIV-seropositive group compared with 0% (0 of 14 persons) in the HIV-seronegative group (P = 0.011). The percentage of cytotoxic lymphocytes in lavage fluid was much higher in HIV-seropositive smokers with emphysema. Conclusions: infection with HIV accelerates the onset of smoking-induced emphysema. The results of this study support the emerging concept that cytotoxic lymphocytes may have an important role in emphysema pathogenesis.	Ohio State Univ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Diaz, PT (corresponding author), Pulm & Crit Care Med, N 325 Means Hall,1654 Upham Dr, Columbus, OH 43210 USA.		Wewers, Mark/AAB-6202-2021; Clanton, Thomas/AAS-9422-2020	Clanton, Thomas/0000-0003-0600-7150	NCRR NIH HHS [2MO1-RR0034] Funding Source: Medline; NHLBI NIH HHS [R01-HL49730, R01-HL53229] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000034] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053229, R01HL049730] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agostini C, 1998, LUNG BIOL HEALTH DIS, V119, P127; BLOT F, 1991, REV MAL RESPIR, V8, P121; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; *CYT SOFTW CORP, 1995, STAT XACT 3; Dhawan S, 1997, BLOOD, V90, P1535; DIAZ PT, 1992, ANN INTERN MED, V116, P124, DOI 10.7326/0003-4819-116-2-124; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Guillemi SA, 1996, EUR RESPIR J, V9, P33, DOI 10.1183/09031936.96.09010033; Hogg J C, 1995, Semin Respir Infect, V10, P244; Keicho N, 1997, AM J RESP CELL MOL, V16, P23, DOI 10.1165/ajrcmb.16.1.8998075; Keicho N, 1997, AM J PHYSIOL-LUNG C, V272, pL1046, DOI 10.1152/ajplung.1997.272.6.L1046; KUHLMAN JE, 1989, RADIOLOGY, V173, P23, DOI 10.1148/radiology.173.1.2781013; LAMB D, 1996, SPENCERS PATHOLOGY L, P597; OGNIBENE FP, 1988, ANN INTERN MED, V109, P874, DOI 10.7326/0003-4819-109-11-874; Pacht ER, 1997, AM J RESP CRIT CARE, V155, P374, DOI 10.1164/ajrccm.155.1.9001339; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; SAS, 1995, JMP VERS 3; SEMENZATO G, 1991, EUR RESPIR J, V4, P94; SNIDER GL, 1992, AM REV RESPIR DIS, V146, P1615, DOI 10.1164/ajrccm/146.6.1615	20	227	231	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2000	132	5					369	372		10.7326/0003-4819-132-5-200003070-00006	http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00006			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KY	10691587				2022-12-28	WOS:000085563000005
J	Phelps, BP				Phelps, BP			Helping medical students help survivors of domestic violence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FAMILY VIOLENCE; CURRICULA		Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Phelps, BP (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.							ABBOTT J, 1995, JAMA-J AM MED ASSOC, V273, P1763, DOI 10.1001/jama.273.22.1763; Alpert EJ, 1998, AM J PREV MED, V14, P273, DOI 10.1016/S0749-3797(98)00008-7; Bower GH, 1998, DEV PSYCHOPATHOL, V10, P625, DOI 10.1017/S0954579498001795; Cullinane PM, 1997, ACAD MED, V72, P48; deLahunta EA, 1998, ACAD MED, V73, P726, DOI 10.1097/00001888-199807000-00003; Jonassen JA, 1999, ACAD MED, V74, P821, DOI 10.1097/00001888-199907000-00017; Koss M P, 1992, Arch Fam Med, V1, P53, DOI 10.1001/archfami.1.1.53; Warshaw C, 1997, ACAD MED, V72, pS26	8	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1199	1199		10.1001/jama.283.9.1199	http://dx.doi.org/10.1001/jama.283.9.1199			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	286BQ	10703786				2022-12-28	WOS:000085424100033
J	MacLachlan, MJ; Ginzburg, M; Coombs, N; Coyle, TW; Raju, NP; Greedan, JE; Ozin, GA; Manners, I				MacLachlan, MJ; Ginzburg, M; Coombs, N; Coyle, TW; Raju, NP; Greedan, JE; Ozin, GA; Manners, I			Shaped ceramics with tunable magnetic properties from metal-containing polymers	SCIENCE			English	Article							RING-OPENING POLYMERIZATION; POLY(FERROCENYLSILANES); <1>SILAFERROCENOPHANE; CARBONITRIDE; CONVERSION; PRECURSORS; PYROLYSIS; NITRIDE; ROUTE	A shaped, magnetic ceramic was obtained from a metal-containing polymer network, which was synthesized by thermal polymerization of a metal-containing organosilicon monomer. Pyrolysis of a cylinder, shape, or film of the metal-containing polymer precursor produced a Low-density magnetic ceramic replica in high yield. The magnetic properties of the shaped ceramic could be tuned between a superparamagnetic and ferromagnetic state by controlling the pyrolysis conditions, with the particular state dependent on the size of iron nanoclusters homogeneously dispersed throughout the carbosilane-graphitic-silicon nitride matrix. These results indicate that cross-linked metal-containing polymers may be useful precursors to ceramic monoliths with tailorable magnetic properties.	Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E4, Canada; McMaster Univ, Brockhouse Inst Mat Res, Hamilton, ON L8S 4M1, Canada	University of Toronto; University of Toronto; McMaster University	Ozin, GA (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	gozin@alchemy.chem.utoronto.ca; imanners@alchemy.chem.utoronto.ca	MacLachlan, Mark J/I-2961-2013; MacLachlan, Mark/Z-2069-2019	MacLachlan, Mark J/0000-0002-3546-7132; MacLachlan, Mark/0000-0002-3546-7132; Manners, Ian/0000-0002-3794-967X				Baldus HP, 1997, ANGEW CHEM INT EDIT, V36, P329; BILL J, 1995, ADV MATER, V7, P775, DOI 10.1002/adma.19950070903; Bourg S, 1998, J MATER CHEM, V8, P1001, DOI 10.1039/a708101d; EPSTEIN LM, 1962, J CHEM PHYS, V36, P2731, DOI 10.1063/1.1732360; FOUCHER DA, 1992, J AM CHEM SOC, V114, P6246, DOI 10.1021/ja00041a053; HE JL, 1995, J AM CERAM SOC, V78, P3009, DOI 10.1111/j.1151-2916.1995.tb09076.x; Houser EJ, 1998, MACROMOLECULES, V31, P4038, DOI 10.1021/ma970181y; LAINE RM, 1993, CHEM MATER, V5, P260, DOI 10.1021/cm00027a007; Liu Q, 1997, CHEM MATER, V9, P2434, DOI 10.1021/cm970316e; MacLachlan MJ, 1998, ADV MATER, V10, P144, DOI 10.1002/(SICI)1521-4095(199801)10:2<144::AID-ADMA144>3.0.CO;2-M; MacLachlan MJ, 1998, ORGANOMETALLICS, V17, P1873, DOI 10.1021/om971071i; Manners I, 1998, CAN J CHEM, V76, P371, DOI 10.1139/cjc-76-4-371; Manners I, 1999, CHEM COMMUN, P857, DOI 10.1039/a810043h; Manners I, 1996, ANGEW CHEM INT EDIT, V35, P1602, DOI 10.1002/anie.199616021; PETERSEN R, 1995, CHEM MATER, V7, P2045, DOI 10.1021/cm00059a010; PEUCKERT M, 1990, ADV MATER, V2, P398, DOI 10.1002/adma.19900020903; Riedel R, 1996, NATURE, V382, P796, DOI 10.1038/382796a0; Segal D., 1991, CHEM SYNTHESIS ADV C; SHACKELFORD JF, 1994, CRC MAT SCI ENG HDB, P514; Thompson D, 1997, NATURE, V389, P675, DOI 10.1038/39475; VISSCHER GT, 1993, SCIENCE, V260, P1496, DOI 10.1126/science.260.5113.1496; Wideman T, 1998, CHEM MATER, V10, P412, DOI 10.1021/cm970572r; YAJIMA S, 1977, NATURE, V267, P823, DOI 10.1038/267823a0	23	263	270	7	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1460	1463		10.1126/science.287.5457.1460	http://dx.doi.org/10.1126/science.287.5457.1460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688788				2022-12-28	WOS:000085531600042
J	Myers, N; Mittermeier, RA; Mittermeier, CG; da Fonseca, GAB; Kent, J				Myers, N; Mittermeier, RA; Mittermeier, CG; da Fonseca, GAB; Kent, J			Biodiversity hotspots for conservation priorities	NATURE			English	Article							EXTINCTION; DIVERSITY; RICHNESS; FOREST; BIRDS; AREAS	Consenrationists are far from able to assist all species under threat, if only for lack of funding. This places a premium on priorities: how can we support the most species at the least cost? One way is to identify 'biodiversity hotspots' where exceptional concentrations of endemic species are undergoing exceptional loss of habitat. As many as 44% of all species of vascular plants and 35% of all species in four vertebrate groups are confined to 25 hotspots comprising only 1.4% of the land surface of the Earth. This opens the way for a 'silver bullet' strategy on the part of conservation planners, focusing on these hotspots in proportion to their share of the world's species at risk.	Univ Oxford Green Coll, Oxford OX3 8SZ, England; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20037 USA	University of Oxford; Conservation International	Myers, N (corresponding author), Univ Oxford Green Coll, Upper Meadow,Old Rd, Oxford OX3 8SZ, England.	myersln@aol.com	campbell, Ian G/F-6006-2011; burke, daniel/D-3668-2009					[Anonymous], 1999, WALKERS MAMMALS WORL; [Anonymous], 1995, GLOBAL BIODIVERSITY; Balmford A, 1995, CONSERV BIOL, V9, P1539, DOI 10.1046/j.1523-1739.1995.09061539.x; Brooks T, 1996, NATURE, V380, P115, DOI 10.1038/380115a0; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Brooks TM, 1997, CONSERV BIOL, V11, P382, DOI 10.1046/j.1523-1739.1997.95493.x; Cowlishaw G, 1999, CONSERV BIOL, V13, P1183, DOI 10.1046/j.1523-1739.1999.98433.x; Davis S.D., 1994, CTR PLANT DIVERSITY; DINERSTEIN E, 1996, GLOBAL 200 KEY ECORE; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; EHRLICH PR, 1994, PHILOS T R SOC B, V344, P99, DOI 10.1098/rstb.1994.0057; ESCHMEYER WN, 1998, CATALOG FISHES; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; GASTON KJ, 1992, FUNCT ECOL, V6, P243, DOI 10.2307/2389513; GASTON KJ, 1995, P ROY SOC B-BIOL SCI, V259, P119, DOI 10.1098/rspb.1995.0018; Ginsberg J, 1999, CONSERV BIOL, V13, P5, DOI 10.1046/j.1523-1739.1999.013001005.x; Glaw Frank, 1998, Herpetological Review, V29, P11; Groombridge B., 1992, GLOBAL BIODIVERSITY; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Laurance WF, 1999, BIOL CONSERV, V91, P101, DOI 10.1016/S0006-3207(99)00087-7; MacArthur R, 1967, THEORY ISLAND BIOGEO; Mittermeier R. A., 1999, CHELONIAN CONSERV BI; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Myers N, 1998, NATURE, V392, P327, DOI 10.1038/32761; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; Myers N, 1996, BIODIVERS CONSERV, V5, P1025, DOI 10.1007/BF00052713; Newmark WD, 1996, CONSERV BIOL, V10, P1549, DOI 10.1046/j.1523-1739.1996.10061549.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PIMM SL, 1995, P NATL ACAD SCI USA, V92, P9343, DOI 10.1073/pnas.92.20.9343; PRANCE GT, IN PRESS TROPICAL FL; Prendergast JR, 1999, CONSERV BIOL, V13, P484, DOI 10.1046/j.1523-1739.1999.97428.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Price PW., 1997, INSECT ECOLOGY, V3rd edn; Reid WV, 1998, TRENDS ECOL EVOL, V13, P275, DOI 10.1016/S0169-5347(98)01363-9; Sibley CG, 1990, DISTRIBUTION TAXONOM; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; Strong D., 1984, INSECTS PLANTS COMMU; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; Uetz P., 1996, HERPETOL REV, V27, P175; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x; WILLIAMS P H, 1991, Australian Systematic Botany, V4, P665, DOI 10.1071/SB9910665; Williams PH, 1997, P ROY SOC B-BIOL SCI, V264, P141, DOI 10.1098/rspb.1997.0021; WILSON E O, 1992	48	17309	19155	206	597	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					853	858		10.1038/35002501	http://dx.doi.org/10.1038/35002501			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706275				2022-12-28	WOS:000085559200046
J	Takasaki, T; Hatakeyama, K; Suzuki, G; Watanabe, M; Isogai, A; Hinata, K				Takasaki, T; Hatakeyama, K; Suzuki, G; Watanabe, M; Isogai, A; Hinata, K			The S receptor kinase determines self-incompatibility in Brassica stigma	NATURE			English	Article							CAMPESTRIS L; MOLECULAR-CLONING; LOCUS GENES; RAPA L; OLERACEA; TRANSFORMATION; ALLELES; GLYCOPROTEINS; EXPRESSION; SEQUENCE	The self-incompatibility possessed by Brassica is an intraspecific reproductive barrier by which the stigma rejects self-pollen but accepts non-self-pollen for fertilization. The molecular/biochemical bases of recognition and rejection have been intensively studied. Self-incompatibility in Brassica is sporophytically controlled by the polymorphic S locus(1). Two tightly linked polymorphic genes at the S locus, S receptor kinase gene (SRK) and S locus glycoprotein gene (SLG), are specifically expressed in the papillar cells of the stigma(2-4), and analyses of self-compatible lines(5-7) of Brassica have suggested that together they control stigma function in self-incompatibility interactions. Here we show, by transforming self-incompatible plants of Brassica rapa with an SRK28 and an SLG(28) transgene separately, that expression of SRK28 alone, but not SLG(28) alone, conferred the ability to reject self (S-28)-pollen on the transgenic plants. We also show that the ability of SRK28 to reject S-28 pollen was enhanced by SLG(28). We conclude that SRK alone determines S haplotype specificity of the stigma, and that SLG acts to promote a full manifestation of the self-incompatibility response.	Seed Prod Co Ltd, Res Inst, Aoba Ku, Sendai, Miyagi 9893204, Japan; Kobe Univ, Fac Agr, Nada Ku, Kobe, Hyogo 6578501, Japan; Osaka Kyoiku Univ, Div Nat Sci, Osaka 5828582, Japan; Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan	Kobe University; Osaka University of Education; Iwate University; Nara Institute of Science & Technology	Takasaki, T (corresponding author), Seed Prod Co Ltd, Res Inst, Aoba Ku, 6-6-3 Minamiyoshinari, Sendai, Miyagi 9893204, Japan.		Isogai, Akira/O-8897-2017; Watanabe, Masao/E-6300-2011; Watanabe, Masao/N-1465-2019	Isogai, Akira/0000-0001-8095-0441; Watanabe, Masao/0000-0002-9419-5149; Watanabe, Masao/0000-0002-9419-5149				Bateman AJ, 1955, HEREDITY, V9, P52, DOI DOI 10.1038/HDY.1955.2; BRACE J, 1993, SEX PLANT REPROD, V6, P133, DOI 10.1007/BF00227658; Conner JA, 1997, PLANT J, V11, P809, DOI 10.1046/j.1365-313X.1997.11040809.x; GORING DR, 1992, PLANT CELL, V4, P1273, DOI 10.1105/tpc.4.10.1273; GORING DR, 1993, PLANT CELL, V5, P531, DOI 10.1105/tpc.5.5.531; Hatakeyama K, 1998, HEREDITY, V80, P241, DOI 10.1046/j.1365-2540.1998.00295.x; Hatakeyama K, 1998, GENETICS, V149, P1587; HINATA K, 1993, INT REV CYTOL, V143, P257; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; KHO YO, 1968, EUPHYTICA, V17, P298; KISHINISHIZAWA N, 1990, PLANT CELL PHYSIOL, V31, P1207; MANOLSON MF, 1988, J BIOL CHEM, V263, P17987; NASRALLAH JB, 1993, PLANT CELL, V5, P1325, DOI 10.2307/3869785; NASRALLAH JB, 1994, PLANT J, V5, P373, DOI 10.1111/j.1365-313X.1994.00373.x; NASRALLAH JB, 1987, NATURE, V326, P617, DOI 10.1038/326617a0; NASRALLAH ME, 1992, PLANT J, V2, P497, DOI 10.1111/j.1365-313X.1992.00497.x; Nishio T, 1996, THEOR APPL GENET, V92, P388, DOI 10.1007/BF00223684; Nishio T, 1997, THEOR APPL GENET, V95, P335, DOI 10.1007/s001220050568; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; SHIBA H, 1995, P JPN ACAD B-PHYS, V71, P81, DOI 10.2183/pjab.71.81; Stahl RJ, 1998, PLANT CELL, V10, P209, DOI 10.1105/tpc.10.2.209; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Suzuki G, 1996, PLANT CELL PHYSIOL, V37, P866, DOI 10.1093/oxfordjournals.pcp.a029024; SUZUKI G, 1995, PLANT CELL PHYSIOL, V36, P1273; Suzuki G, 1999, GENETICS, V153, P391; Takasaki T, 1997, BREEDING SCI, V47, P127; Takasaki T, 1999, PLANT MOL BIOL, V40, P659, DOI 10.1023/A:1006274525421; TAKAYAMA S, 1987, NATURE, V326, P102, DOI 10.1038/326102a0; WATANABE M, 1994, PLANT CELL PHYSIOL, V35, P1221, DOI 10.1093/oxfordjournals.pcp.a078716	30	372	446	6	84	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					913	916		10.1038/35002628	http://dx.doi.org/10.1038/35002628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706292				2022-12-28	WOS:000085559200063
J	Mulnard, RI; Cotman, CW; Kawas, C; van Dyck, CH; Sano, H; Doody, R; Koss, E; Pfeiffer, E; Jin, S; Gamst, A; Grundman, M; Thomas, R; Thal, LJ				Mulnard, RI; Cotman, CW; Kawas, C; van Dyck, CH; Sano, H; Doody, R; Koss, E; Pfeiffer, E; Jin, S; Gamst, A; Grundman, M; Thomas, R; Thal, LJ		Alzheimers Dis Cooperative St	Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GONADAL-STEROIDS; APOLIPOPROTEIN-E; DEMENTIA; RISK; BRAIN; DECLINE; WOMEN; RATS; AGE	Context Several reports from small clinical trials have suggested that estrogen replacement therapy may be useful for the treatment of Alzheimer disease (AD) in women. Objective To determine whether estrogen replacement therapy affects global, cognitive, or functional decline in women with mild to moderate AD. Design The Alzheimer's Disease Cooperative Study, a randomized, double-blind, placebo-controlled clinical trial conducted between October 1995 and January 1999. Setting Thirty-two study sites in the United States. Participants A total of 120 women with mild to moderate AD and a Mini-Mental State Examination score between 12 and 28 who had had a hysterectomy. Interventions Participants were randomized to estrogen, 0.625 mg/d (n = 42), or 1.25 mg/d (n = 39), or to identically appearing placebo (n = 39). One subject withdrew after randomization but before receiving medication; 97 subjects completed the trial. Main Outcome Measures The primary outcome measure was change on the Clinical Global Impression of Change (CGIC) 7-point scale, analyzed by intent to treat; secondary outcome measures included other global measures as well as measures of mood, specific cognitive domains (memory, attention, and language), motor function, and activities of daily living; compared by the combined estrogen groups vs the placebo group at 2, 6, 12, and 15 months of follow-up. Results The CGIC score for estrogen vs placebo was 5.1 vs 5.0 (P = .43); 80% of participants taking estrogen vs 74% of participants taking placebo worsened (P = .48). Secondary outcome measures also showed no significant differences, with the exception of the Clinical Dementia Rating Scale, which suggested worsening among patients taking estrogen (mean posttreatment change in score for estrogen, 0.5 vs 0.2 for placebo; P = .01). Conclusions Estrogen replacement therapy for 1 year did not slow disease progression nor did it improve global, cognitive, or functional outcomes in women with mild to moderate AD. The study does not support the role of estrogen for the treatment of this disease. The potential role of estrogen in the prevention of AD, however, requires further research.	Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA; Johns Hopkins Univ, Baltimore, MD USA; Yale Univ, New Haven, CT USA; Columbia Univ, New York, NY USA; Baylor Coll Med, Houston, TX 77030 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ S Florida, Tampa, FL USA; Univ Calif San Diego, San Diego, CA 92103 USA	University of California System; University of California Irvine; Johns Hopkins University; Yale University; Columbia University; Baylor College of Medicine; Case Western Reserve University; State University System of Florida; University of South Florida; University of California System; University of California San Diego	Mulnard, RI (corresponding author), Univ Calif Irvine, Inst Brain Aging & Dementia, 1113 Gillespie Neurosci Res Facil, Irvine, CA 92697 USA.		Gamst, Anthony/AAH-9440-2019	Kawas, Claudia/0000-0001-9577-230X	NATIONAL INSTITUTE ON AGING [U01AG010483, U19AG010483] Funding Source: NIH RePORTER; NIA NIH HHS [U19 AG010483, U01-AG10483] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Army Individual Test Battery, 1944, ARM COMB FITN TEST; Asthana S, 1999, PSYCHONEUROENDOCRINO, V24, P657, DOI 10.1016/S0306-4530(99)00020-7; Benton A, 1978, PSYCHOL ASSESSMENT R; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; CORDER EH, 1995, NEUROLOGY, V45, P1323, DOI 10.1212/WNL.45.7.1323; Craft S, 1998, NEUROLOGY, V51, P149, DOI 10.1212/WNL.51.1.149; DalForno G, 1996, ARCH NEUROL-CHICAGO, V53, P345; DITKOFF EC, 1991, OBSTET GYNECOL, V78, P991; Dubal DB, 1999, J NEUROSCI, V19, P6385; FILLIT H, 1986, PSYCHONEUROENDOCRINO, V11, P337, DOI 10.1016/0306-4530(86)90019-3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANKFURT M, 1994, NEUROENDOCRINOLOGY, V59, P245, DOI 10.1159/000126665; GOULD E, 1990, J NEUROSCI, V10, P1286; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HIDALGO A, 1995, J NEUROBIOL, V27, P470, DOI 10.1002/neu.480270404; HONJO H, 1989, J STEROID BIOCHEM, V34, P521; Johnson JK, 1998, BRAIN RES, V798, P18, DOI 10.1016/S0006-8993(98)00363-1; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; JOSEPH JA, 1989, BRAIN RES, V505, P195, DOI 10.1016/0006-8993(89)91442-X; Kawas C, 1997, NEUROLOGY, V48, P1517, DOI 10.1212/WNL.48.6.1517; Kritzer MF, 1999, J COMP NEUROL, V409, P438, DOI 10.1002/(SICI)1096-9861(19990705)409:3<438::AID-CNE8>3.0.CO;2-5; LUINE VN, 1985, EXP NEUROL, V89, P484, DOI 10.1016/0014-4886(85)90108-6; MATHEWS CG, 1964, INSTRUCTION MANUAL A; MCDERMOTT JL, 1994, HORM BEHAV, V28, P16, DOI 10.1006/hbeh.1994.1002; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mohs RC, 1997, ALZ DIS ASSOC DIS, V11, pS13; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; MOSS MB, 1986, ARCH NEUROL-CHICAGO, V43, P239, DOI 10.1001/archneur.1986.00520030031008; OHKURA T, 1994, ENDOCR J, V41, P361, DOI 10.1507/endocrj.41.361; PaganiniHill A, 1996, ARCH INTERN MED, V156, P2213, DOI 10.1001/archinte.156.19.2213; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Pike CJ, 1999, J NEUROCHEM, V72, P1552, DOI 10.1046/j.1471-4159.1999.721552.x; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; REITAN RM, 1990, HALSTEAD REITAN NEUR; Rodriguez MM, 1998, CLIN GERIATR MED, V14, P177; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Schneider LS, 1997, ALZ DIS ASSOC DIS, V11, pS22; SHERWIN BB, 1988, PSYCHONEUROENDOCRINO, V13, P345, DOI 10.1016/0306-4530(88)90060-1; Simpkins JW, 1997, AM J MED, V103, P195; Sloane PD, 1998, AM FAM PHYSICIAN, V58, P1577; STERN Y, 1994, J GERONTOL, V49, pM216, DOI 10.1093/geronj/49.5.M216; Su JH, 1996, NEUROREPORT, V7, P437, DOI 10.1097/00001756-199601310-00015; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; TORANALLERAND CD, 1992, P NATL ACAD SCI USA, V89, P4668, DOI 10.1073/pnas.89.10.4668; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Wechsler D., 2008, WECHSLER ADULT INTEL, P257; ZUCKERMAN M, 1965, J CONSULT PSYCHOL, V29, P594, DOI 10.1037/h0022750	49	707	726	0	32	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					1007	1015		10.1001/jama.283.8.1007	http://dx.doi.org/10.1001/jama.283.8.1007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284AM	10697060	Bronze			2022-12-28	WOS:000085308600029
J	Burrows, A				Burrows, A			Supernova explosions in the Universe	NATURE			English	Review							GAMMA-RAY BURST; 28 FEBRUARY 1997; NEUTRINO BURST; ELECTRON-CAPTURE; CORE-COLLAPSE; IA SUPERNOVAE; BLACK-HOLES; ERROR BOX; LOW-MASS; STARS	During the lifetime of our Milky Way galaxy, there have been something like 100 million supernova explosions, which have enriched the Galaxy with the oxygen we breathe, the iron in our cars, the calcium in our bones and the silicon in the rocks beneath our feet. These exploding stars also influence the birth of new stars and are the source of the energetic cosmic rays that irradiate us on the Earth. The prodigious amount of energy (similar to 10(51), Or similar to 2.5 x 10(28) megatonnes of TNT equivalent) and momentum associated with each supernova may even have helped to shape galaxies as they formed in the early Universe. Supernovae are now being used to measure the geometry of the Universe, and have recently been implicated in the decades-old mystery of the origin of the gamma-ray bursts. Together with major conceptual advances in our theoretical understanding of supernovae, these developments have made supernovae the centre of attention in astrophysics.	Univ Arizona, Dept Astron, Tucson, AZ 85721 USA	University of Arizona	Burrows, A (corresponding author), Univ Arizona, Dept Astron, Tucson, AZ 85721 USA.	aburrows@as.arizona.edu						Aguirre AN, 1999, ASTROPHYS J, V512, pL19, DOI 10.1086/311862; ARNETT WD, 1989, ANNU REV ASTRON ASTR, V27, P629, DOI 10.1146/annurev.aa.27.090189.003213; Aschenbach B, 1998, NATURE, V396, P141, DOI 10.1038/24103; Ashworth W. B.  Jr., 1980, Journal for the History of Astronomy, V11, P1; BARI C, 1988, NUCL INSTRUM METH A, V264, P5, DOI 10.1016/0168-9002(88)91094-7; BELLOTTI E, 1988, NUCL INSTRUM METH A, V264, P1, DOI 10.1016/0168-9002(88)91093-5; BETHE HA, 1979, NUCL PHYS A, V324, P487, DOI 10.1016/0375-9474(79)90596-7; BETHE HA, 1985, ASTROPHYS J, V295, P14, DOI 10.1086/163343; BIONTA RM, 1987, PHYS REV LETT, V58, P1494, DOI 10.1103/PhysRevLett.58.1494; Bloom JS, 1999, NATURE, V401, P453, DOI 10.1038/46744; BROWN GE, 1994, ASTROPHYS J, V423, P659, DOI 10.1086/173844; Brown GE, 1996, ASTROPHYS J, V463, P297, DOI 10.1086/177241; BRUENN SW, 1985, ASTROPHYS J SUPPL S, V58, P771, DOI 10.1086/191056; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; BURROWS A, 1993, ASTROPHYS J, V416, pL75, DOI 10.1086/187074; BURROWS A, 1988, ASTROPHYS J, V334, P891, DOI 10.1086/166885; BURROWS A, 1982, ASTROPHYS J, V259, P330, DOI 10.1086/160169; BURROWS A, 1995, ASTROPHYS J, V450, P830, DOI 10.1086/176188; BURROWS A, 1986, ASTROPHYS J, V307, P178, DOI 10.1086/164405; BURROWS A, 1988, PHYS REP, V163, P51, DOI 10.1016/0370-1573(88)90035-X; Chaboyer B, 1998, ASTROPHYS J, V494, P96, DOI 10.1086/305201; COLGATE SA, 1966, ASTROPHYS J, V143, P626, DOI 10.1086/148549; COLGATE SA, 1960, PHYS REV LETT, V5, P235, DOI 10.1103/PhysRevLett.5.235; CORDES JM, 1993, NATURE, V362, P133, DOI 10.1038/362133a0; Costa E, 1997, NATURE, V387, P783, DOI 10.1038/42885; Cowan JJ, 1999, ASTROPHYS J, V521, P194, DOI 10.1086/307512; EWAN GT, 1987, SNO8712; Fryer C, 1998, ASTROPHYS J, V496, P333, DOI 10.1086/305348; FRYER C, 1999, CORE COLLAPSE SIMULA; FRYXELL B, 1991, ASTROPHYS J, V367, P619, DOI 10.1086/169657; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; GIBSON BK, 1999, HST KEY PROJECT EXTR; Hamuy M, 1996, ASTRON J, V112, P2408, DOI 10.1086/118192; HERANT M, 1994, ASTROPHYS J, V435, P339, DOI 10.1086/174817; HIRATA K, 1987, PHYS REV LETT, V58, P1490, DOI 10.1103/PhysRevLett.58.1490; *IC COLL, 1994, 94991 LNGS GRANS LAB; Iyudin AF, 1998, NATURE, V396, P142, DOI 10.1038/24106; Janka HT, 1996, ASTRON ASTROPHYS, V306, P167; KENNICUTT RC, 1995, ASTRON J, V110, P1476, DOI 10.1086/117621; KOSHIBA M, 1992, PHYS REP, V220, P229, DOI 10.1016/0370-1573(92)90083-C; LYNE AG, 1994, NATURE, V369, P127, DOI 10.1038/369127a0; MacFadyen AI, 1999, ASTROPHYS J, V524, P262, DOI 10.1086/307790; Madau P, 1998, MON NOT R ASTRON SOC, V297, pL17, DOI 10.1046/j.1365-8711.1998.01697.x; MAYLE R, 1988, ASTROPHYS J, V334, P909, DOI 10.1086/166886; McNamara BJ, 1998, NATURE, V396, P233, DOI 10.1038/24317; Messer OEB, 1998, ASTROPHYS J, V507, P353, DOI 10.1086/306323; METZGER MR, 1997, NATURE, V387, P879; NOMOTO K, 1984, ASTROPHYS J, V277, P791, DOI 10.1086/161749; NOMOTO K, 1988, PHYS REP, V163, P13, DOI 10.1016/0370-1573(88)90032-4; OSTRIKER JP, 1971, ASTROPHYS J, V164, pL95, DOI 10.1086/180699; PACZYNSKI B, 1999, GAMMARAY BURST SUPER; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; PIRO L, 1997, JOINT EUR NAT ASTR M, P284; Reichart DE, 1999, ASTROPHYS J, V521, pL111, DOI 10.1086/312203; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; RIESS AG, 1999, INDICATION EVOLUTION; SAKAI S, 1999, HUBBLE SPACE TELESCO; Sollerman J, 1998, ASTROPHYS J, V493, P933, DOI 10.1086/305163; Suntzeff NB, 1999, ASTRON J, V117, P1175, DOI 10.1086/300771; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; Totani T, 1998, ASTROPHYS J, V496, P216, DOI 10.1086/305364; TUELLER J, 1990, ASTROPHYS J, V351, pL41, DOI 10.1086/185675; Turatto M, 1998, ASTROPHYS J, V498, pL129, DOI 10.1086/311324; Turner MS, 1999, REV MOD PHYS, V71, pS145, DOI 10.1103/RevModPhys.71.S145; Umeda H, 1999, ASTROPHYS J, V522, pL43, DOI 10.1086/312213; vanParadijs J, 1997, NATURE, V386, P686, DOI 10.1038/386686a0; Wang LF, 1997, ASTROPHYS J, V476, pL27, DOI 10.1086/310495; WHEELER JC, 1999, ASYMMETRIC SUPERNOVA; Wilson J.R., 1985, NUMERICAL ASTROPHYSI, P422; WOODEN DH, 1993, ASTROPHYS J SUPPL S, V88, P477, DOI 10.1086/191830; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WOOSLEY SE, 1992, ASTROPHYS J, V395, P202, DOI 10.1086/171644; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359; Woosley SE, 1999, ASTROPHYS J, V516, P788, DOI 10.1086/307131; Zlatev I, 1999, PHYS REV LETT, V82, P896, DOI 10.1103/PhysRevLett.82.896	78	149	149	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					727	733		10.1038/35001501	http://dx.doi.org/10.1038/35001501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693794				2022-12-28	WOS:000085423100041
J	Di Fonzo, S; Jark, W; Lagomarsino, S; Giannini, C; De Caro, L; Cedola, A; Muller, M				Di Fonzo, S; Jark, W; Lagomarsino, S; Giannini, C; De Caro, L; Cedola, A; Muller, M			Non-destructive determination of local strain with 100-nanometre spatial resolution	NATURE			English	Article							X-RAYS; DIFFRACTION; TECHNOLOGY; STRESS; BEAM	Structure sizes of similar to 180 mm are now standard in microelectronics, and state-of-the-art fabrication techniques can reduce these to just a few tens of nanometres (ref. 1). But at these length scales, the strain induced at interfaces can locally distort the crystal lattice, which may in turn affect device performance in an unpredictable way. A means of non-destructively characterizing such strain fields with high spatial resolution and sensitivity is therefore highly desirable. One approach is to use Raman spectroscopy(2), but this is limited by the intrinsic similar to 0.5-mu m resolution limit of visible light probes. Techniques based on electron-beam diffraction can achieve the desired nanometre-scale resolution But either they require complex sample preparation procedures(3) (which may alter the original strain field) or they are sensitive to distortional (but not dilational) strain within only the top few tens of nanometres of the sample surface(4,5). X-rays, on the other hand, have a much greater penetration depth, but have not hitherto achieved strain analysis with sub-micrometre resolution(6). Here we describe a magnifying diffraction imaging procedure for X-rays which achieves a spatial resolution of 100 nm in one dimension and a sensitivity of 10(-4) for relative lattice variations. We demonstrate the suitability of this procedure for strain analysis by measuring the strain depth profiles beneath oxidized lines on silicon crystals.	Sincrotrone Trieste, I-34012 Trieste, Italy; CNR, Ist Elettron Stato Solido, I-00156 Rome, Italy; Ctr Nazl Ric & Sviluppo Mat, PASTIS, I-72100 Brindisi, Italy; ESRF, F-38043 Grenoble, France	Elettra Sincrotrone Trieste; Consiglio Nazionale delle Ricerche (CNR); European Synchrotron Radiation Facility (ESRF)	Di Fonzo, S (corresponding author), Sincrotrone Trieste, SS 14 Km 163 5 Area Sci Pk, I-34012 Trieste, Italy.	difonzo@elettra.trieste.it	Müller, Martin/I-9328-2017; Cedola, Alessia/F-3865-2012; lagomarsino, stefano/J-1626-2012; Giannini, Cinzia/B-2409-2012	Cedola, Alessia/0000-0002-9256-8853; GIANNINI, CINZIA/0000-0003-0983-2885; lagomarsino, Stefano/0000-0002-0395-6249; DECARO, LIBERATO/0000-0002-7927-6178				APPELS JA, 1970, PHILIPS RES REP, V25, P118; Armigliato A, 1997, J PHYS III, V7, P2375, DOI 10.1051/jp3:1997265; CEDOLA A, 1999, THESIS U GRENOBLE; DEWOLF I, 1993, J APPL PHYS, V74, P4490, DOI 10.1063/1.354365; *ESPRIT MICR ADV R, 2000, DOC IS LOC; Fewster PF, 1996, NATO ADV SCI I B-PHY, V357, P269; HARLAND CJ, 1981, J PHYS E SCI INSTRUM, V14, P175, DOI 10.1088/0022-3735/14/2/011; HU SM, 1991, J APPL PHYS, V70, pR53, DOI 10.1063/1.349282; Jain SC, 1996, J APPL PHYS, V79, P8145, DOI 10.1063/1.362678; Jark W, 1996, J APPL PHYS, V80, P4831, DOI 10.1063/1.363524; Labiche J. C., 1996, ESRF NEWSLETT, V25, P41; Lagomarsino S, 1997, APPL PHYS LETT, V71, P2557, DOI 10.1063/1.119324; LANDOLT HH, 1950, ZAHLENWERTE FUNKTION; SPILLER E, 1974, APPL PHYS LETT, V24, P60, DOI 10.1063/1.1655093; TAUPIN D, 1964, B SOC FR MINERAL CR, V87, P469, DOI 10.3406/bulmi.1964.5769; WANG J, 1992, SCIENCE, V258, P775, DOI 10.1126/science.1439784; Wang PC, 1998, APPL PHYS LETT, V72, P1296, DOI 10.1063/1.120604; Wilkinson AJ, 1996, ULTRAMICROSCOPY, V62, P237, DOI 10.1016/0304-3991(95)00152-2; Yariv A., 1989, QUANTUM ELECTRON, P115	19	109	122	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					638	640		10.1038/35001035	http://dx.doi.org/10.1038/35001035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688195				2022-12-28	WOS:000085288200047
J	Murray, BE				Murray, BE			Drug therapy: Vancomycin-resistant enterococcal infections.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GASTROINTESTINAL-TRACT COLONIZATION; RP-59500 QUINUPRISTIN-DALFOPRISTIN; UNIVERSITY MEDICAL-CENTER; BLOOD-STREAM INFECTIONS; FAECIUM SHUNT INFECTION; INTENSIVE-CARE UNIT; IN-VITRO ACTIVITIES; EXPERIMENTAL ENDOCARDITIS; GLYCOPEPTIDE RESISTANCE; ANTIMICROBIAL AGENTS		Univ Texas, Sch Med, Dept Med, Div Infect Dis, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Div Infect Dis, Houston, TX 77030 USA; Univ Texas, Sch Med, Ctr Study Emerging & Reemerging Pathogens, Houston, TX 77030 USA	University of Texas System; University of Texas System; University of Texas System	Murray, BE (corresponding author), Univ Texas, Sch Med, Dept Med, Div Infect Dis, 6431 Fannin,JFB 1-728, Houston, TX 77030 USA.	infdis@heart.med.uth.tmc.edu						Aarestrup FM, 1996, ANTIMICROB AGENTS CH, V40, P1938, DOI 10.1128/AAC.40.8.1938; Aeschlimann JR, 1998, ANTIMICROB AGENTS CH, V42, P2710, DOI 10.1128/AAC.42.10.2710; Allerberger F, 1999, J ANTIMICROB CHEMOTH, V43, P211, DOI 10.1093/jac/43.2.211; Anglim AM, 1997, ARCH INTERN MED, V157, P1132, DOI 10.1001/archinte.157.10.1132; [Anonymous], 1995, INFECT CONT HOSP EP, V16, P105; Arthur M, 1997, J BACTERIOL, V179, P97, DOI 10.1128/jb.179.1.97-106.1997; Arthur M, 1998, MOL MICROBIOL, V30, P819, DOI 10.1046/j.1365-2958.1998.01114.x; Arthur M, 1996, J INFECTION, V32, P11, DOI 10.1016/S0163-4453(96)80003-X; Aslangul E, 1997, J INFECT DIS, V175, P598, DOI 10.1093/infdis/175.3.598; Beezhold DW, 1997, CLIN INFECT DIS, V24, P704, DOI 10.1093/clind/24.4.704; BINGEN EH, 1991, J CLIN MICROBIOL, V29, P1888, DOI 10.1128/JCM.29.9.1888-1892.1991; Bonten MJM, 1998, ARCH INTERN MED, V158, P1127, DOI 10.1001/archinte.158.10.1127; BOYCE JM, 1995, INFECT CONT HOSP EP, V16, P634; BOYCE JM, 1994, J CLIN MICROBIOL, V32, P1148, DOI 10.1128/JCM.32.5.1148-1153.1994; Boyce JM, 1996, INFECT CONT HOSP EP, V17, P211; BOYLE JF, 1993, J CLIN MICROBIOL, V31, P1280, DOI 10.1128/JCM.31.5.1280-1285.1993; Bradley SJ, 1999, J ANTIMICROB CHEMOTH, V43, P261, DOI 10.1093/jac/43.2.261; Brandt CM, 1996, J INFECT DIS, V173, P909, DOI 10.1093/infdis/173.4.909; Brennen C, 1998, J AM GERIATR SOC, V46, P157, DOI 10.1111/j.1532-5415.1998.tb02532.x; Brooks S, 1998, INFECT CONT HOSP EP, V19, P333; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; Byers KE, 1998, INFECT CONT HOSP EP, V19, P261; Carias LL, 1998, J BACTERIOL, V180, P4426, DOI 10.1128/JB.180.17.4426-4434.1998; CARON F, 1995, J INFECT DIS, V171, P106, DOI 10.1093/infdis/171.1.106; Caron F, 1997, ANTIMICROB AGENTS CH, V41, P2749, DOI 10.1128/AAC.41.12.2749; CERCENADO E, 1992, ANTIMICROB AGENTS CH, V36, P2201, DOI 10.1128/AAC.36.10.2201; Chia JKS, 1995, CLIN INFECT DIS, V21, P1520, DOI 10.1093/clinids/21.6.1520; CLARK NC, 1993, ANTIMICROB AGENTS CH, V37, P2311, DOI 10.1128/AAC.37.11.2311; COHEN MA, 1995, ANTIMICROB AGENTS CH, V39, P2123, DOI 10.1128/AAC.39.9.2123; COLLINS LA, 1993, ANTIMICROB AGENTS CH, V37, P1364, DOI 10.1128/AAC.37.6.1364; Coque TM, 1996, ANTIMICROB AGENTS CH, V40, P2605, DOI 10.1128/AAC.40.11.2605; Dever LL, 1998, AM J INFECT CONTROL, V26, P40, DOI 10.1016/S0196-6553(98)70060-4; Dever LL, 1996, MICROB DRUG RESIST, V2, P415, DOI 10.1089/mdr.1996.2.415; Dodge RA, 1997, CLIN INFECT DIS, V25, P1269, DOI 10.1086/516977; Edmond MB, 1996, CLIN INFECT DIS, V23, P1234, DOI 10.1093/clinids/23.6.1234; EDMOND MB, 1995, CLIN INFECT DIS, V20, P1126, DOI 10.1093/clinids/20.5.1126; ELIOPOULOS GM, 1993, INFECT DIS CLIN N AM, V7, P117; Eliopoulos GM, 1996, ANTIMICROB AGENTS CH, V40, P1745, DOI 10.1128/AAC.40.7.1745; Evans ME, 1996, INFECT CONT HOSP EP, V17, P356; Evers S, 1996, MICROB DRUG RESIST, V2, P219, DOI 10.1089/mdr.1996.2.219; Facklam Richard R., 1995, P308; Fantin B, 1997, ANTIMICROB AGENTS CH, V41, P931, DOI 10.1128/AAC.41.5.931; Fines M, 1999, ANTIMICROB AGENTS CH, V43, P2161, DOI 10.1128/AAC.43.9.2161; Fontana R, 1996, MICROB DRUG RESIST, V2, P209, DOI 10.1089/mdr.1996.2.209; Furlong WB, 1997, CLIN INFECT DIS, V25, P163, DOI 10.1086/516895; GRAYSON ML, 1990, ANTIMICROB AGENTS CH, V34, P1792, DOI 10.1128/AAC.34.9.1792; HANDWERGER S, 1993, CLIN INFECT DIS, V16, P750, DOI 10.1093/clind/16.6.750; HAYDEN MK, 1993, J INFECT DIS, V167, P1224, DOI 10.1093/infdis/167.5.1224; Heaton MP, 1996, GENE, V171, P9, DOI 10.1016/0378-1119(96)00022-4; Henning KJ, 1996, PEDIATR INFECT DIS J, V15, P848, DOI 10.1097/00006454-199610000-00004; HODGES TL, 1992, ANTIMICROB AGENTS CH, V36, P121, DOI 10.1128/AAC.36.1.121; HOFFMANN SA, 1987, ANN INTERN MED, V106, P757, DOI 10.7326/0003-4819-106-5-757; *HOSP INF CONTR PR, 1995, INFECT CONT HOSP EP, V16, P498; Howe RA, 1997, J ANTIMICROB CHEMOTH, V40, P144, DOI 10.1093/jac/40.1.144; INGERMAN M, 1987, J INFECT DIS, V155, P1226, DOI 10.1093/infdis/155.6.1226; Iwen PC, 1997, ANTIMICROB AGENTS CH, V41, P494, DOI 10.1128/AAC.41.2.494; Jensen LB, 1998, J CLIN MICROBIOL, V36, P437, DOI 10.1128/JCM.36.2.437-442.1998; JONES RN, 1995, DIAGN MICR INFEC DIS, V21, P85, DOI 10.1016/0732-8893(94)00147-O; JORDENS JZ, 1994, J ANTIMICROB CHEMOTH, V34, P515, DOI 10.1093/jac/34.4.515; KARANFIL LV, 1992, INFECT CONT HOSP EP, V13, P195, DOI 10.1086/646509; Kim WJ, 1999, J INFECT DIS, V179, P163, DOI 10.1086/314564; Kirst HA, 1998, ANTIMICROB AGENTS CH, V42, P1303, DOI 10.1128/AAC.42.5.1303; KLARE I, 1995, FEMS MICROBIOL LETT, V125, P165, DOI 10.1111/j.1574-6968.1995.tb07353.x; KLARE I, 1995, FEMS MICROBIOL LETT, V127, P273; KORTEN V, 1994, ANTIMICROB AGENTS CH, V38, P611, DOI 10.1128/AAC.38.3.611; LANDMAN D, 1995, J ANTIMICROB CHEMOTH, V36, P253, DOI 10.1093/jac/36.1.253; LANDRY SL, 1989, AM J INFECT CONTROL, V17, P323, DOI 10.1016/0196-6553(89)90001-1; Lautenbach E, 1998, CLIN INFECT DIS, V27, P1259, DOI 10.1086/515002; LECLERCQ R, 1991, ANTIMICROB AGENTS CH, V35, P92, DOI 10.1128/AAC.35.1.92; Leclercq R, 1997, CLIN INFECT DIS, V24, P545, DOI 10.1093/clind/24.4.545; LECLERCQ R, 1989, ANTIMICROB AGENTS CH, V33, P10, DOI 10.1128/AAC.33.1.10; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Linden PK, 1997, J ANTIMICROB CHEMOTH, V39, P145, DOI 10.1093/jac/39.suppl_1.145; Linden PK, 1996, CLIN INFECT DIS, V22, P663, DOI 10.1093/clinids/22.4.663; LIVORNESE LL, 1992, ANN INTERN MED, V117, P112, DOI 10.7326/0003-4819-117-2-112; LOSONSKY GA, 1994, CLIN INFECT DIS, V19, P163, DOI 10.1093/clinids/19.1.163; Lucas GM, 1998, CLIN INFECT DIS, V26, P1127, DOI 10.1086/520311; LYNN WA, 1994, LANCET, V344, P1025, DOI 10.1016/S0140-6736(94)91687-X; MAKI DG, 1988, MEDICINE, V67, P248, DOI 10.1097/00005792-198807000-00005; Mato R, 1996, MICROB DRUG RESIST, V2, P309, DOI 10.1089/mdr.1996.2.309; Mato SP, 1999, PEDIATR INFECT DIS J, V18, P483, DOI 10.1097/00006454-199905000-00023; Matsumura S, 1998, CLIN INFECT DIS, V27, P1554, DOI 10.1086/517755; MCGEER A, 1995, 35 INT C ANT AG CHEM, P283; MEDERSKISAMORAJ BD, 1983, J INFECT DIS, V147, P751, DOI 10.1093/infdis/147.4.751; Mekonen ET, 1995, MICROB DRUG RESIST, V1, P249, DOI 10.1089/mdr.1995.1.249; Mevius D, 1998, J ANTIMICROB CHEMOTH, V42, P275, DOI 10.1093/jac/42.2.275; Moellering RC, 1999, J ANTIMICROB CHEMOTH, V44, P251, DOI 10.1093/jac/44.2.251; Montecalvo MA, 1997, CLIN INFECT DIS, V25, P929, DOI 10.1086/597643; MONTECALVO MA, 1995, ANTIMICROB AGENTS CH, V39, P794, DOI 10.1128/AAC.39.3.794; Montecalvo MA, 1996, ARCH INTERN MED, V156, P1458, DOI 10.1001/archinte.156.13.1458; Montecalvo MA, 1995, INFECT CONT HOSP EP, V16, P680; MONTECALVO MA, 1997, 37 INT C ANT AG CHEM, P303; MORENO F, 1995, CLIN INFECT DIS, V21, P1234, DOI 10.1093/clinids/21.5.1234; MORENO F, 1994, DIAGN MICR INFEC DIS, V20, P41, DOI 10.1016/0732-8893(94)90017-5; MORRIS JG, 1995, ANN INTERN MED, V123, P250, DOI 10.7326/0003-4819-123-4-199508150-00002; MORRISON AJ, 1986, ARCH INTERN MED, V146, P1549, DOI 10.1001/archinte.146.8.1549; MURRAY BE, 1992, ANTIMICROB AGENTS CH, V36, P2355, DOI 10.1128/AAC.36.11.2355; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Nachman SA, 1995, MICROB DRUG RESIST, V1, P95, DOI 10.1089/mdr.1995.1.95; *NAT COMM CLIN LAB, 1997, PERF STAND ANT DISK, P1; NAVARRO F, 1994, ANTIMICROB AGENTS CH, V38, P1788, DOI 10.1128/AAC.38.8.1788; Newell KA, 1998, TRANSPLANTATION, V65, P439, DOI 10.1097/00007890-199802150-00027; NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195; NORRIS AH, 1995, CLIN INFECT DIS, V20, P1137, DOI 10.1093/clinids/20.5.1137; NOSKIN GA, 1995, CLIN INFECT DIS, V20, P296, DOI 10.1093/clinids/20.2.296; Noskin GA, 1999, CLIN INFECT DIS, V28, P689, DOI 10.1086/517221; ODONOVAN CA, 1994, DIAGN MICR INFEC DIS, V18, P105, DOI 10.1016/0732-8893(94)90074-4; ORR KE, 1994, LANCET, V344, P65, DOI 10.1016/S0140-6736(94)91092-8; Papanicolaou GA, 1996, CLIN INFECT DIS, V23, P760, DOI 10.1093/clinids/23.4.760; Pegues DA, 1997, J CLIN MICROBIOL, V35, P1565, DOI 10.1128/JCM.35.6.1565-1570.1997; Perichon B, 1997, ANTIMICROB AGENTS CH, V41, P2016, DOI 10.1128/AAC.41.9.2016; PESTEL M, 1995, ANTIMICROB AGENTS CH, V39, P2341, DOI 10.1128/AAC.39.10.2341; Poyart C, 1997, ANTIMICROB AGENTS CH, V41, P24, DOI 10.1128/AAC.41.1.24; Quale J, 1996, CLIN INFECT DIS, V23, P1020, DOI 10.1093/clinids/23.5.1020; QUINTILIANI R, 1994, FEMS MICROBIOL LETT, V119, P359; Quintiliani R, 1996, GENE, V172, P1, DOI 10.1016/0378-1119(96)00110-2; RENDEFOURNIER R, 1993, ANTIMICROB AGENTS CH, V37, P2119, DOI 10.1128/AAC.37.10.2119; Rippere K, 1998, J INFECT DIS, V178, P584, DOI 10.1086/517480; Roghmann MC, 1997, CLIN INFECT DIS, V24, P514, DOI 10.1093/clinids/24.3.514; RUBIN LG, 1992, INFECT CONT HOSP EP, V13, P700; Rybkine T, 1998, J INFECT DIS, V178, P159, DOI 10.1086/515605; SACHER HL, 1991, J CLIN PHARMACOL, V31, P719, DOI 10.1002/j.1552-4604.1991.tb03766.x; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Satake S, 1997, J CLIN MICROBIOL, V35, P2325, DOI 10.1128/JCM.35.9.2325-2330.1997; Schaberg DR, 1991, AM J MED S3B, V16, P72; Schoonmaker DJ, 1998, J CLIN MICROBIOL, V36, P2105, DOI 10.1128/JCM.36.7.2105-2108.1998; Schwalbe RS, 1999, LANCET, V353, P722, DOI 10.1016/S0140-6736(98)05441-5; SHAY DK, 1995, PEDIATR CLIN N AM, V42, P703; SHAY DK, 1995, J INFECT DIS, V172, P993, DOI 10.1093/infdis/172.4.993; Slaughter S, 1996, ANN INTERN MED, V125, P448, DOI 10.7326/0003-4819-125-6-199609150-00004; Taylor SE, 1998, EUR J CLIN MICROBIOL, V17, P798, DOI 10.1007/s100960050190; Tornieporth NG, 1996, CLIN INFECT DIS, V23, P767, DOI 10.1093/clinids/23.4.767; Tripodi MF, 1998, EUR J CLIN MICROBIOL, V17, P734, DOI 10.1007/s100960050171; Tsai SF, 1998, ANTIMICROB AGENTS CH, V42, P1229, DOI 10.1128/AAC.42.5.1229; Tush GM, 1998, CLIN INFECT DIS, V26, P1460, DOI 10.1086/517663; UTTLEY AHC, 1988, LANCET, V1, P57; vandenBogaard AE, 1997, NEW ENGL J MED, V337, P1558, DOI 10.1056/NEJM199711203372117; VanderAuwera P, 1996, J INFECT DIS, V173, P1129, DOI 10.1093/infdis/173.5.1129; Wade JJ, 1995, MICROB DRUG RESIST, V1, P241, DOI 10.1089/mdr.1995.1.241; Weinstein JT, 1996, INFECT CONT HOSP EP, V17, P36; Weinstein MR, 1999, CLIN INFECT DIS, V29, P361, DOI 10.1086/520216; WELLS CL, 1995, CLIN INFECT DIS, V21, P45, DOI 10.1093/clinids/21.1.45; WHITMAN MS, 1993, ANTIMICROB AGENTS CH, V37, P2069, DOI 10.1128/AAC.37.10.2069; Whitman MS, 1996, ANTIMICROB AGENTS CH, V40, P1526, DOI 10.1128/AAC.40.6.1526; WILSON WR, 1995, JAMA-J AM MED ASSOC, V274, P1706, DOI 10.1001/jama.274.21.1706; Witte W, 1995, MICROB DRUG RESIST, V1, P259, DOI 10.1089/mdr.1995.1.259; Woodford N, 1998, ANTIMICROB AGENTS CH, V42, P502, DOI 10.1128/AAC.42.3.502; Zaman MM, 1996, J ANTIMICROB CHEMOTH, V37, P127, DOI 10.1093/jac/37.1.127; Zhanel GG, 1998, DIAGN MICR INFEC DIS, V31, P343, DOI 10.1016/S0732-8893(98)00019-4	149	615	647	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2000	342	10					710	721		10.1056/NEJM200003093421007	http://dx.doi.org/10.1056/NEJM200003093421007			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ZW	10706902				2022-12-28	WOS:000085708800007
J	Howe, DT; Gornall, R; Wellesley, D; Boyle, T; Barber, J				Howe, DT; Gornall, R; Wellesley, D; Boyle, T; Barber, J			Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans	BRITISH MEDICAL JOURNAL			English	Article							HUMAN CHORIONIC-GONADOTROPIN; SERUM ALPHA-FETOPROTEIN; UNCONJUGATED ESTRIOL; HCG; EXPERIENCES; ENGLAND; PROGRAM; WALES	Objective To assess the effectiveness of antenatal screening for Down's syndrome by maternal age and routine mid-pregnancy ultrasound scanning. Design Retrospective six year survey. Setting Maternity units of a district general hospital. Subjects Pregnant women booked for delivery in hospital between 1 January 1993 and 31 December 1998. Main outcome measures All cases of Down's syndrome occurring in district identified from regional congenital anomaly register and cytogenetic laboratory records. Women's case notes were examined to identify indication for karyotyping, gestation at diagnosis, and outcome of pregnancy. Results 31 259 deliveries occurred during study period, and 57 cases of Down's syndrome were identified, foul in failed pregnancies and 53 in ongoing pregnancies or in neonates. The analysis was confined to ongoing pregnancies or liveborn children. Invasive antenatal tests were performed in 6.6% (2053/31 259), and 68% (95%, confidence interval 56% to 80%) of cases of Down's syndrome were detected antenatally, giving a positive predictive value of 1.8%. There were 17 undetected cases, and in seven of these the women had declined an offer of invasive testing. In women aged less than 35 years the detection rate was 53% (30% to 76%). Most of the cases detected in younger women followed identification of ultrasound anomalies. Conclusions The overall detection rate was considerably higher than assumed ill demonstration projects for serum screening: As a result, the benefits of serum screening are much less than supposed. Before any new methods to identify Down's syndrome are introduced, such as nuchal translucency or first trimester serum screening, the techniques should be tested in properly controlled trials.	Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; Salisbury Dist Hosp, Cytogenet Lab, Salisbury SP2 8BJ, Wilts, England; Princess Anne Hosp, Wessex Maternal & Fetal Med Unit, Southampton SO16 5YA, Hants, England	Salisbury District Hospital; Salisbury District Hospital	Howe, DT (corresponding author), Princess Anne Hosp, Wessex Maternal & Fetal Med Unit, Southampton SO16 5YA, Hants, England.							ADAMS MM, 1981, JAMA-J AM MED ASSOC, V246, P758, DOI 10.1001/jama.246.7.758; BECKHUIS J, 1993, THESIS GRONINGEN U G; BURTON BK, 1993, AM J OBSTET GYNECOL, V169, P526, DOI 10.1016/0002-9378(93)90613-N; Cans C, 1998, PRENATAL DIAG, V18, P683, DOI 10.1002/(SICI)1097-0223(199807)18:7<683::AID-PD327>3.0.CO;2-G; CHENG EY, 1993, OBSTET GYNECOL, V81, P72; Crossley J A, 1994, J Med Screen, V1, P180; CUCKLE H, 1991, PRENATAL DIAG, V11, P29, DOI 10.1002/pd.1970110106; DAVIES T, 1991, BRIT MED J, V303, P312; DAWSON AJ, 1993, BRIT J OBSTET GYNAEC, V100, P875, DOI 10.1111/j.1471-0528.1993.tb14326.x; GOODBURN SF, 1994, PRENATAL DIAG, V14, P391, DOI 10.1002/pd.1970140509; GREEN JM, 1994, BRIT MED J, V309, P769, DOI 10.1136/bmj.309.6957.769; HADDOW JE, 1992, NEW ENGL J MED, V327, P588, DOI 10.1056/NEJM199208273270902; KEATINGE RM, 1991, BRIT MED J, V303, P54, DOI 10.1136/bmj.303.6793.54-d; KELLNER LH, 1995, AM J OBSTET GYNECOL, V172, P831, DOI 10.1016/0002-9378(95)90007-1; Lam YH, 1998, PRENATAL DIAG, V18, P585, DOI 10.1002/(SICI)1097-0223(199806)18:6<585::AID-PD305>3.0.CO;2-R; MACRI JN, 1994, PRENATAL DIAG, V14, P97, DOI 10.1002/pd.1970140204; MANCINI G, 1994, INT J CLIN LAB RES, V24, P49, DOI 10.1007/BF02592410; McDuffie R S Jr, 1996, J Matern Fetal Med, V5, P70; MOONEY RA, 1994, OBSTET GYNECOL, V84, P298; NYBERG DA, 1990, OBSTET GYNECOL, V76, P370; Pandya PP, 1995, BRIT J OBSTET GYNAEC, V102, P957, DOI 10.1111/j.1471-0528.1995.tb10902.x; Pescia G, 1993, Rev Med Suisse Romande, V113, P277; PHILLIPS OP, 1992, OBSTET GYNECOL, V80, P353; Piggott M, 1994, J Med Screen, V1, P45; Royal College of Obstetricians and Gynaecologists, 1993, REP WORK PART BIOCH, P19; Sadler M, 1997, BRIT J OBSTET GYNAEC, V104, P176, DOI 10.1111/j.1471-0528.1997.tb11040.x; Salonen R, 1997, ACTA OBSTET GYN SCAN, V76, P817, DOI 10.3109/00016349709024358; SHELDON T, 1991, BRIT MED J, V303, P55, DOI 10.1136/bmj.303.6793.55-a; SMITH DK, 1994, BRIT MED J, V309, P776, DOI 10.1136/bmj.309.6957.776; SPENCER K, 1993, BRIT MED J, V307, P764, DOI 10.1136/bmj.307.6907.764; STATHAM H, 1993, BRIT MED J, V307, P174, DOI 10.1136/bmj.307.6897.174; Valerio D, 1996, Minerva Ginecol, V48, P169; van Rijn M, 1998, Ned Tijdschr Geneeskd, V142, P409; Wald NJ, 1996, BRIT J OBSTET GYNAEC, V103, P407, DOI 10.1111/j.1471-0528.1996.tb09765.x; WALD NJ, 1992, BMJ-BRIT MED J, V305, P391, DOI 10.1136/bmj.305.6850.391; WELLESLEY D, 1999, ANN REPORT WESSEX AN	36	39	39	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					606	610		10.1136/bmj.320.7235.606	http://dx.doi.org/10.1136/bmj.320.7235.606			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698877	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000085742600023
J	Lezcano, N; Mrzljak, L; Eubanks, S; Levenson, R; Goldman-Rakic, P; Bergson, C				Lezcano, N; Mrzljak, L; Eubanks, S; Levenson, R; Goldman-Rakic, P; Bergson, C			RETRACTED: Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein (Retracted Article. See vol 314, pg 1681, 2006)	SCIENCE			English	Article; Retracted Publication							PREFRONTAL CORTEX; GOLGI-APPARATUS; CEREBRAL-CORTEX; PRIMATE BRAIN; MESSENGER-RNA; LOCALIZATION; RAT; D-1; MODULATION; NEURONS	The synergistic response of cells to the stimulation of multiple receptors has been ascribed to receptor cross talk: however, the specific molecules that mediate the resultant signal amplification have not been defined. Here a 24-kilodalton single transmembrane protein, designated calcyon, we functionally characterize that interacts with the D1 dopamine receptor. Calcyon Localizes to dendritic spines of D1 receptor-expressing pyramidal cells in prefrontal cortex. These studies delineate a mechanism of G(q)- and G(s)-coupled heterotrimeric CTP-binding protein-coupled receptor cross talk by which D1 receptors can shift effector coupling to stimulate robust intracellular calcium (Ca(i)(2+)) release as a result of interaction with calcyon. The role of calcyon in potentiating Ca(2+)-dependent signaling should provide insight into the D1 receptor-modulated cognitive functions of prefrontal cortex.	Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA; Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA	University System of Georgia; Augusta University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Bergson, C (corresponding author), Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	cbergson@mail.mcg.edu		Levenson, Robert/0000-0002-0936-8421	NIMH NIH HHS [P50 MH068789, R01 MH063271, MH56608, P50 MH44866] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068789, R01MH063271, R29MH056608, P50MH044866] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bergson C, 1995, J NEUROSCI, V15, P7821; CASTNER SA, IN PRESS SCIENCE; CEPEDA C, 1992, SYNAPSE, V11, P330, DOI 10.1002/syn.890110408; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GOLDMANRAKIC PS, 1990, J NEUROSCI, V10, P2125; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Konradi C, 1996, J NEUROSCI, V16, P4231; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEZCANO N, UNPUB; MRZLJAK L, 1993, P NATL ACAD SCI USA, V90, P5194, DOI 10.1073/pnas.90.11.5194; Mrzljak L, 1998, J COMP NEUROL, V390, P112; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; RICHARDS FM, 1971, ENZYMES, V4, P647; Saberan-Djoneidi D, 1998, J BIOL CHEM, V273, P3909, DOI 10.1074/jbc.273.7.3909; SABERANDJONEIDI D, 1995, J BIOL CHEM, V270, P1888, DOI 10.1074/jbc.270.4.1888; SMILEY JF, 1994, P NATL ACAD SCI USA, V91, P5720, DOI 10.1073/pnas.91.12.5720; SUTCLIFFE JG, 1983, CELL, V33, P671, DOI 10.1016/0092-8674(83)90010-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UNDIE AS, 1990, J PHARMACOL EXP THER, V253, P987; UNDIE AS, 1994, J NEUROCHEM, V62, P2045; UNDIE AS, 1994, J NEUROCHEM, V63, P222; Wang HY, 1995, MOL PHARMACOL, V48, P988; Wang JQ, 1997, J PHARMACOL EXP THER, V281, P972; Wang Q, 1997, J BIOL CHEM, V272, P26040, DOI 10.1074/jbc.272.41.26040; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; YU PY, 1995, J CLIN INVEST, V95, P304, DOI 10.1172/JCI117656; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; ZHOU QY, 1990, NATURE, V347, P76, DOI 10.1038/347076a0	32	135	145	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1660	1664		10.1126/science.287.5458.1660	http://dx.doi.org/10.1126/science.287.5458.1660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698743				2022-12-28	WOS:000085628200041
J	Henney, JE				Henney, JE			Celecoxib indicated for FAP	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	32	32	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1131	1131		10.1001/jama.283.9.1131	http://dx.doi.org/10.1001/jama.283.9.1131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703765				2022-12-28	WOS:000085424100007
J	Dornhorst, A; Frost, G				Dornhorst, A; Frost, G			Jelly-beans, only a colourful distraction from gestational glucose-challenge tests	LANCET			English	Editorial Material							TOLERANCE		Hammersmith Hosp, Imperial Coll Sch Med, Dept Metab Med, London W12 0NN, England; Hammersmith Hosp, Imperial Coll Sch Med, Dept Nutr & Dietet, London W12 0NN, England	Imperial College London; Imperial College London	Dornhorst, A (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Dept Metab Med, London W12 0NN, England.							*AM DIAB ASS, 1999, DIABETES CARE S1, V22, pS74; HANSON U, 1993, AM J PERINAT, V10, P330, DOI 10.1055/s-2007-994754; Jarrett RJ, 1997, BMJ-BRIT MED J, V315, P736, DOI 10.1136/bmj.315.7110.736; JARRETT RJ, 1993, BMJ-BRIT MED J, V306, P37, DOI 10.1136/bmj.306.6869.37; Lamar ME, 1999, AM J OBSTET GYNECOL, V181, P1154, DOI 10.1016/S0002-9378(99)70099-2; Naylor CD, 1996, JAMA-J AM MED ASSOC, V275, P1165, DOI 10.1001/jama.275.15.1165; Pettitt D.J., 1985, DIABETES, V34, P119, DOI DOI 10.2337/DIAB.34.2.S119; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; WALKINSHAW SA, 1999, COCHRANE LIB; WALKINSHAW SA, 2000, COCHRANE LIB	10	7	7	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					674	674		10.1016/S0140-6736(00)90025-4	http://dx.doi.org/10.1016/S0140-6736(00)90025-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703798				2022-12-28	WOS:000085615600007
J	Molyneux, ME				Molyneux, ME			Impact of malaria on the brain and its prevention	LANCET			English	Editorial Material							CHILDHOOD CEREBRAL MALARIA; SEQUELAE; CHILDREN		Univ Malawi, Coll Med, Wellcome Trust Res Labs, Blantyre 3, Malawi; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool	Molyneux, ME (corresponding author), Univ Malawi, Coll Med, Wellcome Trust Res Labs, Box 30096, Blantyre 3, Malawi.							BONDI FS, 1992, T ROY SOC TROP MED H, V86, P17, DOI 10.1016/0035-9203(92)90420-H; BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7; Holding PA, 1999, T ROY SOC TROP MED H, V93, P529, DOI 10.1016/S0035-9203(99)90368-1; MOLYNEUX ME, 1989, Q J MED, V71, P441; Muntendam AH, 1996, T ROY SOC TROP MED H, V90, P391, DOI 10.1016/S0035-9203(96)90518-0; vanHensbroek MB, 1997, J PEDIATR-US, V131, P125, DOI 10.1016/S0022-3476(97)70135-5	6	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					671	672		10.1016/S0140-6736(99)00435-3	http://dx.doi.org/10.1016/S0140-6736(99)00435-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703796				2022-12-28	WOS:000085615600005
J	Dekker, LV; Segal, AW				Dekker, LV; Segal, AW			Signal transduction - Signals to move cells	SCIENCE			English	Editorial Material							PHOSPHOINOSITIDE		UCL, Ctr Mol Med, London WC1E 6JJ, England	University of London; University College London	Dekker, LV (corresponding author), UCL, Ctr Mol Med, 5 Univ St, London WC1E 6JJ, England.	mhalvd@ucl.ac.uk	Dekker, Lodewijk/J-6934-2013	Dekker, Lodewijk/0000-0001-5247-3297; Segal, Anthony/0000-0001-7602-9043				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bottomley MJ, 1998, BBA-MOL CELL BIOL L, V1436, P165, DOI 10.1016/S0005-2760(98)00141-6; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; STEPHENS L, 1994, CURR BIOL, V4, P203, DOI 10.1016/S0960-9822(00)00049-X; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X	17	95	104	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2000	287	5455					982	+		10.1126/science.287.5455.982	http://dx.doi.org/10.1126/science.287.5455.982			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282WU	10691572				2022-12-28	WOS:000085245400031
J	Isles, CG; Ritchie, LD; Murchie, P; Norrie, J				Isles, CG; Ritchie, LD; Murchie, P; Norrie, J			Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Dumfries & Galloway Royal Infirm, Med Unit, Dumfries DG1 4AP, Scotland; Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Aberdeen; University of Glasgow	Isles, CG (corresponding author), Dumfries & Galloway Royal Infirm, Med Unit, Dumfries DG1 4AP, Scotland.	chrisisles@glebehouse.sol.co.uk		Murchie, Peter/0000-0001-9968-5991				HAQ IU, 1997, HEART, V77, P36; Mann JI, 1996, NEW ZEAL MED J, V109, P224; *SCOTT INT GUID NE, 1999, SIGN PUBL, V40; WINYARD G, 1997, STANDING MED ADVISOR; *WORK PART BRIT CA, 1998, HEART, V80, pS1	5	33	34	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					690	691		10.1136/bmj.320.7236.690	http://dx.doi.org/10.1136/bmj.320.7236.690			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710579	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000085895300023
J	Collins, PG; Bradley, K; Ishigami, M; Zettl, A				Collins, PG; Bradley, K; Ishigami, M; Zettl, A			Extreme oxygen sensitivity of electronic properties of carbon nanotubes	SCIENCE			English	Article							GRAPHITE NANOFIBERS; ADSORPTION; HYDROGEN; STORAGE; ROPES	The electronic properties of single-walled carbon nanotubes are shown here to be extremely sensitive to the chemical environment. Exposure to air or oxygen dramatically influences the nanotubes' electrical resistance, thermoelectric power, and Local density of states, as determined by transport measurements and scanning tunneling spectroscopy. These electronic parameters can be reversibly "tuned" by surprisingly small concentrations of adsorbed gases, and an apparently semiconducting nanotube can be converted into an apparent metal through such exposure. These results, although demonstrating that nanotubes could find use as sensitive chemical gas sensors, Likewise indicate that many supposedly intrinsic properties measured on as-prepared nanotubes may be severely compromised by extrinsic air exposure effects.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zettl, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.		Zettl, Alex K/O-4925-2016; Ishigami, Masahiro/AAO-2083-2021	Zettl, Alex K/0000-0001-6330-136X; 				ABEL H, 1992, TRANSPORT ELECT PROP; Ahn CC, 1998, APPL PHYS LETT, V73, P3378, DOI 10.1063/1.122755; Ayappa KG, 1998, LANGMUIR, V14, P880, DOI 10.1021/la970499j; Bockrath M, 1997, SCIENCE, V275, P1922, DOI 10.1126/science.275.5308.1922; Britto PJ, 1999, ADV MATER, V11, P154, DOI 10.1002/(SICI)1521-4095(199902)11:2<154::AID-ADMA154>3.0.CO;2-B; Chambers A, 1998, J PHYS CHEM B, V102, P4253, DOI 10.1021/jp980114l; Collins P., 1999, B AM PHYS SOC, V44, P1889; COLLINS PG, UNPUB; Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0; Dresselhaus M. S., 1995, SCI FULLERENES CARBO; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Hone J, 1998, PHYS REV LETT, V80, P1042, DOI 10.1103/PhysRevLett.80.1042; Kobayashi N, 1998, J CHEM PHYS, V109, P1983, DOI 10.1063/1.476774; Lee SM, 1999, PHYS REV LETT, V82, P217, DOI 10.1103/PhysRevLett.82.217; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; Nalimova VA, 1997, SYNTHETIC MET, V88, P89, DOI 10.1016/S0379-6779(97)03821-6; Odom TW, 1998, NATURE, V391, P62, DOI 10.1038/34145; SINGER LS, 1961, P 5 CARB C, V2, P37; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; TERSOFF J, 1983, PHYS REV LETT, V50, P25; Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483; TSANG SC, 1994, NATURE, V372, P159, DOI 10.1038/372159a0; WEDLER G, 1987, STUDIES SURFACE SCI, V32; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; Wu GT, 1999, J ELECTROCHEM SOC, V146, P1696, DOI 10.1149/1.1391828	25	2651	2758	14	851	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1801	1804		10.1126/science.287.5459.1801	http://dx.doi.org/10.1126/science.287.5459.1801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710305				2022-12-28	WOS:000085775300037
J	Hirao, A; Kong, YY; Matsuoka, S; Wakeham, A; Ruland, J; Yoshida, H; Liu, D; Elledge, SJ; Mak, TW				Hirao, A; Kong, YY; Matsuoka, S; Wakeham, A; Ruland, J; Yoshida, H; Liu, D; Elledge, SJ; Mak, TW			DNA damage-induced activation of p53 by the checkpoint kinase Chk2	SCIENCE			English	Article							CELL-CYCLE REGULATION; INDUCED APOPTOSIS; RADIATION; ATM; PHOSPHORYLATION; TRANSCRIPTION; LINKAGE; GENE; P21	Chk2 is a protein kinase that is activated in response to DNA damage and may regulate cell cycle arrest. We generated Chk2-deficient mouse cells by gene targeting. Chk2(-/-) embryonic stem cells failed to maintain gamma-irradiation-induced arrest in the Ci phase of the cell cycle. Chk2(-/-) thymocytes were resistant to DNA damage-induced apoptosis. Chk2(-/-) cells were defective for p53 stabilization and for induction of p53-dependent transcripts such as p21 in response to gamma irradiation. Reintroduction of the Chk2 gene restored p53-dependent transcription in response to gamma irradiation. Chk2 directly phosphorylated p53 on serine 20, which is known to interfere with Mdm2 binding. This provides a mechanism for increased stability of p53 by prevention of ubiquitination in response to DNA damage.	Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Baylor Coll Med, Howard Hughes Med Inst, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Mak, TW (corresponding author), Univ Toronto, Ontario Canc Inst, Amgen Inst, 620 Univ Ave,Suite 706, Toronto, ON M5G 2C1, Canada.		Ruland, Jürgen/Q-6680-2018	Ruland, Jürgen/0000-0002-8381-3597	NIGMS NIH HHS [GM44664] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM044664] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bargonetti J, 1997, CELL MOL BIOL, V43, P935; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; HARPER JW, 1993, CELL, V75, P805; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MIYASHITA T, 1995, CELL, V80, P293; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SANCHEZ Y, UNPUB; Schmidt-Kastner PK, 1998, ONCOGENE, V16, P3003, DOI 10.1038/sj.onc.1201835; SELLINS KS, 1987, J IMMUNOL, V139, P3199; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1	25	990	1026	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1824	1827		10.1126/science.287.5459.1824	http://dx.doi.org/10.1126/science.287.5459.1824			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710310				2022-12-28	WOS:000085775300042
J	Sala, OE; Chapin, FS; Armesto, JJ; Berlow, E; Bloomfield, J; Dirzo, R; Huber-Sanwald, E; Huenneke, LF; Jackson, RB; Kinzig, A; Leemans, R; Lodge, DM; Mooney, HA; Oesterheld, M; Poff, NL; Sykes, MT; Walker, BH; Walker, M; Wall, DH				Sala, OE; Chapin, FS; Armesto, JJ; Berlow, E; Bloomfield, J; Dirzo, R; Huber-Sanwald, E; Huenneke, LF; Jackson, RB; Kinzig, A; Leemans, R; Lodge, DM; Mooney, HA; Oesterheld, M; Poff, NL; Sykes, MT; Walker, BH; Walker, M; Wall, DH			Biodiversity - Global biodiversity scenarios for the year 2100	SCIENCE			English	Review							FRESH-WATER; THREATS; CO2; LIMITATION; FUTURE	Scenarios of changes in biodiversity for the year 2100 can now be developed based on scenarios of changes in atmospheric carbon dioxide, climate, vegetation, and Land use and the known sensitivity of biodiversity to these changes. This study identified a ranking of the importance of drivers of change, a ranking of the biomes with respect to expected changes, and the major sources of uncertainties. For terrestrial ecosystems, land-use change probably wilt have the largest effect, followed by climate change, nitrogen deposition, biotic exchange, and elevated carbon dioxide concentration. For freshwater ecosystems, biotic exchange is much more important. Mediterranean climate and grassland ecosystems likely will experience the greatest proportional change in biodiversity because of the substantial influence of all drivers of biodiversity change. Northern temperate ecosystems are estimated to experience the least biodiversity change because major land-use change has already occurred. Plausible changes in biodiversity in other biomes depend on interactions among the causes of biodiversity change. These interactions represent one of the largest uncertainties in projections of future biodiversity change.	Univ Buenos Aires, Dept Ecol, RA-1417 Buenos Aires, DF, Argentina; Univ Buenos Aires, Inst Invest Fisiol & Ecol Vinculadas Agr, Fac Agron, RA-1417 Buenos Aires, DF, Argentina; Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; Univ Alaska, Inst No Forest Cooperat Res, Fairbanks, AK 99775 USA; Univ Chile, Fac Ciencias, Santiago, Chile; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Environm Def Fund, New York, NY 10010 USA; Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; Tech Univ Munich, Lehrstuhl Grunlandlehre, D-85350 Munich, Germany; New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; Duke Univ, Dept Bot, Durham, NC 27708 USA; Arizona State Univ, Dept Biol, Tempe, AZ 85287 USA; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; Univ Notre Dame, Dept Biol, Notre Dame, IN 46556 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; Lund Univ, Ekologihuset, S-22362 Lund, Sweden; Commonwealth Sci & Ind Res Org, Div Wildlife & Ecol, Canberra, ACT, Australia	University of Buenos Aires; University of Buenos Aires; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; Universidad de Chile; University of California System; University of California Berkeley; Environmental Defense Fund; Universidad Nacional Autonoma de Mexico; Technical University of Munich; New Mexico State University; Duke University; Arizona State University; Arizona State University-Tempe; Netherlands National Institute for Public Health & the Environment; University of Notre Dame; Stanford University; Colorado State University; Colorado State University; Lund University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sala, OE (corresponding author), Univ Buenos Aires, Dept Ecol, Ave San Martin 4453, RA-1417 Buenos Aires, DF, Argentina.	sala@ifeva.edu.ar	Jacobs, Jeffrey/GWZ-3790-2022; Poff, Nathan L/C-1239-2009; Huenneke, Laura F/D-3582-2009; Walker, Brian H/F-2386-2011; Armesto, Juan J/G-6467-2016; Leemans, Rik/A-1548-2009; Lodge, David Michael/AAX-1781-2021; Chapin, F Stuart/AAZ-3931-2020; Wall, Diana H/F-5491-2011; Huber-Sannwald, Elisabeth/D-2507-2009	Jacobs, Jeffrey/0000-0003-3772-5323; Huenneke, Laura F/0000-0002-2562-6822; Leemans, Rik/0000-0002-4001-6301; Chapin, F Stuart/0000-0002-2558-9910; Poff, N LeRoy/0000-0002-1390-8742; Jackson, Robert/0000-0001-8846-7147; Oesterheld, Martin/0000-0001-8462-0087; Sala, Osvaldo/0000-0003-0142-9450				ALCARNO J, 1994, IMAGE, V2; Anderson J.M., 1995, GLOBAL BIODIVERSITY, P406; Bailey R.G., 1998, ECOREGIONS ECOSYSTEM; BILLINGS WD, 1973, BIOSCIENCE, V23, P697, DOI 10.2307/1296827; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; CHAPIN FS, FUTURE SCENARIOS GLO; *COMM INL AQ EC WA, 1996, FRESHW EC; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Drake J.A., 1989, BIOL INVASIONS GLOBA, V37; FUNG IY, 1987, J GEOPHYS RES-ATMOS, V92, P2999, DOI 10.1029/JD092iD03p02999; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Haxeltine A, 1996, GLOBAL BIOGEOCHEM CY, V10, P693, DOI 10.1029/96GB02344; Houghton T, 1996, CLIMATE CHANGE 1995; JACKSON RB, 1994, OECOLOGIA, V98, P257, DOI 10.1007/BF00324212; Kattenberg A, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P285; Lodge DM, 1998, AUST J ECOL, V23, P53, DOI 10.1111/j.1442-9993.1998.tb00705.x; Mooney H.A., 1999, TERRESTRIAL BIOSPHER, P141; MOONEY HA, 1991, BIOSCIENCE, V41, P96, DOI 10.2307/1311562; MOONEY HA, 1970, EVOLUTION, V24, P292, DOI 10.1111/j.1558-5646.1970.tb01762.x; OSWOOD MW, 1992, GLOBAL CLIMATE CHANGE AND FRESHWATER ECOSYSTEMS, P192; Overton S., 1977, ECOSYSTEM MODELING T, P49; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Rejmanek M, 1996, ECOL STU AN, V122, P153; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Richter BD, 1997, CONSERV BIOL, V11, P1081, DOI 10.1046/j.1523-1739.1997.96236.x; SALA OE, 1995, GLOBAL BIODIVERSITY; Schindler DW, 1998, BIOSCIENCE, V48, P157, DOI 10.2307/1313261; SISK TD, 1994, BIOSCIENCE, V44, P592, DOI 10.2307/1312459; TILMAN D, 1993, ECOLOGY, V74, P2179, DOI 10.2307/1939572; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; Vitousek PM, 1995, ISLANDS BIOL DIVERSI; Walker BH, 1996, GLOBAL CHANGE TERRES; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	38	5825	6281	182	4520	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2000	287	5459					1770	1774		10.1126/science.287.5459.1770	http://dx.doi.org/10.1126/science.287.5459.1770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710299				2022-12-28	WOS:000085775300030
J	Felts, JH				Felts, JH			Richard Lower: Anatomist and physiologist	ANNALS OF INTERNAL MEDICINE			English	Biographical-Item									Wake Forest Univ, Sch Med, Dept Med Nephrol, Winston Salem, NC 27157 USA	Wake Forest University	Felts, JH (corresponding author), Wake Forest Univ, Sch Med, Dept Med Nephrol, Med Ctr Blvd, Winston Salem, NC 27157 USA.								0	17	18	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2000	132	5					420	423		10.7326/0003-4819-132-5-200003070-00023	http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KY	10691601				2022-12-28	WOS:000085563000021
J	Vadhan-Raj, S; Verschraegen, CF; Bueso-Ramos, C; Broxmeyer, HE; Kudelka, AP; Freedman, RS; Edwards, CL; Gershenson, D; Jones, D; Ashby, M; Kavanagh, JJ				Vadhan-Raj, S; Verschraegen, CF; Bueso-Ramos, C; Broxmeyer, HE; Kudelka, AP; Freedman, RS; Edwards, CL; Gershenson, D; Jones, D; Ashby, M; Kavanagh, JJ			Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer	ANNALS OF INTERNAL MEDICINE			English	Article							COLONY-STIMULATING FACTOR; HUMAN MEGAKARYOCYTE GROWTH; PHASE-I TRIAL; C-MPL LIGAND; OVARIAN-CANCER; LUNG-CANCER; CHEMOTHERAPY; ESCALATION; CLONING	Background: Thrombocytopenia is a significant problem in the treatment of cancer. Objective: To assess the clinical safety of therapy with recombinant human thrombopoietin (rhTPO) and its ability to ameliorate chemotherapy-induced severe thrombocytopenia. Patients: 29 patients with gynecologic cancer. Intervention: Recombinant human thrombopoietin was given before chemotherapy and after a second cycle of carboplatin therapy. Measurements: Peripheral blood counts and platelet transfusions. Design: Phase I/II clinical cohort study Setting: The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Results: Administration of rhTPO after chemotherapy significantly reduced the degree and duration of thrombocytopenia and enhanced platelet recovery. In patients who received the optimal biological dose of rhTPO (1.2 mu g/kg of body weight) in cycle 2 (carboplatin plus rhTPO), the mean platelet count nadir was higher (44 x 10(9) cells/L and 20 x 10(9) cells/L; P = 0.002) and the duration of thrombocytopenia was shorter (days with a platelet count <20 x 10(9) cells/L 1 and 4 [P = 0.002]; days with a platelet count <50 x 10(9) cells/L 4 and 7 [P = 0.006]) than in cycle 1 (carboplatin only). The need for platelet transfusion in this group was reduced from 75% of patients in cycle 1 to 25% of patients in cycle 2 (P = 0.013). Conclusions: Therapy with rhTPO seems to be safe and may attenuate chemotherapy-induced severe thrombocytopenia and reduce the need for platelet transfusions.	Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Genentech Inc, Ctr Oncol, Med Affairs, San Francisco, CA 94080 USA	University of Texas System; UTMD Anderson Cancer Center; Indiana University System; Indiana University-Purdue University Indianapolis; Roche Holding; Genentech	Vadhan-Raj, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Box 002,1515 Holcombe Blvd, Houston, TX 77030 USA.	svadhanr@notes.mdacc.tmc.edu	Verschraegen, Claire/AAE-7620-2020	Verschraegen, Claire/0000-0001-6544-3089	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054037, P01HL053586, R01HL056416] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL54037, P01 HL53586, R01 HL56416] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARTLEY TD, 1994, CELL, V77, P1117, DOI 10.1016/0092-8674(94)90450-2; Basser RL, 1997, BLOOD, V89, P3118; CALVERT AH, 1994, SEMIN ONCOL, V21, P1; CRAWFORD J, 1991, NEW ENGL J MED, V325, P164, DOI 10.1056/NEJM199107183250305; DESAUVAGE FJ, 1994, NATURE, V369, P533, DOI 10.1038/369533a0; DHONDT V, 1993, J CLIN ONCOL, V11, P2063, DOI 10.1200/JCO.1993.11.11.2063; Fanucchi M, 1997, NEW ENGL J MED, V336, P404, DOI 10.1056/NEJM199702063360603; HEYMAN MR, 1990, SEMIN ONCOL, V17, P198; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; LOWE J, 1986, BLOOD S, V88, pA352; NEMUNAITIS J, 1991, NEW ENGL J MED, V324, P1773, DOI 10.1056/NEJM199106203242504; RUSTHOVEN J, 1991, J NATL CANCER I, V83, P1748, DOI 10.1093/jnci/83.23.1748; Tepler I, 1996, BLOOD, V87, P3607; Vadhan-Raj S, 1999, BRIT J HAEMATOL, V104, P403, DOI 10.1046/j.1365-2141.1999.01178.x; VadhanRaj S, 1997, ANN INTERN MED, V126, P673, DOI 10.7326/0003-4819-126-9-199705010-00001; VADHANRAJ S, 1994, J CLIN ONCOL, V12, P707, DOI 10.1200/JCO.1994.12.4.707; VADHANRAJ S, 1994, J CLIN ONCOL, V12, P715, DOI 10.1200/JCO.1994.12.4.715; VADHANRAJ S, 1996, BLOOD S, V88, P448; WEBER J, 1993, J CLIN ONCOL, V11, P499, DOI 10.1200/JCO.1993.11.3.499; WENDLING F, 1994, NATURE, V369, P571, DOI 10.1038/369571a0	20	116	142	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2000	132	5					364	368		10.7326/0003-4819-132-5-200003070-00005	http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00005			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KY	10691586				2022-12-28	WOS:000085563000004
J	Wilson, JA; Hevey, M; Bakken, R; Guest, S; Bray, M; Schmaljohn, AL; Hart, MK				Wilson, JA; Hevey, M; Bakken, R; Guest, S; Bray, M; Schmaljohn, AL; Hart, MK			Epitopes involved in antibody-mediated protection from Ebola virus	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; VIRION GLYCOPROTEINS; PROPHYLAXIS; INFECTION; FEVER	To determine the ability of antibodies to provide protection from Ebola viruses, monoclonal antibodies (mAbs) to the Ebola glycoprotein were generated and evaluated for efficacy. We identified several protective mAbs directed toward five unique epitopes on Ebola glycoprotein. One of the epitopes is conserved among all Ebola viruses that are known to be pathogenic for humans. Some protective mAbs were also effective therapeutically when administered to mice 2 days after exposure to Lethal Ebola virus. The identification of protective mAbs has important implications for developing vaccines and therapies for Ebola virus.	USA, Div Virol, Med Res Inst Infect Dis, Ft Detrick, Frederick, MD 21702 USA		Hart, MK (corresponding author), USA, Div Virol, Med Res Inst Infect Dis, Ft Detrick, 1425 Porter St, Frederick, MD 21702 USA.	marykate.hart@amedd.army.mil		Hevey, Michael/0000-0001-7481-1058				Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; *COMM CAR US LAB A, 1996, NIH PUBL; Hevey M, 1997, VIROLOGY, V239, P206, DOI 10.1006/viro.1997.8883; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Kudoyarova-Zubavichene NM, 1999, J INFECT DIS, V179, pS218, DOI 10.1086/514294; MIKHAILOV VV, 1994, VOP VIRUSOL+, V39, P82; MOE JB, 1981, J CLIN MICROBIOL, V13, P791, DOI 10.1128/JCM.13.4.791-793.1981; Peters CJ, 1999, J INFECT DIS, V179, pIX; Pushko P, 1997, VACCINES, P253; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sanchez A, 1999, J INFECT DIS, V179, pS164, DOI 10.1086/514282; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; STILES BG, 1991, TOXICON, V29, P1195, DOI 10.1016/0041-0101(91)90192-T; Volchkov VE, 1998, VIROLOGY, V245, P110, DOI 10.1006/viro.1998.9143; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; WALDMANN H, 1989, ANNU REV IMMUNOL, V7, P407, DOI 10.1146/annurev.iy.07.040189.002203; WILSON J, UNPUB; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037	19	363	407	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1664	1666		10.1126/science.287.5458.1664	http://dx.doi.org/10.1126/science.287.5458.1664			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698744				2022-12-28	WOS:000085628200042
J	Keshavjee, S; Becerra, MC				Keshavjee, S; Becerra, MC			Disintegrating health services and resurgent tuberculosis in post-Soviet Tajikistan: An example of structural violence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Stanford Univ, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Cultural & Social Anthropol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School	Keshavjee, S (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.			Keshavjee, Salmaan/0000-0002-6967-3305				Bourdieu P., 1993, MISERE MONDE, P159; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; FARMER P, 1995, DAEDALUS, V125, P261; Harvard Medical School and Open Society Institute, 1999, GLOB IMP DRUG RES TU; KESHAVJEE S, 1998, THESIS HARVARD U BOS; Kim J. Y., 2000, DYING GROWTH GLOBAL; NAJIBULLAH F, 1998, TAJIKISTAN HLTH CARE; SCHEPERHUGHES N, 1992, DEATH WEEPING VIOLEN, P128; *WHO, 1999, TAJ HLTH SECT REP 19; World Health Organization, 1994, WHO TUB PROGR FRAM E	10	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1201	1201		10.1001/jama.283.9.1201	http://dx.doi.org/10.1001/jama.283.9.1201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	286BQ	10703788	hybrid			2022-12-28	WOS:000085424100035
J	Lincoln, NB; Husbands, S; Trescoli, C; Drummond, AER; Gladman, JRF; Berman, P				Lincoln, NB; Husbands, S; Trescoli, C; Drummond, AER; Gladman, JRF; Berman, P			Five year follow up of a randomised controlled trial of a stroke rehabilitation unit	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; Univ Nottingham, Ageing & Disabil Res Unit, Nottingham NG7 2UH, England; Nottingham City Hosp NHS Trust, Dept Med, Nottingham NG5 1PB, England	University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Lincoln, NB (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	nbl@psychology.nottingham.ac.uk	Trescolí, Carlos/GLQ-7462-2022; Lincoln, Nadina B/B-9149-2009; Gladman, John/M-7429-2015	Drummond, Avril/0000-0003-1220-8354; Gladman, John/0000-0002-8506-7786				Asplund K, 1997, BMJ-BRIT MED J, V314, P1151; Collin C, 1988, Int Disabil Stud, V10, P61; Indredavik B, 1997, STROKE, V28, P1861, DOI 10.1161/01.STR.28.10.1861; Juby LC, 1996, CEREBROVASC DIS, V6, P106, DOI 10.1159/000108005	4	31	31	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2000	320	7234					549	549		10.1136/bmj.320.7234.549	http://dx.doi.org/10.1136/bmj.320.7234.549			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688561	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000085624000023
J	Weissman, IL				Weissman, IL			Translating stem and progenitor cell biology to the clinic: Barriers and opportunities	SCIENCE			English	Review							VERSUS-HOST DISEASE; BONE-MARROW TRANSPLANTATION; HEMATOPOIETIC-CELLS; ENDOTHELIAL-CELLS; MYELOID-LEUKEMIA; MOUSE; IDENTIFICATION; PURIFICATION; POPULATION; ANTIGENS	Stem cells are the natural units of embryonic generation, and also adult regeneration, of a variety of tissues. Recently, the List of tissues that use the model of differentiation from stem to progenitor to mature cell has increased from blood to include a variety of tissues, including both central and peripheral nervous systems and skeletal muscle; it is also possible that all organs and tissues are derived from, and still contain, stem cells. Because the number and activities of stem cells and their progeny are homeostatically regulated, clinical stem cell transplantation could greatly add to the physician's armamentarium against degenerative diseases.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94302 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94302 USA	Stanford University; Stanford University	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94302 USA.							AKASHI K, IN PRESS NATURE; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Baurmann H, 1998, BLOOD, V92, P3582, DOI 10.1182/blood.V92.10.3582.422k33_3582_3590; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Billinghurst L L, 1998, Semin Pediatr Neurol, V5, P211, DOI 10.1016/S1071-9091(98)80036-3; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bonnett D, 1999, P NATL ACAD SCI USA, V96, P8639, DOI 10.1073/pnas.96.15.8639; Bradford GB, 1997, EXP HEMATOL, V25, P445; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Conlon P, 1999, NEUROBIOL DIS, V6, P149, DOI 10.1006/nbdi.1999.0239; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Dasgupta A, 1996, J Infus Chemother, V6, P12; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Domen J, 1999, MOL MED TODAY, V5, P201, DOI 10.1016/S1357-4310(99)01464-1; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; EZINE S, 1984, NATURE, V309, P629, DOI 10.1038/309629a0; Falkenburg JHF, 1999, BLOOD, V94, P1201, DOI 10.1182/blood.V94.4.1201.416k08_1201_1208; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FORD CE, 1956, NATURE, V177, P452, DOI 10.1038/177452a0; Franklin WA, 1999, BLOOD, V94, P340, DOI 10.1182/blood.V94.1.340.413k09_340_347; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; Gandy KL, 1999, IMMUNITY, V11, P579, DOI 10.1016/S1074-7613(00)80133-8; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; GAZITT Y, 1995, BLOOD, V86, P381, DOI 10.1182/blood.V86.1.381.bloodjournal861381; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goulmy E, 1997, HUM IMMUNOL, V54, P8, DOI 10.1016/S0198-8859(97)00007-4; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; JAKCOSN KA, UNPUB; Jiang YZ, 1997, BONE MARROW TRANSPL, V19, P899, DOI 10.1038/sj.bmt.1700769; KAUFMAN CL, 1994, BLOOD, V84, P2436; Keller G, 1999, NAT MED, V5, P151, DOI 10.1038/5512; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krizik MR, 1999, J ENDOCRINOL, V163, P523, DOI 10.1677/joe.0.1630523; LAPIDOT T, 1992, BLOOD, V80, P2406; MAKINODAN T, 1956, P SOC EXP BIOL MED, V92, P174; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; McSweeney P A, 1999, Biol Blood Marrow Transplant, V5, P192, DOI 10.1053/bbmt.1999.v5.pm10465099; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MICHALLET M, UNPUB; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; NEGRIN RS, IN PRESS BIOL BLOOD; NOWELL PC, 1956, CANCER RES, V16, P258; OREILLY RJ, 1999, HEMATOPOIETIC CELL T, P1154; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pardoll DM, 1998, NAT MED, V4, P525, DOI 10.1038/nm0598supp-525; Petersdorf EW, 1999, IMMUNOGENETICS, V49, P605, DOI 10.1007/s002510050655; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; SHIZURU J, UNPUB; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; SHIZURU JA, 1999, HEMATOPOIETIC CELL T, P63; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Snyder Evan Y., 1994, Current Opinion in Neurobiology, V4, P742, DOI 10.1016/0959-4388(94)90018-3; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STORB R, 1989, BLOOD, V73, P1729; SYKES M, 1988, J IMMUNOL, V141, P2282; THOMAS ED, 1959, J CLIN INVEST, V38, P1709, DOI 10.1172/JCI103949; THOMAS ED, 1975, NEW ENGL J MED, V292, P895, DOI 10.1056/NEJM197504242921706; THOMAS ED, 1999, HEMATOPOIETIC CELL T, P807; TILL J, 1961, RADIAT RES, V14, P1419; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TSUKAMOTO A, 1995, HEMATOPOIETIC STEM C, P85; Uchida N, 1998, P NATL ACAD SCI USA, V95, P11939, DOI 10.1073/pnas.95.20.11939; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; Uchida N., UNPUB; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; VandenEynde BJ, 1997, INT J CLIN LAB RES, V27, P81, DOI 10.1007/BF02912440; VOSE J, UNPUB; Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; Weissman I, 1978, DIFFERENTIATION NORM, V5, P33; WEISSMAN IL, 1963, ADV BIOL MED PHYS, V9, P160; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4; Yee C, 1999, J IMMUNOL, V162, P2227	90	626	729	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1442	1446		10.1126/science.287.5457.1442	http://dx.doi.org/10.1126/science.287.5457.1442			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688785				2022-12-28	WOS:000085531600039
J	Bruner, SD; Norman, DPG; Verdine, GL				Bruner, SD; Norman, DPG; Verdine, GL			Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; EXCISION-REPAIR; DAMAGED DNA; OGG1 GENE; 8-HYDROXYGUANINE 7,8-DIHYDRO-8-OXOGUANINE; ESCHERICHIA-COLI; HUMAN HOMOLOG; HOGG1 GENE; GLYCOSYLASE; CLONING	Spontaneous oxidation of guanine residues in DNA generates 8-oxoguanine (oxoG), By mispairing with adenine during replication, oxoG gives rise to a G.C --> T.A transversion, a frequent somatic mutation in human cancers. The dedicated repair pathway for oxoG centres on 8-oxoguanine DNA glycosylase (h0GG1), an enzyme that recognizes oxoG.C base pairs, catalysing expulsion of the oxoG and cleavage of the DNA backbone. Here we report the X-ray structure of the catalytic core of h0GG1 bound to oxoG.C-containing DNA at 2.1 Angstrom resolution. The structure reveals the mechanistic basis for the recognition and catalytic excision of DNA damage by h0GG1 and by other members of the enzyme superfamily to which it belongs. The structure also provides a rationale for the biochemical effects of inactivating mutations and polymorphisms in hOGG1. One known mutation, R154H, converts h0GG1 to a promutator by relaxing the specificity of the enzyme for the base opposite oxoG.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Verdine, GL (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	verdine@chemistry.harvard.edu						Aburatani H, 1997, CANCER RES, V57, P2151; Arai K, 1997, ONCOGENE, V14, P2857, DOI 10.1038/sj.onc.1201139; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Blons H, 1999, MOL CARCINOGEN, V26, P254; Bruner SD, 1998, CURR BIOL, V8, P393, DOI 10.1016/S0960-9822(98)70158-7; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; Choi JY, 1999, FREE RADICAL BIO MED, V27, P848, DOI 10.1016/S0891-5849(99)00141-0; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; DODSON ML, 1994, J BIOL CHEM, V269, P32709; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; KUO CF, 1992, SCIENCE, V258, P434, DOI 10.1126/science.1411536; Kuo FC, 1997, J EXP MED, V186, P1547, DOI 10.1084/jem.186.9.1547; Labahn J, 1996, CELL, V86, P321, DOI 10.1016/S0092-8674(00)80103-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Nash HM, 1997, CHEM BIOL, V4, P693, DOI 10.1016/S1074-5521(97)90225-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Shinmura K, 1998, JPN J CANCER RES, V89, P825, DOI 10.1111/j.1349-7006.1998.tb00635.x; Shinmura K, 1997, MUTAT RES-DNA REPAIR, V385, P75, DOI 10.1016/S0921-8777(97)00041-4; Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Verdine GL, 1997, CHEM BIOL, V4, P329, DOI 10.1016/S1074-5521(97)90123-X; Yamagata Y, 1996, CELL, V86, P311, DOI 10.1016/S0092-8674(00)80102-6	45	797	821	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					859	866		10.1038/35002510	http://dx.doi.org/10.1038/35002510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706276				2022-12-28	WOS:000085559200047
J	Pellegrino, ED				Pellegrino, ED			Decisions to withdraw life-sustaining treatment - A moral algorithm	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Georgetown Univ, Med Ctr, Ctr Clin Bioeth, Washington, DC 20007 USA	Georgetown University	Pellegrino, ED (corresponding author), Georgetown Univ, Med Ctr, Ctr Clin Bioeth, 4000 Reservoir Rd NW,D-238, Washington, DC 20007 USA.								0	90	96	1	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					1065	1067		10.1001/jama.283.8.1065	http://dx.doi.org/10.1001/jama.283.8.1065			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284AM	10697071				2022-12-28	WOS:000085308600040
J	Zito, JM; Safer, DJ; dosReis, S; Gardner, JF; Boles, M; Lynch, F				Zito, JM; Safer, DJ; dosReis, S; Gardner, JF; Boles, M; Lynch, F			Trends in the prescribing of psychotropic medications to preschoolers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the American-Psychiatric-Association	MAY 15-19, 1999	WASHINGTON, D.C.	Amer Psychiat Assoc			DEFICIT HYPERACTIVITY DISORDER; STIMULANT MEDICATION; CLONIDINE; CHILDREN; PSYCHOPHARMACOLOGY; METHYLPHENIDATE; ADOLESCENTS; PREVALENCE; QUESTIONS; EFFICACY	Context Recent reports on the use of psychotropic medications for preschool-aged children with behavioral and emotional disorders warrant further examination of trends in the type and extent of drug therapy and sociodemographic correlates. Objectives To determine the prevalence of psychotropic medication use in preschool-aged youths and to show utilization trends across a 5-year span. Design Ambulatory care prescription records from 2 state Medicaid programs and a salaried group-model health maintenance organization (HMO) were used to perform a population - based analysis of three 1-year cross-sectional data sets (for the years 1991, 1993, and 1995). Setting and Participants From 1991 to 1995, the number of enrollees aged 2 through 4 years in a Midwestern state Medicaid (MWM) program ranged from 146 369 to 158 060; in a mid-Atlantic state Medicaid (MAM) program, from 34 842 to 54 237; and in an HMO setting in the Northwest, from 19 107 to 19 322. Main Outcome Measures Total, age-specific, and gender-specific utilization prevalences per 1000 enrollees for 3 major psychotropic drug classes (stimulants, antidepressants, and neuroleptics) and 2 leading psychotherapeutic medications (methylphenidate and clonidine); rates of increased use of these drugs from 1991 to 1995, compared across the 3 sites. Results The 1995 rank order of total prevalence in preschoolers (per 1000) in the MWM program was: stimulants (12.3), 90% of which represents methylphenidate (11.1); anti depressants (3.2); clonidine (2,3); and neuroleptics (0.9), A similar rank order was observed for the MAM program, while the HMO had nearly 3 times more clonidine than antidepressant use (1.9 vs 0.7), Sizable increases in prevalence were noted between 1991 and 1995 across the 3 sites for clonidine, stimulants, and antidepressants, while neuroleptic use increased only slightly. Methylphenidate prevalence in 2- through 4-year-olds increased at each site: MWM, 3-fold; MAM, 1.7-fold; and HMO, 3.1-fold. Decreases occurred in the relative proportions of previously dominant psychotherapeutic agents in the stimulant and antidepressant classes, while increases occurred for newer, less established agents. Conclusions In all 3 data sources, psychotropic medications prescribed for preschoolers increased dramatically between 1991 and 1995. The predominance of medications with off-label (unlabeled) indications calls for prospective community-based, multidimensional outcome studies.	Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Kaiser Permanente, Ctr Hlth Res, Portland, OR USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Kaiser Permanente	Zito, JM (corresponding author), Univ Maryland, Sch Pharm, 100 Greene St,Room 5-13, Baltimore, MD 21201 USA.				NIMH NIH HHS [R01 MH55259] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055259] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AHMANN PA, 1993, PEDIATRICS, V91, P1101; Cantwell DP, 1997, J AM ACAD CHILD PSY, V36, P539, DOI 10.1097/00004583-199704000-00017; DAVILLA RR, 1991, CLARIFICATION POLICY; Erickson SJ, 1998, J PAEDIATR CHILD H, V34, P280, DOI 10.1046/j.1440-1754.1998.t01-1-00217.x; Firestone P, 1998, J CHILD ADOL PSYCHOP, V8, P13, DOI 10.1089/cap.1998.8.13; FOXMAN B, 1986, PEDIATRICS, V77, P482; Geller B, 1999, J AM ACAD CHILD PSY, V38, P513, DOI 10.1097/00004583-199905000-00012; Greenhill LL, 1998, CAN J PSYCHIAT, V43, P576, DOI 10.1177/070674379804300604; GRINFELD MJ, 1998, PSYCHIAT TIMES, V15, P69; Hoagwood K, 1996, J AM ACAD CHILD PSY, V35, P1055, DOI 10.1097/00004583-199608000-00017; JENSEN PS, 1994, PSYCHOPHARMACOL BULL, V30, P3; Kappagoda C, 1998, J PAEDIATR CHILD H, V34, P508, DOI 10.1046/j.1440-1754.1998.00301.x; Minde K, 1998, CAN J PSYCHIAT, V43, P571, DOI 10.1177/070674379804300603; PATHIYAL A, 1998, AM SOC CLIN PHARM TH; Perrin JM, 1999, ARCH PEDIAT ADOL MED, V153, P80; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; POPPER CW, 1995, J CHILD ADOL PSYCHOP, V5, P157, DOI 10.1089/cap.1995.5.157; Prince JB, 1996, J AM ACAD CHILD PSY, V35, P599, DOI 10.1097/00004583-199605000-00014; RAPPLEY MD, 1998, PED AC SOC M JOINT S; Safer D.J., 2000, RITALIN THEORY PRACT, P7; Safer DJ, 1996, PEDIATRICS, V98, P1084; Swanson JM, 1995, J CHILD ADOL PSYCHOP, V5, P301, DOI 10.1089/cap.1995.5.301; Traversa G, 1998, J CHILD ADOL PSYCHOP, V8, P175, DOI 10.1089/cap.1998.8.175; Valentine J, 1996, J PAEDIATR CHILD H, V32, P223, DOI 10.1111/j.1440-1754.1996.tb01558.x; Vitiello B, 1997, ARCH GEN PSYCHIAT, V54, P871; Vitiello B, 1998, CAN J PSYCHIAT, V43, P582, DOI 10.1177/070674379804300605; Wilens TE, 1999, J AM ACAD CHILD PSY, V38, P614, DOI 10.1097/00004583-199905000-00025; Zito JM, 1998, J CHILD ADOL PSYCHOP, V8, P99, DOI 10.1089/cap.1998.8.99; ZITO JM, 1998, TRENDS PSYCHOTROPIC	29	634	641	0	35	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					1025	1030		10.1001/jama.283.8.1025	http://dx.doi.org/10.1001/jama.283.8.1025			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284AM	10697062	Bronze			2022-12-28	WOS:000085308600031
J	Bai, T; Pollard, DD; Gao, H				Bai, T; Pollard, DD; Gao, H			Explanation far fracture spacing in layered materials	NATURE			English	Article							BRITTLE FILMS; THIN-FILMS; CRACKING	The spacing of opening-mode fractures in layered materials-such as certain sedimentary rocks and laminated engineering materials-is often proportional to the thickness of the fractured layer(1-4). Experimental studies of this phenomenon(1,5) show that the spacing initially decreases as extensional strain increases in the direction perpendicular to the fractures. But at a certain ratio of spacing to layer thickness, no new fractures form and the additional strain is accommodated by further opening of existing fractures: the spacing then simply scales with layer thickness, which is called fracture saturation(5,6), This is in marked contrast to existing theories of fracture, such as the stress-transfer theory(7,8), which predict that spacing should decrease with increasing strain ad infinitum. Recently(9,10), two of us (T.B. and D.D,P.) have used a combination of numerical simulations and laboratory experiments to show that, with increasing applied stress, the normal stress acting between such fractures undergoes a transition from tensile to compressive, suggesting a cause for fracture saturation. Here we investigate the full stress distribution between such fractures, from which we derive an intuitive physical model of the process of fracture saturation. Such a model should find wide applicability, from geosciences(11-13,14) to engineering(1,2,6,15,16).	Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Bai, T (corresponding author), Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA.	bai@panges.stanford.edu	Bai, Taixu/AAB-4478-2021; Gao, Huajian/F-9360-2010	Gao, Huajian/0000-0002-8656-846X; Pollard, David D/0000-0001-8481-1625; Bai, Taixu/0000-0002-0852-7718				AVESTON J, 1971, PROPERTIES FIBER COM, V15; BAI T, IN PRESS INT J FRACT; Bai TX, 2000, J STRUCT GEOL, V22, P43, DOI 10.1016/S0191-8141(99)00137-6; COX HL, 1952, BRIT J APPL PHYS, V3, P72, DOI 10.1088/0508-3443/3/3/302; GARRETT KW, 1977, J MATER SCI, V12, P157, DOI 10.1007/BF00738481; GROSS MR, 1993, J STRUCT GEOL, V15, P737, DOI 10.1016/0191-8141(93)90059-J; HOBBS DW, 1967, GEOL MAG, V104, P550, DOI 10.1017/S0016756800050226; Hong AP, 1997, J ENG MECH-ASCE, V123, P267, DOI 10.1061/(ASCE)0733-9399(1997)123:3(267); HU MS, 1989, ACTA METALL MATER, V37, P917, DOI 10.1016/0001-6160(89)90018-7; LACHENBRUCH A, 1961, J GEOPHYS RES, V66, P4273, DOI 10.1029/JZ066i012p04273; NARR W, 1991, J STRUCT GEOL, V13, P1037, DOI 10.1016/0191-8141(91)90055-N; National Research Council, 1996, ROCK FRACT FLUID FLO, P551; PARVIZI A, 1978, J MATER SCI, V13, P2131, DOI 10.1007/BF00541666; POLLARD DD, 1988, GEOL SOC AM BULL, V100, P1181, DOI 10.1130/0016-7606(1988)100<1181:PIUJOT>2.3.CO;2; Price N.J, 1966, FAULT JOINT DEV BRIT, P176; Reddish D.J., 1990, MIN SCI TECHNOL, V10, P71, DOI [10.1016/0167-9031(90)90864-O, DOI 10.1016/0167-9031(90)90864-O]; THOULESS MD, 1990, J AM CERAM SOC, V73, P2144, DOI 10.1111/j.1151-2916.1990.tb05290.x; THOULESS MD, 1989, THIN SOLID FILMS, V181, P397, DOI 10.1016/0040-6090(89)90508-7; THOULESS MD, 1992, ACTA METALL MATER, V40, P1287, DOI 10.1016/0956-7151(92)90429-I; Timoshenko SP., 1970, THEORY ELASTICITY 3, P567; WAWRZYNEK PA, 1987, THEOR APPL FRACT MEC, V8, P137, DOI 10.1016/0167-8442(87)90007-3; WU HQ, 1995, J STRUCT GEOL, V17, P887, DOI 10.1016/0191-8141(94)00099-L	22	193	204	8	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					753	756		10.1038/35001550	http://dx.doi.org/10.1038/35001550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693800				2022-12-28	WOS:000085423100047
J	Nishita, M; Hashimoto, MK; Ogata, S; Laurent, MN; Ueno, N; Shibuya, H; Cho, KWY				Nishita, M; Hashimoto, MK; Ogata, S; Laurent, MN; Ueno, N; Shibuya, H; Cho, KWY			Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer	NATURE			English	Article							AXIS SPECIFICATION; SIGNALING PATHWAYS; XENOPUS MESODERM; GENE-EXPRESSION; SMAD PROTEINS; WINGLESS; PATTERN; ESTABLISHMENT; ANTAGONISM; INDUCTION	Members of the Wnt and TGF-beta superfamilies regulate both cell fate and proliferation during development and tissue maintenance(1-3). In the early amphibian embryo, the Wnt and TGF-beta superfamily signalling cascades are required for the establishment of a dorsal signalling centre, Spemann's organizer(4-8). Intracellular proteins of both pathways, upon activation, translocate to the nucleus to participate in transcription. Here we show that beta-catenin and Lef1/Tcf, which are downstream components of the Wnt signalling cascade, form a complex with Smad4, an essential mediator of signals initiated by members of the TGF-beta growth factor superfamily. In Xenopus, this interaction directly and synergistically affects expression of the twin (Xtwn) gene during formation of the organizer. This is, to our knowledge, the first demonstration of a physical interaction between TGF-beta and Wnt signalling components in vivo.	Natl Inst Basic Biol, Dept Dev Biol, Div Morphogenesis, Okazaki, Aichi 4448585, Japan; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92617 USA	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of California System; University of California Irvine	Shibuya, H (corresponding author), Natl Inst Basic Biol, Dept Dev Biol, Div Morphogenesis, Okazaki, Aichi 4448585, Japan.			Ueno, Naoto/0000-0002-8375-2317				Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Candia AF, 1997, DEVELOPMENT, V124, P4467; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Crease DJ, 1998, P NATL ACAD SCI USA, V95, P4398, DOI 10.1073/pnas.95.8.4398; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoodless PA, 1999, DEV BIOL, V207, P364, DOI 10.1006/dbio.1998.9168; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; JONES CM, 1992, DEVELOPMENT, V115, P639; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Laurent MN, 1997, DEVELOPMENT, V124, P4905; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Theisen H, 1996, DEVELOPMENT, V122, P3939; Watabe T, 1995, GENE DEV, V9, P3038, DOI 10.1101/gad.9.24.3038; WATERMAN M L, 1990, New Biologist, V2, P621; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	29	386	399	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					781	785		10.1038/35001602	http://dx.doi.org/10.1038/35001602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693808	Green Submitted			2022-12-28	WOS:000085423100055
J	Glynne, R; Akkaraju, S; Healy, JI; Rayner, J; Goodnow, CC; Mack, DH				Glynne, R; Akkaraju, S; Healy, JI; Rayner, J; Goodnow, CC; Mack, DH			How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis	NATURE			English	Article							TRANSCRIPTION FACTOR; CYCLOSPORINE-A; LYMPHOCYTES; ACTIVATION; RECEPTOR; PROTEIN; GENE; IMMUNOGLOBULIN; PROLIFERATION; EXPRESSION	Therapy for transplant rejection, autoimmune disease and allergy must target mature lymphocytes that have escaped censoring during their development. FK506 and cyclosporin are immunosuppressants which block three antigen-receptor signalling pathways (NFAT, NF kappa B and JNK), through inhibition of calcineurin(1), and inhibit mature lymphocyte proliferation to antigen(2-4) Neither drug induces long-lived tolerance in vivo, however, necessitating chronic use with adverse side effects. Physiological mechanisms of peripheral tolerance to self-antigens provide an opportunity to emulate these processes pharmacologically. Here we use gene-expression arrays to provide a molecular explanation for the loss of mitogenic response in peripheral B-cell anergy, one aspect of immunological tolerance(5). Self-antigen induces a set of genes that includes negative regulators of signalling and transcription but not genes that promote proliferation. FK506 interferes with calcium-dependent components of the tolerance response and blocks an unexpectedly small fraction of the activation response. Many genes that were not previously connected to self-tolerance are revealed, and our findings provide a molecular fingerprint for the development of improved immunosuppressants that prevent lymphocyte activation without blocking peripheral tolerance.	Stanford Univ, Beckman Ctr, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, Canberra, ACT 2601, Australia; Eos Biotechnol, S San Francisco, CA 94080 USA	Stanford University; Australian National University; John Curtin School of Medical Research	Goodnow, CC (corresponding author), Stanford Univ, Beckman Ctr, Dept Microbiol & Immunol, Stanford, CA 94305 USA.		Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155				Adachi T, 1998, J IMMUNOL, V160, P4662; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Grumont RJ, 1996, MOL CELL BIOL, V16, P2913; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Healy JI, 1998, CIBA F SYMP, V215, P137; HONG JX, 1993, J IMMUNOL, V150, P3895; HUO L, 1995, J IMMUNOL, V154, P3300; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; MITTELSTADT PR, 1993, J IMMUNOL, V150, P4822; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; MONROE JG, 1988, J IMMUNOL, V140, P1454; Newton JS, 1996, EUR J IMMUNOL, V26, P811, DOI 10.1002/eji.1830260413; Pfisterer P, 1996, MOL CELL BIOL, V16, P6160; Rathmell JC, 1998, J EXP MED, V188, P651, DOI 10.1084/jem.188.4.651; SEYFERT VL, 1989, MOL CELL BIOL, V9, P2083, DOI 10.1128/MCB.9.5.2083; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; Solvason N, 1996, J EXP MED, V184, P407, DOI 10.1084/jem.184.2.407; Svaren J, 1996, MOL CELL BIOL, V16, P3545; WICKER LS, 1990, EUR J IMMUNOL, V20, P2277, DOI 10.1002/eji.1830201017	30	139	144	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					672	676		10.1038/35001102	http://dx.doi.org/10.1038/35001102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688206				2022-12-28	WOS:000085288200058
J	Ito, K; Uno, M; Nakamura, Y				Ito, K; Uno, M; Nakamura, Y			A tripeptide 'anticodon' deciphers stop codons in messenger RNA	NATURE			English	Article							RELEASE FACTOR-2; AMINO-ACID; ESCHERICHIA-COLI; PEPTIDE; TRANSLATION; SUPPRESSOR; MUTANT	The two translational release factors of prokaryotes, RF1 and RF2, catalyse the termination of polypeptide synthesis at UAG/UAA and UGA/UAA stop codons, respectively(1-3). However, how these polypeptide release factors read both non-identical and identical stop codons is puzzling(4), Here we describe the basis of this recognition. Swaps of each of the conserved domains between RF1 and RF2 in an RF1-RF2. hybrid led to the identification of a domain that could switch recognition specificity. A genetic selection among clones encoding random variants of this domain showed that the tripeptides Pro-Ala-Thr and Ser-Pro-Phe determine release-factor specificity in vivo in RF1 and RF2, respectively. An in vitro release study of tripeptide variants indicated that the first and third amino acids independently discriminate the second and third purine bases, respectively. Analysis with stop codons containing base analogues indicated that the C2 amino group of purine may be the primary target of discrimination of G from A. These findings show that the discriminator tripeptide of bacterial release factors is functionally equivalent to that of the anticodon of transfer RNA, irrespective of the difference between protein and RNA.	Univ Tokyo, Inst Med Sci, Dept Tumor Biol, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Dept Tumor Biol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	nak@ims.u-tokyo.ac.jp	Uno, Masatoshi/V-7934-2019	Ito, Koichi/0000-0002-2042-405X				AULD DS, 1995, SCIENCE, V267, P1994, DOI 10.1126/science.7701322; Buckingham RH, 1997, MOL MICROBIOL, V24, P449, DOI 10.1046/j.1365-2958.1997.3711734.x; GRICK FHC, 1966, J MOL BIOL, V19, P548; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; KAWAKAMI K, 1988, J BACTERIOL, V170, P5378, DOI 10.1128/jb.170.11.5378-5381.1988; MOFFAT JG, 1994, J BIOL CHEM, V269, P18899; MURGOLA EJ, 1988, P NATL ACAD SCI USA, V85, P4162, DOI 10.1073/pnas.85.12.4162; Nakamura Y, 1998, GENES CELLS, V3, P265, DOI 10.1046/j.1365-2443.1998.00191.x; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; RYDEN SM, 1984, MOL GEN GENET, V193, P38, DOI 10.1007/BF00327411; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; SOLL D, 1967, J MOL BIOL, V29, P113, DOI 10.1016/0022-2836(67)90184-2; Uno M, 1996, BIOCHIMIE, V78, P935, DOI 10.1016/S0300-9084(97)86715-6; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Yoshimura K, 1999, GENES CELLS, V4, P253, DOI 10.1046/j.1365-2443.1999.00260.x	16	218	226	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					680	684		10.1038/35001115	http://dx.doi.org/10.1038/35001115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688208				2022-12-28	WOS:000085288200060
J	Smil, V				Smil, V			Laying down the law	NATURE			English	Editorial Material									Univ Manitoba, Dept Geog, Winnipeg, MB, Canada	University of Manitoba	Smil, V (corresponding author), Univ Manitoba, Dept Geog, Winnipeg, MB, Canada.							West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	1	29	29	0	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					597	597		10.1038/35001159	http://dx.doi.org/10.1038/35001159			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688176	Bronze			2022-12-28	WOS:000085288200027
J	Gubitz, G; Sandercock, P				Gubitz, G; Sandercock, P			Extracts from "Clinical evidence" - Acute ischaemic stroke	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE CEREBROVASCULAR-DISEASE; ACUTE ISCHEMIC STROKE; PROJECT 1981-86; BLOOD-PRESSURE; COMMUNITY; TRIAL; HEMORRHAGE; NIMODIPINE		Queen Elizabeth 2 Hlth Sci Ctr, Div Neurol, Halifax, NS B3H 3A7, Canada; Univ Edinburgh, Dept Clin Neurosci, Neurosci Trials Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Queen Elizabeth II Health Sciences Centre; University of Edinburgh	Gubitz, G (corresponding author), Queen Elizabeth 2 Hlth Sci Ctr, Div Neurol, Room 3833,NHI Site,1796 Summer St, Halifax, NS B3H 3A7, Canada.	ggubitz@is.dal.ca	sandercock, peter/GQI-3167-2022	sandercock, peter/0000-0001-8484-0135	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P824, DOI 10.1136/jnnp.53.10.824; BAMFORD J, 1988, J NEUROL NEUROSUR PS, V51, P1373, DOI 10.1136/jnnp.51.11.1373; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; BARER DH, 1988, BRIT MED J, V296, P737, DOI 10.1136/bmj.296.6624.737; Bath FJ, 1997, CEREBROVASC DIS, V7, P205, DOI 10.1159/000108192; *BLOOD PRESS AC ST, 1999, COCHR LIB; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Hankey GJ, 1997, STROKE, V28, P2126, DOI 10.1161/01.STR.28.11.2126; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; HORN J, 1998, CEREBROVASC DIS, V8, P27; Kwiatkowski Thomas G., 1999, New England Journal of Medicine, V340, P1781, DOI 10.1056/NEJM199906103402302; MOHR JP, 1994, CEREBROVASC DIS, V4, P197, DOI 10.1159/000108482; PRASAD K, 1999, COCHRANE LIB; Rodgers A, 1996, BRIT MED J, V313, P147, DOI 10.1136/bmj.313.7050.147; Sandercock P, 1997, LANCET, V349, P1569; SANDERCOCK P, 1990, COCHRANE LIB; SANDERCOCK P, 1999, COCHRANE LIB; Schrader J, 1998, BASIC RES CARDIOL, V93, P69; SLATTERY J, 1995, GUT, V37, P509, DOI 10.1136/gut.37.4.509; Stegmayr B, 1999, STROKE, V30, P709, DOI 10.1161/01.STR.30.4.709; *STROK UN TRIAL CO, 1999, COCHR LIB; SUDLOW C, 1999, CLIN EVIDENCE, V2, P113; WADE DT, 1987, J NEUROL NEUROSUR PS, V50, P177, DOI 10.1136/jnnp.50.2.177; WAHLGREN NG, 1994, CEREBROVASC DIS, V4, P204, DOI 10.1159/000108483; Wardlaw JM, 1999, COCHRANE LIB; WARLOW CP, 1996, STROKE PRACTICAL GUI, P435	28	17	34	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					692	696		10.1136/bmj.320.7236.692	http://dx.doi.org/10.1136/bmj.320.7236.692			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710582	Green Published			2022-12-28	WOS:000085895300024
J	Raoult, D; Birg, ML; La Scola, B; Fournier, PE; Enea, M; Lepidi, H; Roux, V; Piette, JC; Vandenesch, F; Vital-Durand, D; Marrie, TJ				Raoult, D; Birg, ML; La Scola, B; Fournier, PE; Enea, M; Lepidi, H; Roux, V; Piette, JC; Vandenesch, F; Vital-Durand, D; Marrie, TJ			Cultivation of the bacillus of Whipple's disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIAGNOSIS; PATIENT; FEVER; BLOOD	Background: Whipple's disease is a systemic bacterial infection, but to date no isolate of the bacterium has been established in subculture, and no strain of this bacterium has been available for study. Methods: Using specimens from the mitral valve of a patient with endocarditis due to Whipple's disease, we isolated and propagated a bacterium by inoculation in a human fibroblast cell line (HEL) with the use of a shell-vial assay. We tested serum samples from our patient, other patients with Whipple's disease, and control subjects for the presence of antibodies to this bacterium. Results: The bacterium of Whipple's disease was grown successfully in HEL cells, and we established subcultures of the isolate. Indirect immunofluorescence assays showed that the patient's serum reacted specifically against the bacterium. Seven of 9 serum samples from patients with Whipple's disease had IgM antibody titers of 1:50 or more, as compared with 3 of 40 samples from the control subjects (P<0.001). Polyclonal antibodies against the bacterium were generated by inoculation of the microorganism into mice and were used to detect bacteria in the excised cardiac tissue from our patient on immunohistochemical analysis. The 16S ribosomal RNA gene of the cultured bacterium was identical to the sequence for Tropheryma whippelii identified previously in tissue samples from patients with Whipple's disease. The strain we have grown is available in the French National Collection. Conclusions: We cultivated the bacterium of Whipple's disease, detected specific antibodies in tissue from the source patient, and generated specific antibodies in mice to be used in the immunodetection of the microorganism in tissues. The development of a serologic test for Whipple's disease may now be possible. (N Engl J Med 2000;342:620-5.) (C)2000, Massachusetts Medical Society.	Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS UPRESA 6020, F-13385 Marseille, France; Univ Alberta, Dept Med, Edmonton, AB, Canada; Ctr Hosp Lyon Sud, Serv Med Interne, Lyon, France; Hop Louis Pradel, Bacteriol Lab, Lyon, France; Grp Hosp Pitie Salpetriere, Serv Med Interne, F-75634 Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; University of Alberta; CHU Lyon; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Raoult, D (corresponding author), Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS UPRESA 6020, 27 Blvd Jean Moulin, F-13385 Marseille, France.		Fournier, Pierre-Edouard/AAC-6155-2021; RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016; Vandenesch, Francois/C-7209-2014	Fournier, Pierre-Edouard/0000-0001-8463-8885; RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704; Vandenesch, Francois/0000-0001-9412-7106				BLACKSCHAFFER B, 1949, P SOC EXP BIOL MED, V72, P225; BOSTWICK DG, 1981, NEW ENGL J MED, V305, P995, DOI 10.1056/NEJM198110223051708; Celard M, 1999, CLIN INFECT DIS, V29, P1348, DOI 10.1086/313477; GIMENEZ DF, 1964, STAIN TECHNOL, V39, P135, DOI 10.3109/10520296409061219; Hinrikson HP, 1999, INT J SYST BACTERIOL, V49, P1701, DOI 10.1099/00207713-49-4-1701; La Scola B, 1998, J CLIN MICROBIOL, V36, P2847, DOI 10.1128/JCM.36.10.2847-2852.1998; La Scola B, 1999, J CLIN MICROBIOL, V37, P1899, DOI 10.1128/JCM.37.6.1899-1905.1999; La Scola B, 1999, J CLIN MICROBIOL, V37, P785, DOI 10.1128/JCM.37.3.785-787.1999; LaScola B, 1997, CLIN INFECT DIS, V24, P1161, DOI 10.1086/513631; LaScola B, 1996, J CLIN MICROBIOL, V34, P2722, DOI 10.1128/JCM.34.11.2722-2727.1996; MAIZEL H, 1970, MEDICINE, V49, P175, DOI 10.1097/00005792-197005000-00001; MARSHALL B, 1983, LANCET, V1, P1273; MURRAY RGE, 1994, INT J SYST BACTERIOL, V44, P174, DOI 10.1099/00207713-44-1-174; Ramzan NN, 1997, ANN INTERN MED, V126, P520, DOI 10.7326/0003-4819-126-7-199704010-00004; RATLIFF NB, 1984, NEW ENGL J MED, V311, P902, DOI 10.1056/NEJM198410043111407; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Relman DA, 1997, J INFECT DIS, V176, P752, DOI 10.1086/514100; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; ROSE AG, 1978, THORAX, V33, P500, DOI 10.1136/thx.33.4.500; Schoedon G, 1997, J INFECT DIS, V176, P672, DOI 10.1086/514089; SHEPARD CC, 1960, J EXP MED, V112, P445, DOI 10.1084/jem.112.3.445; SILVA MT, 1985, J GEN MICROBIOL, V131, P1001; SLATER LN, 1990, NEW ENGL J MED, V323, P1587, DOI 10.1056/NEJM199012063232303; VITALDURAND D, 1997, MEDICINE, V76, P170; WEISS E, 1960, P SOC EXP BIOL MED, V103, P691, DOI 10.3181/00379727-103-25637; Whipple GH, 1907, B JOHNS HOPKINS HOSP, V18, P382; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z; Woods GL, 1996, CLIN MICROBIOL REV, V9, P382, DOI 10.1128/CMR.9.3.382; YARDLEY JH, 1961, B JOHNS HOPKINS HOSP, V109, P80	29	300	316	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					620	625		10.1056/NEJM200003023420903	http://dx.doi.org/10.1056/NEJM200003023420903			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10699161	Bronze			2022-12-28	WOS:000085575500003
J	Cantor, G				Cantor, G			Fighting the wrong battle - Scientists who scoff at religious belief miss the point and damage their cause	NATURE			English	Editorial Material									Univ Leeds, Sch Philosophy, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Cantor, G (corresponding author), Univ Leeds, Sch Philosophy, Leeds LS2 9JT, W Yorkshire, England.								0	2	2	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					831	831		10.1038/35002681	http://dx.doi.org/10.1038/35002681			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	288JG	10706259	Bronze			2022-12-28	WOS:000085559200027
J	Gavrilets, S				Gavrilets, S			Rapid evolution of reproductive barriers driven by sexual conflict	NATURE			English	Article							INTERSPECIFIC POLLEN COMPETITION; SELECTION; SPECIATION; REARRANGEMENTS; POLYMORPHISM; CHASE	A growing amount of experimental data indicates extremely rapid evolution of traits and proteins related to fertilization in many diverging taxa(1-3). These data come from studies of sperm or pollen competition between closely related species(3-6), and from molecular studies of fertilization proteins(2,7-10). The positive selection for evolutionary novelty that appears to be acting on fertilization systems seems paradoxical because successful reproduction requires the close matching of female and male traits. It has been suggested(11-13) that perpetual coevolution between the sexes can result from sexual conflict in mating. Sexual conflict occurs when characteristics that enhance the reproductive success of one sex reduce the fitness of the other sex(14). Numerous examples of sexual conflict resulting from sensory exploitation, polyspermy and the cost of mating have been discussed in detail(1-3,14,15). The potential for coevolution due to such conflict has been evaluated experimentally(15,16). Here I develop a simple mathematical model describing coevolutionary dynamics of male and female traits involved in reproduction. The model shows that continual change in such traits at a constant speed is expected whenever females (or eggs) experience fitness loss from having too many compatible males (or sperms). The plausibility of runaway coevolution increases with increasing population size. Rapid evolution of reproductive barriers driven by sexual conflict may explain increased speciation rates after colonization of new habitats ('adaptive radiation') and high species richness in resource-rich environments.	Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; Univ Tennessee, Dept Math, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Gavrilets, S (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	sergey@tiem.utk.edu	Langerhans, R. Brian/A-7205-2009					AGUADE M, 1992, GENETICS, V132, P755; ARNOLD ML, 1993, J HERED, V84, P13, DOI 10.1093/oxfordjournals.jhered.a111269; ARNQVIST G, UNPUB P R SOC LOND B; ARNQVIST G, UNPUB ANIM BEHAV; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; BARTON NH, 1991, GENETICS, V127, P229; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Gavrilets S, 1997, J THEOR BIOL, V186, P527, DOI 10.1006/jtbi.1997.0426; Gavrilets S, 1999, AM NAT, V154, P1, DOI 10.1086/303217; Gavrilets S, 1997, TRENDS ECOL EVOL, V12, P307, DOI 10.1016/S0169-5347(97)01098-7; GAVRILETS S, 1995, GENET RES, V65, P63, DOI 10.1017/S0016672300033012; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Howard DJ, 1998, ENDLESS FORMS, P279; IWASA Y, 1995, NATURE, V377, P420, DOI 10.1038/377420a0; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Palumbi SR, 1998, ENDLESS FORMS, P271; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Rice WR, 1998, ENDLESS FORMS, P261; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; RIESEBERG LH, 1995, AM J BOT, V82, P515, DOI 10.2307/2445699; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schluter D, 1998, ENDLESS FORMS, P114; Stockley P, 1997, TRENDS ECOL EVOL, V12, P154, DOI 10.1016/S0169-5347(97)01000-8; Vacquier VD, 1993, ZYGOTE, V1, P181, DOI 10.1017/S0967199400001465; WADE MJ, 1994, HEREDITY, V72, P163, DOI 10.1038/hdy.1994.23; WALSH JB, 1982, AM NAT, V120, P510, DOI 10.1086/284008	30	414	429	0	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					886	889		10.1038/35002564	http://dx.doi.org/10.1038/35002564			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706284				2022-12-28	WOS:000085559200055
J	Holmgren, M; Wagg, J; Bezanilla, F; Rakowski, RF; De Weer, P; Gadsby, DC				Holmgren, M; Wagg, J; Bezanilla, F; Rakowski, RF; De Weer, P; Gadsby, DC			Three distinct and sequential steps in the release of sodium ions by the Na+/K+-ATPase	NATURE			English	Article							VOLTAGE DEPENDENCE; NA,K PUMP; TRANSLOCATION; CHANNEL; NA,K-ATPASE; PATHWAY	The Na+/K+ pump, a P-type ion-motive ATPase, exports three sodium ions and then imports two potassium ions in each transport cycle. Ions on one side of the membrane bind to sites within the protein and become temporarily occluded (trapped within the protein) before being released to the other side(1,2), but details of these occlusion and de-occlusion transitions remain obscure for all P-type ATPases, If it is deprived of potassium ions, the Na+/K+ pump is restricted to sodium translocation steps(3), at least one involving charge movement through the membrane's electric field(4,5). Changes in membrane potential alter the rate of such electrogenic reactions and so shift the distribution of enzyme conformations. Here we use high-speed voltage jumps to initiate this redistribution and show that the resulting pre-steady-state charge movements relax in three identifiable phases, apparently reflecting de-occlusion and release of the three sodium ions. Reciprocal relationships among the sizes of these three charge components show that the three sodium ions are de-occluded and released to the extracellular solution one at a time, in a strict order.	Marine Biol Lab, Woods Hole, MA 02543 USA	Marine Biological Laboratory - Woods Hole	Gadsby, DC (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, 1230 York Ave, New York, NY 10021 USA.							BEAUGE LA, 1979, NATURE, V280, P510, DOI 10.1038/280510a0; BEZANILLA F, 1982, NATURE, V296, P657, DOI 10.1038/296657a0; FENDLER K, 1985, EMBO J, V4, P3079, DOI 10.1002/j.1460-2075.1985.tb04048.x; FORBUSH B, 1987, J BIOL CHEM, V262, P11116; Friedrich T, 1997, BIOPHYS J, V73, P186, DOI 10.1016/S0006-3495(97)78059-7; GADSBY DC, 1993, SCIENCE, V260, P100, DOI 10.1126/science.7682009; GARRAHAM PJ, 1967, J PHYSL, V192, P161; HEYSE S, 1994, J GEN PHYSIOL, V104, P197, DOI 10.1085/jgp.104.2.197; HILGEMANN DW, 1994, SCIENCE, V263, P1429, DOI 10.1126/science.8128223; INESI G, 1987, J BIOL CHEM, V262, P16338; LAIGER P, 1991, ELECTROGENIC ION PUM; LAUGER P, 1988, BIOCHIM BIOPHYS ACTA, V944, P451, DOI 10.1016/0005-2736(88)90516-0; LU CC, 1995, P NATL ACAD SCI USA, V92, P11220, DOI 10.1073/pnas.92.24.11220; NAKAO M, 1986, NATURE, V323, P628, DOI 10.1038/323628a0; POST RL, 1972, J BIOL CHEM, V247, P6350; RAKOWSKI RF, 1989, J GEN PHYSIOL, V93, P903, DOI 10.1085/jgp.93.5.903; WUDDEL I, 1995, BIOPHYS J, V69, P909, DOI 10.1016/S0006-3495(95)79965-9	17	137	139	5	23	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					898	901		10.1038/35002599	http://dx.doi.org/10.1038/35002599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706288				2022-12-28	WOS:000085559200059
J	Mauz-Korholz, C; Harms, D; Calaminus, G; Gobel, U				Mauz-Korholz, C; Harms, D; Calaminus, G; Gobel, U		Maligne Keimzelltumoren Study Grp	Primary chemotherapy and conservative surgery for vaginal yolk-sac tumour	LANCET			English	Article								Vaginal yolk-sac tumours are usually incurable unless radical surgery is done. We have shown, however, that, neoadjuvant cisplatin-based chemotherapy with conservative surgery is effective in the management of these tumours, and results in a good survival rate, unlike germ-cell tumours of other origin.	Univ Dusseldorf, Med Ctr, D-40225 Dusseldorf, Germany; Univ Kiel, Med Ctr, Inst Paidopathol, Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Gobel, U (corresponding author), Univ Dusseldorf, Med Ctr, Moorenstr 5, D-40225 Dusseldorf, Germany.		Mauz-Koerholz, Christine/AAX-4349-2020					GOBEL U, 1990, CRIT REV ONCOL HEMAT, V10, P89; Gobel U, 1998, MED PEDIATR ONCOL, V31, P8; LEVERGER G, 1983, ARCH FR PEDIATR, V40, P85; YOUNG RH, 1984, GYNECOL ONCOL, V18, P380, DOI 10.1016/0090-8258(84)90050-7	4	23	23	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					625	625		10.1016/S0140-6736(99)05215-0	http://dx.doi.org/10.1016/S0140-6736(99)05215-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696987				2022-12-28	WOS:000085615400018
J	Mullen, PE; Burgess, P; Wallace, C; Palmer, S; Ruschena, D				Mullen, PE; Burgess, P; Wallace, C; Palmer, S; Ruschena, D			Community care and criminal offending in schizophrenia	LANCET			English	Article							MENTAL DISORDER; VIOLENCE	Background The introduction of community care in psychiatry is widely thought to have resulted in more offending among the seriously mentally ill. This view affects public policy towards and public perceptions of such people. We investigated the association between the introduction of community care and the pattern of offending in patients with schizophrenia in Victoria, Australia. Methods We established patterns of offending from criminal records in two groups of patients with schizophrenia over their lifetime to date and in the 10 years after their first hospital admission. One group was first admitted in 1975 before major deinstitutionalisation in Victoria, the second group in 1985 when community care was becoming the norm. Each patient was matched to a control, by age, sex, and place of residence to allow for changing patterns of offending over time in the wider community. Findings Compared with controls, significantly more of those with schizophrenia were convicted at least once for ail categories of criminal offending except sexual offences (relative risk of offending in 1975=3.5 [95% CI 2.0-5.5), p=0.001, in 1985=3.0 [1.9-4.9], p=0.001). Among men, more offences were committed in the 1985 group than the 1975 group, but this was matched by a similar increase in convictions among the community controls. Those with schizophrenia who had also received treatment for substance abuse accounted for a disproportionate amount of offending. Analysis of admission data for the patients and the total population of admissions with schizophrenia showed that although there had been an increase of 74 days per annum spent in the community for each of the study population as a whole, first admissions spent only 1 more day in the community in 1985 compared with 1975. Interpretation Increased rates in criminal conviction for those with schizophrenia over the last 20 years are consistent with change in the pattern of offending in the general community. Deinstitutionalisation does not adequately explain such change. Mental-health services should aim to reduce the raised rates of criminal offending associated with schizophrenia, but turning the clock back on community care is unlikely to contribute towards any positive outcome.	Victorian Inst Forens Mental Hlth, Fairfield, Vic 3084, Australia; Mental Hlth Res Inst Victoria, Parkville, Vic, Australia; Monash Univ, Dept Psychol Med, Clayton, Vic 3168, Australia	Monash University	Mullen, PE (corresponding author), Victorian Inst Forens Mental Hlth, Locked Bag 10, Fairfield, Vic 3084, Australia.	pmullen@vicnet.net.au	Burgess, Philip/ABD-3040-2020	Burgess, Philip/0000-0001-7184-0363				BURGESS PM, 1992, SOC PSYCH PSYCH EPID, V27, P83, DOI 10.1007/BF00788511; EATON WW, 1992, SCHIZOPHRENIA BULL, V18, P217, DOI 10.1093/schbul/18.2.217; HALL C, 1998, DAILY TELEGRAPH  FEB; *HLTH COMM SERV, 1993, VICT HLTH REF PSYCH; *HLTH COMM SERV, 1996, VICT MENT HLTH SERV; Krupinski J, 1982, SPECIAL PUBLICATION, V12; LINDQVIST P, 1990, BRIT J PSYCHIAT, V157, P345, DOI 10.1192/bjp.157.3.345; Modestin J, 1996, SCHIZOPHRENIA BULL, V22, P69, DOI 10.1093/schbul/22.1.69; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; TAYLOR PJ, 1984, BRIT MED J, V288, P1945, DOI 10.1136/bmj.288.6435.1945; Taylor PJ, 1999, BRIT J PSYCHIAT, V174, P9, DOI 10.1192/bjp.174.1.9; TAYLOR PJ, 1993, CRIME MENTAL DISORDE, P63; Torrey EF, 1995, AM J PUBLIC HEALTH, V85, P1611, DOI 10.2105/AJPH.85.12.1611; Wallace C, 1998, BRIT J PSYCHIAT, V172, P477, DOI 10.1192/bjp.172.6.477; WESSELY S, 1994, PSYCHOL MED, V24, P483, DOI 10.1017/S0033291700027458	16	141	143	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					614	617		10.1016/S0140-6736(99)05082-5	http://dx.doi.org/10.1016/S0140-6736(99)05082-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	289HX	10696982				2022-12-28	WOS:000085615400013
J	Capy, P				Capy, P			Evolution - Is bigger better in cricket?	SCIENCE			English	Editorial Material							DNA; GENOME		CNRS, Lab Populat Genet & Evolut, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Capy, P (corresponding author), CNRS, Lab Populat Genet & Evolut, F-91198 Gif Sur Yvette, France.							BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; CAPY P, 1997, DYNAMICS EVOLUTION T; Cavalier-Smith T., 1985, P69; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; EICKBUSH TH, 1992, NEW BIOL, V4, P430; GRAUR D, 1989, J MOL EVOL, V28, P279, DOI 10.1007/BF02103423; JOHN B, 1988, EUKATYOTIC GENOME DV; Li W. H, 1997, MOL EVOLUTION; NOVACEK MJ, 1989, TRENDS ECOL EVOL, V4, P285, DOI 10.1016/0169-5347(89)90020-7; Petrov DA, 1997, GENE, V205, P279, DOI 10.1016/S0378-1119(97)00516-7; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765	12	8	9	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2000	287	5455					985	986		10.1126/science.287.5455.985	http://dx.doi.org/10.1126/science.287.5455.985			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282WU	10691573				2022-12-28	WOS:000085245400033
J	Bentley, CR				Bentley, CR			Antarctica - Stirring the icy waters	NATURE			English	Editorial Material							LAKE		Univ Wisconsin, Geophys & Polar Res Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Bentley, CR (corresponding author), Univ Wisconsin, Geophys & Polar Res Ctr, 1215 W Dayton St, Madison, WI 53706 USA.							Abyzov SS, 1998, MICROBIOLOGY+, V67, P451; Bentley C, 1996, NATURE, V381, P645, DOI 10.1038/381645a0; CARSEY F, LAKE VOSTOK CURIOSIT, P21; EllisEvans JC, 1996, NATURE, V381, P644, DOI 10.1038/381644a0; Jouzel J, 1999, SCIENCE, V286, P2138, DOI 10.1126/science.286.5447.2138; Kapitsa AP, 1996, NATURE, V381, P684, DOI 10.1038/381684a0; Karl DM, 1999, SCIENCE, V286, P2144, DOI 10.1126/science.286.5447.2144; MAYER C, IN PRESS J GLACIOL; Priscu JC, 1999, SCIENCE, V286, P2141, DOI 10.1126/science.286.5447.2141; Siegert MJ, 2000, NATURE, V403, P643, DOI 10.1038/35001049; Siegert MJ, 1996, ANTARCT SCI, V8, P281, DOI 10.1017/S0954102096000405	11	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					610	611		10.1038/35001184	http://dx.doi.org/10.1038/35001184			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688183				2022-12-28	WOS:000085288200035
J	Egan, G				Egan, G			Only connect - An elegant demonstration that the universe is made of quantum graphs	NATURE			English	Editorial Material													Egan, Gary F./A-1381-2013						0	0	0	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					599	599		10.1038/35001162	http://dx.doi.org/10.1038/35001162			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688177	Bronze			2022-12-28	WOS:000085288200028
